Clustering O 0 0.13390547037124634
of O 0 0.043215688318014145
missense O 0 0.14499728381633759
mutations O 0 0.037990618497133255
in O 0 0.016220971941947937
the O 0 0.03971441835165024
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 0.034429460763931274
in O 0 0.013008998706936836
a O 0 0.026883160695433617
sporadic B-Disease 1 0.9776291847229004
T I-Disease 1 0.9999998807907104
- I-Disease 1 1.0
cell I-Disease 1 0.9996899366378784
leukaemia I-Disease 1 0.9999998807907104
. O 0 0.06538442522287369

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.052724581211805344
A B-Disease 1 0.9999289512634277
- I-Disease 1 1.0
T I-Disease 1 0.9999997615814209
) O 0 0.01475419569760561
is O 0 0.008837229572236538
a O 0 0.019445614889264107
recessive B-Disease 1 0.9996101260185242
multi I-Disease 1 0.9999996423721313
- I-Disease 1 1.0
system I-Disease 1 0.9997336268424988
disorder I-Disease 1 1.0
caused O 1 0.9975501894950867
by O 0 0.025910502299666405
mutations O 0 0.027388757094740868
in O 0 0.010917305946350098
the O 0 0.02068398892879486
ATM O 1 0.5988419651985168
gene O 0 0.02717057429254055
at O 0 0.027973463758826256
11q22 O 1 0.999144434928894
- O 1 0.9999923706054688
q23 O 1 0.9998012185096741
( O 0 0.05513215437531471
ref O 1 0.9967723488807678
. O 0 0.025206781923770905
3 O 0 0.038305047899484634
) O 0 0.029592178761959076
. O 0 0.031997982412576675

The O 0 0.050737541168928146
risk O 0 0.11566442996263504
of O 0 0.07446567714214325
cancer B-Disease 1 1.0
, O 0 0.139750674366951
especially O 0 0.4707774817943573
lymphoid B-Disease 1 1.0
neoplasias I-Disease 1 0.9999904632568359
, O 0 0.022191666066646576
is O 0 0.013822339475154877
substantially O 0 0.027156595140695572
elevated O 1 0.944754958152771
in O 0 0.017171429470181465
A B-Disease 1 0.9999395608901978
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.999972939491272
and O 0 0.018277963623404503
has O 0 0.016750631853938103
long O 0 0.022962603718042374
been O 0 0.015884902328252792
associated O 0 0.026019807904958725
with O 0 0.03851858153939247
chromosomal O 1 0.9999988079071045
instability O 1 0.9999967813491821
. O 0 0.07888705283403397

By O 0 0.05302757769823074
analysing O 1 0.8046389222145081
tumour B-Disease 1 1.0
DNA O 0 0.053488243371248245
from O 0 0.023962778970599174
patients O 0 0.05981512367725372
with O 0 0.019848469644784927
sporadic B-Disease 1 0.9963485598564148
T I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999994039535522
cell I-Disease 1 0.9501376748085022
prolymphocytic I-Disease 1 0.9999995231628418
leukaemia I-Disease 1 1.0
( O 1 0.8878684639930725
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
PLL I-Disease 1 0.999998927116394
) O 0 0.023672128096222878
, O 0 0.013916709460318089
a O 0 0.021479815244674683
rare O 0 0.05257079005241394
clonal B-Disease 1 0.9999828338623047
malignancy I-Disease 1 0.9999988079071045
with O 0 0.022900326177477837
similarities O 0 0.020395785570144653
to O 0 0.013237500563263893
a O 0 0.022501647472381592
mature B-Disease 0 0.4378199279308319
T I-Disease 1 0.9999992847442627
- I-Disease 1 0.9999998807907104
cell I-Disease 1 0.9988604784011841
leukaemia I-Disease 1 1.0
seen O 0 0.02666340209543705
in O 0 0.016804495826363564
A B-Disease 1 0.9997326731681824
- I-Disease 1 1.0
T I-Disease 1 0.9999978542327881
, O 0 0.017234086990356445
we O 0 0.009767867624759674
demonstrate O 0 0.02039196342229843
a O 0 0.016454193741083145
high O 0 0.025558918714523315
frequency O 0 0.020577924326062202
of O 0 0.023170433938503265
ATM O 1 0.9571906328201294
mutations O 0 0.04304055497050285
in O 0 0.03314349055290222
T B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999988079071045
PLL I-Disease 1 0.9999420642852783
. O 0 0.059413593262434006

In O 0 0.03189416974782944
marked O 0 0.04343399032950401
contrast O 0 0.030281376093626022
to O 0 0.01693582721054554
the O 0 0.025811878964304924
ATM O 1 0.785027801990509
mutation O 0 0.03904805704951286
pattern O 0 0.023500699549913406
in O 0 0.01414311584085226
A B-Disease 1 0.9997976422309875
- I-Disease 1 1.0
T I-Disease 1 0.9999978542327881
, O 0 0.016459349542856216
the O 0 0.014052694663405418
most O 0 0.013975408859550953
frequent O 0 0.03822443634271622
nucleotide O 0 0.038220930844545364
changes O 0 0.01277727261185646
in O 0 0.013228858821094036
this O 0 0.021046334877610207
leukaemia B-Disease 1 0.9999998807907104
were O 0 0.040946219116449356
missense O 1 0.9722968935966492
mutations O 0 0.07964681833982468
. O 0 0.04588766396045685

These O 0 0.027205180376768112
clustered O 0 0.06216350570321083
in O 0 0.016127733513712883
the O 0 0.019605794921517372
region O 0 0.02553204447031021
corresponding O 0 0.021516844630241394
to O 0 0.015667442232370377
the O 0 0.030208256095647812
kinase O 1 0.9993413090705872
domain O 0 0.03885900601744652
, O 0 0.013574977405369282
which O 0 0.009237353689968586
is O 0 0.01008682046085596
highly O 0 0.01974673755466938
conserved O 0 0.02299276925623417
in O 0 0.016558557748794556
ATM O 1 0.9983215928077698
- O 1 0.9999328851699829
related O 0 0.029114138334989548
proteins O 0 0.024283094331622124
in O 0 0.018918728455901146
mouse O 0 0.05767088010907173
, O 0 0.0298463124781847
yeast O 0 0.10931160300970078
and O 0 0.035628750920295715
Drosophila O 0 0.11244393140077591
. O 0 0.04388958960771561

The O 0 0.052726589143276215
resulting O 0 0.06819899380207062
amino O 0 0.087105393409729
- O 1 0.9999889135360718
acid O 0 0.10669421404600143
substitutions O 0 0.04388102516531944
are O 0 0.008462855592370033
predicted O 0 0.023398201912641525
to O 0 0.017705155536532402
interfere O 0 0.046084340661764145
with O 0 0.025967074558138847
ATP O 1 0.9999871253967285
binding O 0 0.052161358296871185
or O 0 0.03292548656463623
substrate O 0 0.07616877555847168
recognition O 0 0.0528455413877964
. O 0 0.04126527160406113

Two O 0 0.01725917123258114
of O 0 0.026428328827023506
seventeen O 0 0.09309615939855576
mutated O 1 0.9989319443702698
T B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999982118606567
PLL I-Disease 1 0.9999517202377319
samples O 0 0.030294932425022125
had O 0 0.013624058105051517
a O 0 0.014118409715592861
previously O 0 0.01705588959157467
reported O 0 0.02816539630293846
A B-Disease 1 0.9865325689315796
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999961853027344
allele O 0 0.1352076381444931
. O 0 0.04636283591389656

In O 0 0.03359467536211014
contrast O 0 0.04400455206632614
, O 0 0.020235443487763405
no O 0 0.018860910087823868
mutations O 0 0.025085914880037308
were O 0 0.010373041033744812
detected O 0 0.02326691336929798
in O 0 0.011078594252467155
the O 0 0.025542771443724632
p53 O 1 0.9916300177574158
gene O 0 0.029782943427562714
, O 0 0.013133816421031952
suggesting O 0 0.016840333119034767
that O 0 0.010844052769243717
this O 0 0.02444799430668354
tumour B-Disease 1 1.0
suppressor O 1 0.9999998807907104
is O 0 0.025389935821294785
not O 0 0.013169422745704651
frequently O 0 0.018371399492025375
altered O 0 0.026774687692523003
in O 0 0.01789640448987484
this O 0 0.03051769733428955
leukaemia B-Disease 1 0.9999997615814209
. O 0 0.06609386950731277

Occasional O 0 0.14418697357177734
missense O 0 0.43609100580215454
mutations O 0 0.059230443090200424
in O 0 0.02324833534657955
ATM O 0 0.08778204023838043
were O 0 0.010633406229317188
also O 0 0.010321506299078465
found O 0 0.011070657521486282
in O 0 0.01988682709634304
tumour B-Disease 1 1.0
DNA O 0 0.0392141155898571
from O 0 0.020261447876691818
patients O 0 0.08566989749670029
with O 0 0.02253798395395279
B B-Disease 1 0.999998927116394
- I-Disease 1 0.9999967813491821
cell I-Disease 0 0.10025524348020554
non I-Disease 1 0.9642078280448914
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 1 0.6008003950119019
B B-Disease 1 0.9999979734420776
- I-Disease 1 0.9999653100967407
NHL I-Disease 0 0.06853660941123962
) O 0 0.014451363123953342
and O 0 0.01179051399230957
a O 0 0.029677998274564743
B B-Disease 1 0.9999878406524658
- I-Disease 1 0.9999856948852539
NHL I-Disease 1 0.9153924584388733
cell O 0 0.06896030902862549
line O 0 0.05469078943133354
. O 0 0.035646095871925354

The O 0 0.03197085112333298
evidence O 0 0.016591714695096016
of O 0 0.013818258419632912
a O 0 0.015469389967620373
significant O 0 0.012165390886366367
proportion O 0 0.019455954432487488
of O 0 0.015625523403286934
loss O 0 0.4209945797920227
- O 1 0.9999901056289673
of O 0 0.047845736145973206
- O 1 0.9999997615814209
function O 0 0.02919885516166687
mutations O 0 0.020896339789032936
and O 0 0.01022488996386528
a O 0 0.015323316678404808
complete O 0 0.022821176797151566
absence O 0 0.031041109934449196
of O 0 0.017036356031894684
the O 0 0.0197941642254591
normal O 0 0.024248063564300537
copy O 0 0.031030606478452682
of O 0 0.01937215030193329
ATM O 0 0.05358297750353813
in O 0 0.00902214739471674
the O 0 0.012640674598515034
majority O 0 0.019228080287575722
of O 0 0.02980109676718712
mutated O 1 0.9977622032165527
tumours B-Disease 1 1.0
establishes O 1 0.9999934434890747
somatic O 1 0.9999784231185913
inactivation O 1 0.9999855756759644
of O 0 0.02370493672788143
this O 0 0.013146895915269852
gene O 0 0.016604604199528694
in O 0 0.007820535451173782
the O 0 0.017960522323846817
pathogenesis O 1 0.9999368190765381
of O 0 0.03890621289610863
sporadic B-Disease 1 0.999982476234436
T I-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.999997615814209
and O 0 0.022963939234614372
suggests O 0 0.024430248886346817
that O 0 0.012061776593327522
ATM O 0 0.06635348498821259
acts O 0 0.026599830016493797
as O 0 0.022902369499206543
a O 0 0.3537474572658539
tumour B-Disease 1 1.0
suppressor O 1 0.9999996423721313
. O 0 0.06644465029239655

As O 0 0.0374486967921257
constitutional O 0 0.05498397350311279
DNA O 0 0.03852328285574913
was O 0 0.02206498011946678
not O 0 0.009081787429749966
available O 0 0.008825654163956642
, O 0 0.011193105019629002
a O 0 0.024965407326817513
putative O 1 0.9913227558135986
hereditary O 1 0.9999995231628418
predisposition O 1 0.9999995231628418
to O 1 0.982910692691803
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999916553497314
will O 0 0.023194819688796997
require O 0 0.019878361374139786
further O 0 0.020915644243359566
investigation O 0 0.03790353983640671
. O 0 0.023897113278508186
. O 0 0.034379009157419205

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9999090433120728
kinase O 1 0.9997374415397644
is O 0 0.019992558285593987
involved O 0 0.014087250456213951
in O 0 0.008960598148405552
the O 0 0.016052313148975372
modulation O 0 0.03444262593984604
of O 0 0.02037116140127182
the O 0 0.04108159989118576
Ca2 O 1 0.9999992847442627
+ O 1 0.9999128580093384
homeostasis O 1 0.9999533891677856
in O 0 0.056793272495269775
skeletal O 1 1.0
muscle O 1 0.9999996423721313
cells O 1 0.8378005623817444
. O 0 0.05470060184597969

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999974966049194
DM B-Disease 1 1.0
) O 0 0.02871921844780445
, O 0 0.012358058243989944
the O 0 0.014687566086649895
most O 0 0.022009795531630516
prevalent O 1 0.999993085861206
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9201035499572754
adults O 1 0.9485678672790527
, O 0 0.02200215868651867
is O 0 0.016836797818541527
caused O 0 0.030213944613933563
by O 0 0.02020120620727539
( O 0 0.03386938199400902
CTG O 1 0.9999901056289673
) O 0 0.029448838904500008
n O 0 0.07925731688737869
- O 1 0.9977905750274658
repeat O 0 0.047027915716171265
expansion O 0 0.02614433877170086
in O 0 0.01032366044819355
a O 0 0.017767611891031265
gene O 0 0.023769067600369453
encoding O 0 0.023909825831651688
a O 0 0.030402595177292824
protein O 0 0.054533716291189194
kinase O 1 0.9973399043083191
( O 0 0.07265733182430267
DM B-Disease 1 1.0
protein O 0 0.1782020479440689
kinase O 1 0.9944267272949219
; O 0 0.04016586393117905
DMPK O 1 0.9999239444732666
) O 0 0.02431340329349041
and O 0 0.014797956682741642
involves O 0 0.02767885848879814
changes O 0 0.017131036147475243
in O 0 0.021233607083559036
cytoarchitecture O 1 0.9992037415504456
and O 0 0.05218040943145752
ion O 1 0.998080849647522
homeostasis O 1 0.9978553652763367
. O 0 0.05732746049761772

To O 0 0.04249020665884018
obtain O 0 0.04016807675361633
clues O 0 0.029964502900838852
to O 0 0.01364264078438282
the O 0 0.01712016947567463
normal O 0 0.02457968331873417
biological O 0 0.024899642914533615
role O 0 0.027595030143857002
of O 0 0.029479121789336205
DMPK O 1 0.9999971389770508
in O 0 0.033247292041778564
cellular O 1 0.9891412258148193
ion O 1 0.9999388456344604
homeostasis O 1 0.999823272228241
, O 0 0.017860379070043564
we O 0 0.00818986538797617
have O 0 0.005730300676077604
compared O 0 0.012517813593149185
the O 0 0.02367759495973587
resting O 1 0.9998748302459717
[ O 1 0.9995208978652954
Ca2 O 1 0.9999997615814209
+ O 1 0.9998412132263184
] O 0 0.06855852901935577
i O 0 0.021697375923395157
, O 0 0.01222240086644888
the O 0 0.016219208016991615
amplitude O 0 0.038754161447286606
and O 0 0.014894843101501465
shape O 0 0.027705129235982895
of O 0 0.0328107513487339
depolarization O 1 0.9999997615814209
- O 1 1.0
induced O 1 1.0
Ca2 O 1 0.9999998807907104
+ O 1 0.9998311996459961
transients O 1 0.9952101111412048
, O 0 0.018620124086737633
and O 0 0.009340324439108372
the O 0 0.012136811390519142
content O 0 0.012832238338887691
of O 0 0.020591378211975098
ATP O 1 0.9999990463256836
- O 1 0.9999963045120239
driven O 0 0.07805348932743073
ion O 0 0.10283197462558746
pumps O 0 0.0697869285941124
in O 0 0.02522941306233406
cultured O 1 0.9996533393859863
skeletal O 1 0.9999995231628418
muscle O 1 0.9999818801879883
cells O 0 0.04117833450436592
of O 0 0.02245238609611988
wild O 0 0.04711928591132164
- O 1 0.999871015548706
type O 0 0.03965924307703972
and O 0 0.0197256188839674
DMPK O 1 0.999997615814209
[ O 1 0.9650973677635193
- O 1 0.9999997615814209
/ O 1 0.9999991655349731
- O 1 0.9999995231628418
] O 1 0.5315142273902893
knockout O 1 0.9947882890701294
mice O 0 0.08090617507696152
. O 0 0.043366074562072754

In O 0 0.03625265881419182
vitro O 0 0.1348753124475479
- O 1 0.9997476935386658
differentiated O 1 0.8222981691360474
DMPK O 1 0.9999853372573853
[ O 1 0.9456400275230408
- O 1 0.9999992847442627
/ O 1 0.9999972581863403
- O 1 0.9999953508377075
] O 0 0.07266802340745926
myotubes O 0 0.2897440195083618
exhibit O 0 0.038122788071632385
a O 0 0.02376316487789154
higher O 0 0.032111719250679016
resting O 1 0.9999593496322632
[ O 1 0.9983367919921875
Ca2 O 1 0.9999986886978149
+ O 1 0.9982864260673523
] O 0 0.054074373096227646
i O 0 0.01973058097064495
than O 0 0.00860031321644783
do O 0 0.012475104071199894
wild O 0 0.036479316651821136
- O 1 0.9999680519104004
type O 0 0.07257711887359619
myotubes O 1 0.9883926510810852
because O 0 0.015629056841135025
of O 0 0.014500117860734463
an O 0 0.014990135096013546
altered O 0 0.025420034304261208
open O 0 0.021978287026286125
probability O 0 0.017810653895139694
of O 0 0.02050212398171425
voltage O 0 0.14013850688934326
- O 1 0.9997878670692444
dependent O 0 0.06268706917762756
l O 1 0.9978378415107727
- O 1 0.9999922513961792
type O 1 0.8518776893615723
Ca2 O 1 0.9999761581420898
+ O 1 0.9063145518302917
and O 0 0.04765690118074417
Na O 1 0.9999964237213135
+ O 0 0.3105192184448242
channels O 0 0.05325682461261749
. O 0 0.037946317344903946

The O 0 0.06735777854919434
mutant O 0 0.46109020709991455
myotubes O 1 0.997998058795929
exhibit O 0 0.06541841477155685
smaller O 0 0.030530896037817
and O 0 0.027605993673205376
slower O 0 0.08925645053386688
Ca2 O 1 0.9999593496322632
+ O 0 0.2161424160003662
responses O 0 0.03529997915029526
upon O 0 0.028651807457208633
triggering O 0 0.07300443202257156
by O 0 0.033719662576913834
acetylcholine O 1 0.9989418387413025
or O 0 0.032334908843040466
high O 0 0.11255362629890442
external O 0 0.2495630532503128
K O 1 0.999607503414154
+ O 0 0.31034648418426514
. O 0 0.04442016780376434

In O 0 0.031892597675323486
addition O 0 0.02803376503288746
, O 0 0.01697481796145439
we O 0 0.011166726239025593
observed O 0 0.014733334071934223
that O 0 0.01124019455164671
these O 0 0.0184501763433218
Ca2 O 1 0.9999816417694092
+ O 1 0.9994494318962097
transients O 1 0.9980509281158447
partially O 0 0.056840211153030396
result O 0 0.01819750852882862
from O 0 0.011621189303696156
an O 0 0.016283104196190834
influx O 0 0.059964340180158615
of O 0 0.04164997488260269
extracellular O 1 0.9999375343322754
Ca2 O 1 0.9999657869338989
+ O 0 0.08065216988325119
through O 0 0.019409330561757088
the O 0 0.03092997521162033
l O 1 0.9990932941436768
- O 1 0.9999969005584717
type O 1 0.9975881576538086
Ca2 O 1 0.9999744892120361
+ O 1 0.8253530859947205
channel O 0 0.06834447383880615
. O 0 0.03931678831577301

Neither O 0 0.06121133640408516
the O 0 0.027783410623669624
content O 0 0.01929403282701969
nor O 0 0.020800145342946053
the O 0 0.013756604865193367
activity O 0 0.0214577354490757
of O 0 0.03487463667988777
Na O 1 0.9999997615814209
+ O 1 0.9998378753662109
/ O 1 0.9999644756317139
K O 1 0.9997039437294006
+ O 1 0.9940213561058044
ATPase O 1 0.9980294108390808
and O 0 0.04845431074500084
sarcoplasmic O 1 0.9999980926513672
reticulum O 1 0.9999984502792358
Ca2 O 1 0.9999995231628418
+ O 1 0.9999827146530151
- O 1 0.9999990463256836
ATPase O 1 0.9995290040969849
are O 0 0.011779074557125568
affected O 0 0.028954004868865013
by O 0 0.029522793367505074
DMPK O 1 0.9999803304672241
absence O 1 0.6303054690361023
. O 0 0.056592099368572235

In O 0 0.0354696623980999
conclusion O 0 0.03786977753043175
, O 0 0.019004736095666885
our O 0 0.021160529926419258
data O 0 0.012936189770698547
suggest O 0 0.015725120902061462
that O 0 0.012929658405482769
DMPK O 1 0.9984560012817383
is O 0 0.02000756375491619
involved O 0 0.01944257877767086
in O 0 0.016619093716144562
modulating O 1 0.616925835609436
the O 0 0.020404482260346413
initial O 0 0.025152036920189857
events O 0 0.015987657010555267
of O 0 0.02546003647148609
excitation O 1 0.9996309280395508
- O 1 0.9999994039535522
contraction O 1 0.9973896145820618
coupling O 1 0.9403030276298523
in O 0 0.04243576526641846
skeletal O 1 0.9999997615814209
muscle O 1 0.9999815225601196
. O 0 0.04353109747171402
. O 0 0.04649467021226883

Constitutional O 0 0.2398090362548828
RB1 O 1 0.9999997615814209
- O 1 0.9999980926513672
gene O 0 0.07093825191259384
mutations O 0 0.04177030920982361
in O 0 0.02160375937819481
patients O 1 0.9832913279533386
with O 0 0.03366393595933914
isolated O 1 0.997655987739563
unilateral B-Disease 1 0.9997221827507019
retinoblastoma I-Disease 1 0.9999996423721313
. O 0 0.07776951044797897

In O 0 0.028236383572220802
most O 0 0.023751890286803246
patients O 0 0.34889692068099976
with O 0 0.022832442075014114
isolated O 1 0.9204529523849487
unilateral B-Disease 1 0.9998873472213745
retinoblastoma I-Disease 1 1.0
, O 1 0.9883777499198914
tumor B-Disease 1 1.0
development O 0 0.044044703245162964
is O 0 0.020633915439248085
initiated O 0 0.052439216524362564
by O 0 0.026558110490441322
somatic O 1 0.9451377391815186
inactivation O 1 0.9994144439697266
of O 0 0.024861618876457214
both O 0 0.02101767621934414
alleles O 0 0.0523814931511879
of O 0 0.0301711093634367
the O 0 0.06599881500005722
RB1 O 1 0.9999997615814209
gene O 0 0.08011271804571152
. O 0 0.04429299756884575

However O 0 0.02979835867881775
, O 0 0.014759860001504421
some O 0 0.008644087240099907
of O 0 0.018151581287384033
these O 0 0.01817944087088108
patients O 1 0.9998401403427124
can O 0 0.03295997902750969
transmit O 1 0.9865816831588745
retinoblastoma B-Disease 1 0.9999998807907104
predisposition O 1 0.999992847442627
to O 0 0.035345979034900665
their O 0 0.02913476526737213
offspring O 0 0.07998328655958176
. O 0 0.04280824959278107

To O 0 0.03251050040125847
determine O 0 0.020663317292928696
the O 0 0.019318679347634315
frequency O 0 0.02062760293483734
and O 0 0.010837079957127571
nature O 0 0.014590982347726822
of O 0 0.016345808282494545
constitutional O 0 0.47790688276290894
RB1 O 1 1.0
- O 1 0.9999998807907104
gene O 0 0.04723091050982475
mutations O 0 0.031753528863191605
in O 0 0.016583329066634178
patients O 1 0.91517573595047
with O 0 0.02412291057407856
isolated O 1 0.9594577550888062
unilateral B-Disease 1 0.9997665286064148
retinoblastoma I-Disease 1 0.9999997615814209
, O 0 0.026828911155462265
we O 0 0.014434956945478916
analyzed O 0 0.02455870248377323
DNA O 0 0.028610393404960632
from O 0 0.029312027618288994
peripheral O 1 0.9999909400939941
blood O 1 0.9991938471794128
and O 0 0.037459176033735275
from O 0 0.4336509108543396
tumor B-Disease 1 1.0
tissue O 1 0.999971866607666
. O 0 0.06217074766755104

The O 0 0.03732675313949585
analysis O 0 0.026536645367741585
of O 0 0.03702673316001892
tumors B-Disease 1 0.9999986886978149
from O 0 0.030938707292079926
54 O 0 0.06439442187547684
( O 0 0.03071911446750164
71 O 0 0.054931025952100754
% O 0 0.020566625520586967
) O 0 0.0141664519906044
of O 0 0.020140238106250763
76 O 0 0.09056081622838974
informative O 0 0.0818398967385292
patients O 0 0.22779813408851624
showed O 0 0.027506502345204353
loss O 0 0.031003177165985107
of O 0 0.02619469352066517
constitutional O 1 0.543282151222229
heterozygosity O 1 0.9999997615814209
( O 1 0.7991536259651184
LOH O 1 1.0
) O 0 0.05056719481945038
at O 0 0.053768329322338104
intragenic O 1 0.999622106552124
loci O 0 0.1488783210515976
. O 0 0.05004500225186348

Three O 0 0.02620452269911766
of O 0 0.034731972962617874
13 O 0 0.0687728077173233
uninformative O 1 0.9999792575836182
patients O 1 0.9996834993362427
had O 0 0.047620225697755814
constitutional O 0 0.09410043060779572
deletions O 0 0.13303077220916748
. O 0 0.05391508340835571

For O 0 0.035755641758441925
39 O 0 0.050345972180366516
randomly O 0 0.03675948455929756
selected O 0 0.05309782922267914
tumors B-Disease 1 0.9999650716781616
, O 0 0.03752250596880913
SSCP O 1 0.999994158744812
, O 0 0.04612749442458153
hetero O 1 0.9999994039535522
- O 1 0.9999991655349731
duplex O 1 0.9994763731956482
analysis O 0 0.02502838708460331
, O 0 0.02000676468014717
sequencing O 0 0.0343158021569252
, O 0 0.01585531421005726
and O 0 0.01655087247490883
Southern O 0 0.05097855627536774
blot O 1 0.9662958979606628
analysis O 0 0.018838198855519295
were O 0 0.009817230515182018
used O 0 0.012057630345225334
to O 0 0.019050471484661102
identify O 0 0.04431738704442978
mutations O 0 0.052694495767354965
. O 0 0.04089741408824921

Mutations O 0 0.06606816500425339
were O 0 0.018059100955724716
detected O 0 0.03373846039175987
in O 0 0.014766151085495949
21 O 0 0.03088737092912197
( O 0 0.024063438177108765
91 O 0 0.05359030142426491
% O 0 0.019531236961483955
) O 0 0.015304852277040482
of O 0 0.02140877954661846
23 O 0 0.08016839623451233
tumors B-Disease 1 0.9999997615814209
with O 0 0.39066237211227417
LOH O 1 1.0
. O 0 0.08293025940656662

In O 0 0.038854844868183136
6 O 0 0.05361205339431763
( O 0 0.028959857299923897
38 O 0 0.03577074408531189
% O 0 0.019943108782172203
) O 0 0.01566951721906662
of O 0 0.019369814544916153
16 O 0 0.05347917973995209
tumors B-Disease 1 0.9999997615814209
without O 0 0.05232303962111473
LOH O 1 1.0
, O 0 0.02553301863372326
one O 0 0.022357959300279617
mutation O 0 0.042847972363233566
was O 0 0.026174938306212425
detected O 0 0.029515136033296585
, O 0 0.012221746146678925
and O 0 0.009925625286996365
in O 0 0.012178553268313408
9 O 0 0.02954973466694355
( O 0 0.02013540454208851
56 O 0 0.03256893530488014
% O 0 0.015366480685770512
) O 0 0.010988258756697178
of O 0 0.015382563695311546
the O 0 0.03792861849069595
tumors B-Disease 1 1.0
without O 1 0.8501070141792297
LOH O 1 1.0
, O 0 0.036179691553115845
both O 0 0.02345646545290947
mutations O 0 0.03354788199067116
were O 0 0.01561188604682684
found O 0 0.021015604957938194
. O 0 0.03141086921095848

Thus O 0 0.03817552700638771
, O 0 0.018036026507616043
a O 0 0.015219693072140217
total O 0 0.013467058539390564
of O 0 0.018443236127495766
45 O 0 0.031145095825195312
mutations O 0 0.024609342217445374
were O 0 0.010855383239686489
identified O 0 0.024828745052218437
in O 0 0.023190584033727646
tumors B-Disease 1 0.9999959468841553
of O 0 0.04504665732383728
36 O 0 0.15090321004390717
patients O 1 0.999750554561615
. O 0 0.0584011971950531

Thirty O 0 0.09219903498888016
- O 0 0.48947399854660034
nine O 0 0.020887890830636024
of O 0 0.017498930916190147
the O 0 0.02575824223458767
mutations O 0 0.046599991619586945
- O 1 0.9901019334793091
including O 0 0.014205234125256538
34 O 0 0.03061635047197342
small O 0 0.023096105083823204
mutations O 0 0.028569960966706276
, O 0 0.01543010026216507
2 O 0 0.027723774313926697
large O 0 0.025506362318992615
structural O 0 0.28623560070991516
alterations O 0 0.06753864884376526
, O 0 0.019939016550779343
and O 0 0.021248871460556984
hypermethylation O 1 0.9999872446060181
in O 0 0.026686787605285645
3 O 1 0.7158794403076172
tumors O 1 1.0
- O 1 0.9999202489852905
were O 0 0.011702987365424633
not O 0 0.009806695394217968
detected O 0 0.020205726847052574
in O 0 0.009647305123507977
the O 0 0.020384345203638077
corresponding O 0 0.06611436605453491
peripheral O 1 0.9999990463256836
blood O 1 0.9998207688331604
DNA O 0 0.08007272332906723
. O 0 0.04533660411834717

In O 0 0.038430020213127136
6 O 0 0.05431478098034859
( O 0 0.028765957802534103
17 O 0 0.03087402880191803
% O 0 0.017894310876727104
) O 0 0.011363530531525612
of O 0 0.012127399444580078
the O 0 0.019740784540772438
36 O 0 0.04932237043976784
patients O 1 0.9959482550621033
, O 0 0.019767098128795624
a O 0 0.02982807531952858
mutation O 0 0.05150951072573662
was O 0 0.027502097189426422
detected O 0 0.02765774540603161
in O 0 0.012221681885421276
constitutional O 0 0.03131880238652229
DNA O 0 0.02631940320134163
, O 0 0.012337379157543182
and O 0 0.010595233179628849
1 O 0 0.020359544083476067
of O 0 0.014173870906233788
these O 0 0.011216413229703903
mutations O 0 0.02910499833524227
is O 0 0.014524190686643124
known O 0 0.018983693793416023
to O 0 0.012849319726228714
be O 0 0.010450884699821472
associated O 0 0.017465118318796158
with O 0 0.020458228886127472
reduced O 0 0.06266654282808304
expressivity O 1 0.999915361404419
. O 0 0.0553077831864357

The O 0 0.03559844568371773
presence O 0 0.029890716075897217
of O 0 0.019001012668013573
a O 0 0.025134827941656113
constitutional O 0 0.05182521790266037
mutation O 0 0.05444524064660072
was O 0 0.022418126463890076
not O 0 0.010216115042567253
associated O 0 0.012129250913858414
with O 0 0.009307251311838627
an O 0 0.013585682027041912
early O 0 0.023831933736801147
age O 0 0.03645904362201691
at O 0 0.04957005754113197
treatment O 1 0.9999525547027588
. O 0 0.05107022449374199

In O 0 0.039429470896720886
1 O 0 0.0685441866517067
patient O 1 0.999542236328125
, O 0 0.04328152537345886
somatic O 1 0.9992732405662537
mosaicism O 1 0.9999830722808838
was O 0 0.0442594438791275
demonstrated O 0 0.03421049192547798
by O 0 0.018533844500780106
molecular O 0 0.02716243825852871
analysis O 0 0.01149861142039299
of O 0 0.014975165016949177
DNA O 0 0.0277677271515131
and O 0 0.020149558782577515
RNA O 0 0.07273711264133453
from O 0 0.040022093802690506
peripheral O 1 0.9999945163726807
blood O 1 0.9992761015892029
. O 0 0.05820012465119362

In O 0 0.041084375232458115
2 O 0 0.05964463949203491
patients O 0 0.08352407068014145
without O 0 0.0182496327906847
a O 0 0.030057348310947418
detectable O 1 0.9969905614852905
mutation O 0 0.07496678084135056
in O 0 0.029622972011566162
peripheral O 1 0.9999994039535522
blood O 1 0.9999715089797974
, O 0 0.04485910013318062
mosaicism O 1 0.9999967813491821
was O 0 0.03172061964869499
suggested O 0 0.018988898023962975
because O 0 0.009471150115132332
1 O 0 0.01705995947122574
of O 0 0.01588449813425541
the O 0 0.028595704585313797
patients O 1 0.9999740123748779
showed O 1 0.9976502060890198
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.03213060647249222
the O 0 0.02429170534014702
other O 0 0.014817518182098866
later O 0 0.027554752305150032
developed O 0 0.04541037976741791
bilateral B-Disease 1 0.7532094120979309
retinoblastoma I-Disease 1 0.9999974966049194
. O 0 0.06477141380310059

In O 0 0.033665020018815994
conclusion O 0 0.036643534898757935
, O 0 0.019314859062433243
our O 0 0.02036384493112564
results O 0 0.015158536843955517
emphasize O 0 0.03323842212557793
that O 0 0.009529818780720234
the O 0 0.020491253584623337
manifestation O 1 0.9997103810310364
and O 0 0.03124830313026905
transmissibility O 1 0.9999932050704956
of O 0 0.13986337184906006
retinoblastoma B-Disease 1 0.9999997615814209
depend O 0 0.02454705350100994
on O 0 0.012965125031769276
the O 0 0.013043501414358616
nature O 0 0.013930895365774632
of O 0 0.010474411770701408
the O 0 0.015606001950800419
first O 0 0.020831288769841194
mutation O 0 0.03108556568622589
, O 0 0.011870956048369408
its O 0 0.010998804122209549
time O 0 0.009991760365664959
in O 0 0.009443414397537708
development O 0 0.01790417544543743
, O 0 0.01221570186316967
and O 0 0.009656963869929314
the O 0 0.012918485328555107
number O 0 0.01142122969031334
and O 0 0.013514604419469833
types O 0 0.017226366326212883
of O 0 0.02369764633476734
cells O 0 0.03677069768309593
that O 0 0.013412799686193466
are O 0 0.009626485407352448
affected O 0 0.03082684800028801
. O 0 0.022554030641913414
. O 0 0.035677470266819

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.11993809789419174
the I-Disease 0 0.07258080691099167
fifth I-Disease 1 0.9991798996925354
component I-Disease 0 0.3268040120601654
of I-Disease 0 0.031792961061000824
complement I-Disease 0 0.06261388212442398
in O 0 0.02592601627111435
man O 0 0.06771539896726608
. O 0 0.03936770558357239

I O 0 0.13939188420772552
. O 0 0.06713594496250153

Clinical O 1 0.9961126446723938
, O 0 0.05855601653456688
immunochemical O 1 0.9998400211334229
, O 0 0.036184098571538925
and O 0 0.03030059114098549
family O 0 0.04763760417699814
studies O 0 0.035367608070373535
. O 0 0.036611661314964294

The O 0 0.03330382704734802
first O 0 0.025994809344410896
recognized O 0 0.03455271199345589
human O 0 0.03648947924375534
kindred O 1 0.9999990463256836
with O 1 0.6805143356323242
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9087540507316589
the I-Disease 0 0.19842177629470825
fifth I-Disease 1 0.9997795224189758
component I-Disease 1 0.7466946244239807
of I-Disease 0 0.02891678363084793
complement I-Disease 1 0.9961643218994141
( O 0 0.08094146847724915
C5 O 1 0.9999996423721313
) O 0 0.028804950416088104
is O 0 0.021558260545134544
described O 0 0.04096636176109314
. O 0 0.03721308335661888

The O 0 0.05346423760056496
proband O 1 0.9816812872886658
, O 0 0.019150692969560623
a O 0 0.019103705883026123
20 O 0 0.022164305672049522
- O 1 0.9842171669006348
year O 0 0.018346447497606277
- O 1 0.9983365535736084
old O 0 0.04156152531504631
black O 0 0.043241050094366074
female O 0 0.3286060094833374
with O 1 0.9851421117782593
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999402761459351
age O 1 0.9410766959190369
11 O 0 0.0355532243847847
, O 0 0.026264183223247528
lacked O 1 0.996461808681488
serum O 1 1.0
hemolytic O 1 1.0
complement O 1 0.9999333620071411
activity O 0 0.0519089438021183
, O 0 0.023434331640601158
even O 0 0.023049652576446533
during O 0 0.04706054925918579
remission O 1 0.999985933303833
. O 0 0.06056398153305054

C5 O 1 0.9999922513961792
was O 0 0.07916781306266785
undetectable O 1 0.9989563226699829
in O 0 0.026861151680350304
her O 0 0.05944051593542099
serum O 1 0.99986732006073
by O 0 0.026437003165483475
both O 0 0.029379205778241158
immunodiffusion O 1 0.999880313873291
and O 0 0.08128072321414948
hemolytic O 1 1.0
assays O 1 0.8523730635643005
. O 0 0.061544615775346756

Other O 0 0.03240472450852394
complement O 0 0.061550065875053406
components O 0 0.028384346514940262
were O 0 0.011568831279873848
normal O 0 0.025983670726418495
during O 0 0.03355550020933151
remission O 1 0.9999966621398926
of O 1 0.995844304561615
lupus O 1 1.0
, O 0 0.4578085243701935
but O 0 0.03507173806428909
C1 O 1 1.0
, O 0 0.051338959485292435
C4 O 1 0.9999991655349731
, O 0 0.04210660979151726
C2 O 1 0.9999998807907104
, O 0 0.030579393729567528
and O 0 0.03705009073019028
C3 O 1 1.0
levels O 0 0.06252045184373856
fell O 1 0.7639340162277222
during O 0 0.08294560015201569
exacerbations O 1 0.9999992847442627
. O 0 0.06817053258419037

A O 0 0.0615541972219944
younger O 0 0.0628003403544426
half O 0 0.04275809973478317
- O 1 0.9999822378158569
sister O 0 0.37835389375686646
, O 0 0.017425740137696266
who O 0 0.01809331774711609
had O 0 0.019517650827765465
no O 0 0.02806253544986248
underlying O 1 0.9999945163726807
disease O 1 1.0
, O 0 0.03280144929885864
was O 0 0.029702359810471535
also O 0 0.013016153126955032
found O 0 0.010732448659837246
to O 0 0.016909029334783554
lack O 0 0.05678367242217064
immunochemically O 1 0.9999891519546509
detectable O 1 0.9999839067459106
C5 O 1 0.9999918937683105
. O 0 0.06667587161064148

By O 0 0.09148065000772476
hemolytic O 1 1.0
assay O 1 0.9996180534362793
, O 0 0.03265276551246643
she O 0 0.026264702901244164
exhibited O 0 0.04193202406167984
1 O 0 0.04749506711959839
- O 1 0.9995336532592773
2 O 0 0.023457521572709084
% O 0 0.010126980021595955
of O 0 0.012066971510648727
the O 0 0.022411782294511795
normal O 0 0.06479747593402863
serum O 1 0.9999994039535522
C5 O 1 0.9999997615814209
level O 0 0.04251895099878311
and O 0 0.02216292917728424
normal O 0 0.0332484133541584
concentrations O 0 0.04846808314323425
of O 0 0.020358122885227203
other O 0 0.019927600398659706
complement O 0 0.07244870811700821
components O 0 0.05345761403441429
. O 0 0.03891773521900177

C5 O 1 0.9999829530715942
levels O 0 0.042957670986652374
of O 0 0.02052687294781208
other O 0 0.013312514871358871
family O 0 0.02396964654326439
members O 0 0.016742577776312828
were O 0 0.009061727672815323
either O 0 0.013977156952023506
normal O 0 0.018186967819929123
or O 0 0.010395086370408535
approximately O 0 0.01377260684967041
half O 0 0.027281878516077995
- O 1 0.99993896484375
normal O 0 0.029588403180241585
, O 0 0.016504257917404175
consistent O 0 0.028628500178456306
with O 0 0.02502145990729332
autosomal O 1 0.9991366267204285
codominant O 1 0.9999423027038574
inheritance O 0 0.07387413084506989
of O 0 0.028235262259840965
the O 0 0.03944218531250954
gene O 0 0.07033523917198181
determining O 1 0.9222901463508606
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.09869243204593658

Normal O 1 0.9396101236343384
hemolytic O 1 1.0
titers O 1 0.9999113082885742
were O 0 0.024351876229047775
restored O 0 0.05019718036055565
to O 0 0.014699178747832775
both O 0 0.016788581386208534
homozygous O 1 0.9513970613479614
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999998807907104
( O 0 0.0806945264339447
C5D B-Disease 1 0.9999998807907104
) O 0 0.03330933675169945
sera O 1 0.9875742793083191
by O 0 0.016745761036872864
addition O 0 0.015477695502340794
of O 0 0.02313506230711937
highly O 0 0.06571603566408157
purified O 1 0.9996556043624878
human O 0 0.13320840895175934
C5 O 1 0.999996542930603
. O 0 0.06039368361234665

In O 0 0.04095473140478134
specific O 0 0.05229152739048004
C5 O 1 0.9999998807907104
titrations O 1 0.9999688863754272
, O 0 0.02669048309326172
however O 0 0.01526667457073927
, O 0 0.013721654191613197
it O 0 0.00860995426774025
was O 0 0.01749107800424099
noted O 0 0.01380304154008627
that O 0 0.007895889692008495
when O 0 0.012941774912178516
limited O 0 0.015713701024651527
amounts O 0 0.017956629395484924
of O 0 0.02889138273894787
C5 O 1 0.9999784231185913
were O 0 0.016763679683208466
assayed O 0 0.05437703803181648
in O 0 0.011208826676011086
the O 0 0.015824273228645325
presence O 0 0.026006542146205902
of O 0 0.02324153669178486
low O 0 0.05357915908098221
dilutions O 1 0.993647038936615
of O 0 0.03944411128759384
either O 0 0.05311829224228859
C5D B-Disease 1 1.0
serum O 1 0.9999969005584717
, O 0 0.03822114318609238
curving O 0 0.10982684791088104
rather O 0 0.017554137855768204
than O 0 0.015450245700776577
linear O 0 0.05101655051112175
dose O 1 0.9999303817749023
- O 1 0.9999521970748901
response O 0 0.03889762982726097
plots O 0 0.03344160318374634
were O 0 0.012349970638751984
consistently O 0 0.028217311948537827
obtained O 0 0.019818279892206192
, O 0 0.017856022343039513
suggesting O 0 0.027809960767626762
some O 0 0.017545564100146294
inhibitory O 0 0.10065051168203354
effect O 0 0.04809641093015671
. O 0 0.03759714215993881

Further O 0 0.040663402527570724
studies O 0 0.021850908175110817
suggested O 0 0.020978132262825966
that O 0 0.012251087464392185
low O 0 0.04179512709379196
dilutions O 1 0.9792268872261047
of O 0 0.055285319685935974
C5D B-Disease 1 1.0
serum O 1 0.9999990463256836
contain O 0 0.04242179915308952
a O 0 0.04167993739247322
factor O 1 0.6541163325309753
( O 0 0.030171094462275505
or O 0 0.022148624062538147
factors O 0 0.024378284811973572
) O 0 0.018388915807008743
interfering O 0 0.03921635448932648
at O 0 0.016553372144699097
some O 0 0.00840367004275322
step O 0 0.02210921421647072
in O 0 0.012660782784223557
the O 0 0.03367738798260689
hemolytic O 1 1.0
assay O 1 0.9999227523803711
of O 1 0.750106692314148
C5 O 1 0.9999998807907104
, O 0 0.01952327974140644
rather O 0 0.01094736997038126
than O 0 0.008430625312030315
a O 0 0.023210983723402023
true O 0 0.06689538061618805
C5 O 1 0.9999998807907104
inhibitor O 1 0.9999957084655762
or O 0 0.0626809224486351
inactivator O 1 0.9987414479255676
. O 0 0.053982704877853394

Of O 0 0.059004440903663635
clinical O 1 0.9753270149230957
interest O 0 0.02591448277235031
are O 0 0.009858430363237858
( O 0 0.01708000898361206
a O 0 0.017416466027498245
) O 0 0.012033695355057716
the O 0 0.01348611619323492
documentation O 0 0.03469332307577133
of O 0 0.04564288258552551
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.999984622001648
vasculitis B-Disease 1 1.0
, O 1 0.9986523985862732
and O 1 0.9997504353523254
arthritis B-Disease 1 1.0
in O 0 0.10363543778657913
an O 0 0.028765449300408363
individual O 0 0.02750418893992901
lacking O 1 0.9991326928138733
C5 O 1 0.9999996423721313
( O 0 0.022358352318406105
and O 0 0.013994228094816208
its O 0 0.023697590455412865
biologic O 1 0.9999028444290161
functions O 0 0.029092352837324142
) O 0 0.019521407783031464
, O 0 0.01665203459560871
and O 0 0.017650621011853218
( O 0 0.02768341638147831
b O 0 0.4956826865673065
) O 0 0.015991758555173874
a O 0 0.017635738477110863
remarkable O 0 0.041277866810560226
propensity O 1 0.9993661046028137
to O 0 0.3272128403186798
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.03601493686437607
the O 0 0.10606984794139862
proband O 1 0.9999727010726929
, O 0 0.018734535202383995
even O 0 0.011477157473564148
during O 0 0.0154676279053092
periods O 0 0.02133483998477459
of O 0 0.02257569693028927
low O 1 0.6542584300041199
- O 1 0.9999799728393555
dose O 1 0.7984570264816284
or O 0 0.022092005237936974
alternate O 0 0.047820739448070526
- O 1 0.9999568462371826
day O 0 0.1886175274848938
corticosteroid O 1 0.9999994039535522
therapy O 1 0.9998903274536133
. O 0 0.062039438635110855

Other O 0 0.026606114581227303
observations O 0 0.02843773365020752
indicate O 0 0.017960455268621445
that O 0 0.009040351025760174
the O 0 0.020989861339330673
C5D B-Disease 1 0.9999861717224121
state O 0 0.01921185478568077
is O 0 0.018941637128591537
compatible O 0 0.04217963665723801
with O 0 0.022508759051561356
normal O 0 0.10101883113384247
coagulation O 1 0.9999995231628418
function O 0 0.036014068871736526
and O 0 0.015322561375796795
the O 0 0.019038161262869835
capacity O 0 0.024799149483442307
to O 0 0.01875079795718193
mount O 0 0.2803814709186554
a O 0 0.0630652979016304
neutrophilic O 1 0.9999997615814209
leukocytosis O 1 0.9999998807907104
during O 1 0.9991950392723083
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.05502958968281746
. O 0 0.05213138461112976

Susceptibility O 1 0.999841570854187
to O 1 0.7288060784339905
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.35401564836502075
twins O 1 0.9993898868560791
: O 0 0.02368200570344925
the O 0 0.01718255504965782
role O 0 0.02536810375750065
of O 0 0.022426465526223183
genes O 0 0.033279769122600555
, O 0 0.036580730229616165
HLA O 1 1.0
, O 0 0.02682979591190815
and O 0 0.01903827302157879
the O 0 0.028206592425704002
environment O 0 0.04416901618242264
. O 0 0.03861721605062485

OBJECTIVE O 0 0.0972888395190239
To O 0 0.0234235767275095
determine O 0 0.01686946116387844
the O 0 0.017222831025719643
relative O 0 0.039433740079402924
effects O 0 0.035325661301612854
of O 0 0.026309287175536156
genetic O 0 0.036613643169403076
and O 0 0.020579246804118156
environmental O 0 0.03557821735739708
factors O 0 0.023005368188023567
in O 0 0.02168247289955616
susceptibility O 1 0.9999783039093018
to O 1 0.9989782571792603
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9998347759246826
AS B-Disease 1 0.9996887445449829
) O 0 0.043132681399583817
. O 0 0.03393085300922394

METHODS O 0 0.06930918246507645
Twins O 0 0.0885506421327591
with O 0 0.020743688568472862
AS B-Disease 0 0.03395373374223709
were O 0 0.00972153153270483
identified O 0 0.012689342722296715
from O 0 0.008021947927772999
the O 0 0.01298681739717722
Royal O 0 0.05214885622262955
National O 1 0.5776300430297852
Hospital O 1 1.0
for O 1 0.9997809529304504
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9928672313690186
. O 0 0.05708586797118187

Clinical O 1 0.9958659410476685
and O 0 0.05843324214220047
radiographic O 1 0.9999465942382812
examinations O 1 0.6130949854850769
were O 0 0.018106481060385704
performed O 0 0.03141501173377037
to O 0 0.019358152523636818
establish O 0 0.05692753568291664
diagnoses O 1 0.9999991655349731
, O 0 0.04364451393485069
and O 0 0.43479159474372864
disease O 1 1.0
severity O 1 0.9999998807907104
was O 1 0.840162456035614
assessed O 0 0.037423331290483475
using O 0 0.01257869228720665
a O 0 0.019372956827282906
combination O 0 0.02871113084256649
of O 0 0.024260887876152992
validated O 0 0.0750919058918953
scoring O 0 0.04671407863497734
systems O 0 0.05654498189687729
. O 0 0.037547677755355835

HLA O 1 0.9999990463256836
typing O 0 0.13745391368865967
for O 0 0.0531267449259758
HLA O 1 1.0
- O 1 0.9999960660934448
B27 O 1 0.999950647354126
, O 0 0.0481676422059536
HLA O 1 1.0
- O 1 0.9999973773956299
B60 O 1 0.9988877177238464
, O 0 0.021126311272382736
and O 0 0.029330791905522346
HLA O 1 1.0
- O 1 0.9999997615814209
DR1 O 1 0.9999746084213257
was O 0 0.02907830849289894
performed O 0 0.028097325935959816
by O 0 0.021607063710689545
polymerase O 1 0.9322575330734253
chain O 0 0.05609641596674919
reaction O 0 0.030060352757573128
with O 0 0.016825862228870392
sequence O 0 0.029499487951397896
- O 1 0.9875438213348389
specific O 0 0.01969396509230137
primers O 0 0.08208499848842621
, O 0 0.021141497418284416
and O 0 0.02576620690524578
zygosity O 1 0.9938021898269653
was O 0 0.04565675929188728
assessed O 0 0.05616731569170952
using O 0 0.03684491291642189
microsatellite O 1 0.6108816862106323
markers O 0 0.10827413946390152
. O 0 0.049500662833452225

Genetic O 0 0.08596760779619217
and O 0 0.032826412469148636
environmental O 0 0.049624912440776825
variance O 0 0.0484427735209465
components O 0 0.027897056192159653
were O 0 0.010003525763750076
assessed O 0 0.02316117100417614
with O 0 0.012875238433480263
the O 0 0.023619484156370163
program O 0 0.051392409950494766
Mx O 1 0.9998403787612915
, O 0 0.01952129602432251
using O 0 0.01008374523371458
data O 0 0.008435011841356754
from O 0 0.00818092655390501
this O 0 0.006638420280069113
and O 0 0.009639931842684746
previous O 0 0.015750980004668236
studies O 0 0.01344808004796505
of O 0 0.019702481105923653
twins O 1 0.8917524218559265
with O 0 0.031409937888383865
AS B-Disease 1 0.9701809883117676
. O 0 0.04365025460720062

RESULTS O 0 0.0322076715528965
Six O 0 0.020489869639277458
of O 0 0.027174117043614388
8 O 0 0.059826742857694626
monozygotic O 1 0.9997138381004333
( O 0 0.08823652565479279
MZ O 1 1.0
) O 0 0.043343108147382736
twin O 0 0.23263467848300934
pairs O 0 0.034782033413648605
were O 0 0.026077713817358017
disease O 1 0.9999973773956299
concordant O 1 0.9999713897705078
, O 0 0.023875610902905464
compared O 0 0.017656484618782997
with O 0 0.012372488155961037
4 O 0 0.01985824666917324
of O 0 0.015661707147955894
15 O 0 0.031320877373218536
B27 O 1 0.9999090433120728
- O 1 0.9999326467514038
positive O 0 0.0479360856115818
dizygotic O 1 0.9998652935028076
( O 0 0.05511467158794403
DZ O 1 0.9999997615814209
) O 0 0.039756231009960175
twin O 0 0.3988226652145386
pairs O 0 0.031423721462488174
( O 0 0.023878047242760658
27 O 0 0.03669756278395653
% O 0 0.01881464570760727
) O 0 0.013443006202578545
and O 0 0.009750214405357838
4 O 0 0.020557157695293427
of O 0 0.02140398509800434
32 O 0 0.05894434452056885
DZ O 1 0.9999994039535522
twin O 1 0.9849322438240051
pairs O 0 0.03566719964146614
overall O 0 0.042715806514024734
( O 0 0.025860389694571495
12 O 0 0.02487463504076004
. O 0 0.016323382034897804
5 O 0 0.03187001869082451
% O 0 0.027232320979237556
) O 0 0.02812248095870018
. O 0 0.03149016201496124

Nonsignificant O 1 0.9937878251075745
increases O 0 0.04946305975317955
in O 0 0.018249936401844025
similarity O 0 0.027483521029353142
with O 0 0.013303760439157486
regard O 0 0.025671398267149925
to O 0 0.017604688182473183
age O 0 0.04135970026254654
at O 1 0.9976773858070374
disease O 1 1.0
onset O 1 1.0
and O 0 0.02185981348156929
all O 0 0.014585099183022976
of O 0 0.025053031742572784
the O 1 0.864709734916687
disease O 1 1.0
severity O 1 0.9999995231628418
scores O 0 0.0661306083202362
assessed O 0 0.03144284337759018
were O 0 0.009477750398218632
noted O 0 0.01765153929591179
in O 0 0.021966855973005295
disease O 1 0.9999994039535522
- O 1 1.0
concordant O 1 0.9999979734420776
MZ O 1 1.0
twins O 1 0.7868426442146301
compared O 0 0.035673756152391434
with O 0 0.039143145084381104
concordant O 1 0.9997056126594543
DZ O 1 0.9999996423721313
twins O 1 0.951597273349762
. O 0 0.06346981972455978

HLA O 1 1.0
- O 1 0.999998927116394
B27 O 1 0.9994547963142395
and O 0 0.035438332706689835
B60 O 1 0.7260287404060364
were O 0 0.011562704108655453
associated O 0 0.015747040510177612
with O 0 0.014009315520524979
the O 0 0.03391226753592491
disease O 1 0.9999998807907104
in O 0 0.028212813660502434
probands O 1 0.9999942779541016
, O 0 0.016929682344198227
and O 0 0.010305882431566715
the O 0 0.013411814346909523
rate O 0 0.021026477217674255
of O 0 0.02843722514808178
disease O 1 0.9999990463256836
concordance O 1 0.9997546076774597
was O 0 0.03912653401494026
significantly O 0 0.027605393901467323
increased O 0 0.024780211970210075
among O 0 0.042257361114025116
DZ O 1 1.0
twin O 1 0.9732182621955872
pairs O 0 0.0213234331458807
in O 0 0.009152174927294254
which O 0 0.008525478653609753
the O 0 0.016901658847928047
co O 1 0.9952303171157837
- O 1 0.9999897480010986
twin O 1 0.8284415602684021
was O 0 0.029079554602503777
positive O 0 0.023975521326065063
for O 0 0.016129693016409874
both O 0 0.025956397876143456
B27 O 1 0.9990418553352356
and O 0 0.05634458363056183
DR1 O 1 0.9996323585510254
. O 0 0.06433353573083878

Additive O 1 0.987281858921051
genetic O 0 0.07661792635917664
effects O 0 0.04449409246444702
were O 0 0.014242195524275303
estimated O 0 0.02088567428290844
to O 0 0.01890224777162075
contribute O 0 0.0338372066617012
97 O 0 0.057177234441041946
% O 0 0.016782822087407112
of O 0 0.015333069488406181
the O 0 0.02297992818057537
population O 0 0.026165921241044998
variance O 0 0.05804557353258133
. O 0 0.03779763728380203

CONCLUSION O 0 0.1208404079079628
Susceptibility O 1 0.9964005947113037
to O 0 0.028667451813817024
AS B-Disease 0 0.07068683207035065
is O 0 0.016347847878932953
largely O 0 0.020900428295135498
genetically O 0 0.024581190198659897
determined O 0 0.02010413073003292
, O 0 0.01201628614217043
and O 0 0.012005562894046307
the O 0 0.01928834803402424
environmental O 0 0.03952978178858757
trigger O 0 0.0736367329955101
for O 0 0.022794052958488464
the O 0 0.16720448434352875
disease O 1 1.0
is O 0 0.0445593036711216
probably O 0 0.04871058464050293
ubiquitous O 1 0.528235912322998
. O 0 0.04528806731104851

HLA O 1 1.0
- O 1 0.9999814033508301
B27 O 1 0.9082635045051575
accounts O 0 0.02080274373292923
for O 0 0.010911324061453342
a O 0 0.01634608395397663
minority O 0 0.024168258532881737
of O 0 0.016620876267552376
the O 0 0.024887463077902794
overall O 0 0.31902652978897095
genetic O 0 0.11988082528114319
susceptibility O 1 0.9997463822364807
to O 0 0.03817199543118477
AS B-Disease 1 0.790385365486145
. O 0 0.03987343609333038

Cell O 1 0.5065522789955139
cycle O 0 0.11200694739818573
- O 1 0.9991437196731567
dependent O 0 0.05934849753975868
colocalization O 0 0.2988370656967163
of O 0 0.04281509295105934
BARD1 O 1 0.999997615814209
and O 0 0.05193357542157173
BRCA1 O 1 0.999966025352478
proteins O 0 0.0402199923992157
in O 0 0.02086765691637993
discrete O 0 0.0552862249314785
nuclear O 0 0.06747491657733917
domains O 0 0.07010086625814438
. O 0 0.04373088479042053

Germ O 1 0.999998927116394
- O 1 0.9999136924743652
line O 0 0.05692537873983383
mutations O 0 0.027458718046545982
of O 0 0.01845117285847664
the O 0 0.03766612708568573
BRCA1 O 1 0.9999959468841553
gene O 0 0.06316124647855759
predispose O 1 0.6784610152244568
women O 0 0.02408435009419918
to O 0 0.015833117067813873
early O 0 0.03468847647309303
- O 1 1.0
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 1 0.513156533241272
compromising O 1 0.9994632601737976
the O 0 0.027710486203432083
genes O 0 0.030840309336781502
presumptive O 1 0.9997161030769348
function O 0 0.02883174642920494
as O 0 0.02096463181078434
a O 0 0.070981465280056
tumor B-Disease 1 1.0
suppressor O 1 0.9999977350234985
. O 0 0.062474705278873444

Although O 0 0.03004768118262291
the O 0 0.029831940308213234
biochemical O 0 0.06438007205724716
properties O 0 0.04072995111346245
of O 0 0.05093502998352051
BRCA1 O 1 0.9999996423721313
polypeptides O 0 0.14041227102279663
are O 0 0.010558973997831345
not O 0 0.011324591934680939
understood O 0 0.024170655757188797
, O 0 0.013798659667372704
their O 0 0.015153282321989536
expression O 0 0.03614269942045212
pattern O 0 0.037706028670072556
and O 0 0.025558896362781525
subcellular O 0 0.11753828078508377
localization O 0 0.07048726826906204
suggest O 0 0.01868058182299137
a O 0 0.018750876188278198
role O 0 0.029766811057925224
in O 0 0.02101784013211727
cell O 1 0.6425243616104126
- O 1 0.9999687671661377
cycle O 0 0.08753321319818497
regulation O 0 0.06085260957479477
. O 0 0.03947757929563522

When O 0 0.08083751797676086
resting O 1 0.9999595880508423
cells O 0 0.08307944983243942
are O 0 0.018582262098789215
induced O 1 0.9914003610610962
to O 0 0.03274628147482872
proliferate O 0 0.09319741278886795
, O 0 0.01642450876533985
the O 0 0.01837882399559021
steady O 0 0.06302051246166229
- O 1 0.8773887753486633
state O 0 0.014439286664128304
levels O 0 0.020749278366565704
of O 0 0.024425169453024864
BRCA1 O 1 0.9925705790519714
increase O 0 0.020550359040498734
in O 0 0.01707061193883419
late O 0 0.049557097256183624
G1 O 1 0.9997987151145935
and O 0 0.018709983676671982
reach O 0 0.027692927047610283
a O 0 0.021692907437682152
maximum O 0 0.03122876212000847
during O 0 0.043304260820150375
S O 1 0.9998406171798706
phase O 0 0.1229221373796463
. O 0 0.04846593365073204

Moreover O 0 0.05753711611032486
, O 0 0.021931273862719536
in O 0 0.022195257246494293
S O 1 0.9999434947967529
phase O 1 0.9972594976425171
cells O 0 0.06529965996742249
, O 0 0.04187896475195885
BRCA1 O 1 0.9990991353988647
polypeptides O 0 0.10662902891635895
are O 0 0.01877850480377674
hyperphosphorylated O 1 0.865527331829071
and O 0 0.028271114453673363
accumulate O 0 0.06670919060707092
into O 0 0.02588578499853611
discrete O 0 0.05907977372407913
subnuclear O 1 0.987818717956543
foci O 1 0.9980719089508057
termed O 1 0.8691220879554749
" O 0 0.09798150509595871
BRCA1 O 1 0.9998468160629272
nuclear O 0 0.1013338714838028
dots O 0 0.10920602083206177
. O 0 0.04265771061182022

" O 0 0.11487731337547302
BRCA1 O 1 0.9998617172241211
associates O 0 0.37346458435058594
in O 0 0.02605164237320423
vivo O 0 0.07895467430353165
with O 0 0.019767064601182938
a O 0 0.036925945430994034
structurally O 1 0.7544606328010559
related O 0 0.05203789845108986
protein O 0 0.06114346161484718
termed O 1 0.5080128908157349
BARD1 O 1 0.9998584985733032
. O 0 0.0617409348487854

Here O 0 0.038771580904722214
we O 0 0.014895305037498474
show O 0 0.014896088279783726
that O 0 0.007257567718625069
the O 0 0.01507896464318037
steady O 0 0.054584238678216934
- O 1 0.9474582672119141
state O 0 0.01448725163936615
levels O 0 0.020584968850016594
of O 0 0.024139754474163055
BARD1 O 1 0.9999866485595703
, O 0 0.02101159654557705
unlike O 0 0.02030724287033081
those O 0 0.010853847488760948
of O 0 0.029144644737243652
BRCA1 O 1 0.999830961227417
, O 0 0.021524839103221893
remain O 0 0.028213847428560257
relatively O 0 0.024281935766339302
constant O 0 0.04510891065001488
during O 0 0.051496703177690506
cell O 1 0.9793738126754761
cycle O 1 0.7513149380683899
progression O 1 0.9996569156646729
. O 0 0.06038897484540939

However O 0 0.03706565126776695
, O 0 0.03293213993310928
immunostaining O 1 0.9843237996101379
revealed O 0 0.04197218269109726
that O 0 0.018921053037047386
BARD1 O 1 0.9997362494468689
resides O 0 0.0842924639582634
within O 0 0.036486104130744934
BRCA1 O 1 0.9993681311607361
nuclear O 0 0.06528905034065247
dots O 0 0.06483767181634903
during O 0 0.03492167964577675
S O 1 0.9965736865997314
phase O 0 0.044181495904922485
of O 0 0.019506197422742844
the O 0 0.030897606164216995
cell O 0 0.4436192214488983
cycle O 0 0.045745015144348145
, O 0 0.015336785465478897
but O 0 0.009566833265125751
not O 0 0.008762700483202934
during O 0 0.02140822820365429
the O 0 0.03808453306555748
G1 O 1 0.9999960660934448
phase O 1 0.692023515701294
. O 0 0.05094771087169647

Nevertheless O 0 0.10401660203933716
, O 0 0.05868350714445114
BARD1 O 1 0.9999877214431763
polypeptides O 0 0.09433557093143463
are O 0 0.009955082088708878
found O 0 0.01192999817430973
exclusively O 0 0.01632010005414486
in O 0 0.009818462654948235
the O 0 0.016256682574748993
nuclear O 0 0.029557522386312485
fractions O 0 0.028997130692005157
of O 0 0.014996113255620003
both O 0 0.023565951734781265
G1 O 1 0.9999967813491821
- O 1 0.9998501539230347
and O 0 0.03321549668908119
S O 1 0.9999985694885254
- O 1 0.999998927116394
phase O 1 0.9959371089935303
cells O 0 0.06275442987680435
. O 0 0.03976958990097046

Therefore O 0 0.04968970641493797
, O 0 0.03319496288895607
progression O 1 0.8242910504341125
to O 0 0.03537631034851074
S O 1 0.9999622106552124
phase O 0 0.10665060579776764
is O 0 0.017487505450844765
accompanied O 0 0.032594528049230576
by O 0 0.013233327306807041
the O 0 0.018823828548192978
aggregation O 0 0.05127682164311409
of O 0 0.02577679045498371
nuclear O 0 0.06573869287967682
BARD1 O 1 0.9996370077133179
polypeptides O 0 0.11812686920166016
into O 0 0.05359151214361191
BRCA1 O 1 0.999052107334137
nuclear O 0 0.09300067275762558
dots O 0 0.10335730016231537
. O 0 0.04690762236714363

This O 0 0.03534046933054924
cell O 0 0.07511121779680252
cycle O 0 0.08348452299833298
- O 1 0.9994598031044006
dependent O 0 0.05187477543950081
colocalization O 1 0.911187469959259
of O 0 0.03994785249233246
BARD1 O 1 0.9999939203262329
and O 0 0.03786483779549599
BRCA1 O 1 0.9996028542518616
indicates O 0 0.031215837225317955
a O 0 0.019106261432170868
role O 0 0.02501550503075123
for O 0 0.020286472514271736
BARD1 O 1 0.9999260902404785
in O 0 0.03570733964443207
BRCA1 O 1 0.9999980926513672
- O 1 0.9999998807907104
mediated O 1 0.9999982118606567
tumor B-Disease 1 1.0
suppression O 1 0.9999951124191284
. O 0 0.0702003464102745

Ethnic O 0 0.05508311465382576
differences O 0 0.02969488687813282
in O 0 0.018461406230926514
the O 0 0.03802277520298958
HFE O 1 0.9999951124191284
codon O 1 0.8153660893440247
282 O 1 0.9950273633003235
( O 0 0.12125265598297119
Cys O 1 1.0
/ O 1 0.9999985694885254
Tyr O 1 0.9999996423721313
) O 0 0.06288554519414902
polymorphism O 0 0.11153028905391693
. O 0 0.04574425518512726

Recent O 0 0.04013364017009735
studies O 0 0.018288306891918182
have O 0 0.008427541702985764
shown O 0 0.01641206443309784
that O 0 0.027197180315852165
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999996423721313
HH B-Disease 1 1.0
) O 0 0.039784837514162064
is O 0 0.017513182014226913
likely O 0 0.015816587954759598
to O 0 0.0117762116715312
be O 0 0.010040545836091042
caused O 0 0.020990191027522087
by O 0 0.01645711250603199
homozygosity O 1 0.9674589037895203
for O 0 0.016917722299695015
a O 0 0.0299935732036829
Cys282Tyr O 1 0.9998757839202881
mutation O 0 0.04116276651620865
in O 0 0.014936964958906174
the O 0 0.03310481831431389
HFE O 1 0.9999977350234985
gene O 0 0.05539730563759804
located O 0 0.04966996610164642
4 O 0 0.04923337325453758
. O 0 0.038271237164735794

5 O 0 0.0978047326207161
Mb O 1 0.9933785200119019
telomeric O 1 0.9917469024658203
to O 0 0.07091645151376724
HLA O 1 1.0
- O 1 0.9999905824661255
A O 0 0.08110389113426208
. O 0 0.04351145401597023

Population O 0 0.03561640530824661
studies O 0 0.022987904027104378
of O 0 0.022028006613254547
this O 0 0.018305020406842232
polymorphism O 0 0.06223537027835846
are O 0 0.010281287133693695
facilitated O 0 0.044984977692365646
by O 0 0.014910411089658737
the O 0 0.015675989910960197
fact O 0 0.014879221096634865
that O 0 0.008607780560851097
the O 0 0.024786407127976418
Cys282Tyr O 1 0.9996441602706909
mutation O 0 0.07562224566936493
creates O 0 0.060763683170080185
a O 0 0.047017619013786316
Rsal O 1 0.9995470643043518
restriction O 0 0.08582702279090881
site O 0 0.056369662284851074
. O 0 0.03501986712217331

We O 0 0.02424941025674343
have O 0 0.00946949515491724
studied O 0 0.019753580912947655
the O 0 0.02321741357445717
codon O 0 0.09694510698318481
282 O 1 0.7382727861404419
( O 0 0.08307793736457825
Cys O 1 1.0
/ O 1 0.9999991655349731
Tyr O 1 0.9999992847442627
) O 0 0.04385984316468239
polymorphism O 0 0.05685851722955704
in O 0 0.01389909815043211
different O 0 0.00933842733502388
ethnic O 0 0.03013780154287815
groups O 0 0.02880336157977581
. O 0 0.03679285943508148

In O 0 0.027014512568712234
agreement O 0 0.02636374719440937
with O 0 0.015314506366848946
previous O 0 0.023456064984202385
observations O 0 0.03167523071169853
the O 0 0.036617085337638855
Tyr O 1 0.9999980926513672
allele O 0 0.09585969895124435
appeared O 0 0.031221114099025726
to O 0 0.01586938090622425
be O 0 0.012082722038030624
rare O 0 0.02458658255636692
or O 0 0.018522409722208977
absent O 0 0.051678616553545
in O 0 0.02215864323079586
Asiatic O 1 0.9998475313186646
( O 0 0.03220457211136818
Indian O 0 0.03818114474415779
, O 0 0.02442546933889389
Chinese O 0 0.03978929668664932
) O 0 0.027611400932073593
populations O 0 0.03530598059296608
. O 0 0.03368857130408287

The O 0 0.04886119067668915
highest O 0 0.09912677109241486
allele O 0 0.12713722884655
frequency O 0 0.04158959165215492
( O 0 0.024669714272022247
7 O 0 0.02796865440905094
. O 0 0.013402290642261505
5 O 0 0.023104919120669365
% O 0 0.0175765547901392
) O 0 0.014957942999899387
was O 0 0.019501909613609314
found O 0 0.013012673705816269
in O 0 0.01736523024737835
Swedes O 0 0.08929657936096191
. O 0 0.039972275495529175

Saamis O 1 0.9998238682746887
( O 0 0.04685528576374054
2 O 0 0.04212752729654312
% O 0 0.025168748572468758
) O 0 0.019590167328715324
and O 0 0.02221057191491127
Mordvinians O 1 0.9996944665908813
( O 0 0.02865101769566536
1 O 0 0.03231910243630409
. O 0 0.014241633005440235
8 O 0 0.027963951230049133
% O 0 0.019352296367287636
) O 0 0.016215715557336807
had O 0 0.015494384802877903
significantly O 0 0.022589057683944702
lower O 0 0.027031049132347107
frequencies O 0 0.01884021796286106
of O 0 0.02149532362818718
the O 0 0.04774060472846031
Tyr O 1 0.9999901056289673
allele O 0 0.17559635639190674
. O 0 0.05794525146484375

Comparisons O 0 0.08166565001010895
with O 0 0.03515293076634407
allele O 0 0.08385980874300003
frequencies O 0 0.023409094661474228
based O 0 0.01682071015238762
on O 0 0.018649134784936905
prevalence O 1 0.9532943367958069
estimates O 0 0.030341556295752525
of O 0 0.04197812080383301
HH B-Disease 1 1.0
showed O 0 0.036518726497888565
some O 0 0.014137637801468372
disagreements O 0 0.044187407940626144
with O 0 0.017399486154317856
the O 0 0.03233660012483597
RFLP O 1 0.9993290901184082
data O 0 0.02072075568139553
, O 0 0.01718207076191902
particularly O 0 0.02500257082283497
in O 0 0.024309348315000534
Finns O 0 0.13361896574497223
. O 0 0.04540213197469711

The O 0 0.0491534024477005
newly O 0 0.09289223700761795
described O 0 0.0795312449336052
HFE O 1 0.9999954700469971
marker O 1 0.9399600028991699
provides O 0 0.029314760118722916
a O 0 0.018695702776312828
new O 0 0.020121771842241287
approach O 0 0.0183901134878397
to O 0 0.011328640393912792
the O 0 0.016392188146710396
screening O 0 0.05096745491027832
of O 0 0.0394783578813076
HH B-Disease 1 1.0
as O 0 0.026760339736938477
well O 0 0.01427143719047308
as O 0 0.011926191858947277
studies O 0 0.009845491498708725
of O 0 0.011117976158857346
the O 0 0.01597902551293373
relationship O 0 0.028730811551213264
between O 0 0.021766943857073784
the O 0 0.041544102132320404
HFE O 1 0.9999998807907104
Tyr O 1 1.0
allele O 1 0.8031975626945496
and O 0 0.03254993259906769
different O 0 0.028091689571738243
disorders O 1 0.9999997615814209
including O 1 0.7805677056312561
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9998868703842163
dominant I-Disease 1 0.9999876022338867
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.05800710991024971
with O 0 0.02093392238020897
a O 0 0.029644418507814407
missense O 0 0.12187788635492325
mutation O 0 0.050269775092601776
encoding O 0 0.04305695369839668
Gly23 O 1 0.9995946288108826
- O 1 0.9999992847442627
- O 1 0.9999988079071045
> O 1 0.9995551705360413
Val O 1 0.999702513217926
in O 0 0.03869563341140747
neurophysin O 1 0.9998422861099243
II O 1 0.9999915361404419
. O 0 0.06139333173632622

Autosomal B-Disease 1 0.9998672008514404
dominant I-Disease 1 0.9999909400939941
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9976012110710144
ADNDI B-Disease 1 0.9999998807907104
) O 0 0.025101790204644203
is O 0 0.01609577238559723
an O 0 0.030539117753505707
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999982118606567
by O 1 0.9770897626876831
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.8365811705589294
the O 1 0.9359285831451416
magnocellular O 1 0.9999998807907104
neurons O 0 0.04436163976788521
of O 0 0.021665900945663452
the O 0 0.03522615507245064
hypothalamus O 1 0.9996404647827148
leading O 0 0.05362972617149353
to O 0 0.02488345094025135
decreased O 0 0.04147282987833023
ability O 0 0.019831445068120956
to O 0 0.015415642410516739
produce O 0 0.016466274857521057
the O 0 0.03637225553393364
hormone O 1 0.9998799562454224
arginine O 1 0.9999442100524902
vasopressin O 1 0.9999904632568359
( O 0 0.11314723640680313
AVP O 1 0.9999974966049194
) O 0 0.04939459636807442
. O 0 0.040866728872060776

Affected O 0 0.06820856034755707
individuals O 0 0.018786853179335594
are O 0 0.008912285789847374
not O 0 0.015967804938554764
symptomatic O 1 0.9999998807907104
at O 0 0.06436028331518173
birth O 1 0.76176518201828
, O 0 0.017142338678240776
but O 0 0.0134075116366148
usually O 0 0.0221853144466877
develop O 1 0.7619779706001282
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 1 0.5916833281517029
1 O 1 0.6613909602165222
- O 1 0.9999794960021973
6 O 0 0.0624697208404541
yr O 1 0.9974566102027893
of O 0 0.03718578442931175
age O 0 0.053159672766923904
. O 0 0.04455301910638809

The O 0 0.045755449682474136
genetic O 0 0.05075330287218094
locus O 0 0.08436813205480576
of O 0 0.026969918981194496
the O 0 0.03988582268357277
disease O 1 0.9999973773956299
is O 0 0.019568154588341713
the O 0 0.030464913696050644
AVP O 1 1.0
- O 1 0.9999997615814209
neurophysin O 1 0.9999979734420776
II O 1 1.0
( O 0 0.05479678139090538
NPII O 1 0.9999988079071045
) O 0 0.029272370040416718
gene O 0 0.02640828676521778
, O 0 0.013759276829659939
and O 0 0.016866866499185562
mutations O 0 0.03052038513123989
that O 0 0.015970127657055855
cause O 1 0.9858927130699158
ADNDI B-Disease 1 0.9999980926513672
have O 0 0.01114574819803238
been O 0 0.010720880702137947
found O 0 0.00850091502070427
in O 0 0.007181387860327959
both O 0 0.008029407821595669
the O 0 0.01704421453177929
signal O 0 0.03821671009063721
peptide O 0 0.03902031108736992
of O 0 0.014824564568698406
the O 0 0.02864312380552292
prepro O 1 0.9999661445617676
- O 1 0.9999996423721313
AVP O 1 0.9999997615814209
- O 1 0.9999983310699463
NPII O 1 0.9999909400939941
precursor O 0 0.1275893747806549
and O 0 0.024692263454198837
within O 0 0.0348718985915184
NPII O 1 0.9995256662368774
itself O 0 0.0687331035733223
. O 0 0.043485548347234726

An O 0 0.04611337184906006
affected O 0 0.054487649351358414
girl O 1 0.7979906797409058
who O 0 0.030022770166397095
presented O 0 0.029418492689728737
at O 0 0.020084481686353683
9 O 0 0.02587912045419216
months O 0 0.016919709742069244
of O 0 0.017352979630231857
age O 0 0.02533603087067604
and O 0 0.018138563260436058
her O 0 0.04019549861550331
similarly O 0 0.04707998037338257
affected O 0 0.0433344803750515
younger O 0 0.4315316677093506
brother O 1 0.9435157775878906
and O 0 0.02343248575925827
father O 0 0.05024850741028786
were O 0 0.010986746288836002
all O 0 0.009479496628046036
found O 0 0.009372306056320667
to O 0 0.00967768020927906
have O 0 0.006168211344629526
a O 0 0.01751818135380745
novel O 0 0.04362167790532112
missense O 0 0.10986906290054321
mutation O 0 0.0575968474149704
( O 0 0.031207691878080368
G1758 O 1 0.9999696016311646
- O 1 0.9999998807907104
- O 1 0.9999998807907104
> O 1 0.9999704360961914
T O 1 0.997542142868042
) O 0 0.019394584000110626
encoding O 0 0.02067837119102478
the O 0 0.017827335745096207
amino O 0 0.03359977900981903
acid O 0 0.05289381742477417
substitution O 0 0.07252059876918793
Gly23 O 1 0.9999796152114868
- O 1 0.9999998807907104
- O 1 0.9999996423721313
> O 1 0.9992951154708862
Val O 1 0.9986867308616638
within O 0 0.05425970256328583
NPII O 1 0.9998145699501038
. O 0 0.05614045262336731

The O 0 0.060656022280454636
mutation O 0 0.07293108850717545
was O 0 0.03421391546726227
confirmed O 0 0.030524827539920807
by O 0 0.028498927131295204
restriction O 0 0.07894682884216309
endonuclease O 1 0.9825204014778137
analysis O 0 0.03588526323437691
. O 0 0.035294901579618454

A O 0 0.1869351863861084
T1 O 1 0.9999978542327881
- O 1 0.99978107213974
weighted O 0 0.08609951287508011
magnetic O 0 0.06256368011236191
resonance O 0 0.05367666855454445
imaging O 0 0.04340418428182602
of O 0 0.01954481564462185
the O 0 0.03244069963693619
fathers O 1 0.9999111890792847
pituitary O 1 1.0
gland O 1 0.999998927116394
demonstrates O 0 0.29545310139656067
an O 0 0.06136690080165863
attenuated O 1 0.9999998807907104
posterior O 1 0.9999997615814209
pituitary O 1 1.0
bright O 1 0.9993911981582642
spot O 0 0.18242907524108887
. O 0 0.04818210378289223

This O 0 0.050490185618400574
mutation O 0 0.08198227733373642
may O 0 0.02026228979229927
be O 0 0.010588646866381168
valuable O 0 0.018452191725373268
for O 0 0.011655928567051888
developing O 0 0.025154830887913704
models O 0 0.019511889666318893
of O 0 0.030728893354535103
dominantly B-Disease 1 0.9999998807907104
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.032203227281570435
as O 0 0.015717389062047005
the O 0 0.013156165368855
early O 0 0.015135318972170353
age O 0 0.018726948648691177
of O 0 0.025364195927977562
onset O 1 1.0
of O 1 0.9998782873153687
symptoms O 1 1.0
suggests O 0 0.23501230776309967
that O 0 0.012941847555339336
this O 0 0.015109766274690628
mutation O 0 0.04185712710022926
may O 0 0.014811505563557148
be O 0 0.010085229761898518
particularly O 0 0.020522447302937508
deleterious O 0 0.06938556581735611
to O 0 0.02279062196612358
the O 0 0.0418071448802948
magnocellular O 1 0.9999995231628418
neuron O 1 0.9985132813453674
. O 0 0.03506460413336754
. O 0 0.04042555391788483

Frequent O 0 0.13625356554985046
inactivation O 1 0.999815046787262
of O 0 0.09133347868919373
PTEN O 1 1.0
/ O 1 0.9999947547912598
MMAC1 O 1 0.9999890327453613
in O 0 0.04970209673047066
primary O 1 0.9999963045120239
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9389537572860718

Sporadic B-Disease 1 0.9999988079071045
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.03768317773938179
the O 0 0.022296931594610214
most O 0 0.01768028736114502
common O 0 0.031188620254397392
male B-Disease 1 0.9998728036880493
cancer I-Disease 1 0.9999998807907104
in O 0 0.01675056666135788
the O 0 0.021023306995630264
Western O 0 0.031214479357004166
world O 0 0.024377794936299324
, O 0 0.011808807030320168
yet O 0 0.010209006257355213
many O 0 0.0054800850339233875
of O 0 0.010583363473415375
the O 0 0.016691753640770912
major O 0 0.032343391329050064
genetic O 0 0.02627655677497387
events O 0 0.011955407448112965
involved O 0 0.012597203254699707
in O 0 0.010397995822131634
the O 0 0.019998740404844284
progression O 1 0.999276340007782
of O 0 0.021472742781043053
this O 0 0.01894630677998066
often O 0 0.03502819314599037
fatal O 1 0.9999998807907104
cancer B-Disease 1 1.0
remain O 0 0.07322336733341217
to O 0 0.030664192512631416
be O 0 0.026028770953416824
elucidated O 0 0.4448975920677185
. O 0 0.04232822358608246

Numerous O 0 0.08914022147655487
cytogenetic O 1 0.9991173148155212
and O 0 0.046844232827425
allelotype O 1 0.9998880624771118
studies O 0 0.023522447794675827
have O 0 0.010304570198059082
reported O 0 0.022301530465483665
frequent O 0 0.03561333566904068
loss O 0 0.035485971719026566
of O 0 0.031727384775877
heterozygosity O 1 0.9999006986618042
on O 0 0.03845132514834404
chromosomal O 1 0.9997413754463196
arm O 1 0.997783362865448
10q O 1 0.9998247027397156
in O 0 0.04869726300239563
sporadic B-Disease 1 0.9999988079071045
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8782817721366882

Deletion O 0 0.21965999901294708
mapping O 0 0.07321920990943909
studies O 0 0.023410610854625702
have O 0 0.011868259869515896
unambiguously O 0 0.06353224813938141
identified O 0 0.020394621416926384
a O 0 0.01820606179535389
region O 0 0.02433563396334648
of O 0 0.030054215341806412
chromosome O 0 0.14627251029014587
10q23 O 1 0.98292475938797
to O 0 0.017311643809080124
be O 0 0.009343735873699188
the O 0 0.014660264365375042
minimal O 0 0.02992408163845539
area O 0 0.0238035898655653
of O 0 0.02488468773663044
loss O 0 0.15764273703098297
. O 0 0.04605884477496147

A O 0 0.0643981322646141
new O 0 0.06681154668331146
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999998807907104
gene O 0 0.07689298689365387
, O 0 0.04581354930996895
PTEN O 1 1.0
/ O 1 0.9999964237213135
MMAC1 O 1 0.9999977350234985
, O 0 0.024651648476719856
was O 0 0.03034774214029312
isolated O 0 0.045213572680950165
recently O 0 0.02318214811384678
at O 0 0.015409381128847599
this O 0 0.008683189749717712
region O 0 0.02029171772301197
of O 0 0.02503419667482376
chromosome O 0 0.4607152044773102
10q23 O 1 0.9993114471435547
and O 0 0.018938014283776283
found O 0 0.011944575235247612
to O 0 0.011859477497637272
be O 0 0.012122065760195255
inactivated O 0 0.1780800074338913
by O 0 0.015547792427241802
mutation O 0 0.03193387761712074
in O 0 0.016979394480586052
three O 0 0.066651351749897
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999983310699463
lines O 0 0.07385262846946716
. O 0 0.04717881605029106

We O 0 0.03748596832156181
screened O 0 0.11601942032575607
80 O 1 0.7725942134857178
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 0.05553286895155907
microsatellite O 1 0.9937114715576172
analysis O 0 0.023478267714381218
and O 0 0.015788771212100983
found O 0 0.021554075181484222
chromosome O 0 0.06903250515460968
10q23 O 1 0.9764704704284668
to O 0 0.022574741393327713
be O 0 0.014243138954043388
deleted O 0 0.03973810747265816
in O 0 0.014723867177963257
23 O 0 0.04006992653012276
cases O 0 0.038070883601903915
. O 0 0.04367903247475624

We O 0 0.03295715153217316
then O 0 0.0269022136926651
proceeded O 0 0.0402379184961319
with O 0 0.014187137596309185
sequence O 0 0.014282308518886566
analysis O 0 0.00865321233868599
of O 0 0.009761992841959
the O 0 0.019266178831458092
entire O 0 0.08860667049884796
PTEN O 1 1.0
/ O 1 0.9999988079071045
MMAC1 O 1 0.9999996423721313
coding O 0 0.09639563411474228
region O 0 0.03507881984114647
and O 0 0.01837090216577053
tested O 0 0.03412725031375885
for O 0 0.01998654007911682
homozygous O 0 0.06499681621789932
deletion O 0 0.06647701561450958
with O 0 0.020621847361326218
new O 0 0.03752700239419937
intragenic O 1 0.9998918771743774
markers O 0 0.057222213596105576
in O 0 0.01373327523469925
these O 0 0.008758456446230412
23 O 0 0.024271510541439056
cases O 0 0.020294593647122383
with O 0 0.02559707686305046
10q23 O 1 0.9999368190765381
loss O 0 0.2747901380062103
of O 0 0.061863627284765244
heterozygosity O 1 0.9999616146087646
. O 0 0.06674976646900177

The O 0 0.034963950514793396
identification O 0 0.0262773260474205
of O 0 0.016199961304664612
the O 0 0.021087773144245148
second O 0 0.05228867009282112
mutational O 1 0.9998070597648621
event O 0 0.03169988468289375
in O 0 0.014769745990633965
10 O 0 0.01882810890674591
( O 0 0.019382696598768234
43 O 0 0.03754758462309837
% O 0 0.030238937586545944
) O 0 0.04052248224616051
tumors B-Disease 1 0.999998927116394
establishes O 1 0.9999872446060181
PTEN O 1 1.0
/ O 1 0.9999978542327881
MMAC1 O 1 0.9999833106994629
as O 0 0.023962995037436485
a O 0 0.025894461199641228
main O 0 0.043420758098363876
inactivation O 1 0.8863117098808289
target O 0 0.023956740275025368
of O 0 0.022309545427560806
10q O 1 0.9962945580482483
loss O 0 0.048895251005887985
in O 0 0.03381795808672905
sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.725852370262146
. O 0 0.05138126388192177

Risk O 0 0.29689082503318787
reversals O 0 0.18718788027763367
in O 0 0.03046208992600441
predictive O 0 0.09281469136476517
testing O 0 0.058439016342163086
for O 1 0.5081667304039001
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.5444543361663818

The O 0 0.030974188819527626
first O 0 0.028079146519303322
predictive O 0 0.05611561983823776
testing O 0 0.03658364340662956
for O 0 0.04641985520720482
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9995096921920776
HD B-Disease 1 0.9999953508377075
) O 0 0.023452382534742355
was O 0 0.02034357190132141
based O 0 0.013320909813046455
on O 0 0.011132827959954739
analysis O 0 0.0119340680539608
of O 0 0.01935568079352379
linked O 0 0.06920090317726135
polymorphic O 1 0.9842234253883362
DNA O 0 0.051892224699258804
markers O 0 0.04540645331144333
to O 0 0.0158380176872015
estimate O 0 0.016060063615441322
the O 0 0.01451447419822216
likelihood O 0 0.03154025599360466
of O 0 0.024098575115203857
inheriting O 1 0.9612312912940979
the O 0 0.0475291907787323
mutation O 0 0.07784586399793625
for O 0 0.039567749947309494
HD B-Disease 1 0.997480571269989
. O 0 0.0524263009428978

Limits O 0 0.04913945496082306
to O 0 0.02339891716837883
accuracy O 0 0.026304511353373528
included O 0 0.022120775654911995
recombination O 0 0.050557661801576614
between O 0 0.016342749819159508
the O 0 0.021888667717576027
DNA O 0 0.03441409021615982
markers O 0 0.0382864847779274
and O 0 0.014494198374450207
the O 0 0.022685501724481583
mutation O 0 0.05232492461800575
, O 0 0.025315068662166595
pedigree O 0 0.2314935028553009
structure O 0 0.031015412881970406
, O 0 0.01512207556515932
and O 0 0.013282058760523796
whether O 0 0.017304008826613426
DNA O 0 0.02533962018787861
samples O 0 0.016215480864048004
were O 0 0.00726793659850955
available O 0 0.009076185524463654
from O 0 0.014742528088390827
family O 0 0.033377233892679214
members O 0 0.033545996993780136
. O 0 0.039480626583099365

With O 0 0.03361582010984421
direct O 0 0.028001651167869568
tests O 0 0.018420102074742317
for O 0 0.01461801864206791
the O 0 0.034643322229385376
HD B-Disease 1 0.9999877214431763
mutation O 0 0.08577932417392731
, O 0 0.01798863150179386
we O 0 0.010261515155434608
have O 0 0.007308802101761103
assessed O 0 0.019319983199238777
the O 0 0.013646433129906654
accuracy O 0 0.016740158200263977
of O 0 0.015750711783766747
results O 0 0.014585635624825954
obtained O 0 0.017558202147483826
by O 0 0.023094255477190018
linkage O 0 0.089693084359169
approaches O 0 0.043974507600069046
when O 0 0.022413358092308044
requested O 0 0.03201178461313248
to O 0 0.016438668593764305
do O 0 0.011834865435957909
so O 0 0.010417817160487175
by O 0 0.012765484862029552
the O 0 0.02289389632642269
test O 0 0.04144697263836861
individuals O 0 0.029058480635285378
. O 0 0.03786102682352066

For O 0 0.03020581230521202
six O 0 0.023729359731078148
such O 0 0.014606243930757046
individuals O 0 0.017669780179858208
, O 0 0.015965661033988
there O 0 0.01174662634730339
was O 0 0.02521957829594612
significant O 0 0.023513952270150185
disparity O 0 0.0715000331401825
between O 0 0.03025348298251629
the O 0 0.033319201320409775
tests O 0 0.0405510738492012
. O 0 0.0402463935315609

Three O 0 0.029082508757710457
went O 0 0.03324465826153755
from O 0 0.021012643352150917
a O 0 0.03370114415884018
decreased O 0 0.41024601459503174
risk O 0 0.04675119370222092
to O 0 0.017881400883197784
an O 0 0.0190330371260643
increased O 0 0.03356281295418739
risk O 1 0.559632420539856
, O 0 0.015355922281742096
while O 0 0.011376743204891682
in O 0 0.008295480161905289
another O 0 0.014601364731788635
three O 0 0.012750084511935711
the O 0 0.02639518491923809
risk O 0 0.42438170313835144
was O 0 0.052678946405649185
decreased O 0 0.21334798634052277
. O 0 0.04449988901615143

Knowledge O 0 0.04375956580042839
of O 0 0.023110540583729744
the O 0 0.025621311739087105
potential O 0 0.03152162954211235
reasons O 0 0.01896435022354126
for O 0 0.012047830037772655
these O 0 0.007620586082339287
changes O 0 0.010257495567202568
in O 0 0.009830936789512634
results O 0 0.010404474101960659
and O 0 0.011826048605144024
impact O 0 0.01922122947871685
of O 0 0.01734280213713646
these O 0 0.014420256949961185
risk O 0 0.12208118289709091
reversals O 1 0.9953599572181702
on O 0 0.02414960041642189
both O 0 0.022298535332083702
patients O 1 0.9958837628364563
and O 0 0.020402824506163597
the O 0 0.030782906338572502
counseling O 1 0.9997510313987732
team O 0 0.026935569941997528
can O 0 0.012583053670823574
assist O 0 0.027833202853798866
in O 0 0.009844458661973476
the O 0 0.014222579076886177
development O 0 0.017848888412117958
of O 0 0.017830757424235344
strategies O 0 0.03049480728805065
for O 0 0.015291419811546803
the O 0 0.026638228446245193
prevention O 1 0.9999977350234985
and O 0 0.021288219839334488
, O 0 0.017250746488571167
where O 0 0.015496829524636269
necessary O 0 0.016340628266334534
, O 0 0.013169880025088787
management O 0 0.0212026946246624
of O 0 0.015523849986493587
a O 0 0.030577922239899635
risk O 0 0.45748937129974365
reversal O 0 0.34988632798194885
in O 0 0.015569220297038555
any O 0 0.020245080813765526
predictive O 0 0.06484340131282806
testing O 0 0.04196058586239815
program O 0 0.036961425095796585
. O 0 0.021739603951573372
. O 0 0.030426593497395515

A O 0 0.08304360508918762
novel O 0 0.07843577116727829
common O 0 0.049908597022295
missense O 0 0.37361258268356323
mutation O 0 0.07650095969438553
G301C O 1 0.6865094304084778
in O 0 0.01496114768087864
the O 0 0.023944508284330368
N O 1 0.9773110747337341
- O 1 0.9998294115066528
acetylgalactosamine O 1 0.9999003410339355
- O 1 0.9999574422836304
6 O 0 0.08534926921129227
- O 1 0.9999972581863403
sulfate O 1 0.9999940395355225
sulfatase O 1 0.9999951124191284
gene O 0 0.05787013843655586
in O 0 0.040814004838466644
mucopolysaccharidosis B-Disease 1 0.9995823502540588
IVA I-Disease 1 0.9999973773956299
. O 0 0.07863370329141617

Mucopolysaccharidosis B-Disease 1 0.9998735189437866
IVA I-Disease 1 0.9999996423721313
( O 0 0.08360999077558517
MPS B-Disease 1 0.9999570846557617
IVA I-Disease 1 1.0
) O 0 0.031328924000263214
is O 0 0.018379442393779755
an O 0 0.027956685051321983
autosomal B-Disease 1 0.9999991655349731
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999552965164185
by O 0 0.03221253305673599
a O 0 0.044238582253456116
genetic B-Disease 1 0.8340251445770264
defect I-Disease 1 0.9999949932098389
in O 0 0.02217154949903488
N O 1 0.9964565634727478
- O 1 0.9999322891235352
acetylgalactosamine O 1 0.9998834133148193
- O 1 0.999966025352478
6 O 0 0.125458762049675
- O 1 0.9999992847442627
sulfate O 1 0.9999992847442627
sulfatase O 1 0.9999997615814209
( O 0 0.08091394603252411
GALNS O 1 0.9999879598617554
) O 0 0.05043123662471771
. O 0 0.040263451635837555

In O 0 0.02803461253643036
previous O 0 0.031324602663517
studies O 0 0.022631237283349037
, O 0 0.01482051145285368
we O 0 0.009244692511856556
have O 0 0.006311125122010708
found O 0 0.008418460376560688
two O 0 0.010095417499542236
common O 0 0.024928763508796692
mutations O 0 0.03448693826794624
in O 0 0.02143886685371399
Caucasians O 1 0.9992524981498718
and O 0 0.025610318407416344
Japanese O 0 0.06874870508909225
, O 0 0.024768980219960213
respectively O 0 0.03597157821059227
. O 0 0.03504486382007599

To O 0 0.05474625527858734
characterize O 0 0.11195030808448792
the O 0 0.05828169733285904
mutational O 1 0.9976373910903931
spectrum O 0 0.06252222508192062
in O 0 0.015663281083106995
various O 0 0.012127417139708996
ethnic O 0 0.025809988379478455
groups O 0 0.017702411860227585
, O 0 0.015980836004018784
mutations O 0 0.020873337984085083
in O 0 0.010967073030769825
the O 0 0.02400270849466324
GALNS O 1 0.9999945163726807
gene O 0 0.030642475932836533
in O 0 0.014697030186653137
Colombian O 0 0.14415553212165833
MPS B-Disease 1 0.9999650716781616
IVA I-Disease 1 1.0
patients O 1 0.9999889135360718
were O 0 0.022317856550216675
investigated O 0 0.05136660486459732
, O 0 0.023002056404948235
and O 0 0.02033487893640995
genetic O 0 0.03127427026629448
backgrounds O 0 0.025795215740799904
were O 0 0.011748204007744789
extensively O 0 0.024839121848344803
analyzed O 0 0.02296765148639679
to O 0 0.014323431067168713
identify O 0 0.02417737804353237
racial O 0 0.03542698174715042
origin O 0 0.014656683430075645
, O 0 0.012993309646844864
based O 0 0.01599843055009842
on O 0 0.022046919912099838
mitochondrial O 0 0.10506150871515274
DNA O 0 0.05312023311853409
( O 0 0.04105692356824875
mtDNA O 0 0.06768924742937088
) O 0 0.03424946591258049
lineages O 0 0.07095589488744736
. O 0 0.04435945674777031

Three O 0 0.04262008145451546
novel O 0 0.09624487906694412
missense O 1 0.8681867718696594
mutations O 0 0.059029195457696915
never O 0 0.03434152901172638
identified O 0 0.023455720394849777
previously O 0 0.016530027613043785
in O 0 0.009790466167032719
other O 0 0.009761679917573929
populations O 0 0.017727253958582878
and O 0 0.012413452379405499
found O 0 0.010785156860947609
in O 0 0.009456457570195198
16 O 0 0.016044054180383682
out O 0 0.012507443316280842
of O 0 0.015151362866163254
19 O 0 0.03799615055322647
Colombian O 0 0.4439387023448944
MPS B-Disease 1 0.9996576309204102
IVA I-Disease 1 1.0
unrelated O 0 0.13701148331165314
alleles O 0 0.08203862607479095
account O 0 0.029832476750016212
for O 0 0.026347242295742035
84 O 0 0.09149350225925446
. O 0 0.04755125939846039

2 O 0 0.05479642003774643
% O 0 0.021714774891734123
of O 0 0.02020327001810074
the O 0 0.028482427820563316
alleles O 0 0.05805695056915283
in O 0 0.019225647673010826
this O 0 0.016608405858278275
study O 0 0.03101617470383644
. O 0 0.036534834653139114

The O 0 0.07652436196804047
G301C O 1 0.9866904020309448
and O 0 0.05125464126467705
S162F O 1 0.9990457892417908
mutations O 0 0.05657130107283592
account O 0 0.027078889310359955
for O 0 0.025496790185570717
68 O 0 0.08094337582588196
. O 0 0.048431284725666046

4 O 0 0.07507525384426117
% O 0 0.03673023730516434
and O 0 0.02627655677497387
10 O 0 0.03651781752705574
. O 0 0.039071470499038696

5 O 0 0.05002113804221153
% O 0 0.025546617805957794
of O 0 0.02950248494744301
mutations O 0 0.04401528835296631
, O 0 0.02038085274398327
respectively O 0 0.02371314913034439
, O 0 0.01633107289671898
whereas O 0 0.020647455006837845
the O 0 0.016405433416366577
remaining O 0 0.043964505195617676
F69V O 1 0.9999555349349976
is O 0 0.019764838740229607
limited O 0 0.01610383205115795
to O 0 0.01420257706195116
a O 0 0.025532975792884827
single O 0 0.05320269986987114
allele O 0 0.09833452105522156
. O 0 0.04242556914687157

The O 0 0.05769732594490051
skewed O 0 0.10511855036020279
prevalence O 1 0.7487782835960388
of O 0 0.04426087439060211
G301C O 1 0.9989890456199646
in O 0 0.02417604625225067
only O 0 0.0220551248639822
Colombian O 1 0.7517749667167664
patients O 1 0.9937506318092346
and O 0 0.030599385499954224
haplotype O 1 0.7543851137161255
analysis O 0 0.018823502585291862
by O 0 0.01875462383031845
restriction O 0 0.04851127415895462
fragment O 0 0.06026501581072807
length O 0 0.02721034176647663
polymorphisms O 0 0.051199402660131454
in O 0 0.014170220121741295
the O 0 0.031055962666869164
GALNS O 1 0.9999582767486572
gene O 0 0.040928106755018234
suggest O 0 0.02139243669807911
that O 0 0.013921499252319336
G301C O 0 0.2636517286300659
originated O 0 0.034868255257606506
from O 0 0.016283655539155006
a O 0 0.026816323399543762
common O 0 0.037586480379104614
ancestor O 0 0.0986156091094017
. O 0 0.044067755341529846

Investigation O 0 0.05531558394432068
of O 0 0.025028282776474953
the O 0 0.03151537850499153
genetic O 0 0.03698429465293884
background O 0 0.027076197788119316
by O 0 0.01504799909889698
means O 0 0.019793862476944923
of O 0 0.022663453593850136
mtDNA O 0 0.05530908331274986
lineages O 0 0.043546922504901886
indicate O 0 0.018021974712610245
that O 0 0.00905167032033205
all O 0 0.012390783987939358
our O 0 0.03003147803246975
patients O 1 0.860238790512085
are O 0 0.010580582544207573
probably O 0 0.02023444138467312
of O 0 0.021577434614300728
native O 0 0.036519646644592285
American O 0 0.06204140558838844
descent O 0 0.13159219920635223

Low O 0 0.0804964080452919
frequency O 0 0.03959306702017784
of O 0 0.042285285890102386
BRCA1 O 1 0.99996018409729
germline O 1 0.9944565296173096
mutations O 0 0.03560496121644974
in O 0 0.013349129818379879
45 O 0 0.03826158866286278
German O 1 0.9998921155929565
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9858520030975342
. O 0 0.06209453195333481

In O 0 0.02461600862443447
this O 0 0.012489045970141888
study O 0 0.013827161863446236
we O 0 0.008122810162603855
investigated O 0 0.026919135823845863
45 O 0 0.032123636454343796
German O 1 0.9994105100631714
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.7914169430732727
for O 0 0.04212459549307823
germline O 1 0.9999523162841797
mutations O 0 0.040751099586486816
in O 0 0.016963617876172066
the O 0 0.038751717656850815
BRCA1 O 1 0.9999654293060303
gene O 0 0.06405361741781235
. O 0 0.04016050323843956

We O 0 0.025566913187503815
identified O 0 0.026066871359944344
four O 0 0.023088790476322174
germline O 0 0.4041827321052551
mutations O 0 0.03477301448583603
in O 0 0.01650586910545826
three O 0 0.038226205855607986
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.029794767498970032
and O 0 0.01125024538487196
in O 0 0.011908729560673237
one O 0 0.04156588390469551
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9998905658721924
. O 0 0.017082514241337776
among O 0 0.013851610943675041
these O 0 0.005574186332523823
were O 0 0.007620300631970167
one O 0 0.02069585770368576
frameshift O 1 0.9973638653755188
mutation O 0 0.05482746288180351
, O 0 0.01824110373854637
one O 0 0.02195608615875244
nonsense O 1 0.7318161725997925
mutation O 0 0.04438972473144531
, O 0 0.016019590198993683
one O 0 0.01729930005967617
novel O 0 0.04912368208169937
splice O 0 0.13963951170444489
site O 0 0.04765097424387932
mutation O 0 0.046285368502140045
, O 0 0.01623365469276905
and O 0 0.018035022541880608
one O 0 0.031071104109287262
missense O 1 0.694770872592926
mutation O 0 0.1000765785574913
. O 0 0.04842115566134453

The O 0 0.061080437153577805
missense O 0 0.4542006552219391
mutation O 0 0.08678330481052399
was O 0 0.03410974144935608
also O 0 0.01708846352994442
found O 0 0.014107477851212025
in O 0 0.017423877492547035
2 O 0 0.040935125201940536
. O 0 0.03329934924840927

8 O 0 0.04462376981973648
% O 0 0.01824747957289219
of O 0 0.0152888847514987
the O 0 0.019618652760982513
general O 0 0.030234016478061676
population O 0 0.018112516030669212
, O 0 0.015409496612846851
suggesting O 0 0.01901528611779213
that O 0 0.00847402960062027
it O 0 0.009527675807476044
is O 0 0.01742389425635338
not O 0 0.023978019133210182
disease O 1 0.9999898672103882
associated O 0 0.051223572343587875
. O 0 0.04884635657072067

The O 0 0.03309433162212372
average O 0 0.03242764249444008
age O 0 0.039027150720357895
of O 1 0.8078985810279846
disease O 1 1.0
onset O 1 1.0
in O 0 0.031240129843354225
those O 0 0.02466334030032158
families O 0 0.053643789142370224
harbouring O 1 0.9999996423721313
causative O 1 0.9999974966049194
mutations O 0 0.066073477268219
was O 0 0.04014512524008751
between O 0 0.03051792085170746
32 O 0 0.05401384457945824
. O 0 0.0388336107134819

3 O 0 0.0705433040857315
and O 0 0.036787550896406174
37 O 0 0.0745747908949852
. O 0 0.04672737047076225

4 O 0 0.05649565905332565
years O 0 0.026824569329619408
, O 0 0.020551316440105438
whereas O 0 0.02464723400771618
the O 0 0.021513953804969788
family O 0 0.04354836419224739
harbouring O 1 0.9998056292533875
the O 0 0.04721638932824135
missense O 1 0.9816869497299194
mutation O 0 0.05360975116491318
had O 0 0.018694818019866943
an O 0 0.015200057998299599
average O 0 0.02044312097132206
age O 0 0.0258223507553339
of O 0 0.032481737434864044
onset O 1 0.999994158744812
of O 0 0.05266907438635826
51 O 0 0.2586551606655121
. O 0 0.05062561482191086

2 O 0 0.08574765920639038
years O 0 0.049179550260305405
. O 0 0.0487792082130909

These O 0 0.020044751465320587
findings O 0 0.026948232203722
show O 0 0.02521553635597229
that O 0 0.019098198041319847
BRCA1 O 1 0.9967005848884583
is O 0 0.023631783202290535
implicated O 0 0.049447573721408844
in O 0 0.01105900015681982
a O 0 0.014379151165485382
small O 0 0.013531346805393696
fraction O 0 0.035150960087776184
of O 0 0.47793424129486084
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.24014554917812347
suggesting O 0 0.032108232378959656
the O 0 0.018119918182492256
involvement O 0 0.03440166264772415
of O 0 0.022931192070245743
another O 0 0.1221335232257843
susceptibility O 1 0.9999972581863403
gene O 0 0.09042198210954666
( O 0 0.04973495006561279
s O 1 0.7747235298156738
) O 0 0.05909484252333641

Paternal O 1 0.9907172322273254
transmission O 1 0.9885225296020508
of O 1 0.9999352693557739
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9995318651199341

We O 0 0.026186339557170868
report O 0 0.019838040694594383
a O 0 0.018780505284667015
rare O 0 0.02530575543642044
case O 0 0.0268253143876791
of O 0 0.04238269105553627
paternally O 1 0.9999873638153076
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.07174655795097351
. O 0 0.043839748948812485

The O 0 0.05951773375272751
proband O 1 0.9943696856498718
is O 0 0.019226310774683952
a O 0 0.01850920356810093
23 O 0 0.023614976555109024
year O 0 0.01803424395620823
old O 0 0.05823415517807007
, O 0 0.03287109360098839
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 1.0
male O 1 0.9998843669891357
who O 1 0.9997902512550354
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9642705321311951

He O 0 0.03770923614501953
presented O 0 0.048708949238061905
with O 0 0.24081264436244965
respiratory O 1 1.0
and O 1 0.9981998205184937
feeding O 1 0.9999886751174927
difficulties O 1 0.9999315738677979
at O 1 0.7652851343154907
birth O 1 0.9983763694763184
. O 0 0.04622244834899902

His O 0 0.06159140169620514
two O 0 0.0451602004468441
sibs O 1 0.9999792575836182
suffer O 1 0.9959356784820557
from O 0 0.07489258795976639
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.626727283000946

Their O 0 0.026295633986592293
late O 0 0.037103038281202316
father O 0 0.04487009346485138
had O 0 0.016072826460003853
the O 0 0.01755325123667717
adult O 0 0.03779533505439758
type O 0 0.05388984456658363
of O 0 0.46673768758773804
DM B-Disease 1 1.0
, O 0 0.03516995161771774
with O 0 0.03198680654168129
onset O 1 0.9999996423721313
around O 0 0.030715689063072205
30 O 0 0.03293029963970184
years O 0 0.029795706272125244
. O 0 0.036912914365530014

Only O 0 0.020493341609835625
six O 0 0.015507113188505173
other O 0 0.009002713486552238
cases O 0 0.013859267346560955
of O 0 0.024902870878577232
paternal O 1 0.999924898147583
transmission O 1 0.9998840093612671
of O 1 0.999994158744812
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.02823822572827339
been O 0 0.02097414806485176
reported O 0 0.02861679159104824
recently O 0 0.04109805449843407
. O 0 0.03389040008187294

We O 0 0.025726497173309326
review O 0 0.03139717876911163
the O 0 0.023985231295228004
sex O 0 0.05167735368013382
related O 0 0.03002363070845604
effects O 0 0.03740576654672623
on O 0 0.02875783108174801
transmission O 1 0.9789922833442688
of O 1 0.9987647533416748
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8986727595329285

Decreased O 0 0.12149477005004883
fertility O 1 0.9336057305335999
of O 0 0.02766302041709423
males O 0 0.02669190987944603
with O 0 0.025681300088763237
adult O 1 0.9995212554931641
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.07434634864330292
contraction O 1 0.6086893081665039
of O 0 0.021846359595656395
the O 0 0.025230225175619125
repeat O 0 0.06633097678422928
upon O 0 0.037664055824279785
male O 0 0.16642044484615326
transmission O 0 0.05151592195034027
contribute O 0 0.02409423142671585
to O 0 0.013042335398495197
the O 0 0.014233642257750034
almost O 0 0.01449886430054903
absent O 0 0.04234236851334572
occurrence O 0 0.039077647030353546
of O 0 0.028510427102446556
paternal O 1 0.9994800686836243
transmission O 1 0.9991061091423035
of O 1 0.9997805953025818
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.930602490901947

Also O 0 0.025957852602005005
the O 0 0.02323850244283676
fathers O 0 0.04613901674747467
of O 0 0.01919364742934704
the O 0 0.027826745063066483
reported O 0 0.049130264669656754
congenitally O 1 0.9999938011169434
affected O 0 0.05056791380047798
children O 0 0.03762071952223778
showed O 0 0.027602417394518852
, O 0 0.015703268349170685
on O 0 0.015261759981513023
average O 0 0.02169799990952015
, O 0 0.020416174083948135
shorter O 0 0.05025065690279007
CTG O 1 0.9998952150344849
repeat O 0 0.09914765506982803
lengths O 0 0.05601627379655838
and O 0 0.022652123123407364
hence O 0 0.03427399322390556
less O 0 0.03178654983639717
severe O 1 0.9999992847442627
clinical O 1 1.0
symptoms O 1 1.0
than O 0 0.023158226162195206
the O 0 0.028708694502711296
mothers O 1 0.9105598330497742
of O 0 0.029895292595028877
children O 1 0.8473402857780457
with O 1 0.9996424913406372
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9900872111320496

We O 0 0.025545738637447357
conclude O 0 0.041123054921627045
that O 0 0.01364213414490223
paternal O 0 0.45617637038230896
transmission O 1 0.8122109174728394
of O 1 0.9989379048347473
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.8329997062683105
rare O 0 0.10900698602199554
and O 0 0.022462842985987663
preferentially O 0 0.08539338409900665
occurs O 0 0.024218887090682983
with O 0 0.01977800391614437
onset O 1 0.9999998807907104
of O 1 0.9891259670257568
DM B-Disease 1 1.0
past O 0 0.037679705768823624
30 O 0 0.023375308141112328
years O 0 0.013258368708193302
in O 0 0.011368594132363796
the O 0 0.023556454107165337
father O 0 0.07343453168869019
. O 0 0.024727605283260345
. O 0 0.03528729826211929

The O 0 0.09557823091745377
RB1 O 1 0.9999960660934448
gene O 0 0.07112544029951096
mutation O 0 0.04843636229634285
in O 0 0.016589637845754623
a O 0 0.030643444508314133
child O 1 0.9521352648735046
with O 0 0.13092105090618134
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.3160072863101959

The O 0 0.09329890459775925
RB1 O 1 0.9999994039535522
gene O 0 0.07268799096345901
mutation O 0 0.054014064371585846
was O 0 0.026225190609693527
investigated O 0 0.034015215933322906
in O 0 0.012317893095314503
a O 0 0.02542302943766117
child O 1 0.7372995615005493
with O 0 0.06270795315504074
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
using O 0 0.033248420804739
DNA O 0 0.02785462699830532
obtained O 0 0.013459471054375172
from O 0 0.009156301617622375
both O 0 0.0121022779494524
the O 0 0.03176363185048103
pineal B-Disease 1 0.999998927116394
and I-Disease 0 0.0958884134888649
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 0 0.1844586580991745
the O 0 0.412017822265625
patient O 1 0.9999912977218628
. O 0 0.05619826912879944

A O 0 0.08276788890361786
nonsense O 1 0.6809474229812622
mutation O 0 0.06105652078986168
in O 0 0.02415347844362259
exon O 0 0.15796566009521484
17 O 0 0.04428882151842117
( O 0 0.03264118358492851
codon O 0 0.08389420062303543
556 O 0 0.10518957674503326
) O 0 0.01794891245663166
of O 0 0.020102227106690407
the O 0 0.038691867142915726
RB1 O 1 0.9999991655349731
gene O 0 0.04218275472521782
was O 0 0.023575780913233757
found O 0 0.010503264144062996
to O 0 0.010721185244619846
be O 0 0.009160247631371021
present O 0 0.02028278447687626
homozygously O 1 0.6560441851615906
in O 0 0.013069875538349152
both O 0 0.015155889093875885
the O 0 0.034986961632966995
retinal B-Disease 1 0.9999984502792358
and I-Disease 0 0.03775542229413986
the I-Disease 1 0.8398445248603821
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.07684459537267685

The O 0 0.04214933514595032
same O 0 0.025540124624967575
mutation O 0 0.04596225544810295
was O 0 0.02853786014020443
present O 0 0.028928209096193314
heterozygously O 1 0.933040201663971
in O 0 0.01346068736165762
the O 0 0.01783084124326706
DNA O 0 0.019947810098528862
from O 0 0.009634152986109257
the O 0 0.013755550608038902
constitutional O 0 0.03287201747298241
cells O 0 0.026112234219908714
of O 0 0.016625553369522095
the O 0 0.02932724542915821
patient O 1 0.9999806880950928
, O 0 0.024300651624798775
proving O 0 0.04478708282113075
it O 0 0.009244443848729134
to O 0 0.011247900314629078
be O 0 0.010150312446057796
of O 0 0.024264724925160408
germline O 1 0.8579485416412354
origin O 0 0.03483819589018822
. O 0 0.0384737104177475

The O 0 0.052877604961395264
initial O 0 0.06265976279973984
mutation O 0 0.06343339383602142
was O 0 0.02904931828379631
shown O 0 0.01604199782013893
to O 0 0.012256585992872715
have O 0 0.007429033517837524
occurred O 0 0.018486514687538147
in O 0 0.011397339403629303
the O 0 0.028365058824419975
paternally O 1 0.966893196105957
derived O 0 0.07717199623584747
RB1 O 1 0.999976396560669
allele O 0 0.16544188559055328
. O 0 0.053827155381441116

The O 0 0.05911165103316307
mutation O 0 0.06483099609613419
is O 0 0.01692085899412632
in O 0 0.010769844055175781
an O 0 0.0112515389919281
area O 0 0.015947913751006126
of O 0 0.012388135306537151
the O 0 0.016828637570142746
gene O 0 0.018767964094877243
that O 0 0.0071639991365373135
encodes O 0 0.02707265503704548
the O 0 0.01966799981892109
protein O 0 0.037834685295820236
- O 1 0.9790545701980591
binding O 0 0.02998720109462738
region O 0 0.021572964265942574
known O 0 0.01916942000389099
as O 0 0.014755756594240665
the O 0 0.02496098354458809
pocket O 1 0.9033567905426025
region O 0 0.031231557950377464
and O 0 0.015016863122582436
has O 0 0.013872934505343437
been O 0 0.014450391754508018
detected O 0 0.025610342621803284
in O 0 0.009946165606379509
other O 0 0.00885598175227642
cases O 0 0.020165100693702698
of O 0 0.044630154967308044
retinoblastoma B-Disease 1 1.0
. O 0 0.04345809668302536
. O 0 0.04496314376592636

Low O 0 0.07666945457458496
levels O 0 0.031468480825424194
of O 0 0.026852427050471306
beta O 1 0.8851094245910645
hexosaminidase O 1 0.9967167973518372
A O 0 0.039432916790246964
in O 0 0.017680983990430832
healthy O 0 0.0467275008559227
individuals O 0 0.016514865681529045
with O 0 0.027537751942873
apparent O 1 0.9999988079071045
deficiency O 1 1.0
of O 1 0.97197026014328
this O 0 0.04353441298007965
enzyme O 0 0.16675160825252533
. O 0 0.04106432944536209

Appreciable O 1 0.98725825548172
beta O 1 0.9962111711502075
hexosaminidase O 1 0.9998414516448975
A O 0 0.06772596389055252
( O 0 0.037796635180711746
hex O 0 0.3805314600467682
A O 0 0.04495835304260254
) O 0 0.02066109888255596
activity O 0 0.016416087746620178
has O 0 0.011640573851764202
been O 0 0.011002974584698677
detected O 0 0.02788964845240116
in O 0 0.022033097222447395
cultured O 1 0.9999011754989624
skin O 1 0.9999995231628418
fibroblasts O 1 0.9999997615814209
and O 1 0.9994475245475769
melanoma B-Disease 1 1.0
tissue O 1 0.9999998807907104
from O 0 0.04349392652511597
healthy O 1 0.8096082210540771
individuals O 0 0.014388008043169975
previously O 0 0.01815367117524147
reported O 0 0.01793081685900688
as O 0 0.018901851028203964
having O 0 0.04692075774073601
deficiency B-Disease 1 1.0
of I-Disease 1 0.5109719634056091
hex I-Disease 1 0.9999465942382812
A I-Disease 0 0.0550616979598999
activity O 0 0.027876820415258408
indistinguishable O 0 0.034460075199604034
from O 0 0.008326276205480099
that O 0 0.005663558840751648
of O 0 0.01395448949187994
patients O 1 0.9948418736457825
with O 1 0.9715506434440613
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9992198944091797
TSD B-Disease 1 1.0
) O 0 0.05789204314351082
. O 0 0.04537229984998703

Identification O 0 0.07085543870925903
and O 0 0.03450316935777664
quantitation O 1 0.8865703344345093
of O 0 0.04700504615902901
hex O 1 0.9822480082511902
A O 0 0.059954509139060974
, O 0 0.028794918209314346
amounting O 0 0.054814908653497696
to O 0 0.02821505069732666
3 O 0 0.048017095774412155
. O 0 0.0362875796854496

5 O 0 0.06371941417455673
% O 0 0.05021561682224274
- O 1 0.9998018145561218
6 O 0 0.06544959545135498
. O 0 0.041110046207904816

9 O 0 0.05012812465429306
% O 0 0.018902739509940147
of O 0 0.018273143097758293
total O 0 0.030860042199492455
beta O 1 0.9926689863204956
hexosaminidase O 1 0.9995883107185364
activity O 0 0.03712823987007141
, O 0 0.01643475890159607
has O 0 0.012532975524663925
been O 0 0.010277275927364826
obtained O 0 0.016559839248657227
by O 0 0.026775995269417763
cellulose O 1 0.9996230602264404
acetate O 1 0.9999896287918091
gel O 1 0.9998643398284912
electrophoresis O 0 0.14045779407024384
, O 0 0.03444184362888336
DEAE O 1 0.9999985694885254
- O 1 0.9999983310699463
cellulose O 1 0.9998679161071777
ion O 1 0.9953851103782654
- O 1 0.9995157718658447
exchange O 0 0.0538826510310173
chromatography O 1 0.9967960715293884
, O 0 0.03414883464574814
radial O 1 0.9981245398521423
immunodiffusion O 1 0.9999330043792725
, O 0 0.03500804305076599
and O 0 0.03527916967868805
radioimmunoassay O 1 0.99928879737854
. O 0 0.049086589366197586

Previous O 0 0.060097794979810715
family O 0 0.05070848390460014
studies O 0 0.022476043552160263
suggested O 0 0.021690355613827705
that O 0 0.009210823103785515
these O 0 0.009248269721865654
individuals O 0 0.013989306055009365
may O 0 0.015913663432002068
be O 0 0.013252245262265205
compound O 0 0.06646959483623505
heterozygotes O 0 0.0915571078658104
for O 0 0.015199837274849415
the O 0 0.02149428240954876
common O 0 0.03905096650123596
mutant O 1 0.9997830986976624
TSD B-Disease 1 0.9999998807907104
gene O 0 0.04709077998995781
and O 0 0.018538691103458405
a O 0 0.027825823053717613
rare O 0 0.0428437739610672
( O 0 0.041339512914419174
allelic O 1 0.9995343685150146
) O 0 0.04455574229359627
mutant O 1 0.8642174601554871
gene O 0 0.06529902666807175
. O 0 0.04145407676696777

Thus O 0 0.03919745236635208
, O 0 0.019191516563296318
the O 0 0.023670323193073273
postulated O 0 0.07313578575849533
rate O 0 0.04089590162038803
mutant O 1 0.7969871759414673
gene O 0 0.03983968868851662
appears O 0 0.026024993509054184
to O 0 0.013806331902742386
code O 0 0.016657862812280655
for O 0 0.010379808023571968
the O 0 0.01589810848236084
expression O 0 0.0229653213173151
of O 0 0.017208890989422798
low O 0 0.03534140810370445
amounts O 0 0.020895792171359062
of O 0 0.027564762160182
hex O 1 0.915230393409729
A O 0 0.06648662686347961
. O 0 0.04217647761106491

Heterozygotes O 0 0.2567138075828552
for O 0 0.031190453097224236
the O 0 0.03513596951961517
rare O 0 0.06398728489875793
mutant O 1 0.9871397614479065
may O 0 0.027594465762376785
be O 0 0.015005527064204216
indistinguishable O 0 0.052282292395830154
from O 0 0.023511337116360664
heterozygotes O 0 0.10617820918560028
for O 0 0.022405097261071205
the O 0 0.0372174046933651
common O 0 0.0674237459897995
TSD B-Disease 1 0.9999983310699463
mutant O 1 0.9832143783569336
. O 0 0.07014019042253494

However O 0 0.04060527682304382
, O 0 0.028271416202187538
direct O 0 0.04127229377627373
visualization O 0 0.07697856426239014
and O 0 0.025843320414423943
quantitation O 1 0.9769324064254761
of O 0 0.03542882576584816
hex O 1 0.6264661550521851
A O 0 0.03511325269937515
by O 0 0.015102445147931576
the O 0 0.017067627981305122
methods O 0 0.016879918053746223
described O 0 0.02611398510634899
may O 0 0.01726396009325981
prevent O 0 0.03753306344151497
false O 0 0.04635271802544594
- O 1 0.9999946355819702
positive O 0 0.05909287929534912
prenatal O 1 0.999998927116394
diagnosis O 1 0.9999986886978149
of O 1 0.6461126804351807
TSD B-Disease 1 1.0
in O 0 0.03735315799713135
fetuses O 0 0.15142081677913666
having O 0 0.02348390966653824
the O 0 0.023240841925144196
incomplete O 0 0.05376885086297989
hex B-Disease 1 0.9962911605834961
A I-Disease 1 0.9609110355377197
deficiency I-Disease 1 1.0
of O 0 0.032322876155376434
the O 0 0.03626444190740585
type O 0 0.3115667998790741
described O 0 0.024604640901088715
in O 0 0.011002259328961372
the O 0 0.018427077680826187
four O 0 0.025292914360761642
healthy O 0 0.09587149322032928
individuals O 0 0.05582771077752113

The O 0 0.09572647511959076
tumor B-Disease 1 1.0
suppressor O 1 0.9999994039535522
gene O 0 0.15622630715370178
Smad4 O 1 0.9999873638153076
/ O 1 0.9999715089797974
Dpc4 O 1 0.9992495179176331
is O 0 0.02304094471037388
required O 0 0.018482275307178497
for O 0 0.01996990665793419
gastrulation O 1 0.999778687953949
and O 0 0.02208021841943264
later O 0 0.025734232738614082
for O 0 0.022498585283756256
anterior O 1 0.9993576407432556
development O 0 0.027933893725275993
of O 0 0.025868268683552742
the O 0 0.04712410643696785
mouse O 1 0.9539028406143188
embryo O 0 0.11655654013156891
. O 0 0.04612260311841965

Mutations O 0 0.052268706262111664
in O 0 0.018575584515929222
the O 0 0.037315186113119125
SMAD4 O 1 0.9999998807907104
/ O 1 0.9999998807907104
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 0 0.04195987060666084
, O 0 0.016195910051465034
a O 0 0.019133325666189194
key O 0 0.032454945147037506
signal O 0 0.043806422501802444
transducer O 0 0.07489704340696335
in O 0 0.01146482490003109
most O 0 0.0189780555665493
TGFbeta O 1 0.9999898672103882
- O 1 0.999998927116394
related O 0 0.04691628739237785
pathways O 0 0.07018671929836273
, O 0 0.014096432365477085
are O 0 0.005596321541815996
involved O 0 0.009953034110367298
in O 0 0.00920877791941166
50 O 0 0.0188809335231781
% O 0 0.024464013054966927
of O 0 0.15142010152339935
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.10909615457057953

Homozygous O 0 0.25650331377983093
Smad4 O 1 0.9997907280921936
mutant O 1 0.9998511075973511
mice O 1 0.9490283727645874
die O 1 0.6832495331764221
before O 0 0.03638968616724014
day O 0 0.04807325452566147
7 O 0 0.05850139260292053
. O 0 0.04029006138443947

5 O 0 0.06463620066642761
of O 0 0.057309553027153015
embryogenesis O 1 0.9713100790977478
. O 0 0.06508540362119675

Mutant O 1 0.5954521894454956
embryos O 0 0.05490754917263985
have O 0 0.015515261329710484
reduced O 0 0.03445218503475189
size O 0 0.026563704013824463
, O 0 0.020469654351472855
fail O 0 0.04595934972167015
to O 0 0.02741096168756485
gastrulate O 1 0.9878472089767456
or O 0 0.026283109560608864
express O 0 0.04673589766025543
a O 0 0.04159899055957794
mesodermal O 1 0.9999473094940186
marker O 1 0.9615066647529602
, O 0 0.02577904239296913
and O 0 0.023144574835896492
show O 0 0.04811745136976242
abnormal O 1 0.9997256398200989
visceral O 1 0.9999966621398926
endoderm O 1 0.9999986886978149
development O 0 0.07589802145957947
. O 0 0.05124826356768608

Growth B-Disease 1 0.9608945250511169
retardation I-Disease 1 0.9999951124191284
of O 0 0.04206576943397522
the O 0 0.06349495053291321
Smad4 O 1 0.9999998807907104
- O 1 0.9999998807907104
deficient O 1 0.9996575117111206
embryos O 0 0.032717276364564896
results O 0 0.013442323543131351
from O 0 0.015596226789057255
reduced O 0 0.0410294309258461
cell O 0 0.2267294079065323
proliferation O 1 0.9390572905540466
rather O 0 0.02084391377866268
than O 0 0.019361412152647972
increased O 0 0.048599544912576675
apoptosis O 1 0.9959779977798462
. O 0 0.052696533501148224

Aggregation O 0 0.11321841180324554
of O 0 0.042496658861637115
mutant O 1 0.9924382567405701
Smad4 O 1 0.9999977350234985
ES O 1 0.9999991655349731
cells O 0 0.04728254675865173
with O 0 0.020961135625839233
wild O 0 0.049348484724760056
- O 1 0.9998745918273926
type O 0 0.08293364197015762
tetraploid O 1 0.9818466305732727
morulae O 1 0.9987910389900208
rescues O 1 0.9412235617637634
the O 0 0.08422601968050003
gastrulation B-Disease 1 0.9999978542327881
defect I-Disease 1 0.999983549118042
. O 0 0.06693360954523087

These O 0 0.022028006613254547
results O 0 0.01974691078066826
indicate O 0 0.021329496055841446
that O 0 0.014642448164522648
Smad4 O 1 0.9942893981933594
is O 0 0.01745978556573391
initially O 0 0.019317056983709335
required O 0 0.01124420017004013
for O 0 0.009931185282766819
the O 0 0.01747083105146885
differentiation O 0 0.0470137745141983
of O 0 0.024120783433318138
the O 0 0.042083997279405594
visceral O 1 0.9999890327453613
endoderm O 1 0.9999822378158569
and O 0 0.022275438532233238
that O 0 0.011944214813411236
the O 0 0.027607981115579605
gastrulation B-Disease 1 0.9999964237213135
defect I-Disease 1 0.999722421169281
in O 0 0.020216748118400574
the O 0 0.03329528123140335
epiblast O 1 0.9999966621398926
is O 0 0.02406780607998371
secondary O 0 0.041842855513095856
and O 0 0.02286284603178501
non O 1 0.9994530081748962
- O 1 0.9999997615814209
cell O 0 0.10292263329029083
autonomous O 0 0.059577275067567825
. O 0 0.039805375039577484

Rescued O 0 0.19648389518260956
embryos O 0 0.08535391837358475
show O 0 0.06989691406488419
severe O 1 0.9999862909317017
anterior O 1 0.9999995231628418
truncations O 1 0.9999986886978149
, O 0 0.041601017117500305
indicating O 0 0.03376266360282898
a O 0 0.022053450345993042
second O 0 0.023614434525370598
important O 0 0.015235546045005322
role O 0 0.025363650172948837
for O 0 0.02089536376297474
Smad4 O 1 0.9999440908432007
in O 0 0.035375844687223434
anterior O 1 0.9999954700469971
patterning O 1 0.9999524354934692
during O 0 0.12756787240505219
embryogenesis O 1 0.9988571405410767
. O 0 0.06163677200675011

Prevalence O 1 0.9984765648841858
of O 0 0.0655333399772644
p16 O 1 0.999138355255127
and O 0 0.048579417169094086
CDK4 O 1 0.9999994039535522
germline O 1 0.9998067021369934
mutations O 0 0.0450633205473423
in O 0 0.022132940590381622
48 O 0 0.2902992367744446
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9998699426651001
families O 0 0.03960699215531349
in O 0 0.02446022443473339
France O 0 0.0709681585431099
. O 0 0.040874384343624115

The O 0 0.056570254266262054
French O 1 0.9166807532310486
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.9624596834182739
Group O 1 0.849651038646698
. O 0 0.04502541571855545

Germline O 1 0.996451735496521
mutations O 0 0.05545858293771744
in O 0 0.01954544149339199
the O 0 0.034641969949007034
p16 O 1 0.998079776763916
and O 0 0.03813587874174118
CDK4 O 1 0.9999971389770508
genes O 0 0.0264216810464859
have O 0 0.0069688656367361546
been O 0 0.007322719320654869
reported O 0 0.010243534110486507
in O 0 0.007327983621507883
a O 0 0.015859734266996384
subset O 0 0.07242485880851746
of O 0 0.06091780588030815
melanoma B-Disease 1 1.0
pedigrees O 1 0.9999101161956787
, O 0 0.02171616069972515
but O 0 0.012243477627635002
their O 0 0.015988344326615334
prevalence O 1 0.9999333620071411
is O 0 0.018794195726513863
not O 0 0.012301673181355
well O 0 0.018367083743214607
known O 0 0.0356648713350296
. O 0 0.03339783847332001

We O 0 0.02946516126394272
searched O 0 0.05427781119942665
for O 0 0.02062814123928547
such O 0 0.020525645464658737
germline O 1 0.893390953540802
mutations O 0 0.03506547585129738
in O 0 0.01699988543987274
48 O 0 0.04964831843972206
French O 1 0.9992653727531433
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9997417330741882
families O 0 0.031821079552173615
selected O 0 0.020867198705673218
according O 0 0.010413860902190208
to O 0 0.009639532305300236
two O 0 0.008576971478760242
major O 0 0.022594595327973366
criteria O 0 0.02674964629113674
families O 0 0.018092621117830276
with O 0 0.011403445154428482
at O 0 0.015023129060864449
least O 0 0.010564634576439857
three O 0 0.011751714162528515
affected O 0 0.023631563410162926
members O 0 0.02516758441925049
( O 0 0.032404351979494095
n O 0 0.08835294842720032
= O 0 0.05851612240076065
20 O 0 0.02366018109023571
) O 0 0.015898019075393677
or O 0 0.011894089169800282
families O 0 0.014972607605159283
with O 0 0.009850557893514633
two O 0 0.010931329801678658
affected O 0 0.02227659709751606
members O 0 0.015829002484679222
, O 0 0.012088460847735405
one O 0 0.010328829288482666
of O 0 0.012013347819447517
them O 0 0.011085974983870983
affected O 0 0.018561948090791702
before O 0 0.014630818739533424
the O 0 0.014757192693650723
age O 0 0.0189470574259758
of O 0 0.020772717893123627
50 O 0 0.029062947258353233
( O 0 0.028075112029910088
n O 0 0.08453743159770966
= O 0 0.05908505618572235
28 O 0 0.03392000496387482
) O 0 0.01787458546459675
, O 0 0.012111939489841461
and O 0 0.011874238960444927
one O 0 0.01646716333925724
additional O 0 0.025671876966953278
minor O 0 0.11591184139251709
criterion O 1 0.9986627101898193
. O 0 0.061567362397909164

Sixteen O 0 0.10120541602373123
different O 0 0.03139808401465416
p16 O 1 0.9988659620285034
germline O 1 0.9967702627182007
mutations O 0 0.04198426008224487
were O 0 0.011512662284076214
found O 0 0.011595684103667736
in O 0 0.011492677964270115
21 O 0 0.02630646526813507
families O 0 0.021441170945763588
, O 0 0.014488933607935905
while O 0 0.014827859587967396
one O 0 0.026892967522144318
germline O 1 0.998867392539978
mutation O 0 0.07141584157943726
, O 0 0.029981497675180435
Arg24His O 1 0.9990599751472473
, O 0 0.023498035967350006
was O 0 0.02743566781282425
detected O 0 0.029738470911979675
in O 0 0.013285677880048752
the O 0 0.03122715838253498
CDK4 O 1 0.9999886751174927
gene O 0 0.07003924250602722
. O 0 0.03837383911013603

The O 0 0.042293060570955276
frequency O 0 0.03821904584765434
of O 0 0.03934049978852272
p16 O 1 0.9977300763130188
gene O 0 0.05050576478242874
mutation O 0 0.03769027069211006
in O 0 0.012152590788900852
our O 0 0.02124577946960926
sample O 0 0.028436677530407906
( O 0 0.019877852872014046
44 O 0 0.0336453802883625
% O 0 0.021680552512407303
) O 0 0.014695505611598492
is O 0 0.010782226920127869
among O 0 0.01345657929778099
the O 0 0.016651276499032974
highest O 0 0.044523898512125015
rates O 0 0.02185949683189392
yet O 0 0.014859550632536411
reported O 0 0.01625504344701767
and O 0 0.013113245368003845
the O 0 0.027763789519667625
CDK4 O 1 0.9999983310699463
mutation O 0 0.04984424635767937
is O 0 0.013895535841584206
the O 0 0.018016621470451355
second O 0 0.04057900235056877
mutation O 0 0.05302274972200394
detected O 0 0.03192443028092384
in O 0 0.013253018260002136
this O 0 0.01568211242556572
gene O 0 0.03904442489147186
worldwide O 0 0.04032902792096138
. O 0 0.038117509335279465

In O 0 0.03464270010590553
summary O 0 0.048038896173238754
, O 0 0.020381154492497444
our O 0 0.02161474898457527
results O 0 0.015170970000326633
show O 0 0.0190427266061306
frequent O 0 0.03274117037653923
involvement O 0 0.035573553293943405
of O 0 0.02136390656232834
the O 0 0.03380018472671509
p16 O 1 0.9995307922363281
gene O 0 0.044670477509498596
in O 0 0.03359060361981392
familial B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.03501138463616371
confirm O 0 0.025341225787997246
the O 0 0.01430362556129694
role O 0 0.020056352019309998
of O 0 0.015336496755480766
the O 0 0.026652511209249496
CDK4 O 1 0.9999700784683228
gene O 0 0.02892124466598034
as O 0 0.019868874922394753
a O 0 0.0481165386736393
melanoma B-Disease 1 1.0
- O 1 1.0
predisposing O 1 0.9999935626983643
gene O 0 0.06688718497753143
. O 0 0.026425445452332497
. O 0 0.03282535821199417

Progression O 1 0.9917175769805908
of O 0 0.07670789211988449
somatic O 1 0.9998243451118469
CTG O 1 0.999995231628418
repeat O 0 0.1265726089477539
length O 0 0.035160355269908905
heterogeneity O 0 0.06847559660673141
in O 0 0.014962678775191307
the O 0 0.028911011293530464
blood O 1 0.9999339580535889
cells O 1 0.8900720477104187
of O 1 0.9983673691749573
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.34397315979003906

The O 0 0.03492269292473793
genetic O 0 0.02948409505188465
basis O 0 0.02176607772707939
of O 1 0.6804986000061035
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DM B-Disease 1 1.0
) O 0 0.02650626190006733
is O 0 0.011699734255671501
the O 0 0.01179452519863844
expansion O 0 0.021824995055794716
of O 0 0.017000284045934677
an O 0 0.027271877974271774
unstable O 1 0.9999842643737793
CTG O 1 0.999998927116394
repeat O 0 0.06324450671672821
in O 0 0.012773275375366211
the O 0 0.015988795086741447
34 O 0 0.03333296626806259
UTR O 0 0.26009401679039
of O 0 0.023714374750852585
the O 0 0.052201732993125916
DM B-Disease 1 1.0
protein O 0 0.23683327436447144
kinase O 1 0.9428005218505859
gene O 0 0.04505470022559166
on O 0 0.029806653037667274
chromosome O 0 0.06672559678554535
19 O 0 0.05452948808670044
. O 0 0.038607046008110046

One O 0 0.022916389629244804
of O 0 0.017013030126690865
the O 0 0.016790447756648064
principal O 0 0.03810235485434532
features O 0 0.014721114188432693
of O 0 0.017139935865998268
the O 0 0.1122480109333992
DM B-Disease 1 1.0
mutation O 1 0.8336083292961121
is O 0 0.014822650700807571
an O 0 0.014938564039766788
extraordinarily O 0 0.10692917555570602
high O 0 0.029603589326143265
level O 0 0.023973947390913963
of O 0 0.03212711960077286
somatic O 1 0.9999943971633911
mosaicism O 1 0.9999997615814209
, O 0 0.0238264761865139
due O 0 0.019570253789424896
to O 0 0.013936038129031658
an O 0 0.013439756818115711
extremely O 0 0.02400285378098488
high O 0 0.02833075262606144
degree O 0 0.029687872156500816
of O 0 0.03932008147239685
somatic O 1 0.9998975992202759
instability O 1 0.9837840795516968
both O 0 0.021854614838957787
within O 0 0.01941586472094059
and O 0 0.019467271864414215
between O 0 0.027217179536819458
different O 0 0.01678708754479885
tissues O 0 0.09826788306236267
. O 0 0.045573703944683075

This O 0 0.0465272031724453
instability O 1 0.7416073679924011
appears O 0 0.04844268411397934
to O 0 0.018782077357172966
be O 0 0.013386020436882973
biased O 0 0.03620166704058647
towards O 0 0.027878526598215103
further O 0 0.016464537009596825
expansion O 0 0.030615173280239105
and O 0 0.016382796689867973
continuous O 0 0.030215732753276825
throughout O 0 0.014263096265494823
the O 0 0.015028384514153004
life O 0 0.019129717722535133
of O 0 0.01564345881342888
an O 0 0.016518916934728622
individual O 0 0.015838343650102615
, O 0 0.013986019417643547
features O 0 0.01585407927632332
that O 0 0.0066014123149216175
could O 0 0.00738134142011404
be O 0 0.0062128459103405476
associated O 0 0.010520370677113533
with O 0 0.009971855208277702
the O 0 0.019894558936357498
progressive O 1 0.9940047860145569
nature O 0 0.0297519713640213
of O 0 0.03039322793483734
the O 0 0.2349032312631607
disease O 1 0.9999997615814209
. O 0 0.06286293268203735

Although O 0 0.03639598563313484
increasing O 0 0.03856347128748894
measured O 0 0.04014548286795616
allele O 0 0.06681954860687256
size O 0 0.028724128380417824
between O 0 0.029894975945353508
patients O 1 0.9845662713050842
clearly O 0 0.0357586145401001
correlates O 0 0.05069630965590477
with O 0 0.013594120740890503
an O 0 0.01571853831410408
increased O 0 0.026298686861991882
severity O 1 0.9999686479568481
of O 1 0.9861117601394653
symptoms O 1 1.0
and O 0 0.023069439455866814
an O 0 0.014518472366034985
earlier O 0 0.015145585872232914
age O 0 0.02286047674715519
of O 0 0.032407574355602264
onset O 1 1.0
, O 0 0.025966135784983635
this O 0 0.01628360152244568
correlation O 0 0.037258148193359375
is O 0 0.014208397828042507
not O 0 0.010338910855352879
precise O 0 0.019908299669623375
and O 0 0.01586684212088585
measured O 0 0.03137730062007904
allele O 0 0.06054791435599327
length O 0 0.02428952418267727
cannot O 0 0.017861200496554375
be O 0 0.00846968311816454
used O 0 0.008804356679320335
as O 0 0.009816962294280529
an O 0 0.012976065278053284
accurate O 0 0.02447589673101902
predictor O 1 0.5829557180404663
of O 0 0.02674827352166176
age O 0 0.046006035059690475
of O 0 0.06158965826034546
onset O 1 0.9999997615814209
. O 0 0.07482033222913742

In O 0 0.031641896814107895
order O 0 0.027504468336701393
to O 0 0.017163189128041267
further O 0 0.01886867545545101
characterize O 0 0.053458403795957565
the O 0 0.022390980273485184
dynamics O 0 0.049465689808130264
of O 0 0.060469385236501694
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 1 0.9999648332595825
somatic O 1 0.9996649026870728
instability O 1 0.9981693029403687
, O 0 0.02400895208120346
we O 0 0.012245855294167995
have O 0 0.008179024793207645
studied O 0 0.021406952291727066
repeat O 0 0.04334435984492302
length O 0 0.01740994118154049
changes O 0 0.010844084434211254
over O 0 0.012596247717738152
time O 0 0.013949399814009666
in O 0 0.02246139943599701
111 O 1 0.9999737739562988
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
with O 0 0.07098867744207382
varying O 0 0.048778269439935684
clinical O 1 0.9999970197677612
severity O 1 0.9999997615814209
and O 0 0.4775407016277313
CTG O 1 0.9999998807907104
repeat O 0 0.09727878123521805
size O 0 0.020485101267695427
over O 0 0.013836906291544437
time O 0 0.011789179407060146
intervals O 0 0.0194189865142107
of O 0 0.016667785122990608
1 O 0 0.04884284362196922
- O 1 0.9992772936820984
7 O 0 0.041950199753046036
years O 0 0.030441123992204666
. O 0 0.033425092697143555

We O 0 0.024738246574997902
have O 0 0.009904454462230206
found O 0 0.011390560306608677
a O 0 0.01888066716492176
direct O 0 0.03158698230981827
progression O 1 0.5730910897254944
of O 0 0.02241266891360283
the O 0 0.0250234454870224
size O 0 0.029413163661956787
heterogeneity O 0 0.07392909377813339
over O 0 0.020840326324105263
time O 0 0.017677338793873787
related O 0 0.01821472868323326
to O 0 0.01835651695728302
initial O 0 0.04763513803482056
CTG O 1 0.9999423027038574
repeat O 0 0.0864662304520607
size O 0 0.026376662775874138
and O 0 0.01563911885023117
the O 0 0.019438134506344795
time O 0 0.021555615589022636
interval O 0 0.05150124058127403
and O 0 0.02050994336605072
always O 0 0.02715483494102955
biased O 0 0.04896657541394234
towards O 0 0.03560343757271767
further O 0 0.02556290291249752
expansion O 0 0.05578048154711723
. O 0 0.038445498794317245

Attempts O 0 0.07017812877893448
to O 0 0.030598856508731842
mathematically O 0 0.04774465039372444
model O 0 0.032524075359106064
the O 0 0.024323351681232452
dynamics O 0 0.042166903614997864
have O 0 0.011775706894695759
proved O 0 0.029016626998782158
only O 0 0.015888726338744164
partially O 0 0.046886153519153595
successful O 0 0.034241244196891785
suggesting O 0 0.025453364476561546
that O 0 0.008474290370941162
individual O 0 0.013094364665448666
specific O 0 0.015031415037810802
genetic O 0 0.03090306743979454
and O 0 0.02981613203883171
/ O 1 0.999997615814209
or O 0 0.026919934898614883
environmental O 0 0.04088510572910309
factors O 0 0.018832992762327194
also O 0 0.01011051144450903
play O 0 0.011281514540314674
a O 0 0.018393581733107567
role O 0 0.03466455638408661
in O 0 0.032026756554841995
somatic O 1 0.9985369443893433
mosaicism O 1 0.9999867677688599
. O 0 0.04088975861668587
. O 0 0.04328363016247749

Aspartylglucosaminuria B-Disease 1 0.999763548374176
among O 0 0.0664963573217392
Palestinian O 0 0.10314224660396576
Arabs O 0 0.10578401386737823
. O 0 0.05502963438630104

Aspartylglucosaminuria B-Disease 1 0.9999998807907104
( O 1 0.9196045398712158
AGU B-Disease 1 1.0
) O 0 0.029987379908561707
is O 0 0.015829818323254585
a O 0 0.025453872978687286
rare O 1 0.9295591711997986
disorder B-Disease 1 1.0
of I-Disease 1 0.9998378753662109
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.999984860420227
caused O 0 0.1537458896636963
by O 0 0.020779278129339218
the O 0 0.035895735025405884
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.03413465619087219
the I-Disease 1 0.6628943085670471
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9999535083770752
aspartylglucosaminidase I-Disease 1 0.9999982118606567
( O 0 0.07798265665769577
AGA O 1 0.9999996423721313
) O 0 0.049559250473976135
. O 0 0.036540716886520386

AGU B-Disease 1 0.9999998807907104
is O 0 0.0502186119556427
inherited O 1 0.9806419014930725
as O 0 0.03141775727272034
an O 0 0.04162324219942093
autosomal O 1 0.9999998807907104
recessive O 1 1.0
trait O 1 0.999992847442627
and O 0 0.0367848202586174
occurs O 0 0.026184674352407455
with O 0 0.014550546184182167
a O 0 0.02315754070878029
high O 0 0.03237852081656456
frequency O 0 0.02133769355714321
in O 0 0.010935311205685139
Finland O 0 0.0347169004380703
because O 0 0.012316293083131313
of O 0 0.01718759536743164
a O 0 0.035830434411764145
founder O 1 0.9957542419433594
effect O 0 0.05292678251862526
. O 0 0.04016644135117531

While O 0 0.036030113697052
very O 0 0.02452928014099598
few O 0 0.02722781151533127
patients O 1 0.9838081002235413
with O 0 0.04552287235856056
AGU B-Disease 1 1.0
have O 0 0.01463144551962614
been O 0 0.01201135478913784
reported O 0 0.014058469794690609
from O 0 0.014063970185816288
non O 0 0.06235861778259277
- O 1 0.9983373880386353
Finnish O 0 0.07398124039173126
origin O 0 0.016384117305278778
, O 0 0.015190874226391315
we O 0 0.017675675451755524
diagnosed O 1 0.9999991655349731
the O 0 0.47287485003471375
disorder O 1 1.0
in O 0 0.03384334221482277
8 O 0 0.2772577404975891
patients O 1 0.9994633793830872
originating O 0 0.04371148720383644
from O 0 0.01931171305477619
3 O 0 0.032469525933265686
unrelated O 0 0.03650513291358948
families O 0 0.022707685828208923
, O 0 0.014653269201517105
all O 0 0.011771433986723423
Palestinian O 0 0.043214187026023865
Arabs O 0 0.03658990561962128
from O 0 0.01380456704646349
the O 0 0.017451606690883636
region O 0 0.02922632358968258
of O 0 0.029067547991871834
Jerusalem O 1 0.6482733488082886
. O 0 0.048362597823143005

The O 0 0.06552928686141968
clinical O 1 0.9999520778656006
diagnosis O 1 1.0
of O 1 0.9999352693557739
AGU B-Disease 1 1.0
is O 0 0.051290303468704224
often O 0 0.019202055409550667
difficult O 0 0.021486330777406693
, O 0 0.012429988011717796
in O 0 0.009678156115114689
particular O 0 0.012957402504980564
early O 0 0.013341068290174007
in O 0 0.00864352472126484
the O 0 0.013110482133924961
course O 0 0.019713953137397766
of O 0 0.01668829657137394
the O 0 0.17955239117145538
disease O 1 0.9999998807907104
, O 0 0.019568905234336853
and O 0 0.011338027194142342
most O 0 0.00903975311666727
of O 0 0.01521147508174181
the O 0 0.029978808015584946
patients O 1 0.9999696016311646
are O 0 0.017359640449285507
diagnosed O 1 0.9999990463256836
after O 0 0.030940797179937363
the O 0 0.023167043924331665
age O 0 0.027570292353630066
of O 0 0.02285599149763584
5 O 0 0.034960366785526276
years O 0 0.028472336009144783
. O 0 0.034592367708683014

However O 0 0.03568156808614731
, O 0 0.02568267099559307
since O 0 0.02680458500981331
these O 0 0.018777338787913322
patients O 1 0.9932423233985901
excrete O 1 0.997879147529602
early O 0 0.03118179552257061
large O 0 0.019274460151791573
amounts O 0 0.01654839515686035
of O 0 0.023063508793711662
aspartylglucosamine O 1 0.9989784955978394
in O 0 0.030021948739886284
urine O 0 0.08074764907360077
, O 0 0.032271016389131546
biochemical O 0 0.08487071096897125
screening O 0 0.07105780392885208
is O 0 0.022254958748817444
easy O 0 0.035897739231586456
by O 0 0.0343782864511013
urine O 1 0.9689441919326782
chromatography O 1 0.9989581108093262
. O 0 0.032966386526823044
. O 0 0.039479512721300125

Detection O 0 0.0944107323884964
of O 0 0.033655084669589996
heterozygous O 0 0.06667755544185638
carriers O 0 0.040705472230911255
of O 0 0.022056391462683678
the O 0 0.04880085960030556
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.06913634389638901
ATM O 1 0.9837052822113037
) O 0 0.020694101229310036
gene O 0 0.024174347519874573
by O 0 0.02503565512597561
G2 O 1 0.9999982118606567
phase O 1 0.8186825513839722
chromosomal O 1 0.9971098303794861
radiosensitivity O 1 0.9999198913574219
of O 1 0.9375372529029846
peripheral O 1 1.0
blood O 1 0.9999998807907104
lymphocytes O 1 0.9999998807907104
. O 0 0.07048458606004715

In O 0 0.059135206043720245
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.049284677952528
A B-Disease 1 0.9999643564224243
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.039264701306819916
patients O 1 0.9958863854408264
, O 0 0.017976416274905205
mutations O 0 0.021525980904698372
in O 0 0.010275005362927914
a O 0 0.019819028675556183
single O 0 0.034575920552015305
gene O 0 0.03061308152973652
, O 0 0.01845986396074295
ATM O 0 0.06826792657375336
, O 0 0.012458725832402706
result O 0 0.011420701630413532
in O 0 0.012018438428640366
an O 0 0.032882582396268845
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.21665923297405243
embraces O 1 0.9998669624328613
a O 0 0.028075631707906723
variety O 0 0.017811987549066544
of O 0 0.02363041788339615
clinical O 1 0.9986094236373901
features O 0 0.032622937113046646
and O 0 0.025966787710785866
manifests O 1 0.9995788931846619
extreme O 1 0.999352753162384
radiosensitivity O 1 0.9999957084655762
and O 0 0.018806448206305504
a O 0 0.021347424015402794
strong O 0 0.03132658451795578
pre O 1 0.994134247303009
- O 1 0.9999805688858032
disposition O 1 0.9983863830566406
to O 0 0.05415564402937889
malignancy B-Disease 1 0.9999973773956299
. O 0 0.05854940414428711

Heterozygotes O 0 0.24421383440494537
for O 0 0.0300110075622797
the O 0 0.039827678352594376
ATM O 1 0.9796096682548523
gene O 0 0.03005906008183956
have O 0 0.00855165347456932
no O 0 0.014762475155293941
clinical O 0 0.03813928738236427
expression O 0 0.021143293008208275
of O 0 0.02131064608693123
A B-Disease 1 0.9999738931655884
- I-Disease 1 1.0
T I-Disease 1 0.9999994039535522
but O 0 0.017374329268932343
may O 0 0.01833684928715229
be O 0 0.018996618688106537
cancer B-Disease 1 0.9999992847442627
prone O 1 0.9996340274810791
with O 0 0.023632310330867767
a O 0 0.03156183660030365
moderate O 0 0.2232341170310974
increase O 0 0.021525658667087555
in O 0 0.01609313115477562
in O 0 0.024263925850391388
vitro O 0 0.46544429659843445
radiosensitivity O 1 0.9971075654029846
. O 0 0.054720256477594376

We O 0 0.03162180259823799
performed O 0 0.043874941766262054
a O 0 0.040444549173116684
blind O 1 0.99931800365448
chromosomal O 1 0.8940341472625732
analysis O 0 0.0209237989038229
on O 0 0.02726774848997593
G2 O 1 1.0
- O 1 0.9999972581863403
phase O 1 0.9583865404129028
lymphocytes O 1 0.9997050166130066
from O 0 0.014919308014214039
7 O 0 0.026591621339321136
unrelated O 0 0.03963744640350342
A B-Disease 1 0.9993836879730225
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9960007071495056
, O 0 0.01888956129550934
13 O 0 0.02771466039121151
obligate O 0 0.3952915668487549
A B-Disease 1 0.9996973276138306
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 1 0.9990774393081665
( O 0 0.024322565644979477
parents O 0 0.02311788685619831
of O 0 0.02018733136355877
the O 0 0.037378549575805664
patients O 1 0.9999914169311523
) O 0 0.022354014217853546
, O 0 0.014467746019363403
and O 0 0.011748806573450565
14 O 0 0.02072099782526493
normal O 0 0.021785246208310127
controls O 0 0.027852928265929222
following O 0 0.026712505146861076
X O 1 0.9998588562011719
- O 1 0.9999665021896362
irradiation O 0 0.08682763576507568
with O 0 0.02151605859398842
1 O 0 0.05012647435069084
Gy O 1 0.99954754114151
in O 0 0.01569700986146927
order O 0 0.020090213045477867
to O 0 0.01665966399013996
evaluate O 0 0.04362327232956886
this O 0 0.0176691934466362
cytogenetic O 1 0.7257347106933594
method O 0 0.025204826146364212
as O 0 0.01649635285139084
a O 0 0.024996312335133553
tool O 0 0.04268151894211769
for O 0 0.020353535190224648
detection O 0 0.05565915256738663
of O 0 0.038055405020713806
ATM O 1 0.9964759945869446
carriers O 0 0.09479911625385284
. O 0 0.04158174619078636

Both O 0 0.03986167162656784
A B-Disease 1 0.9977339506149292
- I-Disease 1 1.0
T I-Disease 1 0.9999996423721313
homozygotes O 1 0.9990668892860413
and O 0 0.04043872281908989
heterozygotes O 1 0.8018376231193542
showed O 0 0.034820955246686935
significantly O 0 0.024688614532351494
increased O 0 0.02043256349861622
levels O 0 0.025343190878629684
of O 0 0.03633641451597214
radiation O 1 0.9999988079071045
- O 1 1.0
induced O 1 0.9999996423721313
chromatid O 1 0.9999992847442627
damage O 0 0.09910161048173904
relative O 0 0.04047592729330063
to O 0 0.015895377844572067
that O 0 0.009927472099661827
of O 0 0.020495949313044548
normal O 0 0.04138224199414253
controls O 0 0.05980820581316948
. O 0 0.041318804025650024

These O 0 0.01848660409450531
results O 0 0.01447741873562336
show O 0 0.014563390985131264
that O 0 0.008060069754719734
the O 0 0.025266101583838463
G2 O 1 1.0
- O 1 0.9999984502792358
phase O 1 0.9987637996673584
chromosomal O 1 0.9999749660491943
radiosensitivity O 1 0.9999983310699463
assay O 1 0.7148200869560242
can O 0 0.012453364208340645
be O 0 0.006480546668171883
used O 0 0.005774930119514465
for O 0 0.006935445126146078
the O 0 0.013686811551451683
detection O 0 0.0355847142636776
of O 0 0.02479846030473709
A B-Disease 1 0.9998708963394165
- I-Disease 1 1.0
T I-Disease 1 0.9999992847442627
heterozygotes O 1 0.9977447986602783
. O 0 0.05356675386428833

In O 0 0.03572157770395279
combination O 0 0.05289182811975479
with O 0 0.02947745844721794
molecular O 0 0.05231991782784462
genetic O 0 0.03698920086026192
analyses O 0 0.027094606310129166
, O 0 0.014490458182990551
this O 0 0.011075805872678757
test O 0 0.025007398799061775
may O 0 0.012967444024980068
be O 0 0.006849837023764849
of O 0 0.009623730555176735
value O 0 0.009680249728262424
in O 0 0.00897626206278801
studies O 0 0.014352494850754738
of O 0 0.024706058204174042
familial B-Disease 1 0.9999996423721313
and I-Disease 0 0.17138178646564484
sporadic I-Disease 1 0.999995231628418
cancers I-Disease 1 0.9999998807907104
aimed O 0 0.0552559457719326
at O 0 0.023083114996552467
determination O 0 0.030865393579006195
of O 0 0.011993985623121262
the O 0 0.014886140823364258
potential O 0 0.01983918994665146
involvement O 0 0.03423624858260155
of O 0 0.0254391860216856
ATM O 1 0.9996930360794067
mutations O 0 0.04986615106463432
in O 0 0.034871675074100494
tumor B-Disease 1 1.0
risk O 1 0.9995854496955872
or O 0 0.0318867452442646
development O 0 0.03734167292714119
. O 0 0.02547127939760685
. O 0 0.035893846303224564

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 0.04003548249602318
identification O 0 0.023943020030856133
and O 0 0.012145430780947208
detection O 0 0.033397234976291656
of O 0 0.023359311744570732
founder O 1 0.9999977350234985
- O 1 0.9999992847442627
effect O 0 0.0281231589615345
mutations O 0 0.02147301845252514
in O 0 0.009986228309571743
the O 0 0.023204617202281952
ATM O 1 0.9109991788864136
gene O 0 0.029567182064056396
in O 0 0.015801534056663513
ethnic O 0 0.038612719625234604
populations O 0 0.047158632427453995
. O 0 0.04200489819049835

To O 0 0.0353398397564888
facilitate O 0 0.047903530299663544
the O 0 0.024808494374155998
evaluation O 0 0.05393208563327789
of O 0 0.034190449863672256
ATM O 1 0.999110758304596
heterozygotes O 1 0.9661082625389099
for O 0 0.028882447630167007
susceptibility O 1 0.8547115921974182
to O 0 0.022763250395655632
other O 0 0.02368614822626114
diseases O 1 0.9999996423721313
, O 0 0.019733160734176636
such O 0 0.01569303125143051
as O 1 0.993036687374115
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.05224102735519409
we O 0 0.013062841258943081
have O 0 0.007444612681865692
attempted O 0 0.02533000148832798
to O 0 0.014414592646062374
define O 0 0.024168746545910835
the O 0 0.016411149874329567
most O 0 0.015413932502269745
common O 0 0.022723527625203133
mutations O 0 0.02363813854753971
and O 0 0.009852037765085697
their O 0 0.00923540722578764
frequencies O 0 0.016077464446425438
in O 0 0.01989239640533924
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0451580286026001
A B-Disease 1 0.9997715353965759
- I-Disease 1 1.0
T I-Disease 1 0.9999990463256836
) O 0 0.03536604717373848
homozygotes O 0 0.13693247735500336
from O 0 0.020169256255030632
10 O 0 0.022503916174173355
ethnic O 0 0.03917262330651283
populations O 0 0.04587533324956894
. O 0 0.04314938932657242

Both O 0 0.05555333197116852
genomic O 0 0.11363798379898071
mutations O 0 0.04996735230088234
and O 0 0.020001348108053207
their O 0 0.019835403189063072
effects O 0 0.04070018604397774
on O 0 0.03182568401098251
cDNA O 0 0.10582070797681808
were O 0 0.025437258183956146
characterized O 0 0.07052365690469742
. O 0 0.048102863132953644

Protein O 0 0.11898784339427948
- O 1 0.9835457801818848
truncation O 0 0.13164857029914856
testing O 0 0.02795647643506527
of O 0 0.01619546301662922
the O 0 0.021073292940855026
entire O 0 0.04762596637010574
ATM O 1 0.7261772751808167
cDNA O 0 0.11565787345170975
detected O 0 0.05655696243047714
92 O 0 0.07677344977855682
( O 0 0.031487274914979935
66 O 0 0.06051640585064888
% O 0 0.03186563774943352
) O 0 0.028453145176172256
truncating O 1 0.6892672777175903
mutations O 0 0.04536443203687668
in O 0 0.021373184397816658
140 O 0 0.07522477954626083
mutant O 1 0.5122312307357788
alleles O 0 0.1280757486820221
screened O 0 0.12881390750408173
. O 0 0.05168168991804123

The O 0 0.05940238758921623
haplotyping O 1 0.9984902143478394
of O 0 0.052709244191646576
patients O 1 0.9976237416267395
with O 0 0.03182733803987503
identical O 0 0.04464907571673393
mutations O 0 0.0435941256582737
indicates O 0 0.028424784541130066
that O 0 0.00772184319794178
almost O 0 0.009327493607997894
all O 0 0.008857409469783306
of O 0 0.012567266821861267
these O 0 0.008513974957168102
represent O 0 0.01726653426885605
common O 0 0.023802172392606735
ancestry O 0 0.03012261539697647
and O 0 0.015381062403321266
that O 0 0.011159325018525124
very O 0 0.013831116259098053
few O 0 0.021513480693101883
spontaneously O 0 0.3776126205921173
recurring O 1 0.9997075200080872
ATM O 1 0.9997305274009705
mutations O 0 0.07154390960931778
exist O 0 0.03746362030506134
. O 0 0.038300059735774994

Assays O 0 0.11145558208227158
requiring O 0 0.0564267598092556
minimal O 0 0.05294486880302429
amounts O 0 0.02352997660636902
of O 0 0.02880704402923584
genomic O 0 0.0706479549407959
DNA O 0 0.033293236047029495
were O 0 0.013222876936197281
designed O 0 0.02786102145910263
to O 0 0.018025025725364685
allow O 0 0.025789150968194008
rapid O 0 0.07155139744281769
screening O 0 0.07178011536598206
for O 0 0.02542576566338539
common O 0 0.03613172098994255
ethnic O 0 0.061591263860464096
mutations O 0 0.07407031208276749
. O 0 0.0455077700316906

These O 0 0.031594596803188324
rapid O 0 0.10869944840669632
assays O 0 0.07552693784236908
detected O 0 0.05644669383764267
mutations O 0 0.02842341549694538
in O 0 0.01321592926979065
76 O 0 0.044476624578237534
% O 0 0.017893372103571892
of O 0 0.022262075915932655
Costa O 0 0.3612801730632782
Rican O 1 0.9996790885925293
patients O 1 0.9997673630714417
( O 0 0.03290703892707825
3 O 0 0.03171389177441597
) O 0 0.014485972002148628
, O 0 0.00994254183024168
50 O 0 0.012757854536175728
% O 0 0.010929850861430168
of O 0 0.016484897583723068
Norwegian O 1 0.9697024822235107
patients O 1 0.9999932050704956
( O 0 0.030743077397346497
1 O 0 0.03445996716618538
) O 0 0.013976401649415493
, O 0 0.00941415410488844
25 O 0 0.012520878575742245
% O 0 0.011214593425393105
of O 0 0.021596601232886314
Polish O 1 0.9999854564666748
patients O 1 0.9999990463256836
( O 0 0.03706298768520355
4 O 0 0.03762594610452652
) O 0 0.017871741205453873
, O 0 0.010952901095151901
and O 0 0.009353429079055786
14 O 0 0.01653704047203064
% O 0 0.013744866475462914
of O 0 0.020013609901070595
Italian O 1 0.9998528957366943
patients O 1 0.9999984502792358
( O 0 0.04125707596540451
1 O 0 0.04629268869757652
) O 0 0.018426982685923576
, O 0 0.012296228669583797
as O 0 0.010743298567831516
well O 0 0.010720396414399147
as O 0 0.011995352804660797
in O 0 0.012874918058514595
patients O 0 0.169308602809906
of O 0 0.03318185731768608
Amish O 1 0.9999161958694458
/ O 1 0.9998997449874878
Mennonite O 1 0.8405539393424988
and O 0 0.03006012924015522
Irish O 0 0.0677461102604866
English O 0 0.041172903031110764
backgrounds O 0 0.0543353296816349
. O 0 0.04002329707145691

Additional O 0 0.053321436047554016
mutations O 0 0.040666211396455765
were O 0 0.012202372774481773
observed O 0 0.01814461313188076
in O 0 0.012852054089307785
Japanese O 0 0.034195974469184875
, O 0 0.018233345821499825
Utah O 0 0.052382584661245346
Mormon O 0 0.08223626762628555
, O 0 0.01979825273156166
and O 0 0.017590532079339027
African O 0 0.053436215966939926
American O 0 0.20512157678604126
patients O 1 0.9997438788414001
. O 0 0.05236866697669029

These O 0 0.030362708494067192
assays O 0 0.05122949928045273
should O 0 0.016062702983617783
facilitate O 0 0.03573209047317505
screening O 0 0.04596138000488281
for O 0 0.020891251042485237
A B-Disease 1 0.9998036026954651
- I-Disease 1 1.0
T I-Disease 1 0.9999992847442627
heterozygotes O 1 0.6118201017379761
in O 0 0.01785622164607048
the O 0 0.023625556379556656
populations O 0 0.03239772841334343
studied O 0 0.03449070081114769
. O 0 0.02488446794450283
. O 0 0.03531401976943016

The O 0 0.054522689431905746
von B-Disease 1 0.9809046387672424
Hippel I-Disease 1 0.9999979734420776
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
tumor I-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 0 0.04969065636396408
is O 0 0.01697884500026703
required O 0 0.01586914248764515
for O 0 0.019638776779174805
cell O 0 0.05511881783604622
cycle O 0 0.06424440443515778
exit O 0 0.08558935672044754
upon O 0 0.06154516711831093
serum O 1 0.9996781349182129
withdrawal O 0 0.16980016231536865
. O 0 0.054464712738990784

The O 0 0.05340256914496422
inactivation O 1 0.8789007663726807
of O 0 0.030577976256608963
the O 0 0.037136416882276535
von B-Disease 1 0.9962170720100403
Hippel I-Disease 1 0.9999978542327881
- I-Disease 1 0.9999997615814209
Lindau I-Disease 1 0.9999997615814209
( I-Disease 0 0.24997341632843018
VHL I-Disease 1 0.9999998807907104
) I-Disease 0 0.4322620630264282
tumor I-Disease 1 1.0
suppressor O 1 0.9999997615814209
gene O 0 0.1651366800069809
predisposes O 1 0.9995324611663818
affected O 0 0.03154550492763519
individuals O 0 0.011335359886288643
to O 0 0.012125033885240555
the O 0 0.022722965106368065
human O 1 0.9973136782646179
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.6842167973518372
is O 0 0.019945833832025528
associated O 0 0.01717943698167801
with O 0 0.01859297603368759
sporadic B-Disease 1 0.9999985694885254
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999690055847168
RCC B-Disease 1 1.0
) O 0 0.04579320177435875
and O 0 0.03937777131795883
brain B-Disease 1 0.9989168643951416
hemangioblastomas I-Disease 1 0.9999059438705444
. O 0 0.05540964752435684

VHL O 1 0.9999736547470093
- O 1 0.9997186064720154
negative O 0 0.07697844505310059
786 O 1 0.9999849796295166
- O 1 0.9999997615814209
0 O 1 0.9916884303092957
RCC B-Disease 1 1.0
cells O 0 0.04833054170012474
are O 0 0.012509428896009922
tumorigenic O 1 0.7849023938179016
in O 0 0.028296098113059998
nude O 1 0.998322069644928
mice O 0 0.05417906865477562
which O 0 0.01578446477651596
is O 0 0.016597801819443703
suppressed O 0 0.04947337135672569
by O 0 0.01782364398241043
the O 0 0.026145795360207558
reintroduction O 0 0.18197506666183472
of O 0 0.06257297098636627
VHL B-Disease 1 0.9999781847000122
. O 0 0.07251147925853729

Remarkably O 0 0.12339086085557938
, O 0 0.03019411861896515
this O 0 0.016131894662976265
occurs O 0 0.023122010752558708
without O 0 0.014425382018089294
affecting O 0 0.028883950784802437
the O 0 0.02017170935869217
growth O 0 0.02737269178032875
rate O 0 0.025093533098697662
and O 0 0.023541273549199104
cell O 0 0.08540061861276627
cycle O 0 0.05129319056868553
profile O 0 0.04531874507665634
of O 0 0.022264111787080765
these O 0 0.016040591523051262
cells O 0 0.03722622990608215
in O 0 0.02209652028977871
culture O 0 0.048280246555805206
. O 0 0.04120447859168053

The O 0 0.05584755167365074
786 O 1 0.9996585845947266
- O 1 0.9999827146530151
0 O 0 0.07836063951253891
cell O 0 0.04963778704404831
line O 0 0.03194713220000267
, O 0 0.014696706086397171
like O 0 0.01932159811258316
many O 0 0.025102689862251282
cancer B-Disease 1 1.0
cells O 1 0.6721640229225159
, O 0 0.024007542058825493
fails O 0 0.05117078125476837
to O 0 0.01753937639296055
exit O 0 0.05108369514346123
the O 0 0.028224559500813484
cell O 0 0.06068519130349159
cycle O 0 0.06284072995185852
upon O 0 0.05349603667855263
serum O 1 0.9998987913131714
withdrawal O 1 0.9599120616912842
. O 0 0.05625623092055321

Here O 0 0.03782416880130768
, O 0 0.02089042216539383
it O 0 0.010292613878846169
is O 0 0.010867659002542496
shown O 0 0.009595499373972416
that O 0 0.007137745153158903
reintroduction O 0 0.04207364097237587
of O 0 0.013842061161994934
the O 0 0.019544359296560287
wild O 0 0.0458214096724987
- O 1 0.9999986886978149
type O 1 0.9604977369308472
VHL B-Disease 1 0.9999970197677612
gene O 0 0.03967674821615219
restores O 0 0.07512035965919495
the O 0 0.014710993506014347
ability O 0 0.015588504262268543
of O 0 0.026275495067238808
VHL O 1 0.9999998807907104
- O 1 0.9999998807907104
negative O 1 0.9997881054878235
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.04479251429438591
to O 0 0.01896391436457634
exit O 0 0.04863143339753151
the O 0 0.026081109419465065
cell O 0 0.05056530982255936
cycle O 0 0.04085744917392731
and O 0 0.021688872948288918
enter O 0 0.07700750976800919
G0 O 1 0.9999998807907104
/ O 1 0.9999730587005615
quiescence O 1 0.9997710585594177
in O 0 0.04366316646337509
low O 0 0.4021032452583313
serum O 1 0.9996117949485779
. O 0 0.05957784503698349

Both O 0 0.06282080709934235
VHL O 1 0.9999946355819702
- O 1 0.9999196529388428
positive O 0 0.039803534746170044
and O 0 0.03440363332629204
VHL O 1 0.9999998807907104
- O 1 0.9999996423721313
negative O 1 0.8809540867805481
RCC B-Disease 1 1.0
cells O 0 0.05553291738033295
exit O 0 0.06574926525354385
the O 0 0.03317616507411003
cell O 0 0.06325660645961761
cycle O 0 0.061384301632642746
by O 0 0.03477538749575615
contact O 0 0.09063798934221268
inhibition O 1 0.8489944934844971
. O 0 0.05294419452548027

The O 0 0.07866901904344559
cyclin O 1 0.9999903440475464
- O 1 0.9999929666519165
dependent O 0 0.39262494444847107
kinase O 1 0.9995998740196228
inhibitor O 1 0.9996840953826904
, O 0 0.0560762956738472
p27 O 1 0.9998536109924316
, O 0 0.0406503863632679
accumulates O 0 0.3842376172542572
upon O 0 0.0512540377676487
serum O 1 0.9999872446060181
withdrawal O 0 0.4179060757160187
, O 0 0.015159490518271923
only O 0 0.007572706323117018
in O 0 0.006996167823672295
the O 0 0.01334754191339016
presence O 0 0.026684142649173737
of O 0 0.029920712113380432
VHL B-Disease 1 0.9999967813491821
, O 0 0.020348267629742622
as O 0 0.013476857915520668
a O 0 0.01502695307135582
result O 0 0.01335675735026598
of O 0 0.014766901731491089
the O 0 0.022003330290317535
stabilization O 1 0.9239736199378967
of O 0 0.027606574818491936
the O 0 0.040053922683000565
protein O 0 0.0504547618329525
. O 0 0.032719094306230545

We O 0 0.027999021112918854
propose O 0 0.03291867673397064
that O 0 0.0075039369985461235
the O 0 0.01176648773252964
loss O 0 0.022097039967775345
of O 0 0.02034086175262928
wild O 0 0.052884481847286224
- O 1 0.9999992847442627
type O 1 0.9965284466743469
VHL B-Disease 1 0.999998927116394
gene O 0 0.03284323588013649
results O 0 0.010269866324961185
in O 0 0.00792876910418272
a O 0 0.015008486807346344
specific O 0 0.01612718217074871
cellular O 0 0.05130783095955849
defect O 1 0.9996757507324219
in O 0 0.030662843957543373
serum O 1 0.9999998807907104
- O 1 0.9999996423721313
dependent O 0 0.05010209232568741
growth O 0 0.03151235729455948
control O 0 0.031253959983587265
, O 0 0.016387229785323143
which O 0 0.016380390152335167
may O 0 0.026964399963617325
initiate O 1 0.9984157085418701
tumor B-Disease 1 0.9999994039535522
formation O 1 0.9134542942047119
. O 0 0.05766947939991951

This O 0 0.026754513382911682
is O 0 0.023132603615522385
corrected O 0 0.049158141016960144
by O 0 0.01236290019005537
the O 0 0.016040651127696037
reintroduction O 0 0.059663381427526474
of O 0 0.023874232545495033
wild O 0 0.05373409390449524
- O 1 0.9999995231628418
type O 1 0.9922019243240356
VHL B-Disease 1 0.9999983310699463
, O 0 0.03821190819144249
implicating O 1 0.999969482421875
VHL B-Disease 1 0.9999532699584961
as O 0 0.020427841693162918
the O 0 0.023462558165192604
first O 0 0.18989576399326324
tumor B-Disease 1 1.0
suppressor O 1 0.9999897480010986
involved O 0 0.018587524071335793
in O 0 0.009979263879358768
the O 0 0.015652712434530258
regulation O 0 0.02391449548304081
of O 0 0.02582465298473835
cell O 1 0.8078043460845947
cycle O 0 0.05884113535284996
exit O 0 0.06470520794391632
, O 0 0.01563292369246483
which O 0 0.008892780169844627
is O 0 0.00958744902163744
consistent O 0 0.01633688621222973
with O 0 0.011730042286217213
its O 0 0.02179132215678692
gatekeeper O 1 0.9999978542327881
function O 0 0.028866922482848167
in O 0 0.01877746917307377
the O 0 0.059854596853256226
kidney O 1 1.0
. O 0 0.04402954876422882
. O 0 0.0454016849398613

Piebaldism B-Disease 1 0.9999951124191284
with O 1 0.644913911819458
deafness B-Disease 1 1.0
: O 0 0.05332200601696968
molecular O 0 0.02894299291074276
evidence O 0 0.01334840152412653
for O 0 0.013911488465964794
an O 0 0.025843307375907898
expanded O 1 0.8847801685333252
syndrome O 1 1.0
. O 0 0.07344001531600952

In O 0 0.024874553084373474
a O 0 0.02562095783650875
South O 0 0.039019908756017685
African O 0 0.044804975390434265
girl O 0 0.08487793058156967
of O 0 0.03613613545894623
Xhosa O 1 0.9999926090240479
stock O 0 0.07334735989570618
with O 0 0.03103557787835598
severe O 1 0.9999959468841553
piebaldism B-Disease 1 0.9999997615814209
and O 1 0.9040517210960388
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.16531644761562347
identified O 0 0.028689799830317497
a O 0 0.022252021357417107
novel O 0 0.04694390669465065
missense O 0 0.09432774782180786
substitution O 0 0.05091102793812752
at O 0 0.022168738767504692
a O 0 0.023196015506982803
highly O 0 0.033821966499090195
conserved O 0 0.03554655611515045
residue O 0 0.04750693216919899
in O 0 0.014395028352737427
the O 0 0.02903304062783718
intracellular O 1 0.9958736300468445
kinase O 0 0.46103525161743164
domain O 0 0.029314236715435982
of O 0 0.015338023193180561
the O 0 0.02812844328582287
KIT O 1 0.9999880790710449
proto O 1 0.9999996423721313
- O 1 0.9999998807907104
oncogene O 1 0.9999955892562866
, O 0 0.05074746161699295
R796G O 1 0.9659280776977539
. O 0 0.04588094353675842

Though O 0 0.08457041531801224
auditory B-Disease 1 0.9989049434661865
anomalies I-Disease 1 0.6819008588790894
have O 0 0.013321668840944767
been O 0 0.01394867803901434
observed O 0 0.018695469945669174
in O 0 0.01420686487108469
mice O 0 0.033406082540750504
with O 0 0.017023911699652672
dominant O 0 0.4321634769439697
white O 1 0.9853672981262207
spotting O 1 0.999975323677063
( O 0 0.05959668755531311
W O 1 0.9999299049377441
) O 0 0.020910078659653664
due O 0 0.02056407369673252
to O 0 0.026980286464095116
KIT O 1 0.9999953508377075
mutations O 0 0.07856191694736481
, O 0 0.04853936657309532
deafness B-Disease 1 1.0
is O 0 0.026729458943009377
not O 0 0.014672682620584965
typical O 0 0.0300266295671463
in O 0 0.018746929243206978
human O 0 0.04375199228525162
piebaldism B-Disease 1 0.9972291588783264
. O 0 0.05050194263458252

Thus O 0 0.03582155704498291
, O 0 0.019731493666768074
the O 0 0.022078828886151314
occurrence O 0 0.06399550288915634
of O 1 0.5728408098220825
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.05054684355854988
this O 0 0.027256960049271584
patient O 1 0.999893069267273
extends O 0 0.06567537784576416
considerably O 0 0.03225179761648178
the O 0 0.01995941437780857
phenotypic O 0 0.0431615486741066
range O 0 0.018434349447488785
of O 0 0.024394357576966286
piebaldism B-Disease 1 0.9955615997314453
due O 0 0.03159957379102707
to O 0 0.030759768560528755
KIT O 1 0.9999934434890747
gene O 0 0.055727768689394
mutation O 0 0.045818354934453964
in O 0 0.018415451049804688
humans O 0 0.02253040485084057
and O 0 0.022803030908107758
tightens O 1 0.983902633190155
the O 0 0.030625153332948685
clinical O 1 0.872183084487915
similarity O 0 0.041725631803274155
between O 0 0.0303287785500288
piebaldism B-Disease 1 0.9950562715530396
and O 0 0.01539764367043972
the O 0 0.013652481138706207
various O 0 0.011095230467617512
forms O 0 0.032173022627830505
of O 1 0.9991357922554016
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.5202981233596802
. O 0 0.054512012749910355

Cycloheximide O 1 0.9979684948921204
facilitates O 0 0.1182158887386322
the O 0 0.032406315207481384
identification O 0 0.034052301198244095
of O 0 0.02981771156191826
aberrant O 1 0.6635498404502869
transcripts O 0 0.057609040290117264
resulting O 0 0.028901664540171623
from O 0 0.01561062503606081
a O 0 0.02479703165590763
novel O 0 0.05553100258111954
splice O 1 0.7505647540092468
- O 1 0.995658278465271
site O 0 0.04067211225628853
mutation O 0 0.03330950066447258
in O 0 0.015997592359781265
COL17A1 O 1 0.999700665473938
in O 0 0.01672397553920746
a O 0 0.029992248862981796
patient O 1 0.9999157190322876
with O 0 0.055742207914590836
generalized O 1 0.9999998807907104
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.11402755230665207

Patients O 1 0.9983811378479004
with O 0 0.07588964700698853
generalized O 1 0.9999997615814209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.04370681196451187
show O 0 0.03113769367337227
decreased O 0 0.03866590932011604
expression O 0 0.032233886420726776
of O 0 0.0323641262948513
type O 1 0.9999847412109375
XVII O 1 1.0
collagen O 1 1.0
, O 0 0.03258340433239937
a O 0 0.043462928384542465
transmembrane O 1 0.999029278755188
hemidesmosomal O 1 0.9998897314071655
protein O 0 0.04511192440986633
encoded O 0 0.025876473635435104
by O 0 0.02878139354288578
COL17A1 O 1 0.9991845488548279
. O 0 0.048548903316259384

This O 0 0.022984325885772705
report O 0 0.019128601998090744
documents O 0 0.017194515094161034
a O 0 0.02296624146401882
novel O 0 0.05961637571454048
splice O 1 0.6598175168037415
- O 1 0.9986603260040283
site O 0 0.04483072832226753
mutation O 0 0.03665752336382866
in O 0 0.015156003646552563
COL17A1 O 1 0.9974537491798401
in O 0 0.017208430916070938
a O 0 0.03356510400772095
patient O 1 0.9986218214035034
with O 0 0.04843919724225998
generalized O 1 0.9999994039535522
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.05243249982595444
and O 0 0.02552037313580513
applies O 0 0.03201848268508911
a O 0 0.022360948845744133
new O 0 0.02542482502758503
methodology O 0 0.03316221758723259
to O 0 0.01804266683757305
define O 0 0.03290839120745659
and O 0 0.019297299906611443
characterize O 0 0.06086884066462517
the O 0 0.029599888250231743
resulting O 0 0.05225961282849312
mRNA O 0 0.09998480975627899
splice O 0 0.14995145797729492
variants O 0 0.05809563770890236
. O 0 0.04219561070203781

Mutational O 1 0.861539363861084
analysis O 0 0.03411424160003662
of O 0 0.03390610218048096
COL17A1 O 1 0.9946685433387756
identified O 0 0.02981671877205372
a O 0 0.0282711423933506
maternally O 0 0.23797714710235596
inherited O 1 0.9994726777076721
G O 1 0.9999744892120361
- O 1 0.9998818635940552
to O 0 0.030198676511645317
- O 1 0.9999973773956299
T O 1 0.9999215602874756
transversion O 1 0.9857696294784546
at O 0 0.018722135573625565
the O 0 0.021626079455018044
- O 1 0.9950752854347229
1 O 0 0.026452023535966873
position O 0 0.023617615923285484
of O 0 0.023415494710206985
exon O 0 0.1469554901123047
32 O 0 0.06421183049678802
. O 0 0.043032385408878326

This O 0 0.04382281005382538
acceptor O 1 0.9429758787155151
splice O 1 0.9574177265167236
- O 1 0.9993994235992432
site O 0 0.04676356166601181
mutation O 0 0.03920961543917656
led O 0 0.026237614452838898
to O 0 0.013337208889424801
the O 0 0.01594887487590313
formation O 0 0.03539946302771568
of O 0 0.025764914229512215
aberrant O 1 0.9992332458496094
transcripts O 0 0.052231114357709885
present O 0 0.02501925639808178
at O 0 0.027924126014113426
extremely O 0 0.04349375143647194
low O 0 0.05848091468214989
levels O 0 0.04746728017926216
. O 0 0.03800738602876663

Based O 0 0.03936491161584854
on O 0 0.019657917320728302
our O 0 0.019087335094809532
recent O 0 0.017689665779471397
finding O 0 0.026044882833957672
that O 0 0.01779518648982048
cycloheximide O 1 0.9991931319236755
stabilized O 1 0.999555766582489
mutant O 1 0.9682556986808777
COL17A1 O 1 0.9999521970748901
transcripts O 0 0.06196712329983711
in O 0 0.02351304329931736
keratinocytes O 0 0.49622631072998047
homozygous O 0 0.0603160485625267
for O 0 0.019444888457655907
a O 0 0.04038142040371895
frameshift O 1 0.9998282194137573
mutation O 0 0.06053647771477699
, O 0 0.017593439668416977
the O 0 0.016741594299674034
effects O 0 0.021987255662679672
of O 0 0.017925618216395378
the O 0 0.03199820965528488
splice O 1 0.993806004524231
- O 1 0.998444139957428
site O 0 0.0407303087413311
mutation O 0 0.03224547579884529
on O 0 0.017060263082385063
splicing O 0 0.039569348096847534
of O 0 0.026729146018624306
COL17A1 O 1 0.9993353486061096
transcripts O 0 0.044753022491931915
were O 0 0.011118494905531406
determined O 0 0.021516377106308937
using O 0 0.01597021520137787
reverse O 0 0.06802429258823395
transcriptase O 1 0.9899919629096985
polymerase O 1 0.9092574119567871
chain O 0 0.07191888988018036
reaction O 0 0.03545090928673744
of O 0 0.02156667970120907
total O 0 0.02764141373336315
RNA O 0 0.06009973958134651
from O 0 0.028124768286943436
keratinocytes O 1 0.77218097448349
incubated O 0 0.13416503369808197
for O 0 0.033045895397663116
2 O 0 0.05870942398905754
. O 0 0.03918612748384476

5 O 0 0.07392822206020355
h O 0 0.09696416556835175
in O 0 0.014640454202890396
the O 0 0.020296499133110046
presence O 0 0.030598126351833344
or O 0 0.01894737407565117
absence O 0 0.03603789582848549
of O 0 0.027163881808519363
10 O 0 0.04599519819021225
microg O 1 0.9979591369628906
cycloheximide O 1 0.9981147050857544
per O 0 0.057787057012319565
ml O 1 0.9833545088768005
. O 0 0.05108592286705971

Using O 0 0.023522650822997093
this O 0 0.013888070359826088
approach O 0 0.02335643395781517
, O 0 0.015320489183068275
an O 0 0.020449211820960045
abnormally O 1 0.9975399971008301
spliced O 0 0.0728868916630745
transcript O 0 0.048971112817525864
was O 0 0.02270890772342682
identified O 0 0.018145106732845306
that O 0 0.008532732725143433
contains O 0 0.016135839745402336
an O 0 0.014077452942728996
extra O 0 0.0296463705599308
264 O 0 0.06925494968891144
bases O 0 0.03550086170434952
upstream O 0 0.04252403974533081
from O 0 0.022259196266531944
exon O 0 0.0992254763841629
32 O 0 0.0384085439145565
, O 0 0.017895929515361786
resulting O 0 0.020930692553520203
in O 0 0.013754948042333126
a O 0 0.03449683263897896
premature O 1 0.9998321533203125
termination O 1 0.9998875856399536
codon O 0 0.23231007158756256
27 O 0 0.05927330628037453
bp O 0 0.07156730443239212
downstream O 0 0.040409304201602936
from O 0 0.015471781603991985
the O 0 0.03428620845079422
cryptic O 0 0.3473787009716034
splice O 0 0.19046086072921753
site O 0 0.058690011501312256
. O 0 0.04023412987589836

Three O 0 0.03396833315491676
other O 0 0.026170633733272552
splice O 0 0.13063637912273407
variants O 0 0.03595314547419548
, O 0 0.016212282702326775
including O 0 0.01368033792823553
one O 0 0.0157210323959589
derived O 0 0.015699192881584167
from O 0 0.011619486846029758
the O 0 0.01906445063650608
skipping O 0 0.055775292217731476
of O 0 0.02998197078704834
exon O 0 0.4854803681373596
32 O 0 0.044327545911073685
, O 0 0.019258840009570122
were O 0 0.012459628283977509
also O 0 0.017958806827664375
identified O 0 0.032145775854587555
. O 0 0.03201555833220482

These O 0 0.02202429249882698
results O 0 0.01726117730140686
indicate O 0 0.016838006675243378
the O 0 0.017528992146253586
usefulness O 0 0.06303635239601135
of O 0 0.03510134667158127
cycloheximide O 1 0.9999983310699463
treatment O 1 0.9999327659606934
in O 0 0.019968459382653236
evaluating O 0 0.04665271192789078
the O 0 0.026111286133527756
abnormal O 1 0.6159580945968628
processing O 0 0.023462291806936264
of O 0 0.020858855918049812
mRNA O 0 0.03762063384056091
due O 0 0.016785047948360443
to O 0 0.019487306475639343
splice O 0 0.43074139952659607
- O 1 0.9993879795074463
site O 0 0.04158151522278786
mutations O 0 0.03337101265788078
, O 0 0.01754496432840824
because O 0 0.01888919249176979
( O 0 0.023972151800990105
i O 0 0.03046328015625477
) O 0 0.02677103877067566
aberrant O 1 0.7864077091217041
splicing O 0 0.05273021385073662
often O 0 0.01371404342353344
generates O 0 0.026005448773503304
a O 0 0.02768854796886444
premature O 1 0.9891055226325989
termination O 1 0.9998302459716797
codon O 1 0.9513871669769287
, O 0 0.02920633554458618
( O 0 0.029304442927241325
ii O 1 0.9893887639045715
) O 0 0.02355084754526615
transcripts O 0 0.03925810009241104
with O 0 0.023352807387709618
premature O 1 0.99982750415802
termination O 1 0.9999799728393555
codons O 1 0.6907757520675659
can O 0 0.01637299545109272
occur O 0 0.015485521405935287
at O 0 0.02451135218143463
low O 0 0.061903100460767746
or O 0 0.031598787754774094
undetectable O 1 0.9998258948326111
levels O 0 0.0269613079726696
due O 0 0.01941114105284214
to O 0 0.019590597599744797
nonsense O 1 0.7834343910217285
- O 1 0.9998533725738525
mediated O 1 0.6032240986824036
mRNA O 0 0.06944236904382706
decay O 0 0.07385116815567017
, O 0 0.01984833925962448
and O 0 0.02153974026441574
( O 0 0.031240837648510933
iii O 1 0.9980401396751404
) O 0 0.019030814990401268
the O 0 0.01760287955403328
levels O 0 0.02131788060069084
of O 0 0.016063205897808075
these O 0 0.012023885734379292
transcripts O 0 0.040047433227300644
can O 0 0.012004968710243702
be O 0 0.010710942558944225
increased O 0 0.022270075976848602
by O 0 0.030713308602571487
cycloheximide O 1 0.9878441095352173
. O 0 0.049729038029909134

A O 0 0.10327975451946259
deletion O 0 0.16656631231307983
mutation O 0 0.07691036909818649
in O 0 0.026762286201119423
COL17A1 O 1 0.9987120628356934
in O 0 0.015953755006194115
five O 0 0.019331354647874832
Austrian O 0 0.07483675330877304
families O 0 0.0356922522187233
with O 0 0.039002448320388794
generalized O 1 0.9999990463256836
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 0 0.19880378246307373
propagation O 0 0.09441840648651123
of O 0 0.03192390874028206
an O 0 0.033492233604192734
ancestral O 1 0.842827320098877
allele O 0 0.1164795383810997
. O 0 0.0437132865190506

Patients O 1 0.999354898929596
with O 0 0.0725124180316925
generalized O 1 0.9999997615814209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.05425034835934639
a O 0 0.03693794459104538
usually O 0 0.025405490770936012
nonlethal O 0 0.08999332785606384
form O 0 0.030712915584445
of O 0 0.053518619388341904
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.04381696507334709
have O 0 0.020690742880105972
generalized O 1 0.8895044922828674
blistering B-Disease 1 0.9999901056289673
, O 1 0.9582825303077698
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9939780235290527
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 0.4956759512424469
and O 1 0.9250462651252747
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
. O 0 0.11096668243408203

Skin B-Disease 1 0.9999996423721313
fragility I-Disease 1 0.9999991655349731
in O 0 0.03142761066555977
most O 0 0.022685067728161812
cases O 0 0.026142656803131104
is O 0 0.01863176003098488
due O 0 0.01974237896502018
to O 0 0.016437910497188568
mutations O 0 0.018845349550247192
in O 0 0.010072184726595879
the O 0 0.018559232354164124
gene O 0 0.0344330258667469
encoding O 0 0.051523130387067795
type O 1 0.9894736409187317
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.5813943147659302
COL17A1 O 1 0.9999966621398926
) O 0 0.047544751316308975
. O 0 0.036223944276571274

Recently O 0 0.062263354659080505
, O 0 0.021971343085169792
we O 0 0.011084333062171936
reported O 0 0.014990894123911858
five O 0 0.014797497540712357
Austrian O 0 0.0672980546951294
families O 0 0.03515974059700966
with O 0 0.04330340772867203
generalized O 1 0.9999995231628418
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.07139220833778381
share O 0 0.03480398654937744
the O 0 0.030369840562343597
same O 0 0.03902881592512131
COL17A1 O 1 0.9999680519104004
mutation O 0 0.10714928060770035
. O 0 0.046038612723350525

Affected O 0 0.0711827427148819
individuals O 0 0.020375089719891548
in O 0 0.014891092665493488
three O 0 0.014183289371430874
families O 0 0.023166490718722343
are O 0 0.010430369526147842
homozygous O 0 0.05612625926733017
for O 0 0.029323114082217216
4003delTC O 1 0.9998268485069275
, O 0 0.0265372171998024
whereas O 0 0.02464081160724163
those O 0 0.0090875793248415
in O 0 0.010093278251588345
two O 0 0.011473668739199638
others O 0 0.018641836941242218
are O 0 0.015398026444017887
compound O 0 0.16485437750816345
heterozygotes O 1 0.9739684462547302
. O 0 0.05706625431776047

To O 0 0.03632010892033577
determine O 0 0.022744810208678246
if O 0 0.014198772609233856
the O 0 0.017209583893418312
occurrence O 0 0.04272729158401489
of O 0 0.028980713337659836
4003delTC O 1 0.9988429546356201
in O 0 0.015623175539076328
these O 0 0.009441208094358444
unrelated O 0 0.03129573538899422
families O 0 0.030289245769381523
signifies O 0 0.3500104248523712
propagation O 0 0.05606529489159584
of O 0 0.019692305475473404
an O 0 0.025273999199271202
ancestral O 1 0.8033540844917297
allele O 0 0.08555231988430023
or O 0 0.021071026101708412
a O 0 0.039557505398988724
mutational O 1 0.9999269247055054
hot O 1 0.9958087205886841
spot O 0 0.07671430706977844
, O 0 0.02738344855606556
haplotypes O 0 0.07534841448068619
were O 0 0.01384224183857441
determined O 0 0.02480628713965416
for O 0 0.018694967031478882
polymorphisms O 0 0.05476151034235954
both O 0 0.015947645530104637
within O 0 0.023190831765532494
and O 0 0.036848925054073334
flanking O 1 0.9998700618743896
COL17A1 O 1 0.9999904632568359
. O 0 0.07737524807453156

Five O 0 0.07922305166721344
intragenic O 1 0.9724888205528259
polymorphisms O 0 0.10238058120012283
were O 0 0.01674143224954605
chosen O 0 0.025579648092389107
based O 0 0.01771942526102066
on O 0 0.015725858509540558
their O 0 0.022965585812926292
informativeness O 1 0.9705193042755127
. O 0 0.047145403921604156

One O 0 0.031494300812482834
of O 0 0.02110721915960312
these O 0 0.011412510648369789
, O 0 0.012904943898320198
not O 0 0.007956128567457199
previously O 0 0.014775976538658142
reported O 0 0.015762684866786003
, O 0 0.013300707563757896
was O 0 0.026195960119366646
2988 O 1 0.9954420328140259
A O 0 0.04148600995540619
or O 0 0.0240410678088665
C O 1 0.5246587991714478
that O 0 0.010675914585590363
introduces O 0 0.04167039692401886
a O 0 0.01755436882376671
new O 0 0.02089264802634716
restriction O 0 0.03746979683637619
site O 0 0.03423616290092468
for O 0 0.0254487507045269
Eco0109 O 1 0.9988607168197632
I O 0 0.0818217396736145
. O 0 0.04598619416356087

All O 0 0.03515255078673363
the O 0 0.04691514000296593
4003delTC O 1 0.9938457608222961
alleles O 0 0.07415944337844849
showed O 0 0.028035350143909454
the O 0 0.023857789114117622
same O 0 0.023253515362739563
haplotype O 0 0.09101647138595581
for O 0 0.018131118267774582
these O 0 0.012673484161496162
five O 0 0.034592386335134506
polymorphic O 1 0.9888460040092468
markers O 0 0.12065194547176361
. O 0 0.05252606421709061

Fourteen O 0 0.16148856282234192
microsatellite O 1 0.9356468319892883
polymorphisms O 0 0.10167455673217773
were O 0 0.014468166045844555
selected O 0 0.01775820180773735
based O 0 0.014288662001490593
on O 0 0.010194605216383934
their O 0 0.01292102038860321
high O 0 0.045131344348192215
heterozygosity O 1 0.9986985921859741
and O 0 0.017619924619793892
their O 0 0.012460851110517979
location O 0 0.022191504016518593
within O 0 0.023616399616003036
10q23 O 1 0.9990288019180298
- O 1 0.9999539852142334
q25 O 1 0.9981831908226013
near O 0 0.10817047953605652
COL17A1 O 1 0.9995816349983215
. O 0 0.050826795399188995

Three O 0 0.034145426005125046
families O 0 0.04744657874107361
shared O 0 0.06851860135793686
microsatellite O 1 0.9855504035949707
polymorphisms O 0 0.11430182307958603
covering O 0 0.049662280827760696
at O 0 0.0275417547672987
most O 0 0.019670238718390465
19 O 0 0.042240675538778305
cM O 0 0.05585039407014847
, O 0 0.01929326541721821
whereas O 0 0.023620037361979485
the O 0 0.018017474561929703
others O 0 0.016156593337655067
shared O 0 0.02618391625583172
smaller O 0 0.019806714728474617
regions O 0 0.018206574022769928
consistent O 0 0.026164958253502846
with O 0 0.017221804708242416
cross O 0 0.06188613921403885
- O 1 0.9997307658195496
over O 0 0.02025674283504486
events O 0 0.013954581692814827
during O 0 0.01595141738653183
passage O 0 0.028466569259762764
of O 0 0.017818421125411987
this O 0 0.016222424805164337
mutation O 0 0.04317314922809601
through O 0 0.02027421072125435
several O 0 0.017809219658374786
generations O 0 0.058090537786483765
. O 0 0.041703466325998306

These O 0 0.024133551865816116
results O 0 0.021878495812416077
indicate O 0 0.02495855651795864
that O 0 0.017469579353928566
4003delTC O 1 0.5667500495910645
occurs O 0 0.024475963786244392
on O 0 0.01384479459375143
a O 0 0.022795364260673523
single O 0 0.043411120772361755
ancestral O 1 0.9334325194358826
allele O 0 0.10368143022060394
. O 0 0.027306891977787018
. O 0 0.03604085370898247

The O 0 0.0732211023569107
haptoglobin O 1 0.9998676776885986
- O 1 0.9999784231185913
gene O 0 0.06907150894403458
deletion O 0 0.08547354489564896
responsible O 0 0.04993036761879921
for O 0 0.03872522711753845
anhaptoglobinemia B-Disease 1 0.9996999502182007
. O 0 0.05516669154167175

We O 0 0.023793574422597885
have O 0 0.009768125601112843
found O 0 0.01100063044577837
an O 0 0.01530110277235508
allelic O 0 0.3064289093017578
deletion O 0 0.062011703848838806
of O 0 0.024948207661509514
the O 0 0.03954004496335983
haptoglobin O 1 0.999996542930603
( O 0 0.04734009876847267
Hp O 1 0.9870997667312622
) O 0 0.024417873471975327
gene O 0 0.02340880036354065
from O 0 0.012120449915528297
an O 0 0.01549199316650629
individual O 0 0.021739361807703972
with O 0 0.03223099932074547
anhaptoglobinemia B-Disease 1 0.99875807762146
. O 0 0.05653245374560356

The O 0 0.05845094472169876
Hp O 1 0.9365001916885376
gene O 0 0.05691264569759369
cluster O 0 0.059145644307136536
consists O 0 0.030924225226044655
of O 0 0.024026300758123398
coding O 0 0.045316122472286224
regions O 0 0.015827346593141556
of O 0 0.01605474017560482
the O 0 0.025960635393857956
alpha O 1 0.9420139789581299
chain O 0 0.050145819783210754
and O 0 0.01857639290392399
beta O 0 0.07683482021093369
chain O 0 0.03554253280162811
of O 0 0.019424621015787125
the O 0 0.033990681171417236
haptoglobin O 1 0.999990701675415
gene O 0 0.06232735514640808
( O 0 0.031825192272663116
Hp O 0 0.14452315866947174
) O 0 0.013539694249629974
and O 0 0.008441690355539322
of O 0 0.012091906741261482
the O 0 0.020881466567516327
alpha O 1 0.9153880476951599
chain O 0 0.04304058477282524
and O 0 0.01802780292928219
beta O 0 0.061173394322395325
chain O 0 0.03125593811273575
of O 0 0.015410438179969788
the O 0 0.025303388014435768
haptoglobin O 1 0.9999955892562866
- O 1 0.9999996423721313
related O 0 0.045783039182424545
gene O 0 0.04832276701927185
( O 0 0.0352170504629612
Hpr O 1 0.9999517202377319
) O 0 0.02455534227192402
, O 0 0.01630682311952114
in O 0 0.016167420893907547
tandem O 0 0.05900539457798004
from O 0 0.0187218077480793
the O 0 0.026287954300642014
5 O 0 0.04098028317093849
side O 0 0.04962616413831711
. O 0 0.03653204068541527

Southern O 0 0.130843386054039
blot O 1 0.9951025247573853
and O 0 0.054641690105199814
PCR O 0 0.1327771693468094
analyses O 0 0.03345441445708275
have O 0 0.009277001954615116
indicated O 0 0.016224723309278488
that O 0 0.006815860979259014
the O 0 0.011313529685139656
individual O 0 0.012581642717123032
with O 0 0.016622841358184814
anhaptoglobinemia B-Disease 1 0.999225378036499
was O 0 0.028747308999300003
homozygous O 0 0.03939268738031387
for O 0 0.01350813452154398
the O 0 0.021844645962119102
gene O 0 0.03510737046599388
deletion O 0 0.045990634709596634
and O 0 0.012263942509889603
that O 0 0.008502173237502575
the O 0 0.018691176548600197
gene O 0 0.032963503152132034
deletion O 0 0.04904763028025627
was O 0 0.02263985387980938
included O 0 0.014534213580191135
at O 0 0.01285241637378931
least O 0 0.008593834936618805
from O 0 0.010568254627287388
the O 0 0.019339432939887047
promoter O 1 0.7789182066917419
region O 0 0.025092877447605133
of O 0 0.024353085085749626
Hp O 1 0.5379454493522644
to O 0 0.035613786429166794
Hpr O 1 0.9996374845504761
alpha O 0 0.08222872763872147
but O 0 0.013499735854566097
not O 0 0.010178003460168839
to O 0 0.024947863072156906
Hpr O 1 0.9999312162399292
beta O 1 0.9978393316268921
( O 0 0.0622207373380661
Hpdel O 1 0.9986029267311096
) O 0 0.04835537448525429
. O 0 0.04106157645583153

In O 0 0.03575417771935463
addition O 0 0.031044969335198402
, O 0 0.01827630214393139
we O 0 0.011025587096810341
found O 0 0.010210360400378704
seven O 0 0.01421013567596674
individuals O 0 0.015272168442606926
with O 0 0.020748212933540344
hypohaptoglobinemia B-Disease 1 0.9940189123153687
in O 0 0.01489928551018238
three O 0 0.013903758488595486
families O 0 0.022386424243450165
, O 0 0.014534692279994488
and O 0 0.01337698008865118
the O 0 0.022504396736621857
genotypes O 0 0.09946584701538086
of O 0 0.01714283600449562
six O 0 0.01581718772649765
of O 0 0.016153773292899132
the O 0 0.018010664731264114
seven O 0 0.019883116707205772
individuals O 0 0.013918619602918625
were O 0 0.0094052879139781
found O 0 0.011879745870828629
to O 0 0.017190156504511833
be O 0 0.02319370210170746
Hp2 O 1 0.9999399185180664
/ O 1 0.9999003410339355
Hpdel O 1 0.9990098476409912
. O 0 0.05913720279932022

The O 0 0.07265511155128479
phenotypes O 0 0.14312861859798431
and O 0 0.039731498807668686
genotypes O 0 0.14241193234920502
in O 0 0.017665792256593704
one O 0 0.014741996303200722
of O 0 0.01328846625983715
these O 0 0.007709743920713663
three O 0 0.009497081860899925
families O 0 0.018645107746124268
showed O 0 0.01864086091518402
the O 0 0.01772049069404602
father O 0 0.03827223554253578
to O 0 0.017928684130311012
be O 0 0.018176129087805748
hypohaptoglobinemic B-Disease 1 0.9951582551002502
( O 0 0.04036669060587883
Hp2 O 1 0.9977039694786072
) O 0 0.02624521404504776
and O 0 0.026251118630170822
Hp2 O 1 0.9999899864196777
/ O 1 0.999983549118042
Hpdel O 1 0.9997813105583191
, O 0 0.021200094372034073
the O 0 0.01963699236512184
mother O 0 0.04143976420164108
to O 0 0.01544130314141512
be O 0 0.01512504369020462
Hp2 O 1 0.9988969564437866
- O 1 0.9995852112770081
1 O 0 0.0387222059071064
and O 0 0.030202923342585564
Hp1 O 1 0.9999436140060425
/ O 1 0.9999382495880127
Hp2 O 1 0.998528242111206
, O 0 0.016906794160604477
one O 0 0.010031795129179955
of O 0 0.01164630614221096
the O 0 0.012721438892185688
two O 0 0.009963136166334152
children O 0 0.020067451521754265
to O 0 0.016052689403295517
be O 0 0.017595477402210236
hypohaptoglobinemic B-Disease 1 0.9999490976333618
( O 0 0.03697681799530983
Hp2 O 1 0.9995971322059631
) O 0 0.024639949202537537
and O 0 0.02790599688887596
Hp2 O 1 0.9999933242797852
/ O 1 0.9999985694885254
Hpdel O 1 0.999931812286377
, O 0 0.022788332775235176
and O 0 0.013608641922473907
the O 0 0.01504296064376831
other O 0 0.011120476759970188
child O 0 0.038795631378889084
to O 0 0.01889323629438877
be O 0 0.01684485748410225
Hp1 O 1 0.9870350956916809
and O 0 0.034894295036792755
Hp1 O 1 0.9999973773956299
/ O 1 0.9999821186065674
Hpdel O 1 0.9988497495651245
, O 0 0.023541027680039406
showing O 0 0.02592458948493004
an O 0 0.01959383673965931
anomalous O 1 0.7169604301452637
inheritance O 0 0.07998451590538025
of O 0 0.03771952539682388
Hp O 1 0.9989620447158813
phenotypes O 0 0.07467009127140045
in O 0 0.017677191644906998
the O 0 0.027845505625009537
child O 0 0.3020636737346649
with O 0 0.042721036821603775
Hp1 O 1 0.9999455213546753
. O 0 0.055689334869384766

The O 0 0.08026532828807831
Hp2 O 1 0.999992847442627
/ O 1 0.9999955892562866
Hpdel O 1 0.9999433755874634
individuals O 0 0.021483873948454857
had O 0 0.015941616147756577
an O 0 0.013454546220600605
extremely O 0 0.023314936086535454
low O 0 0.028132053092122078
level O 0 0.018400918692350388
of O 0 0.021044304594397545
Hp O 1 0.9492954611778259
( O 0 0.02569129876792431
mean O 0 0.03410389646887779
+ O 1 0.9486846923828125
/ O 1 0.9994459748268127
- O 1 0.9999852180480957
SD O 1 0.99993896484375
= O 0 0.06749196350574493
0 O 0 0.04146136716008186
. O 0 0.023094313219189644
049 O 1 0.999756395816803
+ O 1 0.9978262782096863
/ O 1 0.9989491105079651
- O 1 0.9965316653251648
0 O 0 0.04959070682525635
. O 0 0.02495192363858223
043 O 1 0.9990583062171936
mg O 1 0.9999784231185913
/ O 1 0.9999796152114868
ml O 1 0.9998928308486938
; O 0 0.036146022379398346
n O 0 0.08960054814815521
= O 0 0.0605492927134037
6 O 0 0.030252736061811447
) O 0 0.013466425240039825
, O 0 0.009380321018397808
compared O 0 0.010511822067201138
with O 0 0.009594913572072983
the O 0 0.01569236069917679
level O 0 0.024659834802150726
( O 0 0.017777809873223305
1 O 0 0.022870462387800217
. O 0 0.011768423020839691
64 O 0 0.043546486645936966
+ O 1 0.9955462217330933
/ O 1 0.9998738765716553
- O 1 0.9994474053382874
1 O 0 0.03635983541607857
. O 0 0.02227768674492836
07 O 1 0.9985532164573669
mg O 1 0.999998927116394
/ O 1 0.9999970197677612
ml O 1 0.9998652935028076
) O 0 0.020653661340475082
obtained O 0 0.015161220915615559
from O 0 0.014219316653907299
52 O 0 0.04770825803279877
healthy O 0 0.0614934004843235
volunteers O 0 0.0651971623301506
having O 0 0.04262291267514229
phenotype O 1 0.9896367192268372
Hp2 O 1 0.999847412109375
, O 0 0.027255192399024963
whereas O 0 0.031604472547769547
the O 0 0.033134423196315765
serum O 1 0.999967098236084
Hp O 1 0.7135810852050781
level O 0 0.02456929162144661
of O 0 0.015719400718808174
an O 0 0.014827866107225418
individual O 0 0.015918660908937454
with O 0 0.02519470453262329
Hp1 O 1 0.9999986886978149
/ O 1 0.9999963045120239
Hpdel O 1 0.9999161958694458
was O 0 0.05805755406618118
0 O 0 0.07617735117673874
. O 0 0.04196697100996971

50 O 0 0.09628366678953171
mg O 1 0.9999936819076538
/ O 1 0.9999986886978149
ml O 1 0.9999896287918091
, O 0 0.02273210696876049
which O 0 0.011555027216672897
was O 0 0.015915365889668465
approximately O 0 0.010959421284496784
half O 0 0.011441349983215332
the O 0 0.013463151641190052
level O 0 0.020023448392748833
of O 0 0.02212657406926155
Hp O 0 0.19592826068401337
in O 0 0.016932858154177666
control O 0 0.03556647524237633
sera O 1 0.9961100220680237
from O 0 0.018226105719804764
the O 0 0.030327707529067993
Hp1 O 1 0.9999916553497314
phenotype O 1 0.9981372356414795
( O 0 0.02553493157029152
1 O 0 0.02614397369325161
. O 0 0.012683607637882233
26 O 0 0.03492507338523865
+ O 1 0.9849300384521484
/ O 1 0.9993485808372498
- O 1 0.9961389899253845
0 O 0 0.037320151925086975
. O 0 0.013000663369894028
33 O 0 0.048059284687042236
mg O 1 0.9999550580978394
/ O 1 0.9999825954437256
ml O 1 0.9999665021896362
; O 0 0.035679034888744354
n O 0 0.08472292870283127
= O 0 0.057033080607652664
9 O 0 0.03100479021668434
) O 0 0.01333540864288807
, O 0 0.01022573933005333
showing O 0 0.020323697477579117
a O 0 0.02817080169916153
gene O 0 0.06828684359788895
- O 1 0.9999722242355347
dosage O 1 0.999035120010376
effect O 0 0.052305735647678375
. O 0 0.03881458938121796

The O 0 0.043514594435691833
other O 0 0.02921927534043789
allele O 0 0.10659714788198471
( O 0 0.03666774928569794
Hp2 O 1 0.9993440508842468
) O 0 0.017254643142223358
of O 0 0.01351808849722147
individuals O 0 0.014287545345723629
with O 0 0.02738935872912407
Hp2 O 1 1.0
/ O 1 0.9999998807907104
Hpdel O 1 0.9999903440475464
was O 0 0.028715629130601883
found O 0 0.010699721984565258
to O 0 0.008954429998993874
have O 0 0.005260809790343046
, O 0 0.007985955104231834
in O 0 0.007365215569734573
all O 0 0.010520504787564278
exons O 0 0.05132691189646721
, O 0 0.017295459285378456
no O 0 0.01971994712948799
mutation O 0 0.038750555366277695
, O 0 0.015326562337577343
by O 0 0.02135566808283329
DNA O 0 0.04594799503684044
sequencing O 0 0.05770426616072655
. O 0 0.03603677079081535

On O 0 0.02807268127799034
the O 0 0.01784115843474865
basis O 0 0.01296227052807808
of O 0 0.013607081025838852
the O 0 0.01665297895669937
present O 0 0.0194033645093441
study O 0 0.015393677167594433
, O 0 0.012844689190387726
the O 0 0.016053171828389168
mechanism O 0 0.0355481393635273
of O 0 0.025621630251407623
anhaptoglobinemia B-Disease 1 0.9996896982192993
and O 0 0.019315527752041817
the O 0 0.019738713279366493
mechanism O 0 0.032500069588422775
of O 0 0.025880536064505577
anomalous O 1 0.9974741339683533
inheritance O 1 0.8274502754211426
of O 0 0.053169142454862595
Hp O 1 0.9999486207962036
phenotypes O 1 0.6474032998085022
were O 0 0.019066305831074715
well O 0 0.023981615900993347
explained O 0 0.046021949499845505
. O 0 0.034050483256578445

However O 0 0.03851819410920143
, O 0 0.022890526801347733
the O 0 0.028392642736434937
mechanism O 0 0.05180780962109566
of O 0 0.04138513654470444
hypohaptoglobinemia B-Disease 1 0.9995812773704529
remains O 0 0.10400859266519547
unknown O 0 0.09259918332099915

ATM O 1 0.9324106574058533
mutations O 0 0.05954032018780708
and O 0 0.027314983308315277
phenotypes O 0 0.09362514317035675
in O 0 0.04316966235637665
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999998807907104
families O 0 0.033060021698474884
in O 0 0.012797216884791851
the O 0 0.016384508460760117
British O 0 0.03471729904413223
Isles O 0 0.26427844166755676
: O 0 0.02219899371266365
expression O 0 0.01972155086696148
of O 0 0.01889396458864212
mutant O 1 0.6762434840202332
ATM O 0 0.07940856367349625
and O 0 0.011981029063463211
the O 0 0.015286672860383987
risk O 0 0.036893926560878754
of O 1 0.6390817165374756
leukemia B-Disease 1 1.0
, O 1 0.9999997615814209
lymphoma B-Disease 1 1.0
, O 1 0.9999873638153076
and O 1 0.9999723434448242
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.2981351315975189

We O 0 0.02512175217270851
report O 0 0.01689356565475464
the O 0 0.01692758873105049
spectrum O 0 0.03241530433297157
of O 0 0.02069813758134842
59 O 0 0.06706979870796204
ATM O 1 0.9360138773918152
mutations O 0 0.03074183128774166
observed O 0 0.018803196027874947
in O 0 0.02317165583372116
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.047432541847229004
A B-Disease 1 0.9999815225601196
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.03156399726867676
patients O 0 0.052849236875772476
in O 0 0.01568002998828888
the O 0 0.02794051170349121
British O 0 0.06743889302015305
Isles O 0 0.20560242235660553
. O 0 0.05176086351275444

Of O 0 0.06421732157468796
51 O 0 0.12028945237398148
ATM O 1 0.9837070107460022
mutations O 0 0.0500885434448719
identified O 0 0.023506425321102142
in O 0 0.01264108531177044
families O 0 0.019453871995210648
native O 0 0.01822744682431221
to O 0 0.014062886126339436
the O 0 0.01909339614212513
British O 0 0.039913542568683624
Isles O 0 0.08379731327295303
, O 0 0.017575690522789955
11 O 0 0.019296476617455482
were O 0 0.014354662038385868
founder O 1 0.9938305020332336
mutations O 0 0.03718806430697441
, O 0 0.01664072275161743
and O 0 0.013402403332293034
2 O 0 0.0200822614133358
of O 0 0.012723445892333984
these O 0 0.008179929107427597
11 O 0 0.021716304123401642
conferred O 0 0.0657406747341156
a O 0 0.04241754114627838
milder O 1 0.9773598313331604
clinical O 1 0.9997711777687073
phenotype O 1 0.8847638368606567
with O 0 0.019338401034474373
respect O 0 0.027778424322605133
to O 0 0.023715943098068237
both O 0 0.03959839046001434
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9274635314941406
cellular O 1 0.9806997179985046
features O 0 0.04487539455294609
. O 0 0.03681952878832817

We O 0 0.02470991760492325
report O 0 0.01776907779276371
, O 0 0.009372301399707794
in O 0 0.007127432618290186
two O 0 0.010636703111231327
A B-Disease 1 0.8981580138206482
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999815225601196
families O 0 0.02411089651286602
, O 0 0.013074574992060661
an O 0 0.01721377670764923
ATM O 0 0.4389658272266388
mutation O 0 0.04183627665042877
( O 0 0.024531792849302292
7271T O 1 0.9999184608459473
- O 1 0.9999998807907104
- O 1 0.9999998807907104
> O 1 0.9999955892562866
G O 1 0.9998536109924316
) O 0 0.017247295007109642
that O 0 0.008815358392894268
may O 0 0.01089183334261179
be O 0 0.006530086509883404
associated O 0 0.009693524800240993
with O 0 0.008123848587274551
an O 0 0.011578137055039406
increased O 0 0.024703260511159897
risk O 1 0.9700739979743958
of O 1 0.9982255101203918
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.03489061817526817
both O 0 0.030521802604198456
homozygotes O 1 0.9999430179595947
and O 0 0.034975092858076096
heterozygotes O 1 0.9993926286697388
( O 0 0.03260020911693573
relative O 0 0.0446467399597168
risk O 0 0.04056289792060852
12 O 0 0.024353014305233955
. O 0 0.01532293763011694
7 O 0 0.035402361303567886
; O 0 0.029446344822645187
P O 1 0.9993723034858704
= O 0 0.07498490810394287
. O 0 0.026499176397919655
0025 O 1 0.9997372031211853
) O 0 0.019772086292505264
, O 0 0.01149917021393776
although O 0 0.0076322853565216064
there O 0 0.006265346426516771
is O 0 0.008012691512703896
a O 0 0.01242750696837902
less O 0 0.014653241261839867
severe O 1 0.9998612403869629
A B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 0.28611257672309875
in O 0 0.01045488752424717
terms O 0 0.009912673383951187
of O 0 0.01212073303759098
the O 0 0.019248727709054947
degree O 0 0.03986139968037605
of O 1 0.6437974572181702
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.8569929599761963

This O 0 0.034308984875679016
mutation O 0 0.06298630684614182
( O 0 0.03823886811733246
7271T O 1 0.9999146461486816
- O 1 0.9999997615814209
- O 1 0.9999998807907104
> O 1 0.999956488609314
G O 1 0.9943445920944214
) O 0 0.020799297839403152
also O 0 0.012395674362778664
allows O 0 0.013458914123475552
expression O 0 0.015927469357848167
of O 0 0.013477097265422344
full O 0 0.031777795404195786
- O 1 0.9996209144592285
length O 0 0.032943688333034515
ATM O 1 0.8391622304916382
protein O 0 0.02592768892645836
at O 0 0.015409329906105995
a O 0 0.016754228621721268
level O 0 0.021061694249510765
comparable O 0 0.027144981548190117
with O 0 0.013923488557338715
that O 0 0.011032996699213982
in O 0 0.020905524492263794
unaffected O 1 0.5401921272277832
individuals O 0 0.03501855581998825
. O 0 0.04257288947701454

In O 0 0.031052038073539734
addition O 0 0.02554200030863285
, O 0 0.014906692318618298
we O 0 0.008110503666102886
have O 0 0.004911140073090792
studied O 0 0.012470840476453304
18 O 0 0.02183731086552143
A B-Disease 1 0.9998342990875244
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9998557567596436
, O 0 0.015384550206363201
in O 0 0.009771917946636677
15 O 0 0.016215957701206207
families O 0 0.01695086993277073
, O 0 0.011843211017549038
who O 0 0.02202552556991577
developed O 1 0.7221688628196716
leukemia B-Disease 1 1.0
, O 1 0.9999194145202637
lymphoma B-Disease 1 1.0
, O 1 0.9970443844795227
preleukemic O 1 0.9999998807907104
T O 1 1.0
- O 1 0.9999997615814209
cell O 1 0.8075465559959412
proliferation O 1 0.9865518808364868
, O 0 0.02914709411561489
or O 1 0.9971267580986023
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9891913533210754
mostly O 0 0.030092429369688034
in O 0 0.02822529710829258
childhood O 1 0.9997712969779968
. O 0 0.049494799226522446

A O 0 0.06184022128582001
wide O 0 0.03614683821797371
variety O 0 0.0216705109924078
of O 0 0.03321421891450882
ATM O 1 0.9997239708900452
mutation O 0 0.07019888609647751
types O 0 0.021712960675358772
, O 0 0.01409984566271305
including O 0 0.01700354553759098
missense O 1 0.7383996248245239
mutations O 0 0.034012455493211746
and O 0 0.017407964915037155
in O 0 0.023237507790327072
- O 1 0.9999971389770508
frame O 0 0.1032610759139061
deletions O 0 0.059569213539361954
, O 0 0.016477547585964203
were O 0 0.011231716722249985
seen O 0 0.02131459303200245
in O 0 0.017565490677952766
these O 0 0.020983783528208733
patients O 1 0.8963017463684082
. O 0 0.04764096811413765

We O 0 0.02587265335023403
also O 0 0.015012393705546856
show O 0 0.014399128966033459
that O 0 0.007325444370508194
25 O 0 0.012368321418762207
% O 0 0.008520256727933884
of O 0 0.009234941564500332
all O 0 0.013098591938614845
A B-Disease 1 0.9997113347053528
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9616713523864746
carried O 0 0.024306701496243477
in O 0 0.019600877538323402
- O 1 0.9998995065689087
frame O 0 0.07977920770645142
deletions O 0 0.07254701107740402
or O 0 0.03002993017435074
missense O 1 0.7697268724441528
mutations O 0 0.03569750487804413
, O 0 0.01342072058469057
many O 0 0.0075482516549527645
of O 0 0.012395665049552917
which O 0 0.009121784009039402
were O 0 0.008131063543260098
also O 0 0.009633471257984638
associated O 0 0.013193647377192974
with O 0 0.01126085314899683
expression O 0 0.022820809856057167
of O 0 0.02981586568057537
mutant O 1 0.9999178647994995
ATM O 1 0.999958872795105
protein O 0 0.061745867133140564
. O 0 0.03558165207505226

The O 0 0.05461948737502098
DMPK O 1 0.9999626874923706
gene O 0 0.049245547503232956
of O 0 0.039400067180395126
severely O 1 0.9999971389770508
affected O 1 0.9999945163726807
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.99617600440979
hypermethylated O 1 0.9999992847442627
proximal O 1 0.999970555305481
to O 0 0.028796685859560966
the O 0 0.02446490153670311
largely O 0 0.03291167691349983
expanded O 0 0.05855489894747734
CTG O 1 0.999930739402771
repeat O 0 0.14231519401073456
. O 0 0.053918905556201935

Using O 0 0.04713816195726395
methylation O 0 0.12251851707696915
- O 1 0.9998469352722168
sensitive O 0 0.0827334076166153
restriction O 0 0.06982433795928955
enzymes O 0 0.04844798892736435
, O 0 0.018240753561258316
we O 0 0.013677551411092281
characterized O 0 0.033614467829465866
the O 0 0.026013078168034554
methylation O 0 0.0547330304980278
pattern O 0 0.031035499647259712
on O 0 0.014762740582227707
the O 0 0.017221426591277122
5 O 0 0.020664559677243233
side O 0 0.019652416929602623
of O 0 0.016450267285108566
the O 0 0.030002795159816742
CTG O 1 0.9999638795852661
repeat O 0 0.05393819138407707
in O 0 0.013292111456394196
the O 0 0.026787523180246353
DMPK O 1 0.9999953508377075
gene O 0 0.03193064406514168
of O 0 0.017559600993990898
normal O 0 0.02384859509766102
individuals O 0 0.011329231783747673
and O 0 0.013376041315495968
of O 0 0.027264496311545372
patients O 1 0.9999961853027344
affected O 1 0.9154096245765686
with O 1 0.9990596175193787
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.22034534811973572
showing O 0 0.048371344804763794
expansions O 0 0.059328049421310425
of O 0 0.02868051826953888
the O 0 0.03989277780056
repetitive O 1 0.7692660093307495
sequence O 0 0.04880252480506897
. O 0 0.04122554138302803

The O 0 0.06044788286089897
gene O 0 0.05984371528029442
segment O 0 0.053629521280527115
analyzed O 0 0.02941252291202545
corresponds O 0 0.030372241511940956
to O 0 0.015408202074468136
the O 0 0.025005994364619255
genomic O 0 0.08177690207958221
SacI O 1 0.9998251795768738
- O 1 0.9998819828033447
HindIII O 1 0.9945645332336426
fragment O 0 0.07050973176956177
carrying O 0 0.040751226246356964
exons O 0 0.07986459881067276
11 O 0 0.045195359736680984
- O 1 0.9835949540138245
15 O 0 0.04446457326412201
. O 0 0.03930485248565674

There O 0 0.03281295672059059
is O 0 0.030033107846975327
constitutive O 0 0.21616670489311218
methylation O 0 0.07180783897638321
in O 0 0.026485558599233627
intron O 1 0.9990537762641907
12 O 0 0.029462387785315514
at O 0 0.022705668583512306
restriction O 0 0.03165024518966675
sites O 0 0.016572050750255585
of O 0 0.021442582830786705
SacII O 1 0.9955915212631226
and O 0 0.03135506063699722
HhaI O 1 0.999584972858429
, O 0 0.02927028201520443
localized O 0 0.06701919436454773
1 O 0 0.035028159618377686
, O 0 0.02123069018125534
159 O 0 0.13373598456382751
- O 1 0.9990755319595337
1 O 0 0.0367690771818161
, O 0 0.01888294517993927
232 O 0 0.06919077038764954
bp O 0 0.05820837616920471
upstream O 0 0.03033616952598095
of O 0 0.016533486545085907
the O 0 0.036157187074422836
CTG O 1 0.9999953508377075
repeat O 0 0.27436208724975586
, O 0 0.02689991146326065
whereas O 0 0.02943827584385872
most O 0 0.015224411152303219
, O 0 0.014463177882134914
if O 0 0.011465310119092464
not O 0 0.007317515555769205
all O 0 0.008028894662857056
, O 0 0.009648840874433517
of O 0 0.011332286521792412
the O 0 0.013683889992535114
other O 0 0.008918432518839836
sites O 0 0.018210744485259056
of O 0 0.02383064106106758
SacII O 1 0.9996395111083984
, O 0 0.034091249108314514
HhaI O 1 0.9995548129081726
, O 0 0.024976877495646477
and O 0 0.023916924372315407
HpaII O 1 0.9947110414505005
in O 0 0.014931871555745602
this O 0 0.012001334689557552
region O 0 0.022172624245285988
are O 0 0.011410423554480076
unmethylated O 1 0.9655466079711914
, O 0 0.020923268049955368
in O 0 0.014396177604794502
normal O 0 0.02464798279106617
individuals O 0 0.01263357698917389
and O 0 0.011549272574484348
most O 0 0.011667095124721527
of O 0 0.023758603259921074
the O 0 0.045166563242673874
patients O 1 0.999756395816803
. O 0 0.05301963537931442

In O 0 0.02054167166352272
a O 0 0.01836121454834938
number O 0 0.011601734906435013
of O 0 0.02033039554953575
young O 1 0.9524604678153992
and O 0 0.03751277178525925
severely O 1 0.9999982118606567
affected O 1 0.9820273518562317
patients O 1 0.9999643564224243
, O 0 0.022204790264368057
however O 0 0.014752020128071308
, O 0 0.01430563535541296
complete O 0 0.025475798174738884
methylation O 0 0.04400714486837387
of O 0 0.01665116846561432
these O 0 0.009814710356295109
restriction O 0 0.03242003172636032
sites O 0 0.018833409994840622
was O 0 0.018211914226412773
found O 0 0.011220632120966911
in O 0 0.013076752424240112
the O 0 0.03455960378050804
mutated O 0 0.13422660529613495
allele O 0 0.12234926968812943
. O 0 0.051643677055835724

In O 0 0.023652764037251472
most O 0 0.015358086675405502
of O 0 0.018377605825662613
these O 0 0.01477519329637289
patients O 1 0.9705455899238586
, O 0 0.017259690910577774
the O 0 0.02502068132162094
onset O 1 0.999998927116394
of O 0 0.061643943190574646
the O 1 0.9997368454933167
disease O 1 1.0
was O 1 0.9999998807907104
congenital O 1 1.0
. O 1 0.9601576924324036

Preliminary O 0 0.059078771620988846
in O 0 0.04013478010892868
vivo O 1 0.5933133363723755
footprinting O 1 0.9978173971176147
data O 0 0.015996014699339867
gave O 0 0.018264079466462135
evidence O 0 0.012521933764219284
for O 0 0.017862167209386826
protein O 0 0.04101110249757767
- O 1 0.9961791038513184
DNA O 0 0.03451806306838989
contact O 0 0.029534319415688515
in O 0 0.014299880713224411
normal O 0 0.025519827380776405
genes O 0 0.020286360755562782
at O 0 0.020206686109304428
an O 0 0.025742853060364723
Sp1 O 1 0.9999033212661743
consensus O 0 0.045406732708215714
binding O 0 0.032835375517606735
site O 0 0.026047980412840843
upstream O 0 0.028129853308200836
of O 0 0.016526944935321808
the O 0 0.0319165475666523
CTG O 1 0.9999924898147583
repeat O 0 0.07277333736419678
and O 0 0.01641760766506195
for O 0 0.013470200821757317
a O 0 0.01785203255712986
significant O 0 0.0162066500633955
reduction O 0 0.028371380642056465
of O 0 0.01572849228978157
this O 0 0.01249278150498867
interaction O 0 0.023643454536795616
in O 0 0.013867155648767948
cells O 0 0.02545272558927536
with O 0 0.015323310159146786
a O 0 0.039303917437791824
hypermethylated O 1 0.9999798536300659
DMPK O 1 0.9999970197677612
gene O 0 0.07059257477521896
. O 0 0.028523609042167664
. O 0 0.03767916187644005

The O 0 0.10109318792819977
hemochromatosis B-Disease 1 1.0
gene O 0 0.09800852090120316
product O 0 0.045186761766672134
complexes O 0 0.06327875703573227
with O 0 0.01943451724946499
the O 0 0.038900140672922134
transferrin O 1 0.9999990463256836
receptor O 1 0.9959632158279419
and O 0 0.031100276857614517
lowers O 1 0.9879269003868103
its O 0 0.0301364678889513
affinity O 0 0.06046951562166214
for O 0 0.032477669417858124
ligand O 1 0.6611627340316772
binding O 0 0.060771334916353226
. O 0 0.041530318558216095

We O 0 0.027193792164325714
recently O 0 0.03279152512550354
reported O 0 0.020700661465525627
the O 0 0.019994212314486504
positional O 0 0.06367569416761398
cloning O 0 0.033114805817604065
of O 0 0.0160375963896513
a O 0 0.02060559205710888
candidate O 0 0.03796463459730148
gene O 0 0.0336134135723114
for O 0 0.03546880558133125
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999995231628418
HFE O 1 0.9999998807907104
. O 0 0.07916267216205597

The O 0 0.05441965162754059
gene O 0 0.04754270240664482
product O 0 0.024166690185666084
, O 0 0.011492709629237652
a O 0 0.01490676961839199
member O 0 0.01871645450592041
of O 0 0.012891496531665325
the O 0 0.018461793661117554
major O 0 0.08208227157592773
histocompatibility O 1 1.0
complex O 1 0.6596727967262268
class O 1 0.9836040139198303
I O 1 0.9868313074111938
- O 1 0.9999868869781494
like O 0 0.023287829011678696
family O 0 0.026223476976156235
, O 0 0.014151088893413544
was O 0 0.01802794635295868
found O 0 0.008016269654035568
to O 0 0.008453098125755787
have O 0 0.006103121675550938
a O 0 0.016482753679156303
mutation O 0 0.0358525812625885
, O 0 0.0246041901409626
Cys O 1 0.9999994039535522
- O 1 0.9999561309814453
282 O 1 0.9966118931770325
- O 1 0.9999992847442627
- O 1 0.999998927116394
> O 1 0.9998176693916321
Tyr O 1 0.9999934434890747
( O 0 0.05814117565751076
C282Y O 1 0.9936608076095581
) O 0 0.023449314758181572
, O 0 0.014479799196124077
in O 0 0.012666541151702404
85 O 0 0.042373690754175186
% O 0 0.027201425284147263
of O 0 0.03947172313928604
patient O 1 0.999858021736145
chromosomes O 0 0.10066576302051544
. O 0 0.05499948933720589

This O 0 0.04262816533446312
mutation O 0 0.07231424003839493
eliminates O 0 0.07629740983247757
the O 0 0.02381761558353901
ability O 0 0.022689063102006912
of O 0 0.02672267146408558
HFE O 1 0.9999661445617676
to O 0 0.019595731049776077
associate O 0 0.03628432750701904
with O 0 0.02107207104563713
beta2 O 1 0.9999958276748657
- O 1 0.9999997615814209
microglobulin O 1 0.9999934434890747
( O 0 0.036968160420656204
beta2m O 1 0.9992808699607849
) O 0 0.020736709237098694
and O 0 0.02045462466776371
prevents O 1 0.9953623414039612
cell O 1 0.9988798499107361
- O 1 0.9999940395355225
surface O 0 0.0580771304666996
expression O 0 0.047047313302755356
. O 0 0.03304854407906532

A O 0 0.06833438575267792
second O 0 0.05891101807355881
mutation O 0 0.048284463584423065
that O 0 0.010823368094861507
has O 0 0.012058764696121216
no O 0 0.013210359029471874
effect O 0 0.017998727038502693
on O 0 0.02245076186954975
beta2m O 1 0.9998589754104614
association O 0 0.04317892715334892
, O 0 0.031194694340229034
H63D O 1 0.9999912977218628
, O 0 0.021178098395466805
was O 0 0.021326715126633644
found O 0 0.009348994120955467
in O 0 0.0075479052029550076
eight O 0 0.011061149649322033
out O 0 0.013185852207243443
of O 0 0.018567029386758804
nine O 0 0.03901655599474907
patients O 1 0.9811433553695679
heterozygous O 0 0.06409678608179092
for O 0 0.026263529434800148
the O 0 0.0460832417011261
C282Y O 1 0.9996973276138306
mutant O 1 0.8146334290504456
. O 0 0.05825604498386383

In O 0 0.02646408975124359
this O 0 0.015934474766254425
report O 0 0.022234002128243446
, O 0 0.01513627078384161
we O 0 0.010114607401192188
demonstrate O 0 0.023693909868597984
in O 0 0.018868878483772278
cultured O 0 0.09878896921873093
293 O 1 0.5630260705947876
cells O 0 0.06939037144184113
overexpressing O 1 0.992229163646698
wild O 0 0.07571680843830109
- O 1 0.9999666213989258
type O 0 0.059493254870176315
or O 0 0.03445827588438988
mutant O 1 0.9942935109138489
HFE O 1 0.999994158744812
proteins O 0 0.028350915759801865
that O 0 0.0074594710022211075
both O 0 0.007550473790615797
the O 0 0.016202818602323532
wild O 0 0.03921571746468544
- O 1 0.9999194145202637
type O 0 0.049719396978616714
and O 0 0.033343106508255005
H63D O 1 0.9999983310699463
HFE O 1 0.9999991655349731
proteins O 0 0.04961559548974037
form O 0 0.031914789229631424
stable O 0 0.10644641518592834
complexes O 0 0.06728868931531906
with O 0 0.02110493928194046
the O 0 0.044917915016412735
transferrin O 1 0.9999997615814209
receptor O 1 0.9997707009315491
( O 0 0.07024209946393967
TfR O 1 0.9998998641967773
) O 0 0.046128466725349426
. O 0 0.03865055367350578

The O 0 0.0646255761384964
C282Y O 1 0.9998180270195007
mutation O 0 0.07019367814064026
nearly O 0 0.03280824050307274
completely O 0 0.0465078242123127
prevents O 0 0.045747410506010056
the O 0 0.017777742817997932
association O 0 0.020393768325448036
of O 0 0.018072623759508133
the O 0 0.033655282109975815
mutant O 1 0.9998399019241333
HFE O 1 0.9999996423721313
protein O 0 0.05027284473180771
with O 0 0.02197990007698536
the O 0 0.03950979560613632
TfR O 1 0.9997513890266418
. O 0 0.052133578807115555

Studies O 0 0.03488099202513695
on O 0 0.03068208135664463
cell O 0 0.11865977197885513
- O 1 0.9997037053108215
associated O 0 0.03985869884490967
transferrin O 1 0.9989354014396667
at O 0 0.03206925839185715
37 O 0 0.04454262554645538
degrees O 0 0.03897503390908241
C O 0 0.08120521157979965
suggest O 0 0.015545494854450226
that O 0 0.007216122467070818
the O 0 0.01776054874062538
overexpressed O 1 0.759349524974823
wild O 0 0.05308347940444946
- O 1 0.9999978542327881
type O 1 0.9989749193191528
HFE O 1 0.9999997615814209
protein O 0 0.05131128057837486
decreases O 0 0.03936858847737312
the O 0 0.020234692841768265
affinity O 0 0.04194960743188858
of O 0 0.022240949794650078
the O 0 0.039948489516973495
TfR O 1 0.9999656677246094
for O 0 0.05580951273441315
transferrin O 1 0.9997884631156921
. O 0 0.06591363996267319

The O 0 0.08201713860034943
overexpressed O 1 0.999932050704956
H63D O 1 0.9999985694885254
protein O 0 0.05857830122113228
does O 0 0.01843089796602726
not O 0 0.008211146108806133
have O 0 0.00635868776589632
this O 0 0.00823693536221981
effect O 0 0.01973757892847061
, O 0 0.01347083505243063
providing O 0 0.016894133761525154
the O 0 0.013473305851221085
first O 0 0.016678977757692337
direct O 0 0.01791382022202015
evidence O 0 0.013595706783235073
for O 0 0.011786108836531639
a O 0 0.022123662754893303
functional O 0 0.04046113044023514
consequence O 0 0.04147385433316231
of O 0 0.025987643748521805
the O 0 0.04887827858328819
H63D O 1 0.9999996423721313
mutation O 0 0.21813273429870605
. O 0 0.047296419739723206

Addition O 0 0.035911235958337784
of O 0 0.037191640585660934
soluble O 1 0.9940642714500427
wild O 0 0.07412520051002502
- O 1 0.9999991655349731
type O 1 0.9973439574241638
HFE O 1 0.9999997615814209
/ O 1 0.9999943971633911
beta2m O 1 0.9999043941497803
heterodimers O 1 0.9998881816864014
to O 0 0.04509856551885605
cultured O 1 0.9964005947113037
cells O 0 0.044649068266153336
also O 0 0.01633833721280098
decreased O 0 0.03130154311656952
the O 0 0.02298271283507347
apparent O 0 0.060939617455005646
affinity O 0 0.04456964507699013
of O 0 0.019358277320861816
the O 0 0.027912616729736328
TfR O 1 0.9995198249816895
for O 0 0.0175315048545599
its O 0 0.021066270768642426
ligand O 0 0.0725974291563034
under O 0 0.02745942398905754
steady O 1 0.690069854259491
- O 1 0.9994131326675415
state O 0 0.016422631219029427
conditions O 0 0.023960549384355545
, O 0 0.011105877347290516
both O 0 0.009240413084626198
in O 0 0.015475789085030556
293 O 1 0.9974929094314575
cells O 0 0.044953662902116776
and O 0 0.025395741686224937
in O 0 0.039496250450611115
HeLa O 1 0.9999995231628418
cells O 0 0.09593771398067474
. O 0 0.0459984615445137

Furthermore O 0 0.06725507229566574
, O 0 0.024047160521149635
at O 0 0.02388683892786503
4 O 0 0.03505243360996246
degrees O 0 0.04029049724340439
C O 1 0.8052541613578796
, O 0 0.015570566058158875
the O 0 0.018917080014944077
added O 0 0.02842002920806408
soluble O 0 0.24368898570537567
complex O 0 0.03719976171851158
of O 0 0.042408090084791183
HFE O 1 1.0
/ O 1 0.9999990463256836
beta2m O 1 0.9999781847000122
inhibited O 1 0.835683286190033
binding O 0 0.03630417585372925
of O 0 0.03020556829869747
transferrin O 1 0.9989811778068542
to O 0 0.04163817688822746
HeLa O 1 0.9999966621398926
cell O 0 0.09088578075170517
TfR O 1 0.9814040660858154
in O 0 0.018186047673225403
a O 0 0.03685971722006798
concentration O 1 0.9997463822364807
- O 1 0.9999971389770508
dependent O 0 0.06121232360601425
manner O 0 0.049159616231918335
. O 0 0.037190020084381104

Scatchard O 0 0.2232026904821396
plots O 0 0.05841181427240372
of O 0 0.02413100004196167
these O 0 0.01133871078491211
data O 0 0.01067533902823925
indicate O 0 0.014157744124531746
that O 0 0.007281301077455282
the O 0 0.016074731945991516
added O 0 0.029792990535497665
heterodimer O 1 0.9995195865631104
substantially O 0 0.03972245752811432
reduced O 0 0.02781825140118599
the O 0 0.02281831204891205
affinity O 0 0.05374092236161232
of O 0 0.04118724167346954
TfR O 1 0.999955415725708
for O 0 0.05867255851626396
transferrin O 1 0.9998397827148438
. O 0 0.06583290547132492

These O 0 0.019541742280125618
results O 0 0.017444543540477753
establish O 0 0.03184571862220764
a O 0 0.028632689267396927
molecular O 0 0.04258625581860542
link O 0 0.047198351472616196
between O 0 0.03420918062329292
HFE O 1 0.9999885559082031
and O 0 0.021904798224568367
a O 0 0.028254738077521324
key O 0 0.04010062664747238
protein O 0 0.024781830608844757
involved O 0 0.014746434986591339
in O 0 0.016413003206253052
iron O 1 0.9998099207878113
transport O 0 0.05330786108970642
, O 0 0.019144374877214432
the O 0 0.02775748260319233
TfR O 1 0.9999977350234985
, O 0 0.020227989181876183
and O 0 0.014312832616269588
raise O 0 0.022157784551382065
the O 0 0.016226641833782196
possibility O 0 0.021315710619091988
that O 0 0.011370023712515831
alterations O 0 0.03293083980679512
in O 0 0.012662380002439022
this O 0 0.013980494812130928
regulatory O 0 0.060998257249593735
mechanism O 0 0.048146411776542664
may O 0 0.014176109805703163
play O 0 0.010717391967773438
a O 0 0.013597330078482628
role O 0 0.018729988485574722
in O 0 0.010534225031733513
the O 0 0.02441956102848053
pathogenesis O 1 0.9999996423721313
of O 1 0.9996600151062012
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9940154552459717
. O 0 0.0570652112364769

Genomic O 0 0.09306938201189041
organization O 0 0.03885321319103241
of O 0 0.02609269507229328
the O 0 0.04906251281499863
UBE3A O 1 0.9999997615814209
/ O 1 0.9999970197677612
E6 O 1 0.9999998807907104
- O 1 0.9999995231628418
AP O 1 0.9511463642120361
gene O 0 0.04543996974825859
and O 0 0.023573553189635277
related O 0 0.04061850160360336
pseudogenes O 0 0.14163070917129517
. O 0 0.05388328433036804

The O 0 0.07513345032930374
UBE3A O 1 0.9998645782470703
gene O 0 0.06031546741724014
encodes O 0 0.04997202008962631
the O 0 0.030971622094511986
E6 O 1 0.9999336004257202
- O 1 0.9999338388442993
AP O 1 0.9637656807899475
ubiquitin O 1 0.9997166991233826
- O 1 0.9999876022338867
protein O 0 0.05002020671963692
ligase O 0 0.05658414587378502
and O 0 0.014760567806661129
has O 0 0.014330245554447174
recently O 0 0.019814075902104378
been O 0 0.00900073628872633
shown O 0 0.009247317910194397
to O 0 0.009261238388717175
be O 0 0.010804209858179092
mutated O 0 0.0723128691315651
in O 1 0.7134291529655457
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.9976208806037903
lack O 1 0.9990313053131104
15q11 O 1 0.9999998807907104
- O 1 0.9999997615814209
q13 O 1 0.9998509883880615
deletions O 0 0.10928237438201904
or O 0 0.034171320497989655
chromosome O 0 0.07132060080766678
15 O 0 0.05523333698511124
paternal O 1 0.9972167015075684
uniparental B-Disease 1 0.9999994039535522
disomy I-Disease 1 0.999951958656311
. O 0 0.07234159111976624

Previous O 0 0.1115102544426918
UBE3A O 1 0.9998670816421509
cDNA O 0 0.15693694353103638
analysis O 0 0.0268320981413126
has O 0 0.01747119054198265
shown O 0 0.017085380852222443
a O 0 0.024435918778181076
coding O 0 0.05061652138829231
region O 0 0.024931957945227623
of O 0 0.02191917411983013
approximately O 0 0.030383586883544922
2 O 0 0.05117416009306908
. O 0 0.03578529134392738

6 O 0 0.08148560672998428
kb O 0 0.11879010498523712
and O 0 0.018559033051133156
a O 0 0.027318540960550308
3 O 0 0.04849125072360039
- O 1 0.9999492168426514
untranslated O 1 0.9812784790992737
region O 0 0.04094860702753067
( O 0 0.03309781476855278
UTR O 1 0.9943167567253113
) O 0 0.020231444388628006
of O 0 0.027235856279730797
< O 1 0.9859374165534973
50 O 0 0.03641091287136078
bp O 0 0.06219400092959404
, O 0 0.018348153680562973
whereas O 0 0.024531831964850426
Northern O 0 0.02631964720785618
analysis O 0 0.012724300846457481
has O 0 0.012976467609405518
indicated O 0 0.023532386869192123
mRNA O 0 0.031300853937864304
sizes O 0 0.013605846092104912
of O 0 0.01804749108850956
5 O 0 0.04530048370361328
- O 1 0.9993090629577637
8 O 0 0.07132571935653687
kb O 0 0.28257012367248535
. O 0 0.05267056077718735

We O 0 0.025906173512339592
have O 0 0.012739765457808971
analyzed O 0 0.025718562304973602
additional O 0 0.024857209995388985
cDNA O 0 0.12977775931358337
clones O 0 0.10041777789592743
and O 0 0.02152164652943611
provide O 0 0.02095155045390129
evidence O 0 0.014936445280909538
for O 0 0.014326440170407295
an O 0 0.01929660327732563
additional O 0 0.0292043574154377
0 O 0 0.0692986249923706
. O 0 0.043842166662216187

5 O 0 0.057591620832681656
kb O 0 0.10726102441549301
of O 0 0.03160052374005318
5 O 0 0.05559925362467766
- O 1 0.9999570846557617
UTR O 1 0.9988207221031189
and O 0 0.0330643393099308
> O 0 0.37568479776382446
2 O 0 0.043627940118312836
kb O 0 0.0928923636674881
of O 0 0.033500224351882935
3 O 0 0.06912876665592194
- O 1 0.999798595905304
UTR O 1 0.9954054355621338
. O 0 0.04765371233224869

We O 0 0.02160707488656044
have O 0 0.008718485943973064
established O 0 0.022989489138126373
the O 0 0.020259419456124306
genomic O 0 0.0468718446791172
organization O 0 0.03162382170557976
of O 0 0.03013339452445507
UBE3A O 1 0.9999949932098389
and O 0 0.021136116236448288
the O 0 0.019932499155402184
sequence O 0 0.019976962357759476
of O 0 0.03602497652173042
intron O 1 0.9999979734420776
- O 1 0.9999850988388062
exon O 0 0.3942015469074249
borders O 0 0.07240834087133408
. O 0 0.047768689692020416

We O 0 0.02713235467672348
have O 0 0.012289131060242653
also O 0 0.014395623467862606
mapped O 0 0.031449735164642334
two O 0 0.013041382655501366
highly O 0 0.040684666484594345
homologous O 0 0.08256840705871582
processed O 0 0.05042865872383118
pseudogenes O 0 0.11762116849422455
, O 0 0.04008287936449051
UBE3AP1 O 1 0.999977707862854
and O 0 0.037750083953142166
UBE3AP2 O 1 0.9999823570251465
, O 0 0.02184404991567135
to O 0 0.019689708948135376
chromosomes O 0 0.034490641206502914
2 O 0 0.026475554332137108
and O 0 0.014753428287804127
21 O 0 0.028928011655807495
, O 0 0.018240898847579956
respectively O 0 0.02125929854810238
, O 0 0.015201286412775517
and O 0 0.013779602013528347
determined O 0 0.023335712030529976
their O 0 0.019066909328103065
genomic O 0 0.06667563319206238
organization O 0 0.05074238032102585
. O 0 0.03875196725130081

These O 0 0.022886060178279877
results O 0 0.018301477655768394
will O 0 0.013575736433267593
form O 0 0.013984388671815395
the O 0 0.013204480521380901
basis O 0 0.011400504037737846
for O 0 0.011585899628698826
studies O 0 0.014157131314277649
of O 0 0.022758333012461662
mutation O 0 0.05470169335603714
and O 0 0.03001754730939865
imprinting O 1 0.9994434714317322
of O 0 0.07369351387023926
UBE3A O 1 0.9999986886978149
. O 0 0.06838489323854446

Mutation O 0 0.1402132362127304
spectrum O 0 0.07189242541790009
and O 0 0.042071256786584854
genotype O 1 0.9996452331542969
- O 1 0.9999899864196777
phenotype O 0 0.3323632478713989
analyses O 0 0.03427228704094887
in O 0 0.026890134438872337
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999996423721313
and O 0 0.11252523213624954
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.036563895642757416
two O 0 0.04511655122041702
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9937238097190857
germline O 1 0.9999998807907104
PTEN O 1 0.9999997615814209
mutation O 1 0.7863864302635193
. O 0 0.05738916993141174

The O 1 0.7380198240280151
tumour B-Disease 1 1.0
suppressor O 1 1.0
gene O 1 0.9947859644889832
PTEN O 1 0.9999819993972778
, O 0 0.029606221243739128
which O 0 0.017154473811388016
maps O 0 0.025980055332183838
to O 0 0.029270727187395096
10q23 O 1 0.591921865940094
. O 0 0.04573512449860573

3 O 0 0.05376835912466049
and O 0 0.027838297188282013
encodes O 0 0.05575805902481079
a O 0 0.03677397593855858
403 O 0 0.13002674281597137
amino O 0 0.06830853223800659
acid O 0 0.08131341636180878
dual O 0 0.08528397977352142
specificity O 0 0.3376147449016571
phosphatase O 1 0.9999806880950928
( O 0 0.05127686262130737
protein O 0 0.06404635310173035
tyrosine O 1 0.980941116809845
phosphatase O 1 0.9998764991760254
; O 0 0.040745846927165985
PTPase O 1 0.9998407363891602
) O 0 0.024534650146961212
, O 0 0.016852978616952896
was O 0 0.019771795719861984
shown O 0 0.014867343939840794
recently O 0 0.019795754924416542
to O 0 0.011083637364208698
play O 0 0.01154555007815361
a O 0 0.019943876191973686
broad O 0 0.03963252529501915
role O 0 0.042143069207668304
in O 0 0.027788400650024414
human O 0 0.12714502215385437
malignancy B-Disease 1 0.9999998807907104
. O 0 0.06700192391872406

Somatic O 1 0.9996022582054138
PTEN O 1 0.9999860525131226
deletions O 0 0.1317993700504303
and O 0 0.0319507010281086
mutations O 0 0.03080650418996811
were O 0 0.009028454311192036
observed O 0 0.01561578456312418
in O 0 0.013705981895327568
sporadic B-Disease 1 0.997078537940979
breast I-Disease 1 1.0
, I-Disease 1 0.9882110357284546
brain I-Disease 1 0.9999979734420776
, I-Disease 1 0.9652798175811768
prostate I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999995231628418
lines O 0 0.027270833030343056
and O 0 0.01042897254228592
in O 0 0.007689881604164839
several O 0 0.009904861450195312
primary O 1 0.6421878337860107
tumours B-Disease 1 1.0
such O 0 0.023442886769771576
as O 1 0.8944046497344971
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999997615814209
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.997424840927124

In O 0 0.03392065316438675
addition O 0 0.03478918597102165
, O 0 0.037932656705379486
PTEN O 1 0.9999589920043945
was O 0 0.032130930572748184
identified O 0 0.020283197984099388
as O 0 0.013121170923113823
the O 0 0.02190585620701313
susceptibility O 1 0.9695522785186768
gene O 0 0.025398485362529755
for O 0 0.016294283792376518
two O 0 0.03266236186027527
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9996716976165771
CD B-Disease 1 0.9999756813049316
; O 0 0.04683557152748108
MIM O 1 0.9999998807907104
158350 O 1 0.9994309544563293
) O 0 0.02320859581232071
and O 0 0.022674504667520523
Bannayan B-Disease 1 0.999995231628418
- I-Disease 1 0.9999995231628418
Zonana I-Disease 1 0.9999957084655762
( I-Disease 0 0.06140962988138199
BZS I-Disease 1 0.9999362230300903
) I-Disease 0 0.028478382155299187
or I-Disease 0 0.0251760333776474
Ruvalcaba I-Disease 1 0.9999613761901855
- I-Disease 1 0.9999871253967285
Riley I-Disease 1 0.9998389482498169
- I-Disease 1 1.0
Smith I-Disease 1 0.999993085861206
syndrome I-Disease 1 1.0
( O 1 0.9927964806556702
MIM O 1 1.0
153480 O 1 0.9999955892562866
) O 0 0.05341556668281555
. O 0 0.043235938996076584

Constitutive O 1 0.8745156526565552
DNA O 0 0.055959101766347885
from O 0 0.02597741410136223
37 O 0 0.05468159168958664
CD B-Disease 0 0.08384314179420471
families O 0 0.02602601982653141
and O 0 0.01739501766860485
seven O 0 0.035543881356716156
BZS B-Disease 1 0.9987554550170898
families O 0 0.041327062994241714
was O 0 0.03678515553474426
screened O 0 0.07916349172592163
for O 0 0.042851582169532776
germline O 1 0.9999887943267822
PTEN O 1 0.9999991655349731
mutations O 0 0.10962692648172379
. O 0 0.056581951677799225

PTEN O 1 0.9999157190322876
mutations O 0 0.060597267001867294
were O 0 0.013750634156167507
identified O 0 0.018049858510494232
in O 0 0.010240294970571995
30 O 0 0.016473837196826935
of O 0 0.018904168158769608
37 O 0 0.04385359212756157
( O 0 0.028078867122530937
81 O 0 0.06239558383822441
% O 0 0.02628905139863491
) O 0 0.02588256262242794
CD B-Disease 0 0.06497613340616226
families O 0 0.02502848580479622
, O 0 0.01647941581904888
including O 0 0.019366854801774025
missense O 0 0.09530653059482574
and O 0 0.027399417012929916
nonsense O 1 0.5923857092857361
point O 0 0.04463881626725197
mutations O 0 0.038434647023677826
, O 0 0.021330121904611588
deletions O 0 0.061185937374830246
, O 0 0.02375122159719467
insertions O 0 0.08069425076246262
, O 0 0.02055608108639717
a O 0 0.037530045956373215
deletion O 1 0.9873886108398438
/ O 1 0.9999265670776367
insertion O 1 0.6261401176452637
and O 0 0.03734489902853966
splice O 1 0.6797693371772766
site O 0 0.06072808429598808
mutations O 0 0.05515590310096741
. O 0 0.03761295974254608

These O 0 0.031863607466220856
mutations O 0 0.03202101215720177
were O 0 0.00972890667617321
scattered O 0 0.019466320052742958
over O 0 0.015421867370605469
the O 0 0.016402592882514
entire O 0 0.030648356303572655
length O 0 0.02476964145898819
of O 0 0.035266514867544174
PTEN O 1 0.999993085861206
, O 0 0.01857742667198181
with O 0 0.011749825440347195
the O 0 0.014634264633059502
exception O 0 0.02183486893773079
of O 0 0.01389703806489706
the O 0 0.016580501571297646
first O 0 0.018813159316778183
, O 0 0.01649967022240162
fourth O 0 0.03940914571285248
and O 0 0.020955277606844902
last O 0 0.039747610688209534
exons O 0 0.09886839240789413
. O 0 0.04190201684832573

A O 0 0.08827514946460724
hot O 0 0.4872157573699951
spot O 0 0.06475535780191422
for O 0 0.03546450287103653
PTEN O 1 0.9999986886978149
mutation O 0 0.05973749980330467
in O 0 0.019217481836676598
CD B-Disease 0 0.12308701127767563
was O 0 0.02316984161734581
identified O 0 0.015391955152153969
in O 0 0.011535161174833775
exon O 0 0.06678164750337601
5 O 0 0.018382996320724487
that O 0 0.0072660064324736595
contains O 0 0.014600375667214394
the O 0 0.020292267203330994
PTPase O 1 0.9998937845230103
core O 1 0.5878801941871643
motif O 0 0.07105903327465057
, O 0 0.013267542235553265
with O 0 0.009884698316454887
13 O 0 0.01873965561389923
of O 0 0.018248245120048523
30 O 0 0.02579176239669323
( O 0 0.021710995584726334
43 O 0 0.0409611314535141
% O 0 0.027096014469861984
) O 0 0.02924444153904915
CD B-Disease 0 0.0924360528588295
mutations O 0 0.039287347346544266
identified O 0 0.023386502638459206
in O 0 0.01611284352838993
this O 0 0.02250751480460167
exon O 0 0.14242060482501984
. O 0 0.04829259216785431

Seven O 0 0.0385466068983078
of O 0 0.028798826038837433
30 O 0 0.034824129194021225
( O 0 0.026016641408205032
23 O 0 0.033061861991882324
% O 0 0.018221568316221237
) O 0 0.011221961118280888
were O 0 0.005959978327155113
within O 0 0.009495825506746769
the O 0 0.020511601120233536
core O 1 0.6722140908241272
motif O 0 0.11785703152418137
, O 0 0.013264085166156292
the O 0 0.014823177829384804
majority O 0 0.01956433244049549
( O 0 0.01383356936275959
five O 0 0.009738389402627945
of O 0 0.012615043669939041
seven O 0 0.017814749851822853
) O 0 0.01409896370023489
of O 0 0.013510623946785927
which O 0 0.012661413289606571
were O 0 0.01700429990887642
missense O 0 0.43681851029396057
mutations O 0 0.047291867434978485
, O 0 0.021161917597055435
possibly O 0 0.024815525859594345
pointing O 0 0.026059160009026527
to O 0 0.015018049627542496
the O 0 0.02062980644404888
functional O 0 0.03774023801088333
significance O 0 0.024639269337058067
of O 0 0.019024381414055824
this O 0 0.018207432702183723
region O 0 0.04418940469622612
. O 0 0.0377245768904686

Germline O 1 0.9999884366989136
PTEN O 1 0.9999829530715942
mutations O 0 0.06294196844100952
were O 0 0.015511387959122658
identified O 0 0.017940256744623184
in O 0 0.009137174114584923
four O 0 0.009809437207877636
of O 0 0.017163384705781937
seven O 0 0.028351159766316414
( O 0 0.03179477900266647
57 O 0 0.06419777125120163
% O 0 0.042737215757369995
) O 0 0.04364040493965149
BZS B-Disease 1 0.9931527376174927
families O 0 0.05558726191520691
studied O 0 0.05686989054083824
. O 0 0.046057380735874176

Interestingly O 0 0.1136033833026886
, O 0 0.027105575427412987
none O 0 0.021352289244532585
of O 0 0.019357018172740936
these O 0 0.013953170739114285
mutations O 0 0.03138101100921631
was O 0 0.02379007078707218
observed O 0 0.019426578655838966
in O 0 0.014387006871402264
the O 0 0.03572588413953781
PTPase O 1 0.9999328851699829
core O 1 0.8175345659255981
motif O 0 0.12733623385429382
. O 0 0.04582585394382477

It O 0 0.02555256523191929
is O 0 0.018082601949572563
also O 0 0.015445124357938766
worthy O 0 0.04986099153757095
of O 0 0.01861770823597908
note O 0 0.023105258122086525
that O 0 0.007698823232203722
a O 0 0.016071002930402756
single O 0 0.033139683306217194
nonsense O 0 0.06691700965166092
point O 0 0.03118719719350338
mutation O 0 0.05043883994221687
, O 0 0.02387922815978527
R233X O 1 0.9968985319137573
, O 0 0.019399024546146393
was O 0 0.02186674065887928
observed O 0 0.014946727082133293
in O 0 0.010596132837235928
the O 0 0.023660406470298767
germline O 1 0.5757062435150146
DNA O 0 0.03150778263807297
from O 0 0.013214250095188618
two O 0 0.014080696739256382
unrelated O 0 0.05135615915060043
CD B-Disease 0 0.16712740063667297
families O 0 0.03404179587960243
and O 0 0.02419297769665718
one O 0 0.041991882026195526
BZS B-Disease 1 0.9999210834503174
family O 0 0.07868748903274536
. O 0 0.04904435947537422

Genotype O 1 0.999982476234436
- O 1 0.9999980926513672
phenotype O 1 0.7846157550811768
studies O 0 0.020961636677384377
were O 0 0.010786246508359909
not O 0 0.009957370348274708
performed O 0 0.019620679318904877
on O 0 0.010940942913293839
this O 0 0.008221006952226162
small O 0 0.015837213024497032
group O 0 0.032213497906923294
of O 0 0.03795892372727394
BZS B-Disease 1 0.9999185800552368
families O 0 0.05808258056640625
. O 0 0.04774543270468712

However O 0 0.0412294901907444
, O 0 0.04125487804412842
genotype O 1 0.9977827668190002
- O 1 0.9999758005142212
phenotype O 0 0.1212649941444397
analysis O 0 0.026774847880005836
inthe O 1 0.7554659843444824
group O 0 0.03823850303888321
of O 0 0.024866361171007156
CD B-Disease 0 0.20386682450771332
families O 0 0.027144847437739372
revealed O 0 0.023615790531039238
two O 0 0.010919756256043911
possible O 0 0.01826462894678116
associations O 0 0.02458849735558033
worthy O 0 0.05621534585952759
of O 0 0.02422962710261345
follow O 0 0.04042665660381317
- O 1 0.9982798099517822
up O 0 0.024938836693763733
in O 0 0.01504241582006216
independent O 0 0.0334346778690815
analyses O 0 0.040590643882751465
. O 0 0.03256896138191223

The O 0 0.032879751175642014
first O 0 0.028326891362667084
was O 0 0.02666105516254902
an O 0 0.01655225269496441
association O 0 0.02315070852637291
noted O 0 0.013002736493945122
in O 0 0.007892756722867489
the O 0 0.013037953525781631
group O 0 0.021351896226406097
of O 0 0.018529720604419708
CD B-Disease 1 0.5415263772010803
families O 0 0.040122948586940765
with O 1 0.5088210105895996
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.8664458990097046

A O 0 0.07586221396923065
correlation O 0 0.05990615114569664
was O 0 0.026625454425811768
observed O 0 0.01694355346262455
between O 0 0.013529131188988686
the O 0 0.019342724233865738
presence O 0 0.04221316799521446
/ O 1 0.9915581941604614
absence O 0 0.03832268342375755
of O 0 0.024562830105423927
a O 0 0.05004772171378136
PTEN O 1 0.9999992847442627
mutation O 0 0.048621878027915955
and O 0 0.015534515492618084
the O 0 0.01880345679819584
type O 0 0.042334266006946564
of O 0 0.04358407482504845
breast O 1 1.0
involvement O 1 0.9999802112579346
( O 0 0.07097190618515015
unaffected O 1 0.9993782043457031
versus O 1 0.9995360374450684
benign O 1 1.0
versus O 1 0.9999985694885254
malignant O 1 1.0
) O 0 0.06446871161460876
. O 0 0.045057348906993866

Specifically O 0 0.0443262979388237
and O 0 0.01759803295135498
more O 0 0.01047276146709919
directly O 0 0.01627265103161335
, O 0 0.012933713383972645
an O 0 0.013966508209705353
association O 0 0.026016738265752792
was O 0 0.02325362339615822
also O 0 0.011808952316641808
observed O 0 0.011075537651777267
between O 0 0.009519688785076141
the O 0 0.010298949666321278
presence O 0 0.016739295795559883
of O 0 0.01561005413532257
a O 0 0.03925446793437004
PTEN O 1 0.9999998807907104
mutation O 1 0.9982434511184692
and O 1 0.9952059388160706
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9856047034263611

Secondly O 1 0.7043072581291199
, O 0 0.03149016201496124
there O 0 0.016098011285066605
appeared O 0 0.02022474817931652
to O 0 0.013555452227592468
be O 0 0.01033245213329792
an O 0 0.018644951283931732
interdependent O 1 0.9894363880157471
association O 0 0.03954903408885002
between O 0 0.033718712627887726
mutations O 0 0.0441916361451149
upstream O 0 0.037360791116952896
and O 0 0.011407127603888512
within O 0 0.013796025887131691
the O 0 0.027927640825510025
PTPase O 1 0.9999330043792725
core O 1 0.7899206280708313
motif O 0 0.07714537531137466
, O 0 0.017652036622166634
the O 0 0.022499803453683853
core O 0 0.055914413183927536
motif O 0 0.053912729024887085
containing O 0 0.016640186309814453
the O 0 0.012474223971366882
majority O 0 0.01913791336119175
of O 0 0.027233975008130074
missense O 1 0.9918619394302368
mutations O 0 0.03800082579255104
, O 0 0.014259395189583302
and O 0 0.010626395232975483
the O 0 0.013421440497040749
involvement O 0 0.02459033951163292
of O 0 0.012500508688390255
all O 0 0.012080837972462177
major O 0 0.0457107275724411
organ O 1 0.9999988079071045
systems O 0 0.26978108286857605
( O 0 0.019587872549891472
central O 0 0.03133797273039818
nervous O 1 0.995568573474884
system O 0 0.034368228167295456
, O 0 0.07213533669710159
thyroid O 1 1.0
, O 1 0.9996410608291626
breast O 1 1.0
, O 1 0.99997878074646
skin O 1 1.0
and O 1 0.9999910593032837
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9135721921920776
. O 0 0.0510651133954525

However O 0 0.035796113312244415
, O 0 0.02039852924644947
these O 0 0.009858962148427963
observations O 0 0.02046048268675804
would O 0 0.010917234234511852
need O 0 0.013075299561023712
to O 0 0.010505554266273975
be O 0 0.007886960171163082
confirmed O 0 0.012681722640991211
by O 0 0.009201089851558208
studying O 0 0.014809432439506054
a O 0 0.015206484124064445
larger O 0 0.015599038451910019
number O 0 0.012636617757380009
of O 0 0.02649376355111599
CD B-Disease 0 0.33376026153564453
families O 0 0.04917672276496887
. O 0 0.04132174700498581

Molecular O 1 0.674321174621582
defects O 1 0.9967194199562073
leading O 0 0.04925458878278732
to O 0 0.022849200293421745
human O 0 0.035847436636686325
complement B-Disease 1 0.9985396862030029
component I-Disease 1 0.9999998807907104
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.025436516851186752
an O 0 0.023611703887581825
African O 1 0.6471281051635742
- O 1 0.9999247789382935
American O 0 0.045274849981069565
family O 0 0.045896194875240326
. O 0 0.03395741432905197

Complement B-Disease 1 0.9983532428741455
component I-Disease 1 0.9999991655349731
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9889984726905823
C6D B-Disease 1 0.9999997615814209
) O 0 0.035930585116147995
was O 0 0.04229234158992767
diagnosed O 1 0.9999327659606934
in O 0 0.014441411010921001
a O 0 0.02081000618636608
16 O 0 0.028501367196440697
- O 1 0.9945412278175354
year O 0 0.02041437476873398
- O 1 0.985253632068634
old O 0 0.039024509489536285
African O 0 0.03923210874199867
- O 1 0.9937765598297119
American O 0 0.03633219376206398
male O 0 0.26081565022468567
with O 0 0.33569180965423584
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9932261109352112

The O 0 0.06784673035144806
patients O 1 0.9986372590065002
father O 0 0.2846989333629608
and O 0 0.020807093009352684
two O 0 0.01577707938849926
brothers O 0 0.048718586564064026
also O 0 0.01750800758600235
had O 0 0.025639668107032776
C6D B-Disease 1 0.9999698400497437
, O 0 0.01652972772717476
but O 0 0.008826430886983871
gave O 0 0.015654683113098145
no O 0 0.009985078126192093
history O 0 0.02162986248731613
of O 0 0.06071474775671959
meningitis B-Disease 1 1.0
or O 1 0.7707338333129883
other O 0 0.044397249817848206
neisserial B-Disease 1 1.0
infection I-Disease 1 0.9999998807907104
. O 0 0.07052954286336899

By O 0 0.030079461634159088
using O 0 0.024376237764954567
exon O 0 0.4235113561153412
- O 1 0.9944522976875305
specific O 0 0.028110384941101074
polymerase O 1 0.8856029510498047
chain O 0 0.08711491525173187
reaction O 0 0.056630153208971024
( O 0 0.03678259626030922
PCR O 0 0.15947149693965912
) O 0 0.032855283468961716
/ O 1 0.9348770976066589
single O 0 0.0535072423517704
- O 1 0.9997972846031189
strand O 0 0.1012333482503891
conformation O 0 0.07399911433458328
polymorphism O 0 0.058597829192876816
as O 0 0.018759094178676605
a O 0 0.02682783082127571
screening O 0 0.06404753774404526
step O 0 0.04308277368545532
and O 0 0.020853316411376
nucleotide O 0 0.04404596611857414
sequencing O 0 0.026633474975824356
of O 0 0.01866636611521244
target O 0 0.03245793282985687
exons O 0 0.057161711156368256
, O 0 0.01555250957608223
we O 0 0.010087044909596443
determined O 0 0.017179347574710846
that O 0 0.008387398906052113
the O 0 0.019362732768058777
proband O 0 0.4390348792076111
was O 0 0.02990797720849514
a O 0 0.03053649142384529
compound O 0 0.07106217741966248
heterozygote O 1 0.8022422790527344
for O 0 0.022415542975068092
two O 0 0.03342874348163605
C6 O 1 0.9999998807907104
gene O 0 0.08810707181692123
mutations O 0 0.06522686034440994
. O 0 0.044868454337120056

The O 0 0.036845337599515915
first O 0 0.030483193695545197
, O 0 0.024927182123064995
1195delC O 1 0.9664748311042786
located O 0 0.036092501133680344
in O 0 0.01633741706609726
exon O 0 0.1250452697277069
7 O 0 0.03435748815536499
, O 0 0.016109907999634743
is O 0 0.013218790292739868
a O 0 0.02299441769719124
novel O 0 0.05090653896331787
mutation O 0 0.0442226268351078
, O 0 0.014648491516709328
while O 0 0.012590157799422741
the O 0 0.015817128121852875
second O 0 0.02906014770269394
, O 0 0.021341580897569656
1936delG O 1 0.8253540992736816
in O 0 0.020573312416672707
exon O 0 0.10852014273405075
12 O 0 0.026779426261782646
, O 0 0.01603791117668152
has O 0 0.011685825884342194
been O 0 0.009966242127120495
described O 0 0.019020644947886467
before O 0 0.015458115376532078
to O 0 0.01998630166053772
cause O 0 0.19620934128761292
C6D B-Disease 1 0.9999861717224121
in O 0 0.0174960196018219
an O 0 0.01686149090528488
unrelated O 0 0.04203581437468529
African O 0 0.07098189741373062
- O 1 0.9999051094055176
American O 0 0.04693232849240303
individual O 0 0.02921316772699356
. O 0 0.03275337070226669

Both O 0 0.04255835711956024
mutations O 0 0.048380691558122635
result O 0 0.026156404986977577
in O 0 0.029852285981178284
premature O 1 0.9999254941940308
termination O 1 0.9999840259552002
codons O 1 0.9082484245300293
and O 0 0.06672494113445282
C6 O 1 0.9999996423721313
null O 1 0.9415498971939087
alleles O 0 0.1192343458533287
. O 0 0.05098304525017738

Allele O 1 0.8203265070915222
- O 1 0.9970531463623047
specific O 0 0.030460475012660027
PCR O 0 0.07950170338153839
indicated O 0 0.02188078686594963
that O 0 0.008233134634792805
the O 0 0.018759524449706078
probands O 1 0.5888258814811707
two O 0 0.017137741670012474
brothers O 0 0.049110252410173416
also O 0 0.020918263122439384
inherited O 0 0.21435275673866272
the O 0 0.03885898366570473
1195delC O 1 0.9999710321426392
mutation O 0 0.05207109823822975
from O 0 0.015118326991796494
their O 0 0.015423986129462719
heterozygous O 0 0.05836905539035797
mother O 0 0.05128404125571251
and O 0 0.01969420164823532
the O 0 0.028771450743079185
1936delG O 1 0.9995133876800537
mutation O 0 0.049069907516241074
from O 0 0.01601146161556244
their O 0 0.018495332449674606
homozygous O 0 0.07691308856010437
father O 0 0.08669441193342209
. O 0 0.03255430981516838
. O 0 0.038234129548072815

PAX6 O 1 0.9999911785125732
mutations O 0 0.13364587724208832
reviewed O 0 0.08833152055740356
. O 0 0.05533070117235184

Mutations O 0 0.08435424417257309
in O 0 0.0326877236366272
PAX6 O 1 0.9999978542327881
are O 0 0.012193857692182064
responsible O 0 0.03028937242925167
for O 0 0.017637142911553383
human O 0 0.07796575874090195
aniridia B-Disease 1 0.9999997615814209
and O 0 0.01686812937259674
have O 0 0.007764061912894249
also O 0 0.008525519631803036
been O 0 0.007640538737177849
found O 0 0.008717736229300499
in O 0 0.011502579785883427
patients O 1 0.6152905225753784
with O 0 0.026716098189353943
Peters B-Disease 1 0.9999995231628418
anomaly I-Disease 1 0.9999995231628418
, O 0 0.04466816782951355
with O 1 0.9995409250259399
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9998358488082886
with O 1 0.9863226413726807
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.06633909791707993
and O 0 0.02368951588869095
with O 0 0.030590591952204704
isolated B-Disease 1 0.9999507665634155
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.08283687382936478

No O 0 0.05098899453878403
locus O 0 0.09651564061641693
other O 0 0.01637887768447399
than O 0 0.020825764164328575
chromosome O 0 0.07976359874010086
11p13 O 1 0.9971597194671631
has O 0 0.020777327939867973
been O 0 0.01686462014913559
implicated O 0 0.08776579052209854
in O 0 0.025291524827480316
aniridia B-Disease 1 0.9999980926513672
, O 0 0.026178475469350815
and O 0 0.02962421253323555
PAX6 O 1 1.0
is O 0 0.024073608219623566
clearly O 0 0.01876288279891014
the O 0 0.0165203046053648
major O 0 0.025621889159083366
, O 0 0.01520079281181097
if O 0 0.011281966231763363
not O 0 0.0076338243670761585
only O 0 0.011262685991823673
, O 0 0.020968547090888023
gene O 0 0.037988800555467606
responsible O 0 0.04967215284705162
. O 0 0.041261009871959686

Twenty O 0 0.09732644259929657
- O 0 0.27537229657173157
eight O 0 0.018558811396360397
percent O 0 0.017922792583703995
of O 0 0.019291037693619728
identified O 0 0.04243193939328194
PAX6 O 1 0.9999994039535522
mutations O 0 0.047694817185401917
are O 0 0.016292141750454903
C O 1 0.999702513217926
- O 1 0.999998927116394
T O 1 0.9950582981109619
changes O 0 0.019879505038261414
at O 0 0.03180641680955887
CpG O 1 0.9838683605194092
dinucleotides O 1 0.9939071536064148
, O 0 0.022171596065163612
20 O 0 0.020824700593948364
% O 0 0.0158813688904047
are O 0 0.009237326681613922
splicing O 0 0.04876673221588135
errors O 0 0.03143608197569847
, O 0 0.015068847686052322
and O 0 0.01075150165706873
more O 0 0.007255966775119305
than O 0 0.00949423760175705
30 O 0 0.02025735378265381
% O 0 0.017740627750754356
are O 0 0.012368228286504745
deletion O 0 0.07727906852960587
or O 0 0.03603418543934822
insertion O 0 0.2696021795272827
events O 0 0.042333703488111496
. O 0 0.041654955595731735

There O 0 0.027778780087828636
is O 0 0.020600568503141403
a O 0 0.031197750940918922
noticeably O 0 0.09860704094171524
elevated O 1 0.9995014667510986
level O 0 0.032805848866701126
of O 0 0.02559390477836132
mutation O 0 0.04017475247383118
in O 0 0.014394277706742287
the O 0 0.022250978276133537
paired O 0 0.050506509840488434
domain O 0 0.031568743288517
compared O 0 0.0132622504606843
with O 0 0.009636527858674526
the O 0 0.01300827506929636
rest O 0 0.02154700644314289
of O 0 0.020175514742732048
the O 0 0.03317083790898323
gene O 0 0.05131051316857338
. O 0 0.037442028522491455

Increased O 0 0.0645570382475853
mutation O 0 0.05650269240140915
in O 0 0.016894055530428886
the O 0 0.03207225725054741
homeodomain O 1 0.996823787689209
is O 0 0.019782228395342827
accounted O 0 0.025890035554766655
for O 0 0.013254988938570023
by O 0 0.016628455370664597
the O 0 0.03554205596446991
hypermutable O 1 0.9999263286590576
CpG O 1 0.9987462759017944
dinucleotide O 1 0.9829034209251404
in O 0 0.04017286002635956
codon O 0 0.11919308453798294
240 O 0 0.08811168372631073
. O 0 0.04395155981183052

Very O 0 0.03645865619182587
nearly O 0 0.02662358433008194
all O 0 0.01990756392478943
mutations O 0 0.035268355160951614
appear O 0 0.01916307397186756
to O 0 0.018299253657460213
cause O 0 0.0373283252120018
loss O 0 0.03195866569876671
of O 0 0.021513065323233604
function O 0 0.019506080076098442
of O 0 0.016377557069063187
the O 0 0.028322216123342514
mutant O 1 0.9987735152244568
allele O 0 0.09762223064899445
, O 0 0.016453677788376808
and O 0 0.010615656152367592
more O 0 0.006594511680305004
than O 0 0.008059070445597172
80 O 0 0.022163569927215576
% O 0 0.016022102907299995
of O 0 0.024414321407675743
exonic O 1 0.9964216947555542
substitutions O 0 0.0609339103102684
result O 0 0.026013216003775597
in O 0 0.027412174269557
nonsense O 0 0.44985586404800415
codons O 0 0.12094513326883316
. O 0 0.04762929677963257

In O 0 0.02968197502195835
a O 0 0.034577660262584686
gene O 0 0.033961910754442215
with O 0 0.01671884022653103
such O 0 0.016708023846149445
extraordinarily O 0 0.38226282596588135
high O 0 0.04926149174571037
sequence O 0 0.02671615220606327
conservation O 0 0.03130542114377022
throughout O 0 0.016543088480830193
evolution O 0 0.02454175427556038
, O 0 0.013418366201221943
there O 0 0.009777604602277279
are O 0 0.009779156185686588
presumed O 0 0.07166984677314758
undiscovered O 1 0.9999632835388184
missense O 1 0.996417760848999
mutations O 0 0.056306105107069016
, O 0 0.019954916089773178
these O 0 0.0100979870185256
are O 0 0.008131067268550396
hypothesized O 0 0.035577740520238876
to O 0 0.012446558102965355
exist O 0 0.01174903940409422
in O 0 0.011313187889754772
as O 0 0.02257315069437027
- O 1 0.9998268485069275
yet O 0 0.0309068001806736
unidentified O 0 0.076120525598526
phenotypes O 0 0.0904790386557579
. O 0 0.02698536217212677
. O 0 0.033732276409864426

Genetic O 0 0.11231931298971176
heterogeneity O 0 0.22376789152622223
and O 0 0.035477470606565475
penetrance O 1 0.9837440848350525
analysis O 0 0.017047539353370667
of O 0 0.017164671793580055
the O 0 0.03154376521706581
BRCA1 O 1 0.9999504089355469
and O 0 0.036221545189619064
BRCA2 O 1 0.9999837875366211
genes O 0 0.04699118807911873
in O 0 0.05577494576573372
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.6396993398666382
. O 0 0.05383240804076195

The O 1 0.9968440532684326
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999996423721313
Consortium O 1 0.9610379338264465
. O 0 0.05385607108473778

The O 0 0.03350839763879776
contribution O 0 0.04310835152864456
of O 0 0.038128986954689026
BRCA1 O 1 0.9997915625572205
and O 0 0.03270468860864639
BRCA2 O 1 0.9999418258666992
to O 0 0.23930807411670685
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9999001026153564
assessed O 0 0.06031353026628494
by O 0 0.027254849672317505
linkage O 0 0.4171377420425415
and O 0 0.022901836782693863
mutation O 0 0.04087735339999199
analysis O 0 0.012937803752720356
in O 0 0.012913207523524761
237 O 0 0.06461016088724136
families O 0 0.02325187623500824
, O 0 0.013033720664680004
each O 0 0.0060404324904084206
with O 0 0.008101379498839378
at O 0 0.01173890009522438
least O 0 0.007678696420043707
four O 0 0.008821859955787659
cases O 0 0.019219767302274704
of O 1 0.7678735256195068
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.02371867559850216
collected O 0 0.014651148580014706
by O 0 0.017649639397859573
the O 0 0.1984442174434662
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999995231628418
Consortium O 1 0.8294062614440918
. O 0 0.04745839908719063

Families O 0 0.043927181512117386
were O 0 0.014082019217312336
included O 0 0.017856881022453308
without O 0 0.012316976673901081
regard O 0 0.02261871099472046
to O 0 0.013155056163668633
the O 0 0.01875562034547329
occurrence O 0 0.07785163074731827
of O 1 0.9036383032798767
ovarian B-Disease 1 1.0
or I-Disease 1 0.9444129467010498
other I-Disease 0 0.04310745745897293
cancers I-Disease 1 0.9999978542327881
. O 0 0.05473431199789047

Overall O 0 0.11653271317481995
, O 0 0.07272003591060638
disease O 1 0.9999992847442627
was O 1 0.6648872494697571
linked O 0 0.2071673572063446
to O 0 0.028126589953899384
BRCA1 O 1 0.9931584000587463
in O 0 0.013363883830606937
an O 0 0.013699730858206749
estimated O 0 0.01802724227309227
52 O 0 0.033110152930021286
% O 0 0.01556688454002142
of O 0 0.015607197768986225
families O 0 0.022599922493100166
, O 0 0.017467228695750237
to O 0 0.022399375215172768
BRCA2 O 1 0.9283339977264404
in O 0 0.015322484076023102
32 O 0 0.02842552214860916
% O 0 0.016161583364009857
of O 0 0.015914790332317352
families O 0 0.023629510775208473
, O 0 0.0142514081671834
and O 0 0.011154768988490105
to O 0 0.01460228394716978
neither O 0 0.027694096788764
gene O 0 0.023181429132819176
in O 0 0.011889226734638214
16 O 0 0.02588522620499134
% O 0 0.02209068462252617
( O 0 0.021032234653830528
95 O 0 0.0383676216006279
% O 0 0.025918714702129364
confidence O 0 0.055294495075941086
interval O 0 0.10285107791423798
[ O 0 0.2302791178226471
CI O 1 0.9999986886978149
] O 0 0.06940371543169022
6 O 0 0.03988243639469147
% O 0 0.03003036417067051
- O 1 0.9919208288192749
28 O 0 0.03785966336727142
% O 0 0.02323121950030327
) O 0 0.01906399428844452
, O 0 0.019169900566339493
suggesting O 0 0.035333625972270966
other O 0 0.028579119592905045
predisposition O 1 0.9998587369918823
genes O 0 0.058517664670944214
. O 0 0.04617914929986

The O 0 0.038984112441539764
majority O 0 0.038737162947654724
( O 0 0.026510881260037422
81 O 0 0.0464409664273262
% O 0 0.01564500667154789
) O 0 0.009880462661385536
of O 0 0.012835090979933739
the O 0 0.04530998691916466
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.21545369923114777
were O 0 0.013047060929238796
due O 0 0.01848638616502285
to O 0 0.021658699959516525
BRCA1 O 1 0.9998859167098999
, O 0 0.014612880535423756
with O 0 0.011330871842801571
most O 0 0.012361887842416763
others O 0 0.01613246276974678
( O 0 0.01815303973853588
14 O 0 0.028418878093361855
% O 0 0.023573894053697586
) O 0 0.019899656996130943
due O 0 0.027257822453975677
to O 0 0.039925467222929
BRCA2 O 1 0.9993532299995422
. O 0 0.05319533869624138

Conversely O 0 0.1068805679678917
, O 0 0.022240079939365387
the O 0 0.017036419361829758
majority O 0 0.018279457464814186
of O 0 0.016557026654481888
families O 0 0.022185780107975006
with O 0 0.01587711274623871
male B-Disease 0 0.054101139307022095
and I-Disease 0 0.027473855763673782
female I-Disease 1 0.9999986886978149
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.023223400115966797
due O 0 0.03378558158874512
to O 0 0.03500744700431824
BRCA2 O 1 0.9999858140945435
( O 0 0.03673190623521805
76 O 0 0.28944382071495056
% O 0 0.037097860127687454
) O 0 0.03107132762670517
. O 0 0.033812832087278366

The O 0 0.04628075286746025
largest O 0 0.06869854778051376
proportion O 0 0.05586414039134979
( O 0 0.03163405507802963
67 O 0 0.05361976474523544
% O 0 0.021690255030989647
) O 0 0.01604549214243889
of O 0 0.014961224980652332
families O 0 0.020743252709507942
due O 0 0.020203042775392532
to O 0 0.014894269406795502
other O 0 0.011797361075878143
genes O 0 0.017961349338293076
was O 0 0.017020145431160927
found O 0 0.00934467650949955
in O 0 0.008097080513834953
families O 0 0.013735056854784489
with O 0 0.009627112187445164
four O 0 0.010791314765810966
or O 0 0.009002543054521084
five O 0 0.010526100173592567
cases O 0 0.017104635015130043
of O 0 0.035764750093221664
female O 1 0.9999992847442627
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.061080873012542725
. O 0 0.05148972570896149

These O 0 0.02238851599395275
estimates O 0 0.02131921984255314
were O 0 0.011430740356445312
not O 0 0.013349983841180801
substantially O 0 0.03375891596078873
affected O 0 0.025621745735406876
either O 0 0.014198778197169304
by O 0 0.013943707570433617
changing O 0 0.020221134647727013
the O 0 0.020754432305693626
assumed O 0 0.05429643765091896
penetrance O 1 0.9985685348510742
model O 0 0.041942790150642395
for O 0 0.02835002727806568
BRCA1 O 1 0.9987069368362427
or O 0 0.019747750833630562
by O 0 0.01538792997598648
including O 0 0.019486499950289726
or O 0 0.027722371742129326
excluding O 0 0.10243120044469833
BRCA1 O 1 0.9999873638153076
mutation O 0 0.0861806645989418
data O 0 0.026253018528223038
. O 0 0.03261357545852661

Among O 0 0.03862941265106201
those O 0 0.01757810078561306
families O 0 0.03447161987423897
with O 0 0.03794075548648834
disease O 1 0.9999998807907104
due O 1 0.8248153328895569
to O 0 0.05646413564682007
BRCA1 O 1 0.999983549118042
that O 0 0.013269254937767982
were O 0 0.009975919499993324
tested O 0 0.019997624680399895
by O 0 0.009191532619297504
one O 0 0.00927392952144146
of O 0 0.012152126990258694
the O 0 0.019810477271676064
standard O 0 0.040934767574071884
screening O 0 0.07309406995773315
methods O 0 0.019752994179725647
, O 0 0.01720266416668892
mutations O 0 0.02173142321407795
were O 0 0.010704634711146355
detected O 0 0.026870427653193474
in O 0 0.011074280366301537
the O 0 0.022188004106283188
coding O 0 0.05401768535375595
sequence O 0 0.02230418473482132
or O 0 0.0204560998827219
splice O 0 0.07138735800981522
sites O 0 0.017359569668769836
in O 0 0.009410806000232697
an O 0 0.014186549931764603
estimated O 0 0.02318226732313633
63 O 0 0.051510948687791824
% O 0 0.02471695840358734
( O 0 0.025095853954553604
95 O 0 0.042885009199380875
% O 0 0.03957130387425423
CI O 1 0.9999041557312012
51 O 0 0.07397549599409103
% O 0 0.04621113836765289
- O 1 0.9996423721313477
77 O 0 0.08570271730422974
% O 0 0.03708542138338089
) O 0 0.03132568672299385
. O 0 0.03293918818235397

The O 0 0.04987414926290512
estimated O 0 0.04194029048085213
sensitivity O 0 0.057814475148916245
was O 0 0.03090326115489006
identical O 0 0.02296723611652851
for O 0 0.0182258952409029
direct O 0 0.032768364995718
sequencing O 0 0.04238255321979523
and O 0 0.018967919051647186
other O 0 0.01697096787393093
techniques O 0 0.032862670719623566
. O 0 0.032285090535879135

The O 0 0.06000332906842232
penetrance O 1 0.996056079864502
of O 0 0.06140400096774101
BRCA2 O 1 0.9994107484817505
was O 0 0.040223151445388794
estimated O 0 0.023906415328383446
by O 0 0.02044062502682209
maximizing O 0 0.07041048258543015
the O 0 0.03344251960515976
LOD O 1 0.9999165534973145
score O 0 0.031384848058223724
in O 0 0.026560872793197632
BRCA2 O 1 0.9999493360519409
- O 1 0.999992847442627
mutation O 0 0.06194918975234032
families O 0 0.021894272416830063
, O 0 0.014184869825839996
over O 0 0.01578967459499836
all O 0 0.015854422003030777
possible O 0 0.03712040185928345
penetrance O 1 0.9980400204658508
functions O 0 0.04672941938042641
. O 0 0.04235461726784706

The O 0 0.035902075469493866
estimated O 0 0.03348618373274803
cumulative O 0 0.07214624434709549
risk O 0 0.20549476146697998
of O 1 0.9526639580726624
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 1 0.9538223147392273
28 O 0 0.0471540205180645
% O 0 0.02072119526565075
( O 0 0.01868920773267746
95 O 0 0.03861602768301964
% O 0 0.03298091143369675
CI O 1 0.9999767541885376
9 O 0 0.04195399209856987
% O 0 0.02865653857588768
- O 1 0.9830563068389893
44 O 0 0.03893516957759857
% O 0 0.019762752577662468
) O 0 0.01367171946913004
by O 0 0.011854991316795349
age O 0 0.02076670713722706
50 O 0 0.01977081224322319
years O 0 0.015724344179034233
and O 0 0.01578459143638611
84 O 0 0.05220763012766838
% O 0 0.023502349853515625
( O 0 0.02127251774072647
95 O 0 0.038422103971242905
% O 0 0.03525073453783989
CI O 1 0.9999611377716064
43 O 0 0.053637586534023285
% O 0 0.035012055188417435
- O 1 0.9964520931243896
95 O 0 0.04201759025454521
% O 0 0.020709747448563576
) O 0 0.01438379567116499
by O 0 0.015512173064053059
age O 0 0.028691301122307777
70 O 0 0.03730415552854538
years O 0 0.03086523525416851
. O 0 0.0375976525247097

The O 0 0.08021023124456406
corresponding O 1 0.9999717473983765
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999971389770508
were O 0 0.03743922710418701
0 O 0 0.08255988359451294
. O 0 0.04304656386375427

4 O 0 0.06806542724370956
% O 0 0.03451976925134659
( O 0 0.026650676503777504
95 O 0 0.05012696981430054
% O 0 0.04028846696019173
CI O 1 0.9999862909317017
0 O 0 0.06215855851769447
% O 0 0.03639253228902817
- O 1 0.9960519671440125
1 O 0 0.03582224249839783
% O 0 0.01940002478659153
) O 0 0.01227497961372137
by O 0 0.011421121656894684
age O 0 0.020508652552962303
50 O 0 0.018842186778783798
years O 0 0.015016580000519753
and O 0 0.015495563857257366
27 O 0 0.03373197838664055
% O 0 0.02041141875088215
( O 0 0.02066061459481716
95 O 0 0.03890090435743332
% O 0 0.03365504369139671
CI O 1 0.9999889135360718
0 O 0 0.05434582009911537
% O 0 0.029027026146650314
- O 1 0.9684838652610779
47 O 0 0.04607919603586197
% O 0 0.019967932254076004
) O 0 0.014005389995872974
by O 0 0.013968195766210556
age O 0 0.030899617820978165
70 O 0 0.03736592084169388
years O 0 0.03229598328471184
. O 0 0.03505731374025345

The O 0 0.04034283757209778
lifetime O 0 0.222153440117836
risk O 1 0.9802535772323608
of O 1 0.9997112154960632
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 1 0.8553023338317871
similar O 0 0.013736969791352749
to O 0 0.01344124786555767
the O 0 0.018395299091935158
risk O 0 0.05763109028339386
in O 0 0.027378495782613754
BRCA1 O 1 0.999998927116394
carriers O 0 0.14089007675647736
, O 0 0.016694696620106697
but O 0 0.009183770045638084
there O 0 0.007248952519148588
was O 0 0.012467904947698116
some O 0 0.006406883243471384
suggestion O 0 0.025869300588965416
of O 0 0.014311148785054684
a O 0 0.024443957954645157
lower O 0 0.042037952691316605
risk O 0 0.052139606326818466
in O 0 0.03154243901371956
BRCA2 O 1 0.9999489784240723
carriers O 0 0.26274409890174866
< O 1 0.9448906779289246
50 O 0 0.027096502482891083
years O 0 0.020144039765000343
of O 0 0.026690173894166946
age O 0 0.04794428125023842
. O 0 0.042552247643470764

Eye B-Disease 1 0.9999711513519287
movement I-Disease 1 0.988969087600708
abnormalities I-Disease 1 0.99974125623703
correlate O 0 0.08326601982116699
with O 0 0.035585664212703705
genotype O 1 0.9039018750190735
in O 0 0.03544691950082779
autosomal O 1 0.9999862909317017
dominant O 1 0.9999996423721313
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999991655349731
I I-Disease 1 0.9988090991973877
. O 0 0.049557849764823914

We O 0 0.03714299201965332
compared O 0 0.047355711460113525
horizontal O 1 0.5248666405677795
eye O 1 0.999749481678009
movements O 0 0.0665276050567627
( O 0 0.04099661856889725
visually O 0 0.08231192082166672
guided O 0 0.25941023230552673
saccades O 1 0.9999991655349731
, O 0 0.04183231666684151
antisaccades O 1 0.9995482563972473
, O 0 0.022553715854883194
and O 0 0.02069907635450363
smooth O 0 0.07140328735113144
pursuit O 0 0.09067321568727493
) O 0 0.01747436821460724
in O 0 0.011941739358007908
control O 0 0.029707791283726692
subjects O 0 0.0347464382648468
( O 0 0.029397932812571526
n O 0 0.2136642038822174
= O 0 0.05922308564186096
14 O 0 0.028269339352846146
) O 0 0.018457112833857536
and O 0 0.017353393137454987
patients O 0 0.05729304254055023
with O 0 0.013150075450539589
three O 0 0.012522653676569462
forms O 0 0.021844210103154182
of O 0 0.03116929531097412
autosomal O 1 0.9999961853027344
dominant O 1 0.9999901056289673
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999998807907104
type I-Disease 1 0.9997281432151794
I I-Disease 1 0.9990617632865906
spinocerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999901056289673
1 I-Disease 0 0.04403121396899223
and I-Disease 0 0.020336931571364403
2 I-Disease 0 0.03491691127419472
( O 0 0.031287841498851776
SCA1 B-Disease 1 0.999562680721283
, O 0 0.0303808506578207
n O 0 0.07193144410848618
= O 0 0.05332185700535774
11 O 0 0.02668232098221779
; O 0 0.027221838012337685
SCA2 B-Disease 1 0.9998645782470703
, O 0 0.032622791826725006
n O 0 0.07352204620838165
= O 0 0.04768725484609604
10 O 0 0.016526324674487114
) O 0 0.014545152895152569
and O 0 0.019606944173574448
SCA3 B-Disease 1 0.9999994039535522
/ O 1 0.9999830722808838
Machado B-Disease 1 0.999976634979248
- I-Disease 1 0.9999997615814209
Joseph I-Disease 1 0.9999984502792358
disease I-Disease 1 1.0
( O 1 0.881885826587677
MJD B-Disease 1 1.0
) O 0 0.043005120009183884
( O 0 0.03850007802248001
n O 0 0.10486914962530136
= O 0 0.07006760686635971
16 O 0 0.038364991545677185
) O 0 0.030768368393182755
. O 0 0.03190859034657478

In O 0 0.06125557795166969
SCA1 B-Disease 1 0.9999599456787109
, O 0 0.056208740919828415
saccade O 1 0.9993739724159241
amplitude O 0 0.09095189720392227
was O 0 0.04069150239229202
significantly O 0 0.03409494459629059
increased O 0 0.026361241936683655
, O 0 0.021900644525885582
resulting O 0 0.03165566921234131
in O 0 0.03129285201430321
hypermetria B-Disease 1 0.999422550201416
. O 0 0.05722411721944809

The O 0 0.06652573496103287
smooth O 0 0.12104728072881699
pursuit O 0 0.18127793073654175
gain O 0 0.06116379797458649
was O 0 0.05832243710756302
decreased O 0 0.09097043424844742
. O 0 0.050398893654346466

In O 0 0.06199664622545242
SCA2 B-Disease 1 0.9999498128890991
, O 0 0.06514143198728561
saccade O 1 0.9994029998779297
velocity O 0 0.09253504127264023
was O 0 0.06250722706317902
markedly O 0 0.10741173475980759
decreased O 0 0.09916603565216064
. O 0 0.050942614674568176

The O 0 0.035849761217832565
percentage O 0 0.03150104731321335
of O 0 0.021227305755019188
errors O 0 0.03474990278482437
in O 0 0.0219254270195961
antisaccades O 1 0.999992847442627
was O 0 0.03727702051401138
greatly O 0 0.031808771193027496
increased O 0 0.019496550783514977
and O 0 0.013039573095738888
was O 0 0.02274424023926258
significantly O 0 0.02533581294119358
correlated O 0 0.040327440947294235
with O 0 0.01929779164493084
age O 0 0.06715048849582672
at O 1 0.9978579878807068
disease O 1 1.0
onset O 1 1.0
. O 0 0.24927876889705658

In O 0 0.03254050761461258
addition O 0 0.02581029199063778
, O 0 0.018083978444337845
a O 0 0.02881951630115509
correlation O 0 0.04699835926294327
between O 0 0.029866471886634827
smooth O 0 0.11384375393390656
pursuit O 0 0.08538579195737839
gain O 0 0.027315393090248108
and O 0 0.012021863833069801
the O 0 0.013402637094259262
number O 0 0.011536607518792152
of O 0 0.029843898490071297
trinucleotide O 1 0.999933123588562
repeats O 0 0.08670534938573837
was O 0 0.04529491066932678
found O 0 0.02697143331170082
. O 0 0.03217016160488129

In O 0 0.05456133559346199
SCA3 B-Disease 1 0.9999978542327881
, O 0 0.05118963122367859
gaze B-Disease 1 0.9999332427978516
- I-Disease 1 0.9999997615814209
evoked I-Disease 1 0.9996809959411621
nystagmus I-Disease 1 0.999997615814209
was O 0 0.038534682244062424
often O 0 0.014806495979428291
present O 0 0.017864979803562164
as O 0 0.020280178636312485
was O 0 0.04403388127684593
saccade O 1 0.9999033212661743
hypometria O 1 0.9997643828392029
and O 0 0.03522514924407005
smooth O 0 0.08843546360731125
pursuit O 0 0.1338682621717453
gain O 0 0.053974464535713196
was O 0 0.050004515796899796
markedly O 0 0.09739115089178085
decreased O 0 0.08386118710041046
. O 0 0.045027051120996475

Three O 0 0.03968988358974457
major O 0 0.05748259648680687
criteria O 0 0.06018650159239769
, O 0 0.04440445825457573
saccade O 1 0.9998962879180908
amplitude O 0 0.14841397106647491
, O 0 0.04226956516504288
saccade O 1 0.9986155033111572
velocity O 0 0.0560961551964283
, O 0 0.015972165390849113
and O 0 0.012410137802362442
presence O 0 0.025536833330988884
of O 0 0.029308849945664406
gaze B-Disease 1 0.9999442100524902
- I-Disease 1 0.9999996423721313
evoked I-Disease 1 0.9993399977684021
nystagmus I-Disease 1 0.9999909400939941
, O 0 0.02586592733860016
permitted O 0 0.027459323406219482
the O 0 0.02145359292626381
correct O 0 0.040619198232889175
assignment O 0 0.04578104615211487
of O 0 0.016250165179371834
90 O 0 0.02141493558883667
% O 0 0.012579367496073246
of O 0 0.015614444389939308
the O 0 0.029675409197807312
SCA1 B-Disease 1 0.9999504089355469
, O 0 0.01799430139362812
90 O 0 0.019329361617565155
% O 0 0.011206507682800293
of O 0 0.013013187795877457
the O 0 0.024730516597628593
SCA2 B-Disease 1 0.9999885559082031
, O 0 0.018403226509690285
and O 0 0.013329963199794292
93 O 0 0.038532912731170654
% O 0 0.014263657853007317
of O 0 0.015597878955304623
the O 0 0.0250996220856905
patients O 1 0.9832543730735779
with O 0 0.026196470484137535
SCA3 B-Disease 1 0.9999995231628418
to O 0 0.016407063230872154
their O 0 0.010793177410960197
genetically O 0 0.022629179060459137
confirmed O 0 0.028884397819638252
patient O 1 0.9992939233779907
group O 0 0.036750320345163345
and O 0 0.01611948199570179
, O 0 0.0161922425031662
therefore O 0 0.01782842166721821
, O 0 0.01488669402897358
may O 0 0.01601073145866394
help O 0 0.03196851536631584
orient O 1 0.9936794638633728
diagnoses O 1 0.999650239944458
of O 0 0.04762277379631996
SCA1 B-Disease 1 0.9999997615814209
, O 0 0.045784562826156616
SCA2 B-Disease 1 0.9999899864196777
, O 0 0.02618495188653469
and O 0 0.024969259276986122
SCA3 B-Disease 1 0.9999994039535522
at O 0 0.02776319533586502
early O 0 0.027832841500639915
clinical O 0 0.07637666910886765
stages O 0 0.03668103739619255
of O 0 0.03361131250858307
the O 1 0.849297046661377
diseases O 1 0.9999998807907104
. O 0 0.04099225997924805
. O 0 0.04593748599290848

Genetic O 0 0.0600627176463604
basis O 0 0.025630470365285873
and O 0 0.026946159079670906
molecular O 0 0.06781423836946487
mechanism O 1 0.8090551495552063
for O 1 0.9835270047187805
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9960451722145081

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9999717473983765
more O 0 0.018046410754323006
than O 0 0.014251019805669785
300 O 0 0.028401074931025505
, O 0 0.020702963694930077
000 O 0 0.05533931404352188
sudden O 1 0.640029788017273
deaths O 0 0.043964602053165436
each O 0 0.012866909615695477
year O 0 0.01680353656411171
in O 0 0.014569222927093506
the O 0 0.02772407978773117
USA O 0 0.08514943718910217
alone O 0 0.04983067512512207
. O 0 0.03977302461862564

In O 0 0.024146387353539467
approximately O 0 0.02304345741868019
5 O 0 0.0387394018471241
- O 1 0.9935099482536316
12 O 0 0.02234693244099617
% O 0 0.013736821711063385
of O 0 0.0129479905590415
these O 0 0.00929095409810543
cases O 0 0.016740581020712852
, O 0 0.012590460479259491
there O 0 0.007892484776675701
are O 0 0.005735979415476322
no O 0 0.01840747334063053
demonstrable O 1 0.9999988079071045
cardiac O 1 1.0
or O 1 0.669074535369873
non O 1 0.9999998807907104
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.9996892213821411
to O 0 0.01930132880806923
account O 0 0.013233845122158527
for O 0 0.009254650212824345
the O 0 0.014740187674760818
episode O 0 0.03404771164059639
, O 0 0.013125247322022915
which O 0 0.008957468904554844
is O 0 0.01019471138715744
therefore O 0 0.014003166928887367
classified O 0 0.039299193769693375
as O 0 0.08242800086736679
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.999997615814209
IVF B-Disease 1 1.0
) O 0 0.06291291117668152
. O 0 0.04921337962150574

A O 0 0.049683328717947006
distinct O 0 0.02738051488995552
group O 0 0.03929346054792404
of O 0 0.05416134372353554
IVF B-Disease 1 1.0
patients O 1 0.9999948740005493
has O 0 0.024283500388264656
been O 0 0.013605672866106033
found O 0 0.009282412007451057
to O 0 0.010994106531143188
present O 0 0.014201977290213108
with O 0 0.015091809444129467
a O 0 0.03393783047795296
characteristic O 1 0.8179090023040771
electrocardiographic O 1 0.9999794960021973
pattern O 0 0.22678785026073456
. O 0 0.05427554249763489

Because O 0 0.02924049086868763
of O 0 0.019163446500897408
the O 0 0.021736161783337593
small O 0 0.018503939732909203
size O 0 0.015861237421631813
of O 0 0.013840848580002785
most O 0 0.0142753841355443
pedigrees O 0 0.05203622207045555
and O 0 0.01450159028172493
the O 0 0.019835561513900757
high O 0 0.1409710943698883
incidence O 1 0.9999939203262329
of O 0 0.3518901467323303
sudden B-Disease 1 0.9999988079071045
death I-Disease 1 0.9998700618743896
, O 0 0.02269679494202137
however O 0 0.014065597206354141
, O 0 0.015650728717446327
molecular O 0 0.026812070980668068
genetic O 0 0.022942915558815002
studies O 0 0.015907220542430878
of O 0 0.030112100765109062
IVF B-Disease 1 0.9999998807907104
have O 0 0.015893125906586647
not O 0 0.012553169392049313
yet O 0 0.018243856728076935
been O 0 0.01826431043446064
done O 0 0.02801259607076645
. O 0 0.0313795730471611

Because O 0 0.29593944549560547
IVF B-Disease 1 1.0
causes O 1 1.0
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999998807907104
, O 0 0.027746377512812614
we O 0 0.014892148785293102
investigated O 0 0.035352978855371475
whether O 0 0.024013789370656013
malfunction O 1 0.9991740584373474
of O 0 0.030872685834765434
ion O 1 0.9352512359619141
channels O 0 0.025549352169036865
could O 0 0.015876727178692818
cause O 0 0.03506077080965042
the O 0 0.03205019608139992
disorder O 1 0.9999995231628418
by O 0 0.023456115275621414
studying O 0 0.02745272032916546
mutations O 0 0.02673923596739769
in O 0 0.01382891833782196
the O 0 0.03764679655432701
cardiac O 1 1.0
sodium O 1 0.9999872446060181
channel O 0 0.08372028172016144
gene O 0 0.06628230959177017
SCN5A O 1 0.9973908066749573
. O 0 0.05146562308073044

We O 0 0.022903691977262497
have O 0 0.01046055369079113
now O 0 0.01631835475564003
identified O 0 0.018357526510953903
a O 0 0.023884903639554977
missense O 0 0.10059884190559387
mutation O 0 0.04307015985250473
, O 0 0.015292869880795479
a O 0 0.02732676826417446
splice O 1 0.994419515132904
- O 1 0.9999963045120239
donor O 1 0.995209276676178
mutation O 0 0.049933917820453644
, O 0 0.014476620592176914
and O 0 0.01586466282606125
a O 0 0.030797261744737625
frameshift O 1 0.9968817234039307
mutation O 0 0.04451098293066025
in O 0 0.013773727230727673
the O 0 0.02195446565747261
coding O 0 0.04735969752073288
region O 0 0.025533214211463928
of O 0 0.02700910158455372
SCN5A O 1 0.9998483657836914
in O 0 0.025326797738671303
three O 0 0.032966483384370804
IVF B-Disease 1 0.999971866607666
families O 0 0.06840863823890686
. O 0 0.054467350244522095

We O 0 0.031818192452192307
show O 0 0.02971733920276165
that O 0 0.01661958545446396
sodium O 0 0.05404426157474518
channels O 0 0.0177739467471838
with O 0 0.012569457292556763
the O 0 0.027666443958878517
missense O 1 0.6662498712539673
mutation O 0 0.07523282617330551
recover O 0 0.10189708322286606
from O 0 0.03296199440956116
inactivation O 1 0.9998775720596313
more O 0 0.015360342338681221
rapidly O 0 0.03195016831159592
than O 0 0.011005404405295849
normal O 0 0.019935782998800278
and O 0 0.011150109581649303
that O 0 0.00939521286636591
the O 0 0.0274016335606575
frameshift O 1 0.9999860525131226
mutation O 1 0.9054673314094543
causes O 1 0.6636731028556824
the O 0 0.035522498190402985
sodium O 0 0.3210533857345581
channel O 0 0.02775685489177704
to O 0 0.013947274535894394
be O 0 0.014549614861607552
non O 0 0.07601791620254517
- O 1 0.9999351501464844
functional O 0 0.07832272350788116
. O 0 0.04527333006262779

Our O 0 0.0468548983335495
results O 0 0.02119564078748226
indicate O 0 0.017935484647750854
that O 0 0.010773656889796257
mutations O 0 0.03067724034190178
in O 0 0.027238458395004272
cardiac O 1 1.0
ion O 1 0.9999973773956299
- O 1 0.9999978542327881
channel O 0 0.046242330223321915
genes O 0 0.018808545544743538
contribute O 0 0.017559854313731194
to O 0 0.011407976970076561
the O 0 0.018036719411611557
risk O 0 0.03917036950588226
of O 0 0.033149197697639465
developing O 1 0.9316782355308533
IVF B-Disease 1 0.9999996423721313
. O 0 0.04307983070611954
. O 0 0.045743584632873535

Molecular O 0 0.10192444175481796
heterogeneity O 0 0.13962334394454956
in O 0 0.04401208460330963
mucopolysaccharidosis B-Disease 1 0.99986732006073
IVA I-Disease 1 0.9999988079071045
in O 0 0.025054901838302612
Australia O 0 0.029238203540444374
and O 0 0.015788709744811058
Northern O 0 0.02564065530896187
Ireland O 0 0.03513685241341591
: O 0 0.02067369595170021
nine O 0 0.022178512066602707
novel O 0 0.04956462234258652
mutations O 0 0.035193465650081635
including O 0 0.023666663095355034
T312S O 1 0.9990829229354858
, O 0 0.022387182340025902
a O 0 0.02465946413576603
common O 0 0.028029844164848328
allele O 0 0.06794233620166779
that O 0 0.019428547471761703
confers O 1 0.9888958930969238
a O 0 0.06674446165561676
mild O 1 0.9999722242355347
phenotype O 1 0.9984620809555054
. O 0 0.05641845986247063

Mucopolysaccharidosis B-Disease 1 0.9999599456787109
IVA I-Disease 1 0.9999998807907104
( O 0 0.08741676062345505
MPS B-Disease 1 0.9999322891235352
IVA I-Disease 1 1.0
) O 0 0.03225615248084068
is O 0 0.018965106457471848
an O 0 0.028635196387767792
autosomal B-Disease 1 0.9999984502792358
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9997654557228088
by O 0 0.030440520495176315
a O 0 0.03903966769576073
genetic B-Disease 1 0.8512405753135681
defect I-Disease 1 0.9999974966049194
in O 0 0.021591758355498314
N O 1 0.9958135485649109
- O 1 0.9998700618743896
acetylgalactosamine O 1 0.9994064569473267
- O 1 0.9998922348022461
6 O 0 0.08369714766740799
- O 1 0.9999992847442627
sulfate O 1 0.9999996423721313
sulfatase O 1 0.9999997615814209
( O 0 0.0850987508893013
GALNS O 1 0.9999978542327881
) O 0 0.048166241496801376
. O 0 0.037373803555965424

Previous O 0 0.04859793186187744
studies O 0 0.027587922289967537
of O 0 0.027855344116687775
patients O 1 0.8949407339096069
from O 0 0.016614636406302452
a O 0 0.025294063612818718
British O 0 0.04560070484876633
- O 1 0.9996490478515625
Irish O 0 0.03727893903851509
population O 0 0.012855078093707561
showed O 0 0.01369200274348259
that O 0 0.008017415180802345
the O 0 0.02218620479106903
I113F O 1 0.9997835755348206
mutation O 0 0.042562901973724365
is O 0 0.01235951203852892
the O 0 0.012495327740907669
most O 0 0.009934017434716225
common O 0 0.01760256662964821
single O 0 0.031686991453170776
mutation O 0 0.04329100623726845
among O 0 0.03424075245857239
MPS B-Disease 1 0.9999985694885254
IVA I-Disease 1 1.0
patients O 1 0.9999996423721313
and O 0 0.038748547434806824
produces O 0 0.05009893700480461
a O 0 0.05881708487868309
severe O 1 0.9999996423721313
clinical O 1 1.0
phenotype O 1 0.9999972581863403
. O 0 0.06648194789886475

We O 0 0.0329902358353138
studied O 0 0.037018682807683945
mutations O 0 0.028788631781935692
in O 0 0.012981647625565529
the O 0 0.028878742828965187
GALNS O 1 0.9999908208847046
gene O 0 0.034712594002485275
from O 0 0.013304437510669231
23 O 0 0.024713383987545967
additional O 0 0.02805497869849205
MPS B-Disease 1 0.9999788999557495
IVA I-Disease 1 1.0
patients O 1 0.9999996423721313
( O 0 0.033440157771110535
15 O 0 0.02225503697991371
from O 0 0.013988017104566097
Australia O 0 0.01977616921067238
, O 0 0.012831936590373516
8 O 0 0.018157854676246643
from O 0 0.010724523104727268
Northern O 0 0.022419650107622147
Ireland O 0 0.029532762244343758
) O 0 0.01408036332577467
, O 0 0.010392697528004646
with O 0 0.01030073780566454
various O 0 0.015293492935597897
clinical O 1 0.9999855756759644
phenotypes O 1 0.9999964237213135
( O 1 0.9492982625961304
severe O 1 0.9999994039535522
, O 0 0.031905174255371094
16 O 0 0.03313389793038368
cases O 0 0.029098326340317726
; O 0 0.023286662995815277
intermediate O 0 0.08564746379852295
, O 0 0.019292661920189857
4 O 0 0.03280511498451233
cases O 0 0.032193344086408615
; O 0 0.02950647845864296
mild O 1 0.9993119239807129
, O 0 0.029425589367747307
3 O 0 0.04211507365107536
cases O 0 0.03463766351342201
) O 0 0.029877442866563797
. O 0 0.03295477107167244

We O 0 0.026106787845492363
found O 0 0.016423402354121208
two O 0 0.014069491997361183
common O 0 0.026856670156121254
mutations O 0 0.03042455017566681
that O 0 0.010345762595534325
together O 0 0.015743661671876907
accounted O 0 0.026407582685351372
for O 0 0.013992588967084885
32 O 0 0.024416176602244377
% O 0 0.013151424936950207
of O 0 0.014051096513867378
the O 0 0.02136480249464512
44 O 0 0.051266640424728394
unrelated O 0 0.05739942565560341
alleles O 0 0.0705079585313797
in O 0 0.022775495424866676
these O 0 0.02545343153178692
patients O 1 0.9925001263618469
. O 0 0.054300710558891296

One O 0 0.03223128244280815
is O 0 0.01958778128027916
the O 0 0.030473917722702026
T312S O 1 0.9995504021644592
mutation O 0 0.06332209706306458
, O 0 0.020104428753256798
a O 0 0.028832854703068733
novel O 0 0.058996446430683136
mutation O 0 0.050669215619564056
found O 0 0.018692225217819214
exclusively O 0 0.03095519170165062
in O 0 0.030708936974406242
milder O 1 0.9894277453422546
patients O 1 0.9996451139450073
. O 0 0.05852379649877548

The O 0 0.03673229739069939
other O 0 0.014400036074221134
is O 0 0.013501426205039024
the O 0 0.015668097883462906
previously O 0 0.02261330559849739
described O 0 0.037919435650110245
I113F O 1 0.9962777495384216
that O 0 0.017774321138858795
produces O 0 0.04008025676012039
a O 0 0.04990430548787117
severe O 1 0.9999902248382568
phenotype O 1 0.9998170733451843
. O 0 0.06523449718952179

The O 0 0.06783974915742874
I113F O 1 0.9853862524032593
and O 0 0.04383675381541252
T312S O 1 0.998548686504364
mutations O 0 0.05071653798222542
accounted O 0 0.03672267496585846
for O 0 0.019125118851661682
8 O 0 0.034938883036375046
( O 0 0.022307194769382477
18 O 0 0.023034214973449707
% O 0 0.02013113908469677
) O 0 0.01680273376405239
and O 0 0.0147169791162014
6 O 0 0.03157157450914383
( O 0 0.020773863419890404
14 O 0 0.02311132289469242
% O 0 0.016801008954644203
) O 0 0.013663072139024734
of O 0 0.019146237522363663
44 O 0 0.05214162915945053
unrelated O 0 0.07539572566747665
alleles O 0 0.09341089427471161
, O 0 0.034382205456495285
respectively O 0 0.04934250935912132
. O 0 0.045061178505420685

The O 0 0.05051851272583008
relatively O 0 0.04618926718831062
high O 0 0.08218691498041153
residual O 1 0.999001681804657
GALNS O 1 0.9999927282333374
activity O 0 0.042073994874954224
seen O 0 0.024373551830649376
when O 0 0.018887978047132492
the O 0 0.024521421641111374
T312S O 1 0.9562246799468994
mutant O 0 0.12606662511825562
cDNA O 0 0.1108366847038269
is O 0 0.028460483998060226
overexpressed O 0 0.13380736112594604
in O 0 0.028171127662062645
mutant O 1 0.6900556683540344
cells O 0 0.04328024387359619
provides O 0 0.023523977026343346
an O 0 0.013117837719619274
explanation O 0 0.020284125581383705
for O 0 0.01340777799487114
the O 0 0.030745411291718483
mild O 1 0.9999959468841553
phenotype O 1 0.9999549388885498
in O 0 0.03364470973610878
patients O 1 0.9996604919433594
with O 0 0.027412857860326767
this O 0 0.02626587450504303
mutation O 0 0.07138020545244217
. O 0 0.041924718767404556

The O 0 0.04907570406794548
distribution O 0 0.034320276230573654
and O 0 0.018590211868286133
relative O 0 0.031243233010172844
frequencies O 0 0.017360420897603035
of O 0 0.015425268560647964
the O 0 0.02886165678501129
I113F O 1 0.997338593006134
and O 0 0.038116924464702606
T312S O 1 0.999822199344635
mutations O 0 0.03706694021821022
in O 0 0.014250684529542923
Australia O 0 0.02515474334359169
corresponded O 0 0.03533821180462837
to O 0 0.015080776065587997
those O 0 0.011048214510083199
observed O 0 0.015031540766358376
in O 0 0.010419517755508423
Northern O 0 0.023782994598150253
Ireland O 0 0.030620716512203217
and O 0 0.013909068889915943
are O 0 0.006583780981600285
unique O 0 0.011253990232944489
to O 0 0.009272790513932705
these O 0 0.006065812893211842
two O 0 0.008658348582684994
populations O 0 0.018308723345398903
, O 0 0.015383891761302948
suggesting O 0 0.022743593901395798
that O 0 0.009885892271995544
both O 0 0.014423700049519539
mutations O 0 0.024972790852189064
were O 0 0.01090201921761036
probably O 0 0.018295960500836372
introduced O 0 0.0176808163523674
to O 0 0.012683083303272724
Australia O 0 0.020909981802105904
by O 0 0.015450130216777325
Irish O 0 0.04349271580576897
migrants O 0 0.035809487104415894
during O 0 0.023425931110978127
the O 0 0.027332453057169914
19th O 0 0.0599934346973896
century O 0 0.06829806417226791
. O 0 0.047713205218315125

Haplotype O 0 0.24593491852283478
analysis O 0 0.03230328857898712
using O 0 0.020915040746331215
6 O 0 0.048381999135017395
RFLPs O 1 0.9646284580230713
provides O 0 0.02665751613676548
additional O 0 0.012850685976445675
data O 0 0.008049425669014454
that O 0 0.0073133050464093685
the O 0 0.023075532168149948
I113F O 1 0.993770182132721
mutation O 0 0.06326060742139816
originated O 0 0.03501700237393379
from O 0 0.01717643439769745
a O 0 0.028631826862692833
common O 0 0.038548942655324936
ancestor O 0 0.10406879335641861
. O 0 0.047168828547000885

The O 0 0.03734580799937248
other O 0 0.017555290833115578
9 O 0 0.04077083244919777
novel O 0 0.05337994173169136
mutations O 0 0.03656035289168358
identified O 0 0.020542314276099205
in O 0 0.012529755011200905
these O 0 0.010994229465723038
23 O 0 0.040883488953113556
patients O 1 0.9583192467689514
were O 0 0.011759042739868164
each O 0 0.008483164943754673
limited O 0 0.013442374765872955
to O 0 0.012840842828154564
a O 0 0.024576721712946892
single O 0 0.04418338090181351
family O 0 0.04563372954726219
. O 0 0.03912779316306114

These O 0 0.02531631663441658
data O 0 0.017412053421139717
provide O 0 0.01542589906603098
further O 0 0.013744098134338856
evidence O 0 0.01480848528444767
for O 0 0.017390282824635506
extensive O 0 0.04752396419644356
allelic O 1 0.9439814686775208
heterogeneity O 0 0.4554135203361511
in O 0 0.03415362164378166
MPS B-Disease 1 0.9965732097625732
IVA I-Disease 1 0.9999996423721313
in O 0 0.02963077835738659
British O 0 0.1555269956588745
- O 1 0.999997615814209
Irish O 1 0.9808601140975952
patients O 1 0.9997351765632629
and O 0 0.01960364170372486
provide O 0 0.016807489097118378
evidence O 0 0.013296138495206833
for O 0 0.01090629305690527
their O 0 0.013995220884680748
transmission O 0 0.027500594034790993
to O 0 0.012155240401625633
Australia O 0 0.017638301476836205
by O 0 0.01578306406736374
British O 0 0.04376458749175072
- O 1 0.9995577931404114
Irish O 0 0.06588929146528244
migrants O 0 0.049539580941200256
. O 0 0.023148994892835617
. O 0 0.03302191197872162

Identification O 0 0.04957805201411247
of O 0 0.030619371682405472
constitutional O 0 0.15544508397579193
WT1 O 1 0.9999997615814209
mutations O 0 0.05601075291633606
, O 0 0.020163077861070633
in O 0 0.017483416944742203
patients O 1 0.9539467692375183
with O 0 0.03372563049197197
isolated O 1 0.9999954700469971
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.04918218031525612
and O 0 0.02384042739868164
analysis O 0 0.018777385354042053
of O 0 0.03740348294377327
genotype O 1 0.9999903440475464
/ O 1 0.9999933242797852
phenotype O 1 0.6034266352653503
correlations O 0 0.046221304684877396
by O 0 0.014867175370454788
use O 0 0.011340759694576263
of O 0 0.017268506810069084
a O 0 0.03638987988233566
computerized O 1 0.6320689916610718
mutation O 0 0.07727718353271484
database O 0 0.05091530457139015
. O 0 0.03700379654765129

Constitutional O 0 0.07360497862100601
mutations O 0 0.039442699402570724
of O 0 0.025369815528392792
the O 0 0.04212301969528198
WT1 O 1 0.9999992847442627
gene O 0 0.04093502461910248
, O 0 0.016812486574053764
encoding O 0 0.02501184120774269
a O 0 0.03272676840424538
zinc O 1 0.9999637603759766
- O 1 0.9999914169311523
finger O 1 0.997112512588501
transcription O 1 0.5279425382614136
factor O 0 0.03871386498212814
involved O 0 0.018950002267956734
in O 0 0.030225152149796486
renal O 1 1.0
and O 1 0.9983356595039368
gonadal O 1 1.0
development O 1 0.6093595623970032
, O 0 0.017434019595384598
are O 0 0.0056173428893089294
found O 0 0.007387410383671522
in O 0 0.007311951369047165
most O 0 0.010413143783807755
patients O 0 0.052407536655664444
with O 0 0.028964422643184662
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999393224716187
DDS B-Disease 1 1.0
) O 0 0.03247085586190224
, O 0 0.023691236972808838
or O 0 0.03971320018172264
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999972581863403
DMS B-Disease 1 1.0
) O 0 0.028870683163404465
associated O 0 0.019380716606974602
with O 0 0.019235879182815552
pseudohermaphroditism B-Disease 1 0.9999982118606567
and O 0 0.034833718091249466
/ O 1 0.9999972581863403
or O 1 0.9837871193885803
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9992769360542297
WT B-Disease 1 0.9999998807907104
) O 0 0.04533509537577629
. O 0 0.03998276963829994

Most O 0 0.04810889810323715
mutations O 0 0.07446229457855225
in O 0 0.047857772558927536
DDS B-Disease 1 1.0
patients O 1 0.9999693632125854
lie O 0 0.12347311526536942
in O 0 0.027020087465643883
exon O 1 0.5659931898117065
8 O 0 0.038130439817905426
or O 0 0.02166433446109295
exon O 0 0.09445265680551529
9 O 0 0.0380685031414032
, O 0 0.02402225323021412
encoding O 0 0.05376904085278511
zinc O 1 0.9995371103286743
finger O 1 0.8527231216430664
2 O 0 0.056558575481176376
or O 0 0.04111780226230621
zinc O 1 0.9999985694885254
finger O 1 0.9995468258857727
3 O 0 0.036340728402137756
, O 0 0.01576242595911026
respectively O 0 0.016345638781785965
, O 0 0.01072854083031416
with O 0 0.012299205176532269
a O 0 0.028380677103996277
hot O 1 0.9563915729522705
spot O 0 0.07577710598707199
( O 0 0.03470698744058609
R394W O 1 0.9778510928153992
) O 0 0.02400236763060093
in O 0 0.019573304802179337
exon O 0 0.22685086727142334
9 O 0 0.059203118085861206
. O 0 0.03881426155567169

We O 0 0.025448467582464218
analyzed O 0 0.0244536604732275
a O 0 0.015827301889657974
series O 0 0.01760079525411129
of O 0 0.020386744290590286
24 O 0 0.039423029869794846
patients O 1 0.9605088829994202
, O 0 0.017290571704506874
10 O 0 0.017001494765281677
with O 0 0.021473094820976257
isolated B-Disease 1 0.9996377229690552
DMS I-Disease 1 1.0
( O 1 0.7044711709022522
IDMS B-Disease 1 0.9999998807907104
) O 0 0.025970658287405968
, O 0 0.014363711699843407
10 O 0 0.01862950809299946
with O 0 0.026181945577263832
DDS B-Disease 1 1.0
, O 0 0.02266266755759716
and O 0 0.015733616426587105
4 O 0 0.032893918454647064
with O 0 0.03716786205768585
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.9962873458862305
/ O 1 0.9999997615814209
or O 0 0.35843607783317566
WT B-Disease 1 0.9999948740005493
. O 0 0.05846042558550835

We O 0 0.03516428545117378
report O 0 0.048164431005716324
WT1 O 1 0.9999204874038696
heterozygous O 0 0.10913660377264023
mutations O 0 0.04595014080405235
in O 0 0.019462715834379196
16 O 0 0.04288468137383461
patients O 1 0.9836331009864807
, O 0 0.02134949155151844
4 O 0 0.027613410726189613
of O 0 0.022432994097471237
whom O 0 0.039651058614254
presented O 0 0.04422254115343094
with O 0 0.04618128389120102
IDMS B-Disease 1 0.9999991655349731
. O 0 0.07182411849498749

One O 0 0.04406896233558655
male O 0 0.04784586653113365
and O 0 0.018245186656713486
two O 0 0.02030997909605503
female O 1 0.9650446176528931
IDMS B-Disease 1 1.0
patients O 1 0.999988317489624
with O 1 0.8737106919288635
WT1 O 1 1.0
mutations O 1 0.9995203018188477
underwent O 1 0.9999984502792358
normal O 1 0.9914935827255249
puberty O 1 0.9999340772628784
. O 0 0.06800039857625961

Two O 0 0.0396864227950573
mutations O 0 0.0593404583632946
associated O 0 0.03450460731983185
with O 0 0.03384341672062874
IDMS B-Disease 1 0.9999995231628418
are O 0 0.010622140020132065
different O 0 0.005627598147839308
from O 0 0.009716043248772621
those O 0 0.011319920420646667
described O 0 0.037641916424036026
in O 0 0.042816195636987686
DDS B-Disease 1 1.0
patients O 1 0.9999843835830688
. O 0 0.06549758464097977

No O 0 0.09616517275571823
WT1 O 1 0.9999908208847046
mutations O 0 0.06138726696372032
were O 0 0.01694297417998314
detected O 0 0.0284211914986372
in O 0 0.010163022205233574
the O 0 0.016198350116610527
six O 0 0.02536347135901451
other O 0 0.03041938878595829
IDMS B-Disease 1 1.0
patients O 1 0.9999350309371948
, O 0 0.03104296512901783
suggesting O 0 0.04119749367237091
genetic O 0 0.03809315711259842
heterogeneity O 0 0.469447523355484
of O 0 0.03715308755636215
this O 0 0.03942398726940155
disease O 1 0.9999986886978149
. O 0 0.06315555423498154

We O 0 0.042730215936899185
analyzed O 0 0.0864841639995575
genotype O 1 0.9987303614616394
/ O 1 0.9998972415924072
phenotype O 1 0.7482191324234009
correlations O 0 0.07480346411466599
, O 0 0.019237006083130836
on O 0 0.012506690807640553
the O 0 0.011754799634218216
basis O 0 0.008967248722910881
of O 0 0.010871903039515018
the O 0 0.014126868918538094
constitution O 0 0.023480363190174103
of O 0 0.021571917459368706
a O 0 0.04527811333537102
WT1 O 1 0.9999821186065674
mutation O 0 0.0524696446955204
database O 0 0.02376542054116726
of O 0 0.02187742106616497
84 O 1 0.6314630508422852
germ O 1 0.9999997615814209
- O 1 0.9999985694885254
line O 0 0.059902165085077286
mutations O 0 0.0299092847853899
, O 0 0.012196442112326622
to O 0 0.011735593900084496
compare O 0 0.020644329488277435
the O 0 0.015606792643666267
distribution O 0 0.019378211349248886
and O 0 0.01600128598511219
type O 0 0.03634899854660034
of O 0 0.026318499818444252
mutations O 0 0.03387965261936188
, O 0 0.014427347108721733
according O 0 0.012001503258943558
to O 0 0.014668029733002186
the O 0 0.022606277838349342
different O 0 0.020386332646012306
symptoms O 1 0.9997774958610535
. O 0 0.05244525521993637

This O 0 0.031216083094477654
demonstrated O 0 0.04879155382514
( O 0 0.028914127498865128
1 O 0 0.033363908529281616
) O 0 0.01633268967270851
the O 0 0.016523294150829315
association O 0 0.026426929980516434
between O 0 0.022318188101053238
mutations O 0 0.02673458866775036
in O 0 0.015817152336239815
exons O 0 0.057816050946712494
8 O 0 0.028291864320635796
and O 0 0.014470766298472881
9 O 0 0.03561701253056526
and O 0 0.030460651963949203
DMS B-Disease 1 1.0
; O 0 0.028321946039795876
( O 0 0.023566212505102158
2 O 0 0.029980555176734924
) O 0 0.018071908503770828
among O 0 0.025837667286396027
patients O 1 0.9903625845909119
with O 0 0.04543488845229149
DMS B-Disease 1 1.0
, O 0 0.022725392132997513
a O 0 0.019486762583255768
higher O 0 0.017274342477321625
frequency O 0 0.016861900687217712
of O 0 0.01964706741273403
exon O 0 0.10139776766300201
8 O 0 0.03754529729485512
mutations O 0 0.029360013082623482
among O 0 0.019848454743623734
46 O 0 0.04735605791211128
, O 0 0.039750080555677414
XY O 1 0.9999995231628418
patients O 1 0.998988687992096
with O 0 0.02966754324734211
female O 1 0.5711850523948669
phenotype O 0 0.1454540193080902
than O 0 0.01342359371483326
among O 0 0.023359747603535652
46 O 0 0.048481687903404236
, O 0 0.038782939314842224
XY O 1 0.9999990463256836
patients O 1 0.9820839762687683
with O 0 0.026956832036376
sexual O 0 0.26229092478752136
ambiguity O 1 0.9440237283706665
or O 0 0.03614044934511185
male O 1 0.9989520311355591
phenotype O 1 0.9997594952583313
; O 0 0.025990424677729607
and O 0 0.020798370242118835
( O 0 0.024790436029434204
3 O 0 0.027770256623625755
) O 0 0.01487614493817091
statistically O 0 0.01638135313987732
significant O 0 0.011358034797012806
evidence O 0 0.012636134400963783
that O 0 0.010412272997200489
mutations O 0 0.022626765072345734
in O 0 0.015394587069749832
exons O 0 0.05853331834077835
8 O 0 0.030248751863837242
and O 0 0.01967264711856842
9 O 0 0.04288681596517563
preferentially O 0 0.08849037438631058
affect O 0 0.042496439069509506
amino O 0 0.04157304763793945
acids O 0 0.026668790727853775
with O 0 0.013318716548383236
different O 0 0.010204467922449112
functions O 0 0.02266591228544712
. O 0 0.02091781422495842
. O 0 0.031043345108628273

The O 0 0.08777227997779846
185delAG O 1 0.9999136924743652
BRCA1 O 1 0.9999035596847534
mutation O 0 0.0905364379286766
originated O 0 0.042906925082206726
before O 0 0.020402872934937477
the O 0 0.02352386713027954
dispersion O 0 0.05750033259391785
of O 0 0.01895405538380146
Jews O 0 0.03293190523982048
in O 0 0.014133372344076633
the O 0 0.020792698487639427
diaspora O 0 0.053364966064691544
and O 0 0.01951819285750389
is O 0 0.01602771133184433
not O 0 0.011834419332444668
limited O 0 0.02382531203329563
to O 0 0.032127879559993744
Ashkenazim O 1 0.9834875464439392
. O 0 0.05365094169974327

The O 0 0.06458287686109543
185delAG O 1 0.9984245300292969
mutation O 0 0.0874820202589035
in O 0 0.03228649124503136
BRCA1 O 1 0.9996556043624878
is O 0 0.024738505482673645
detected O 0 0.03198252618312836
in O 0 0.01401869859546423
Ashkenazi O 0 0.07621768862009048
Jews O 0 0.029250042513012886
both O 0 0.012795452028512955
in O 0 0.02464297227561474
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.7136580944061279
in O 0 0.019434809684753418
the O 0 0.021256262436509132
general O 0 0.03517713397741318
population O 0 0.024503571912646294
. O 0 0.03228295221924782

All O 0 0.043907541781663895
tested O 0 0.09119779616594315
Ashkenazi O 1 0.995925784111023
mutation O 0 0.09296102076768875
carriers O 0 0.052949339151382446
share O 0 0.02056412398815155
the O 0 0.01642615906894207
same O 0 0.018426360562443733
allelic O 0 0.2755879759788513
pattern O 0 0.04012620076537132
at O 0 0.03014056570827961
the O 0 0.04430641233921051
BRCA1 O 1 0.9999856948852539
locus O 1 0.9909335374832153
. O 0 0.05063782259821892

Our O 0 0.044578298926353455
previous O 0 0.030915601179003716
study O 0 0.022099638357758522
showed O 0 0.01934099569916725
that O 0 0.0090850330889225
this O 0 0.014513138681650162
Ashkenazi O 1 0.9975048899650574
mutation O 0 0.06615327298641205
also O 0 0.020400023087859154
occurs O 0 0.019871290773153305
in O 0 0.012290594168007374
Iraqi O 0 0.03091585449874401
Jews O 0 0.03268444538116455
with O 0 0.01595655269920826
a O 0 0.02629978023469448
similar O 0 0.028651554137468338
allelic O 1 0.8903561234474182
pattern O 0 0.0864655151963234
. O 0 0.04907328262925148

We O 0 0.032921794801950455
extended O 0 0.0380571223795414
our O 0 0.021771056577563286
analysis O 0 0.01203019730746746
to O 0 0.01044632401317358
other O 0 0.009382147341966629
non O 0 0.06099431961774826
- O 1 0.9997887015342712
Ashkenazi O 1 0.9378018975257874
subsets O 0 0.1068035140633583
354 O 0 0.09406734257936478
of O 0 0.029566235840320587
Moroccan O 0 0.08719111233949661
origin O 0 0.02146313339471817
, O 0 0.01998600922524929
200 O 0 0.03880006819963455
Yemenites O 1 0.7876800298690796
and O 0 0.02748313546180725
150 O 0 0.03915835916996002
Iranian O 0 0.04629383608698845
Jews O 0 0.06531132757663727
. O 0 0.04020024463534355

Heteroduplex O 1 0.9632601737976074
analysis O 0 0.03781942278146744
complemented O 0 0.06099996715784073
by O 0 0.01865645870566368
direct O 0 0.02951187826693058
DNA O 0 0.035689715296030045
sequencing O 0 0.038263287395238876
of O 0 0.037344228476285934
abnormally O 1 0.9935258626937866
migrating O 0 0.08092119544744492
bands O 0 0.05515040457248688
were O 0 0.019756030291318893
employed O 0 0.04985336586833
. O 0 0.04091938957571983

Four O 0 0.025326648727059364
of O 0 0.027031660079956055
Moroccan O 0 0.09398142993450165
origin O 0 0.021354790776968002
( O 0 0.020581912249326706
1 O 0 0.02720538154244423
. O 0 0.014006280340254307
1 O 0 0.028856562450528145
% O 0 0.018796224147081375
) O 0 0.013720635324716568
and O 0 0.009627030231058598
none O 0 0.013460713438689709
of O 0 0.01583106629550457
the O 0 0.030971163883805275
Yemenites O 1 0.9998817443847656
or O 0 0.024338115006685257
Iranians O 0 0.033052362501621246
was O 0 0.02189004421234131
a O 0 0.02211972512304783
carrier O 0 0.059500399976968765
of O 0 0.022521372884511948
the O 0 0.0414046049118042
185delAG O 1 0.9996671676635742
mutation O 0 0.10003317892551422
. O 0 0.047099657356739044

BRCA1 O 1 0.9999219179153442
allelic O 1 0.9881595373153687
patterns O 0 0.037534549832344055
were O 0 0.012689856812357903
determined O 0 0.02019527554512024
for O 0 0.011515224352478981
four O 0 0.011113221757113934
of O 0 0.014735153876245022
these O 0 0.009038545191287994
individuals O 0 0.01162148080766201
and O 0 0.011282030493021011
for O 0 0.011876997537910938
12 O 0 0.018316438421607018
additional O 0 0.01587820239365101
non O 0 0.06056534871459007
- O 1 0.9999113082885742
Ashkenazi O 1 0.9986853003501892
185delAG O 1 0.9991940855979919
mutation O 0 0.055981457233428955
carriers O 0 0.040262412279844284
who O 0 0.02855454571545124
had O 0 0.40567171573638916
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9886647462844849

Six O 0 0.05365678295493126
non O 1 0.5686085224151611
- O 1 0.999963641166687
Ashkenazi O 1 0.9129632115364075
individuals O 0 0.022919490933418274
shared O 0 0.02922283113002777
the O 0 0.024564150720834732
common O 0 0.04033871740102768
Ashkenazi O 1 0.9999111890792847
haplotype O 1 0.9981885552406311
, O 0 0.017756212502717972
four O 0 0.01180686429142952
had O 0 0.015417782589793205
a O 0 0.019129076972603798
closely O 0 0.02294251322746277
related O 0 0.024062354117631912
pattern O 0 0.03231976181268692
, O 0 0.014450772665441036
and O 0 0.011612889356911182
the O 0 0.01997845619916916
rest O 0 0.039278071373701096
( O 0 0.03461796045303345
n O 0 0.09418259561061859
= O 0 0.06507973372936249
6 O 0 0.034533482044935226
) O 0 0.01680653914809227
displayed O 0 0.023684436455368996
a O 0 0.02721528522670269
distinct O 0 0.050462257117033005
BRCA1 O 1 0.9997949004173279
allelic O 1 0.9993453621864319
pattern O 0 0.14617687463760376
. O 0 0.05667273327708244

We O 0 0.027607763186097145
conclude O 0 0.03836267441511154
that O 0 0.011472398415207863
the O 0 0.029708530753850937
185delAG O 1 0.9999878406524658
BRCA1 O 1 0.9999924898147583
mutation O 0 0.07596833258867264
occurs O 0 0.020917514339089394
in O 0 0.009906076826155186
some O 0 0.010154865682125092
non O 0 0.09870103746652603
- O 1 0.9999836683273315
Ashkenazi O 1 0.9933699369430542
populations O 0 0.02789885364472866
at O 0 0.021680912002921104
rates O 0 0.0235940869897604
comparable O 0 0.02527199685573578
with O 0 0.012798046693205833
that O 0 0.01261111255735159
of O 0 0.033063676208257675
Ashkenazim O 1 0.9996238946914673
. O 0 0.054950471967458725

The O 0 0.032739538699388504
majority O 0 0.028475292026996613
of O 0 0.029942505061626434
Jewish O 0 0.11346748471260071
185delAG O 1 0.9999827146530151
mutation O 0 0.1332414150238037
carriers O 0 0.04654301702976227
have O 0 0.009750043973326683
a O 0 0.021508948877453804
common O 0 0.03168138116598129
allelic O 1 0.9957295060157776
pattern O 0 0.04942738264799118
, O 0 0.01912395842373371
supporting O 0 0.02909773401916027
the O 0 0.02513892389833927
founder O 1 0.9962785840034485
effect O 0 0.030093932524323463
notion O 0 0.03608480468392372
, O 0 0.016679322347044945
but O 0 0.011761614121496677
dating O 0 0.027585169300436974
the O 0 0.019693804904818535
mutations O 0 0.023032013326883316
origin O 0 0.010195234790444374
to O 0 0.010635478422045708
an O 0 0.01079899724572897
earlier O 0 0.016876358538866043
date O 0 0.01763193868100643
than O 0 0.009585556574165821
currently O 0 0.01985197700560093
estimated O 0 0.030090855434536934
. O 0 0.03329724073410034

However O 0 0.028504222631454468
, O 0 0.01702284999191761
the O 0 0.01597689464688301
different O 0 0.009153715334832668
allelic O 0 0.10048998892307281
pattern O 0 0.03583097830414772
at O 0 0.024814287200570107
the O 0 0.0342838279902935
BRCA1 O 1 0.9999821186065674
locus O 0 0.36138221621513367
even O 0 0.014726703986525536
in O 0 0.010154789313673973
some O 0 0.010514907538890839
Jewish O 0 0.055330559611320496
mutation O 0 0.07224714010953903
carriers O 0 0.05529063567519188
, O 0 0.01856648549437523
might O 0 0.015612559393048286
suggest O 0 0.01368282176554203
that O 0 0.009087981656193733
the O 0 0.023669211193919182
mutation O 0 0.05477350577712059
arose O 0 0.047343648970127106
independently O 0 0.030623523518443108
. O 0 0.023151375353336334
. O 0 0.03174911439418793

Crystal O 0 0.13291119039058685
structure O 0 0.04553196206688881
of O 0 0.03383224830031395
the O 0 0.07513310760259628
hemochromatosis B-Disease 1 1.0
protein O 1 0.9601927995681763
HFE O 1 0.9999866485595703
and O 0 0.030833475291728973
characterization O 0 0.050277624279260635
of O 0 0.01941770501434803
its O 0 0.023528600111603737
interaction O 0 0.036205317825078964
with O 0 0.0348220057785511
transferrin O 1 0.9999951124191284
receptor O 1 0.7723448872566223
. O 0 0.050875771790742874

HFE O 1 0.9998657703399658
is O 0 0.03397529944777489
an O 0 0.03723309189081192
MHC O 1 0.9999998807907104
- O 1 0.9999994039535522
related O 0 0.02945558913052082
protein O 0 0.021012770012021065
that O 0 0.006830304861068726
is O 0 0.010287950746715069
mutated O 0 0.029438480734825134
in O 0 0.010223133489489555
the O 0 0.025435179471969604
iron B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999728202819824

HFE O 1 0.9995421171188354
binds O 0 0.18112893402576447
to O 0 0.06082708016037941
transferrin O 1 0.9999954700469971
receptor O 1 0.9985747337341309
( O 0 0.058935679495334625
TfR O 1 0.9999585151672363
) O 0 0.026029912754893303
and O 0 0.01853676326572895
reduces O 0 0.04430951178073883
its O 0 0.017918149009346962
affinity O 0 0.04121796041727066
for O 0 0.022626588121056557
iron O 1 0.9998824596405029
- O 1 0.9999862909317017
loaded O 0 0.07745081186294556
transferrin O 1 0.9990190267562866
, O 0 0.03898569568991661
implicating O 1 0.9999203681945801
HFE O 1 0.9999990463256836
in O 0 0.06455504894256592
iron O 1 0.9999985694885254
metabolism O 1 0.999681830406189
. O 0 0.05831838771700859

The O 0 0.07093586772680283
2 O 0 0.07902202755212784
. O 0 0.052826691418886185

6 O 0 0.06649541109800339
A O 0 0.061438627541065216
crystal O 0 0.14412182569503784
structure O 0 0.044921163469552994
of O 0 0.039967913180589676
HFE O 1 0.9999947547912598
reveals O 0 0.06212417781352997
the O 0 0.02068357542157173
locations O 0 0.021574126556515694
of O 0 0.04139862582087517
hemochromatosis B-Disease 1 1.0
mutations O 0 0.14743229746818542
and O 0 0.023751817643642426
a O 0 0.039101336151361465
patch O 1 0.9999628067016602
of O 0 0.03202147036790848
histidines O 1 0.9995298385620117
that O 0 0.01123754307627678
could O 0 0.008560591377317905
be O 0 0.006854909472167492
involved O 0 0.012996478006243706
in O 0 0.024483446031808853
pH O 1 0.9999991655349731
- O 1 0.9999991655349731
dependent O 0 0.07965343445539474
interactions O 0 0.05175513029098511
. O 0 0.03644131124019623

We O 0 0.028617581352591515
also O 0 0.020531795918941498
demonstrate O 0 0.03702562674880028
that O 0 0.023073533549904823
soluble O 1 0.9981918931007385
TfR O 1 0.9999849796295166
and O 0 0.0531838983297348
HFE O 1 0.999997615814209
bind O 0 0.17746874690055847
tightly O 0 0.06220988929271698
at O 0 0.023044442757964134
the O 0 0.02206394076347351
basic O 0 0.03990873694419861
pH O 1 0.9535238742828369
of O 0 0.022359374910593033
the O 0 0.03231451287865639
cell O 1 0.7177015542984009
surface O 0 0.02945394068956375
, O 0 0.013639380224049091
but O 0 0.007923707365989685
not O 0 0.0076937247067689896
at O 0 0.017801929265260696
the O 0 0.033324211835861206
acidic O 1 0.9996477365493774
pH O 1 0.9999048709869385
of O 0 0.07257120311260223
intracellular O 1 0.9999926090240479
vesicles O 1 0.9993122816085815
. O 0 0.05451381951570511

TfR O 1 0.9999685287475586
HFE O 1 0.9999961853027344
stoichiometry O 1 0.9992403984069824
( O 0 0.050072357058525085
2 O 0 0.047869160771369934
1 O 0 0.04385020583868027
) O 0 0.02130218967795372
differs O 0 0.029441846534609795
from O 0 0.03215048462152481
TfR O 1 0.9999405145645142
transferrin O 1 0.9999749660491943
stoichiometry O 1 0.9964457154273987
( O 0 0.040522269904613495
2 O 0 0.04377160966396332
2 O 0 0.037135157734155655
) O 0 0.020020756870508194
, O 0 0.015241017565131187
implying O 0 0.03265365958213806
a O 0 0.015356095507740974
different O 0 0.006315654143691063
mode O 0 0.02807028964161873
of O 0 0.017971180379390717
binding O 0 0.0350470207631588
for O 0 0.03234928846359253
HFE O 1 0.9999929666519165
and O 0 0.04432763531804085
transferrin O 1 0.9996930360794067
to O 0 0.043395716696977615
TfR O 1 0.9999885559082031
, O 0 0.023677973076701164
consistent O 0 0.025496577844023705
with O 0 0.013604764826595783
our O 0 0.021090805530548096
demonstration O 0 0.0466918982565403
that O 0 0.01874246634542942
HFE O 1 0.9999901056289673
, O 0 0.039383262395858765
transferrin O 1 0.9999208450317383
, O 0 0.029541652649641037
and O 0 0.02697453461587429
TfR O 1 0.9999454021453857
form O 0 0.03753158822655678
a O 0 0.04829248785972595
ternary O 1 0.9967718720436096
complex O 0 0.06681714206933975
. O 0 0.04481378570199013

Identification O 0 0.04758225008845329
of O 0 0.023106204345822334
three O 0 0.02056949771940708
novel O 0 0.05549074336886406
mutations O 0 0.032912395894527435
and O 0 0.01483592763543129
a O 0 0.021203016862273216
high O 0 0.029507974162697792
frequency O 0 0.018442749977111816
of O 0 0.013721242547035217
the O 0 0.02563096210360527
Arg778Leu O 1 0.9999792575836182
mutation O 0 0.04680194705724716
in O 0 0.018931502476334572
Korean O 1 0.9917479753494263
patients O 1 0.9994946718215942
with O 0 0.06544408947229385
Wilson B-Disease 1 0.9999980926513672
disease I-Disease 1 0.9999998807907104
. O 0 0.07693885266780853

Four O 0 0.04281756281852722
mutations O 0 0.08657201379537582
- O 1 0.9999784231185913
- O 1 0.9999707937240601
R778L O 1 0.9989103078842163
, O 0 0.03524459898471832
A874V O 1 0.9931238293647766
, O 0 0.027802208438515663
L1083F O 1 0.949670135974884
, O 0 0.019619276747107506
and O 0 0.01961577869951725
2304delC O 1 0.9999775886535645
- O 1 0.999997615814209
- O 1 0.9959127306938171
in O 0 0.01036099623888731
the O 0 0.017318693920969963
copper O 0 0.17812004685401917
- O 1 0.9975507855415344
transporting O 0 0.05381163954734802
enzyme O 0 0.04679078981280327
, O 0 0.023051496595144272
P O 1 0.9999537467956543
- O 1 0.9999990463256836
type O 1 0.9952672719955444
ATPase O 1 0.999991774559021
( O 0 0.0475800596177578
ATP7B O 1 0.9999868869781494
) O 0 0.019934624433517456
, O 0 0.010702407918870449
were O 0 0.007868616841733456
identified O 0 0.01649031788110733
in O 0 0.015367881394922733
Korean O 1 0.8805642127990723
Patients O 1 0.9999336004257202
with O 0 0.06658907234668732
Wilson B-Disease 1 0.9999970197677612
disease I-Disease 1 0.9999997615814209
. O 0 0.06664974987506866

Arg778Leu O 1 0.9953638315200806
, O 0 0.03164992853999138
the O 0 0.02223241701722145
most O 0 0.01530532632023096
frequently O 0 0.01835055463016033
reported O 0 0.022919045761227608
mutation O 0 0.034100815653800964
of O 0 0.01895524375140667
this O 0 0.018130464479327202
enzyme O 0 0.05281767621636391
, O 0 0.016296667978167534
was O 0 0.01963767595589161
found O 0 0.009051508270204067
in O 0 0.007350508589297533
six O 0 0.01084819808602333
of O 0 0.016524551436305046
eight O 0 0.029575547203421593
unrelated O 0 0.0821281224489212
patients O 1 0.9979179501533508
studied O 0 0.03419661521911621
, O 0 0.021201210096478462
an O 0 0.02519875578582287
allele O 0 0.07271108031272888
frequency O 0 0.026593416929244995
of O 0 0.024064576253294945
37 O 0 0.05872044339776039
. O 0 0.04154101386666298

5 O 0 0.05983542650938034
% O 0 0.0313018336892128
, O 0 0.01970773935317993
which O 0 0.013637976720929146
is O 0 0.01457207091152668
considerably O 0 0.020962268114089966
higher O 0 0.014988550916314125
than O 0 0.008796129375696182
those O 0 0.009642308577895164
in O 0 0.013002834282815456
other O 0 0.014667210169136524
Asian O 0 0.04799562692642212
populations O 0 0.04230678081512451
. O 0 0.03984145447611809

The O 0 0.04303375631570816
novel O 0 0.06402803212404251
single O 0 0.05176382511854172
nucleotide O 0 0.07314768433570862
deletion O 0 0.08192174881696701
, O 0 0.03181909769773483
2304delC O 1 0.9991649389266968
, O 0 0.021082764491438866
was O 0 0.022911114618182182
found O 0 0.012780589051544666
in O 0 0.014284431003034115
one O 0 0.029825108125805855
patient O 1 0.9979378581047058
. O 0 0.048017702996730804

Since O 0 0.03917815908789635
a O 0 0.0371323861181736
mutation O 0 0.0581466369330883
at O 0 0.03465317562222481
cDNA O 0 0.13879097998142242
nucleotide O 0 0.11997484415769577
2302 O 1 0.9999610185623169
( O 0 0.04766993224620819
2302insC O 1 0.9988767504692078
) O 0 0.01932024583220482
had O 0 0.013214255683124065
been O 0 0.010222622193396091
previously O 0 0.018103092908859253
described O 0 0.020702194422483444
, O 0 0.01100934948772192
this O 0 0.007083236705511808
region O 0 0.015284378081560135
of O 0 0.016329187899827957
the O 0 0.033657338470220566
ATP7B O 1 0.9999995231628418
gene O 0 0.05258701741695404
may O 0 0.022419441491365433
be O 0 0.015004751272499561
susceptible O 0 0.0658043920993805
to O 0 0.02944999188184738
gene O 0 0.0638502687215805
rearrangements O 1 0.9991111159324646
causing O 1 0.9997496008872986
Wilson B-Disease 1 0.999994158744812
disease I-Disease 1 0.9999997615814209
. O 0 0.08003287762403488

Disruption O 0 0.13502652943134308
of O 0 0.03910968080163002
splicing O 0 0.05633232370018959
regulated O 0 0.027183854952454567
by O 0 0.013546439819037914
a O 0 0.029542293399572372
CUG O 1 0.9999949932098389
- O 1 0.9999953508377075
binding O 0 0.06167355552315712
protein O 0 0.04964710772037506
in O 0 0.047925904393196106
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.10919324308633804

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999986886978149
DM B-Disease 1 1.0
) O 0 0.04530596360564232
is O 0 0.0202559195458889
caused O 0 0.027795609086751938
by O 0 0.015898391604423523
a O 0 0.03330786153674126
CTG O 1 0.9999512434005737
expansion O 0 0.03696634992957115
in O 0 0.013254877179861069
the O 0 0.01923360675573349
3 O 0 0.03342461585998535
untranslated O 0 0.17164397239685059
region O 0 0.02819983661174774
of O 0 0.026985475793480873
the O 0 0.06282275170087814
DM B-Disease 1 1.0
gene O 0 0.09080609679222107
. O 0 0.04896203801035881

One O 0 0.038005530834198
model O 0 0.04761150851845741
of O 0 0.0672844648361206
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
suggests O 0 0.05432756245136261
that O 0 0.020230494439601898
RNAs O 0 0.06870537996292114
from O 0 0.010589072480797768
the O 0 0.014196522533893585
expanded O 0 0.025969186797738075
allele O 0 0.04491003230214119
create O 0 0.015851518139243126
a O 0 0.01651572436094284
gain O 0 0.030244456604123116
- O 1 0.9977160692214966
of O 0 0.02948787994682789
- O 1 0.9999889135360718
function O 0 0.029425378888845444
mutation O 0 0.027076436206698418
by O 0 0.011617384850978851
the O 0 0.018631959334015846
inappropriate O 0 0.0442008338868618
binding O 0 0.025863327085971832
of O 0 0.019440455362200737
proteins O 0 0.02273881807923317
to O 0 0.01643461175262928
the O 0 0.03516184538602829
CUG O 1 0.9999675750732422
repeats O 0 0.10367415845394135
. O 0 0.043180909007787704

Data O 0 0.0317874513566494
presented O 0 0.02977072261273861
here O 0 0.016544818878173828
indicate O 0 0.014085078611969948
that O 0 0.006823314819484949
the O 0 0.01656370609998703
conserved O 0 0.041915230453014374
heterogeneous O 0 0.08238964527845383
nuclear O 0 0.06652102619409561
ribonucleoprotein O 1 0.9993171691894531
, O 0 0.03587109595537186
CUG O 1 0.9999871253967285
- O 1 0.9999805688858032
binding O 0 0.04977274686098099
protein O 0 0.0381191186606884
( O 0 0.030203383415937424
CUG O 1 0.9999901056289673
- O 1 0.9999967813491821
BP O 1 0.7013947367668152
) O 0 0.020067662000656128
, O 0 0.014725195243954659
may O 0 0.014069579541683197
mediate O 0 0.05375659465789795
the O 0 0.029375936836004257
trans O 1 0.9971197843551636
- O 1 0.9996181726455688
dominant O 0 0.0562397837638855
effect O 0 0.022624855861067772
of O 0 0.01805584691464901
the O 0 0.033135946840047836
RNA O 0 0.08439046144485474
. O 0 0.03471183776855469

CUG O 1 0.9999898672103882
- O 1 0.9999817609786987
BP O 0 0.2074146419763565
was O 0 0.029215455055236816
found O 0 0.012687268666923046
to O 0 0.012820430099964142
bind O 0 0.02946331351995468
to O 0 0.012279491871595383
the O 0 0.02157236821949482
human O 1 0.6458673477172852
cardiac O 1 1.0
troponin O 1 1.0
T O 1 0.9999998807907104
( O 0 0.050331030040979385
cTNT O 1 0.9949684739112854
) O 0 0.027277842164039612
pre O 1 0.7700204849243164
- O 1 0.9999878406524658
messenger O 1 0.6730203628540039
RNA O 0 0.05366198346018791
and O 0 0.01547846570611
regulate O 0 0.03397485986351967
its O 0 0.023562613874673843
alternative O 0 0.05280540511012077
splicing O 0 0.07992808520793915
. O 0 0.03460220620036125

Splicing O 0 0.10074952989816666
of O 0 0.04145081713795662
cTNT O 1 0.9426714777946472
was O 0 0.04692508652806282
disrupted O 0 0.10689222812652588
in O 0 0.06342477351427078
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999957084655762
and O 0 0.029891738668084145
in O 0 0.0240640752017498
normal O 0 0.04679718241095543
cells O 0 0.0429123193025589
expressing O 0 0.05290982872247696
transcripts O 0 0.05045720934867859
that O 0 0.017460791394114494
contain O 0 0.04675495624542236
CUG O 1 0.9998705387115479
repeats O 0 0.10688971728086472
. O 0 0.04855729639530182

Altered O 0 0.0721803680062294
expression O 0 0.0373738631606102
of O 0 0.02459409087896347
genes O 0 0.02742302417755127
regulated O 0 0.040551748126745224
posttranscriptionally O 1 0.8596703410148621
by O 0 0.03688056394457817
CUG O 1 0.9999995231628418
- O 1 0.9999982118606567
BP O 1 0.5364590287208557
therefore O 0 0.024747520685195923
may O 0 0.021336141973733902
contribute O 0 0.0364106111228466
to O 0 0.05422857403755188
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
. O 0 0.04611547663807869
. O 0 0.043798815459012985

Identification O 0 0.0496828630566597
of O 0 0.023778444156050682
a O 0 0.03253459185361862
novel O 0 0.06311030685901642
nonsense O 1 0.9503976702690125
mutation O 0 0.0494033619761467
and O 0 0.017016004770994186
a O 0 0.02545784041285515
missense O 0 0.09211894869804382
substitution O 0 0.04085727408528328
in O 0 0.013174700550734997
the O 0 0.024400487542152405
vasopressin O 1 0.999903678894043
- O 1 0.9999977350234985
neurophysin O 1 0.9999867677688599
II O 1 0.9999991655349731
gene O 0 0.03237561136484146
in O 0 0.010264328680932522
two O 0 0.01070157065987587
Spanish O 0 0.03815842047333717
kindreds O 1 0.5301280617713928
with O 0 0.049450624734163284
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.3689557611942291

Familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9998542070388794
FNDI B-Disease 1 1.0
) O 0 0.027016067877411842
is O 0 0.015277747996151447
an O 0 0.021677609533071518
autosomal B-Disease 1 0.999998927116394
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
caused O 1 0.9999992847442627
by O 1 0.9997078776359558
deficiency O 1 1.0
in O 0 0.036255843937397
the O 1 0.958615243434906
antidiuretic O 1 1.0
hormone O 1 0.9999995231628418
arginine O 1 0.9999896287918091
vasopressin O 1 0.9999805688858032
( O 0 0.06015074998140335
AVP O 1 0.9999990463256836
) O 0 0.020062033087015152
encoded O 0 0.012844808399677277
by O 0 0.009835380129516125
the O 0 0.022955359891057014
AVP O 1 0.9999984502792358
- O 1 0.9999946355819702
neurophysin O 1 0.9999752044677734
II O 1 0.9999997615814209
( O 0 0.08499357849359512
AVP O 1 0.9999998807907104
- O 1 0.9999991655349731
NPII O 1 0.9999961853027344
) O 0 0.03562286123633385
gene O 0 0.03673568740487099
on O 0 0.03251189365983009
chromosome O 0 0.09822192043066025
20p13 O 1 0.9449639916419983
. O 0 0.05516105145215988

In O 0 0.03171870857477188
this O 0 0.017724115401506424
study O 0 0.022512929514050484
, O 0 0.017069227993488312
we O 0 0.010910234414041042
analyzed O 0 0.01720760017633438
two O 0 0.008421172387897968
families O 0 0.0206274576485157
with O 0 0.02493683248758316
FNDI B-Disease 1 0.9999916553497314
using O 0 0.021520087495446205
direct O 0 0.030134448781609535
automated O 0 0.06914127618074417
fluorescent O 0 0.08883360773324966
, O 0 0.020711202174425125
solid O 0 0.04211173579096794
phase O 0 0.053152114152908325
, O 0 0.02119303122162819
single O 0 0.041842300444841385
- O 1 0.964346706867218
stranded O 0 0.0803656056523323
DNA O 0 0.029829345643520355
sequencing O 0 0.026997441425919533
of O 0 0.025130419060587883
PCR O 1 0.5028303861618042
- O 1 0.9997337460517883
amplified O 1 0.9395779371261597
AVP O 1 0.9999990463256836
- O 1 0.9999810457229614
NPII O 1 0.9997650980949402
DNA O 0 0.07425260543823242
. O 0 0.04164191707968712

In O 0 0.020614080131053925
one O 0 0.014196114614605904
of O 0 0.014628172852098942
the O 0 0.01987287774682045
families O 0 0.025868769735097885
, O 0 0.020884400233626366
affected O 0 0.02515293098986149
individuals O 0 0.013056447729468346
presented O 0 0.02393634058535099
a O 0 0.024863533675670624
novel O 0 0.05149426311254501
nonsense O 0 0.4046221673488617
mutation O 0 0.04530792310833931
in O 0 0.016626402735710144
exon O 0 0.07979264855384827
3 O 0 0.022261373698711395
of O 0 0.015250726602971554
the O 0 0.021994618698954582
gene O 0 0.02416425384581089
, O 0 0.013374212197959423
consisting O 0 0.0197855643928051
in O 0 0.01194065809249878
a O 0 0.02748453989624977
G O 1 0.8822104930877686
to O 0 0.031093670055270195
T O 1 0.998400866985321
transition O 0 0.056174471974372864
at O 0 0.03736449405550957
nucleotide O 0 0.0810459554195404
2101 O 1 0.9974085688591003
, O 0 0.0219182837754488
which O 0 0.013227451592683792
produces O 0 0.022188415750861168
a O 0 0.021260639652609825
stop O 0 0.038818471133708954
signal O 0 0.03661758825182915
in O 0 0.01801600679755211
codon O 0 0.08680147677659988
82 O 0 0.09147375822067261
( O 0 0.056231435388326645
Glu O 1 0.9999951124191284
) O 0 0.038726288825273514
of O 0 0.0422307588160038
NPII O 1 0.9997760653495789
. O 0 0.06002438813447952

The O 0 0.07388701289892197
premature O 1 0.9976187348365784
termination O 1 0.9908714890480042
eliminates O 0 0.11674869060516357
part O 0 0.028586097061634064
of O 0 0.020218292251229286
the O 0 0.033399973064661026
C O 1 0.9999221563339233
- O 1 0.9999949932098389
terminal O 1 0.8221691250801086
domain O 0 0.04090090095996857
of O 0 0.027954302728176117
NPII O 1 0.9998308420181274
, O 0 0.018074123188853264
including O 0 0.012911122292280197
a O 0 0.027434328570961952
cysteine O 0 0.0858047753572464
residue O 0 0.06566403061151505
in O 0 0.014655410312116146
position O 0 0.027522649616003036
85 O 0 0.039445195347070694
, O 0 0.015496991574764252
which O 0 0.009791417978703976
could O 0 0.009093948639929295
be O 0 0.0068032508715987206
involved O 0 0.010597886517643929
in O 0 0.009206830523908138
the O 0 0.019448697566986084
correct O 0 0.04490478336811066
folding O 0 0.08060862123966217
of O 0 0.03311482444405556
the O 0 0.05630440637469292
prohormone O 1 0.9999924898147583
. O 0 0.06451046466827393

In O 0 0.022881092503666878
the O 0 0.02335652895271778
second O 0 0.034558411687612534
family O 0 0.029511833563447
, O 0 0.015429014340043068
a O 0 0.02489437162876129
G279A O 1 0.9954324960708618
substitution O 0 0.04621072858572006
at O 0 0.020264694467186928
position O 0 0.027460969984531403
- O 1 0.9010140299797058
1 O 0 0.0174183938652277
of O 0 0.011738712899386883
the O 0 0.01828005537390709
signal O 0 0.048728153109550476
peptide O 0 0.059219907969236374
was O 0 0.023957308381795883
observed O 0 0.01608590967953205
in O 0 0.011290568858385086
all O 0 0.01488029770553112
affected O 0 0.03421201556921005
individuals O 0 0.027750328183174133
. O 0 0.04270071163773537

This O 0 0.03778888285160065
missense O 0 0.3232569992542267
mutation O 0 0.06587126851081848
, O 0 0.01937655545771122
which O 0 0.019785501062870026
replaces O 1 0.9979629516601562
Ala O 1 0.9999995231628418
with O 0 0.04271700233221054
Thr O 1 0.9999994039535522
, O 0 0.02555808611214161
is O 0 0.01762460730969906
frequent O 0 0.04513189196586609
among O 0 0.25691303610801697
FNDI B-Disease 1 1.0
patients O 1 0.9999997615814209
and O 0 0.03096640668809414
is O 0 0.01940021850168705
thought O 0 0.016393525525927544
to O 0 0.013428539037704468
reduce O 0 0.02384832128882408
the O 0 0.01862313039600849
efficiency O 0 0.036676809191703796
of O 0 0.03080655075609684
cleavage O 1 0.9993845224380493
by O 0 0.0369231216609478
signal O 0 0.08239272981882095
peptidases O 1 0.6354790925979614
. O 0 0.028623992577195168
. O 0 0.03513152152299881

Genetic O 0 0.0646662637591362
heterogeneity O 0 0.10193320363759995
of O 0 0.05027194321155548
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0374063178896904
due O 0 0.03608165308833122
to O 0 0.03204643726348877
TWIST O 1 0.9915363788604736
and O 0 0.04989779740571976
FGFR O 1 0.9999933242797852
mutations O 0 0.07983160018920898
. O 0 0.047749150544404984

Thirty O 0 0.1084376871585846
- O 1 0.9550290107727051
two O 0 0.022411521524190903
unrelated O 0 0.049509335309267044
patients O 0 0.3727686405181885
with O 0 0.015849055722355843
features O 0 0.018571682274341583
of O 0 0.025320757180452347
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.02776879444718361
a O 0 0.029112251475453377
common O 0 0.03704740107059479
autosomal B-Disease 1 0.9999574422836304
dominant I-Disease 1 0.9997267127037048
condition I-Disease 1 0.9999755620956421
of O 1 0.99986732006073
craniosynostosis B-Disease 1 1.0
and O 1 0.999971866607666
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999942779541016
, O 0 0.021798480302095413
were O 0 0.012053222395479679
screened O 0 0.041472453624010086
for O 0 0.015459517017006874
mutations O 0 0.027896545827388763
in O 0 0.018007779493927956
TWIST O 1 0.9889361262321472
, O 0 0.03925515338778496
FGFR2 O 1 0.9999940395355225
, O 0 0.036074940115213394
and O 0 0.03882144019007683
FGFR3 O 1 0.9999399185180664
. O 0 0.05291178077459335

Nine O 0 0.04922906309366226
novel O 0 0.059379998594522476
and O 0 0.024258775636553764
three O 0 0.03474054113030434
recurrent O 1 0.9999995231628418
TWIST O 1 0.9999920129776001
mutations O 0 0.05206555873155594
were O 0 0.014380943961441517
found O 0 0.013830596581101418
in O 0 0.013256486505270004
12 O 0 0.03050857037305832
families O 0 0.03791771084070206
. O 0 0.039798803627491

Seven O 0 0.041657451540231705
families O 0 0.030363351106643677
were O 0 0.011185199953615665
found O 0 0.010664879344403744
to O 0 0.010167257860302925
have O 0 0.007018139120191336
the O 0 0.024374544620513916
FGFR3 O 1 0.9999983310699463
P250R O 1 0.9999966621398926
mutation O 0 0.10249226540327072
, O 0 0.019112179055809975
and O 0 0.01351130660623312
one O 0 0.01522008515894413
individual O 0 0.014132673852145672
was O 0 0.019374895840883255
found O 0 0.01014164462685585
to O 0 0.009475808590650558
have O 0 0.00719708576798439
an O 0 0.020259035751223564
FGFR2 O 1 0.9999411106109619
VV269 O 1 0.9999431371688843
- O 1 0.9999216794967651
270 O 0 0.10888686776161194
deletion O 0 0.11345168948173523
. O 0 0.04204140231013298

To O 0 0.03481452167034149
date O 0 0.02957456186413765
, O 0 0.01801474019885063
our O 0 0.025376232340931892
detection O 0 0.047011200338602066
rate O 0 0.02124921791255474
for O 0 0.02218201570212841
TWIST O 1 0.802445650100708
or O 0 0.033737242221832275
FGFR O 1 0.9999901056289673
mutations O 0 0.045483462512493134
is O 0 0.017738493159413338
68 O 0 0.03321585804224014
% O 0 0.013218317180871964
in O 0 0.010193532332777977
our O 0 0.027029208838939667
Saethre B-Disease 1 0.9999983310699463
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
, O 0 0.029638510197401047
including O 0 0.01886114291846752
our O 0 0.025790372863411903
five O 0 0.02717958204448223
patients O 1 0.9975695013999939
elsewhere O 0 0.028829095885157585
reported O 0 0.02840505726635456
with O 0 0.03088454343378544
TWIST O 1 0.9973915815353394
mutations O 0 0.07066363841295242
. O 0 0.04312106594443321

More O 0 0.02052663266658783
than O 0 0.014204413630068302
35 O 0 0.02772829867899418
different O 0 0.01229850947856903
TWIST O 1 0.6558920741081238
mutations O 0 0.03553737699985504
are O 0 0.009220746345818043
now O 0 0.01733466051518917
known O 0 0.021898649632930756
in O 0 0.013994255103170872
the O 0 0.023651879280805588
literature O 0 0.03512553125619888
. O 0 0.03595606982707977

The O 0 0.040943775326013565
most O 0 0.025422587990760803
common O 0 0.032332662492990494
phenotypic O 0 0.07353650778532028
features O 0 0.0281464084982872
, O 0 0.015477584674954414
present O 0 0.013919994235038757
in O 0 0.007857397198677063
more O 0 0.005464400630444288
than O 0 0.0062356689013540745
a O 0 0.012278982438147068
third O 0 0.022100243717432022
of O 0 0.017328377813100815
our O 0 0.027650991454720497
patients O 1 0.9978680610656738
with O 0 0.02607877552509308
TWIST O 1 0.9999821186065674
mutations O 0 0.0419461764395237
, O 0 0.017360007390379906
are O 0 0.011958652175962925
coronal B-Disease 1 0.999661922454834
synostosis I-Disease 1 0.9996199607849121
, O 0 0.03423492982983589
brachycephaly B-Disease 1 0.9982378482818604
, O 0 0.03366873040795326
low B-Disease 1 0.9694628715515137
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 1 0.9993796348571777
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 1 0.9837521314620972
ptosis B-Disease 1 1.0
, O 0 0.07660402357578278
hypertelorism B-Disease 1 0.9999995231628418
, O 0 0.03561711683869362
broad B-Disease 1 0.5829763412475586
great I-Disease 1 0.9613086581230164
toes I-Disease 1 0.9999639987945557
, O 0 0.03361988067626953
and O 0 0.033554937690496445
clinodactyly B-Disease 1 0.9996262788772583
. O 0 0.05169350281357765

Significant O 0 0.06962166726589203
intra O 1 0.9999090433120728
- O 1 0.9999892711639404
and O 0 0.044356461614370346
interfamilial O 1 0.9993512034416199
phenotypic O 0 0.10779266059398651
variability O 0 0.06252958625555038
is O 0 0.017110712826251984
present O 0 0.0175370741635561
for O 0 0.01821376010775566
either O 0 0.03303682059049606
TWIST O 1 0.9847266674041748
mutations O 0 0.07512057572603226
or O 0 0.049417540431022644
FGFR O 1 0.9999904632568359
mutations O 0 0.08872497826814651
. O 0 0.05295376479625702

The O 0 0.04860770329833031
overlap O 0 0.044784706085920334
in O 0 0.024034898728132248
clinical O 0 0.37972062826156616
features O 0 0.026959871873259544
and O 0 0.0161091610789299
the O 0 0.018902059644460678
presence O 0 0.026182690635323524
, O 0 0.011961684562265873
in O 0 0.008626853115856647
the O 0 0.013299900107085705
same O 0 0.012645513750612736
genes O 0 0.015317966230213642
, O 0 0.011494043283164501
of O 0 0.015259966254234314
mutations O 0 0.022580908611416817
for O 0 0.009896409697830677
more O 0 0.006706553511321545
than O 0 0.008751392364501953
one O 0 0.01799021288752556
craniosynostotic B-Disease 1 0.9999402761459351
condition I-Disease 1 0.9087242484092712
- O 1 0.99695885181427
such O 0 0.012014401145279408
as O 0 0.022274021059274673
Saethre B-Disease 1 0.9999685287475586
- I-Disease 1 0.9999946355819702
Chotzen I-Disease 1 0.9994316697120667
, I-Disease 0 0.029360665008425713
Crouzon I-Disease 1 0.9951686859130859
, I-Disease 0 0.023682810366153717
and I-Disease 0 0.03466479107737541
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 0.9999997615814209
support O 0 0.03760687634348869
the O 0 0.025099920108914375
hypothesis O 0 0.034404877573251724
that O 0 0.013828931376338005
TWIST O 0 0.1893860548734665
and O 0 0.021872950717806816
FGFRs O 1 0.9892052412033081
are O 0 0.00819359254091978
components O 0 0.016743997111916542
of O 0 0.012591859325766563
the O 0 0.016890857368707657
same O 0 0.018579058349132538
molecular O 0 0.03946923837065697
pathway O 0 0.046053703874349594
involved O 0 0.012401871383190155
in O 0 0.009343351237475872
the O 0 0.019082702696323395
modulation O 0 0.0651116669178009
of O 0 0.05202008783817291
craniofacial O 1 1.0
and O 1 0.9997770190238953
limb O 1 1.0
development O 1 0.9165230393409729
in O 0 0.0274913739413023
humans O 0 0.029999956488609314
. O 0 0.022447822615504265
. O 0 0.032701101154088974

Mutation O 0 0.08803751319646835
analysis O 0 0.024427611380815506
of O 0 0.04170817509293556
UBE3A O 1 0.9999998807907104
in O 1 0.9997451901435852
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9819549918174744

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9998376369476318
AS B-Disease 1 0.9999977350234985
) O 0 0.026886779814958572
is O 0 0.0172589048743248
caused O 0 0.02719852328300476
by O 0 0.022770250216126442
chromosome O 0 0.34505435824394226
15q11 O 1 0.999972939491272
- O 1 0.9999939203262329
q13 O 1 0.9983541965484619
deletions O 0 0.06885764002799988
of O 0 0.030866369605064392
maternal O 1 0.902809202671051
origin O 0 0.020426198840141296
, O 0 0.0166279636323452
by O 0 0.023519426584243774
paternal O 1 0.9957210421562195
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999992847442627
( O 1 0.7440284490585327
UPD B-Disease 1 1.0
) O 0 0.027635660022497177
15 O 0 0.02360173873603344
, O 0 0.018322940915822983
by O 0 0.031001530587673187
imprinting O 1 0.9999985694885254
defects O 1 0.9999853372573853
, O 0 0.021756136789917946
and O 0 0.01529137697070837
by O 0 0.01959417015314102
mutations O 0 0.028343552723526955
in O 0 0.016401462256908417
the O 0 0.041088443249464035
UBE3A O 1 0.9999995231628418
gene O 0 0.08262939006090164
. O 0 0.04182567074894905

UBE3A O 1 0.9996817111968994
encodes O 0 0.10255832225084305
a O 0 0.05861566215753555
ubiquitin O 1 0.9975607395172119
- O 1 0.9999854564666748
protein O 0 0.05305754765868187
ligase O 0 0.06796686351299286
and O 0 0.023827165365219116
shows O 0 0.04393104463815689
brain O 1 0.9992849230766296
- O 1 0.9999499320983887
specific O 0 0.042289555072784424
imprinting O 1 0.8221018314361572
. O 0 0.04823416471481323

Here O 0 0.03727661073207855
we O 0 0.020963091403245926
describe O 0 0.05565569922327995
UBE3A O 1 0.9999831914901733
coding O 1 0.5392027497291565
- O 1 0.9996700286865234
region O 0 0.05077261105179787
mutations O 0 0.04624522849917412
detected O 0 0.04048137366771698
by O 0 0.0266103632748127
SSCP O 1 0.9998113512992859
analysis O 0 0.018361268565058708
in O 0 0.013318893499672413
13 O 0 0.03125274181365967
AS B-Disease 0 0.04944854974746704
individuals O 0 0.024119907990098
or O 0 0.025352321565151215
families O 0 0.04122867062687874
. O 0 0.039504047483205795

Two O 0 0.023388946428894997
identical O 0 0.03661003336310387
de O 0 0.09407583624124527
novo O 0 0.3294585645198822
5 O 0 0.06596977263689041
- O 1 0.9935932755470276
bp O 0 0.08242706209421158
duplications O 0 0.08487240970134735
in O 0 0.023214422166347504
exon O 0 0.10612065345048904
16 O 0 0.031227650120854378
were O 0 0.017055394127964973
found O 0 0.022443102672696114
. O 0 0.03249781206250191

Among O 0 0.03892306610941887
the O 0 0.023830246180295944
other O 0 0.013700143434107304
11 O 0 0.027428993955254555
unique O 0 0.02720624767243862
mutations O 0 0.03590913116931915
, O 0 0.0183231420814991
8 O 0 0.024891499429941177
were O 0 0.011743178591132164
small O 0 0.021629374474287033
deletions O 0 0.06673214584589005
or O 0 0.028982724994421005
insertions O 0 0.09884512424468994
predicted O 0 0.03994733467698097
to O 0 0.026153339073061943
cause O 0 0.11705653369426727
frameshifts O 1 0.9992795586585999
, O 0 0.02288675867021084
1 O 0 0.028378980234265327
was O 0 0.023451844230294228
a O 0 0.02065497636795044
mutation O 0 0.03061591647565365
to O 0 0.01257600449025631
a O 0 0.019438032060861588
stop O 0 0.038548972457647324
codon O 0 0.05882805585861206
, O 0 0.015066627413034439
1 O 0 0.020301343873143196
was O 0 0.020274557173252106
a O 0 0.02542056329548359
missense O 1 0.8918752074241638
mutation O 0 0.05085591599345207
, O 0 0.016413351520895958
and O 0 0.013762990944087505
1 O 0 0.02754233218729496
was O 0 0.024416044354438782
predicted O 0 0.02711779624223709
to O 0 0.019826417788863182
cause O 0 0.044019099324941635
insertion O 0 0.0688520222902298
of O 0 0.024043457582592964
an O 0 0.026958487927913666
isoleucine O 1 0.9717669486999512
in O 0 0.014117932878434658
the O 0 0.0222198273986578
hect O 1 0.6431494951248169
domain O 0 0.029690902680158615
of O 0 0.016843697056174278
the O 0 0.03370223194360733
UBE3A O 1 1.0
protein O 0 0.0414532832801342
, O 0 0.013925682753324509
which O 0 0.010461965575814247
functions O 0 0.014759576879441738
in O 0 0.021165881305933
E2 O 1 0.9999428987503052
binding O 0 0.048651162534952164
and O 0 0.030211249366402626
ubiquitin O 0 0.43926119804382324
transfer O 0 0.055072955787181854
. O 0 0.04292167350649834

Eight O 0 0.032991692423820496
of O 0 0.023739464581012726
the O 0 0.025606976822018623
cases O 0 0.02928510680794716
were O 0 0.024725662544369698
familial O 1 0.99998939037323
, O 0 0.028330041095614433
and O 0 0.01899023912847042
five O 0 0.020769193768501282
were O 0 0.02046508900821209
sporadic O 0 0.0750214233994484
. O 0 0.04752764478325844

In O 0 0.030939139425754547
two O 0 0.02750357612967491
familial O 1 0.9999920129776001
cases O 0 0.03820245340466499
and O 0 0.022238345816731453
one O 0 0.022398006170988083
sporadic O 0 0.14260399341583252
case O 0 0.03702855482697487
, O 0 0.029942035675048828
mosaicism O 1 0.9999600648880005
for O 0 0.040461864322423935
UBE3A O 1 0.9999998807907104
mutations O 0 0.05637018755078316
was O 0 0.03128313645720482
detected O 0 0.027031227946281433
in O 0 0.00914812833070755
the O 0 0.01503672357648611
mother O 0 0.03269030153751373
of O 0 0.01309297140687704
three O 0 0.014286471530795097
AS B-Disease 0 0.40201425552368164
sons O 1 0.9124912023544312
, O 0 0.014658922329545021
in O 0 0.010276992805302143
the O 0 0.02129775658249855
maternal O 1 0.9885572195053101
grandfather O 0 0.38403579592704773
of O 0 0.017238091677427292
two O 0 0.013594191521406174
AS B-Disease 0 0.13485220074653625
first O 0 0.02738933078944683
cousins O 0 0.05872252583503723
, O 0 0.014802783727645874
and O 0 0.010036242194473743
in O 0 0.009935094974935055
the O 0 0.016852566972374916
mother O 0 0.04516680911183357
of O 0 0.021407363936305046
an O 0 0.02616078592836857
AS B-Disease 1 0.9805994033813477
daughter O 1 0.9990377426147461
. O 0 0.04980810359120369

The O 0 0.04441751912236214
frequencies O 0 0.024625783786177635
with O 0 0.013167833909392357
which O 0 0.011728339828550816
we O 0 0.013599772937595844
detected O 0 0.037259314209222794
mutations O 0 0.025258807465434074
were O 0 0.011213076300919056
5 O 0 0.02369098737835884
( O 0 0.018802473321557045
14 O 0 0.023140210658311844
% O 0 0.017241807654500008
) O 0 0.011516016907989979
of O 0 0.011936823837459087
35 O 0 0.022453486919403076
in O 0 0.014285451732575893
sporadic O 0 0.04808999225497246
cases O 0 0.026842089369893074
and O 0 0.02205696888267994
8 O 0 0.0373074971139431
( O 0 0.022864865139126778
80 O 0 0.028847305104136467
% O 0 0.018712148070335388
) O 0 0.013376791961491108
of O 0 0.014781183563172817
10 O 0 0.022988993674516678
in O 0 0.024882256984710693
familial O 1 0.9999755620956421
cases O 0 0.05636360123753548
. O 0 0.032739799469709396
. O 0 0.04173292964696884

The O 0 0.08409006148576736
hemochromatosis B-Disease 1 1.0
845 O 1 0.9999977350234985
G O 1 0.9999992847442627
- O 1 0.9999997615814209
- O 1 0.9999923706054688
> O 0 0.11195231974124908
A O 0 0.029376067221164703
and O 0 0.013990174978971481
187 O 0 0.0704212486743927
C O 1 0.9990742206573486
- O 1 0.9999985694885254
- O 1 0.9999946355819702
> O 1 0.9991711378097534
G O 1 0.9963501691818237
mutations O 0 0.044845450669527054
: O 0 0.028414752334356308
prevalence O 1 0.9665929675102234
in O 0 0.02356066182255745
non O 1 0.9983880519866943
- O 1 0.9999991655349731
Caucasian O 1 0.9992820620536804
populations O 0 0.05414900928735733
. O 0 0.04235898703336716

Hemochromatosis B-Disease 1 0.9999977350234985
, O 0 0.03982045501470566
the O 0 0.061816588044166565
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999991655349731
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 0.034344613552093506
leads O 0 0.41629496216773987
, O 0 0.02081526443362236
if O 0 0.021815594285726547
untreated O 1 0.9999897480010986
, O 0 0.020975913852453232
to O 0 0.027889015153050423
progressive O 1 0.9999997615814209
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.3044971227645874
premature B-Disease 1 0.9999867677688599
death I-Disease 1 0.9973031282424927
. O 0 0.04911794513463974

The O 0 0.10478828102350235
hemochromatosis B-Disease 1 1.0
gene O 1 0.9154900908470154
, O 0 0.046203773468732834
HFE O 1 0.9999992847442627
, O 0 0.027745084837079048
recently O 0 0.02692796103656292
has O 0 0.013246098533272743
been O 0 0.011989166028797626
identified O 0 0.01638530008494854
, O 0 0.010766959749162197
and O 0 0.011564110405743122
characterization O 0 0.03806275501847267
of O 0 0.017470210790634155
this O 0 0.013620642945170403
gene O 0 0.02294367365539074
has O 0 0.011909116990864277
shown O 0 0.010158498771488667
that O 0 0.006627294700592756
it O 0 0.006836672779172659
contains O 0 0.012978190556168556
two O 0 0.010234487242996693
mutations O 0 0.023342786356806755
that O 0 0.009019700810313225
result O 0 0.0156966932117939
in O 0 0.016973743215203285
amino O 0 0.04175325110554695
acid O 0 0.05713970586657524
substitutions O 0 0.0604039765894413
- O 1 0.9519886374473572
cDNA O 0 0.08954945206642151
nucleotides O 0 0.04725823551416397
845 O 1 0.7442942261695862
G O 1 0.9994895458221436
- O 1 0.9999974966049194
- O 1 0.9999963045120239
> O 1 0.9827547669410706
A O 0 0.04418691620230675
( O 0 0.031507380306720734
C282Y O 1 0.8534528017044067
) O 0 0.014748306013643742
and O 0 0.011957514099776745
187 O 0 0.064467653632164
C O 1 0.9998471736907959
- O 1 0.9999998807907104
- O 1 0.9999997615814209
> O 1 0.9999426603317261
G O 1 0.9996345043182373
( O 0 0.057317424565553665
H63D O 1 0.9998514652252197
) O 0 0.04441426321864128
. O 0 0.037225887179374695

Although O 0 0.09383431077003479
hemochromatosis B-Disease 1 1.0
is O 0 0.03652886673808098
common O 0 0.030323488637804985
in O 0 0.022429553791880608
Caucasians O 1 0.9977905750274658
, O 0 0.03234981745481491
affecting O 1 0.6270286440849304
> O 1 0.9998902082443237
= O 0 0.10068303346633911
1 O 0 0.055584706366062164
/ O 1 0.5082951188087463
300 O 0 0.023258443921804428
individuals O 0 0.010341188870370388
of O 0 0.012929841876029968
northern O 0 0.023331910371780396
European O 0 0.01823616214096546
origin O 0 0.013788851909339428
, O 0 0.012073754332959652
it O 0 0.007455203216522932
has O 0 0.0095632653683424
not O 0 0.006710724905133247
been O 0 0.009680784307420254
recognized O 0 0.01878638006746769
in O 0 0.01190053578466177
other O 0 0.014120122417807579
populations O 0 0.035161711275577545
. O 0 0.03791520744562149

The O 0 0.04284759983420372
present O 0 0.0281318798661232
study O 0 0.02520379051566124
used O 0 0.021068986505270004
PCR O 0 0.0793888196349144
and O 0 0.02547074295580387
restriction O 0 0.08809039741754532
- O 1 0.9999964237213135
enzyme O 0 0.15412156283855438
digestion O 0 0.1410023272037506
to O 0 0.017580637708306313
analyze O 0 0.024413689970970154
the O 0 0.012689114548265934
frequency O 0 0.013078315183520317
of O 0 0.010711295530200005
the O 0 0.020942889153957367
845 O 1 0.999823272228241
G O 1 0.9999896287918091
- O 1 0.9999995231628418
- O 1 0.99998939037323
> O 0 0.14285488426685333
A O 0 0.02545948512852192
and O 0 0.015777673572301865
187 O 0 0.06603872030973434
C O 1 0.9976068735122681
- O 1 0.9999973773956299
- O 1 0.9999958276748657
> O 1 0.9994140863418579
G O 1 0.93105149269104
mutations O 0 0.04170442000031471
in O 0 0.029396016150712967
HLA O 1 1.0
- O 1 0.9998425245285034
typed O 0 0.05853264033794403
samples O 0 0.017489930614829063
from O 0 0.013348753564059734
non O 0 0.061778176575899124
- O 1 0.9999691247940063
Caucasian O 1 0.9918560981750488
populations O 0 0.03011958673596382
, O 0 0.01660611294209957
comprising O 0 0.03171408176422119
Australian O 0 0.040426794439554214
Aboriginal O 0 0.07242751866579056
, O 0 0.02354615181684494
Chinese O 0 0.03475255146622658
, O 0 0.019628316164016724
and O 0 0.021798521280288696
Pacific O 0 0.061892129480838776
Islanders O 0 0.10208291560411453
. O 0 0.04204345867037773

Results O 0 0.028820553794503212
showed O 0 0.0203427542001009
that O 0 0.009806321002542973
the O 0 0.02046426758170128
845 O 1 0.996403694152832
G O 1 0.9999749660491943
- O 1 0.9999995231628418
- O 1 0.9999969005584717
> O 1 0.9336925745010376
A O 0 0.04132413864135742
mutation O 0 0.040251102298498154
was O 0 0.020156560465693474
present O 0 0.014502489939332008
in O 0 0.009291984140872955
these O 0 0.008475563488900661
populations O 0 0.022656451910734177
( O 0 0.02835664339363575
allele O 0 0.06514982879161835
frequency O 0 0.028142616152763367
0 O 0 0.03233175724744797
. O 0 0.01197586115449667
32 O 0 0.02664109319448471
% O 0 0.018940361216664314
) O 0 0.01524263620376587
, O 0 0.013172928243875504
and O 0 0.012867617420852184
, O 0 0.014976250007748604
furthermore O 0 0.023365095257759094
, O 0 0.012310098856687546
it O 0 0.008639732375741005
was O 0 0.01800226978957653
always O 0 0.015118262730538845
seen O 0 0.015216519124805927
in O 0 0.012372861616313457
conjunction O 0 0.045529693365097046
with O 0 0.03707414120435715
HLA O 1 1.0
haplotypes O 1 0.9960702657699585
common O 0 0.03493256866931915
in O 0 0.022163378074765205
Caucasians O 1 0.992265522480011
, O 0 0.01848689652979374
suggesting O 0 0.021061595529317856
that O 0 0.010937466286122799
845 O 1 0.9989091157913208
G O 1 0.999993085861206
- O 1 0.9999998807907104
- O 1 0.9999998807907104
> O 1 0.9993384480476379
A O 0 0.03626812621951103
may O 0 0.01528002880513668
have O 0 0.006387733388692141
been O 0 0.00919498410075903
introduced O 0 0.014114496298134327
into O 0 0.011950868181884289
these O 0 0.0077507677488029
populations O 0 0.019691213965415955
by O 0 0.02980988472700119
Caucasian O 1 0.9992223978042603
admixture O 1 0.9947150349617004
. O 0 0.061671387404203415

187 O 0 0.15091800689697266
C O 1 0.9991832375526428
- O 1 0.9999979734420776
- O 1 0.9999991655349731
> O 1 0.9997406601905823
G O 1 0.8499556183815002
was O 0 0.025809315964579582
present O 0 0.017563877627253532
at O 0 0.017945105209946632
an O 0 0.018446356058120728
allele O 0 0.0586828887462616
frequency O 0 0.02781805209815502
of O 0 0.023616282269358635
2 O 0 0.05158232897520065
. O 0 0.03713555634021759

68 O 0 0.08508482575416565
% O 0 0.023398742079734802
in O 0 0.01138900313526392
the O 0 0.015707703307271004
two O 0 0.012976858764886856
populations O 0 0.025594910606741905
analyzed O 0 0.029661690816283226
( O 0 0.022543160244822502
Australian O 0 0.04117876663804054
Aboriginal O 0 0.06905097514390945
and O 0 0.027783356606960297
Chinese O 0 0.04960360750555992
) O 0 0.035171084105968475
. O 0 0.03427954763174057

In O 0 0.02650483511388302
the O 0 0.023928791284561157
Australian O 0 0.04161572456359863
Aboriginal O 0 0.05767492204904556
samples O 0 0.025065917521715164
, O 0 0.015783293172717094
187 O 0 0.06523861736059189
C O 1 0.9993153810501099
- O 1 0.9999992847442627
- O 1 0.9999994039535522
> O 1 0.9997660517692566
G O 1 0.8686611652374268
was O 0 0.02345256507396698
found O 0 0.009436088614165783
to O 0 0.009833605960011482
be O 0 0.008776702918112278
associated O 0 0.018552368506789207
with O 0 0.030547333881258965
HLA O 1 1.0
haplotypes O 1 0.9988747239112854
common O 0 0.03626594319939613
in O 0 0.025447048246860504
Caucasians O 1 0.9965242743492126
, O 0 0.022944465279579163
suggesting O 0 0.02215898409485817
that O 0 0.007784439716488123
it O 0 0.00762787414714694
was O 0 0.019117562100291252
introduced O 0 0.018787752836942673
by O 0 0.017028819769620895
recent O 0 0.03297143429517746
admixture O 0 0.17424820363521576
. O 0 0.04852892830967903

In O 0 0.02492697350680828
the O 0 0.022341620177030563
Chinese O 0 0.034180957823991776
samples O 0 0.020400110632181168
analyzed O 0 0.015839027240872383
, O 0 0.012206579558551311
187 O 0 0.057977981865406036
C O 1 0.9995204210281372
- O 1 0.9999997615814209
- O 1 0.9999998807907104
> O 1 0.999737560749054
G O 1 0.9449964761734009
was O 0 0.02430013194680214
present O 0 0.01563107594847679
in O 0 0.011118756607174873
association O 0 0.019528506323695183
with O 0 0.012132542207837105
a O 0 0.017894210293889046
wide O 0 0.022551823407411575
variety O 0 0.02004632167518139
of O 0 0.04867096245288849
HLA O 1 1.0
haplotypes O 1 0.9998550415039062
, O 0 0.02445809543132782
showing O 0 0.02570319175720215
this O 0 0.013191524893045425
mutation O 0 0.03275493159890175
to O 0 0.013083536177873611
be O 0 0.011260752566158772
widespread O 0 0.026592528447508812
and O 0 0.016914214938879013
likely O 0 0.018142515793442726
to O 0 0.016327304765582085
predate O 0 0.05510789155960083
the O 0 0.015698682516813278
more O 0 0.009127361699938774
genetically O 0 0.023903854191303253
restricted O 0 0.030748598277568817
845 O 1 0.9973862767219543
G O 1 0.9999912977218628
- O 1 0.9999998807907104
- O 1 0.9999994039535522
> O 1 0.9956310987472534
A O 0 0.070862777531147
mutation O 0 0.07666092365980148
. O 0 0.03936140984296799

Genotype O 1 0.9985275268554688
- O 1 0.999887228012085
phenotype O 1 0.6322319507598877
correlations O 0 0.11174212396144867
in O 0 0.05987991765141487
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.20128822326660156

Germ O 1 0.9999988079071045
- O 1 0.9999569654464722
line O 0 0.05136866867542267
mutations O 0 0.027886835858225822
of O 0 0.020926564931869507
the O 0 0.06678900867700577
tumor B-Disease 1 1.0
suppressor O 1 1.0
APC O 1 0.9999868869781494
are O 0 0.014654816128313541
implicated O 0 0.06692875176668167
in O 0 0.034181252121925354
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999305009841919
AAPC B-Disease 1 1.0
) O 0 0.02579791285097599
, O 0 0.014112019911408424
a O 0 0.021370014175772667
variant O 0 0.04932643845677376
of O 0 0.04996112734079361
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999990463256836
FAP B-Disease 1 1.0
) O 0 0.06976340711116791
. O 0 0.0503140389919281

AAPC B-Disease 1 0.9999865293502808
is O 0 0.038275957107543945
recognized O 0 0.028066858649253845
by O 0 0.015127984806895256
the O 0 0.01998315379023552
occurrence O 0 0.04883662983775139
of O 0 0.036632243543863297
< O 1 0.9999133348464966
100 O 0 0.06744330376386642
colonic B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999958276748657
and O 0 0.019939616322517395
a O 0 0.021290132775902748
later O 0 0.028697147965431213
onset O 1 0.9999998807907104
of O 1 0.9999988079071045
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9997548460960388
age O 1 0.9937964677810669
> O 1 0.9995585083961487
40 O 0 0.038212306797504425
years O 0 0.03002326190471649
) O 0 0.02977658621966839
. O 0 0.03179642930626869

The O 0 0.042370133101940155
aim O 0 0.04286230728030205
of O 0 0.01965256780385971
this O 0 0.012036981992423534
study O 0 0.01504893321543932
was O 0 0.019579509273171425
to O 0 0.019321326166391373
assess O 0 0.07307684421539307
genotype O 1 0.9996774196624756
- O 1 0.9999856948852539
phenotype O 1 0.7744850516319275
correlations O 0 0.09732469916343689
in O 0 0.0465037077665329
AAPC B-Disease 1 0.999998927116394
families O 0 0.06779657304286957
. O 0 0.05114779621362686

By O 0 0.052721258252859116
protein O 0 0.07152020186185837
- O 1 0.9985319375991821
truncation O 1 0.8497776985168457
test O 0 0.05393174663186073
( O 0 0.04016418009996414
PTT O 1 0.9780381917953491
) O 0 0.02695595659315586
assay O 0 0.04944730922579765
, O 0 0.01126677356660366
the O 0 0.015128767117857933
entire O 0 0.03138882294297218
coding O 0 0.03964758664369583
region O 0 0.01869291067123413
of O 0 0.015910983085632324
the O 0 0.03130865469574928
APC B-Disease 1 0.999997615814209
gene O 0 0.038375239819288254
was O 0 0.02823619917035103
screened O 0 0.051632530987262726
in O 0 0.014506674371659756
affected O 0 0.02346867136657238
individuals O 0 0.015283983200788498
from O 0 0.022418584674596786
11 O 0 0.09434238821268082
AAPC B-Disease 1 1.0
kindreds O 1 0.9999610185623169
, O 0 0.027949541807174683
and O 0 0.017105378210544586
their O 0 0.016595294699072838
phenotypic O 0 0.055613115429878235
differences O 0 0.03014080412685871
were O 0 0.020983776077628136
examined O 0 0.0665789470076561
. O 0 0.04352584108710289

Five O 0 0.04230694845318794
novel O 0 0.09391876310110092
germ O 1 0.9999985694885254
- O 1 0.9999979734420776
line O 0 0.30587562918663025
APC B-Disease 1 0.9999853372573853
mutations O 0 0.040274862200021744
were O 0 0.01316910982131958
identified O 0 0.021566146984696388
in O 0 0.016835959628224373
seven O 0 0.042047929018735886
kindreds O 1 0.9556967616081238
. O 0 0.05973043665289879

Mutations O 0 0.06862707436084747
were O 0 0.015025639906525612
located O 0 0.027324123308062553
in O 0 0.009336235001683235
three O 0 0.008177469484508038
different O 0 0.004520624876022339
regions O 0 0.0099547253921628
of O 0 0.015472957864403725
the O 0 0.03354669362306595
APC B-Disease 1 0.9999998807907104
gene O 0 0.05721016973257065
( O 0 0.02462632581591606
1 O 0 0.02875443361699581
) O 0 0.013074107468128204
at O 0 0.013138417154550552
the O 0 0.013700807467103004
5 O 0 0.02026478387415409
end O 0 0.027605269104242325
spanning O 0 0.043688274919986725
exons O 0 0.06386404484510422
4 O 0 0.03017869032919407
and O 0 0.01748489961028099
5 O 0 0.02815536968410015
, O 0 0.02057337947189808
( O 0 0.02016828954219818
2 O 0 0.025459351018071175
) O 0 0.01289193332195282
within O 0 0.015268382616341114
exon O 0 0.10017629712820053
9 O 0 0.03799457475543022
, O 0 0.020094534382224083
and O 0 0.01736178807914257
( O 0 0.020728129893541336
3 O 0 0.024419080466032028
) O 0 0.014104785397648811
at O 0 0.015168648213148117
the O 0 0.01796731911599636
3 O 0 0.03935340791940689
distal O 1 0.9986170530319214
end O 0 0.03552775830030441
of O 0 0.026626428589224815
the O 0 0.03672408685088158
gene O 0 0.05047883093357086
. O 0 0.0366521030664444

Variability O 0 0.07477778196334839
in O 0 0.014034406282007694
the O 0 0.01508398074656725
number O 0 0.01737367734313011
of O 1 0.956301212310791
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9038068056106567
most O 0 0.019954167306423187
apparent O 0 0.050717711448669434
in O 0 0.013688202016055584
individuals O 0 0.011429993435740471
with O 0 0.013253818266093731
mutations O 0 0.023623088374733925
in O 0 0.011594146490097046
region O 0 0.02149873785674572
1 O 0 0.022305803373456
, O 0 0.012429109774529934
and O 0 0.01932985708117485
upper O 1 0.9999991655349731
- O 1 1.0
gastrointestinal O 1 1.0
manifestations O 1 0.9999998807907104
were O 0 0.023170968517661095
more O 0 0.0192254651337862
severe O 1 0.9993543028831482
in O 0 0.022353840991854668
them O 0 0.024528570473194122
. O 0 0.03803667053580284

In O 0 0.03261881694197655
individuals O 0 0.020488886162638664
with O 0 0.020593829452991486
mutations O 0 0.030866723507642746
in O 0 0.01397551316767931
either O 0 0.01842222549021244
region O 0 0.026763835921883583
2 O 0 0.029502151533961296
or O 0 0.015647467225790024
region O 0 0.022922243922948837
3 O 0 0.022421181201934814
, O 0 0.011282498016953468
the O 0 0.01209241896867752
average O 0 0.015370876528322697
number O 0 0.013951354660093784
of O 0 0.03176617994904518
adenomas B-Disease 1 0.9999994039535522
tended O 0 0.05972319468855858
to O 0 0.020579298958182335
be O 0 0.012527065351605415
lower O 0 0.018938304856419563
than O 0 0.008275325410068035
those O 0 0.008238107897341251
in O 0 0.009895868599414825
individuals O 0 0.01335448119789362
with O 0 0.016363611444830894
mutations O 0 0.02822265960276127
in O 0 0.014334632083773613
region O 0 0.029225381091237068
1 O 0 0.029072729870676994
, O 0 0.013950120657682419
although O 0 0.011946736834943295
age O 0 0.02916044555604458
at O 0 0.05614776164293289
diagnosis O 1 0.9999984502792358
was O 0 0.044067975133657455
similar O 0 0.02931491658091545
. O 0 0.036088068038225174

In O 0 0.03687737509608269
all O 0 0.04590240865945816
AAPC B-Disease 1 0.9999994039535522
kindreds O 1 0.998128354549408
, O 0 0.02284994348883629
a O 0 0.023097136989235878
predominance O 1 0.7776406407356262
of O 0 0.029068054631352425
right O 1 0.9087150692939758
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999630451202393
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999992847442627
was O 0 0.12184933573007584
observed O 0 0.04719047620892525
. O 0 0.034470334649086

No O 0 0.09500984847545624
desmoid B-Disease 1 0.9999947547912598
tumors I-Disease 1 0.9999983310699463
were O 0 0.025719812139868736
found O 0 0.019649390131235123
in O 0 0.019999418407678604
these O 0 0.02396809682250023
kindreds O 1 0.9632536172866821
. O 0 0.053123462945222855

Our O 0 0.049588121473789215
data O 0 0.018440041691064835
suggest O 0 0.016591155901551247
that O 0 0.008769312873482704
, O 0 0.014607486315071583
in O 0 0.021260008215904236
AAPC B-Disease 1 0.9999992847442627
families O 0 0.03282639756798744
, O 0 0.01525578461587429
the O 0 0.013637796975672245
location O 0 0.01676207035779953
of O 0 0.018257636576890945
the O 0 0.03957879915833473
APC B-Disease 1 0.9999995231628418
mutation O 0 0.27583521604537964
may O 0 0.03686238080263138
partially O 0 0.06528644263744354
predict O 0 0.0466960109770298
specific O 0 0.025368010625243187
phenotypic O 0 0.09096632897853851
expression O 0 0.06421209126710892
. O 0 0.04653014615178108

This O 0 0.02681392803788185
should O 0 0.018788227811455727
help O 0 0.021071312949061394
in O 0 0.008932077325880527
the O 0 0.013624538667500019
design O 0 0.019795695319771767
of O 0 0.020357266068458557
tailored O 1 0.5440348982810974
clinical O 1 0.9999945163726807
- O 1 1.0
management O 1 0.6454410552978516
protocols O 0 0.05598767474293709
in O 0 0.012415041215717793
this O 0 0.011300981044769287
subset O 0 0.07988685369491577
of O 0 0.10042677074670792
FAP B-Disease 1 1.0
patients O 1 0.9999959468841553
. O 0 0.038029368966817856
. O 0 0.04095753654837608

Wilms B-Disease 1 0.9999998807907104
' I-Disease 1 0.9999639987945557
tumor I-Disease 1 0.9999992847442627
1 O 0 0.05480770766735077
and O 0 0.0353371687233448
Dax O 1 0.9999986886978149
- O 1 0.9999212026596069
1 O 0 0.0406845360994339
modulate O 0 0.05952077731490135
the O 0 0.02303248643875122
orphan O 1 0.9999653100967407
nuclear O 0 0.12510176002979279
receptor O 1 0.9983153343200684
SF O 1 1.0
- O 1 0.9994331002235413
1 O 0 0.02934972569346428
in O 0 0.014783364720642567
sex O 0 0.05409061908721924
- O 1 0.9997437596321106
specific O 0 0.028226597234606743
gene O 0 0.0422927550971508
expression O 0 0.04471210017800331
. O 0 0.034343574196100235

Products O 0 0.05050655081868172
of O 0 0.04141556844115257
steroidogenic O 1 0.9999995231628418
factor O 1 0.8244345188140869
1 O 0 0.05110552906990051
( O 0 0.042511194944381714
SF O 1 1.0
- O 1 0.9999909400939941
1 O 0 0.03557803854346275
) O 0 0.01972096972167492
and O 0 0.026553045958280563
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
1 O 1 0.9664996266365051
( O 0 0.06715273857116699
WT1 O 1 0.9999961853027344
) O 0 0.033595092594623566
genes O 0 0.01965760812163353
are O 0 0.007893895730376244
essential O 0 0.026365892961621284
for O 0 0.022417688742280006
mammalian O 0 0.08705530315637589
gonadogenesis O 1 0.9786590337753296
prior O 0 0.04048052430152893
to O 0 0.03307802230119705
sexual O 0 0.1581156998872757
differentiation O 1 0.9633479118347168
. O 0 0.0568871833384037

In O 0 0.030246125534176826
males O 0 0.03773373365402222
, O 0 0.04219472408294678
SF O 1 1.0
- O 1 0.9999984502792358
1 O 0 0.051606256514787674
participates O 0 0.051558587700128555
in O 0 0.014429111033678055
sexual O 0 0.03250088170170784
development O 0 0.02355244569480419
by O 0 0.017013883218169212
regulating O 0 0.041859425604343414
expression O 0 0.021603718400001526
of O 0 0.016720062121748924
the O 0 0.03326898440718651
polypeptide O 1 0.9999915361404419
hormone O 1 0.9999841451644897
Mullerian O 1 1.0
inhibiting O 1 0.999996542930603
substance O 1 0.9999638795852661
( O 0 0.17472346127033234
MIS O 1 0.9999997615814209
) O 0 0.042775657027959824
. O 0 0.03663293272256851

Here O 0 0.03872768208384514
, O 0 0.019876249134540558
we O 0 0.011816877871751785
show O 0 0.01907709613442421
that O 0 0.020748639479279518
WT1 O 1 0.9999973773956299
- O 1 0.9999960660934448
KTS O 1 0.9999891519546509
isoforms O 0 0.05859309062361717
associate O 0 0.0520017147064209
and O 0 0.023615093901753426
synergize O 1 0.9996858835220337
with O 0 0.049108490347862244
SF O 1 1.0
- O 1 0.9999957084655762
1 O 0 0.0432187058031559
to O 0 0.027360761538147926
promote O 0 0.07837599515914917
MIS O 1 0.9999914169311523
expression O 0 0.06392571330070496
. O 0 0.04374626278877258

In O 0 0.03842815384268761
contrast O 0 0.056179795414209366
, O 0 0.0483507364988327
WT1 O 1 0.9999971389770508
missense O 1 0.9849274158477783
mutations O 0 0.05082579329609871
, O 0 0.019583776593208313
associated O 0 0.0176654364913702
with O 0 0.016024034470319748
male B-Disease 0 0.06803199648857117
pseudohermaphroditism I-Disease 1 0.9999926090240479
in O 0 0.03301205858588219
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.04351324588060379
fail O 0 0.07624465227127075
to O 0 0.0295527633279562
synergize O 1 0.9999773502349854
with O 0 0.06623085588216782
SF O 1 1.0
- O 1 0.999998927116394
1 O 0 0.0647716149687767
. O 0 0.03794035688042641

Additionally O 0 0.050225839018821716
, O 0 0.020349618047475815
the O 0 0.027261078357696533
X O 1 0.9993830919265747
- O 1 0.9999681711196899
linked O 0 0.04514747112989426
, O 0 0.018203241750597954
candidate O 0 0.04477987438440323
dosage O 1 0.9988672733306885
- O 1 0.9998365640640259
sensitive O 0 0.0543707013130188
sex O 0 0.059009019285440445
- O 1 0.9997864365577698
reversal O 0 0.2642696499824524
gene O 0 0.03699597343802452
, O 0 0.026019247248768806
Dax O 1 0.9999912977218628
- O 1 0.9996744394302368
1 O 0 0.03933102637529373
, O 0 0.02396935038268566
antagonizes O 1 0.8210021257400513
synergy O 0 0.14884258806705475
between O 0 0.04873719438910484
SF O 1 1.0
- O 1 0.9999977350234985
1 O 0 0.04670408368110657
and O 0 0.028391486033797264
WT1 O 1 0.9999921321868896
, O 0 0.018510451540350914
most O 0 0.01243093702942133
likely O 0 0.014459799975156784
through O 0 0.01091121044009924
a O 0 0.01681702956557274
direct O 0 0.022831520065665245
interaction O 0 0.03028806671500206
with O 0 0.033906228840351105
SF O 1 1.0
- O 1 0.9999949932098389
1 O 0 0.05939898639917374
. O 0 0.03604187071323395

We O 0 0.031240830197930336
propose O 0 0.053572751581668854
that O 0 0.02199975959956646
WT1 O 1 0.999808132648468
and O 0 0.041444841772317886
Dax O 1 0.9999994039535522
- O 1 0.9999947547912598
1 O 0 0.050186872482299805
functionally O 0 0.058993931859731674
oppose O 0 0.030701151117682457
each O 0 0.008403722196817398
other O 0 0.008306464180350304
in O 0 0.01372584979981184
testis O 1 0.998958945274353
development O 0 0.0277869775891304
by O 0 0.030978990718722343
modulating O 1 0.9999972581863403
SF O 1 1.0
- O 1 0.9999990463256836
1 O 0 0.11932624131441116
- O 1 0.9999269247055054
mediated O 1 0.9294829964637756
transactivation O 1 0.9987205862998962
. O 0 0.030946213752031326
. O 0 0.036528803408145905

A O 0 0.06810597330331802
mouse O 0 0.07177148759365082
model O 0 0.0340891033411026
for O 0 0.03558829426765442
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.9991181492805481
mutations O 0 0.07441055029630661
. O 0 0.04176899418234825

Imprinting O 0 0.17218723893165588
in O 0 0.02145148441195488
the O 0 0.03469325602054596
15q11 O 1 0.9999051094055176
- O 1 0.9999871253967285
q13 O 1 0.9954238533973694
region O 0 0.036270707845687866
involves O 0 0.028202945366501808
an O 0 0.024042945355176926
imprinting O 1 0.999981164932251
centre O 1 0.9994500279426575
( O 0 0.06624599546194077
IC O 1 0.9999951124191284
) O 0 0.026569770649075508
, O 0 0.017289655283093452
mapping O 0 0.024567317217588425
in O 0 0.009748524986207485
part O 0 0.01670725829899311
to O 0 0.01307618711143732
the O 0 0.020159177482128143
promoter O 0 0.3937397301197052
and O 0 0.015876755118370056
first O 0 0.026808105409145355
exon O 0 0.18248790502548218
of O 0 0.047365471720695496
SNRPN O 1 0.9999567270278931
. O 0 0.056939415633678436

Deletion O 0 0.11986028403043747
of O 0 0.03768867626786232
this O 0 0.03228112682700157
IC O 1 0.9997789263725281
abolishes O 1 0.9989327788352966
local O 0 0.04237549379467964
paternally O 0 0.15754027664661407
derived O 0 0.03446925804018974
gene O 0 0.02764704078435898
expression O 0 0.019936004653573036
and O 0 0.010318681597709656
results O 0 0.011829547584056854
in O 0 0.025102399289608
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999966621398926
PWS B-Disease 1 1.0
) O 0 0.06763114035129547
. O 0 0.04719654843211174

We O 0 0.02518450655043125
have O 0 0.01185819786041975
created O 0 0.022796528413891792
two O 0 0.017634499818086624
deletion O 0 0.09451519697904587
mutations O 0 0.04467547684907913
in O 0 0.023435555398464203
mice O 0 0.04988323897123337
to O 0 0.02840050868690014
understand O 0 0.05669572576880455
PWS B-Disease 1 1.0
and O 0 0.025786228477954865
the O 0 0.025891412049531937
mechanism O 0 0.04210507497191429
of O 0 0.026385793462395668
this O 0 0.029971113428473473
IC O 1 0.9999089241027832
. O 0 0.04965228959918022

Mice O 0 0.18237817287445068
harbouring O 1 0.997020423412323
an O 0 0.04433538764715195
intragenic O 1 0.9998120665550232
deletion O 0 0.11952827125787735
in O 0 0.03002730943262577
Snrpn O 1 0.9998373985290527
are O 0 0.018057405948638916
phenotypically O 1 0.8266449570655823
normal O 0 0.03700542822480202
, O 0 0.019154122099280357
suggesting O 0 0.0259711891412735
that O 0 0.012271870858967304
mutations O 0 0.02918243780732155
of O 0 0.029744785279035568
SNRPN O 1 0.9999369382858276
are O 0 0.011383002623915672
not O 0 0.012075010687112808
sufficient O 0 0.03303849324584007
to O 0 0.04265426844358444
induce O 1 0.9998034834861755
PWS B-Disease 1 0.9999998807907104
. O 0 0.08167092502117157

Mice O 0 0.08529529720544815
with O 0 0.020999237895011902
a O 0 0.027777252718806267
larger O 0 0.033230043947696686
deletion O 0 0.06725480407476425
involving O 0 0.031030768528580666
both O 0 0.02076152339577675
Snrpn O 1 0.9921167492866516
and O 0 0.01835772395133972
the O 0 0.030777396634221077
putative O 1 0.9999892711639404
PWS O 1 1.0
- O 1 1.0
IC O 1 0.9999862909317017
lack O 0 0.0410388745367527
expression O 0 0.028381511569023132
of O 0 0.018754001706838608
the O 0 0.030260952189564705
imprinted O 1 0.9974669218063354
genes O 0 0.046358298510313034
Zfp127 O 1 0.9976547956466675
( O 0 0.034239254891872406
mouse O 0 0.06470388174057007
homologue O 0 0.1332058608531952
of O 0 0.04150271415710449
ZNF127 O 1 0.9999973773956299
) O 0 0.03589818254113197
, O 0 0.036900896579027176
Ndn O 1 0.9999843835830688
and O 0 0.039900537580251694
Ipw O 1 0.9945706725120544
, O 0 0.023094285279512405
and O 0 0.02192792296409607
manifest O 0 0.06457997858524323
several O 0 0.020132379606366158
phenotypes O 0 0.3194563686847687
common O 0 0.05006710812449455
to O 0 0.39953717589378357
PWS B-Disease 1 1.0
infants O 1 0.9999959468841553
. O 0 0.07432913035154343

These O 0 0.022397221997380257
data O 0 0.01663137786090374
demonstrate O 0 0.023108093068003654
that O 0 0.007604922633618116
both O 0 0.007190617732703686
the O 0 0.012513818219304085
position O 0 0.019888143986463547
of O 0 0.017040587961673737
the O 0 0.028071677312254906
IC O 1 0.9999666213989258
and O 0 0.01469513215124607
its O 0 0.014360222965478897
role O 0 0.021352818235754967
in O 0 0.010511880740523338
the O 0 0.016437996178865433
coordinate O 0 0.044827695935964584
expression O 0 0.026594292372465134
of O 0 0.02037513256072998
genes O 0 0.02141556516289711
is O 0 0.015145877376198769
conserved O 0 0.0292273610830307
between O 0 0.02381299063563347
mouse O 0 0.057704564183950424
and O 0 0.02027769759297371
human O 0 0.023972610011696815
, O 0 0.015286847949028015
and O 0 0.012380985543131828
indicate O 0 0.014204151928424835
that O 0 0.00829781498759985
the O 0 0.0179845429956913
mouse O 0 0.04223474860191345
is O 0 0.012976467609405518
a O 0 0.019556302577257156
suitable O 0 0.0382990688085556
model O 0 0.028598494827747345
system O 0 0.020548967644572258
in O 0 0.009243256412446499
which O 0 0.00874282605946064
to O 0 0.011836220510303974
investigate O 0 0.03424271568655968
the O 0 0.023507535457611084
molecular O 0 0.035231590270996094
mechanisms O 0 0.02683274634182453
of O 0 0.02502358704805374
imprinting O 1 0.9620104432106018
in O 0 0.013116874732077122
this O 0 0.008669406175613403
region O 0 0.018047761172056198
of O 0 0.01665472984313965
the O 0 0.0278251264244318
genome O 0 0.04789635166525841
. O 0 0.02399999275803566
. O 0 0.03441106155514717

Mutations O 0 0.05573581904172897
of O 0 0.02602630853652954
the O 0 0.03437488153576851
ATM O 1 0.9877778887748718
gene O 0 0.035791266709566116
detected O 0 0.026503827422857285
in O 0 0.014238097704946995
Japanese O 0 0.4045369327068329
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999839067459106
: O 0 0.03611774370074272
possible O 0 0.0247541144490242
preponderance O 0 0.15090212225914001
of O 0 0.020340926945209503
the O 0 0.02152455970644951
two O 0 0.021961113438010216
founder O 1 0.988849401473999
mutations O 0 0.0765649601817131
4612del165 O 1 0.9990453124046326
and O 0 0.04897293075919151
7883del5 O 1 0.9983009696006775
. O 0 0.05139393359422684

The O 0 0.046660687774419785
ATM O 0 0.48011964559555054
( O 0 0.03173454478383064
A O 1 0.9913138747215271
- O 1 1.0
T O 1 0.9999990463256836
, O 0 0.03009064868092537
mutated O 0 0.07836374640464783
) O 0 0.024305066093802452
gene O 0 0.02793854847550392
on O 0 0.020549491047859192
human O 0 0.04391627013683319
chromosome O 0 0.22252297401428223
11q22 O 1 0.9969509840011597
. O 0 0.05125468969345093

3 O 0 0.049498893320560455
has O 0 0.022869795560836792
recently O 0 0.025196872651576996
been O 0 0.011109271086752415
identified O 0 0.013937086798250675
as O 0 0.010400885716080666
the O 0 0.01402288954705
gene O 0 0.020016616210341454
responsible O 0 0.018062260001897812
for O 0 0.010158906690776348
the O 0 0.02007698267698288
human O 0 0.1325482577085495
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.7466017603874207
A B-Disease 1 0.9999969005584717
- I-Disease 1 1.0
T I-Disease 1 0.999998927116394
) O 0 0.03502461686730385
. O 0 0.03246736899018288

In O 0 0.027073107659816742
order O 0 0.024855973199009895
to O 0 0.016791267320513725
define O 0 0.023330334573984146
the O 0 0.01614326611161232
types O 0 0.01944553479552269
of O 0 0.056559327989816666
disease O 1 1.0
- O 1 1.0
causing O 1 0.9999430179595947
ATM O 1 0.9988188147544861
mutations O 0 0.022253019735217094
in O 0 0.009010102599859238
Japanese O 0 0.03490908443927765
A B-Disease 1 0.9997811913490295
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9995792508125305
as O 0 0.020827436819672585
well O 0 0.013122407719492912
as O 0 0.012299168854951859
to O 0 0.013271838426589966
look O 0 0.01921968162059784
for O 0 0.013514973223209381
possible O 0 0.030921701341867447
mutational O 1 0.9996460676193237
hotspots O 1 0.9888020753860474
, O 0 0.028137963265180588
reverse O 0 0.07710102200508118
- O 1 0.9999192953109741
transcribed O 0 0.06894779950380325
RNA O 0 0.04704248532652855
derived O 0 0.01586037315428257
from O 0 0.012962721288204193
ten O 0 0.02736414223909378
patients O 0 0.07152371853590012
belonging O 0 0.03423463553190231
to O 0 0.01460261270403862
eight O 0 0.016556724905967712
unrelated O 0 0.03288596495985985
Japanese O 0 0.04731494188308716
A B-Disease 1 0.9992393255233765
- I-Disease 1 1.0
T I-Disease 1 0.9999954700469971
families O 0 0.029249396175146103
was O 0 0.02557351440191269
analyzed O 0 0.023333244025707245
for O 0 0.015553354285657406
mutations O 0 0.024985192343592644
by O 0 0.01657143607735634
the O 0 0.029182156547904015
restriction O 0 0.0783323273062706
endonuclease O 1 0.9957804679870605
fingerprinting O 0 0.12549057602882385
method O 0 0.04915757477283478
. O 0 0.03463560715317726

As O 0 0.03934544697403908
has O 0 0.02045547589659691
been O 0 0.01528267003595829
reported O 0 0.019849499687552452
by O 0 0.015859898179769516
others O 0 0.020890135318040848
, O 0 0.020235102623701096
mutations O 0 0.02453692816197872
that O 0 0.010478881187736988
lead O 0 0.0273849219083786
to O 0 0.02517891675233841
exon O 1 0.7686781883239746
skipping O 0 0.15137888491153717
or O 0 0.039228927344083786
premature O 1 0.9998352527618408
protein O 0 0.052321907132864
truncation O 0 0.0938921794295311
were O 0 0.014146353118121624
also O 0 0.015564119443297386
predominant O 0 0.04911564290523529
in O 0 0.019580459222197533
our O 0 0.039439938962459564
mutants O 0 0.23996762931346893
. O 0 0.052146412432193756

Six O 0 0.04005177319049835
different O 0 0.015597822144627571
mutations O 0 0.02898426726460457
were O 0 0.009368153288960457
identified O 0 0.0167129747569561
on O 0 0.011241094209253788
12 O 0 0.013887906447052956
of O 0 0.014817650429904461
the O 0 0.023075684905052185
16 O 0 0.0438256599009037
alleles O 0 0.08251170068979263
examined O 0 0.07996167987585068
. O 0 0.04497820883989334

Four O 0 0.02816416323184967
were O 0 0.019687281921505928
deletions O 0 0.05897403135895729
involving O 0 0.02914646826684475
a O 0 0.023097826167941093
loss O 0 0.030492613092064857
of O 0 0.022265465930104256
a O 0 0.02959566004574299
single O 0 0.04285416379570961
exon O 1 0.5654529929161072
exon O 0 0.12961992621421814
7 O 0 0.040268417447805405
, O 0 0.022589700296521187
exon O 0 0.09030512720346451
16 O 0 0.031816136091947556
, O 0 0.027181485667824745
exon O 0 0.11467504501342773
33 O 0 0.05762123316526413
or O 0 0.030831510201096535
exon O 0 0.1299726963043213
35 O 0 0.06425219029188156
. O 0 0.04267612099647522

The O 0 0.04858732968568802
others O 0 0.026838308200240135
were O 0 0.01700686849653721
minute O 0 0.05014640837907791
deletions O 0 0.07600026577711105
, O 0 0.031505223363637924
4649delA O 0 0.14687056839466095
in O 0 0.029384087771177292
exon O 0 0.12770408391952515
33 O 0 0.053523868322372437
and O 0 0.030244529247283936
7883del5 O 1 0.9072432518005371
in O 0 0.03409362584352493
exon O 0 0.2835131883621216
55 O 0 0.07479209452867508
. O 0 0.042505498975515366

The O 0 0.06945352256298065
mutations O 0 0.0962216928601265
4612del165 O 1 0.9971816539764404
and O 0 0.038553036749362946
7883del5 O 1 0.9963036775588989
were O 0 0.01430747751146555
found O 0 0.010130354203283787
in O 0 0.008052303455770016
more O 0 0.005615151487290859
than O 0 0.00732327438890934
two O 0 0.010224166326224804
unrelated O 0 0.03240562230348587
families O 0 0.02686302177608013
; O 0 0.02142123132944107
44 O 0 0.037090931087732315
% O 0 0.02140294760465622
( O 0 0.016993151977658272
7 O 0 0.021898092702031136
of O 0 0.015647130087018013
16 O 0 0.021636225283145905
) O 0 0.011250011622905731
of O 0 0.012581263668835163
the O 0 0.024414552375674248
mutant O 1 0.6453433632850647
alleles O 0 0.05497542768716812
had O 0 0.017798971384763718
one O 0 0.012386479414999485
of O 0 0.015981856733560562
the O 0 0.021376198157668114
two O 0 0.024111516773700714
mutations O 0 0.05567139759659767
. O 0 0.0398731492459774

The O 0 0.08213822543621063
4612del165 O 1 0.9997164607048035
mutations O 0 0.04482181742787361
in O 0 0.012726565822958946
three O 0 0.010672676376998425
different O 0 0.006392371840775013
families O 0 0.013151603750884533
were O 0 0.007411645259708166
all O 0 0.010359274223446846
ascribed O 0 0.036264244467020035
to O 0 0.01075750682502985
the O 0 0.015097339637577534
same O 0 0.01953093148767948
T O 1 0.9999971389770508
- O 1 0.9999994039535522
- O 1 0.9999927282333374
> O 1 0.5001933574676514
A O 0 0.035608045756816864
substitution O 0 0.03755301609635353
at O 0 0.01927153393626213
the O 0 0.02469424344599247
splice O 0 0.13137951493263245
donor O 0 0.06827469915151596
site O 0 0.03819955140352249
in O 0 0.027312472462654114
intron O 1 0.9981881976127625
33 O 0 0.08461793512105942
. O 0 0.048102378845214844

Microsatellite O 1 0.9818477630615234
genotyping O 1 0.7337663769721985
around O 0 0.030207831412553787
the O 0 0.036266762763261795
ATM O 1 0.9952523708343506
locus O 0 0.1480378657579422
also O 0 0.017532212659716606
indicated O 0 0.020151732489466667
that O 0 0.008314505219459534
a O 0 0.02159898728132248
common O 0 0.030099015682935715
haplotype O 0 0.15828870236873627
was O 0 0.024309629574418068
shared O 0 0.022103607654571533
by O 0 0.01443339791148901
the O 0 0.023264950141310692
mutant O 1 0.6825675964355469
alleles O 0 0.06987903267145157
in O 0 0.023596398532390594
both O 0 0.029401227831840515
mutations O 0 0.06066206470131874
. O 0 0.04157151281833649

This O 0 0.026364248245954514
suggests O 0 0.027640830725431442
that O 0 0.008122557774186134
these O 0 0.0067522767931222916
two O 0 0.01536939013749361
founder O 1 0.9998167157173157
mutations O 0 0.04850739985704422
may O 0 0.019396258518099785
be O 0 0.012533466331660748
predominant O 0 0.04681608825922012
among O 0 0.028457999229431152
Japanese O 0 0.0716184601187706
ATM O 1 0.988673985004425
mutant O 1 0.7179332971572876
alleles O 0 0.11939642578363419
. O 0 0.051636893302202225

W474C O 1 0.9996558427810669
amino O 0 0.12323155254125595
acid O 0 0.1368686556816101
substitution O 0 0.09046659618616104
affects O 0 0.04736364260315895
early O 0 0.02078898996114731
processing O 0 0.013409064151346684
of O 0 0.010514658875763416
the O 0 0.017873641103506088
alpha O 0 0.17264701426029205
- O 1 0.9348130226135254
subunit O 0 0.05302281677722931
of O 0 0.021703073754906654
beta O 1 0.8765925765037537
- O 1 0.9998893737792969
hexosaminidase O 1 0.9764629602432251
A O 0 0.03449588268995285
and O 0 0.015380325727164745
is O 0 0.014679254963994026
associated O 0 0.02235533855855465
with O 0 0.03756868094205856
subacute O 1 1.0
G B-Disease 1 0.9999998807907104
( I-Disease 0 0.43276578187942505
M2 I-Disease 1 0.9999319314956665
) I-Disease 0 0.056648194789886475
gangliosidosis I-Disease 1 0.9746583104133606
. O 0 0.05304745212197304

Mutations O 0 0.0671183317899704
in O 0 0.021481890231370926
the O 0 0.04446681588888168
HEXA O 1 1.0
gene O 0 0.042650189250707626
, O 0 0.014554047025740147
encoding O 0 0.018356310203671455
the O 0 0.017045246437191963
alpha O 0 0.07315313816070557
- O 0 0.20660406351089478
subunit O 0 0.053829893469810486
of O 0 0.02071751281619072
beta O 0 0.45806625485420227
- O 1 0.9997648596763611
hexosaminidase O 1 0.9980073571205139
A O 0 0.05195073038339615
( O 0 0.03458070009946823
Hex O 1 0.7581695318222046
A O 0 0.04004107043147087
) O 0 0.017573492601513863
, O 0 0.011516548693180084
that O 0 0.00860786996781826
abolish O 0 0.06016213074326515
Hex O 0 0.16253302991390228
A O 0 0.04293300583958626
enzyme O 0 0.05448385328054428
activity O 0 0.03527355194091797
cause O 1 0.9997493624687195
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9872775673866272
TSD B-Disease 1 1.0
) O 0 0.0273135956376791
, O 0 0.01625949703156948
the O 0 0.025375518947839737
fatal O 1 0.999994158744812
infantile B-Disease 1 1.0
form I-Disease 0 0.37864193320274353
of I-Disease 1 0.9768874645233154
G I-Disease 1 0.9999998807907104
( I-Disease 0 0.060547661036252975
M2 I-Disease 1 0.9999517202377319
) I-Disease 0 0.03820331394672394
gangliosidosis I-Disease 1 0.9941191673278809
, I-Disease 0 0.03711714595556259
Type I-Disease 0 0.06838635355234146
1 I-Disease 0 0.054571039974689484
. O 0 0.04070596396923065

Less O 0 0.05228311941027641
severe O 1 0.9997480511665344
, O 0 0.07668213546276093
subacute O 1 1.0
( O 1 0.9314048886299133
juvenile O 1 1.0
- O 1 1.0
onset O 1 1.0
) O 0 0.08591115474700928
and O 0 0.14114008843898773
chronic O 1 1.0
( O 1 0.938193142414093
adult O 1 0.9999724626541138
- O 1 1.0
onset O 1 1.0
) O 0 0.030989116057753563
variants O 0 0.02419942244887352
are O 0 0.006828124634921551
characterized O 0 0.02435661107301712
by O 0 0.01312611997127533
a O 0 0.022683892399072647
broad O 0 0.0467187762260437
spectrum O 0 0.04962762072682381
of O 0 0.03585149347782135
clinical O 1 0.9999977350234985
manifestations O 1 0.9999998807907104
and O 0 0.02971753664314747
are O 0 0.009643091820180416
associated O 0 0.01642184518277645
with O 0 0.017444903030991554
residual O 1 0.9713810682296753
levels O 0 0.02849826030433178
of O 0 0.027552900835871696
Hex O 1 0.999428927898407
A O 1 0.5841996669769287
enzyme O 0 0.11404130607843399
activity O 0 0.041827861219644547
. O 0 0.034717459231615067

We O 0 0.022188354283571243
identified O 0 0.026766207069158554
a O 0 0.03235336020588875
1422 O 1 0.9999650716781616
G O 1 0.9999898672103882
- O 1 0.9999997615814209
- O 1 0.9999991655349731
> O 1 0.9995854496955872
C O 1 0.9978271126747131
( O 0 0.042897917330265045
amino O 0 0.06126421317458153
acid O 0 0.34042006731033325
W474C O 1 0.9985210299491882
) O 0 0.024601858109235764
substitution O 0 0.03360084071755409
in O 0 0.009957888163626194
the O 0 0.013043145649135113
first O 0 0.015357514843344688
position O 0 0.020920371636748314
of O 0 0.017674947157502174
exon O 0 0.07465806603431702
13 O 0 0.025572828948497772
of O 0 0.028254074975848198
HEXA O 1 0.9999858140945435
of O 0 0.023282423615455627
a O 0 0.02865258976817131
non O 0 0.16523048281669617
- O 1 0.999629020690918
Jewish O 0 0.06663228571414948
proband O 1 0.9793074131011963
who O 0 0.034010741859674454
manifested O 0 0.42324134707450867
a O 0 0.05117305740714073
subacute O 1 1.0
variant O 0 0.48842599987983704
of O 0 0.09706088900566101
G B-Disease 1 0.9999991655349731
( I-Disease 0 0.0706866905093193
M2 I-Disease 1 0.9999074935913086
) I-Disease 0 0.05135326460003853
gangliosidosis I-Disease 1 0.9399243593215942
. O 0 0.05023523047566414

On O 0 0.027721408754587173
the O 0 0.024030214175581932
second O 0 0.053189631551504135
maternally O 1 0.9965893030166626
inherited O 1 0.9997499585151672
allele O 0 0.12667204439640045
, O 0 0.016870755702257156
we O 0 0.008218892849981785
identified O 0 0.01405642181634903
the O 0 0.016133416444063187
common O 0 0.26371827721595764
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9999645948410034
4 O 0 0.29620954394340515
- O 1 0.9999679327011108
bp O 0 0.08321421593427658
insertion O 0 0.0871998593211174
, O 0 0.03634372726082802
+ O 1 0.7374363541603088
TATC O 1 0.9999690055847168
1278 O 1 0.9999328851699829
, O 0 0.03115411289036274
in O 0 0.026477638632059097
exon O 0 0.13367247581481934
11 O 0 0.05364871397614479
. O 0 0.04078008234500885

Pulse O 1 0.9995150566101074
- O 1 0.9997255206108093
chase O 0 0.10047208517789841
analysis O 0 0.02461642026901245
using O 0 0.02148950845003128
proband O 1 0.9856840372085571
fibroblasts O 0 0.21070903539657593
revealed O 0 0.029198545962572098
that O 0 0.008292139507830143
the O 0 0.01788589172065258
W474C O 1 0.9985108971595764
- O 1 0.9959459900856018
containing O 0 0.030000003054738045
alpha O 0 0.254292368888855
- O 1 0.9986099004745483
subunit O 0 0.10853135585784912
precursor O 0 0.06710327416658401
was O 0 0.02981751039624214
normally O 0 0.028577305376529694
synthesized O 0 0.04636424407362938
, O 0 0.01466238684952259
but O 0 0.010388010181486607
not O 0 0.014236913062632084
phosphorylated O 1 0.5224870443344116
or O 0 0.02470841445028782
secreted O 0 0.05175946280360222
, O 0 0.012452613562345505
and O 0 0.01035086065530777
the O 0 0.01881062611937523
mature O 0 0.25974392890930176
lysosomal O 1 0.9999997615814209
alpha O 1 0.9999638795852661
- O 1 0.9999912977218628
subunit O 0 0.1120816171169281
was O 0 0.03463765233755112
not O 0 0.01965361461043358
detected O 0 0.05266974866390228
. O 0 0.03230636194348335

When O 0 0.031912628561258316
the O 0 0.029489608481526375
W474C O 1 0.9858112335205078
- O 1 0.9955825209617615
containing O 0 0.03289102017879486
alpha O 0 0.39081767201423645
- O 1 0.9982073307037354
subunit O 0 0.07439550757408142
was O 0 0.03521747142076492
transiently O 1 0.6020368337631226
co O 0 0.4425342381000519
- O 1 0.7723443508148193
expressed O 0 0.018371526151895523
with O 0 0.010505564510822296
the O 0 0.019059227779507637
beta O 1 0.881894588470459
- O 1 0.996990442276001
subunit O 0 0.06120533496141434
to O 0 0.014376151375472546
produce O 0 0.017808541655540466
Hex O 0 0.09509383141994476
A O 0 0.04506085813045502
( O 0 0.03029797226190567
alphabeta O 1 0.9575306177139282
) O 0 0.0187707357108593
in O 0 0.01994253881275654
COS O 1 0.9999998807907104
- O 1 0.9999979734420776
7 O 0 0.047469642013311386
cells O 0 0.02549319714307785
, O 0 0.010072707198560238
the O 0 0.01487887091934681
mature O 0 0.04449379816651344
alpha O 1 0.9169968366622925
- O 1 0.9999485015869141
subunit O 0 0.08357171714305878
was O 0 0.022582247853279114
present O 0 0.015412991866469383
, O 0 0.01113789901137352
but O 0 0.006897511892020702
its O 0 0.010619169101119041
level O 0 0.017804022878408432
was O 0 0.017216261476278305
much O 0 0.012359488755464554
lower O 0 0.017605042085051537
than O 0 0.006376358214765787
that O 0 0.005379434209316969
from O 0 0.010174968279898167
normal O 0 0.026923974975943565
alpha O 1 0.9103173613548279
- O 1 0.9998998641967773
subunit O 0 0.4174954295158386
transfections O 1 0.9323853850364685
, O 0 0.01892990618944168
although O 0 0.012306349352002144
higher O 0 0.011920535936951637
than O 0 0.008016284555196762
in O 0 0.011414200067520142
those O 0 0.015084397047758102
cells O 0 0.037397127598524094
transfected O 0 0.11036950349807739
with O 0 0.015805235132575035
an O 0 0.022185098379850388
alpha O 1 0.9255690574645996
- O 1 0.9993759989738464
subunit O 0 0.10113353282213211
associated O 0 0.03562181442975998
with O 0 0.042214348912239075
infantile O 1 1.0
TSD B-Disease 1 0.9999998807907104
. O 0 0.09353844076395035

Furthermore O 0 0.06391728669404984
, O 0 0.023606285452842712
the O 0 0.022914083674550056
precursor O 0 0.05245493724942207
level O 0 0.01964639499783516
of O 0 0.015694689005613327
the O 0 0.024949904531240463
W474C O 1 0.9999669790267944
alpha O 1 0.99894779920578
- O 1 0.9998569488525391
subunit O 0 0.08067174255847931
was O 0 0.02632841095328331
found O 0 0.013589492067694664
to O 0 0.01623506285250187
accumulate O 0 0.04255291819572449
in O 0 0.011618544347584248
comparison O 0 0.0163296926766634
to O 0 0.01079449150711298
the O 0 0.017048608511686325
normal O 0 0.03603043407201767
alpha O 1 0.969109296798706
- O 1 0.9999381303787231
subunit O 0 0.22758634388446808
precursor O 0 0.10955154895782471
levels O 0 0.050351426005363464
. O 0 0.038749683648347855

We O 0 0.026680948212742805
conclude O 0 0.03554469347000122
that O 0 0.010322807356715202
the O 0 0.022398874163627625
1422 O 1 0.9999940395355225
G O 1 0.9999963045120239
- O 1 0.9999998807907104
- O 1 0.9999995231628418
> O 1 0.999853253364563
C O 1 0.975590705871582
mutation O 0 0.03837212547659874
is O 0 0.01198133360594511
the O 0 0.015822170302271843
cause O 0 0.03146323934197426
of O 0 0.028271960094571114
Hex B-Disease 1 0.999957799911499
A I-Disease 1 0.9999347925186157
enzyme I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
in O 0 0.03545253351330757
the O 0 0.05409407615661621
proband O 1 0.9997819066047668
. O 0 0.05096950754523277

The O 0 0.05769147351384163
resulting O 0 0.07347678393125534
W474C O 1 0.9921030402183533
substitution O 0 0.08062118291854858
clearly O 0 0.03405629098415375
interferes O 0 0.08361497521400452
with O 0 0.02326597087085247
alpha O 1 0.9966729879379272
- O 1 0.9999631643295288
subunit O 0 0.131631001830101
processing O 0 0.02439325861632824
, O 0 0.012877112254500389
but O 0 0.009335754439234734
because O 0 0.011213424615561962
the O 0 0.01629810407757759
base O 0 0.03891342133283615
substitution O 0 0.04783342406153679
falls O 0 0.05314137786626816
at O 0 0.01611783169209957
the O 0 0.011382810771465302
first O 0 0.013367419131100178
position O 0 0.017953189089894295
of O 0 0.02036825567483902
exon O 0 0.09182147681713104
13 O 0 0.03236391767859459
, O 0 0.026494698598980904
aberrant O 1 0.9981170892715454
splicing O 0 0.06639857590198517
may O 0 0.016204072162508965
also O 0 0.010658392682671547
contribute O 0 0.020981354638934135
to O 0 0.02123827300965786
Hex B-Disease 1 0.9987694621086121
A I-Disease 1 0.9989649057388306
deficiency I-Disease 1 1.0
in O 0 0.030672354623675346
this O 0 0.027011225000023842
proband O 1 0.9986129999160767
. O 0 0.030550824478268623
. O 0 0.0320265106856823

Two O 0 0.03455521538853645
frequent O 0 0.08469686657190323
missense O 1 0.901237428188324
mutations O 0 0.0882289931178093
in O 0 0.06268913298845291
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.734222412109375

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.10836625099182129
an O 1 0.9902790188789368
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9932060241699219
early O 1 0.9998874664306641
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999953508377075
goiter B-Disease 1 1.0
. O 1 0.7746519446372986

A O 0 0.05433925241231918
century O 0 0.04218814894556999
after O 0 0.02562795765697956
its O 0 0.016604900360107422
recognition O 0 0.026563338935375214
as O 0 0.020002910867333412
a O 0 0.0452461801469326
syndrome O 1 1.0
by O 0 0.04004712775349617
Vaughan O 1 0.9999961853027344
Pendred O 1 0.9999967813491821
, O 0 0.02816927433013916
the O 0 0.049219388514757156
disease O 1 1.0
gene O 1 0.981097936630249
( O 0 0.06488551199436188
PDS O 1 0.9999995231628418
) O 0 0.02814330719411373
was O 0 0.028515802696347237
mapped O 0 0.04122323915362358
to O 0 0.02791961096227169
chromosome O 0 0.09941678494215012
7q22 O 1 0.9996495246887207
- O 1 0.9999395608901978
q31 O 1 0.9851678609848022
. O 0 0.057524655014276505

1 O 0 0.06202148273587227
and O 0 0.02665601298213005
, O 0 0.02326289564371109
recently O 0 0.02876475639641285
, O 0 0.014367857947945595
found O 0 0.010698248632252216
to O 0 0.013983559794723988
encode O 0 0.037794120609760284
a O 0 0.0499056801199913
putative O 1 0.9992094039916992
sulfate O 1 0.9999949932098389
transporter O 1 0.9997519850730896
. O 0 0.05648161098361015

We O 0 0.0359635204076767
performed O 0 0.04947865381836891
mutation O 0 0.03938913345336914
analysis O 0 0.012197441421449184
of O 0 0.016943449154496193
the O 0 0.03289712965488434
PDS B-Disease 1 1.0
gene O 0 0.04561866819858551
in O 0 0.022441137582063675
patients O 1 0.6771916747093201
from O 0 0.022360553964972496
14 O 0 0.04345032572746277
Pendred B-Disease 1 0.9976213574409485
families O 0 0.035701047629117966
originating O 0 0.0387410968542099
from O 0 0.013599389232695103
seven O 0 0.015775319188833237
countries O 0 0.011434965766966343
and O 0 0.015221751295030117
identified O 0 0.026856431737542152
all O 0 0.021147005259990692
mutations O 0 0.05360547825694084
. O 0 0.037571702152490616

The O 0 0.05700594559311867
mutations O 0 0.04379991069436073
include O 0 0.01962248608469963
three O 0 0.016291577368974686
single O 0 0.03812345489859581
base O 0 0.05363656207919121
deletions O 0 0.06091853603720665
, O 0 0.017462002113461494
one O 0 0.02277485653758049
splice O 0 0.1073416918516159
site O 0 0.04635241627693176
mutation O 0 0.04494740068912506
and O 0 0.020769566297531128
10 O 0 0.039030566811561584
missense O 1 0.6227564215660095
mutations O 0 0.0754828006029129
. O 0 0.04371866211295128

One O 0 0.058841072022914886
missense O 1 0.9173787832260132
mutation O 0 0.24332822859287262
( O 0 0.05050511658191681
L236P O 1 0.9998924732208252
) O 0 0.02458735927939415
was O 0 0.020516270771622658
found O 0 0.010541567578911781
in O 0 0.008674821816384792
a O 0 0.017832528799772263
homozygous O 0 0.03956042230129242
state O 0 0.011369510553777218
in O 0 0.011061462573707104
two O 0 0.017466943711042404
consanguineous O 1 0.9972694516181946
families O 0 0.029275117442011833
and O 0 0.014659004285931587
in O 0 0.01259341835975647
a O 0 0.02132154069840908
heterozygous O 0 0.03690028935670853
state O 0 0.010292195715010166
in O 0 0.00900896918028593
five O 0 0.013484352268278599
additional O 0 0.023132797330617905
non O 0 0.22437074780464172
- O 1 0.9999881982803345
consanguineous O 1 0.999220609664917
families O 0 0.06520626693964005
. O 0 0.0486934669315815

Another O 0 0.08597584068775177
missense O 1 0.9804794788360596
mutation O 1 0.5411570072174072
( O 0 0.046852078288793564
T416P O 1 0.9995661377906799
) O 0 0.023747729137539864
was O 0 0.019103607162833214
found O 0 0.010078195482492447
in O 0 0.008439255878329277
a O 0 0.01581217162311077
homozygous O 0 0.035956963896751404
state O 0 0.0107005899772048
in O 0 0.01073658186942339
one O 0 0.014875390566885471
family O 0 0.02359543927013874
and O 0 0.01400341559201479
in O 0 0.011946038343012333
a O 0 0.02228976972401142
heterozygous O 0 0.044287677854299545
state O 0 0.012954303994774818
in O 0 0.01304855477064848
four O 0 0.020647156983613968
families O 0 0.03930739313364029
. O 0 0.041986435651779175

Pendred B-Disease 1 0.9999109506607056
patients O 0 0.44522204995155334
in O 0 0.019460348412394524
three O 0 0.023156678304076195
non O 1 0.9231992959976196
- O 1 0.9999969005584717
consanguineous O 1 0.9991567134857178
families O 0 0.02852248214185238
were O 0 0.012040067464113235
shown O 0 0.014118006452918053
to O 0 0.014484433457255363
be O 0 0.015312211588025093
compound O 0 0.0675850436091423
heterozygotes O 0 0.35229790210723877
for O 0 0.03877171874046326
L236P O 1 0.998957633972168
and O 0 0.0515398345887661
T416P O 1 0.9987275004386902
. O 0 0.05687421187758446

In O 0 0.026947589591145515
total O 0 0.022601891309022903
, O 0 0.017238430678844452
one O 0 0.014504240825772285
or O 0 0.012847869656980038
both O 0 0.010792291723191738
of O 0 0.016972845420241356
these O 0 0.012979705817997456
mutations O 0 0.02458919584751129
were O 0 0.009079063311219215
found O 0 0.009747549891471863
in O 0 0.008470091968774796
nine O 0 0.014238573610782623
of O 0 0.01730683259665966
the O 0 0.026223599910736084
14 O 0 0.038114044815301895
families O 0 0.039883922785520554
analyzed O 0 0.04805832728743553
. O 0 0.03890508413314819

The O 0 0.03576318919658661
identification O 0 0.028493888676166534
of O 0 0.01833179220557213
two O 0 0.019741058349609375
frequent O 1 0.7576022148132324
PDS B-Disease 1 1.0
mutations O 0 0.047792498022317886
will O 0 0.015643693506717682
facilitate O 0 0.03214263170957565
the O 0 0.02570401504635811
molecular O 0 0.06776686757802963
diagnosis O 1 0.999996542930603
of O 1 0.9997660517692566
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9209365844726562

Insertional O 1 0.9961303472518921
mutation O 0 0.09206553548574448
by O 0 0.04231274500489235
transposable O 1 0.99959796667099
element O 0 0.11503750830888748
, O 0 0.033358097076416016
L1 O 1 0.9997621178627014
, O 0 0.015434781089425087
in O 0 0.012483284808695316
the O 0 0.03018857352435589
DMD B-Disease 1 1.0
gene O 0 0.03317313268780708
results O 0 0.0133082065731287
in O 0 0.01867532730102539
X B-Disease 1 0.9999144077301025
- I-Disease 1 0.9999997615814209
linked I-Disease 1 0.9999043941497803
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
. O 0 0.12802770733833313

X B-Disease 1 0.9997656941413879
- I-Disease 1 0.9999996423721313
linked I-Disease 1 0.9999706745147705
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9997562766075134
XLDCM B-Disease 1 1.0
) O 0 0.027147116139531136
is O 0 0.015416785143315792
a O 0 0.026066979393363
clinical O 1 0.9100660085678101
phenotype O 1 0.8726632595062256
of O 0 0.037335559725761414
dystrophinopathy B-Disease 1 0.999975323677063
which O 0 0.02000550739467144
is O 0 0.019120123237371445
characterized O 0 0.04180392995476723
by O 0 0.03372602537274361
preferential O 1 0.999993085861206
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.999509334564209
without O 0 0.024477491155266762
any O 0 0.02048058807849884
overt O 1 0.9819874167442322
clinical O 1 0.9997921586036682
signs O 1 0.9705213308334351
of O 1 0.9995713829994202
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.35659274458885193

To O 0 0.02956596575677395
date O 0 0.023806210607290268
, O 0 0.011784881353378296
several O 0 0.008638964965939522
mutations O 0 0.019146688282489777
in O 0 0.013494301587343216
the O 0 0.04762335121631622
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999973773956299
, O 1 0.9947075843811035
DMD O 1 1.0
, O 0 0.02310292050242424
have O 0 0.00885814055800438
been O 0 0.011353271082043648
identified O 0 0.017562001943588257
in O 0 0.015307948924601078
patients O 1 0.8529409766197205
with O 0 0.028983715921640396
XLDCM B-Disease 1 0.9999985694885254
, O 0 0.022054972127079964
but O 0 0.012709945440292358
a O 0 0.022229120135307312
pathogenic O 0 0.0555901937186718
correlation O 0 0.031892552971839905
of O 0 0.018197549507021904
these O 0 0.014574139378964901
cardiospecific O 1 0.9997053742408752
mutations O 0 0.04787047579884529
in O 0 0.02750321477651596
DMD O 1 0.9999998807907104
with O 0 0.027623029425740242
the O 0 0.048706624656915665
XLDCM B-Disease 1 1.0
phenotype O 1 0.9983127117156982
has O 0 0.02361380122601986
remained O 0 0.04238501191139221
to O 0 0.02254427969455719
be O 0 0.02365240268409252
elucidated O 0 0.15250448882579803
. O 0 0.042553167790174484

We O 0 0.026026645675301552
report O 0 0.01848299242556095
here O 0 0.011803466826677322
the O 0 0.013212491758167744
identification O 0 0.017301423475146294
of O 0 0.012373838573694229
a O 0 0.01942279562354088
unique O 0 0.02464325726032257
de O 0 0.08513692021369934
novo O 1 0.9969758987426758
L1 O 1 0.999879002571106
insertion O 0 0.09321491420269012
in O 0 0.017267301678657532
the O 0 0.02997349202632904
muscle O 1 0.9943313598632812
exon O 1 0.9615892171859741
1 O 0 0.04326141998171806
in O 0 0.027366332709789276
DMD O 1 0.9999996423721313
in O 0 0.021566186100244522
three O 0 0.03046441823244095
XLDCM B-Disease 1 0.9999996423721313
patients O 1 0.9989952445030212
from O 0 0.022892508655786514
two O 0 0.019131436944007874
unrelated O 0 0.04839557036757469
Japanese O 0 0.06095285341143608
families O 0 0.04957832768559456
. O 0 0.04038320109248161

The O 0 0.04578760266304016
insertion O 0 0.08466431498527527
was O 0 0.02711479924619198
a O 0 0.024876069277524948
5 O 0 0.03711196407675743
- O 1 0.9972599744796753
truncated O 0 0.06698554009199142
form O 0 0.021516896784305573
of O 0 0.020774707198143005
human O 0 0.04112247750163078
L1 O 1 0.9999736547470093
inversely O 0 0.0891508013010025
integrated O 0 0.04213719815015793
in O 0 0.010653405450284481
the O 0 0.01658044569194317
5 O 0 0.036157719790935516
- O 1 0.999758780002594
untranslated O 1 0.855769157409668
region O 0 0.022671647369861603
in O 0 0.01306100096553564
the O 0 0.02550705336034298
muscle O 1 0.9998680353164673
exon O 1 0.9991293549537659
1 O 0 0.03900860622525215
, O 0 0.015288153663277626
which O 0 0.0098745571449399
affected O 0 0.01889987476170063
the O 0 0.019623741507530212
transcription O 0 0.05200463905930519
or O 0 0.012676623649895191
the O 0 0.016368603333830833
stability O 0 0.03315318003296852
of O 0 0.02040737122297287
the O 0 0.03273746371269226
muscle O 1 0.9993984699249268
form O 0 0.02724357135593891
of O 0 0.03852791339159012
dystrophin O 1 0.9999734163284302
transcripts O 0 0.04024716839194298
but O 0 0.008752435445785522
not O 0 0.004974250216037035
that O 0 0.004401505924761295
of O 0 0.011860896833240986
the O 0 0.02565358579158783
brain O 1 0.9992766976356506
or O 0 0.044838301837444305
Purkinje O 1 0.9999998807907104
cell O 1 0.9216101765632629
form O 0 0.02950674667954445
, O 0 0.019369326531887054
probably O 0 0.01822163723409176
due O 0 0.01469484157860279
to O 0 0.012012182734906673
its O 0 0.013299436308443546
unique O 0 0.020030908286571503
site O 0 0.02894945628941059
of O 0 0.026900550350546837
integration O 0 0.06867124885320663
. O 0 0.0470876507461071

We O 0 0.031020071357488632
speculate O 0 0.037993207573890686
that O 0 0.009142252616584301
this O 0 0.008481256663799286
insertion O 0 0.044639308005571365
of O 0 0.017513109371066093
an O 0 0.023997455835342407
L1 O 1 0.999818742275238
sequence O 0 0.0305420383810997
in O 0 0.02832288295030594
DMD O 1 1.0
is O 0 0.02133754827082157
responsible O 0 0.025359343737363815
for O 0 0.00947832316160202
some O 0 0.006037665065377951
of O 0 0.010357925668358803
the O 0 0.014253419823944569
population O 0 0.013164965435862541
of O 0 0.01927897147834301
Japanese O 0 0.1263570636510849
patients O 1 0.9994018077850342
with O 0 0.04274356737732887
XLDCM B-Disease 1 0.9999994039535522
. O 0 0.03608053922653198
. O 0 0.03828445449471474

Severe O 1 0.9986250400543213
early O 0 0.4033048748970032
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999997615814209
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999196529388428
red O 1 1.0
hair O 1 0.9999995231628418
pigmentation O 1 0.9999998807907104
caused O 1 0.9996566772460938
by O 0 0.49586784839630127
POMC O 1 1.0
mutations O 0 0.0740431696176529
in O 0 0.028873106464743614
humans O 0 0.04075145721435547
. O 0 0.03949259594082832

Sequential O 0 0.1205819770693779
cleavage O 0 0.19035115838050842
of O 0 0.028531474992632866
the O 0 0.03257163241505623
precursor O 0 0.09272327274084091
protein O 0 0.03679419681429863
pre O 0 0.07939860969781876
- O 1 0.9997425675392151
pro O 1 0.983896017074585
- O 1 0.9999949932098389
opiomelanocortin O 1 0.9999076128005981
( O 0 0.05466173216700554
POMC O 1 0.9999468326568604
) O 0 0.027865326032042503
generates O 0 0.034663353115320206
the O 0 0.036433909088373184
melanocortin O 1 0.999950647354126
peptides O 0 0.16565591096878052
adrenocorticotrophin O 1 0.9999068975448608
( O 0 0.07330804318189621
ACTH O 1 0.9999958276748657
) O 0 0.031306054443120956
, O 0 0.034457121044397354
melanocyte O 1 0.9999997615814209
- O 1 0.9999998807907104
stimulating O 1 0.9999935626983643
hormones O 1 0.998794436454773
( O 0 0.06062229722738266
MSH O 1 1.0
) O 0 0.034598466008901596
alpha O 0 0.1559479534626007
, O 0 0.023286918178200722
beta O 0 0.06832294911146164
and O 0 0.020459339022636414
gamma O 0 0.06409727036952972
as O 0 0.01287528220564127
well O 0 0.00863113533705473
as O 0 0.009932348504662514
the O 0 0.020695481449365616
opioid O 1 0.9999978542327881
- O 1 0.9999990463256836
receptor O 1 0.9982039928436279
ligand O 1 0.9958114624023438
beta O 1 0.9957476258277893
- O 1 0.9999589920043945
endorphin O 1 0.9993463158607483
. O 0 0.05612373352050781

While O 0 0.032035522162914276
a O 0 0.02394634671509266
few O 0 0.01638738438487053
cases O 0 0.02150592766702175
of O 0 0.04154577851295471
isolated O 1 0.999998927116394
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.02000008150935173
been O 0 0.017666148021817207
reported O 0 0.029003705829381943
( O 0 0.04055383801460266
OMIM O 1 0.9999998807907104
201400 O 1 0.9999794960021973
) O 0 0.021485742181539536
, O 0 0.016047606244683266
an O 0 0.02567138522863388
inherited O 1 0.9999997615814209
POMC O 1 1.0
defect O 1 0.9999998807907104
has O 0 0.025444967672228813
not O 0 0.01242024078965187
been O 0 0.014901295304298401
described O 0 0.026028510183095932
so O 0 0.016047796234488487
far O 0 0.02206750214099884
. O 0 0.030144991353154182

Recent O 0 0.04920823872089386
studies O 0 0.026631100103259087
in O 0 0.01764032244682312
animal O 0 0.03345585614442825
models O 0 0.026026727631688118
elucidated O 0 0.07436095923185349
a O 0 0.01790972799062729
central O 0 0.019331078976392746
role O 0 0.025189148262143135
of O 0 0.0270161684602499
alpha O 1 0.9998743534088135
- O 1 0.9999972581863403
MSH O 1 0.9999940395355225
in O 0 0.01381584070622921
the O 0 0.016636431217193604
regulation O 0 0.026232220232486725
of O 0 0.022359494119882584
food O 0 0.04172629863023758
intake O 0 0.18129713833332062
by O 0 0.017388466745615005
activation O 0 0.03689579665660858
of O 0 0.016019778326153755
the O 0 0.02637835219502449
brain O 1 0.9975661039352417
melanocortin O 1 1.0
- O 1 0.9999971389770508
4 O 0 0.06000601872801781
- O 1 0.9999607801437378
receptor O 0 0.4583902060985565
( O 0 0.04111962020397186
MC4 O 1 0.9999988079071045
- O 1 0.9999904632568359
R O 1 0.9678179025650024
; O 0 0.02646154724061489
refs O 0 0.08726473897695541
3 O 0 0.04349914938211441
- O 1 0.9988956451416016
5 O 0 0.02772180549800396
) O 0 0.01231189165264368
and O 0 0.00865556113421917
the O 0 0.014991042204201221
linkage O 0 0.05859306454658508
of O 0 0.026225242763757706
human O 1 0.6613944172859192
obesity B-Disease 1 1.0
to O 0 0.0688544288277626
chromosome O 1 0.5164782404899597
2 O 0 0.027097420766949654
in O 0 0.011902756057679653
close O 0 0.021468373015522957
proximity O 0 0.03310885652899742
to O 0 0.017673397436738014
the O 0 0.035983387380838394
POMC O 1 0.9999997615814209
locus O 1 0.9253351092338562
, O 0 0.02208600379526615
led O 0 0.02627892605960369
to O 0 0.013182037509977818
the O 0 0.01366625539958477
proposal O 0 0.01872214488685131
of O 0 0.012635706923902035
an O 0 0.014699144288897514
association O 0 0.02665393427014351
of O 0 0.035334471613168716
POMC O 1 0.9999997615814209
with O 0 0.04966958239674568
human O 1 0.9948447942733765
obesity B-Disease 1 1.0
. O 0 0.0785159021615982

The O 0 0.03914943337440491
dual O 0 0.05723653361201286
role O 0 0.036779601126909256
of O 0 0.03417588397860527
alpha O 1 0.9995598196983337
- O 1 0.9999979734420776
MSH O 1 0.9999986886978149
in O 0 0.02527531236410141
regulating O 0 0.06555875390768051
food O 0 0.05735153704881668
intake O 1 0.973730206489563
and O 0 0.029099969193339348
influencing O 1 0.9909554123878479
hair O 1 0.9997057318687439
pigmentation O 1 0.999997615814209
predicts O 0 0.10525017976760864
that O 0 0.014425395056605339
the O 0 0.026548251509666443
phenotype O 0 0.07991491258144379
associated O 0 0.020104659721255302
with O 0 0.01625945046544075
a O 0 0.03542416915297508
defect O 1 0.9999667406082153
in O 0 0.03359213098883629
POMC O 1 0.9999997615814209
function O 0 0.03298850357532501
would O 0 0.018038149923086166
include O 0 0.03380632400512695
obesity B-Disease 1 1.0
, O 0 0.03943675756454468
alteration O 1 0.9997274279594421
in O 0 0.0515289343893528
pigmentation O 1 1.0
and O 1 0.9999407529830933
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.25134506821632385

The O 0 0.04956384003162384
observation O 0 0.07975377142429352
of O 0 0.033434461802244186
these O 0 0.0238677728921175
symptoms O 1 0.9999877214431763
in O 0 0.0214893389493227
two O 0 0.02673441916704178
probands O 1 0.9990403056144714
prompted O 0 0.06266176700592041
us O 0 0.027974670752882957
to O 0 0.016349995508790016
search O 0 0.027287941426038742
for O 0 0.016916077584028244
mutations O 0 0.02740507200360298
within O 0 0.018646765500307083
their O 0 0.03357590362429619
POMC O 1 0.9999985694885254
genes O 0 0.05805754289031029
. O 0 0.04074284806847572

Patient O 1 0.9996399879455566
1 O 0 0.05350642278790474
was O 0 0.030604472383856773
found O 0 0.012164942920207977
to O 0 0.010247789323329926
be O 0 0.007921585813164711
a O 0 0.020981773734092712
compound O 0 0.06343118101358414
heterozygote O 0 0.16170527040958405
for O 0 0.015570858493447304
two O 0 0.013060608878731728
mutations O 0 0.0268345158547163
in O 0 0.01804928295314312
exon O 0 0.3728143274784088
3 O 0 0.04139196500182152
( O 0 0.037366725504398346
G7013T O 1 0.9984409213066101
, O 0 0.036992039531469345
C7133delta O 1 0.9998325109481812
) O 0 0.020989108830690384
which O 0 0.013281865045428276
interfere O 0 0.029871679842472076
with O 0 0.013615621253848076
appropriate O 0 0.027279317378997803
synthesis O 0 0.03947589546442032
of O 0 0.03293692693114281
ACTH O 1 0.9999983310699463
and O 0 0.04157106205821037
alpha O 1 0.9999237060546875
- O 1 0.9999946355819702
MSH O 1 0.9999839067459106
. O 0 0.05990620329976082

Patient O 1 0.9985702037811279
2 O 0 0.05363966152071953
was O 0 0.035029336810112
homozygous O 0 0.04919755086302757
for O 0 0.015315305441617966
a O 0 0.024199793115258217
mutation O 0 0.042689498513936996
in O 0 0.020063403993844986
exon O 1 0.8737523555755615
2 O 0 0.051429323852062225
( O 0 0.04085586220026016
C3804A O 1 0.9927043914794922
) O 0 0.030856238678097725
which O 0 0.02866632305085659
abolishes O 1 0.999818742275238
POMC O 1 0.9999809265136719
translation O 0 0.09049853682518005
. O 0 0.05119120329618454

These O 0 0.02275988832116127
findings O 0 0.023633675649762154
represent O 0 0.015740102156996727
the O 0 0.014275697991251945
first O 0 0.018043264746665955
examples O 0 0.01831452175974846
of O 0 0.018395209684967995
a O 0 0.03816186264157295
genetic B-Disease 1 0.9974077343940735
defect I-Disease 1 0.999996542930603
within O 0 0.02669548988342285
the O 0 0.04184773564338684
POMC O 1 0.9999998807907104
gene O 0 0.03307243064045906
and O 0 0.013279684819281101
define O 0 0.023912357166409492
a O 0 0.02192743867635727
new O 0 0.051667969673871994
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.05154457315802574
in O 0 0.017916420474648476
early O 0 0.06866366416215897
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999998807907104
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999520778656006
red O 1 1.0
hair O 1 0.9999997615814209
pigmentation O 1 0.9999998807907104
. O 0 0.04362008720636368
. O 0 0.043805673718452454

A O 0 0.06663771718740463
European O 0 0.04516978934407234
multicenter O 1 0.9893087148666382
study O 0 0.03918422386050224
of O 0 0.07446423172950745
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.13399355113506317
classification O 0 0.07984607666730881
of O 0 0.02868618443608284
105 O 0 0.21963495016098022
mutations O 0 0.030400563031435013
and O 0 0.012408764101564884
a O 0 0.01695302315056324
general O 0 0.028254929929971695
system O 0 0.022311268374323845
for O 0 0.02019370160996914
genotype O 1 0.9627838730812073
- O 1 0.9852893948554993
based O 0 0.027845818549394608
prediction O 0 0.05381154268980026
of O 0 0.0518585667014122
metabolic O 1 0.9999855756759644
phenotype O 1 0.9985960125923157
. O 0 0.06423560529947281

Phenylketonuria B-Disease 1 0.9999998807907104
( O 1 0.973405122756958
PKU B-Disease 1 1.0
) O 0 0.050290416926145554
and O 0 0.04332202300429344
mild B-Disease 1 0.999998927116394
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.999491810798645
MHP B-Disease 1 1.0
) O 0 0.03688863664865494
are O 0 0.020306818187236786
allelic B-Disease 1 0.9999983310699463
disorders I-Disease 1 1.0
caused O 1 0.9994552731513977
by O 0 0.033137522637844086
mutations O 0 0.02859247289597988
in O 0 0.012106754817068577
the O 0 0.023080257698893547
gene O 0 0.04353899881243706
encoding O 0 0.06445834040641785
phenylalanine O 1 0.999854326248169
hydroxylase O 1 0.9999973773956299
( O 1 0.9166147708892822
PAH O 1 1.0
) O 0 0.058748915791511536
. O 0 0.04563042148947716

Previous O 0 0.05202797055244446
studies O 0 0.023613031953573227
have O 0 0.009540064260363579
suggested O 0 0.015117091126739979
that O 0 0.007503912318497896
the O 0 0.014647754840552807
highly O 0 0.03802693635225296
variable O 0 0.055956289172172546
metabolic O 1 0.9997953772544861
phenotypes O 1 0.9983696341514587
of O 1 0.9999899864196777
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.999997615814209
with O 1 0.9995726943016052
PAH O 1 1.0
genotypes O 1 0.9999009370803833
. O 0 0.06400046497583389

We O 0 0.030174732208251953
identified O 0 0.03227972984313965
both O 0 0.027538666501641273
causative O 1 0.9963074922561646
mutations O 0 0.05237574130296707
in O 0 0.030924301594495773
686 O 1 0.9999971389770508
patients O 1 0.9994575381278992
from O 0 0.02483861707150936
seven O 0 0.02697593718767166
European O 0 0.036635540425777435
centers O 0 0.056304991245269775
. O 0 0.03775433078408241

On O 0 0.02748459205031395
the O 0 0.018461866304278374
basis O 0 0.012498348020017147
of O 0 0.014917570166289806
the O 0 0.02120567299425602
phenotypic O 0 0.04901745542883873
characteristics O 0 0.03075185976922512
of O 0 0.03018389269709587
297 O 1 0.9998173117637634
functionally O 1 0.9998195767402649
hemizygous O 1 0.9999970197677612
patients O 1 0.9977116584777832
, O 0 0.02447347715497017
105 O 0 0.0478777214884758
of O 0 0.01993488147854805
the O 0 0.023441800847649574
mutations O 0 0.025100309401750565
were O 0 0.009833578951656818
assigned O 0 0.027603305876255035
to O 0 0.011866705492138863
one O 0 0.010727183893322945
of O 0 0.014455283060669899
four O 0 0.021274669095873833
arbitrary O 0 0.05467749759554863
phenotype O 0 0.38050687313079834
categories O 0 0.05342293158173561
. O 0 0.04548273980617523

We O 0 0.030670078471302986
proposed O 0 0.03102802485227585
and O 0 0.02000311017036438
tested O 0 0.04056328907608986
a O 0 0.026826834306120872
simple O 0 0.02787858620285988
model O 0 0.027049768716096878
for O 0 0.019004616886377335
correlation O 0 0.050364330410957336
between O 0 0.040459148585796356
genotype O 1 0.7044805884361267
and O 0 0.032640241086483
phenotypic O 0 0.08604863286018372
outcome O 0 0.060256507247686386
. O 0 0.04646558687090874

The O 0 0.05575281009078026
observed O 0 0.04875405877828598
phenotype O 0 0.08312049508094788
matched O 0 0.04198409989476204
the O 0 0.02706538513302803
predicted O 0 0.04819769039750099
phenotype O 0 0.07128889113664627
in O 0 0.01844898797571659
79 O 0 0.05024011433124542
% O 0 0.017037369310855865
of O 0 0.015323677100241184
the O 0 0.021019531413912773
cases O 0 0.02114952728152275
, O 0 0.014853982254862785
and O 0 0.010379583574831486
in O 0 0.00805293582379818
only O 0 0.008449005894362926
5 O 0 0.015413274057209492
of O 0 0.01808813400566578
184 O 1 0.9620426893234253
patients O 1 0.9994656443595886
was O 0 0.029649868607521057
the O 0 0.024570446461439133
observed O 0 0.028880387544631958
phenotype O 0 0.05420942232012749
more O 0 0.009030574932694435
than O 0 0.010523390024900436
one O 0 0.01650395058095455
category O 0 0.03136075288057327
away O 0 0.02018020488321781
from O 0 0.015607218258082867
that O 0 0.012565026059746742
expected O 0 0.027373479679226875
. O 0 0.03521212935447693

Among O 0 0.036955926567316055
the O 0 0.021971503272652626
seven O 0 0.025448234751820564
contributing O 0 0.04869736731052399
centers O 0 0.03681150823831558
, O 0 0.015442818403244019
the O 0 0.01626233384013176
proportion O 0 0.03267291560769081
of O 0 0.02888893336057663
patients O 1 0.9968757629394531
for O 0 0.02131807990372181
whom O 0 0.033896107226610184
the O 0 0.02623656950891018
observed O 0 0.035104330629110336
phenotype O 0 0.07036648690700531
did O 0 0.013942159712314606
not O 0 0.008120137266814709
match O 0 0.018047930672764778
the O 0 0.019238082692027092
predicted O 0 0.03690459951758385
phenotype O 0 0.06455764919519424
was O 0 0.026330824941396713
4 O 0 0.030515506863594055
% O 0 0.025659019127488136
- O 1 0.9714415073394775
23 O 0 0.03339974954724312
% O 0 0.025007503107190132
( O 0 0.03557323291897774
P O 1 0.9999737739562988
< O 1 0.9998955726623535
. O 0 0.0338481068611145
0001 O 1 0.9997387528419495
) O 0 0.023472700268030167
, O 0 0.01590544544160366
suggesting O 0 0.02044626697897911
that O 0 0.008024296723306179
differences O 0 0.015140971168875694
in O 0 0.010946766473352909
methods O 0 0.01354457251727581
used O 0 0.011450305581092834
for O 0 0.018927929922938347
mutation O 0 0.10852083563804626
detection O 1 0.8053455352783203
or O 0 0.04376332834362984
phenotype O 1 0.9956094622612
classification O 0 0.09683536738157272
may O 0 0.017384689301252365
account O 0 0.012668527662754059
for O 0 0.010095249861478806
a O 0 0.01438604760915041
considerable O 0 0.023622609674930573
proportion O 0 0.036880481988191605
of O 0 0.039486151188611984
genotype O 1 0.9999839067459106
- O 1 0.9999972581863403
phenotype O 1 0.9086547493934631
inconsistencies O 0 0.10220459848642349
. O 0 0.050826460123062134

Our O 0 0.03970906883478165
data O 0 0.013697477988898754
indicate O 0 0.012488605454564095
that O 0 0.008862346410751343
the O 0 0.03562622144818306
PAH O 1 1.0
- O 1 0.9999998807907104
mutation O 0 0.10160551220178604
genotype O 0 0.08065100014209747
is O 0 0.011120676063001156
the O 0 0.0134363304823637
main O 0 0.036351174116134644
determinant O 1 0.9974029660224915
of O 0 0.045568425208330154
metabolic O 1 0.9999992847442627
phenotype O 1 0.9879592657089233
in O 0 0.017620470374822617
most O 0 0.027022359892725945
patients O 1 0.9999980926513672
with O 1 0.9999946355819702
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.8148531913757324

In O 0 0.025314150378108025
the O 0 0.023329108953475952
present O 0 0.022158373147249222
study O 0 0.016298914328217506
, O 0 0.012053360231220722
the O 0 0.01655442826449871
classification O 0 0.04484158754348755
of O 0 0.034461528062820435
105 O 1 0.9999924898147583
PAH O 1 1.0
mutations O 0 0.06338241696357727
may O 0 0.016947604715824127
allow O 0 0.013370279222726822
the O 0 0.014285451732575893
prediction O 0 0.02958528697490692
of O 0 0.015031865797936916
the O 0 0.027099262923002243
biochemical O 1 0.599624752998352
phenotype O 1 0.7145013809204102
in O 0 0.023603277280926704
> O 1 0.9724406003952026
10 O 0 0.02263708971440792
, O 0 0.02059515193104744
000 O 0 0.06229621171951294
genotypes O 1 0.9413080811500549
, O 0 0.023148298263549805
which O 0 0.01616271771490574
may O 0 0.014676777645945549
be O 0 0.008370029740035534
useful O 0 0.012240778654813766
for O 0 0.008737249299883842
the O 0 0.016356591135263443
management O 0 0.036734987050294876
of O 0 0.035825107246637344
hyperphenylalaninemia B-Disease 1 0.9999998807907104
in O 0 0.04926811531186104
newborns O 1 0.9997931122779846
. O 0 0.05673538148403168

Somatic O 1 0.9545300006866455
instability O 0 0.12436381727457047
of O 0 0.03703976795077324
the O 0 0.05017445981502533
CTG O 1 0.9999852180480957
repeat O 0 0.09226307272911072
in O 0 0.024607034400105476
mice O 0 0.05036073923110962
transgenic O 0 0.06419702619314194
for O 0 0.022831162437796593
the O 0 0.15847723186016083
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9965800642967224
is O 0 0.03277969732880592
age O 0 0.038133230060338974
dependent O 0 0.035131316632032394
but O 0 0.012966967187821865
not O 0 0.009477813728153706
correlated O 0 0.02858962118625641
to O 0 0.012358587235212326
the O 0 0.018820371478796005
relative O 0 0.0518781952559948
intertissue O 1 0.9997794032096863
transcription O 0 0.2829146683216095
levels O 0 0.05195199325680733
and O 0 0.04972631111741066
proliferative O 1 0.9999997615814209
capacities O 1 0.7026350498199463
. O 0 0.06328700482845306

A O 0 0.09799357503652573
( O 0 0.0609646700322628
CTG O 1 0.9999939203262329
) O 0 0.030723920091986656
nexpansion O 0 0.142268106341362
in O 0 0.013246061280369759
the O 0 0.01912931352853775
3 O 0 0.04182565584778786
- O 1 0.9998623132705688
untranslated O 1 0.9786183834075928
region O 0 0.037075839936733246
( O 0 0.028910117223858833
UTR O 1 0.8254488110542297
) O 0 0.013116307556629181
of O 0 0.015179750509560108
the O 0 0.0457836277782917
DM O 1 1.0
protein O 1 0.6518774628639221
kinase O 1 0.9948800802230835
gene O 0 0.04722597450017929
( O 0 0.035183172672986984
DMPK O 1 0.9996269941329956
) O 0 0.019523221999406815
is O 0 0.013473941013216972
responsible O 0 0.026436083018779755
for O 0 0.029895758256316185
causing O 1 0.9999984502792358
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.06521426141262054
. O 0 0.04292909801006317

Major O 0 0.20742230117321014
instability O 1 0.9983468055725098
, O 0 0.026142312213778496
with O 0 0.01821090094745159
very O 0 0.01531114149838686
large O 0 0.018633387982845306
expansions O 0 0.047651488333940506
between O 0 0.02301148883998394
generations O 0 0.03518616780638695
and O 0 0.0158479493111372
high O 0 0.03231002762913704
levels O 0 0.026546038687229156
of O 0 0.03645551577210426
somatic O 1 0.9999860525131226
mosaicism O 1 0.9999988079071045
, O 0 0.0329715795814991
is O 0 0.02271699346601963
observed O 0 0.02814399264752865
in O 0 0.02761850878596306
patients O 1 0.9763436317443848
. O 0 0.05077624320983887

There O 0 0.03024018369615078
is O 0 0.020830105990171432
a O 0 0.024888796731829643
good O 0 0.030484039336442947
correlation O 0 0.042179301381111145
between O 0 0.024190401658415794
repeat O 0 0.0649789422750473
size O 0 0.02611667662858963
( O 0 0.018241122364997864
at O 0 0.01511995866894722
least O 0 0.01087129395455122
in O 0 0.01649039424955845
leucocytes O 1 0.9996333122253418
) O 0 0.027620965614914894
, O 0 0.02359304390847683
clinical O 1 0.9638767838478088
severity O 1 0.9995450377464294
and O 0 0.030658017843961716
age O 0 0.05823089927434921
of O 0 0.397258996963501
onset O 1 1.0
. O 0 0.07797401398420334

The O 0 0.07197745144367218
trinucleotide O 1 0.9998819828033447
repeat O 1 0.9976071119308472
instability O 1 0.999702513217926
mechanisms O 0 0.05422915518283844
involved O 0 0.029208149760961533
in O 0 0.031215105205774307
DM B-Disease 1 1.0
and O 0 0.02628702111542225
other O 0 0.020380420610308647
human O 1 0.817864716053009
genetic B-Disease 1 0.9999940395355225
diseases I-Disease 1 1.0
are O 0 0.024691922590136528
unknown O 0 0.049076423048973083
. O 0 0.03491232171654701

We O 0 0.041964270174503326
studied O 0 0.061997801065444946
somatic O 0 0.3460761308670044
instability O 0 0.10794113576412201
by O 0 0.027804069221019745
measuring O 0 0.05935848131775856
the O 0 0.04178931936621666
CTG O 1 0.9999972581863403
repeat O 0 0.07947488129138947
length O 0 0.024462830275297165
at O 0 0.018511228263378143
several O 0 0.01098557561635971
ages O 0 0.021585825830698013
in O 0 0.011930892243981361
various O 0 0.012737546116113663
tissues O 0 0.043159693479537964
of O 0 0.03121122159063816
transgenic O 1 0.9505212903022766
mice O 0 0.049880970269441605
carrying O 0 0.036404673010110855
a O 0 0.03591098636388779
( O 0 0.04290688410401344
CTG O 1 0.9999737739562988
) O 0 0.036732256412506104
55expansion O 1 0.5140683650970459
surrounded O 0 0.051054589450359344
by O 0 0.017918484285473824
45 O 0 0.027516983449459076
kb O 0 0.07016938179731369
of O 0 0.02103538252413273
the O 0 0.028845515102148056
human O 1 0.7960395812988281
DM B-Disease 1 1.0
region O 0 0.04692360386252403
, O 0 0.02022620104253292
using O 0 0.016111642122268677
small O 0 0.030190033838152885
- O 1 0.999812662601471
pool O 0 0.1821092665195465
PCR O 0 0.14341843128204346
. O 0 0.04516439139842987

These O 0 0.04137660190463066
mice O 0 0.05869317054748535
have O 0 0.012619196437299252
been O 0 0.013440749607980251
shown O 0 0.01578919216990471
to O 0 0.016745856031775475
reproduce O 0 0.035500746220350266
the O 0 0.031592484563589096
intergenerational O 1 0.9985787868499756
and O 0 0.03933187201619148
somatic O 1 0.9777519106864929
instability O 0 0.41355660557746887
of O 0 0.0277561042457819
the O 0 0.03491516038775444
55 O 0 0.07820475846529007
CTG O 1 0.9999803304672241
repeat O 0 0.08623490482568741
suggesting O 0 0.033411137759685516
that O 0 0.011865844950079918
surrounding O 0 0.027280891314148903
sequences O 0 0.014823666773736477
and O 0 0.012441325932741165
the O 0 0.02347685396671295
chromatin O 1 0.7675222158432007
environment O 0 0.03025883249938488
are O 0 0.0092321140691638
involved O 0 0.021491849794983864
in O 0 0.026331542059779167
instability O 1 0.9909923076629639
mechanisms O 0 0.07930640131235123
. O 0 0.05027099698781967

As O 0 0.03196301683783531
observed O 0 0.01802746392786503
in O 0 0.00883814413100481
some O 0 0.005748586729168892
of O 0 0.012181118130683899
the O 0 0.022328123450279236
tissues O 1 0.982223391532898
of O 1 0.9989514350891113
DM B-Disease 1 1.0
patients O 1 1.0
, O 0 0.022852616384625435
there O 0 0.012556207366287708
is O 0 0.012746051885187626
a O 0 0.019953740760684013
tendency O 0 0.039280738681554794
for O 0 0.01944909803569317
repeat O 0 0.06825137883424759
length O 0 0.028638750314712524
and O 0 0.02875807136297226
somatic O 1 0.9967825412750244
mosaicism O 1 0.9999141693115234
to O 0 0.021272722631692886
increase O 0 0.014306093566119671
with O 0 0.010974658653140068
the O 0 0.016200007870793343
age O 0 0.02388845570385456
of O 0 0.02330559492111206
the O 0 0.03882759064435959
mouse O 0 0.10667119175195694
. O 0 0.04162878915667534

Furthermore O 0 0.07649656385183334
, O 0 0.02550906501710415
we O 0 0.012794396840035915
observed O 0 0.016231238842010498
no O 0 0.013488146476447582
correlation O 0 0.02677936851978302
between O 0 0.01642742194235325
the O 0 0.027523085474967957
somatic O 1 0.997352123260498
mutation O 0 0.07077161222696304
rate O 0 0.03703819587826729
and O 0 0.03851163014769554
tissue O 1 0.9999295473098755
proliferation O 1 0.9999712705612183
capacity O 0 0.08004282414913177
. O 0 0.050110653042793274

The O 0 0.0757051557302475
somatic O 1 0.9964861869812012
mutation O 0 0.07621197402477264
rates O 0 0.03158043324947357
in O 0 0.015634635463356972
different O 0 0.011048899032175541
tissues O 0 0.037355974316596985
were O 0 0.010308129712939262
also O 0 0.011103142984211445
not O 0 0.009578850120306015
correlated O 0 0.027272522449493408
to O 0 0.010885351337492466
the O 0 0.014029853977262974
relative O 0 0.040847767144441605
inter O 1 0.9999700784683228
- O 1 0.9999996423721313
tissue O 1 0.8875218629837036
difference O 0 0.023941770195961
in O 0 0.015479707159101963
transcriptional O 0 0.059382129460573196
levels O 0 0.01700691506266594
of O 0 0.01089145801961422
the O 0 0.014896550215780735
three O 0 0.015648171305656433
genes O 0 0.02682085894048214
( O 0 0.031059669330716133
DMAHP O 1 0.9999579191207886
, O 0 0.036146894097328186
DMPK O 1 0.999951958656311
and O 0 0.02645036019384861
59 O 0 0.05696210637688637
) O 0 0.021854115650057793
surrounding O 0 0.031890999525785446
the O 0 0.02927350625395775
repeat O 0 0.17714747786521912
. O 0 0.03013584017753601
. O 0 0.03531277924776077

A O 0 0.08204498142004013
novel O 0 0.09624151885509491
missense O 1 0.7425853610038757
mutation O 0 0.07223176956176758
in O 0 0.02254502661526203
patients O 1 0.9837183356285095
from O 0 0.022415636107325554
a O 0 0.04674013704061508
retinoblastoma B-Disease 1 0.9999998807907104
pedigree O 1 0.9693992137908936
showing O 0 0.03617114573717117
only O 0 0.019766487181186676
mild O 0 0.41529449820518494
expression O 0 0.032399982213974
of O 0 0.028821716085076332
the O 0 0.34833824634552
tumor B-Disease 1 1.0
phenotype O 1 0.999580442905426
. O 0 0.057369425892829895

We O 0 0.028090888634324074
have O 0 0.013472583144903183
used O 0 0.017130274325609207
single O 0 0.04535868018865585
strand O 0 0.09871483594179153
conformation O 0 0.08956283330917358
polymorphism O 0 0.06923514604568481
analysis O 0 0.013791433535516262
to O 0 0.011056121438741684
study O 0 0.012570640072226524
the O 0 0.01433346513658762
27 O 0 0.03197626769542694
exons O 0 0.04539869353175163
of O 0 0.020709706470370293
the O 0 0.04064689204096794
RB1 O 1 0.9999995231628418
gene O 0 0.03792914003133774
in O 0 0.012626363895833492
individuals O 0 0.011206399649381638
from O 0 0.011511588469147682
a O 0 0.022049563005566597
family O 0 0.03540356457233429
showing O 0 0.039446692913770676
mild O 1 0.9890987873077393
expression O 0 0.037942927330732346
of O 0 0.03226829692721367
the O 0 0.1005384624004364
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.9983779191970825
. O 0 0.059809643775224686

In O 0 0.028232784941792488
this O 0 0.01729312352836132
family O 0 0.036506492644548416
affected O 0 0.03389667719602585
individuals O 0 0.0218355730175972
developed O 0 0.09554505348205566
unilateral B-Disease 1 0.9999991655349731
tumors I-Disease 1 1.0
and O 0 0.031626537442207336
, O 0 0.017285969108343124
as O 0 0.013944651931524277
a O 0 0.017504233866930008
result O 0 0.015002989210188389
of O 0 0.022334342822432518
linkage O 1 0.5964466333389282
analysis O 0 0.02192550152540207
, O 0 0.02480662614107132
unaffected O 1 0.955392599105835
mutation O 0 0.0643932893872261
carriers O 0 0.043937988579273224
were O 0 0.011461731977760792
also O 0 0.012676898390054703
identified O 0 0.017624208703637123
within O 0 0.014446866698563099
the O 0 0.02977859042584896
pedigree O 0 0.10331091284751892
. O 0 0.04905850440263748

A O 0 0.07738736271858215
single O 0 0.05764475092291832
band O 0 0.06737370043992996
shift O 0 0.04373887926340103
using O 0 0.02141626924276352
SSCP O 1 0.9963196516036987
was O 0 0.03181973844766617
identified O 0 0.020575150847434998
in O 0 0.015352231450378895
exon O 0 0.08886327594518661
21 O 0 0.02696174755692482
which O 0 0.01172889769077301
resulted O 0 0.02167597971856594
in O 0 0.011912567541003227
a O 0 0.023725828155875206
missense O 0 0.0924847424030304
mutation O 0 0.04425884038209915
converting O 0 0.040990836918354034
a O 0 0.04254889488220215
cys O 1 0.9999995231628418
- O 1 0.9999996423721313
- O 1 0.9999994039535522
> O 1 0.9996403455734253
arg O 1 0.9997983574867249
at O 0 0.032775092869997025
nucleotide O 0 0.043606214225292206
position O 0 0.023599963635206223
28 O 0 0.023256629705429077
in O 0 0.013880530372262001
the O 0 0.030743177980184555
exon O 0 0.15303097665309906
. O 0 0.04737088456749916

The O 0 0.05833571404218674
mutation O 0 0.07808069884777069
destroyed O 0 0.06428137421607971
an O 0 0.038647111505270004
NdeI O 1 0.9993581175804138
restriction O 0 0.11572282761335373
enzyme O 0 0.09520985931158066
site O 0 0.056746453046798706
. O 0 0.03604964166879654

Analysis O 0 0.02974557690322399
of O 0 0.01901889592409134
all O 0 0.014908702112734318
family O 0 0.028160035610198975
members O 0 0.0187729112803936
demonstrated O 0 0.02116575837135315
that O 0 0.008172601461410522
the O 0 0.017377829179167747
missense O 0 0.10091893374919891
mutation O 0 0.06152837723493576
co O 1 0.8744937777519226
- O 1 0.999956488609314
segregated O 1 0.9792035818099976
with O 0 0.03157743066549301
patients O 1 0.9999833106994629
with O 1 0.9655207991600037
tumors B-Disease 1 1.0
or O 0 0.052950140088796616
who O 0 0.027721837162971497
, O 0 0.01482379250228405
as O 0 0.011880792677402496
a O 0 0.016182269901037216
result O 0 0.017772797495126724
of O 0 0.022299135103821754
linkage O 0 0.4250483810901642
analysis O 0 0.017284942790865898
had O 0 0.014745285734534264
been O 0 0.012908692471683025
predicted O 0 0.022777771577239037
to O 0 0.015150023624300957
carry O 0 0.026348330080509186
the O 0 0.0409296415746212
predisposing O 1 0.9971485733985901
mutation O 0 0.11143721640110016
. O 0 0.053527433425188065

These O 0 0.026659656316041946
observations O 0 0.02841225080192089
point O 0 0.02018563635647297
to O 0 0.013224208727478981
another O 0 0.017354141920804977
region O 0 0.020901421085000038
of O 0 0.020335199311375618
the O 0 0.039974093437194824
RB1 O 1 0.9999997615814209
gene O 0 0.05028770491480827
where O 0 0.027107954025268555
mutations O 0 0.02318916842341423
only O 0 0.01031159982085228
modify O 0 0.028470829129219055
the O 0 0.01639619469642639
function O 0 0.019676221534609795
of O 0 0.015804804861545563
the O 0 0.024074412882328033
gene O 0 0.028181998059153557
and O 0 0.014463409781455994
raise O 0 0.024898434057831764
important O 0 0.014750411733984947
questions O 0 0.01897948794066906
for O 0 0.01892920956015587
genetic O 0 0.040777988731861115
counseling O 1 0.9748517274856567
in O 0 0.01857081800699234
families O 0 0.02418270707130432
with O 0 0.016485268250107765
these O 0 0.01571662910282612
distinctive O 0 0.1385374665260315
phenotypes O 1 0.9288387894630432
. O 0 0.033507090061903
. O 0 0.03853187337517738

Maternal B-Disease 1 0.9964973330497742
disomy I-Disease 1 0.9998064637184143
and O 0 0.18226258456707
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.996298611164093
with O 0 0.06575474888086319
gamete O 1 0.9999969005584717
complementation O 1 0.9999978542327881
in O 0 0.018906520679593086
a O 0 0.02090768702328205
case O 0 0.023507175967097282
of O 0 0.03034706972539425
familial O 1 1.0
translocation O 1 0.999997615814209
( O 0 0.03564123064279556
3 O 0 0.03279447555541992
; O 0 0.01871989667415619
15 O 0 0.024281123653054237
) O 0 0.024546664208173752
( O 0 0.03307700157165527
p25 O 1 0.9990200996398926
; O 0 0.0419057235121727
q11 O 1 0.9406255483627319
. O 0 0.028321651741862297
2 O 0 0.04858379811048508
) O 0 0.033174965530633926
. O 0 0.035812634974718094

Maternal B-Disease 1 0.9999719858169556
uniparental I-Disease 1 1.0
disomy I-Disease 1 0.9999996423721313
( I-Disease 1 0.8593581914901733
UPD I-Disease 1 1.0
) I-Disease 0 0.03202229365706444
for I-Disease 0 0.02318410389125347
chromosome I-Disease 0 0.05033160001039505
15 I-Disease 0 0.020949233323335648
is O 0 0.01331858616322279
responsible O 0 0.019960297271609306
for O 0 0.010907366871833801
an O 0 0.011321596801280975
estimated O 0 0.0146514642983675
30 O 0 0.013831532560288906
% O 0 0.009039881639182568
of O 0 0.00939637515693903
cases O 0 0.018013348802924156
of O 0 0.23530733585357666
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
PWS B-Disease 1 1.0
) O 0 0.07007894665002823
. O 0 0.045339927077293396

We O 0 0.02830641344189644
report O 0 0.01942981407046318
on O 0 0.013069432228803635
an O 0 0.012650974094867706
unusual O 0 0.018404174596071243
case O 0 0.02277160994708538
of O 0 0.02790764905512333
maternal B-Disease 1 0.9998672008514404
disomy I-Disease 1 0.9999843835830688
15 I-Disease 0 0.04126511141657829
in O 0 0.030176423490047455
PWS B-Disease 1 1.0
that O 0 0.015771113336086273
is O 0 0.012281220406293869
most O 0 0.008490821346640587
consistent O 0 0.01918572559952736
with O 0 0.013759910129010677
adjacent O 0 0.04524184390902519
- O 1 0.9974125027656555
1 O 0 0.030181728303432465
segregation O 0 0.061536889523267746
of O 0 0.020441457629203796
a O 0 0.03769213706254959
paternal O 1 0.9997228980064392
t O 1 0.9995154142379761
( O 0 0.029012497514486313
3 O 0 0.029518701136112213
; O 0 0.019312089309096336
15 O 0 0.02612512744963169
) O 0 0.024692630395293236
( O 0 0.03297397866845131
p25 O 1 0.9989390969276428
; O 0 0.03533123433589935
q11 O 1 0.9760581851005554
. O 0 0.021248741075396538
2 O 0 0.031374491751194
) O 0 0.013920512050390244
with O 0 0.013209960423409939
simultaneous O 0 0.04442760348320007
maternal O 1 0.9995182752609253
meiotic O 1 0.9999991655349731
nondisjunction O 1 0.9999839067459106
for O 0 0.056280575692653656
chromosome O 0 0.09914577007293701
15 O 0 0.048451706767082214
. O 0 0.03930334374308586

The O 0 0.06468016654253006
patient O 1 0.9999788999557495
( O 0 0.07644092291593552
J O 1 0.9999998807907104
. O 0 0.03206195682287216
B O 1 0.9999374151229858
. O 0 0.015033137053251266
) O 0 0.010596208274364471
, O 0 0.007766825146973133
a O 0 0.012234034948050976
17 O 0 0.0279832873493433
- O 1 0.9976679682731628
year O 0 0.020805401727557182
- O 1 0.9983015060424805
old O 0 0.05027233809232712
white O 0 0.05245813727378845
male O 0 0.057760175317525864
with O 0 0.039788082242012024
PWS B-Disease 1 1.0
, O 0 0.03040139190852642
was O 0 0.027047717943787575
found O 0 0.011000318452715874
to O 0 0.00986142735928297
have O 0 0.007715200539678335
47 O 0 0.03042823076248169
chromosomes O 0 0.03041079454123974
with O 0 0.01481995452195406
a O 0 0.03211179003119469
supernumerary O 1 0.9999442100524902
, O 0 0.0427718348801136
paternal O 1 0.999762237071991
der O 1 0.9999475479125977
( O 0 0.02911790832877159
15 O 0 0.02230064384639263
) O 0 0.013406062498688698
consisting O 0 0.016779398545622826
of O 0 0.013487447053194046
the O 0 0.019727259874343872
short O 0 0.03130096197128296
arm O 0 0.4050377309322357
and O 0 0.017288263887166977
the O 0 0.02951286919414997
proximal O 1 0.9999998807907104
long O 0 0.08783374726772308
arm O 1 0.9754152297973633
of O 0 0.034284550696611404
chromosome O 0 0.21256648004055023
15 O 0 0.028814436867833138
, O 0 0.0217197984457016
and O 0 0.030026940628886223
distal O 1 0.9999992847442627
chromosome O 1 0.9998384714126587
arm O 1 0.9998340606689453
3p O 1 0.9999445676803589
. O 0 0.05936438962817192

The O 0 0.07983148843050003
t O 1 0.999257504940033
( O 0 0.035709112882614136
3 O 0 0.03561970591545105
; O 0 0.017941374331712723
15 O 0 0.021309630945324898
) O 0 0.01519105862826109
was O 0 0.017417006194591522
present O 0 0.013237406499683857
in O 0 0.009476680308580399
the O 0 0.014008157886564732
balanced O 0 0.022492870688438416
state O 0 0.010096918791532516
in O 0 0.012192594818770885
the O 0 0.02500886470079422
patients O 1 0.9997403025627136
father O 1 0.8655673861503601
and O 0 0.026704708114266396
a O 0 0.04202193766832352
sister O 1 0.7088266611099243
. O 0 0.04606662318110466

Fluorescent O 1 0.5035396814346313
in O 0 0.04857764020562172
situ O 1 0.9480367302894592
hybridization O 0 0.06649206578731537
analysis O 0 0.019141150638461113
demonstrated O 0 0.02396553009748459
that O 0 0.011556362733244896
the O 0 0.03158973902463913
PWS B-Disease 1 1.0
critical O 0 0.06482044607400894
region O 0 0.03916851058602333
resided O 0 0.05906645208597183
on O 0 0.01920395903289318
the O 0 0.024500340223312378
derivative O 1 0.8027471899986267
chromosome O 0 0.05908507853746414
3 O 0 0.02374163642525673
and O 0 0.01075026299804449
that O 0 0.006648965645581484
there O 0 0.008004095405340195
was O 0 0.01547054573893547
no O 0 0.0121848089620471
deletion O 0 0.03973839432001114
of O 0 0.02205374836921692
the O 0 0.04231356829404831
PWS B-Disease 1 1.0
region O 0 0.03848455473780632
on O 0 0.017931949347257614
the O 0 0.018876971676945686
normal O 0 0.02516975998878479
pair O 0 0.02773764543235302
of O 0 0.02722635306417942
15s O 1 0.9997910857200623
present O 0 0.043013282120227814
in O 0 0.03856591135263443
J O 1 0.9999948740005493
. O 0 0.05372679606080055

B O 1 0.9993898868560791
. O 0 0.07140316814184189

Methylation O 0 0.10459305346012115
analysis O 0 0.02036520466208458
at O 0 0.024784142151474953
exon O 0 0.09412994235754013
alpha O 0 0.053341176360845566
of O 0 0.01424645259976387
the O 0 0.014608776196837425
small O 0 0.019486311823129654
nuclear O 0 0.05347999557852745
ribonucleoprotein O 1 0.9999756813049316
- O 1 0.9999381303787231
associated O 0 0.047525323927402496
polypeptide O 1 0.9992013573646545
N O 1 0.9912797808647156
( O 0 0.04663196951150894
SNRPN O 1 0.9999834299087524
) O 0 0.029371270909905434
gene O 0 0.026800554245710373
showed O 0 0.018660932779312134
a O 0 0.021632006391882896
pattern O 0 0.03347422927618027
characteristic O 0 0.028110889717936516
of O 0 0.014134136028587818
only O 0 0.011850143782794476
the O 0 0.024578984826803207
maternal O 1 0.9999884366989136
chromosome O 0 0.43875324726104736
15 O 0 0.03735443204641342
in O 0 0.032533057034015656
J O 1 0.999987006187439
. O 0 0.0555243119597435

B O 1 0.9966141581535339
. O 0 0.07873629033565521

Maternal B-Disease 1 0.9997249245643616
disomy I-Disease 1 0.999275267124176
was O 0 0.046831145882606506
confirmed O 0 0.031595081090927124
by O 0 0.029691003262996674
polymerase O 1 0.8298969268798828
chain O 0 0.06917078793048859
reaction O 0 0.03777853399515152
analysis O 0 0.014747819863259792
of O 0 0.021744372323155403
microsatellite O 0 0.15788033604621887
repeats O 0 0.04045908525586128
at O 0 0.01882759854197502
the O 0 0.022952960804104805
gamma O 1 0.9934037327766418
- O 1 0.9999741315841675
aminobutyric O 1 0.9999561309814453
acid O 1 0.941218912601471
receptor O 1 0.6121411323547363
beta3 O 1 0.9990102052688599
subunit O 1 0.6849578022956848
( O 0 0.05535018444061279
GABRB3 O 1 0.9999326467514038
) O 0 0.05477378889918327
locus O 0 0.13404150307178497
. O 0 0.04378422722220421

A O 0 0.10830884426832199
niece O 1 0.9999788999557495
( O 0 0.06605285406112671
B O 1 0.999969482421875
. O 0 0.03025692142546177
B O 1 0.9995905756950378
. O 0 0.01671742834150791
) O 0 0.012976450845599174
with O 0 0.010337445884943008
45 O 0 0.02434033527970314
chromosomes O 0 0.028760727494955063
and O 0 0.012219568714499474
the O 0 0.02060692198574543
derivative O 0 0.05241350084543228
3 O 0 0.021174732595682144
but O 0 0.01022165734320879
without O 0 0.011080935597419739
the O 0 0.026337720453739166
der O 1 0.9988264441490173
( O 0 0.026294058188796043
15 O 0 0.026278719305992126
) O 0 0.018607985228300095
demonstrated O 0 0.027798613533377647
a O 0 0.029966017231345177
phenotype O 0 0.08016562461853027
consistent O 0 0.02892017923295498
with O 0 0.013748525641858578
that O 0 0.008646850474178791
reported O 0 0.018233826383948326
for O 0 0.01879674196243286
haploinsufficiency O 1 0.9954160451889038
of O 0 0.04712800309062004
distal O 1 0.9999926090240479
3 O 0 0.1029152125120163
p O 1 0.6346547603607178
. O 0 0.04981667920947075

Uniparental B-Disease 1 0.9999990463256836
disomy I-Disease 1 0.9999681711196899
associated O 0 0.04878861457109451
with O 0 0.02832772210240364
unbalanced O 1 0.9698008894920349
segregation O 1 0.8218504786491394
of O 0 0.037834130227565765
non O 1 0.9996405839920044
- O 1 0.9999997615814209
Robertsonian O 1 0.9999977350234985
translocations O 1 0.9150578379631042
has O 0 0.01824985072016716
been O 0 0.011885429732501507
reported O 0 0.015562980435788631
previously O 0 0.017165400087833405
but O 0 0.010269532911479473
has O 0 0.011938059702515602
not O 0 0.007926620543003082
, O 0 0.009941363707184792
to O 0 0.011755320243537426
our O 0 0.01782296784222126
knowledge O 0 0.019071005284786224
, O 0 0.012296819128096104
been O 0 0.009494686499238014
observed O 0 0.011849584989249706
in O 0 0.009063280187547207
a O 0 0.018736911937594414
case O 0 0.03277520835399628
of O 0 0.052637211978435516
PWS B-Disease 1 1.0
. O 0 0.07532984018325806

Furthermore O 0 0.07972734421491623
, O 0 0.026199085637927055
our O 0 0.024448927491903305
findings O 0 0.01977243274450302
are O 0 0.007026578765362501
best O 0 0.017283054068684578
interpreted O 0 0.01754341833293438
as O 0 0.01694304682314396
true O 0 0.0479469820857048
gamete O 1 0.9995207786560059
complementation O 1 0.9999957084655762
resulting O 0 0.06139620766043663
in O 0 0.04038669168949127
maternal B-Disease 1 0.9999990463256836
UPD I-Disease 1 1.0
15 I-Disease 0 0.10424575954675674
and O 0 0.08371216058731079
PWS B-Disease 1 0.9999995231628418

Schwartz B-Disease 1 0.9996675252914429
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 1 0.9985766410827637
2 I-Disease 0 0.04547657072544098
and O 0 0.02772378735244274
Stuve B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.03714953735470772
a O 0 0.026792095974087715
case O 0 0.02770591340959072
for O 0 0.0203494094312191
" O 0 0.046816691756248474
lumping O 1 0.9566289782524109
" O 0 0.05799822136759758
. O 0 0.03846059367060661

Recent O 0 0.047735415399074554
studies O 0 0.025707004591822624
demonstrated O 0 0.02516435645520687
the O 0 0.016503645107150078
existence O 0 0.021498076617717743
of O 0 0.01708289235830307
a O 0 0.027076298370957375
genetically O 0 0.03312363103032112
distinct O 0 0.020998189225792885
, O 0 0.016080865636467934
usually O 0 0.01449783518910408
lethal O 0 0.032229945063591
form O 0 0.013080629520118237
of O 0 0.013887233100831509
the O 0 0.023313522338867188
Schwartz B-Disease 1 0.9999805688858032
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9993054866790771
SJS B-Disease 1 1.0
) O 0 0.030825987458229065
of O 0 0.03810662776231766
myotonia B-Disease 1 1.0
and O 1 0.9983034133911133
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.031395744532346725
which O 0 0.014921944588422775
we O 0 0.016152366995811462
called O 1 0.6240829825401306
SJS B-Disease 1 1.0
type I-Disease 0 0.27698594331741333
2 I-Disease 0 0.056485481560230255
. O 0 0.03695785254240036

This O 0 0.05164599046111107
disorder O 1 0.9999996423721313
is O 0 0.03146059066057205
reminiscent O 0 0.331631064414978
of O 0 0.022430572658777237
another O 0 0.029995281249284744
rare O 0 0.03469742462038994
condition O 0 0.03944829851388931
, O 0 0.014267925173044205
the O 0 0.025629334151744843
Stuve B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9995236396789551
SWS B-Disease 1 1.0
) O 0 0.026102887466549873
, O 0 0.012507385574281216
which O 0 0.009113270789384842
comprises O 0 0.03313998878002167
campomelia B-Disease 1 0.757062554359436
at O 0 0.02602066472172737
birth O 0 0.2717215418815613
with O 0 0.06571318954229355
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9998557567596436
contractures B-Disease 1 1.0
, O 0 0.03635016456246376
and O 0 0.02154853753745556
early B-Disease 0 0.036144986748695374
death I-Disease 1 0.5477408170700073
. O 0 0.040973275899887085

To O 0 0.03551661968231201
test O 0 0.03304274380207062
for O 0 0.017738068476319313
possible O 0 0.029972944408655167
nosologic O 1 0.9644532799720764
identity O 0 0.0402042530477047
between O 0 0.029185568913817406
these O 0 0.022922668606042862
disorders O 1 0.9999996423721313
, O 0 0.023431753739714622
we O 0 0.013772683218121529
reviewed O 0 0.025219568982720375
the O 0 0.0145859494805336
literature O 0 0.013843114487826824
and O 0 0.009642686694860458
obtained O 0 0.012451805174350739
a O 0 0.0171623844653368
follow O 0 0.028750233352184296
- O 1 0.8456676602363586
up O 0 0.014829802326858044
of O 0 0.011018281802535057
the O 0 0.012302344664931297
only O 0 0.008221135474741459
two O 0 0.01071320753544569
surviving O 1 0.8343157172203064
patients O 1 0.962361216545105
, O 0 0.01739422045648098
one O 0 0.01700843870639801
with O 0 0.03395896777510643
SJS B-Disease 1 1.0
type I-Disease 1 0.9729881882667542
2 I-Disease 0 0.03410295397043228
at O 0 0.02028357982635498
age O 0 0.02040638029575348
10 O 0 0.012587864883244038
years O 0 0.011647876352071762
and O 0 0.01135939545929432
another O 0 0.02224458009004593
with O 0 0.02600228041410446
SWS B-Disease 1 0.999998927116394
at O 0 0.03770646080374718
age O 0 0.03570021316409111
7 O 0 0.04372389242053032
years O 0 0.032420724630355835
. O 0 0.035651665180921555

Patients O 1 0.9753485321998596
reported O 0 0.03191068023443222
as O 0 0.019438916817307472
having O 0 0.03027307242155075
either O 0 0.05644524097442627
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.09777010977268219
SWS B-Disease 1 0.9999911785125732
presented O 0 0.030887648463249207
a O 0 0.02041585184633732
combination O 0 0.02507445402443409
of O 0 0.01641004905104637
a O 0 0.027835916727781296
severe O 1 0.999943733215332
, O 1 0.5487122535705566
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999468326568604
with O 1 0.9998179078102112
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999998807907104
respiratory O 1 1.0
and O 1 0.9997571110725403
feeding O 1 0.9999926090240479
difficulties O 1 0.9999089241027832
, O 0 0.03574446588754654
tendency O 1 0.9677133560180664
to O 0 0.03993542864918709
hyperthermia B-Disease 1 1.0
, O 0 0.025310494005680084
and O 0 0.01650089956820011
frequent O 0 0.03891709819436073
death O 0 0.4235250949859619
in O 0 0.02058958262205124
infancy O 1 0.9988573789596558
) O 0 0.01452006958425045
with O 0 0.0094878189265728
a O 0 0.01795528270304203
distinct O 0 0.031145324930548668
campomelic B-Disease 1 0.9999943971633911
- I-Disease 1 1.0
metaphyseal I-Disease 1 0.9999998807907104
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.08510324358940125

The O 0 0.03733314946293831
similarity O 0 0.03694706782698631
of O 0 0.024550853297114372
the O 0 0.03358455374836922
clinical O 1 0.9993188381195068
and O 0 0.03317118063569069
radiographic O 1 0.9999914169311523
findings O 0 0.03646800294518471
is O 0 0.017744343727827072
so O 0 0.012521191500127316
extensive O 0 0.022778434678912163
that O 0 0.01274728775024414
these O 0 0.017134329304099083
disorders O 1 0.9999961853027344
appear O 0 0.027376661077141762
to O 0 0.016775576397776604
be O 0 0.011376850306987762
a O 0 0.023619364947080612
single O 0 0.044592007994651794
entity O 0 0.06932689249515533
. O 0 0.040809545665979385

The O 0 0.04109181836247444
follow O 0 0.04652628302574158
- O 1 0.9826717376708984
up O 0 0.02565647102892399
observation O 0 0.038904812186956406
of O 0 0.01447257399559021
an O 0 0.013653597794473171
identical O 0 0.015161455608904362
and O 0 0.011013789102435112
unique O 0 0.015319028869271278
pattern O 0 0.028734466060996056
of O 0 0.041051678359508514
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.025183850899338722
the O 0 0.02447633631527424
two O 0 0.0192849300801754
patients O 1 0.9978795051574707
( O 0 0.02084471844136715
one O 0 0.01792997680604458
with O 0 0.03548469394445419
SJS B-Disease 1 1.0
type I-Disease 0 0.11203210055828094
2 I-Disease 0 0.030388658866286278
, O 0 0.013899181969463825
one O 0 0.013664196245372295
with O 0 0.023016080260276794
SWS B-Disease 1 0.9999988079071045
) O 0 0.02947344444692135
surviving O 0 0.0774182602763176
beyond O 0 0.04546704888343811
infancy O 1 0.6003113389015198
adds O 0 0.03847641497850418
to O 0 0.012930753640830517
the O 0 0.014088403433561325
evidence O 0 0.011070259846746922
in O 0 0.0096988994628191
favor O 0 0.019458508118987083
of O 0 0.024858852848410606
identity O 0 0.04661741107702255
. O 0 0.03742770850658417

The O 0 0.04320552945137024
hypothesis O 0 0.055866461247205734
that O 0 0.025392921641469002
SWS B-Disease 1 0.9999977350234985
and O 0 0.08291543275117874
SJS B-Disease 1 1.0
type I-Disease 0 0.34493348002433777
2 I-Disease 0 0.027329713106155396
are O 0 0.0063788508996367455
the O 0 0.017524829134345055
same O 0 0.028909781947731972
disorder O 1 0.9999992847442627
should O 0 0.02544369362294674
be O 0 0.01746847666800022
testable O 0 0.06293866038322449
by O 0 0.023983847349882126
molecular O 0 0.04278431832790375
methods O 0 0.022674571722745895
. O 0 0.021920787170529366
. O 0 0.034420445561409

A O 0 0.07178216427564621
mouse O 0 0.07309181988239288
model O 0 0.03706745803356171
of O 0 0.036015670746564865
severe O 1 0.9999996423721313
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999971389770508
defects O 1 1.0
in O 1 0.8515492081642151
hemostasis O 1 1.0
and O 1 0.9989972710609436
thrombosis B-Disease 1 1.0
. O 0 0.15392974019050598

von B-Disease 1 0.9995031356811523
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9996455907821655
( I-Disease 1 0.7092686295509338
vWf I-Disease 1 0.9999992847442627
) I-Disease 1 0.9978561997413635
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.988335907459259
humans O 0 0.06255604326725006
. O 0 0.04356285557150841

We O 0 0.026759572327136993
generated O 0 0.02655666507780552
a O 0 0.031147241592407227
mouse O 0 0.05659794807434082
model O 0 0.02711160108447075
for O 0 0.017255064100027084
this O 0 0.018864361569285393
disease O 1 0.9999549388885498
by O 0 0.027054769918322563
using O 0 0.02636478655040264
gene O 0 0.04788326099514961
targeting O 0 0.05439058691263199
. O 0 0.038860540837049484

vWf B-Disease 1 0.9999972581863403
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 0.9999964237213135
mice O 0 0.09115063399076462
appeared O 0 0.03782334923744202
normal O 0 0.03509197756648064
at O 0 0.03172731772065163
birth O 0 0.06090269610285759
; O 0 0.0174903254956007
they O 0 0.008546116761863232
were O 0 0.012202003970742226
viable O 0 0.05072128400206566
and O 0 0.03008302114903927
fertile O 0 0.11446365714073181
. O 0 0.052856046706438065

Neither O 0 0.14001120626926422
vWf O 1 0.9929051995277405
nor O 0 0.11712779104709625
vWf O 1 0.9963615536689758
propolypeptide O 1 0.9981069564819336
( O 0 0.07092920690774918
von B-Disease 1 0.9998372793197632
Willebrand I-Disease 1 1.0
antigen O 1 1.0
II O 1 0.9999996423721313
) O 0 0.026275349780917168
were O 0 0.013280377723276615
detectable O 0 0.06196627765893936
in O 0 0.019284358248114586
plasma O 1 0.9958894848823547
, O 0 0.03329486399888992
platelets O 1 0.9999973773956299
, O 0 0.03109411522746086
or O 0 0.03290456905961037
endothelial O 1 0.9999603033065796
cells O 0 0.03283343464136124
of O 0 0.018611058592796326
the O 0 0.033259615302085876
homozygous O 1 0.56367427110672
mutant O 1 0.9946141839027405
mice O 0 0.10769014805555344
. O 0 0.05244150012731552

The O 0 0.06823520362377167
mutant O 1 0.999228835105896
mice O 1 0.8448199033737183
exhibited O 1 0.9587118625640869
defects O 1 0.9999594688415527
in O 0 0.03225881978869438
hemostasis O 1 0.9999991655349731
with O 0 0.025327004492282867
a O 0 0.03875679895281792
highly O 1 0.9563739895820618
prolonged O 1 0.9999998807907104
bleeding O 1 1.0
time O 0 0.04360811412334442
and O 0 0.04371136426925659
spontaneous O 1 0.9999710321426392
bleeding O 1 0.9999998807907104
events O 0 0.022782884538173676
in O 0 0.013668734580278397
approximately O 0 0.01669502444565296
10 O 0 0.020282981917262077
% O 0 0.022391440346837044
of O 0 0.03854629024863243
neonates O 1 0.9989424347877502
. O 0 0.05719830095767975

As O 0 0.02691032551229
in O 0 0.014322886243462563
the O 0 0.02458731085062027
human O 0 0.4420951306819916
disease O 1 0.9999986886978149
, O 0 0.021419839933514595
the O 0 0.030638335272669792
factor O 1 0.9972035884857178
VIII O 1 1.0
level O 0 0.032123614102602005
in O 0 0.013844898901879787
these O 0 0.01113173458725214
mice O 0 0.03443729877471924
was O 0 0.021061474457383156
reduced O 0 0.02193361148238182
strongly O 0 0.018501097336411476
as O 0 0.012416567653417587
a O 0 0.014374854043126106
result O 0 0.012300422415137291
of O 0 0.012481238692998886
the O 0 0.01795983500778675
lack O 0 0.02631935477256775
of O 0 0.026808205991983414
protection O 0 0.3408690392971039
provided O 0 0.03421540558338165
by O 0 0.037138473242521286
vWf O 1 0.9996720552444458
. O 0 0.05060286447405815

Defective O 1 0.9999978542327881
thrombosis B-Disease 1 1.0
in O 0 0.07680150866508484
mutant O 1 0.9999985694885254
mice O 1 0.759607195854187
was O 0 0.03186463564634323
also O 0 0.015285827219486237
evident O 0 0.027540139853954315
in O 0 0.01031480636447668
an O 0 0.013115146197378635
in O 0 0.017566988244652748
vivo O 0 0.19225706160068512
model O 0 0.048397719860076904
of O 0 0.2153770923614502
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999996423721313
. O 0 0.15693151950836182

In O 0 0.028482874855399132
this O 0 0.016154835000634193
model O 0 0.027756379917263985
, O 0 0.01581064984202385
the O 0 0.025957079604268074
exteriorized O 1 0.9991098046302795
mesentery O 1 0.9997567534446716
was O 0 0.06025748327374458
superfused O 1 0.9998310804367065
with O 0 0.0521179735660553
ferric O 1 1.0
chloride O 1 0.9999889135360718
and O 0 0.02275339886546135
the O 0 0.02784799598157406
accumulation O 1 0.6906687617301941
of O 0 0.04400703310966492
fluorescently O 1 0.9999988079071045
labeled O 1 0.9995312690734863
platelets O 1 0.9999690055847168
was O 0 0.04660281166434288
observed O 0 0.032657690346241
by O 0 0.03405940532684326
intravital O 1 0.9959667921066284
microscopy O 0 0.10903158783912659
. O 0 0.04971767216920853

We O 0 0.03131851926445961
conclude O 0 0.0479188896715641
that O 0 0.01269184984266758
these O 0 0.011688816361129284
mice O 0 0.03432396054267883
very O 0 0.016178399324417114
closely O 0 0.029985742643475533
mimic O 1 0.9636653661727905
severe O 1 0.9999669790267944
human O 1 0.9998871088027954
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9743866920471191
will O 0 0.02239537052810192
be O 0 0.011314277537167072
very O 0 0.011357061564922333
useful O 0 0.012762047350406647
for O 0 0.009132702834904194
investigating O 0 0.021315693855285645
the O 0 0.016346221789717674
role O 0 0.03200553357601166
of O 0 0.03261857479810715
vWf O 1 0.9998557567596436
in O 0 0.02386873960494995
normal O 0 0.04415507614612579
physiology O 1 0.9299495220184326
and O 0 0.028782352805137634
in O 0 0.040598753839731216
disease O 1 1.0
models O 0 0.052240949124097824
. O 0 0.028164785355329514
. O 0 0.0369223989546299

Oral O 1 0.9968209266662598
contraceptives O 1 0.9998503923416138
and O 0 0.024449018761515617
the O 0 0.028057554736733437
risk O 1 0.9621710181236267
of O 1 0.9973435997962952
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9996684789657593

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 1.0
Study O 1 0.971710205078125
Group O 1 0.6094099879264832
. O 0 0.04058297723531723

BACKGROUND O 0 0.1054125726222992
Women O 0 0.050640374422073364
with O 0 0.027012890204787254
mutations O 0 0.03165190666913986
in O 0 0.014035356231033802
either O 0 0.017408031970262527
the O 0 0.027791060507297516
BRCA1 O 1 0.9996707439422607
or O 0 0.024827316403388977
the O 0 0.03418989107012749
BRCA2 O 1 0.9998465776443481
gene O 0 0.02667609602212906
have O 0 0.00660573597997427
a O 0 0.01578652299940586
high O 0 0.03591889515519142
lifetime O 1 0.7695446610450745
risk O 1 0.9996497631072998
of O 1 0.9999785423278809
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9987945556640625

Oral O 1 0.9721961617469788
contraceptives O 1 0.9999852180480957
protect O 1 0.9989485144615173
against O 1 0.9999998807907104
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.24386247992515564
general O 1 0.7872671484947205
, O 0 0.01607837714254856
but O 0 0.00934584066271782
it O 0 0.006789593957364559
is O 0 0.008722159080207348
not O 0 0.006903734058141708
known O 0 0.013808079063892365
whether O 0 0.009191704913973808
they O 0 0.005509033799171448
also O 0 0.00855822954326868
protect O 0 0.022855738177895546
against O 0 0.029462311416864395
hereditary B-Disease 1 0.9999998807907104
forms I-Disease 1 0.9966980218887329
of I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9979721903800964

METHODS O 0 0.048454247415065765
We O 0 0.019610216841101646
enrolled O 0 0.05374999716877937
207 O 0 0.08992238342761993
women O 0 0.040066447108983994
with O 0 0.3111427426338196
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.991095781326294
161 O 1 0.9833661913871765
of O 0 0.02115326188504696
their O 0 0.01594115048646927
sisters O 1 0.6321542263031006
as O 0 0.015582366846501827
controls O 0 0.02379182167351246
in O 0 0.010232951492071152
a O 0 0.020818453282117844
case O 0 0.04132212698459625
- O 1 0.9999703168869019
control O 0 0.04683192819356918
study O 0 0.032661810517311096
. O 0 0.032538656145334244

All O 0 0.02757227048277855
the O 0 0.032501671463251114
patients O 1 0.8633454442024231
carried O 0 0.029592493548989296
a O 0 0.03286348655819893
pathogenic O 1 0.7354931235313416
mutation O 0 0.04481031373143196
in O 0 0.01662394218146801
either O 0 0.028974389657378197
BRCA1 O 1 0.9996343851089478
( O 0 0.03052784875035286
179 O 0 0.10061996430158615
women O 0 0.041057806462049484
) O 0 0.03216490522027016
or O 0 0.036733053624629974
BRCA2 O 1 0.9999582767486572
( O 0 0.03826756030321121
28 O 0 0.05464266985654831
women O 0 0.05274453014135361
) O 0 0.037699438631534576
. O 0 0.037381891161203384

The O 0 0.05665881186723709
control O 0 0.055945105850696564
women O 0 0.037216830998659134
were O 0 0.017935939133167267
enrolled O 0 0.05363816022872925
regardless O 0 0.031575385481119156
of O 0 0.02164960466325283
whether O 0 0.022639255970716476
or O 0 0.01567802205681801
not O 0 0.00953286699950695
they O 0 0.008538410998880863
had O 0 0.019349439069628716
either O 0 0.02915872260928154
mutation O 0 0.06416475772857666
. O 0 0.03799315169453621

Lifetime O 0 0.09658069163560867
histories O 0 0.07540952414274216
of O 0 0.04209136217832565
oral O 1 0.9999926090240479
- O 1 1.0
contraceptive O 1 0.9999997615814209
use O 0 0.016668306663632393
were O 0 0.00802442617714405
obtained O 0 0.011738060042262077
by O 0 0.011739830486476421
interview O 0 0.027400914579629898
or O 0 0.012456473894417286
by O 0 0.012110472656786442
written O 0 0.018555058166384697
questionnaire O 0 0.03872455283999443
and O 0 0.011461624875664711
were O 0 0.009982273913919926
compared O 0 0.019240502268075943
between O 0 0.026631128042936325
patients O 1 0.9998584985733032
and O 0 0.023173632100224495
control O 0 0.12948918342590332
women O 0 0.03602853789925575
, O 0 0.018597271293401718
after O 0 0.026758961379528046
adjustment O 0 0.04494577273726463
for O 0 0.014485604129731655
year O 0 0.018016964197158813
of O 0 0.024764372035861015
birth O 0 0.2783520817756653
and O 0 0.03764962777495384
parity O 0 0.3389974534511566
. O 0 0.04825867712497711

RESULTS O 0 0.03454533591866493
The O 0 0.024204593151807785
adjusted O 0 0.04148072376847267
odds O 0 0.06589220464229584
ratio O 0 0.10819874703884125
for O 1 0.9313547611236572
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.4291399419307709
with O 0 0.019015055149793625
any O 0 0.014373326674103737
past O 0 0.018736960366368294
use O 0 0.01278735138475895
of O 0 0.024162888526916504
oral O 1 0.9963667392730713
contraceptives O 1 0.999984860420227
was O 0 0.07017125934362411
0 O 0 0.08024203032255173
. O 0 0.03980850800871849

5 O 0 0.060855407267808914
( O 0 0.0304699894040823
95 O 0 0.03924862667918205
percent O 0 0.028036002069711685
confidence O 0 0.05162394791841507
interval O 0 0.05968594551086426
, O 0 0.022490253672003746
0 O 0 0.03500175476074219
. O 0 0.011705965735018253
3 O 0 0.020312516018748283
to O 0 0.017277993261814117
0 O 0 0.04540108144283295
. O 0 0.01934836618602276
8 O 0 0.039460789412260056
) O 0 0.02961985021829605
. O 0 0.03393702581524849

The O 0 0.06917493045330048
risk O 1 0.9465970993041992
decreased O 0 0.06133829802274704
with O 0 0.020846281200647354
increasing O 0 0.030863773077726364
duration O 0 0.04339520260691643
of O 0 0.02034730464220047
use O 0 0.019671158865094185
( O 0 0.02805929444730282
P O 0 0.44936347007751465
for O 0 0.017360128462314606
trend O 0 0.042594119906425476
, O 0 0.027977783232927322
< O 1 0.9982251524925232
0 O 0 0.05335564911365509
. O 0 0.02371012233197689
001 O 1 0.9991670846939087
) O 0 0.021757610142230988
; O 0 0.012065907940268517
use O 0 0.008550084196031094
for O 0 0.0098518505692482
six O 0 0.013702462427318096
or O 0 0.010739892721176147
more O 0 0.00730849476531148
years O 0 0.012979167513549328
was O 0 0.021728605031967163
associated O 0 0.015093425288796425
with O 0 0.01127528678625822
a O 0 0.019456561654806137
60 O 0 0.027694707736372948
percent O 0 0.0274423286318779
reduction O 0 0.05284849554300308
in O 0 0.02741752751171589
risk O 0 0.3599787652492523
. O 0 0.044878412038087845

Oral O 1 0.9974844455718994
- O 1 0.9999933242797852
contraceptive O 1 0.9999666213989258
use O 0 0.02377205528318882
protected O 0 0.14112873375415802
against O 1 0.9999821186065674
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.028414864093065262
for O 0 0.019447332248091698
carriers O 0 0.032949235290288925
of O 0 0.016602620482444763
the O 0 0.032244469970464706
BRCA1 O 1 0.9999972581863403
mutation O 0 0.1105346530675888
( O 0 0.028276853263378143
odds O 0 0.07456321269273758
ratio O 0 0.05059528350830078
, O 0 0.019049696624279022
0 O 0 0.03690239042043686
. O 0 0.013338753022253513
5 O 0 0.020480047911405563
; O 0 0.01458737626671791
95 O 0 0.027293242514133453
percent O 0 0.023684276267886162
confidence O 0 0.052804671227931976
interval O 0 0.0599738284945488
, O 0 0.0200074203312397
0 O 0 0.03414417803287506
. O 0 0.011415609158575535
3 O 0 0.017407242208719254
to O 0 0.014651251025497913
0 O 0 0.033747218549251556
. O 0 0.013888651505112648
9 O 0 0.024019071832299232
) O 0 0.011736665852367878
and O 0 0.008897791616618633
for O 0 0.011014437302947044
carriers O 0 0.03064357489347458
of O 0 0.01875818334519863
the O 0 0.038361482322216034
BRCA2 O 1 0.9999911785125732
mutation O 0 0.40860480070114136
( O 0 0.031058263033628464
odds O 0 0.06901765614748001
ratio O 0 0.049537427723407745
, O 0 0.01920945942401886
0 O 0 0.03563313186168671
. O 0 0.014070465229451656
4 O 0 0.022744737565517426
; O 0 0.014341101050376892
95 O 0 0.026748735457658768
percent O 0 0.022412102669477463
confidence O 0 0.044462885707616806
interval O 0 0.05370372161269188
, O 0 0.019086962565779686
0 O 0 0.03149184212088585
. O 0 0.010984507389366627
2 O 0 0.019473038613796234
to O 0 0.015003709122538567
1 O 0 0.030269572511315346
. O 0 0.01710507646203041
1 O 0 0.04076513648033142
) O 0 0.029366806149482727
. O 0 0.03211398795247078

CONCLUSIONS O 0 0.1057308167219162
Oral O 1 0.9996881484985352
- O 1 0.9999996423721313
contraceptive O 1 0.9999986886978149
use O 0 0.020136229693889618
may O 0 0.014481664635241032
reduce O 0 0.020798077806830406
the O 0 0.017194120213389397
risk O 1 0.8683388233184814
of O 1 0.9997959733009338
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.10732782632112503
women O 0 0.07416567951440811
with O 0 0.025811519473791122
pathogenic O 1 0.9552105069160461
mutations O 0 0.0316375307738781
in O 0 0.01546957902610302
the O 0 0.04035218060016632
BRCA1 O 1 0.999998927116394
or O 0 0.07202241569757462
BRCA2 O 1 0.9999034404754639
gene O 0 0.11253274232149124

A O 0 0.0630560889840126
Japanese O 0 0.06439077854156494
family O 0 0.045543331652879715
with O 0 0.03407593071460724
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.02631773054599762
a O 0 0.036639947444200516
codon O 0 0.12012216448783875
291 O 0 0.1392195224761963
deletion O 0 0.09111157804727554
: O 0 0.02742660790681839
a O 0 0.02961496077477932
clinical O 1 0.9535605907440186
, O 0 0.03192641958594322
biochemical O 1 0.9576951861381531
, O 0 0.03405933082103729
pathological O 1 0.9999785423278809
, O 0 0.029371162876486778
and O 0 0.025828693062067032
genetic O 0 0.03879861533641815
report O 0 0.02949678897857666
. O 0 0.03261521831154823

We O 0 0.02184700220823288
report O 0 0.01457974873483181
a O 0 0.01700819842517376
Japanese O 0 0.03608795627951622
family O 0 0.03729013353586197
with O 0 0.0465899333357811
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999862909317017
ALD B-Disease 1 1.0
) O 0 0.026465915143489838
with O 0 0.013039255514740944
a O 0 0.0156180365011096
three O 0 0.013221116736531258
base O 0 0.035630207508802414
pair O 0 0.036368656903505325
deletion O 0 0.09148043394088745
( O 0 0.03706847503781319
delGAG O 1 0.9984234571456909
291 O 0 0.13230843842029572
) O 0 0.022127265110611916
in O 0 0.017786268144845963
the O 0 0.051802247762680054
ALD B-Disease 1 1.0
gene O 0 0.09138887375593185
. O 0 0.048925481736660004

A O 0 0.06283403187990189
variety O 0 0.030109941959381104
of O 0 0.031147023662924767
phenotypes O 0 0.08805827051401138
were O 0 0.01547302957624197
observed O 0 0.02117915078997612
within O 0 0.01536272931843996
this O 0 0.01632353663444519
family O 0 0.046933863312006
. O 0 0.03820326551795006

While O 0 0.03300043195486069
the O 0 0.03939244523644447
proband O 1 0.9999746084213257
( O 0 0.049925047904253006
patient O 1 0.9998069405555725
1 O 0 0.04166216775774956
) O 0 0.01668289676308632
was O 0 0.018012888729572296
classified O 0 0.02340998873114586
as O 0 0.011333821341395378
having O 0 0.014181401580572128
a O 0 0.019069334492087364
rare O 0 0.029423914849758148
intermediate O 0 0.4112817645072937
type O 0 0.03961218520998955
of O 0 0.025176452472805977
adult O 1 0.9116098284721375
cerebral O 1 0.9999996423721313
and O 1 0.5455139875411987
cerebello O 1 1.0
- O 1 1.0
brain O 1 0.9999815225601196
stem O 0 0.050806187093257904
forms O 0 0.020687365904450417
, O 0 0.013895979151129723
his O 0 0.024907829239964485
younger O 1 0.7856545448303223
brother O 1 0.9991645812988281
( O 0 0.036227159202098846
patient O 1 0.9999003410339355
2 O 0 0.03937475383281708
) O 0 0.018476275727152824
and O 0 0.019196823239326477
nephew O 1 0.9999886751174927
( O 0 0.04187765344977379
patient O 1 0.9998478889465332
3 O 0 0.03415260836482048
) O 0 0.01708933152258396
had O 0 0.01843719556927681
a O 0 0.047462936490774155
childhood O 1 0.9999995231628418
ALD B-Disease 1 1.0
type O 1 0.9999016523361206
. O 0 0.06224290654063225

Another O 0 0.08523773401975632
nephew O 1 0.9999874830245972
( O 0 0.056555215269327164
patient O 1 0.9998793601989746
4 O 0 0.03947983682155609
) O 0 0.01737861894071102
of O 0 0.02053898014128208
patient O 1 0.9980924725532532
1 O 0 0.036117881536483765
was O 0 0.024840697646141052
classified O 0 0.025842495262622833
as O 0 0.013274112716317177
having O 0 0.02039249986410141
an O 0 0.027763722464442253
adolescent O 1 0.9999979734420776
form O 0 0.06352262198925018
. O 0 0.048652295023202896

The O 0 0.05420679971575737
tau O 1 0.9078227281570435
level O 0 0.031650252640247345
in O 0 0.01789821684360504
the O 0 0.04110482335090637
cerebrospinal O 1 1.0
fluid O 1 0.9999665021896362
( O 1 0.5337161421775818
CSF O 1 0.9999998807907104
) O 0 0.023428747430443764
in O 0 0.017039310187101364
patient O 1 0.9888400435447693
1 O 0 0.029131971299648285
was O 0 0.02018102817237377
as O 0 0.011685450561344624
high O 0 0.017166970297694206
as O 0 0.00867092702537775
that O 0 0.006011056248098612
of O 0 0.017165152356028557
patients O 1 0.9999872446060181
with O 1 0.9999405145645142
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9996572732925415
AD B-Disease 1 0.9996992349624634
) O 0 0.03747984766960144
. O 0 0.030069362372159958

His O 0 0.1439267098903656
brain O 1 0.9993902444839478
magnetic O 0 0.10929116606712341
resonance O 1 0.9817311763763428
image O 1 0.9775345325469971
( O 0 0.04900900274515152
MRI O 1 0.9996817111968994
) O 0 0.02491849847137928
showed O 0 0.02747281827032566
abnormalities B-Disease 0 0.23798362910747528
in I-Disease 0 0.01350297499448061
the I-Disease 0 0.02645471878349781
bilateral I-Disease 1 0.999657392501831
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9999842643737793
and O 1 0.9613279104232788
brain O 1 0.9999992847442627
stem O 1 0.9941197633743286
, O 0 0.017465660348534584
but O 0 0.009534753859043121
not O 0 0.0072256592102348804
in O 0 0.01021102536469698
the O 0 0.027568677440285683
cerebral O 1 0.9999969005584717
white O 1 0.9376230835914612
matter O 0 0.022592900320887566
, O 0 0.013754411600530148
where O 0 0.013972031883895397
marked O 0 0.025578537955880165
reductions O 0 0.027023201808333397
of O 0 0.01970347948372364
the O 0 0.42189064621925354
cerebral O 1 1.0
blood O 1 0.9999994039535522
flow O 0 0.40789246559143066
and O 0 0.03897920250892639
oxygen O 1 0.9990636706352234
metabolism O 0 0.2188379317522049
were O 0 0.013635782524943352
clearly O 0 0.019444705918431282
demonstrated O 0 0.02700434997677803
by O 0 0.027067003771662712
positron O 1 0.998164713382721
emission O 1 0.8270686864852905
tomography O 1 0.9811045527458191
( O 0 0.05917996168136597
PET O 1 0.998062789440155
) O 0 0.037110090255737305
. O 0 0.0351424515247345

In O 0 0.04809211939573288
patients O 1 0.998018741607666
2 O 0 0.043089285492897034
and O 0 0.020291617140173912
3 O 0 0.026977313682436943
, O 0 0.014611206017434597
the O 0 0.018567420542240143
autopsy O 0 0.10733358561992645
findings O 0 0.024729721248149872
showed O 0 0.026742009446024895
massive O 1 0.8881211280822754
demyelination B-Disease 1 0.9999998807907104
of I-Disease 0 0.04444204270839691
the I-Disease 1 0.6976883411407471
cerebral I-Disease 1 0.9999998807907104
white I-Disease 1 0.9592970013618469
matter I-Disease 0 0.01990092173218727
with O 0 0.012474259361624718
sparing O 0 0.05383117124438286
of O 0 0.01954035460948944
the O 0 0.03470515459775925
U O 1 0.9999998807907104
- O 1 0.9999998807907104
fibers O 1 0.8532074093818665
, O 0 0.018980013206601143
compatible O 0 0.03280681371688843
with O 0 0.010796421207487583
the O 0 0.01543462835252285
findings O 0 0.02464551292359829
of O 0 0.0448286235332489
childhood O 1 0.9999998807907104
ALD B-Disease 1 1.0
. O 0 0.18004943430423737

Oleic O 1 0.99960857629776
and O 0 0.07982686161994934
erucic O 1 0.999998927116394
acids O 0 0.09892474114894867
( O 0 0.049987658858299255
Lorenzos O 1 0.9996179342269897
Oil O 0 0.04298168048262596
) O 0 0.014568885788321495
were O 0 0.008901081047952175
administered O 0 0.04352549836039543
to O 0 0.024190377444028854
patients O 1 0.9962800145149231
1 O 0 0.03921734541654587
and O 0 0.01932080276310444
4 O 0 0.02984025329351425
, O 0 0.015316749922931194
but O 0 0.01181467343121767
sufficient O 0 0.028247419744729996
effectiveness O 0 0.046479687094688416
was O 0 0.03080192767083645
not O 0 0.015744563192129135
obtained O 0 0.02700323797762394
. O 0 0.03041798248887062

The O 0 0.0377059131860733
findings O 0 0.025023851543664932
in O 0 0.012571641243994236
this O 0 0.01051272451877594
family O 0 0.023396246135234833
suggest O 0 0.01701371558010578
that O 0 0.012123486958444118
delGAG291 O 1 0.9852333664894104
is O 0 0.012928635813295841
part O 0 0.016232769936323166
of O 0 0.014629093930125237
the O 0 0.021205367520451546
cause O 0 0.044958893209695816
of O 0 0.03532664105296135
Japanese O 1 0.9993347525596619
ALD B-Disease 1 1.0
with O 0 0.05208997055888176
phenotypic O 0 0.1201404333114624
variations O 0 0.054667163640260696
. O 0 0.04240969941020012

Moreover O 0 0.06917478889226913
, O 0 0.020534250885248184
although O 0 0.011506115086376667
the O 0 0.012865429744124413
scale O 0 0.02102452516555786
of O 0 0.013742579147219658
the O 0 0.018007587641477585
study O 0 0.018327904865145683
is O 0 0.013558894395828247
limited O 0 0.014859900809824467
, O 0 0.010816274210810661
there O 0 0.007896339520812035
is O 0 0.008694920688867569
a O 0 0.013816185295581818
possibility O 0 0.02446640469133854
that O 0 0.01528765819966793
PET O 1 0.9957131147384644
can O 0 0.016203418374061584
detect O 0 0.04617081582546234
an O 0 0.029591029509902
insidious B-Disease 1 0.9999997615814209
lesion I-Disease 1 0.9999996423721313
which O 0 0.019890084862709045
is O 0 0.021170755848288536
undetectable O 1 0.9096332788467407
by O 0 0.025697458535432816
computed O 0 0.06430511921644211
tomogram O 1 0.9999715089797974
( O 0 0.07439915835857391
CT O 1 0.9999995231628418
) O 0 0.03695385903120041
or O 0 0.029700370505452156
MRI O 1 0.9910300970077515
analysis O 0 0.017365993931889534
, O 0 0.011351291090250015
and O 0 0.008410956710577011
that O 0 0.00555809773504734
the O 0 0.010776553303003311
higher O 0 0.013946618884801865
level O 0 0.01751590706408024
of O 0 0.020703433081507683
tau O 1 0.9946894645690918
reflects O 0 0.03706898167729378
the O 0 0.017330918461084366
process O 0 0.021569354459643364
of O 0 0.03572097420692444
neuronal B-Disease 1 0.9996324777603149
degeneration I-Disease 1 1.0
in O 1 0.9574105143547058
ALD B-Disease 1 1.0
. O 0 0.09052099287509918

Lorenzos O 1 0.9998171925544739
Oil O 0 0.05463135614991188
should O 0 0.01704562082886696
be O 0 0.008546723052859306
given O 0 0.010276556946337223
in O 0 0.01001741923391819
the O 0 0.017916740849614143
early O 0 0.032298412173986435
stage O 0 0.060297586023807526
. O 0 0.024723932147026062
. O 0 0.03445950523018837

Nonsense O 0 0.22259962558746338
mutation O 0 0.07698173820972443
in O 0 0.02306603454053402
exon O 0 0.10307863354682922
4 O 0 0.030507341027259827
of O 0 0.022188179194927216
human O 0 0.034813154488801956
complement O 1 0.9228043556213379
C9 O 1 1.0
gene O 0 0.04039964824914932
is O 0 0.014251435175538063
the O 0 0.01631751097738743
major O 0 0.026140600442886353
cause O 0 0.03438122570514679
of O 0 0.026531308889389038
Japanese O 1 0.9849299788475037
complement B-Disease 1 0.9999953508377075
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.09937591105699539

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.04433318227529526
the I-Disease 0 0.04207194223999977
ninth I-Disease 1 0.9991292357444763
component I-Disease 0 0.10290467739105225
of I-Disease 0 0.02391665242612362
human I-Disease 0 0.034753985702991486
complement I-Disease 1 0.7080551385879517
( O 0 0.0432245209813118
C9 O 1 0.9999991655349731
) O 0 0.020393168553709984
is O 0 0.01048852689564228
the O 0 0.011672825552523136
most O 0 0.014348260127007961
common O 0 0.05839882418513298
complement B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
in O 0 0.03264457732439041
Japan O 0 0.1544567346572876
but O 0 0.015887713059782982
is O 0 0.015947489067912102
rare O 0 0.02310190349817276
in O 0 0.01312651950865984
other O 0 0.012255477719008923
countries O 0 0.01733238995075226
. O 0 0.03399435430765152

We O 0 0.028345614671707153
studied O 0 0.024453863501548767
the O 0 0.018772393465042114
molecular O 0 0.025013510137796402
basis O 0 0.017790885642170906
of O 0 0.046420518308877945
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.023706190288066864
four O 0 0.023928780108690262
Japanese O 1 0.8054391741752625
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999997615814209
patients O 1 0.9997501969337463
who O 0 0.03622819855809212
had O 0 0.03718677535653114
suffered O 1 0.9999988079071045
from O 1 0.9998799562454224
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9906308054924011

Direct O 0 0.06274119019508362
sequencing O 0 0.05195075273513794
of O 0 0.038989920169115067
amplified O 0 0.42670416831970215
C9 O 1 0.9999675750732422
cDNA O 0 0.12450665980577469
and O 0 0.024352680891752243
DNA O 0 0.028385616838932037
revealed O 0 0.024218715727329254
a O 0 0.02333412691950798
nonsense O 0 0.0749661922454834
substitution O 0 0.054168060421943665
( O 0 0.02847336418926716
CGA O 1 0.9665833711624146
- O 1 0.999998927116394
- O 1 0.9999984502792358
> O 1 0.9996672868728638
TGA O 1 0.9999690055847168
) O 0 0.023938078433275223
at O 0 0.020989088341593742
codon O 0 0.05516631901264191
95 O 0 0.02948513813316822
in O 0 0.014091549441218376
exon O 0 0.07069546729326248
4 O 0 0.020920660346746445
in O 0 0.008802002295851707
the O 0 0.015724655240774155
four O 0 0.03641056269407272
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999558925628662
individuals O 0 0.0420195534825325
. O 0 0.04291604831814766

An O 0 0.047555387020111084
allele O 0 0.1814320981502533
- O 1 0.9983654618263245
specific O 0 0.03142512962222099
polymerase O 1 0.9578660726547241
chain O 0 0.11097260564565659
reaction O 0 0.051906611770391464
system O 0 0.03318914771080017
designed O 0 0.031419962644577026
to O 0 0.019539620727300644
detect O 0 0.04029373824596405
exclusively O 0 0.0176133643835783
only O 0 0.0075672646053135395
one O 0 0.008293841034173965
of O 0 0.011870027519762516
the O 0 0.018367234617471695
normal O 0 0.03003867156803608
and O 0 0.024774739518761635
mutant O 1 0.9266864061355591
alleles O 0 0.06464538723230362
indicated O 0 0.02211098000407219
that O 0 0.007067960221320391
all O 0 0.007488511968404055
the O 0 0.01417990867048502
four O 0 0.019231358543038368
patients O 0 0.30450329184532166
were O 0 0.014208847656846046
homozygous O 0 0.043692417442798615
for O 0 0.015805063769221306
the O 0 0.02312186360359192
mutation O 0 0.044547583907842636
in O 0 0.019847886636853218
exon O 1 0.5412602424621582
4 O 0 0.025501733645796776
and O 0 0.010855404660105705
that O 0 0.007209634408354759
the O 0 0.01408994011580944
parents O 0 0.027029043063521385
of O 0 0.02563442476093769
patient O 1 0.9999071359634399
2 O 0 0.04770752787590027
were O 0 0.0237128846347332
heterozygous O 0 0.08180899173021317
. O 0 0.03997713699936867

The O 0 0.05432754382491112
common O 0 0.04609740525484085
mutation O 0 0.06370992958545685
at O 0 0.03347595036029816
codon O 0 0.07288722693920135
95 O 0 0.03773033618927002
in O 0 0.020284567028284073
exon O 0 0.10397271811962128
4 O 0 0.03201623260974884
might O 0 0.016091184690594673
be O 0 0.007200717926025391
responsible O 0 0.01815566048026085
for O 0 0.01163392048329115
most O 0 0.020131941884756088
Japanese O 1 0.9994969367980957
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.05379879102110863
. O 0 0.051018375903367996

BRCA1 O 1 0.9847022891044617
required O 0 0.0282689668238163
for O 0 0.02561093494296074
transcription O 1 0.9920037388801575
- O 1 0.999996542930603
coupled O 1 0.7957934141159058
repair O 1 0.9942798614501953
of O 0 0.058725591748952866
oxidative O 1 0.999981164932251
DNA O 0 0.11954530328512192
damage O 0 0.10357945412397385
. O 0 0.04637787118554115

The O 0 0.08347371220588684
breast B-Disease 1 1.0
and I-Disease 1 0.9999368190765381
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9999494552612305
BRCA1 O 1 0.9999971389770508
encodes O 0 0.07740087807178497
a O 0 0.048509273678064346
zinc O 1 0.999964714050293
finger O 1 0.9873517751693726
protein O 0 0.041390374302864075
of O 0 0.025829458609223366
unknown O 0 0.04587817192077637
function O 0 0.03959896042943001
. O 0 0.03394528105854988

Association O 0 0.050017304718494415
of O 0 0.029723551124334335
the O 0 0.044943299144506454
BRCA1 O 1 0.9999469518661499
protein O 0 0.029819535091519356
with O 0 0.01172566507011652
the O 0 0.023683905601501465
DNA O 0 0.05833940580487251
repair O 1 0.9995031356811523
protein O 0 0.06614052504301071
Rad51 O 1 0.9889698028564453
and O 0 0.018372762948274612
changes O 0 0.012417866848409176
in O 0 0.011112530715763569
the O 0 0.019435381516814232
phosphorylation O 0 0.04884277656674385
and O 0 0.019256873056292534
cellular O 0 0.03641035035252571
localization O 0 0.04723768308758736
of O 0 0.016858968883752823
the O 0 0.023220393806695938
protein O 0 0.025667183101177216
after O 0 0.02197316288948059
exposure O 0 0.037990130484104156
to O 0 0.019902700558304787
DNA O 0 0.051109254360198975
- O 1 0.9999719858169556
damaging O 0 0.08012976497411728
agents O 0 0.021534305065870285
are O 0 0.005732088815420866
consistent O 0 0.017553268000483513
with O 0 0.010444593615829945
a O 0 0.019232166931033134
role O 0 0.03339162841439247
for O 0 0.02761813998222351
BRCA1 O 1 0.999530553817749
in O 0 0.033703360706567764
DNA O 0 0.07398095726966858
repair O 1 0.9337444305419922
. O 0 0.05037013441324234

Here O 0 0.040964413434267044
, O 0 0.020359160378575325
it O 0 0.009356938302516937
is O 0 0.010815712623298168
shown O 0 0.012235337868332863
that O 0 0.011398961767554283
mouse O 0 0.06117035448551178
embryonic O 1 0.5789057016372681
stem O 1 0.795737624168396
cells O 0 0.3007311224937439
deficient B-Disease 1 0.9998652935028076
in I-Disease 0 0.03799273818731308
BRCA1 I-Disease 1 0.9999088048934937
are O 0 0.021098259836435318
defective O 1 0.6013568639755249
in O 0 0.0176573283970356
the O 0 0.021657684817910194
ability O 0 0.018807346001267433
to O 0 0.013161434791982174
carry O 0 0.01705639436841011
out O 0 0.02191496081650257
transcription O 0 0.3894278109073639
- O 1 0.9998958110809326
coupled O 0 0.1488254964351654
repair O 1 0.9762073159217834
of O 0 0.04277084395289421
oxidative O 1 0.9999852180480957
DNA O 0 0.1930565983057022
damage O 0 0.14506091177463531
, O 0 0.019989565014839172
and O 0 0.01692725531756878
are O 0 0.01307867281138897
hypersensitive O 1 0.9999582767486572
to O 0 0.049832653254270554
ionizing O 1 0.9999967813491821
radiation O 1 0.9989996552467346
and O 0 0.04851895198225975
hydrogen O 0 0.14104008674621582
peroxide O 1 0.5994038581848145
. O 0 0.047876711934804916

These O 0 0.020143022760748863
results O 0 0.01809060573577881
suggest O 0 0.021179506555199623
that O 0 0.020124388858675957
BRCA1 O 1 0.9999828338623047
participates O 1 0.7930319309234619
, O 0 0.023584721609950066
directly O 0 0.020528726279735565
or O 0 0.014546661637723446
indirectly O 0 0.024200020357966423
, O 0 0.011632805690169334
in O 0 0.01589411124587059
transcription O 1 0.9316011071205139
- O 1 0.99998939037323
coupled O 0 0.47265902161598206
repair O 1 0.995488703250885
of O 0 0.04959110915660858
oxidative O 1 0.9999724626541138
DNA O 0 0.144252210855484
damage O 0 0.08142686635255814
. O 0 0.027522485703229904
. O 0 0.034677162766456604

Truncation O 1 0.8987137675285339
mutations O 0 0.05393289402127266
in O 0 0.017276110127568245
the O 0 0.027647871524095535
transactivation O 1 0.9972725510597229
region O 0 0.04007001966238022
of O 0 0.0378953292965889
PAX6 O 1 0.9999996423721313
result O 0 0.029463496059179306
in O 0 0.022211935371160507
dominant O 1 0.997568666934967
- O 1 0.9999879598617554
negative O 0 0.06889481842517853
mutants O 0 0.22693076729774475
. O 0 0.044777367264032364

PAX6 O 1 0.9999860525131226
is O 0 0.03737981989979744
a O 0 0.037349820137023926
transcription O 0 0.07329291850328445
factor O 0 0.03163454681634903
with O 0 0.010829998180270195
two O 0 0.012440024875104427
DNA O 0 0.041975826025009155
- O 1 0.9994686245918274
binding O 0 0.04445228725671768
domains O 0 0.04888478294014931
( O 0 0.02751529961824417
paired O 0 0.059835560619831085
box O 0 0.06525416672229767
and O 0 0.030425233766436577
homeobox O 1 0.9997900128364563
) O 0 0.02027982287108898
and O 0 0.01431049220263958
a O 0 0.027950860559940338
proline O 1 0.9959539175033569
- O 1 0.9999792575836182
serine O 1 0.999836802482605
- O 1 0.9999936819076538
threonine O 1 0.998828113079071
( O 0 0.04198944941163063
PST O 1 0.9999021291732788
) O 0 0.03653617575764656
- O 1 0.9982818365097046
rich O 0 0.07057063281536102
transactivation O 1 0.999504804611206
domain O 0 0.07534198462963104
. O 0 0.0422636941075325

PAX6 O 1 0.9999985694885254
regulates O 1 0.9987776875495911
eye O 1 0.9994584918022156
development O 0 0.04204670339822769
in O 0 0.01989256776869297
animals O 0 0.01852504163980484
ranging O 0 0.027771174907684326
from O 0 0.0256472397595644
jellyfish O 0 0.11212503910064697
to O 0 0.03025027923285961
Drosophila O 0 0.08347384631633759
to O 0 0.03134412318468094
humans O 0 0.03743055835366249
. O 0 0.03579472377896309

Heterozygous O 0 0.15048734843730927
mutations O 0 0.04646148160099983
in O 0 0.016348760575056076
the O 0 0.029718127101659775
human O 0 0.05659851059317589
PAX6 O 1 0.9999998807907104
gene O 0 0.052150659263134
result O 0 0.02040863037109375
in O 0 0.013621591031551361
various O 0 0.01737605594098568
phenotypes O 0 0.06536737829446793
, O 0 0.02171109803020954
including O 0 0.025970371440052986
aniridia B-Disease 1 0.9999986886978149
, O 0 0.044632501900196075
Peters B-Disease 1 0.9999967813491821
anomaly I-Disease 1 0.9999972581863403
, O 0 0.042584024369716644
autosomal B-Disease 1 0.9999959468841553
dominant I-Disease 1 0.9999980926513672
keratitis I-Disease 1 1.0
, O 0 0.15274249017238617
and O 0 0.08667635172605515
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.10156068205833435

It O 0 0.024660680443048477
is O 0 0.01575903221964836
believed O 0 0.01819298416376114
that O 0 0.007597785443067551
the O 0 0.017140312120318413
mutated O 0 0.06524548679590225
allele O 0 0.06041763722896576
of O 0 0.03441420570015907
PAX6 O 1 0.9999997615814209
produces O 0 0.044975392520427704
an O 0 0.03012327291071415
inactive O 1 0.999382734298706
protein O 0 0.041882503777742386
and O 0 0.027056895196437836
aniridia B-Disease 1 0.9999990463256836
is O 0 0.03159886598587036
caused O 0 0.05008811131119728
due O 0 0.03446807339787483
to O 0 0.03793155029416084
genetic O 0 0.06708391010761261
haploinsufficiency O 1 0.9985705614089966
. O 0 0.05691063776612282

However O 0 0.032026439905166626
, O 0 0.021885817870497704
several O 0 0.019091349095106125
truncation O 1 0.996893048286438
mutations O 0 0.04008431360125542
have O 0 0.009877636097371578
been O 0 0.010444268584251404
found O 0 0.009256470948457718
to O 0 0.009899335913360119
occur O 0 0.008442121557891369
in O 0 0.008557306602597237
the O 0 0.02290431782603264
C O 1 0.999970555305481
- O 1 0.9999762773513794
terminal O 0 0.06664884090423584
half O 0 0.01786907948553562
of O 0 0.028851112350821495
PAX6 O 1 0.9999997615814209
in O 0 0.026500849053263664
patients O 1 0.9814957976341248
with O 0 0.03246362879872322
Aniridia B-Disease 1 1.0
resulting O 0 0.046716004610061646
in O 0 0.023163119331002235
mutant O 0 0.30494779348373413
proteins O 0 0.022901413962244987
that O 0 0.00827814731746912
retain O 0 0.028179533779621124
the O 0 0.020061727613210678
DNA O 0 0.04678405821323395
- O 1 0.9995450377464294
binding O 0 0.0406782329082489
domains O 0 0.030177678912878036
but O 0 0.009035586379468441
have O 0 0.006134256720542908
lost O 0 0.02003699541091919
most O 0 0.010203848592936993
of O 0 0.018484769389033318
the O 0 0.040532320737838745
transactivation O 1 0.9998464584350586
domain O 0 0.08886729180812836
. O 0 0.04247017577290535

It O 0 0.028403470292687416
is O 0 0.01793581247329712
not O 0 0.00981131847947836
clear O 0 0.01861743815243244
whether O 0 0.015594040043652058
such O 0 0.014495975337922573
mutants O 0 0.14519421756267548
really O 0 0.03169390931725502
behave O 0 0.029271157458424568
as O 0 0.014640509150922298
loss O 0 0.03996553272008896
- O 1 0.9999030828475952
of O 0 0.03476477041840553
- O 1 0.9999966621398926
function O 0 0.03189858794212341
mutants O 0 0.07131651043891907
as O 0 0.02127668261528015
predicted O 0 0.03447279334068298
by O 0 0.028674747794866562
haploinsufficiency O 1 0.9889813661575317
. O 0 0.04636896029114723

Contrary O 0 0.05973118916153908
to O 0 0.0207517072558403
this O 0 0.013620833866298199
theory O 0 0.022109979763627052
, O 0 0.01323594432324171
our O 0 0.015638966113328934
data O 0 0.009553356096148491
showed O 0 0.013237356208264828
that O 0 0.00722841639071703
these O 0 0.008222896605730057
mutants O 0 0.05622563883662224
are O 0 0.0101401936262846
dominant O 0 0.25298240780830383
- O 1 0.9997351765632629
negative O 0 0.037967830896377563
in O 0 0.028631430119276047
transient O 1 0.9993915557861328
transfection O 1 0.9999079704284668
assays O 0 0.05829906836152077
when O 0 0.019011974334716797
they O 0 0.007471547927707434
are O 0 0.006750477012246847
coexpressed O 0 0.08480525016784668
with O 0 0.021443607285618782
wild O 0 0.06124809384346008
- O 1 0.9999974966049194
type O 1 0.9836724400520325
PAX6 O 1 0.9999970197677612
. O 0 0.06549239903688431

We O 0 0.02090531587600708
found O 0 0.011754616163671017
that O 0 0.007181850727647543
the O 0 0.018685350194573402
dominant O 1 0.997543215751648
- O 1 0.9999992847442627
negative O 0 0.04309529811143875
effects O 0 0.031858544796705246
result O 0 0.015241676941514015
from O 0 0.012117376551032066
the O 0 0.020549073815345764
enhanced O 0 0.056813571602106094
DNA O 0 0.03446422517299652
binding O 0 0.027154117822647095
ability O 0 0.016634153202176094
of O 0 0.01831527054309845
these O 0 0.01829841546714306
mutants O 0 0.13221648335456848
. O 0 0.04882235825061798

Kinetic O 0 0.10760840773582458
studies O 0 0.026794912293553352
of O 0 0.02578216977417469
binding O 0 0.04404878988862038
and O 0 0.025986969470977783
dissociation O 0 0.25755929946899414
revealed O 0 0.02838081866502762
that O 0 0.009229405783116817
various O 0 0.01113331038504839
truncation O 1 0.7367448806762695
mutants O 0 0.17154322564601898
have O 0 0.012098698876798153
3 O 0 0.036258142441511154
- O 1 0.9991523027420044
5 O 0 0.040867388248443604
- O 1 0.9969998002052307
fold O 0 0.05019603669643402
higher O 0 0.020087897777557373
affinity O 0 0.030976099893450737
to O 0 0.012576216831803322
various O 0 0.010738789103925228
DNA O 0 0.03476918488740921
- O 1 0.9712845683097839
binding O 0 0.027954695746302605
sites O 0 0.014154428616166115
when O 0 0.010133443400263786
compared O 0 0.010200606659054756
with O 0 0.009426124393939972
the O 0 0.01887008361518383
wild O 0 0.056101810187101364
- O 1 0.9999953508377075
type O 1 0.9705798625946045
PAX6 O 1 0.9999920129776001
. O 0 0.06605973839759827

These O 0 0.02306331694126129
results O 0 0.01623525284230709
provide O 0 0.017051806673407555
a O 0 0.017717285081744194
new O 0 0.021274151280522346
insight O 0 0.03094308264553547
into O 0 0.013325830921530724
the O 0 0.013482068665325642
role O 0 0.027418872341513634
of O 0 0.03112865425646305
mutant O 1 0.9997445940971375
PAX6 O 1 0.9999998807907104
in O 0 0.05172146111726761
causing O 1 0.9963531494140625
aniridia B-Disease 1 0.9999974966049194
. O 0 0.0377202183008194
. O 0 0.041116997599601746

Reversal O 0 0.35074129700660706
of O 1 0.704033374786377
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999661445617676
excellent O 1 0.999466598033905
neuropsychologic O 1 0.9999775886535645
outcome O 0 0.027159277349710464
in O 0 0.010931205935776234
very B-Disease 0 0.014367208816111088
- I-Disease 1 0.9995912909507751
long I-Disease 0 0.03392529860138893
- I-Disease 1 0.9999306201934814
chain I-Disease 1 0.8605141639709473
acyl I-Disease 1 0.9999959468841553
- I-Disease 1 0.9999994039535522
coenzyme I-Disease 1 0.9999421834945679
A I-Disease 1 0.9999136924743652
dehydrogenase I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.08522745966911316

Very B-Disease 0 0.046340346336364746
- I-Disease 1 0.9988677501678467
long I-Disease 0 0.051429443061351776
- I-Disease 1 0.999931812286377
chain I-Disease 0 0.22713586688041687
acyl I-Disease 1 0.999944806098938
- I-Disease 1 0.9999953508377075
coenzyme I-Disease 1 0.999040424823761
A I-Disease 1 0.8431611061096191
dehydrogenase I-Disease 1 0.999971866607666
( I-Disease 0 0.05835912749171257
VLCAD I-Disease 1 0.9999998807907104
) I-Disease 1 0.6448745131492615
deficiency I-Disease 1 1.0
is O 0 0.027325138449668884
a O 0 0.04805363714694977
disorder O 1 1.0
of O 1 0.9998856782913208
fatty O 1 1.0
acid O 1 0.9999984502792358
beta O 1 0.9998853206634521
oxidation O 1 0.5066959857940674
that O 0 0.013211377896368504
reportedly O 0 0.029553944244980812
has O 0 0.014050382189452648
high O 0 0.026560058817267418
rates O 0 0.02700158953666687
of O 0 0.036878254264593124
morbidity O 1 0.9999986886978149
and O 0 0.06252638250589371
mortality O 1 0.9999589920043945
. O 0 0.061410799622535706

We O 0 0.024948684498667717
describe O 0 0.025138622149825096
the O 0 0.014053210616111755
outcome O 0 0.015965024009346962
of O 0 0.011897911317646503
a O 0 0.017927836626768112
5 O 0 0.028128808364272118
- O 1 0.993473470211029
year O 0 0.018437279388308525
- O 1 0.9990285634994507
old O 0 0.06978145241737366
girl O 1 0.9676554799079895
with O 0 0.09723225235939026
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.6354582905769348
was O 0 0.03122449852526188
first O 0 0.019562646746635437
seen O 0 0.01885979063808918
at O 0 0.014604851603507996
5 O 0 0.014135698787868023
months O 0 0.010818478651344776
of O 0 0.013328321278095245
age O 0 0.02680586650967598
with O 0 0.03674378618597984
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999997615814209
encephalopathy B-Disease 1 1.0
, O 1 0.8490753173828125
and O 0 0.10125003755092621
hypotonia B-Disease 1 0.999995231628418
. O 0 0.06428904086351395

Biochemical O 0 0.1423916071653366
studies O 0 0.05025326833128929
indicated O 1 0.9424528479576111
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999604225158691
by O 0 0.03444087877869606
a O 0 0.043929796665906906
stable O 1 0.911666214466095
yet O 0 0.045138273388147354
inactive O 1 0.9989463686943054
enzyme O 0 0.08853684365749359
. O 0 0.04254220798611641

Molecular O 0 0.0876760184764862
genetic O 0 0.035112414509058
analysis O 0 0.014200454577803612
of O 0 0.019310778006911278
her O 0 0.05249941721558571
VLCAD O 1 0.9999972581863403
gene O 0 0.041881050914525986
revealed O 0 0.03421410545706749
a O 0 0.03646034747362137
T1372C O 1 0.9995253086090088
( O 0 0.04851970076560974
F458L O 1 0.9989782571792603
) O 0 0.03842218592762947
missense O 0 0.11326968669891357
mutation O 0 0.054339244961738586
and O 0 0.02341979555785656
a O 0 0.047141183167696
1668 O 1 0.9999169111251831
ACAG O 1 0.999994158744812
1669 O 1 0.9999357461929321
splice O 1 0.9511513710021973
site O 0 0.07680834084749222
mutation O 0 0.07717505842447281
. O 0 0.041106756776571274

After O 0 0.0600181519985199
initial O 0 0.06006823852658272
treatment O 1 0.9994899034500122
with O 0 0.06405860185623169
intravenous O 1 1.0
glucose O 1 0.9999996423721313
and O 0 0.4775412976741791
carnitine O 1 1.0
, O 0 0.02972446009516716
the O 0 0.032027438282966614
patient O 1 0.9995934367179871
has O 0 0.02069278247654438
thrived O 0 0.05467742681503296
on O 0 0.015933388844132423
a O 0 0.023200662806630135
low O 0 0.08668230473995209
- O 1 0.9999936819076538
fat O 0 0.3082877993583679
diet O 0 0.06136350333690643
supplemented O 0 0.0395616814494133
with O 0 0.02128441445529461
medium O 0 0.0811687558889389
- O 1 0.9999818801879883
chain O 0 0.3028024733066559
triglyceride O 1 0.9950980544090271
oil O 0 0.047362376004457474
and O 0 0.03748486191034317
carnitine O 1 0.9999936819076538
and O 0 0.04254020377993584
avoidance O 1 0.9999864101409912
of O 0 0.250554621219635
fasting O 1 0.9998608827590942
. O 0 0.05873817205429077

Her O 1 0.9999140501022339
ventricular O 1 1.0
hypertrophy O 1 1.0
resolved O 1 0.8891226649284363
significantly O 0 0.03792248293757439
over O 0 0.022624611854553223
1 O 0 0.031475573778152466
year O 0 0.0196992140263319
, O 0 0.018668025732040405
and O 0 0.021496914327144623
cognitively O 1 0.999369204044342
, O 0 0.021266309544444084
she O 0 0.019316697493195534
is O 0 0.011666576378047466
in O 0 0.009109887294471264
the O 0 0.017923781648278236
superior O 0 0.04537752643227577
range O 0 0.02633642964065075
for O 0 0.02379998378455639
age O 0 0.04549209773540497
. O 0 0.04325886443257332

Clinical O 0 0.36278629302978516
recognition O 0 0.06169487535953522
of O 1 0.9989246726036072
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.428472638130188
important O 0 0.021647004410624504
because O 0 0.01264937873929739
it O 0 0.007422310765832663
is O 0 0.007490423042327166
one O 0 0.006914154160767794
of O 0 0.009939759038388729
the O 0 0.01422834862023592
few O 0 0.016893422231078148
directly O 0 0.03532843664288521
treatable O 1 1.0
causes O 1 0.9999252557754517
of O 1 0.9998718500137329
cardiomyopathy B-Disease 1 1.0
in O 1 0.9489765167236328
children O 1 0.9850630760192871
. O 0 0.02907414175570011
. O 0 0.03403308615088463

Cloning O 0 0.06918039172887802
of O 0 0.024642709642648697
a O 0 0.02461923286318779
novel O 0 0.035605158656835556
member O 0 0.02253383956849575
of O 0 0.014019079506397247
the O 0 0.022833000868558884
low O 1 0.725498616695404
- O 1 0.9999994039535522
density O 1 0.9924771189689636
lipoprotein O 1 1.0
receptor O 1 0.9864144921302795
family O 0 0.05952766537666321
. O 0 0.04080905765295029

A O 0 0.07036882638931274
gene O 0 0.045685648918151855
encoding O 0 0.03058207780122757
a O 0 0.028601884841918945
novel O 0 0.07658257335424423
transmembrane O 1 0.9995993971824646
protein O 0 0.03697549179196358
was O 0 0.02275281399488449
identified O 0 0.0175019484013319
by O 0 0.01267602201551199
DNA O 0 0.020123977214097977
sequence O 0 0.01132083497941494
analysis O 0 0.00660138763487339
within O 0 0.008673672564327717
the O 0 0.022280408069491386
insulin B-Disease 1 0.9999970197677612
- I-Disease 1 1.0
dependent I-Disease 1 0.999971866607666
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9976034760475159
IDDM B-Disease 1 0.9999996423721313
) O 0 0.06128702312707901
locus O 1 0.8379808068275452
IDDM4 O 1 0.9996355772018433
on O 0 0.057881250977516174
chromosome O 0 0.13133648037910461
11q13 O 1 0.9304037094116211
. O 0 0.05822589993476868

Based O 0 0.031575024127960205
on O 0 0.018590008839964867
its O 0 0.02698206529021263
chromosomal O 1 0.8871676921844482
position O 0 0.03177228942513466
, O 0 0.0172735583037138
this O 0 0.012177894823253155
gene O 0 0.02164016291499138
is O 0 0.011489970609545708
a O 0 0.01685471087694168
candidate O 0 0.030139338225126266
for O 0 0.022287651896476746
conferring O 1 0.9916286468505859
susceptibility O 1 0.999995231628418
to O 1 0.5549201369285583
diabetes B-Disease 1 1.0
. O 0 0.08260316401720047

The O 0 0.045094579458236694
gene O 0 0.039133887737989426
, O 0 0.018878744915127754
termed O 0 0.05961652100086212
low O 0 0.0878688171505928
- O 1 0.9999908208847046
density O 0 0.44481682777404785
lipoprotein O 1 0.9999998807907104
receptor O 1 0.9957114458084106
related O 0 0.03716464713215828
protein O 0 0.03448208048939705
5 O 0 0.03084515780210495
( O 0 0.03397088497877121
LRP5 O 1 0.9998679161071777
) O 0 0.021070554852485657
, O 0 0.016081470996141434
encodes O 0 0.03617791458964348
a O 0 0.022390291094779968
protein O 0 0.027382083237171173
of O 0 0.02624189481139183
1615 O 1 0.9955427050590515
amino O 0 0.04946381226181984
acids O 0 0.025173787027597427
that O 0 0.009494246914982796
contains O 0 0.02230783738195896
conserved O 0 0.03515486419200897
modules O 0 0.033164046704769135
which O 0 0.008383014239370823
are O 0 0.004768041893839836
characteristic O 0 0.017275333404541016
of O 0 0.012406117282807827
the O 0 0.02048565447330475
low O 1 0.9152907133102417
- O 1 0.9999996423721313
density O 1 0.9983643889427185
lipoprotein O 1 1.0
( O 1 0.9879561066627502
LDL O 1 1.0
) O 0 0.05755475535988808
receptor O 1 0.5737866759300232
family O 0 0.055602848529815674
. O 0 0.03820134326815605

These O 0 0.027173297479748726
modules O 0 0.05150940641760826
include O 0 0.023153729736804962
a O 0 0.03436832129955292
putative O 1 0.9753857254981995
signal O 0 0.06876584887504578
peptide O 0 0.06863332539796829
for O 0 0.021640324965119362
protein O 0 0.025043541565537453
export O 0 0.02025717869400978
, O 0 0.013335608877241611
four O 0 0.023127906024456024
epidermal O 1 0.9999810457229614
growth O 0 0.12396688759326935
factor O 1 0.9882783889770508
( O 0 0.055061280727386475
EGF O 1 0.9999840259552002
) O 0 0.03259908780455589
repeats O 0 0.04565052688121796
with O 0 0.021137889474630356
associated O 0 0.03495766595005989
spacer O 1 0.6874751448631287
domains O 0 0.04632270708680153
, O 0 0.019747072830796242
three O 0 0.03089563362300396
LDL O 1 1.0
- O 1 1.0
receptor O 1 0.9993608593940735
( O 0 0.04113800451159477
LDLR O 1 0.9998908042907715
) O 0 0.02536482736468315
repeats O 0 0.03794107958674431
, O 0 0.014732358045876026
a O 0 0.021875394508242607
single O 0 0.04209553450345993
transmembrane O 1 0.5694292187690735
spanning O 0 0.05551394820213318
domain O 0 0.04600821062922478
, O 0 0.018457336351275444
and O 0 0.018373997882008553
a O 0 0.039723094552755356
cytoplasmic O 1 0.8550825715065002
domain O 0 0.0766967236995697
. O 0 0.042089466005563736

The O 0 0.045609090477228165
encoded O 0 0.04216603934764862
protein O 0 0.025576839223504066
has O 0 0.011425849050283432
a O 0 0.01396932639181614
unique O 0 0.01573479175567627
organization O 0 0.027244459837675095
of O 0 0.03661727532744408
EGF O 1 0.999998927116394
and O 0 0.04635044187307358
LDLR O 1 0.9999994039535522
repeats O 0 0.10183729231357574
; O 0 0.024534370750188828
therefore O 0 0.022323064506053925
, O 0 0.022927165031433105
LRP5 O 1 0.9996458292007446
likely O 0 0.023594334721565247
represents O 0 0.026075320318341255
a O 0 0.017225049436092377
new O 0 0.01968286745250225
category O 0 0.025121809914708138
of O 0 0.02080840803682804
the O 0 0.0416891910135746
LDLR O 1 0.9999860525131226
family O 0 0.0791807621717453
. O 0 0.047402430325746536

Both O 0 0.03517145290970802
human O 0 0.04103696346282959
and O 0 0.035463184118270874
mouse O 1 0.9739444851875305
LRP5 O 1 0.9999988079071045
cDNAs O 1 0.9993627667427063
have O 0 0.01381723117083311
been O 0 0.01549670659005642
isolated O 0 0.03607165440917015
and O 0 0.014047570526599884
the O 0 0.02183215133845806
encoded O 0 0.03681917116045952
mature O 0 0.05027204379439354
proteins O 0 0.02274159900844097
are O 0 0.006647709757089615
95 O 0 0.029013503342866898
% O 0 0.017999276518821716
identical O 0 0.020702309906482697
, O 0 0.01481249462813139
indicating O 0 0.02431989274919033
a O 0 0.02072342298924923
high O 0 0.033193085342645645
degree O 0 0.028556976467370987
of O 0 0.027961570769548416
evolutionary O 0 0.05095653980970383
conservation O 0 0.0523984432220459
. O 0 0.02533135749399662
. O 0 0.033704739063978195

The O 0 0.07178224623203278
APC B-Disease 1 0.9987108707427979
variants O 0 0.07087542116641998
I1307K O 1 0.9883314967155457
and O 0 0.02822992019355297
E1317Q O 1 0.9865818023681641
are O 0 0.009996062144637108
associated O 0 0.03215288370847702
with O 1 0.9978759288787842
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.6857437491416931
but O 0 0.017986571416258812
not O 0 0.01203131303191185
always O 0 0.015665236860513687
with O 0 0.01120762713253498
a O 0 0.02260708063840866
family O 0 0.037028536200523376
history O 0 0.042607299983501434
. O 0 0.04127159342169762

Classical O 0 0.24065762758255005
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999983310699463
FAP B-Disease 1 1.0
) O 0 0.028106234967708588
is O 0 0.012746813707053661
a O 0 0.018715856596827507
high O 0 0.05593624711036682
- O 1 0.9999994039535522
penetrance O 1 0.9999998807907104
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 0.030933214351534843
predisposes O 1 0.9999806880950928
to O 0 0.01836794801056385
hundreds O 0 0.017296820878982544
or O 0 0.01119951345026493
thousands O 0 0.02574414573609829
of O 1 0.9362117648124695
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999998927116394
carcinoma I-Disease 1 1.0
and O 0 0.03750992193818092
that O 0 0.015169830992817879
results O 0 0.01441587321460247
from O 0 0.01925550401210785
truncating O 1 0.7368379831314087
mutations O 0 0.04056853428483009
in O 0 0.018316691741347313
the O 0 0.042036257684230804
APC B-Disease 1 0.9999878406524658
gene O 0 0.0674130767583847
. O 0 0.041908711194992065

A O 0 0.06704360991716385
variant O 0 0.06446287781000137
of O 0 0.04546584561467171
FAP B-Disease 1 1.0
is O 0 0.19806253910064697
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.03450806066393852
which O 0 0.012784354388713837
results O 0 0.011352777481079102
from O 0 0.019226687029004097
germ O 1 0.9999996423721313
- O 1 0.9999961853027344
line O 0 0.04455450177192688
mutations O 0 0.02348647639155388
in O 0 0.009065153077244759
the O 0 0.01393277570605278
5 O 0 0.02108372189104557
and O 0 0.012405399233102798
3 O 0 0.01934121549129486
regions O 0 0.014839893206954002
of O 0 0.01861603744328022
the O 0 0.04117799550294876
APC B-Disease 1 0.9999982118606567
gene O 0 0.06982353329658508
. O 0 0.04321395233273506

Attenuated B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999998807907104
have O 0 0.023299790918827057
" O 0 0.043601203709840775
multiple O 0 0.04916149005293846
" O 1 0.9999681711196899
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.21825340390205383
typically O 0 0.022763250395655632
fewer O 0 0.015476363711059093
than O 0 0.010579499416053295
100 O 0 0.020693698897957802
) O 0 0.013962090015411377
without O 0 0.011321725323796272
the O 0 0.024642715230584145
florid O 1 0.9997422099113464
phenotype O 1 0.8283844590187073
of O 0 0.04985165223479271
classical O 1 0.542534351348877
FAP B-Disease 1 1.0
. O 0 0.06475085020065308

Another O 0 0.052394039928913116
group O 0 0.04024823009967804
of O 0 0.03239816054701805
patients O 1 0.9978796243667603
with O 0 0.029315920546650887
multiple O 0 0.41798412799835205
adenomas B-Disease 1 1.0
has O 0 0.025901582092046738
no O 0 0.017990143969655037
mutations O 0 0.021677842363715172
in O 0 0.011485637165606022
the O 0 0.027975929901003838
APC B-Disease 1 0.9999998807907104
gene O 0 0.03785980865359306
, O 0 0.016700053587555885
and O 0 0.013553551398217678
their O 0 0.017602823674678802
phenotype O 0 0.19143104553222656
probably O 0 0.02097182162106037
results O 0 0.010556966997683048
from O 0 0.011774413287639618
variation O 0 0.022176312282681465
at O 0 0.01998567394912243
a O 0 0.028897535055875778
locus O 1 0.9791576266288757
, O 0 0.027055932208895683
or O 0 0.024401772767305374
loci O 0 0.07078073918819427
, O 0 0.019218051806092262
elsewhere O 0 0.019345596432685852
in O 0 0.014086482115089893
the O 0 0.027498334646224976
genome O 0 0.05494624003767967
. O 0 0.03570861741900444

Recently O 0 0.06624115258455276
, O 0 0.02229999750852585
however O 0 0.013422292657196522
, O 0 0.013175946660339832
a O 0 0.021858077496290207
missense O 0 0.08920028805732727
variant O 0 0.05371161177754402
of O 0 0.03882049769163132
APC B-Disease 1 0.9999997615814209
( O 0 0.047907616943120956
I1307K O 1 0.9999266862869263
) O 0 0.019320137798786163
was O 0 0.017862804234027863
described O 0 0.018463557586073875
that O 0 0.009250441566109657
confers O 0 0.048553310334682465
an O 0 0.01443589385598898
increased O 0 0.024801261723041534
risk O 1 0.9904928803443909
of O 1 0.9999321699142456
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9599847793579102
including O 0 0.04233982041478157
multiple O 0 0.17442984879016876
adenomas B-Disease 1 0.9999998807907104
, O 0 0.0392884723842144
in O 0 0.03889444097876549
Ashkenazim O 1 0.9984011054039001
. O 0 0.05947638303041458

We O 0 0.024058517068624496
have O 0 0.009989265352487564
studied O 0 0.016103683039546013
a O 0 0.013884146697819233
set O 0 0.015297760255634785
of O 0 0.019959256052970886
164 O 1 0.5318182706832886
patients O 1 0.9990826845169067
with O 0 0.041957926005125046
multiple O 1 0.9999631643295288
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999895095825195
/ I-Disease 1 1.0
or I-Disease 1 0.9937314391136169
carcinoma I-Disease 1 1.0
and O 0 0.03410293906927109
analyzed O 0 0.04370848461985588
codons O 0 0.10021144151687622
1263 O 1 0.9999148845672607
- O 1 0.9999957084655762
1377 O 1 0.9998960494995117
( O 0 0.04872478172183037
exon O 1 0.7641893625259399
15G O 1 0.9618023037910461
) O 0 0.015736348927021027
of O 0 0.015071112662553787
the O 0 0.02656315639615059
APC B-Disease 1 0.9999767541885376
gene O 0 0.039671532809734344
for O 0 0.02981751039624214
germ O 1 0.9999988079071045
- O 1 0.9999854564666748
line O 0 0.06860803067684174
variants O 0 0.05188737064599991
. O 0 0.033275045454502106

Three O 0 0.045752398669719696
patients O 0 0.3277241587638855
with O 0 0.024592671543359756
the O 0 0.04182619974017143
I1307K O 1 0.9999724626541138
allele O 0 0.09382089227437973
were O 0 0.018794754520058632
detected O 0 0.03330983594059944
, O 0 0.013439959846436977
each O 0 0.009263250045478344
of O 0 0.025869587436318398
Ashkenazi O 1 0.9901093244552612
descent O 0 0.10197800397872925
. O 0 0.04931206628680229

Four O 0 0.04767758399248123
patients O 0 0.13229331374168396
had O 0 0.029083264991641045
a O 0 0.047842804342508316
germ O 1 0.9999983310699463
- O 1 0.9999617338180542
line O 0 0.07185947149991989
E1317Q O 1 0.9711563587188721
missense O 0 0.1444246768951416
variant O 0 0.062213487923145294
of O 0 0.03191715106368065
APC O 1 0.9999489784240723
that O 0 0.01166501734405756
was O 0 0.017676841467618942
not O 0 0.007593336049467325
present O 0 0.012764324434101582
in O 0 0.01111694797873497
controls O 0 0.027418317273259163
; O 0 0.013669834472239017
one O 0 0.011540621519088745
of O 0 0.012342219240963459
these O 0 0.008238249458372593
individuals O 0 0.012246891856193542
had O 0 0.01443092804402113
an O 0 0.013929172419011593
unusually O 0 0.03191721811890602
large O 0 0.015007260255515575
number O 0 0.013505669310688972
of O 0 0.02753668650984764
metaplastic B-Disease 1 0.9999710321426392
polyps I-Disease 1 0.9999591112136841
of I-Disease 0 0.04119047522544861
the I-Disease 0 0.058265216648578644
colorectum I-Disease 1 0.9998109936714172
. O 0 0.05758723244071007

There O 0 0.029079275205731392
is O 0 0.020183252170681953
increasing O 0 0.021501462906599045
evidence O 0 0.014429496601223946
that O 0 0.008978340774774551
there O 0 0.011357082054018974
exist O 0 0.023258592933416367
germ O 1 0.9999574422836304
- O 1 0.9994487166404724
line O 0 0.038359545171260834
variants O 0 0.019021140411496162
of O 0 0.015226026996970177
the O 0 0.03074561059474945
APC B-Disease 1 0.9999873638153076
gene O 0 0.03643709421157837
that O 0 0.014431769959628582
predispose O 0 0.06497010588645935
to O 0 0.01243498083204031
the O 0 0.012829410843551159
development O 0 0.018033886328339577
of O 0 0.027332017198204994
multiple O 1 0.9988019466400146
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
carcinoma I-Disease 1 1.0
, O 0 0.04642270505428314
but O 0 0.013212771154940128
without O 0 0.010962492786347866
the O 0 0.020029403269290924
florid O 1 0.9997708201408386
phenotype O 0 0.15690580010414124
of O 0 0.031670719385147095
classical O 1 0.8364303112030029
FAP B-Disease 1 1.0
, O 0 0.02188209444284439
and O 0 0.01169437076896429
possibly O 0 0.01411498710513115
with O 0 0.010403856635093689
importance O 0 0.03346901014447212
for O 1 0.9999200105667114
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999994039535522
in O 0 0.02037535235285759
the O 0 0.02263626456260681
general O 0 0.03673723712563515
population O 0 0.02279086969792843
. O 0 0.020564597100019455
. O 0 0.029261592775583267

Genomic O 0 0.0975193977355957
structure O 0 0.03301500901579857
of O 0 0.023207159712910652
the O 0 0.04039032384753227
human O 1 0.999993085861206
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.11976990848779678
gene O 0 0.06085691228508949
. O 0 0.03832988440990448

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999998807907104
CLD B-Disease 1 1.0
) O 0 0.04801877215504646
is O 0 0.02056899294257164
caused O 0 0.02810000814497471
by O 0 0.01486795675009489
mutations O 0 0.0212254635989666
in O 0 0.00987209565937519
a O 0 0.019078144803643227
gene O 0 0.024111267179250717
which O 0 0.015629734843969345
encodes O 0 0.05914827808737755
an O 0 0.05153222009539604
intestinal O 1 1.0
anion O 1 0.9999998807907104
transporter O 1 0.9999803304672241
. O 0 0.06133270263671875

We O 0 0.027131889015436172
report O 0 0.018658151850104332
here O 0 0.01343614049255848
the O 0 0.014778094366192818
complete O 0 0.030968591570854187
genomic O 0 0.0448836013674736
organization O 0 0.02645946480333805
of O 0 0.01692024990916252
the O 0 0.026856491342186928
human O 0 0.06118481233716011
CLD B-Disease 1 1.0
gene O 0 0.04806489124894142
which O 0 0.01687302626669407
spans O 0 0.04729915037751198
approximately O 0 0.02887815237045288
39kb O 1 0.9539501070976257
, O 0 0.02120169624686241
and O 0 0.02066251076757908
comprises O 0 0.053272902965545654
21 O 0 0.058019887655973434
exons O 0 0.1106300950050354
. O 0 0.04404514282941818

All O 0 0.05979461222887039
exon O 1 0.9801028370857239
/ O 1 0.9969250559806824
intron O 1 0.9801289439201355
boundaries O 0 0.03650164604187012
conform O 0 0.048524193465709686
to O 0 0.02065475843846798
the O 0 0.04105059430003166
GT O 1 0.9999911785125732
/ O 1 0.9999916553497314
AG O 1 0.9999517202377319
rule O 0 0.08017923682928085
. O 0 0.051760490983724594

An O 0 0.03109649382531643
analysis O 0 0.016116714105010033
of O 0 0.016891013830900192
the O 0 0.029456928372383118
putative O 1 0.9871297478675842
promoter O 1 0.9049925208091736
region O 0 0.03420538455247879
sequence O 0 0.018397534266114235
shows O 0 0.015751156955957413
a O 0 0.03214271366596222
putative O 1 0.998903751373291
TATA O 1 0.9999994039535522
box O 0 0.10803430527448654
and O 0 0.032616209238767624
predicts O 0 0.08256449550390244
multiple O 0 0.04616962745785713
transcription O 0 0.11014353483915329
factor O 0 0.06644102931022644
binding O 0 0.051743198186159134
sites O 0 0.034320928156375885
. O 0 0.03235502541065216

The O 0 0.05848270282149315
genomic O 0 0.08760049194097519
structure O 0 0.039235953241586685
was O 0 0.028242483735084534
determined O 0 0.026190144941210747
using O 0 0.012458514422178268
DNA O 0 0.01676330529153347
from O 0 0.0080567616969347
several O 0 0.006258569657802582
sources O 0 0.009771392680704594
including O 0 0.010151999071240425
multiple O 0 0.019093897193670273
large O 0 0.034151770174503326
- O 1 0.9999947547912598
insert O 1 0.9752081632614136
libaries O 1 0.9928076267242432
and O 0 0.026088906452059746
genomic O 0 0.05386631563305855
DNA O 0 0.03430700674653053
from O 0 0.028070664033293724
Finnish O 1 0.9997463822364807
CLD B-Disease 1 1.0
patients O 1 0.9999834299087524
and O 0 0.04704293608665466
controls O 0 0.08509689569473267
. O 0 0.04727112874388695

Exon O 1 0.9944678544998169
- O 1 0.9987823367118835
specific O 0 0.03706913813948631
primers O 0 0.22996163368225098
developed O 0 0.030881790444254875
in O 0 0.012330012395977974
this O 0 0.009232180193066597
study O 0 0.015333919785916805
will O 0 0.014454915188252926
facilitate O 0 0.04544662684202194
mutation O 0 0.05854438990354538
screening O 0 0.05933838710188866
studies O 0 0.019304877147078514
of O 0 0.027308711782097816
patients O 1 0.9995124340057373
with O 0 0.03213869035243988
the O 1 0.8672813773155212
disease O 1 1.0
. O 0 0.07179868221282959

Genomic O 0 0.10631641745567322
sequencing O 0 0.04432502016425133
of O 0 0.026332775130867958
a O 0 0.05064956471323967
BAC O 1 0.9999949932098389
clone O 1 0.9999021291732788
H O 1 0.9999966621398926
_ O 0 0.05645057559013367
RG364P16 O 1 0.9704041481018066
revealed O 0 0.02884868159890175
the O 0 0.015259278938174248
presence O 0 0.01982123777270317
of O 0 0.014761220663785934
another O 0 0.02223094552755356
, O 0 0.01666596159338951
highly O 0 0.03138352930545807
homologous O 0 0.05861421674489975
gene O 0 0.025099754333496094
3 O 0 0.019038787111639977
of O 0 0.017935501411557198
the O 0 0.036746393889188766
CLD B-Disease 1 0.9999998807907104
gene O 0 0.03828636556863785
, O 0 0.013327029533684254
with O 0 0.01168062910437584
a O 0 0.017590608447790146
similar O 0 0.015062225982546806
genomic O 0 0.04555303230881691
structure O 0 0.025492308661341667
, O 0 0.012816084548830986
recently O 0 0.016264118254184723
identified O 0 0.012419363483786583
as O 0 0.013105683960020542
the O 0 0.0372411385178566
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999550580978394
( O 1 0.9586973786354065
PDS B-Disease 1 1.0
) O 0 0.03674237057566643
. O 0 0.023482223972678185
. O 0 0.030496664345264435

The O 0 0.06870570033788681
APCI1307K O 1 0.9999966621398926
allele O 1 0.9833390712738037
and O 0 0.061176545917987823
cancer B-Disease 1 1.0
risk O 1 0.9778989553451538
in O 0 0.01701774261891842
a O 0 0.024500135332345963
community O 0 0.035975128412246704
- O 1 0.9974105954170227
based O 0 0.019069897010922432
study O 0 0.0162602961063385
of O 0 0.024970723316073418
Ashkenazi O 1 0.941382110118866
Jews O 0 0.08429209887981415
. O 0 0.04889925569295883

Mutations O 0 0.08785715699195862
in O 0 0.033873796463012695
APC O 1 0.9998749494552612
are O 0 0.01902325265109539
classically O 1 0.9922277331352234
associated O 0 0.02996841073036194
with O 0 0.03954531252384186
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999995231628418
FAP B-Disease 1 1.0
) O 0 0.02919556014239788
, O 0 0.014917304739356041
a O 0 0.022296009585261345
highly O 0 0.06156972050666809
penetrant O 1 0.9999996423721313
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999996423721313
by O 1 0.9986812472343445
multiple O 1 0.9999949932098389
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.6812687516212463
, O 0 0.025727035477757454
without O 0 0.02216242253780365
surgical O 1 0.9999990463256836
intervention O 1 0.9925811290740967
, O 0 0.012769126333296299
the O 0 0.013384610414505005
development O 0 0.028187712654471397
of O 1 0.9990118741989136
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999994039535522
CRC B-Disease 1 1.0
) O 0 0.05192205309867859
. O 0 0.039575956761837006

APC B-Disease 1 0.9976911544799805
is O 0 0.030626436695456505
a O 0 0.055926479399204254
tumour O 1 1.0
- O 1 1.0
suppressor O 1 1.0
gene O 0 0.0465751476585865
, O 0 0.01844772882759571
and O 0 0.021375389769673347
somatic O 1 0.9887149930000305
loss O 1 0.8814687728881836
occurs O 0 0.05430491641163826
in O 0 0.045585691928863525
tumours B-Disease 1 1.0
. O 0 0.06950204074382782

The O 0 0.06247827783226967
germline O 1 0.9998181462287903
T O 1 0.9999741315841675
- O 1 0.999567449092865
to O 0 0.030611610040068626
- O 1 0.9986818432807922
A O 0 0.043106768280267715
transversion O 1 0.9542838931083679
responsible O 0 0.03020188957452774
for O 0 0.017189472913742065
the O 0 0.032814037054777145
APC O 1 0.999903678894043
I1307K O 1 0.9967394471168518
allele O 0 0.08263276517391205
converts O 0 0.04066881909966469
the O 0 0.02112523280084133
wild O 0 0.04059869050979614
- O 1 0.9971985816955566
type O 0 0.031184986233711243
sequence O 0 0.012802760116755962
to O 0 0.012661985121667385
a O 0 0.03128872811794281
homopolymer O 1 0.9999960660934448
tract O 1 0.9999998807907104
( O 1 0.9033086895942688
A8 O 1 1.0
) O 0 0.02455529198050499
that O 0 0.01112397015094757
is O 0 0.017661433666944504
genetically O 0 0.04510819539427757
unstable O 1 0.9933912754058838
and O 0 0.03483932837843895
prone O 1 0.9985235333442688
to O 0 0.05118847265839577
somatic O 1 0.9976708292961121
mutation O 0 0.10474468022584915
. O 0 0.0510985367000103

The O 0 0.07725021988153458
I1307K O 1 0.9988489151000977
allele O 0 0.11959114670753479
was O 0 0.039226729422807693
found O 0 0.020155690610408783
in O 0 0.018705740571022034
6 O 0 0.05112827941775322
. O 0 0.040028635412454605

1 O 0 0.05764734372496605
% O 0 0.02738083153963089
of O 0 0.03392286226153374
unselected O 1 0.9969105124473572
Ashkenazi O 1 0.9926736950874329
Jews O 0 0.05575580149888992
and O 0 0.021225715056061745
higher O 0 0.024237949401140213
proportions O 0 0.05431255325675011
of O 0 0.030478406697511673
Ashkenazim O 1 0.9999557733535767
with O 0 0.02624763362109661
family O 0 0.034775592386722565
or O 0 0.016523828729987144
personal O 0 0.03140396252274513
histories O 0 0.047034598886966705
of O 0 0.045025985687971115
CRC B-Disease 1 1.0
( O 0 0.0852852314710617
ref O 1 0.9999784231185913
. O 0 0.023125026375055313
2 O 0 0.04267267510294914
) O 0 0.02689662203192711
. O 0 0.028920380398631096

To O 0 0.03409001603722572
evaluate O 0 0.04431670531630516
the O 0 0.018172962591052055
role O 0 0.027121927589178085
of O 0 0.02781292051076889
I1307K O 1 0.9999935626983643
in O 0 0.041445113718509674
cancer B-Disease 1 1.0
, O 0 0.02587985061109066
we O 0 0.01955580897629261
genotyped O 1 0.9079847931861877
5 O 0 0.036528632044792175
, O 0 0.030002286657691002
081 O 1 0.9992650151252747
Ashkenazi O 1 0.9726549386978149
volunteers O 0 0.05942698195576668
in O 0 0.018159085884690285
a O 0 0.027638254687190056
community O 0 0.03806380182504654
survey O 0 0.04110817611217499
. O 0 0.0319945402443409

Risk O 0 0.08756182342767715
of O 0 0.050208620727062225
developing O 1 0.9999681711196899
colorectal B-Disease 1 1.0
, I-Disease 1 0.9999804496765137
breast I-Disease 1 1.0
and I-Disease 0 0.04814324155449867
other I-Disease 0 0.02666216902434826
cancers I-Disease 1 0.9999808073043823
were O 0 0.014107318595051765
compared O 0 0.0192889254540205
between O 0 0.0275189820677042
genotyped O 1 0.9999195337295532
I1307K O 1 0.99991774559021
carriers O 0 0.06225981190800667
and O 0 0.020517241209745407
non O 1 0.8254133462905884
- O 1 0.9998857975006104
carriers O 0 0.04018262401223183
and O 0 0.011557201854884624
their O 0 0.011174669489264488
first O 0 0.028585556894540787
- O 1 0.9990923404693604
degree O 0 0.05299632251262665
relatives O 0 0.07226217538118362
. O 0 0.04045752435922623

Sperm O 0 0.09906168282032013
DNA O 0 0.04029224440455437
analysis O 0 0.014675302430987358
in O 0 0.014629334211349487
a O 0 0.04468788951635361
Friedreich B-Disease 1 0.9999991655349731
ataxia I-Disease 1 1.0
premutation O 1 0.9999995231628418
carrier O 1 0.999870777130127
suggests O 0 0.04387417063117027
both O 0 0.026365328580141068
meiotic O 1 0.9998264908790588
and O 0 0.03479507938027382
mitotic O 1 0.9951255917549133
expansion O 0 0.053605709224939346
in O 0 0.021725796163082123
the O 0 0.041587863117456436
FRDA B-Disease 1 0.9999638795852661
gene O 0 0.07164274156093597
. O 0 0.04233541339635849

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.05662309750914574
usually O 0 0.028960134834051132
caused O 0 0.03278292343020439
by O 0 0.014883819967508316
an O 0 0.014208847656846046
expansion O 0 0.0248023122549057
of O 0 0.0174444280564785
a O 0 0.03007594123482704
GAA O 1 0.9125340580940247
trinucleotide O 1 0.9992345571517944
repeat O 0 0.08273691684007645
in O 0 0.02931363321840763
intron O 1 0.9995119571685791
1 O 0 0.03725475072860718
of O 0 0.023866184055805206
the O 0 0.04077927768230438
FRDA B-Disease 1 0.9999872446060181
gene O 0 0.07587125152349472
. O 0 0.04305499047040939

Occasionally O 0 0.059968456625938416
, O 0 0.02328455075621605
a O 0 0.025723161175847054
fully O 0 0.037037625908851624
expanded O 0 0.03983191400766373
allele O 0 0.0651867687702179
has O 0 0.017147399485111237
been O 0 0.0134125342592597
found O 0 0.011954821646213531
to O 0 0.014534274116158485
arise O 0 0.02679251693189144
from O 0 0.014735575765371323
a O 0 0.025775061920285225
premutation O 1 0.9525750279426575
of O 0 0.023946892470121384
100 O 0 0.0305793359875679
or O 0 0.02368670515716076
less O 0 0.031941674649715424
triplet O 1 0.9993109703063965
repeats O 0 0.10515659302473068
. O 0 0.04810618236660957

We O 0 0.028416337445378304
have O 0 0.012978526763617992
examined O 0 0.035177115350961685
the O 0 0.019716529175639153
sperm O 0 0.039171379059553146
DNA O 0 0.02390318736433983
of O 0 0.020252930000424385
a O 0 0.0461089164018631
premutation O 1 0.999870777130127
carrier O 1 0.9341816902160645
. O 0 0.04697069153189659

This O 0 0.036236874759197235
mans O 0 0.18492157757282257
leucocyte O 1 0.9799011945724487
DNA O 0 0.04477669298648834
showed O 0 0.026110824197530746
one O 0 0.020282339304685593
normal O 0 0.03573932126164436
allele O 0 0.058446254581213
and O 0 0.017096741124987602
one O 0 0.019793642684817314
allele O 0 0.05090454965829849
of O 0 0.02182083949446678
approximately O 0 0.025651274248957634
100 O 0 0.04160519689321518
repeats O 0 0.0765797421336174
. O 0 0.04253508895635605

His O 0 0.05700843036174774
sperm O 0 0.052601248025894165
showed O 0 0.022671591490507126
an O 0 0.016904473304748535
expanded O 0 0.03402428701519966
allele O 0 0.0566030815243721
in O 0 0.014775616116821766
a O 0 0.026948390528559685
tight O 0 0.05085704103112221
range O 0 0.026187481358647346
centering O 0 0.06791290640830994
on O 0 0.015581137500703335
a O 0 0.016848452389240265
size O 0 0.015502344816923141
of O 0 0.016646359115839005
approximately O 0 0.030249692499637604
320 O 0 0.10537102073431015
trinucleotide O 1 0.9988025426864624
repeats O 0 0.125022292137146
. O 0 0.052691616117954254

His O 0 0.06774388253688812
affected O 0 0.06761881709098816
son O 1 0.9907488226890564
has O 0 0.03475528955459595
repeat O 0 0.0749758780002594
sizes O 0 0.032623179256916046
of O 0 0.03801589086651802
1040 O 1 0.99951171875
and O 0 0.04272414743900299
540 O 0 0.19656939804553986
. O 0 0.050612922757864

These O 0 0.020985577255487442
data O 0 0.015343721024692059
suggest O 0 0.017307594418525696
that O 0 0.01043701171875
expansion O 0 0.03169320151209831
occurs O 0 0.019825318828225136
in O 0 0.010568399913609028
two O 0 0.010858333669602871
stages O 0 0.03037257120013237
, O 0 0.014325295574963093
the O 0 0.01652671955525875
first O 0 0.02269485965371132
during O 0 0.030593834817409515
meiosis O 0 0.4373200237751007
followed O 0 0.032140783965587616
by O 0 0.01780560612678528
a O 0 0.027188949286937714
second O 0 0.052805542945861816
mitotic O 1 0.9794592261314392
expansion O 0 0.08466670662164688
. O 0 0.05062786862254143

We O 0 0.028188349679112434
also O 0 0.017024749889969826
show O 0 0.018320420756936073
that O 0 0.007187011186033487
in O 0 0.008538653142750263
all O 0 0.012481415644288063
informative O 0 0.05670589953660965
carrier O 0 0.09239090234041214
father O 0 0.04895933344960213
to O 0 0.02237766608595848
affected O 0 0.036027587950229645
child O 1 0.7729150652885437
transmissions O 0 0.05560126155614853
, O 0 0.014197969809174538
with O 0 0.010209772735834122
the O 0 0.014054612256586552
notable O 0 0.019611041992902756
exception O 0 0.024619992822408676
of O 0 0.017824672162532806
the O 0 0.029409749433398247
premutation O 1 0.9999676942825317
carrier O 1 0.775296151638031
, O 0 0.018168296664953232
the O 0 0.01782367005944252
expansion O 0 0.041444431990385056
size O 0 0.033953625708818436
decreases O 0 0.05881068855524063
. O 0 0.026095902547240257
. O 0 0.033717647194862366

The O 0 0.06544223427772522
R496H O 1 0.9865210056304932
mutation O 0 0.06966664642095566
of O 0 0.037419870495796204
arylsulfatase O 1 0.9997844099998474
A O 0 0.055170223116874695
does O 0 0.026298722252249718
not O 0 0.024367867037653923
cause O 1 0.9755654335021973
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 1.0
. O 0 0.0880921483039856

Deficiency B-Disease 1 1.0
of I-Disease 0 0.08392788469791412
arylsulfatase I-Disease 1 0.9999985694885254
A I-Disease 1 0.9981961846351624
( O 0 0.08324478566646576
ARSA O 1 0.9999996423721313
) O 0 0.04943988472223282
enzyme O 0 0.08597715944051743
activity O 0 0.04998131841421127
causes O 1 0.9995694756507874
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9989627599716187
MLD B-Disease 1 1.0
) O 0 0.0609344020485878
. O 0 0.04391865059733391

A O 0 0.04714987054467201
number O 0 0.019284598529338837
of O 0 0.04094433784484863
ARSA O 1 0.9999998807907104
gene O 0 0.0687803402543068
mutations O 0 0.04467099905014038
responsible O 0 0.043928682804107666
for O 0 0.040577422827482224
MLD B-Disease 1 1.0
have O 0 0.019872654229402542
been O 0 0.022399844601750374
identified O 0 0.03322858363389969
. O 0 0.031354870647192

Recently O 0 0.05820997804403305
, O 0 0.02187415584921837
the O 0 0.029878823086619377
R496H O 1 0.994318425655365
mutation O 0 0.05866793915629387
of O 0 0.039951615035533905
ARSA O 1 0.9999992847442627
was O 0 0.02971009723842144
proposed O 0 0.016472136601805687
to O 0 0.010150600224733353
be O 0 0.007353068795055151
a O 0 0.017508991062641144
cause O 0 0.039505816996097565
of O 0 0.045173533260822296
MLD B-Disease 1 1.0
( O 0 0.062057141214609146
Draghia O 1 0.9999803304672241
et O 0 0.2528071999549866
al O 0 0.24832215905189514
. O 0 0.019160626456141472
, O 0 0.02145470306277275
1997 O 0 0.04272471368312836
) O 0 0.03221569582819939
. O 0 0.031908974051475525

We O 0 0.022577708587050438
have O 0 0.01012144424021244
investigated O 0 0.033472973853349686
the O 0 0.029992710798978806
R496H O 1 0.9999110698699951
mutation O 0 0.0584762841463089
and O 0 0.015065946616232395
found O 0 0.01177963986992836
this O 0 0.010763912461698055
mutation O 0 0.030553976073861122
at O 0 0.01651214249432087
a O 0 0.0168137326836586
relatively O 0 0.01860796846449375
high O 0 0.026915524154901505
frequency O 0 0.01710590161383152
in O 0 0.008034867234528065
an O 0 0.010893994942307472
African O 0 0.026662098243832588
American O 0 0.027301713824272156
population O 0 0.01934039033949375
( O 0 0.02956440858542919
f O 0 0.08829823136329651
= O 0 0.05881180614233017
0 O 0 0.04267212375998497
. O 0 0.018871160224080086
09 O 0 0.09009739756584167
, O 0 0.030023394152522087
n O 0 0.08582396805286407
= O 0 0.07255735993385315
61 O 0 0.06726109981536865
subjects O 0 0.04981590807437897
) O 0 0.032847318798303604
. O 0 0.03613331541419029

The O 0 0.09247607737779617
ARSA O 1 0.9999998807907104
enzyme O 1 0.5285392999649048
activity O 0 0.03277956694364548
in O 0 0.01515939086675644
subjects O 0 0.02323320135474205
with O 0 0.013371355831623077
and O 0 0.012871257029473782
without O 0 0.013511858880519867
the O 0 0.026668252423405647
R496H O 1 0.9999808073043823
mutation O 0 0.06327463686466217
was O 0 0.02834450826048851
determined O 0 0.027707107365131378
and O 0 0.014644005335867405
found O 0 0.012847252190113068
to O 0 0.015683555975556374
be O 0 0.015459583140909672
normal O 0 0.03868991509079933
. O 0 0.036595866084098816

It O 0 0.030679985880851746
is O 0 0.02126285433769226
therefore O 0 0.017602533102035522
concluded O 0 0.024230090901255608
that O 0 0.009392908774316311
the O 0 0.023513732478022575
R496H O 1 0.9993035793304443
mutation O 0 0.0674036368727684
of O 0 0.04471362382173538
ARSA O 1 0.9999994039535522
does O 0 0.026583418250083923
not O 0 0.01210226584225893
negatively O 0 0.02370598539710045
influence O 0 0.018825238570570946
the O 0 0.016099482774734497
activity O 0 0.02319791167974472
of O 0 0.03128410130739212
ARSA O 1 0.9999992847442627
and O 0 0.023851092904806137
is O 0 0.01562407799065113
not O 0 0.010781693272292614
a O 0 0.027509232982993126
cause O 0 0.06350056827068329
of O 0 0.07363011687994003
MLD B-Disease 1 0.9999998807907104

Down O 0 0.09797906130552292
- O 1 0.9566885828971863
regulation O 0 0.03400803357362747
of O 0 0.02797923982143402
transmembrane O 1 0.9984602928161621
carbonic O 1 0.9999734163284302
anhydrases O 1 0.9999864101409912
in O 1 0.7961369752883911
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9994403719902039
lines O 0 0.030674085021018982
by O 0 0.017778707668185234
wild O 0 0.03987443074584007
- O 1 0.9998576641082764
type O 0 0.07872042804956436
von B-Disease 1 0.994892954826355
Hippel I-Disease 1 0.999995231628418
- I-Disease 1 0.9999970197677612
Lindau I-Disease 1 0.9999767541885376
transgenes O 1 0.9678013920783997
. O 0 0.0668259710073471

To O 0 0.046234000474214554
discover O 0 0.06363865733146667
genes O 0 0.02171437256038189
involved O 0 0.015582696534693241
in O 0 0.01803138293325901
von B-Disease 1 0.9653688073158264
Hippel I-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999998807907104
( O 0 0.07494217902421951
VHL B-Disease 1 0.9999949932098389
) O 0 0.04665567725896835
- O 1 0.9999773502349854
mediated O 1 0.9961223006248474
carcinogenesis O 1 0.9999856948852539
, O 0 0.022480199113488197
we O 0 0.016200220212340355
used O 0 0.03670170158147812
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9984654188156128
lines O 0 0.06406960636377335
stably O 0 0.3589354157447815
transfected O 0 0.2518303096294403
with O 0 0.024055790156126022
wild O 0 0.060084935277700424
- O 1 0.9999977350234985
type O 1 0.9958515167236328
VHL O 1 0.9999997615814209
- O 1 0.9999945163726807
expressing O 0 0.2282276451587677
transgenes O 1 0.631374180316925
. O 0 0.05261104926466942

Large O 0 0.0697549432516098
- O 1 0.9977816939353943
scale O 0 0.07829876989126205
RNA O 0 0.0956091582775116
differential O 0 0.07017403841018677
display O 0 0.04219437763094902
technology O 0 0.030276475474238396
applied O 0 0.017611021175980568
to O 0 0.013040346093475819
these O 0 0.010716375894844532
cell O 0 0.032106950879096985
lines O 0 0.020889712497591972
identified O 0 0.01866409182548523
several O 0 0.012429741211235523
differentially O 0 0.07742468267679214
expressed O 0 0.03316500037908554
genes O 0 0.02218109555542469
, O 0 0.012105927802622318
including O 0 0.012059390544891357
an O 0 0.024266591295599937
alpha O 1 0.9894112944602966
carbonic O 1 0.9999229907989502
anhydrase O 1 0.999983549118042
gene O 0 0.0645754486322403
, O 0 0.0389726385474205
termed O 0 0.2713080048561096
CA12 O 1 0.9999716281890869
. O 0 0.06293798238039017

The O 0 0.05437462031841278
deduced O 0 0.09379571676254272
protein O 0 0.03780596703290939
sequence O 0 0.017241712659597397
was O 0 0.019267624244093895
classified O 0 0.023021666333079338
as O 0 0.011205111630260944
a O 0 0.01864052377641201
one O 0 0.024832477793097496
- O 1 0.9998456239700317
pass O 0 0.06384333223104477
transmembrane O 1 0.9860987663269043
CA O 0 0.060809001326560974
possessing O 0 0.03541697561740875
an O 0 0.0190759114921093
apparently O 0 0.03147723525762558
intact O 0 0.05983809754252434
catalytic O 0 0.089643694460392
domain O 0 0.03505394235253334
in O 0 0.016381582245230675
the O 0 0.03553598001599312
extracellular O 1 0.9981759786605835
CA O 1 0.8096235990524292
module O 1 0.5991928577423096
. O 0 0.046528883278369904

Reintroduced O 0 0.12995976209640503
wild O 0 0.09371282160282135
- O 1 0.9999918937683105
type O 1 0.9780846834182739
VHL B-Disease 1 0.9999951124191284
strongly O 0 0.05237753689289093
inhibited O 0 0.08556858450174332
the O 0 0.025555675849318504
overexpression O 0 0.08997709304094315
of O 0 0.020092658698558807
the O 0 0.02872336655855179
CA12 O 1 0.9999842643737793
gene O 0 0.025711026042699814
in O 0 0.011509055271744728
the O 0 0.03143356367945671
parental O 1 0.9999998807907104
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.999976396560669
lines O 0 0.06947287917137146
. O 0 0.04303286224603653

Similar O 0 0.030612552538514137
results O 0 0.016222508624196053
were O 0 0.01038830541074276
obtained O 0 0.01853029616177082
with O 0 0.02365708164870739
CA9 O 1 0.9999793767929077
, O 0 0.027568401768803596
encoding O 0 0.04097757488489151
another O 0 0.04245046526193619
transmembrane O 1 0.9854587316513062
CA O 0 0.056613050401210785
with O 0 0.01853344403207302
an O 0 0.02572488971054554
intact O 0 0.11315369606018066
catalytic O 1 0.8656299710273743
domain O 0 0.06998400390148163
. O 0 0.0394148975610733

Although O 0 0.025844300165772438
both O 0 0.01732409931719303
domains O 0 0.03846130147576332
of O 0 0.023707875981926918
the O 0 0.047691818326711655
VHL B-Disease 1 0.9999997615814209
protein O 0 0.04373279586434364
contribute O 0 0.023943809792399406
to O 0 0.014233320020139217
regulation O 0 0.02685757540166378
of O 0 0.028821105137467384
CA12 O 1 0.9999984502792358
expression O 0 0.041253842413425446
, O 0 0.019028911367058754
the O 0 0.02786981128156185
elongin O 1 0.9958131909370422
binding O 0 0.04600538685917854
domain O 0 0.04325943440198898
alone O 0 0.027228426188230515
could O 0 0.01762663573026657
effectively O 0 0.05311764031648636
regulate O 0 0.10836292803287506
CA9 O 1 0.9999769926071167
expression O 0 0.0913492888212204
. O 0 0.048429179936647415

We O 0 0.0433967262506485
mapped O 0 0.09630473703145981
CA12 O 1 0.9996519088745117
and O 0 0.058133356273174286
CA9 O 1 0.9999866485595703
loci O 0 0.12631092965602875
to O 0 0.04192301258444786
chromosome O 0 0.08500667661428452
bands O 0 0.07870818674564362
15q22 O 1 0.9970922470092773
and O 0 0.04891553521156311
17q21 O 1 0.9984134435653687
. O 0 0.05510204657912254

2 O 0 0.0654221773147583
respectively O 0 0.03762903809547424
, O 0 0.024165991693735123
regions O 0 0.03065931424498558
prone O 1 0.6238689422607422
to O 0 0.02948014996945858
amplification O 0 0.1567942053079605
in O 0 0.017722150310873985
some O 0 0.018426965922117233
human O 0 0.2868105173110962
cancers B-Disease 1 0.9999943971633911
. O 0 0.06141257658600807

Additional O 0 0.052081990987062454
experiments O 0 0.034903839230537415
are O 0 0.008921538479626179
needed O 0 0.019083062186837196
to O 0 0.013144859112799168
define O 0 0.024292796850204468
the O 0 0.015561722218990326
role O 0 0.028047339990735054
of O 0 0.028214696794748306
CA O 1 0.9941540360450745
IX O 1 1.0
and O 0 0.04855458438396454
CA O 1 0.9983069896697998
XII O 1 1.0
enzymes O 0 0.05051117017865181
in O 0 0.012514820322394371
the O 0 0.01703900843858719
regulation O 0 0.026344776153564453
of O 0 0.025880608707666397
pH O 1 0.9988930821418762
in O 0 0.015585819259285927
the O 0 0.02776261791586876
extracellular O 1 0.9966627955436707
microenvironment O 1 0.9986675977706909
and O 0 0.01620020531117916
its O 0 0.016207851469516754
potential O 0 0.02556951344013214
impact O 0 0.029645223170518875
on O 0 0.040009647607803345
cancer B-Disease 1 1.0
cell O 1 0.9977933168411255
growth O 0 0.05790717154741287
. O 0 0.038300663232803345

A O 0 0.06865188479423523
gene O 0 0.041444480419158936
encoding O 0 0.03170736879110336
a O 0 0.03401397913694382
transmembrane O 1 0.7866190671920776
protein O 0 0.03407265990972519
is O 0 0.016097888350486755
mutated O 0 0.04882638156414032
in O 0 0.018595881760120392
patients O 1 0.9998511075973511
with O 1 0.9985826015472412
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999997615814209
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.31905224919319153
. O 0 0.04663366079330444

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9995940327644348
WFS B-Disease 1 1.0
; O 1 0.5110469460487366
OMIM O 1 0.9999998807907104
222300 O 1 0.9999836683273315
) O 0 0.02628655731678009
is O 0 0.01794629730284214
an O 0 0.028168372809886932
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.12185038626194
by O 0 0.024847712367773056
young O 1 0.9995505213737488
- O 1 1.0
onset O 1 1.0
non O 1 0.9999991655349731
- O 1 1.0
immune O 1 1.0
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 0.9999852180480957
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999901056289673
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 0.10662109404802322

Linkage O 0 0.16541990637779236
to O 0 0.03743400424718857
markers O 0 0.06895015388727188
on O 0 0.039393119513988495
chromosome O 0 0.40401723980903625
4p O 1 0.9999804496765137
was O 0 0.03879769518971443
confirmed O 0 0.024954350665211678
in O 0 0.012528227642178535
five O 0 0.020411264151334763
families O 0 0.03864707425236702
. O 0 0.03943153843283653

On O 0 0.02322632074356079
the O 0 0.017182568088173866
basis O 0 0.014107290655374527
of O 0 0.026995711028575897
meiotic O 1 0.9999982118606567
recombinants O 1 0.9999990463256836
and O 1 0.8649174571037292
disease O 1 1.0
- O 1 1.0
associated O 0 0.052147191017866135
haplotypes O 1 0.7282657623291016
, O 0 0.01860380731523037
the O 0 0.03089977614581585
WFS B-Disease 1 0.9999998807907104
gene O 0 0.04371132329106331
was O 0 0.02824983559548855
localized O 0 0.04832238331437111
to O 0 0.020620087161660194
a O 0 0.04409563168883324
BAC O 1 0.9999997615814209
/ O 1 0.9999932050704956
P1 O 1 0.9999442100524902
contig O 1 0.9681549072265625
of O 0 0.024533778429031372
less O 0 0.018343709409236908
than O 0 0.01701703481376171
250 O 0 0.0546187199652195
kb O 0 0.18060660362243652
. O 0 0.0517425462603569

Mutations O 0 0.06056736037135124
in O 0 0.018749307841062546
a O 0 0.031692057847976685
novel O 0 0.07067156583070755
gene O 0 0.052905675023794174
( O 0 0.03704777732491493
WFS1 O 1 0.9996538162231445
) O 0 0.02416365221142769
encoding O 0 0.02614017203450203
a O 0 0.03059040755033493
putative O 1 0.9910037517547607
transmembrane O 1 0.996746301651001
protein O 0 0.031035592779517174
were O 0 0.00876711681485176
found O 0 0.009480150416493416
in O 0 0.009132759645581245
all O 0 0.011007994413375854
affected O 0 0.021317187696695328
individuals O 0 0.012680993415415287
in O 0 0.014365332201123238
six O 0 0.03863181918859482
WFS B-Disease 1 0.9999998807907104
families O 0 0.04180177301168442
, O 0 0.019240275025367737
and O 0 0.01493675448000431
these O 0 0.009954147972166538
mutations O 0 0.02176053635776043
were O 0 0.009191547520458698
associated O 0 0.019272608682513237
with O 0 0.020426910370588303
the O 0 0.3596270680427551
disease O 1 1.0
phenotype O 1 0.999988317489624
. O 0 0.06224275007843971

WFS1 O 1 0.9995632767677307
appears O 0 0.05670877546072006
to O 0 0.021736523136496544
function O 0 0.019418125972151756
in O 0 0.010265186429023743
survival O 0 0.03858845680952072
of O 0 0.02701021544635296
islet O 1 0.9999946355819702
beta O 1 0.9999901056289673
- O 1 0.9999997615814209
cells O 0 0.08563385903835297
and O 0 0.02923070639371872
neurons O 0 0.05195917189121246
. O 0 0.022103816270828247
. O 0 0.03414026275277138

Stable O 0 0.15505360066890717
interaction O 0 0.04108799248933792
between O 0 0.017890706658363342
the O 0 0.017522020265460014
products O 0 0.0176989808678627
of O 0 0.017088865861296654
the O 0 0.03174702078104019
BRCA1 O 1 0.9999929666519165
and O 0 0.06522109359502792
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999995231628418
genes O 0 0.042640320956707
in O 0 0.02759738452732563
mitotic O 1 0.9967813491821289
and O 0 0.05905519425868988
meiotic O 1 0.9999963045120239
cells O 0 0.12052296847105026
. O 0 0.054761484265327454

BRCA1 O 1 0.9999363422393799
and O 0 0.05616696551442146
BRCA2 O 1 0.9899702668190002
account O 0 0.024501562118530273
for O 0 0.01256559882313013
most O 0 0.010669116862118244
cases O 0 0.017352426424622536
of O 0 0.02338523231446743
familial O 1 0.9999974966049194
, O 0 0.02484099380671978
early O 0 0.3693297207355499
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999673366546631
/ I-Disease 1 1.0
or I-Disease 1 0.9999951124191284
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.7434747815132141
encode O 0 0.04984259605407715
products O 0 0.026679683476686478
that O 0 0.010902250185608864
each O 0 0.013288434594869614
interact O 0 0.032361287623643875
with O 0 0.030577434226870537
hRAD51 O 1 0.9895203113555908
. O 0 0.051871467381715775

Results O 0 0.0343521386384964
presented O 0 0.027299581095576286
here O 0 0.018089618533849716
show O 0 0.022507840767502785
that O 0 0.019584525376558304
BRCA1 O 1 0.9996316432952881
and O 0 0.039580635726451874
BRCA2 O 1 0.9999610185623169
coexist O 0 0.06937285512685776
in O 0 0.022322293370962143
a O 0 0.03645068034529686
biochemical O 0 0.06884091347455978
complex O 0 0.03408851847052574
and O 0 0.023603767156600952
colocalize O 1 0.9882140159606934
in O 0 0.02812272123992443
subnuclear O 1 0.9997637867927551
foci O 1 0.9990906715393066
in O 0 0.040975019335746765
somatic O 1 0.9991662502288818
cells O 0 0.04421038180589676
and O 0 0.01751266047358513
on O 0 0.015833185985684395
the O 0 0.02307412400841713
axial O 0 0.06815910339355469
elements O 0 0.030110973864793777
of O 0 0.03187159448862076
developing O 0 0.07719790935516357
synaptonemal O 1 0.9999805688858032
complexes O 1 0.8862314820289612
. O 0 0.051648031920194626

Like O 0 0.0974874198436737
BRCA1 O 1 0.9995063543319702
and O 0 0.06628256291151047
RAD51 O 1 0.9999988079071045
, O 0 0.06622280925512314
BRCA2 O 1 0.9992497563362122
relocates O 1 0.9799153804779053
to O 0 0.05988507345318794
PCNA O 1 0.9999713897705078
+ O 1 0.6834338307380676
replication O 0 0.07921522855758667
sites O 0 0.022371146827936172
following O 0 0.023434842005372047
exposure O 0 0.0469500869512558
of O 0 0.034207239747047424
S O 1 0.9999980926513672
phase O 1 0.9918555021286011
cells O 0 0.05529547855257988
to O 0 0.0410580039024353
hydroxyurea O 1 0.9999961853027344
or O 0 0.11540362238883972
UV O 1 0.9999997615814209
irradiation O 1 0.9992424249649048
. O 0 0.0583290196955204

Thus O 0 0.059772297739982605
, O 0 0.05057533457875252
BRCA1 O 1 0.9997283816337585
and O 0 0.038605641573667526
BRCA2 O 1 0.9997718930244446
participate O 0 0.032427072525024414
, O 0 0.016417531296610832
together O 0 0.01372869685292244
, O 0 0.011491378769278526
in O 0 0.011125389486551285
a O 0 0.030563119798898697
pathway O 1 0.9969332218170166
( O 0 0.03240388631820679
s O 1 0.9595907330513
) O 0 0.01689205877482891
associated O 0 0.011915010400116444
with O 0 0.009666024707257748
the O 0 0.01589158922433853
activation O 0 0.03963601216673851
of O 0 0.021556168794631958
double O 0 0.07257934659719467
- O 1 0.9999827146530151
strand O 0 0.0981525108218193
break O 0 0.06433337181806564
repair O 1 0.9866103529930115
and O 0 0.0427558608353138
/ O 1 0.9998561143875122
or O 0 0.043610937893390656
homologous O 0 0.14845003187656403
recombination O 0 0.14140476286411285
. O 0 0.05388341844081879

Dysfunction O 1 0.9999997615814209
of O 0 0.055283550173044205
this O 0 0.035163816064596176
pathway O 1 0.9882425665855408
may O 0 0.01720961555838585
be O 0 0.008341684937477112
a O 0 0.015206084586679935
general O 0 0.025226984173059464
phenomenon O 0 0.028778033331036568
in O 0 0.007915712893009186
the O 0 0.009690147824585438
majority O 0 0.011884241364896297
of O 0 0.01101726945489645
cases O 0 0.016409510746598244
of O 0 0.043773017823696136
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999988079071045
/ I-Disease 1 1.0
or I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.4046648144721985
. O 0 0.04740006849169731

A O 0 0.0834907814860344
novel O 0 0.09604953974485397
Arg362Ser O 1 0.9926665425300598
mutation O 0 0.04966125637292862
in O 0 0.01273274328559637
the O 0 0.022247547283768654
sterol O 1 0.9661250710487366
27 O 0 0.06422565132379532
- O 1 0.9999977350234985
hydroxylase O 1 0.9999918937683105
gene O 0 0.056848060339689255
( O 0 0.03666797652840614
CYP27 O 1 0.9998056292533875
) O 0 0.023794017732143402
: O 0 0.016293060034513474
its O 0 0.01357648428529501
effects O 0 0.02341526746749878
on O 0 0.01855655200779438
pre O 1 0.7730920314788818
- O 1 0.9998854398727417
mRNA O 0 0.07860730588436127
splicing O 0 0.06689846515655518
and O 0 0.02734757959842682
enzyme O 0 0.07117965072393417
activity O 0 0.04260015860199928
. O 0 0.03685475513339043

A O 0 0.07996073365211487
novel O 0 0.08303120732307434
C O 0 0.10474839061498642
to O 0 0.02235296554863453
A O 0 0.03707324340939522
mutation O 0 0.03298693522810936
in O 0 0.010194089263677597
the O 0 0.01987043023109436
sterol O 1 0.9932132959365845
27 O 0 0.06644783914089203
- O 1 0.9999986886978149
hydroxylase O 1 0.9999668598175049
gene O 0 0.05175529792904854
( O 0 0.035209447145462036
CYP27 O 1 0.9999438524246216
) O 0 0.021917587146162987
was O 0 0.020203735679388046
identified O 0 0.016694603487849236
by O 0 0.014157491736114025
sequencing O 0 0.04438767582178116
amplified O 0 0.09607470035552979
CYP27 O 1 0.9998704195022583
gene O 0 0.03572874888777733
products O 0 0.019690122455358505
from O 0 0.013037033379077911
a O 0 0.025053946301341057
patient O 1 0.9905361533164978
with O 0 0.04099271446466446
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 1 0.9723927974700928
CTX B-Disease 1 1.0
) O 0 0.051075082272291183
. O 0 0.041573312133550644

The O 0 0.06135501712560654
mutation O 0 0.0739811435341835
changed O 0 0.03201112523674965
the O 0 0.03746042773127556
adrenodoxin O 1 0.99898761510849
cofactor O 1 0.9990872144699097
binding O 0 0.06779459863901138
residue O 0 0.10660922527313232
362Arg O 0 0.4253719747066498
to O 0 0.03904413804411888
362Ser O 1 0.9941950440406799
( O 0 0.05021457001566887
CGT O 1 0.999599039554596
362Arg O 1 0.9991557598114014
to O 0 0.0562923289835453
AGT O 1 1.0
362Ser O 1 0.999997615814209
) O 0 0.024097662419080734
, O 0 0.012110283598303795
and O 0 0.009887517429888248
was O 0 0.019129373133182526
responsible O 0 0.030395017936825752
for O 0 0.028355322778224945
deficiency O 1 1.0
in O 0 0.020545143634080887
the O 0 0.03019901178777218
sterol O 1 0.9996132254600525
27 O 0 0.3858773708343506
- O 1 0.9999998807907104
hydroxylase O 1 0.9999639987945557
activity O 0 0.025548409670591354
, O 0 0.01238843984901905
as O 0 0.010881290771067142
confirmed O 0 0.014029921032488346
by O 0 0.010727639310061932
expression O 0 0.01946122758090496
of O 0 0.017744841054081917
mutant O 0 0.0811440572142601
cDNA O 0 0.09940177947282791
into O 0 0.04994562640786171
COS O 1 0.9999992847442627
- O 1 0.9999933242797852
1 O 0 0.07462798058986664
cells O 0 0.05692103132605553
. O 0 0.03799379616975784

Quantitative O 0 0.06691288203001022
analysis O 0 0.022543996572494507
showed O 0 0.017304709181189537
that O 0 0.007452801335602999
the O 0 0.013587958179414272
expression O 0 0.02572293020784855
of O 0 0.02897929958999157
CYP27 O 1 0.9999898672103882
gene O 0 0.04609251767396927
mRNA O 0 0.04001230746507645
in O 0 0.012438454665243626
the O 0 0.02798917144536972
patient O 1 0.6176417469978333
represented O 0 0.04194535315036774
52 O 0 0.08126185089349747
. O 0 0.045614030212163925

5 O 0 0.046834178268909454
% O 0 0.022652985528111458
of O 0 0.021474244073033333
the O 0 0.030962055549025536
normal O 0 0.050320807844400406
level O 0 0.05316117778420448
. O 0 0.04090769961476326

As O 0 0.03786427155137062
the O 0 0.034037720412015915
mutation O 0 0.05293479934334755
occurred O 0 0.0303572379052639
at O 0 0.019857432693243027
the O 0 0.0240681953728199
penultimate O 1 0.9880114197731018
nucleotide O 0 0.04881613329052925
of O 0 0.024873465299606323
exon O 0 0.18754224479198456
6 O 0 0.04836837947368622
( O 0 0.03285963460803032
- O 1 0.8833309412002563
2 O 0 0.024664143100380898
position O 0 0.020077524706721306
of O 0 0.020678816363215446
exon O 0 0.11512837558984756
6 O 0 0.0621071495115757
- O 1 0.999396562576294
intron O 1 0.9992069602012634
6 O 0 0.06134770065546036
splice O 0 0.10052841156721115
site O 0 0.026349598541855812
) O 0 0.010861641727387905
of O 0 0.011624437756836414
the O 0 0.02106226235628128
gene O 0 0.026792781427502632
, O 0 0.014352226629853249
we O 0 0.012051189318299294
hypothesized O 0 0.03240128606557846
that O 0 0.009842302650213242
the O 0 0.02336171641945839
mutation O 0 0.056239284574985504
may O 0 0.02221125178039074
partially O 0 0.041027043014764786
affect O 0 0.02186473459005356
the O 0 0.019731801003217697
normal O 0 0.03718176484107971
splicing O 0 0.05410376936197281
efficiency O 0 0.03602752462029457
in O 0 0.01864014007151127
exon O 0 0.10946270823478699
6 O 0 0.04323762655258179
and O 0 0.02601080760359764
cause O 0 0.05542325600981712
alternative O 0 0.050048764795064926
splicing O 0 0.05149064213037491
elsewhere O 0 0.02246411144733429
, O 0 0.01385361235588789
which O 0 0.010830468498170376
resulted O 0 0.023306235671043396
in O 0 0.01621188223361969
decreased O 0 0.05190908536314964
transcript O 0 0.048350606113672256
in O 0 0.016316616907715797
the O 0 0.032129447907209396
patient O 1 0.9990696310997009
. O 0 0.04752324894070625

Transfection O 1 0.992051362991333
of O 0 0.050011806190013885
constructed O 0 0.08302421122789383
minigenes O 1 0.9993516802787781
, O 0 0.023193078115582466
with O 0 0.01583305187523365
or O 0 0.013905641622841358
without O 0 0.011172492988407612
the O 0 0.016670558601617813
mutation O 0 0.032545652240514755
, O 0 0.015128296799957752
into O 0 0.030014269053936005
COS O 1 1.0
- O 1 0.9999983310699463
1 O 0 0.046510450541973114
cells O 0 0.0253140926361084
confirmed O 0 0.014737999998033047
that O 0 0.006513072643429041
the O 0 0.016739310696721077
mutant O 0 0.19090636074543
minigene O 1 0.9986419081687927
was O 0 0.03095298819243908
responsible O 0 0.028955386951565742
for O 0 0.015306520275771618
a O 0 0.02465912327170372
mRNA O 0 0.0434965156018734
species O 0 0.012641151435673237
alternatively O 0 0.03760764002799988
spliced O 0 0.046808257699012756
at O 0 0.02234313264489174
an O 0 0.025594012811779976
activated O 1 0.9648303985595703
cryptic O 0 0.11118102073669434
5 O 0 0.04777451604604721
splice O 0 0.11114219576120377
site O 0 0.039965879172086716
88 O 0 0.06507309526205063
bp O 0 0.06049344688653946
upstream O 0 0.03528553247451782
from O 0 0.012327457778155804
the O 0 0.01533579733222723
3 O 0 0.022761208936572075
end O 0 0.02638568915426731
of O 0 0.030854230746626854
exon O 1 0.9668186902999878
6 O 0 0.06373021006584167
. O 0 0.03996875509619713

Our O 0 0.04685627296566963
data O 0 0.018843863159418106
suggest O 0 0.014722968451678753
that O 0 0.008581188507378101
the O 0 0.01954697258770466
C O 0 0.07284333556890488
to O 0 0.0186937153339386
A O 0 0.038019709289073944
mutation O 0 0.03964788839221001
at O 0 0.018534095957875252
the O 0 0.022843152284622192
penultimate O 1 0.9971721768379211
nucleotide O 0 0.04062170907855034
of O 0 0.02108605019748211
exon O 0 0.08137445151805878
6 O 0 0.024421794340014458
of O 0 0.015699287876486778
the O 0 0.026796722784638405
CYP27 O 1 0.9999963045120239
gene O 0 0.029948744922876358
not O 0 0.008633511140942574
only O 0 0.013098998926579952
causes O 0 0.461745947599411
the O 0 0.10278359055519104
deficiency B-Disease 1 1.0
in I-Disease 0 0.020786749199032784
the I-Disease 0 0.030466800555586815
sterol I-Disease 1 0.9998979568481445
27 I-Disease 0 0.27591338753700256
- I-Disease 1 0.9999997615814209
hydroxylase I-Disease 1 0.9999942779541016
activity I-Disease 0 0.029817884787917137
, O 0 0.014304185286164284
but O 0 0.00960554089397192
also O 0 0.013190519995987415
partially O 0 0.03791305422782898
leads O 0 0.031113972887396812
to O 0 0.017095273360610008
alternative O 0 0.033708538860082626
pre O 0 0.09689109027385712
- O 1 0.9957625269889832
mRNA O 0 0.05463016405701637
splicing O 0 0.03765222802758217
of O 0 0.01829530857503414
the O 0 0.03074800968170166
gene O 0 0.047997184097766876
. O 0 0.0374387763440609

To O 0 0.03915441781282425
our O 0 0.03451959788799286
knowledge O 0 0.028536397963762283
, O 0 0.014335020445287228
this O 0 0.008661876432597637
is O 0 0.010344747453927994
the O 0 0.012252350337803364
first O 0 0.016927681863307953
report O 0 0.016400432214140892
regarding O 0 0.020916156470775604
effects O 0 0.025673162192106247
on O 0 0.02046624943614006
pre O 1 0.5173135995864868
- O 1 0.9994840621948242
mRNA O 0 0.045271944254636765
splicing O 0 0.027471555396914482
of O 0 0.01174861378967762
a O 0 0.020122190937399864
mutation O 0 0.029436741024255753
at O 0 0.0170407947152853
the O 0 0.02411704696714878
- O 1 0.997268557548523
2 O 0 0.0233840961009264
position O 0 0.01964920200407505
of O 0 0.014205154031515121
a O 0 0.025893812999129295
5 O 0 0.04523126035928726
splice O 0 0.11731194704771042
site O 0 0.04875588044524193
. O 0 0.03198790177702904

ATM O 1 0.9679390788078308
germline O 1 0.975111722946167
mutations O 0 0.04683646187186241
in O 0 0.02320285700261593
classical O 0 0.18599766492843628
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999523162841797
in O 0 0.023925472050905228
the O 0 0.02765009179711342
Dutch O 0 0.0640072152018547
population O 0 0.03096373938024044
. O 0 0.03423945978283882

Germline O 1 0.9922161102294922
mutations O 0 0.05505780503153801
in O 0 0.018296292051672935
the O 0 0.02896757610142231
ATM O 1 0.9565611481666565
gene O 0 0.0209487434476614
are O 0 0.004615618847310543
responsible O 0 0.014279872179031372
for O 0 0.01141649391502142
the O 0 0.03382224589586258
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9940968751907349
A B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
T I-Disease 1 0.9999996423721313
) O 0 0.03297850862145424
. O 0 0.029354916885495186

In O 0 0.03240741416811943
our O 0 0.031212538480758667
study O 0 0.0213056281208992
, O 0 0.013686149381101131
we O 0 0.007999149151146412
have O 0 0.006006447598338127
determined O 0 0.0166260227560997
the O 0 0.021255839616060257
ATM O 1 0.8628370761871338
mutation O 0 0.04621589183807373
spectrum O 0 0.02940790355205536
in O 0 0.010627699084579945
19 O 0 0.02278059907257557
classical O 0 0.031217161566019058
A B-Disease 1 0.9997588992118835
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9995299577713013
, O 0 0.016519226133823395
including O 0 0.011620943434536457
some O 0 0.011953452602028847
immigrant O 0 0.050117868930101395
populations O 0 0.023620938882231712
, O 0 0.0150774409994483
as O 0 0.013782694935798645
well O 0 0.010989761911332607
as O 0 0.011639700271189213
12 O 0 0.017133992165327072
of O 0 0.017725147306919098
Dutch O 0 0.05239146202802658
ethnic O 0 0.03356514498591423
origin O 0 0.027979589998722076
. O 0 0.034557126462459564

Both O 0 0.031006718054413795
the O 0 0.039546724408864975
protein O 0 0.054060399532318115
truncation O 0 0.14101019501686096
test O 0 0.05348334088921547
( O 0 0.037516675889492035
PTT O 1 0.9374404549598694
) O 0 0.016984989866614342
and O 0 0.010759460739791393
the O 0 0.018672795966267586
restriction O 0 0.05942675843834877
endonuclease O 1 0.9995986819267273
fingerprinting O 1 0.90235435962677
( O 0 0.057964518666267395
REF O 1 0.9999803304672241
) O 0 0.023503366857767105
method O 0 0.016132161021232605
were O 0 0.007934773340821266
used O 0 0.010256919078528881
and O 0 0.01040200050920248
compared O 0 0.013808812014758587
for O 0 0.01216401532292366
their O 0 0.016037210822105408
detection O 0 0.053832828998565674
efficiency O 0 0.03984835371375084
, O 0 0.018263155594468117
identifying O 0 0.035288482904434204
76 O 0 0.05519096925854683
% O 0 0.01841156929731369
and O 0 0.012167442589998245
60 O 0 0.017166970297694206
% O 0 0.013504614122211933
of O 0 0.01612185500562191
the O 0 0.0309121236205101
mutations O 0 0.047480273991823196
, O 0 0.02898692898452282
respectively O 0 0.04205957427620888
. O 0 0.03866945579648018

Most O 0 0.060812246054410934
patients O 1 0.7970803380012512
were O 0 0.018074866384267807
found O 0 0.015512523241341114
to O 0 0.019990665838122368
be O 0 0.020836932584643364
compound O 0 0.09745311737060547
heterozygote O 1 0.8146604895591736
. O 0 0.049803972244262695

Seventeen O 0 0.1348440945148468
mutations O 0 0.05230303481221199
were O 0 0.014131439849734306
distinct O 0 0.019259383901953697
, O 0 0.015107637271285057
of O 0 0.014815151691436768
which O 0 0.01267145574092865
10 O 0 0.01380357425659895
were O 0 0.008927857503294945
not O 0 0.01021393109112978
reported O 0 0.02423720434308052
previously O 0 0.0371931754052639
. O 0 0.03674039617180824

Mutations O 0 0.08359629660844803
are O 0 0.01594209484755993
small O 0 0.03128821402788162
deletions O 0 0.08275444060564041
or O 0 0.030738873407244682
point O 0 0.04483092948794365
mutations O 0 0.05158261954784393
frequently O 0 0.03840380162000656
affecting O 0 0.07127279788255692
splice O 0 0.146623432636261
sites O 0 0.04696781560778618
. O 0 0.0384213849902153

Moreover O 0 0.0850495770573616
, O 0 0.03162975609302521
a O 0 0.03627521172165871
16 O 0 0.05310576781630516
. O 0 0.0434383861720562

7 O 0 0.10528727620840073
- O 1 0.9997797608375549
kb O 1 0.8165869116783142
genomic O 0 0.08911428600549698
deletion O 0 0.06425604224205017
of O 0 0.02040708065032959
the O 0 0.02265208028256893
3 O 0 0.024668829515576363
end O 0 0.021408680826425552
of O 0 0.017558282241225243
the O 0 0.02388957142829895
gene O 0 0.02778449095785618
, O 0 0.013089066371321678
most O 0 0.010019659996032715
likely O 0 0.014189296402037144
a O 0 0.015402192249894142
result O 0 0.01520294975489378
of O 0 0.019801806658506393
recombination O 0 0.054490044713020325
between O 0 0.01758567988872528
two O 0 0.013766448944807053
LINE O 0 0.05232847481966019
elements O 0 0.027765590697526932
, O 0 0.018703574314713478
was O 0 0.03255023807287216
identified O 0 0.03581978753209114
. O 0 0.0336420051753521

The O 0 0.04107879847288132
most O 0 0.023173285648226738
frequently O 0 0.025823650881648064
found O 0 0.021118542179465294
mutation O 0 0.040453314781188965
, O 0 0.01372409425675869
identified O 0 0.01413571834564209
in O 0 0.006754457950592041
three O 0 0.008669746108353138
unrelated O 0 0.026513706892728806
Turkish O 0 0.04369129613041878
A B-Disease 1 0.9999262094497681
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
individuals O 0 0.019267497584223747
, O 0 0.0156391691416502
was O 0 0.021479804068803787
previously O 0 0.018894605338573456
described O 0 0.018867596983909607
to O 0 0.010143376886844635
be O 0 0.007112522143870592
a O 0 0.01314470637589693
Turkish O 0 0.036051467061042786
A B-Disease 1 0.9919025301933289
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999996423721313
founder O 1 0.9997615218162537
mutation O 0 0.09229171276092529
. O 0 0.042760565876960754

The O 0 0.032912615686655045
presence O 0 0.030547315254807472
of O 0 0.022212959825992584
a O 0 0.03733936697244644
founder O 1 0.9994674324989319
mutation O 0 0.057259853929281235
among O 0 0.022395428270101547
relatively O 0 0.020904740318655968
small O 0 0.015131906606256962
ethnic O 0 0.020738080143928528
population O 0 0.01526775024831295
groups O 0 0.013822091743350029
in O 0 0.01116926409304142
Western O 0 0.024774819612503052
Europe O 0 0.024566330015659332
could O 0 0.012809197418391705
indicate O 0 0.01565963588654995
a O 0 0.020768607035279274
high O 0 0.04477943852543831
carrier O 0 0.447074294090271
frequency O 0 0.028070392087101936
in O 0 0.014571001753211021
such O 0 0.01540595106780529
communities O 0 0.03447316586971283
. O 0 0.036679722368717194

In O 0 0.04387657344341278
patients O 0 0.1480681300163269
of O 0 0.030130963772535324
Dutch O 0 0.06169891357421875
ethnic O 0 0.03574366122484207
origin O 0 0.01874862238764763
, O 0 0.014396246522665024
however O 0 0.011132145300507545
, O 0 0.01180598046630621
no O 0 0.012574269436299801
significant O 0 0.0206571314483881
founder O 1 0.9963107705116272
effect O 0 0.03071235865354538
could O 0 0.017416588962078094
be O 0 0.014105819165706635
identified O 0 0.030125802382826805
. O 0 0.031592000275850296

The O 0 0.05325727164745331
observed O 0 0.050234172493219376
genetic O 0 0.046290259808301926
heterogeneity O 0 0.0817531868815422
including O 0 0.018323631957173347
the O 0 0.02117718756198883
relative O 0 0.034406814724206924
high O 0 0.029864104464650154
percentage O 0 0.02518194355070591
of O 0 0.026270363479852676
splice O 1 0.9883108139038086
- O 1 0.9996168613433838
site O 0 0.04382070526480675
mutations O 0 0.028914161026477814
had O 0 0.019125958904623985
no O 0 0.02018095552921295
reflection O 0 0.0487513467669487
on O 0 0.02520134299993515
the O 0 0.03936440497636795
phenotype O 0 0.14001861214637756
. O 0 0.04622315615415573

All O 0 0.04227466881275177
patients O 1 0.9082688689231873
manifested O 1 0.9651396870613098
classical O 0 0.05975586548447609
A B-Disease 1 0.9999676942825317
- I-Disease 1 1.0
T I-Disease 1 0.9999984502792358
and O 0 0.02600610814988613
increased O 0 0.04040013253688812
cellular O 0 0.08010543882846832
radioresistant O 1 0.9990085959434509
DNA O 0 0.07012183964252472
synthesis O 0 0.07321153581142426
. O 0 0.03974359109997749

Determination O 0 0.08029314875602722
of O 0 0.028236357495188713
the O 0 0.03080114722251892
genomic O 0 0.05065978318452835
structure O 0 0.02296745404601097
of O 0 0.017826009541749954
the O 0 0.030483685433864594
COL4A4 O 1 0.9999977350234985
gene O 0 0.032791875302791595
and O 0 0.014357379637658596
of O 0 0.022955432534217834
novel O 0 0.06941068917512894
mutations O 0 0.08105053752660751
causing O 1 0.9986271858215332
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998925924301147

Autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9977065324783325
a O 1 0.9906662106513977
progressive O 1 1.0
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9973732233047485
by O 0 0.1088821142911911
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999996423721313
abnormalities I-Disease 1 0.9999877214431763
and O 0 0.024164238944649696
associated O 0 0.022015351802110672
with O 0 0.018001127988100052
mutations O 0 0.023814324289560318
in O 0 0.010932764038443565
either O 0 0.013442805036902428
the O 0 0.022971585392951965
COL4A3 O 1 0.9999090433120728
or O 0 0.02055988274514675
the O 0 0.029913123697042465
COL4A4 O 1 0.9999996423721313
gene O 0 0.03516525775194168
, O 0 0.0141581567004323
which O 0 0.009451732970774174
encode O 0 0.021775564178824425
the O 0 0.02084925025701523
alpha3 O 1 0.7517426013946533
and O 0 0.035620786249637604
alpha4 O 1 0.9999644756317139
type O 1 0.9999030828475952
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9965547323226929
, O 0 0.04302370548248291
respectively O 0 0.04993792250752449
. O 0 0.04065852612257004

To O 0 0.03286545351147652
date O 0 0.032726723700761795
, O 0 0.025371668860316277
mutation O 0 0.048517003655433655
screening O 0 0.04277538135647774
in O 0 0.011070692911744118
the O 0 0.01451656874269247
two O 0 0.012329628691077232
genes O 0 0.018115609884262085
has O 0 0.01369100995361805
been O 0 0.014924298971891403
hampered O 0 0.05375872179865837
by O 0 0.015467976219952106
the O 0 0.020038332790136337
lack O 0 0.03272613510489464
of O 0 0.034667547792196274
genomic O 0 0.08853913098573685
structure O 0 0.04856516048312187
information O 0 0.02698194608092308
. O 0 0.033025287091732025

We O 0 0.027608776465058327
report O 0 0.02058204635977745
here O 0 0.014035170897841454
the O 0 0.01679302379488945
complete O 0 0.026145124807953835
characterization O 0 0.04564198851585388
of O 0 0.01664862409234047
the O 0 0.01847955770790577
48 O 0 0.032153449952602386
exons O 0 0.04370497167110443
of O 0 0.018023384734988213
the O 0 0.030954133719205856
COL4A4 O 1 0.9999984502792358
gene O 0 0.03719210624694824
, O 0 0.015259007923305035
a O 0 0.023824069648981094
comprehensive O 0 0.06780357658863068
gene O 0 0.03988080471754074
screen O 0 0.03472202643752098
, O 0 0.014668704941868782
and O 0 0.011267200112342834
the O 0 0.016387728974223137
subsequent O 0 0.03111998364329338
detection O 0 0.041360318660736084
of O 0 0.018858883529901505
10 O 0 0.021191703155636787
novel O 0 0.039198994636535645
mutations O 0 0.025664959102869034
in O 0 0.014212995767593384
eight O 0 0.03724498674273491
patients O 1 0.9999994039535522
diagnosed O 1 1.0
with O 1 0.9997840523719788
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996659755706787

Furthermore O 0 0.0733461081981659
, O 0 0.02275107614696026
we O 0 0.013952928595244884
identified O 0 0.02058938704431057
a O 0 0.025376899167895317
glycine O 0 0.0792229101061821
to O 0 0.02548792026937008
alanine O 0 0.10338273644447327
substitution O 0 0.04591101408004761
in O 0 0.013817205093801022
the O 0 0.03162941336631775
collagenous O 1 0.9999949932098389
domain O 0 0.04768379032611847
that O 0 0.011442937888205051
is O 0 0.014636065810918808
apparently O 0 0.024349316954612732
silent O 0 0.04652116820216179
in O 0 0.013698660768568516
the O 0 0.023612933233380318
heterozygous O 0 0.07816166430711746
carriers O 0 0.06003429740667343
, O 0 0.02170371636748314
in O 0 0.0189317986369133
11 O 0 0.04313891753554344
. O 0 0.03961261734366417

5 O 0 0.04477471113204956
% O 0 0.01974501833319664
of O 0 0.018386511132121086
all O 0 0.017396632581949234
control O 0 0.03341711312532425
individuals O 0 0.01691305823624134
, O 0 0.014614137820899487
and O 0 0.011694882996380329
in O 0 0.010976812802255154
one O 0 0.01527436263859272
control O 0 0.026901395991444588
individual O 0 0.017886299639940262
homozygous O 0 0.05313459783792496
for O 0 0.021836431697010994
this O 0 0.024588873609900475
glycine O 0 0.1823173314332962
substitution O 0 0.09503999352455139
. O 0 0.04519523307681084

There O 0 0.027579590678215027
has O 0 0.01698363572359085
been O 0 0.011412080377340317
no O 0 0.010859203524887562
previous O 0 0.01612274721264839
finding O 0 0.021345455199480057
of O 0 0.01761160045862198
a O 0 0.03456221520900726
glycine O 0 0.3729674816131592
substitution O 0 0.04897003620862961
that O 0 0.010468720458447933
is O 0 0.01206153817474842
not O 0 0.00900188460946083
associated O 0 0.013801385648548603
with O 0 0.01325689721852541
any O 0 0.02116549015045166
obvious O 0 0.06199638918042183
phenotype O 1 0.935914158821106
in O 0 0.03074653074145317
homozygous O 0 0.0958801731467247
individuals O 0 0.038533568382263184
. O 0 0.04481073096394539

Founder O 1 0.9998868703842163
BRCA1 O 1 0.9999399185180664
and O 0 0.0539674274623394
BRCA2 O 1 0.9993070363998413
mutations O 0 0.03778456896543503
in O 0 0.016312528401613235
French O 0 0.057305820286273956
Canadian O 1 0.9976434111595154
breast B-Disease 1 1.0
and I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9999107122421265
. O 0 0.06239592656493187

We O 0 0.023469865322113037
have O 0 0.010417291894555092
identified O 0 0.017746612429618835
four O 0 0.014074844308197498
mutations O 0 0.018399782478809357
in O 0 0.007323884870857
each O 0 0.005662533920258284
of O 0 0.014276578091084957
the O 0 0.062029335647821426
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 1.0
susceptibility O 1 0.9999997615814209
genes O 0 0.04011623188853264
, O 0 0.029467055574059486
BRCA1 O 1 0.999118983745575
and O 0 0.025803517550230026
BRCA2 O 1 0.9769383072853088
, O 0 0.01218018215149641
in O 0 0.009930266067385674
French O 0 0.04233253747224808
Canadian O 1 0.9964410662651062
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999996423721313
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9856125116348267
from O 0 0.039126861840486526
Quebec O 0 0.41938284039497375
. O 0 0.040732406079769135

To O 0 0.04080398008227348
identify O 0 0.05806683003902435
founder O 1 0.9996860027313232
effects O 0 0.058697544038295746
, O 0 0.020749863237142563
we O 0 0.014137045480310917
examined O 0 0.03225284069776535
independently O 0 0.019219355657696724
ascertained O 0 0.057899460196495056
French O 0 0.055704858154058456
Canadian O 0 0.07310780137777328
cancer B-Disease 1 0.9999698400497437
families O 0 0.026653915643692017
for O 0 0.015436303801834583
the O 0 0.017921574413776398
distribution O 0 0.017813630402088165
of O 0 0.017241427674889565
these O 0 0.013717111200094223
eight O 0 0.03761763870716095
mutations O 0 0.06028789281845093
. O 0 0.04563553258776665

Mutations O 0 0.06556539237499237
were O 0 0.014347342774271965
found O 0 0.013239555060863495
in O 0 0.01295158639550209
41 O 0 0.036957185715436935
of O 0 0.028172574937343597
97 O 0 0.09496518224477768
families O 0 0.0539974719285965
. O 0 0.0443766787648201

Six O 0 0.03417728841304779
of O 0 0.02755732648074627
eight O 0 0.03423329070210457
mutations O 0 0.03523145988583565
were O 0 0.012149871326982975
observed O 0 0.021504757925868034
at O 0 0.026026062667369843
least O 0 0.020693697035312653
twice O 0 0.042060431092977524
. O 0 0.03927481174468994

The O 0 0.08271195739507675
BRCA1 O 1 0.9999619722366333
C4446T O 1 0.9999123811721802
mutation O 0 0.07255396991968155
was O 0 0.027722546830773354
the O 0 0.01762472093105316
most O 0 0.016802724450826645
common O 0 0.027085907757282257
mutation O 0 0.03905537724494934
found O 0 0.01395417470484972
, O 0 0.013242409564554691
followed O 0 0.01884668692946434
by O 0 0.017740370705723763
the O 0 0.04108103737235069
BRCA2 O 1 0.9999897480010986
8765delAG O 1 0.9999951124191284
mutation O 0 0.18042215704917908
. O 0 0.0468679778277874

Together O 0 0.049238406121730804
, O 0 0.027544107288122177
these O 0 0.013553909957408905
mutations O 0 0.025008508935570717
were O 0 0.009150609374046326
found O 0 0.009653124026954174
in O 0 0.009233670309185982
28 O 0 0.021606948226690292
of O 0 0.01765955425798893
41 O 0 0.03975546732544899
families O 0 0.02296214923262596
identified O 0 0.021014241501688957
to O 0 0.013074537739157677
have O 0 0.010926607996225357
a O 0 0.031171754002571106
mutation O 0 0.06918428838253021
. O 0 0.037966471165418625

The O 0 0.04646369069814682
odds O 0 0.06600581854581833
of O 0 0.02935931831598282
detection O 0 0.042960237711668015
of O 0 0.01529343705624342
any O 0 0.010345522314310074
of O 0 0.013307034969329834
the O 0 0.01983422227203846
four O 0 0.032509367913007736
BRCA1 O 1 0.9999666213989258
mutations O 0 0.058039918541908264
was O 0 0.043510157614946365
18 O 0 0.047612082213163376
. O 0 0.04094503074884415

7x O 1 0.9998823404312134
greater O 0 0.04564468562602997
if O 0 0.01899811252951622
one O 0 0.01271103322505951
or O 0 0.009774756617844105
more O 0 0.007141462992876768
cases O 0 0.022167064249515533
of O 1 0.9997959733009338
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.02664601244032383
also O 0 0.015797145664691925
present O 0 0.016071883961558342
in O 0 0.012353762984275818
the O 0 0.023897549137473106
family O 0 0.04687104374170303
. O 0 0.035517990589141846

The O 0 0.04306618869304657
odds O 0 0.06256014853715897
of O 0 0.029666883870959282
detection O 0 0.04473954066634178
of O 0 0.016841456294059753
any O 0 0.012000100687146187
of O 0 0.013912181369960308
the O 0 0.020814185962080956
four O 0 0.03461288660764694
BRCA2 O 1 0.999975323677063
mutations O 0 0.06075010448694229
was O 0 0.04218911752104759
5 O 0 0.046320125460624695
. O 0 0.034583207219839096

3x O 1 0.9923197627067566
greater O 0 0.048597268760204315
if O 0 0.01973903737962246
there O 0 0.00900640245527029
were O 0 0.00709039019420743
at O 0 0.010521567426621914
least O 0 0.007553119212388992
five O 0 0.010187307372689247
cases O 0 0.02060733363032341
of O 1 0.8596985340118408
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.03431791067123413
the O 0 0.040536973625421524
family O 0 0.05299452692270279
. O 0 0.03660019487142563

Interestingly O 0 0.08624625205993652
, O 0 0.017138369381427765
the O 0 0.014243264682590961
presence O 0 0.0210564024746418
of O 0 0.02182832360267639
a O 1 0.9768054485321045
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.999651312828064
< O 1 0.9999158382415771
36 O 0 0.03330834582448006
years O 0 0.015151760540902615
of O 0 0.016215145587921143
age O 0 0.023882102221250534
was O 0 0.024923982098698616
strongly O 0 0.023388458415865898
predictive O 0 0.03320293501019478
of O 0 0.01292089931666851
the O 0 0.01526891253888607
presence O 0 0.020317720249295235
of O 0 0.012340540997684002
any O 0 0.010126414708793163
of O 0 0.015300878323614597
the O 0 0.022226406261324883
eight O 0 0.03711850568652153
mutations O 0 0.059651970863342285
screened O 0 0.09967416524887085
. O 0 0.04691775143146515

Carriers O 0 0.07566768676042557
of O 0 0.025283217430114746
the O 0 0.026752863079309464
same O 0 0.02487926371395588
mutation O 0 0.04678929224610329
, O 0 0.014892848208546638
from O 0 0.011278221383690834
different O 0 0.0064904093742370605
families O 0 0.01878591999411583
, O 0 0.017345737665891647
shared O 0 0.02794412523508072
similar O 0 0.0233713760972023
haplotypes O 0 0.09577201306819916
, O 0 0.018993845209479332
indicating O 0 0.0239610206335783
that O 0 0.009568053297698498
the O 0 0.02266787365078926
mutant O 1 0.6092339754104614
alleles O 0 0.05531788617372513
were O 0 0.012771577574312687
likely O 0 0.01683979667723179
to O 0 0.012308487668633461
be O 0 0.008068636991083622
identical O 0 0.014214732684195042
by O 0 0.013318403623998165
descent O 0 0.032075438648462296
for O 0 0.013826810754835606
a O 0 0.025030234828591347
mutation O 0 0.03588994964957237
in O 0 0.014762114733457565
the O 0 0.027267416939139366
founder O 1 0.8019169569015503
population O 0 0.03345509245991707
. O 0 0.03856656327843666

The O 0 0.03384573385119438
identification O 0 0.03302715718746185
of O 0 0.027213983237743378
common O 0 0.16838450729846954
BRCA1 O 1 0.9999997615814209
and O 0 0.1187683492898941
BRCA2 O 1 0.9999979734420776
mutations O 0 0.04759693890810013
will O 0 0.01986094005405903
facilitate O 0 0.045999906957149506
carrier O 0 0.08539629727602005
detection O 0 0.03619882091879845
in O 0 0.011104840785264969
French O 0 0.04398592561483383
Canadian O 1 0.7995269298553467
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999995231628418
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.997138261795044
. O 0 0.05872110277414322

Are O 0 0.029751872643828392
Dp71 O 1 0.9909569621086121
and O 0 0.050232354551553726
Dp140 O 1 0.9999954700469971
brain O 1 0.9999798536300659
dystrophin O 1 0.999985933303833
isoforms O 0 0.061651527881622314
related O 0 0.028170324862003326
to O 0 0.02932744286954403
cognitive B-Disease 1 0.9886398315429688
impairment I-Disease 1 0.9999996423721313
in O 1 0.9979196190834045
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999696016311646

Molecular O 0 0.09323140233755112
study O 0 0.03739634528756142
and O 0 0.029765916988253593
neuropsychological O 1 0.8289819955825806
analysis O 0 0.018061194568872452
were O 0 0.010082335211336613
performed O 0 0.024248620495200157
concurrently O 0 0.029666727408766747
on O 0 0.01758069545030594
49 O 0 0.05124646797776222
patients O 1 0.9991014003753662
with O 1 0.9324671626091003
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999996423721313
DMD B-Disease 1 1.0
) O 0 0.030921928584575653
in O 0 0.013397284783422947
order O 0 0.016733143478631973
to O 0 0.013341269455850124
find O 0 0.018553417176008224
a O 0 0.018495604395866394
molecular O 0 0.024998251348733902
explanation O 0 0.019856920465826988
for O 0 0.01332775503396988
the O 0 0.028339877724647522
cognitive B-Disease 1 0.9899265766143799
impairment I-Disease 1 0.999993085861206
observed O 0 0.03583444654941559
in O 0 0.026904625818133354
most O 0 0.05632253363728523
DMD B-Disease 1 1.0
patients O 1 0.9999908208847046
. O 0 0.07226190716028214

Complete O 0 0.05037614703178406
analysis O 0 0.01926896534860134
of O 0 0.01866764947772026
the O 0 0.035219818353652954
dystrophin O 1 0.9999765157699585
gene O 0 0.04883682355284691
was O 0 0.03155697137117386
performed O 0 0.028275461867451668
to O 0 0.016464367508888245
define O 0 0.031860798597335815
the O 0 0.023142457008361816
localization O 0 0.06709354370832443
of O 0 0.02956901118159294
deletions O 0 0.07476082444190979
and O 0 0.028618667274713516
duplications O 0 0.0781773179769516
in O 0 0.019101396203041077
relation O 0 0.0311422199010849
to O 0 0.018279023468494415
the O 0 0.025115933269262314
different O 0 0.025842495262622833
DMD B-Disease 1 0.9999997615814209
promoters O 1 0.9942052960395813
. O 0 0.056755997240543365

Qualitative O 0 0.07248280197381973
analysis O 0 0.0194975808262825
of O 0 0.019352735951542854
the O 0 0.03183642774820328
Dp71 O 1 0.9987793564796448
transcript O 0 0.06074705347418785
and O 0 0.017859743908047676
testing O 0 0.021122805774211884
for O 0 0.011607259511947632
the O 0 0.013203050941228867
specific O 0 0.010344957001507282
first O 0 0.019754407927393913
exon O 0 0.08346159756183624
of O 0 0.03368669003248215
Dp140 O 1 0.9968120455741882
were O 0 0.015933560207486153
also O 0 0.016069840639829636
carried O 0 0.026042668148875237
out O 0 0.025801554322242737
. O 0 0.03247228264808655

Neuropsychological O 1 0.9910449981689453
analysis O 0 0.04701074957847595
assessed O 0 0.06430657207965851
verbal O 0 0.08326742798089981
and O 0 0.04469917714595795
visuospatial O 1 0.9999330043792725
intelligence O 0 0.053724031895399094
, O 0 0.034734927117824554
verbal O 1 0.7669411301612854
memory O 1 0.9957326054573059
, O 0 0.028345156461000443
and O 0 0.024894779548048973
reading O 0 0.059689585119485855
skills O 0 0.0589025653898716
. O 0 0.04454382508993149

Comparison O 0 0.06556732952594757
of O 0 0.04180379584431648
molecular O 0 0.054516781121492386
and O 0 0.030032740905880928
psychometric O 1 0.9527608752250671
findings O 0 0.03768080845475197
demonstrated O 0 0.035348694771528244
that O 0 0.016968997195363045
deletions O 0 0.0581880621612072
and O 0 0.02433311566710472
duplications O 0 0.06576865911483765
that O 0 0.013001665472984314
were O 0 0.014068626798689365
localized O 0 0.04571838304400444
in O 0 0.014414375647902489
the O 0 0.025407735258340836
distal O 1 0.9994246959686279
part O 0 0.02719634398818016
of O 0 0.02086334489285946
the O 0 0.026730593293905258
gene O 0 0.02789822593331337
seemed O 0 0.02328255958855152
to O 0 0.01463390700519085
be O 0 0.01332725491374731
preferentially O 0 0.0585908517241478
associated O 0 0.028227511793375015
with O 0 0.03348280489444733
cognitive B-Disease 1 0.9969933032989502
impairment I-Disease 1 0.9999971389770508
. O 0 0.07540377229452133

Two O 0 0.03684474527835846
altered O 0 0.06394222378730774
Dp71 O 1 0.6254725456237793
transcripts O 0 0.05705510824918747
and O 0 0.018618714064359665
two O 0 0.01645529828965664
deleted O 0 0.0683068335056305
Dp140 O 1 0.6955648064613342
DNA O 0 0.03569730371236801
sequences O 0 0.01466150488704443
were O 0 0.007583431899547577
found O 0 0.00942971371114254
in O 0 0.010361465625464916
four O 0 0.02460573986172676
patients O 1 0.999904990196228
with O 1 0.9799352288246155
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9970967769622803

These O 0 0.026019832119345665
findings O 0 0.032481104135513306
suggest O 0 0.020253196358680725
that O 0 0.00859837792813778
some O 0 0.008647496812045574
sequences O 0 0.013971669599413872
located O 0 0.021127071231603622
in O 0 0.011136580258607864
the O 0 0.023496657609939575
distal O 1 0.9956523776054382
part O 0 0.027269063517451286
of O 0 0.02018917165696621
the O 0 0.026272140443325043
gene O 0 0.02739000879228115
and O 0 0.013686774298548698
, O 0 0.012491940520703793
in O 0 0.010963122360408306
particular O 0 0.014366831630468369
, O 0 0.013683144003152847
some O 0 0.018569866195321083
DMD B-Disease 1 1.0
isoforms O 0 0.04293137043714523
expressed O 0 0.0218953974545002
in O 0 0.01682858169078827
the O 0 0.033471137285232544
brain O 1 0.997612714767456
may O 0 0.017505604773759842
be O 0 0.009001195430755615
related O 0 0.012276853434741497
to O 0 0.01346498727798462
the O 0 0.02642478235065937
cognitive B-Disease 1 0.9943550825119019
impairment I-Disease 1 0.9999996423721313
associated O 1 0.6082528233528137
with O 1 0.7883105278015137
DMD B-Disease 1 1.0
. O 0 0.04119307920336723
. O 0 0.04135001823306084

I1307K O 1 0.9995936751365662
APC O 1 0.9998619556427002
and O 0 0.05189187824726105
hMLH1 O 1 0.998719334602356
mutations O 0 0.03648843616247177
in O 0 0.012406234629452229
a O 0 0.02093435265123844
non O 0 0.05544085428118706
- O 1 0.9918930530548096
Jewish O 0 0.0332927331328392
family O 0 0.02187451347708702
with O 0 0.015904167667031288
hereditary B-Disease 1 0.9999997615814209
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9987472295761108

We O 0 0.024025797843933105
describe O 0 0.026650728657841682
a O 0 0.018810568377375603
French O 0 0.03671767935156822
Canadian O 0 0.04181383177638054
hereditary B-Disease 1 0.9999967813491821
non I-Disease 1 0.9999986886978149
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.11256726831197739
kindred O 1 0.9998960494995117
which O 0 0.017680395394563675
carries O 0 0.027611631900072098
a O 0 0.025613348931074142
novel O 0 0.06620189547538757
truncating O 1 0.9993863105773926
mutation O 0 0.08899708092212677
in O 0 0.03561226278543472
hMLH1 O 1 0.9929051995277405
. O 0 0.053955838084220886

Interestingly O 0 0.10306036472320557
, O 0 0.026008524000644684
the O 0 0.03793848678469658
I1307K O 1 0.9999864101409912
APC O 1 0.9999991655349731
polymorphism O 0 0.12280109524726868
, O 0 0.018687043339014053
associated O 0 0.013036125339567661
with O 0 0.009729431010782719
an O 0 0.012108225375413895
increased O 0 0.02156689576804638
risk O 1 0.9988685846328735
of O 1 0.9999924898147583
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.997647225856781
is O 0 0.01838064379990101
also O 0 0.010011207312345505
present O 0 0.011838742531836033
in O 0 0.010420913808047771
this O 0 0.013681451790034771
family O 0 0.03844594955444336
. O 0 0.03458109125494957

The O 0 0.07727345824241638
I1307K O 1 0.9990224838256836
polymorphism O 0 0.09584563225507736
has O 0 0.02083013579249382
previously O 0 0.01756361499428749
only O 0 0.009113206528127193
been O 0 0.010218946263194084
identified O 0 0.013510853052139282
in O 0 0.007750276476144791
individuals O 0 0.010305512696504593
of O 0 0.019976940006017685
self O 1 0.9940005540847778
- O 1 0.9999618530273438
reported O 0 0.03791174292564392
Ashkenazi O 0 0.31788045167922974
Jewish O 0 0.07045288383960724
origins O 0 0.06602974981069565
. O 0 0.035625845193862915

In O 0 0.028409963473677635
addition O 0 0.023765698075294495
, O 0 0.014562070369720459
in O 0 0.01097063347697258
this O 0 0.011575594544410706
family O 0 0.025655778124928474
, O 0 0.014613368548452854
there O 0 0.010685985907912254
appears O 0 0.02034146711230278
to O 0 0.011307850480079651
be O 0 0.008726604282855988
no O 0 0.011803233064711094
relationship O 0 0.02279316447675228
between O 0 0.016924191266298294
the O 0 0.026855746284127235
I1307K O 1 0.9994876384735107
polymorphism O 0 0.06071235612034798
and O 0 0.014980344101786613
the O 0 0.017538143321871758
presence O 0 0.029946662485599518
or O 0 0.018267475068569183
absence O 0 0.09192796051502228
of O 1 0.632784903049469
cancer B-Disease 1 1.0
. O 0 0.03888722136616707
. O 0 0.04030736908316612

Identification O 0 0.046519115567207336
of O 0 0.02188638225197792
a O 0 0.02980225160717964
novel O 0 0.05269038304686546
mutation O 0 0.0410388745367527
of O 0 0.019841467961668968
the O 0 0.03244101628661156
CPO O 1 0.9998422861099243
gene O 0 0.02823755331337452
in O 0 0.012190491892397404
a O 0 0.025062160566449165
Japanese O 0 0.07165563106536865
hereditary B-Disease 1 0.9999992847442627
coproporphyria I-Disease 1 0.9999990463256836
family O 0 0.09040505439043045
. O 0 0.04805571213364601

Hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.9999998807907104
( O 1 0.8706846833229065
HCP B-Disease 1 0.9999998807907104
) O 0 0.025304341688752174
is O 0 0.015235044993460178
an O 0 0.021725047379732132
autosomal B-Disease 1 0.9999969005584717
dominant I-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
characterized O 1 0.9983783960342407
by O 0 0.032108429819345474
a O 1 0.88631272315979
deficiency B-Disease 1 1.0
of I-Disease 1 0.99937504529953
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 1.0
( O 0 0.0727757140994072
CPO O 1 0.9997703433036804
) O 0 0.026266127824783325
caused O 0 0.02908523567020893
by O 0 0.016165995970368385
a O 0 0.025321893393993378
mutation O 0 0.04047905653715134
in O 0 0.016799133270978928
the O 0 0.036489710211753845
CPO O 1 0.9996386766433716
gene O 0 0.06535988301038742
. O 0 0.039111897349357605

Only O 0 0.028428269550204277
11 O 0 0.03380246087908745
mutations O 0 0.026115991175174713
of O 0 0.017010631039738655
the O 0 0.02413571998476982
gene O 0 0.024135630577802658
have O 0 0.0072474670596420765
been O 0 0.011749344877898693
reported O 0 0.02500712126493454
in O 0 0.035732515156269073
HCP B-Disease 1 1.0
patients O 1 0.9999823570251465
. O 0 0.06355689465999603

We O 0 0.02703702263534069
report O 0 0.02252786234021187
another O 0 0.029042229056358337
mutation O 0 0.04023411124944687
in O 0 0.014004955999553204
a O 0 0.027102138847112656
Japanese O 0 0.058517031371593475
family O 0 0.0551069937646389
. O 0 0.0401749350130558

Polymerase O 1 0.983715832233429
chain O 0 0.10882338136434555
reaction O 0 0.07474586367607117
- O 1 0.999397873878479
single O 0 0.05609900876879692
strand O 0 0.1068965494632721
conformational O 0 0.09534880518913269
polymorphism O 0 0.06634417921304703
and O 0 0.018519602715969086
direct O 0 0.023808881640434265
sequence O 0 0.01992146484553814
analyses O 0 0.02271912433207035
demonstrated O 0 0.02497141994535923
a O 0 0.02899579517543316
C O 1 0.6540559530258179
to O 0 0.031817156821489334
T O 1 0.9661797285079956
substitution O 0 0.04395851120352745
in O 0 0.01491179782897234
exon O 0 0.07467704266309738
1 O 0 0.02619064599275589
of O 0 0.017186427488923073
the O 0 0.02926117740571499
CPO O 1 0.9979711174964905
gene O 0 0.03591502457857132
at O 0 0.024940602481365204
nucleotide O 0 0.04333995282649994
position O 0 0.0283348485827446
85 O 0 0.04009654372930527
, O 0 0.016148455440998077
which O 0 0.010799813084304333
lies O 0 0.02841562032699585
in O 0 0.011423425748944283
the O 0 0.02381543256342411
putative O 1 0.9360998868942261
presequence O 1 0.9950063228607178
for O 0 0.027119064703583717
targeting O 0 0.049117621034383774
to O 0 0.033060699701309204
mitochondria O 0 0.09736812859773636
. O 0 0.04715839773416519

This O 0 0.03795977681875229
mutation O 0 0.0606592558324337
changes O 0 0.018728045746684074
the O 0 0.026098350062966347
codon O 0 0.07506624609231949
for O 0 0.024820182472467422
glutamine O 0 0.06925103068351746
to O 0 0.020173359662294388
a O 0 0.03315036743879318
termination O 1 0.9583846926689148
codon O 0 0.13528841733932495
at O 0 0.0499163419008255
amino O 0 0.06169217452406883
acid O 0 0.06852217763662338
position O 0 0.04306564852595329
29 O 0 0.06230548396706581
. O 0 0.040203504264354706

MaeI O 1 0.9791408181190491
restriction O 0 0.08681708574295044
analysis O 0 0.024585045874118805
showed O 0 0.01891343854367733
two O 0 0.010111666284501553
other O 0 0.01179192028939724
carriers O 0 0.036028340458869934
in O 0 0.014094351790845394
the O 0 0.027352655306458473
family O 0 0.054362937808036804
. O 0 0.04068535193800926

The O 0 0.0663294792175293
C O 1 0.9999884366989136
- O 1 0.9999998807907104
T O 1 0.9999945163726807
mutation O 0 0.05489446222782135
is O 0 0.016235070303082466
located O 0 0.023058468475937843
within O 0 0.011380106210708618
a O 0 0.01521121896803379
recently O 0 0.0219305120408535
proposed O 0 0.01962333545088768
putative O 0 0.07645760476589203
alternative O 0 0.029524322599172592
translation O 0 0.032661885023117065
initiation O 1 0.5937513113021851
codon O 0 0.2078043520450592
( O 0 0.04999848082661629
TIC O 1 0.9999998807907104
- O 1 0.9999960660934448
1 O 0 0.03922269120812416
) O 0 0.014713888987898827
, O 0 0.010611671954393387
supporting O 0 0.024486443027853966
that O 0 0.01745242439210415
TIC O 1 0.9999997615814209
- O 1 0.9999529123306274
1 O 0 0.030019739642739296
is O 0 0.0122469961643219
the O 0 0.017898568883538246
real O 0 0.04138607159256935
TIC O 1 0.9999747276306152
rather O 0 0.01947411336004734
than O 0 0.02488125115633011
TIC O 1 1.0
- O 1 0.999996542930603
2 O 0 0.0474698580801487
. O 0 0.02111007086932659
. O 0 0.027619030326604843

Human B-Disease 0 0.06422378122806549
complement I-Disease 0 0.49427536129951477
factor I-Disease 1 0.9997853636741638
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9916102290153503
with O 1 0.9999874830245972
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999340772628784

This O 0 0.024299828335642815
study O 0 0.019865188747644424
reports O 0 0.014887875877320766
on O 0 0.011111418716609478
six O 0 0.014550750143826008
cases O 0 0.022941654548048973
of O 1 0.6393988132476807
deficiency B-Disease 1 1.0
in I-Disease 0 0.021769611164927483
the I-Disease 0 0.02386595495045185
human I-Disease 0 0.028291812166571617
complement I-Disease 0 0.05679244175553322
regulatory I-Disease 0 0.05664168670773506
protein I-Disease 0 0.04897318780422211
Factor I-Disease 1 0.9648379683494568
H I-Disease 1 0.9999998807907104
( O 0 0.05675055459141731
FH O 1 0.9999979734420776
) O 0 0.015259385108947754
in O 0 0.006769889034330845
the O 0 0.010426865890622139
context O 0 0.017421968281269073
of O 0 0.026133207604289055
an O 1 0.9998815059661865
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.999990701675415

Five O 0 0.02619677595794201
of O 0 0.021894266828894615
the O 0 0.0220999363809824
cases O 0 0.019794436171650887
were O 0 0.010977338999509811
observed O 0 0.015292604453861713
in O 0 0.010492980480194092
children O 0 0.024725329130887985
presenting O 0 0.050576742738485336
with O 1 0.9843835830688477
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9190122485160828
. O 0 0.051529478281736374

Two O 0 0.01716258004307747
of O 0 0.019350795075297356
the O 0 0.022702975198626518
children O 0 0.03994009271264076
exhibited O 0 0.06873965263366699
a O 0 0.2645021677017212
homozygous O 1 0.9999933242797852
deficiency O 1 1.0
characterized O 1 0.9972769618034363
by O 0 0.025483058765530586
the O 0 0.023772625252604485
absence O 0 0.03501945734024048
of O 0 0.01774938963353634
the O 0 0.022190673276782036
150 O 0 0.04263393580913544
- O 1 0.999862790107727
kD O 1 0.9975307583808899
form O 0 0.02456982061266899
of O 0 0.03134679049253464
Factor O 1 0.9972594976425171
H O 1 0.9999963045120239
and O 0 0.018564356490969658
the O 0 0.01838556118309498
presence O 0 0.028012830764055252
, O 0 0.014905817806720734
upon O 0 0.023171881213784218
immunoblotting O 1 0.9117687344551086
, O 0 0.011931381188333035
of O 0 0.011175385676324368
the O 0 0.016765229403972626
42 O 0 0.047236181795597076
- O 1 0.9998815059661865
kD O 1 0.9999529123306274
Factor O 1 0.9385596513748169
H O 1 0.9999991655349731
- O 1 0.9998180270195007
like O 0 0.025236137211322784
protein O 0 0.026043929159641266
1 O 0 0.027390001341700554
( O 0 0.030361369252204895
FHL O 1 0.9999947547912598
- O 1 0.9999719858169556
1 O 0 0.03553728759288788
) O 0 0.01222055871039629
and O 0 0.01012502796947956
other O 0 0.016314320266246796
FH O 1 0.9999998807907104
- O 1 0.9999980926513672
related O 0 0.06946557015180588
protein O 0 0.058445993810892105
( O 0 0.0452616848051548
FHR O 1 0.9999270439147949
) O 0 0.041894178837537766
bands O 0 0.06565425544977188
. O 0 0.040887076407670975

Southern O 0 0.1174381822347641
blot O 1 0.9542083740234375
and O 0 0.04146767407655716
PCR O 0 0.08400916308164597
analysis O 0 0.014353272505104542
of O 0 0.014656683430075645
DNA O 0 0.02113765850663185
of O 0 0.015404562465846539
one O 0 0.020476456731557846
patient O 1 0.9951791763305664
with O 0 0.038479581475257874
homozygous O 1 0.9999327659606934
deficiency O 1 1.0
ruled O 0 0.23329919576644897
out O 0 0.02239992842078209
the O 0 0.017793552950024605
presence O 0 0.020608853548765182
of O 0 0.01305975392460823
a O 0 0.017015064135193825
large O 0 0.016229137778282166
deletion O 0 0.040359288454055786
of O 0 0.018299641087651253
the O 0 0.03500508889555931
FH O 1 0.9999998807907104
gene O 0 0.03414769843220711
as O 0 0.01493153627961874
the O 0 0.024167578667402267
underlying O 1 0.9436161518096924
defect O 1 0.9999943971633911
for O 0 0.03633304685354233
the O 1 0.9382341504096985
deficiency O 1 1.0
. O 0 0.08420384675264359

The O 0 0.03181254118680954
other O 0 0.01132193859666586
four O 0 0.014147065579891205
children O 0 0.025460047647356987
presented O 0 0.03063710406422615
with O 0 0.03238869830965996
heterozygous O 1 0.9999867677688599
deficiency O 1 1.0
and O 0 0.05322977527976036
exhibited O 1 0.8139675855636597
a O 0 0.038796789944171906
normal O 0 0.04935655742883682
immunoblotting O 1 0.9982263445854187
pattern O 0 0.03659980371594429
of O 0 0.02173927053809166
proteins O 0 0.021599290892481804
of O 0 0.01840442605316639
the O 0 0.042670462280511856
FH O 1 0.9999998807907104
family O 0 0.07376273721456528
. O 0 0.04672664776444435

Factor B-Disease 1 0.9999737739562988
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.027299119159579277
the O 0 0.025765998288989067
only O 0 0.031121889129281044
complement B-Disease 1 0.9999960660934448
deficiency I-Disease 1 1.0
associated O 1 0.7464799880981445
with O 1 0.9354547262191772
HUS B-Disease 1 1.0
. O 0 0.0878092348575592

These O 0 0.021712681278586388
observations O 0 0.028698621317744255
suggest O 0 0.017712805420160294
a O 0 0.017171967774629593
role O 0 0.032172929495573044
for O 0 0.029488686472177505
FH O 1 0.9999998807907104
and O 0 0.050226401537656784
/ O 1 0.9999985694885254
or O 0 0.05893205851316452
FH O 1 1.0
receptors O 0 0.05016127601265907
in O 0 0.014538777060806751
the O 0 0.029110601171851158
pathogenesis O 1 0.999998927116394
of O 1 0.9993433356285095
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.2705589234828949
. O 0 0.058970026671886444

Further O 0 0.03030342049896717
evidence O 0 0.015910916030406952
for O 0 0.011620987206697464
a O 0 0.019225966185331345
major O 0 0.029638037085533142
ancient O 0 0.04744722321629524
mutation O 1 0.9829164147377014
underlying O 1 0.9999959468841553
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9991955161094666
linkage O 1 0.9999953508377075
disequilibrium O 1 0.999969482421875
studies O 0 0.024397829547524452
in O 0 0.013173449784517288
the O 0 0.020529717206954956
Japanese O 0 0.04981842637062073
population O 0 0.028853105381131172
. O 0 0.035720065236091614

The O 1 0.8366559743881226
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999991655349731
DM B-Disease 1 1.0
) O 0 0.05531952157616615
mutation O 0 0.048755545169115067
is O 0 0.01753089763224125
an O 0 0.025818051770329475
unstable O 1 0.9999737739562988
( O 0 0.05298251286149025
CTG O 1 0.9999964237213135
) O 0 0.03511804714798927
n O 0 0.06796352565288544
repeat O 0 0.05261056497693062
, O 0 0.014969863928854465
present O 0 0.01394254807382822
at O 0 0.014632848091423512
a O 0 0.01595497503876686
copy O 0 0.021836519241333008
number O 0 0.00784207507967949
of O 0 0.015299541875720024
5 O 0 0.03363518416881561
- O 1 0.9882344007492065
37 O 0 0.044635139405727386
repeats O 0 0.04112177714705467
on O 0 0.01898776926100254
normal O 0 0.029313581064343452
chromosomes O 0 0.034612927585840225
but O 0 0.014140862040221691
amplified O 0 0.04398200288414955
to O 0 0.01717408373951912
50 O 0 0.03259463235735893
- O 1 0.9316719174385071
3000 O 0 0.06943210959434509
copies O 0 0.035310473293066025
on O 0 0.047199591994285583
DM B-Disease 1 0.9999998807907104
chromosomes O 0 0.10863391309976578
. O 0 0.05128474906086922

Previous O 0 0.04482411593198776
findings O 0 0.02829131670296192
in O 0 0.016814254224300385
Caucasian O 0 0.09498188644647598
populations O 0 0.022800328209996223
of O 0 0.024235256016254425
a O 1 0.8053923845291138
DM B-Disease 1 1.0
founder O 1 0.9999990463256836
chromosome O 0 0.2693999111652374
raise O 0 0.033786922693252563
a O 0 0.019760293886065483
question O 0 0.01757754199206829
about O 0 0.010433057323098183
the O 0 0.018327629193663597
molecular O 0 0.02724144048988819
events O 0 0.01359578873962164
involved O 0 0.014684420078992844
in O 0 0.012058119289577007
the O 0 0.02555091306567192
expansion O 0 0.07363279908895493
mutation O 0 0.08305724710226059
. O 0 0.04424566775560379

To O 0 0.031292859464883804
investigate O 0 0.041599757969379425
whether O 0 0.016599658876657486
a O 0 0.025821726769208908
founder O 1 0.9362664222717285
chromosome O 0 0.048557933419942856
for O 0 0.020079828798770905
the O 0 0.06176815181970596
DM B-Disease 1 1.0
mutation O 0 0.4172361195087433
exists O 0 0.028446152806282043
in O 0 0.009819427505135536
the O 0 0.016243640333414078
Japanese O 0 0.0316665880382061
population O 0 0.015600238926708698
, O 0 0.015097140334546566
we O 0 0.015510994009673595
genotyped O 0 0.1536446213722229
families O 0 0.028427934274077415
using O 0 0.019850194454193115
polymorphic O 0 0.11481372267007828
markers O 0 0.05966375395655632
near O 0 0.04058161750435829
the O 0 0.02937859110534191
( O 0 0.04441589489579201
CTG O 1 0.9999816417694092
) O 0 0.037909988313913345
n O 0 0.08255583792924881
repeat O 0 0.07079990208148956
region O 0 0.040665868669748306
and O 0 0.03219497948884964
constructed O 0 0.08728882670402527
haplotypes O 0 0.17759400606155396
. O 0 0.055298641324043274

Six O 0 0.035988159477710724
different O 0 0.0168716199696064
haplotypes O 0 0.07627151906490326
were O 0 0.014745417982339859
found O 0 0.01995854452252388
and O 0 0.038147784769535065
DM B-Disease 1 1.0
alleles O 0 0.23450468480587006
were O 0 0.02285100892186165
always O 0 0.04478990659117699
haplotype O 1 0.5179844498634338
A O 0 0.06494417786598206
. O 0 0.04254225268959999

To O 0 0.03375527262687683
find O 0 0.0267808735370636
an O 0 0.012915128841996193
origin O 0 0.010592814534902573
of O 0 0.015465782955288887
the O 0 0.026986580342054367
( O 0 0.04510754719376564
CTG O 1 0.9999908208847046
) O 0 0.04048540070652962
n O 0 0.0872538834810257
repeat O 0 0.08427543193101883
mutation O 0 0.04375290498137474
and O 0 0.013258432038128376
to O 0 0.014210141263902187
investigate O 0 0.03280392289161682
the O 0 0.01868440769612789
mechanism O 0 0.025495145469903946
of O 0 0.014074929058551788
the O 0 0.019514257088303566
expansion O 0 0.04548752307891846
mutation O 0 0.03511282801628113
in O 0 0.012020113877952099
the O 0 0.017170406877994537
Japanese O 0 0.03166154772043228
population O 0 0.013390972279012203
we O 0 0.00852199736982584
have O 0 0.006378829944878817
studied O 0 0.01747640036046505
90 O 0 0.03176671266555786
Japanese O 0 0.08466996252536774
DM B-Disease 1 1.0
families O 0 0.04556560516357422
comprising O 0 0.055542200803756714
190 O 0 0.07395443320274353
affected O 0 0.042793646454811096
and O 0 0.02680162340402603
130 O 0 0.06888564676046371
unaffected O 0 0.147245854139328
members O 0 0.043537262827157974
. O 0 0.04235031083226204

The O 0 0.04366181790828705
results O 0 0.022228209301829338
suggest O 0 0.01703859120607376
that O 0 0.0091513367369771
a O 0 0.01658482290804386
few O 0 0.017041275277733803
common O 0 0.02790015935897827
ancestral O 1 0.7749716639518738
mutations O 0 0.037474460899829865
in O 0 0.015781139954924583
both O 0 0.020749889314174652
Caucasian O 1 0.9708245992660522
and O 0 0.024073129519820213
Japanese O 0 0.04031524434685707
populations O 0 0.02081531472504139
have O 0 0.008336196653544903
originated O 0 0.01693785935640335
by O 0 0.009878306649625301
expansion O 0 0.021689221262931824
of O 0 0.015263205394148827
an O 0 0.022016622126102448
ancestral O 1 0.9656927585601807
n O 0 0.0934130847454071
= O 0 0.05395476892590523
5 O 0 0.027283580973744392
repeat O 0 0.04977928474545479
to O 0 0.02481464482843876
n O 0 0.07722403109073639
= O 0 0.06174800172448158
19 O 0 0.05035290867090225
- O 1 0.8770073056221008
37 O 0 0.0518476702272892
copies O 0 0.03701176866889
. O 0 0.03280191123485565

These O 0 0.02142573520541191
data O 0 0.018800511956214905
support O 0 0.031051991507411003
multistep O 0 0.09842012077569962
models O 0 0.029305148869752884
of O 0 0.033395759761333466
triplet O 1 0.9999115467071533
repeat O 0 0.17309026420116425
expansion O 0 0.04515288770198822
that O 0 0.010662712156772614
have O 0 0.0059020305052399635
been O 0 0.007766894530504942
proposed O 0 0.014460867270827293
for O 0 0.014130907133221626
both O 0 0.03222876414656639
DM B-Disease 1 1.0
and O 0 0.4552396237850189
Friedreichs B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999998807907104
. O 0 0.0464155487716198
. O 0 0.046288151293992996

The O 0 0.042913034558296204
molecular O 0 0.042620811611413956
basis O 0 0.026361020281910896
of O 1 0.5191630125045776
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.031140148639678955
the O 0 0.029825948178768158
western O 0 0.04177241772413254
Cape O 0 0.13458532094955444
, O 0 0.026940369978547096
South O 0 0.05155462399125099
Africa O 0 0.06108831241726875
. O 0 0.041827451437711716

Deficiency B-Disease 1 0.9999995231628418
of I-Disease 0 0.03678698465228081
the I-Disease 0 0.035064831376075745
sixth I-Disease 1 0.9968439340591431
component I-Disease 0 0.07067045569419861
of I-Disease 0 0.02317436970770359
human I-Disease 0 0.03647412359714508
complement I-Disease 1 0.9993316531181335
( O 1 0.5220438241958618
C6 O 1 1.0
) O 0 0.021374095231294632
has O 0 0.01119612343609333
been O 0 0.008830377832055092
reported O 0 0.012480699457228184
in O 0 0.007711050100624561
a O 0 0.012476691976189613
number O 0 0.008693506941199303
of O 0 0.012324613519012928
families O 0 0.017810609191656113
from O 0 0.01223846711218357
the O 0 0.018777895718812943
western O 0 0.03410273417830467
Cape O 0 0.08548256754875183
, O 0 0.027828235179185867
South O 0 0.04751086235046387
Africa O 0 0.06539494544267654
. O 0 0.04245984926819801

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.274173766374588
endemic O 1 0.9974954128265381
in O 0 0.022651823237538338
the O 0 0.02690816856920719
Cape O 0 0.07456738501787186
and O 0 0.016054216772317886
almost O 0 0.012362672947347164
all O 0 0.010786048136651516
pedigrees O 0 0.05291319638490677
of O 0 0.030102118849754333
total O 1 0.9819332957267761
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9998767375946045
C6Q0 O 1 1.0
) O 0 0.023703910410404205
have O 0 0.0077445171773433685
been O 0 0.011701499111950397
ascertained O 0 0.04730871692299843
because O 0 0.019563497975468636
of O 0 0.05468357726931572
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.9081811904907227

We O 0 0.024962807074189186
have O 0 0.01145219523459673
sequenced O 0 0.033536314964294434
the O 0 0.01610122062265873
expressed O 0 0.024570520967245102
exons O 0 0.05175551027059555
of O 0 0.02459193579852581
the O 0 0.04278105869889259
C6 O 1 0.9999998807907104
gene O 0 0.04214002937078476
from O 0 0.016659360378980637
selected O 0 0.02388783171772957
cases O 0 0.01844385266304016
and O 0 0.01304703764617443
have O 0 0.007454798556864262
found O 0 0.010077648796141148
three O 0 0.015942685306072235
molecular O 0 0.0560297854244709
defects O 1 0.9979619979858398
leading O 0 0.0507611408829689
to O 0 0.029202507808804512
total O 0 0.22960521280765533
deficiency O 1 1.0
879delG O 1 0.9999998807907104
, O 0 0.023800427094101906
which O 0 0.011718792840838432
is O 0 0.011211326345801353
the O 0 0.016534944996237755
common O 0 0.029349789023399353
defect O 1 0.9993997812271118
in O 0 0.01593783125281334
the O 0 0.02441074140369892
Cape O 0 0.19470034539699554
and O 0 0.026031799614429474
hitherto O 1 0.5932325124740601
unreported O 0 0.49945780634880066
, O 0 0.021968184038996696
and O 0 0.02357500232756138
1195delC O 1 0.9998109936714172
and O 0 0.031467508524656296
1936delG O 1 0.9999282360076904
, O 0 0.019814204424619675
which O 0 0.01019767951220274
have O 0 0.006273804698139429
been O 0 0.007956670597195625
previously O 0 0.013421332463622093
reported O 0 0.016443779692053795
in O 0 0.016553279012441635
African O 0 0.06373845040798187
- O 1 0.9990625977516174
Americans O 0 0.056718818843364716
. O 0 0.03931574523448944

We O 0 0.027638502418994904
also O 0 0.015577840618789196
show O 0 0.01626824028789997
that O 0 0.008038424886763096
the O 0 0.02027297578752041
879delG O 1 0.9989691972732544
and O 0 0.040524087846279144
1195delC O 1 0.9999991655349731
defects O 1 0.9999493360519409
are O 0 0.010851831175386906
associated O 0 0.020925162360072136
with O 0 0.025195349007844925
characteristic O 1 0.9999901056289673
C6 O 1 1.0
/ O 1 1.0
C7 O 1 0.9999998807907104
region O 0 0.06947953253984451
DNA O 0 0.06157075613737106
marker O 1 0.6097444295883179
haplotypes O 0 0.11669392883777618
, O 0 0.019002724438905716
although O 0 0.015065409243106842
small O 0 0.01898246258497238
variations O 0 0.022360138595104218
were O 0 0.014653930440545082
observed O 0 0.0330192893743515
. O 0 0.03707270324230194

The O 0 0.08257339894771576
1936delG O 1 0.99998939037323
defect O 1 0.9999847412109375
was O 0 0.040564265102148056
observed O 0 0.022717565298080444
only O 0 0.010426649823784828
once O 0 0.017755674198269844
in O 0 0.009734798222780228
the O 0 0.019500330090522766
Cape O 0 0.07245021313428879
, O 0 0.015542654320597649
but O 0 0.009882607497274876
its O 0 0.01813124492764473
associated O 0 0.03386140614748001
haplotype O 1 0.8189910054206848
could O 0 0.021693890914320946
be O 0 0.019295603036880493
deduced O 0 0.06912119686603546
. O 0 0.037596914917230606

The O 0 0.039025165140628815
data O 0 0.0181385837495327
from O 0 0.01574617438018322
the O 0 0.028126591816544533
haplotypes O 0 0.09905605018138885
indicate O 0 0.023097999393939972
that O 0 0.009277045726776123
these O 0 0.008175102062523365
three O 0 0.018934354186058044
molecular O 0 0.05141281336545944
defects O 1 0.8958698511123657
account O 0 0.02167590707540512
for O 0 0.01716640777885914
the O 0 0.030802719295024872
defects O 1 0.9989978671073914
in O 0 0.013101884163916111
all O 0 0.011610711924731731
the O 0 0.0210519190877676
38 O 0 0.048188481479883194
unrelated O 0 0.08395644277334213
C6Q0 O 1 0.99997878074646
individuals O 0 0.021523846313357353
we O 0 0.011121934279799461
have O 0 0.0077604991383850574
studied O 0 0.016813023015856743
from O 0 0.013837907463312149
the O 0 0.02766985073685646
Cape O 0 0.2716895341873169
. O 0 0.0435636080801487

We O 0 0.026021543890237808
have O 0 0.011047731153666973
also O 0 0.012292730621993542
observed O 0 0.018189869821071625
the O 0 0.025223586708307266
879delG O 1 0.999679684638977
defect O 1 0.9712139368057251
in O 0 0.01298796571791172
two O 0 0.015660105273127556
Dutch O 1 0.9887112379074097
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999998807907104
kindreds O 1 0.9994621872901917
, O 0 0.02037416771054268
but O 0 0.013232599012553692
the O 0 0.027002861723303795
879delG O 1 0.9999468326568604
defect O 1 0.999842643737793
in O 0 0.02008042484521866
the O 0 0.027355069294571877
Cape O 0 0.27391284704208374
probably O 0 0.024927128106355667
did O 0 0.014133737422525883
not O 0 0.00938990619033575
come O 0 0.012449447996914387
from O 0 0.012264208868145943
The O 0 0.023187821730971336
Netherlands O 0 0.06341656297445297
. O 0 0.027701571583747864
. O 0 0.03442862257361412

Complement B-Disease 1 0.9999939203262329
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.05613122880458832
seven O 0 0.03600388765335083
further O 0 0.03861478716135025
molecular O 1 0.7272634506225586
defects O 1 0.999160647392273
and O 0 0.021822234615683556
their O 0 0.023397162556648254
associated O 0 0.045335449278354645
marker O 1 0.9982761144638062
haplotypes O 1 0.7089265584945679
. O 0 0.04775768145918846

Seven O 0 0.03289102017879486
further O 0 0.024160128086805344
molecular O 0 0.03597617894411087
bases O 0 0.038905203342437744
of O 1 0.9937412142753601
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.03636518493294716
described O 0 0.06822746992111206
. O 0 0.04244090989232063

All O 0 0.022146902978420258
these O 0 0.013688221573829651
new O 0 0.031061183661222458
molecular O 0 0.05935782939195633
defects O 1 0.9880604147911072
involve O 0 0.03983525186777115
single O 0 0.4735089838504791
- O 1 0.999995231628418
nucleotide O 0 0.06204075366258621
events O 0 0.020986810326576233
, O 0 0.02136845700442791
deletions O 0 0.052272897213697433
and O 0 0.019235920161008835
substitutions O 0 0.04194897785782814
, O 0 0.012857905589044094
some O 0 0.00825368333607912
of O 0 0.015102757140994072
which O 0 0.017634086310863495
alter O 0 0.056190330535173416
splice O 0 0.10737535357475281
sites O 0 0.028906283900141716
, O 0 0.020754752680659294
and O 0 0.019779233261942863
others O 0 0.032621145248413086
codons O 0 0.09836778044700623
. O 0 0.04645760729908943

They O 0 0.019538940861821175
are O 0 0.008503129705786705
distributed O 0 0.016486218199133873
along O 0 0.021762024611234665
the O 0 0.03874688968062401
C7 O 1 0.9999996423721313
gene O 0 0.049888309091329575
, O 0 0.0188144464045763
but O 0 0.011648129671812057
predominantly O 0 0.02839467115700245
towards O 0 0.03257790580391884
the O 0 0.027822183445096016
3 O 0 0.04457193985581398
end O 0 0.0506618395447731
. O 0 0.043876152485609055

All O 0 0.024639464914798737
were O 0 0.015218107029795647
found O 0 0.016257163137197495
in O 0 0.021353522315621376
compound O 0 0.26494646072387695
heterozygous O 0 0.09644639492034912
individuals O 0 0.03479882329702377
. O 0 0.04529986158013344

The O 0 0.1148335337638855
C6 O 1 1.0
/ O 1 0.9999997615814209
C7 O 1 1.0
marker O 1 0.9995712637901306
haplotypes O 1 0.6909705996513367
associated O 0 0.025784678757190704
with O 0 0.02011786587536335
most O 0 0.04066696763038635
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999958276748657
are O 0 0.018363628536462784
tabulated O 0 0.047936730086803436
. O 0 0.024298617616295815
. O 0 0.034561529755592346

A O 0 0.0874217078089714
genome O 0 0.08743590861558914
- O 0 0.4651775360107422
wide O 0 0.03356287255883217
search O 0 0.03578980639576912
for O 0 0.02635294198989868
chromosomal O 1 0.9300496578216553
loci O 0 0.11631578207015991
linked O 0 0.06108204275369644
to O 0 0.0361303873360157
mental O 1 0.9999998807907104
health O 1 0.9999992847442627
wellness O 1 0.9999998807907104
in O 0 0.02366729825735092
relatives O 0 0.04694365710020065
at O 0 0.024894792586565018
high O 0 0.23385655879974365
risk O 1 0.9957654476165771
for O 1 0.9961128234863281
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.47553449869155884
the O 0 0.04264204204082489
Old O 1 0.5356191396713257
Order O 0 0.05158939212560654
Amish O 0 0.3989298641681671
. O 0 0.04288170114159584

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9998989105224609
BPAD B-Disease 1 1.0
; O 1 0.999716579914093
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.04402611404657364
is O 0 0.016971072182059288
characterized O 0 0.02690749429166317
by O 0 0.013431539759039879
episodes O 0 0.031032957136631012
of O 0 0.04567909985780716
mania B-Disease 1 1.0
and O 1 0.9574142694473267
/ O 1 0.9999997615814209
or O 0 0.08753127604722977
hypomania B-Disease 1 0.9999998807907104
interspersed O 0 0.11804778128862381
with O 0 0.02337491139769554
periods O 0 0.04575095698237419
of O 0 0.05543503537774086
depression B-Disease 1 0.9999998807907104
. O 0 0.07822109013795853

Compelling O 0 0.076344795525074
evidence O 0 0.026608724147081375
supports O 0 0.0355229489505291
a O 0 0.022442597895860672
significant O 0 0.023265600204467773
genetic O 0 0.0347941629588604
component O 0 0.042912572622299194
in O 0 0.015349031426012516
the O 0 0.0297099556773901
susceptibility O 1 0.9980906844139099
to O 0 0.03997226804494858
develop O 0 0.397943913936615
BPAD B-Disease 1 0.9999992847442627
. O 0 0.06289464235305786

To O 0 0.03479882329702377
date O 0 0.03367115929722786
, O 0 0.020731594413518906
however O 0 0.016988622024655342
, O 0 0.022768599912524223
linkage O 0 0.07585767656564713
studies O 0 0.016384487971663475
have O 0 0.007914035581052303
attempted O 0 0.02647995576262474
only O 0 0.010870878584682941
to O 0 0.018230769783258438
identify O 0 0.04582845792174339
chromosomal O 1 0.9994625449180603
loci O 0 0.24262821674346924
that O 0 0.020549073815345764
cause O 0 0.06341654062271118
or O 0 0.016732491552829742
increase O 0 0.01586288958787918
the O 0 0.02240127883851528
risk O 0 0.05307637155056
of O 0 0.0369635634124279
developing O 1 0.5885434150695801
BPAD B-Disease 1 0.9999995231628418
. O 0 0.070845827460289

To O 0 0.035163503140211105
determine O 0 0.02283688262104988
whether O 0 0.015940016135573387
there O 0 0.00950164906680584
could O 0 0.011128293350338936
be O 0 0.01456781942397356
protective O 1 0.9860060214996338
alleles O 0 0.05546895042061806
that O 0 0.014175617136061192
prevent O 0 0.04297850281000137
or O 0 0.01828613132238388
reduce O 0 0.029586676508188248
the O 0 0.020467810332775116
risk O 0 0.034121934324502945
of O 0 0.0256575308740139
developing O 1 0.7221084833145142
BPAD B-Disease 1 1.0
, O 0 0.02109854482114315
similar O 0 0.011237840168178082
to O 0 0.009676126763224602
what O 0 0.008781840093433857
is O 0 0.00925799272954464
observed O 0 0.011140850372612476
in O 0 0.010114863514900208
other O 0 0.018660442903637886
genetic B-Disease 1 0.9999666213989258
disorders I-Disease 1 1.0
, O 0 0.05587158352136612
we O 0 0.01750411093235016
used O 0 0.025321010500192642
mental O 1 0.9999998807907104
health O 1 0.9999998807907104
wellness O 1 1.0
( O 0 0.031255435198545456
absence O 0 0.03974007070064545
of O 0 0.0251143928617239
any O 0 0.12897436320781708
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.041277311742305756
as O 0 0.017345070838928223
the O 0 0.021216711029410362
phenotype O 0 0.05675303936004639
in O 0 0.013644500635564327
our O 0 0.02595289796590805
genome O 0 0.046171970665454865
- O 1 0.9965043067932129
wide O 0 0.04534880071878433
linkage O 0 0.0964498370885849
scan O 0 0.04974602907896042
of O 0 0.01615435816347599
several O 0 0.0133523466065526
large O 0 0.024933528155088425
multigeneration O 0 0.44352075457572937
Old O 0 0.06774475425481796
Order O 0 0.04813196137547493
Amish O 0 0.26100969314575195
pedigrees O 0 0.11788785457611084
exhibiting O 0 0.06302780658006668
an O 0 0.025160696357488632
extremely O 0 0.0435737743973732
high O 0 0.4497891962528229
incidence O 1 0.9999910593032837
of O 1 0.9103522300720215
BPAD B-Disease 1 1.0
. O 0 0.07633072882890701

We O 0 0.027466341853141785
have O 0 0.010285183787345886
found O 0 0.010950107127428055
strong O 0 0.015404006466269493
evidence O 0 0.012075488455593586
for O 0 0.011568962596356869
a O 0 0.026078034192323685
locus O 0 0.08597095310688019
on O 0 0.030656296759843826
chromosome O 0 0.09654118120670319
4p O 1 0.9999840259552002
at O 0 0.04819222539663315
D4S2949 O 1 0.9821434617042542
( O 0 0.02978549525141716
maximum O 0 0.04963398352265358
GENEHUNTER O 1 0.9999746084213257
- O 1 0.999735414981842
PLUS O 0 0.09174767881631851
nonparametric O 0 0.15640148520469666
linkage O 0 0.10120517760515213
score O 0 0.03885563835501671
= O 0 0.05184808000922203
4 O 0 0.029231326654553413
. O 0 0.01832456700503826
05 O 0 0.1789981722831726
, O 0 0.03140581026673317
P O 1 0.9984070658683777
= O 0 0.05216158553957939
5 O 0 0.020002739503979683
. O 0 0.00946424063295126
22 O 0 0.02195555344223976
x O 0 0.04641787335276604
10 O 0 0.023821929469704628
( O 0 0.028837447986006737
- O 1 0.9993202686309814
4 O 0 0.032528556883335114
) O 0 0.019449956715106964
; O 0 0.02202795445919037
SIBPAL O 1 0.9964367151260376
Pempirical O 1 0.9835020899772644
value O 0 0.03191768378019333
< O 1 0.7789527177810669
3 O 0 0.03211966156959534
x O 0 0.047127846628427505
10 O 0 0.022322552278637886
( O 0 0.03078296035528183
- O 1 0.999876856803894
5 O 0 0.034671444445848465
) O 0 0.02051100693643093
) O 0 0.016018591821193695
and O 0 0.015199015848338604
suggestive O 0 0.05216798186302185
evidence O 0 0.014109659940004349
for O 0 0.013064198195934296
a O 0 0.02711891382932663
locus O 0 0.14341871440410614
on O 0 0.03343082219362259
chromosome O 0 0.10070053488016129
4q O 1 0.9997658133506775
at O 0 0.0429619625210762
D4S397 O 1 0.9982996582984924
( O 0 0.03001767210662365
maximum O 0 0.04603194445371628
GENEHUNTER O 1 0.9999797344207764
- O 1 0.9995249509811401
PLUS O 0 0.08932168036699295
nonparametric O 0 0.2693275213241577
linkage O 0 0.08829762041568756
score O 0 0.036849312484264374
= O 0 0.04961076006293297
3 O 0 0.024789467453956604
. O 0 0.011556852608919144
29 O 0 0.03047928959131241
, O 0 0.02607874944806099
P O 1 0.9858344197273254
= O 0 0.054236505180597305
2 O 0 0.026990259066224098
. O 0 0.01298673264682293
57 O 0 0.04049884155392647
x O 0 0.05251460149884224
10 O 0 0.02584870159626007
( O 0 0.03380066528916359
- O 1 0.9967910647392273
3 O 0 0.03466120362281799
) O 0 0.022021308541297913
; O 0 0.02260488271713257
SIBPAL O 1 0.997514009475708
Pempirical O 1 0.9884967803955078
value O 0 0.031979747116565704
< O 1 0.9651790857315063
1 O 0 0.03670221567153931
x O 0 0.047787073999643326
10 O 0 0.02134481817483902
( O 0 0.02625555731356144
- O 1 0.9993096590042114
3 O 0 0.03370802849531174
) O 0 0.01678750477731228
) O 0 0.010692616924643517
that O 0 0.006386553402990103
are O 0 0.00623219832777977
linked O 0 0.03643359616398811
to O 0 0.03538354113698006
mental O 1 1.0
health O 1 0.9999997615814209
wellness O 1 0.9999998807907104
. O 0 0.08060109615325928

These O 0 0.021457888185977936
findings O 0 0.02530791237950325
are O 0 0.009049421176314354
consistent O 0 0.023069953545928
with O 0 0.013777158223092556
the O 0 0.021043166518211365
hypothesis O 0 0.03608374297618866
that O 0 0.011189304292201996
certain O 0 0.018149718642234802
alleles O 0 0.05141041800379753
could O 0 0.01961161568760872
prevent O 0 0.040203120559453964
or O 0 0.019354315474629402
modify O 0 0.04170180857181549
the O 0 0.025701137259602547
clinical O 1 0.9782230257987976
manifestations O 1 0.999984860420227
of O 1 0.9127686023712158
BPAD B-Disease 1 1.0
and O 0 0.03272806480526924
perhaps O 0 0.02936999499797821
other O 0 0.023118093609809875
related O 1 0.9769768118858337
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.8960914015769958

Segregation O 1 0.9992949962615967
distortion O 1 0.999811589717865
in O 1 0.7333484292030334
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.48587071895599365

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999990701675415
DM B-Disease 1 1.0
) O 0 0.03305048123002052
is O 0 0.019555479288101196
an O 0 0.025075700134038925
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
which O 0 0.020778674632310867
, O 0 0.014530211687088013
in O 0 0.010034163482487202
the O 0 0.018408723175525665
typical O 0 0.04181481897830963
pedigree O 0 0.06271306425333023
, O 0 0.015284565277397633
shows O 0 0.013790071941912174
a O 0 0.0174564216285944
three O 0 0.018394257873296738
generation O 0 0.09147008508443832
anticipation O 0 0.17901729047298431
cascade O 1 0.997255265712738
. O 0 0.05504725128412247

This O 0 0.02029937133193016
results O 0 0.018621070310473442
in O 0 0.026591787114739418
infertility B-Disease 1 1.0
and O 1 0.999998927116394
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
CDM B-Disease 1 1.0
) O 0 0.022105319425463676
with O 0 0.012361607514321804
the O 0 0.017991473898291588
disappearance O 0 0.08543335646390915
of O 0 0.051299020648002625
DM B-Disease 1 1.0
in O 0 0.0287933386862278
that O 0 0.024592462927103043
pedigree O 0 0.09017396718263626
. O 0 0.03929860517382622

The O 0 0.03346742317080498
concept O 0 0.03359099477529526
of O 0 0.03408164903521538
segregation O 1 0.9999948740005493
distortion O 1 0.9999727010726929
, O 0 0.02033502236008644
where O 0 0.014869746752083302
there O 0 0.00978784542530775
is O 0 0.014127413742244244
preferential O 0 0.05911281704902649
transmission O 0 0.031561627984046936
of O 0 0.014047938399016857
the O 0 0.015774333849549294
larger O 0 0.019758041948080063
allele O 0 0.048646483570337296
at O 0 0.02380014769732952
the O 0 0.042550139129161835
DM B-Disease 1 1.0
locus O 1 0.9997753500938416
, O 0 0.023524262011051178
has O 0 0.01578775979578495
been O 0 0.012404212728142738
put O 0 0.02005561627447605
forward O 0 0.01787257008254528
to O 0 0.013579445891082287
explain O 0 0.023001721128821373
partially O 0 0.03213653340935707
the O 0 0.02052343264222145
maintenance O 1 0.5085593461990356
of O 0 0.0587092824280262
DM B-Disease 1 1.0
in O 0 0.024757934734225273
the O 0 0.02580239251255989
population O 0 0.02766319364309311
. O 0 0.03490477427840233

In O 0 0.024901576340198517
a O 0 0.025932027027010918
survey O 0 0.030627191066741943
of O 0 0.041619472205638885
DM B-Disease 1 1.0
in O 0 0.026295116171240807
Northern O 0 0.04118945449590683
Ireland O 0 0.04304277151823044
, O 0 0.02753056399524212
59 O 0 0.06695159524679184
pedigrees O 0 0.10119018703699112
were O 0 0.031797319650650024
ascertained O 0 0.11024714261293411
. O 0 0.04348590597510338

Sibships O 1 0.9394276738166809
where O 0 0.02984517812728882
the O 0 0.019804423674941063
status O 0 0.031228486448526382
of O 0 0.014871197752654552
all O 0 0.011136491782963276
the O 0 0.01533560361713171
members O 0 0.01605302095413208
had O 0 0.014160704798996449
been O 0 0.012535236775875092
identified O 0 0.015722425654530525
were O 0 0.00850346777588129
examined O 0 0.024944936856627464
to O 0 0.011405637487769127
determine O 0 0.011761469766497612
the O 0 0.014008209109306335
transmission O 0 0.0282810740172863
of O 0 0.017987176775932312
the O 0 0.046111881732940674
DM B-Disease 1 1.0
expansion O 0 0.08939988911151886
from O 0 0.023854168131947517
affected O 0 0.0318005308508873
parents O 0 0.02895279787480831
to O 0 0.018566712737083435
their O 0 0.02153724990785122
offspring O 0 0.07916101813316345
. O 0 0.04155217483639717

Where O 0 0.03684702143073082
the O 0 0.035256195813417435
transmitting O 1 0.5006421208381653
parent O 0 0.19298772513866425
was O 0 0.04588984325528145
male O 0 0.06088029593229294
, O 0 0.030222633853554726
58 O 0 0.07217658311128616
. O 0 0.043101534247398376

3 O 0 0.04580460488796234
% O 0 0.019717616960406303
of O 0 0.01827370747923851
the O 0 0.02531176060438156
offspring O 0 0.06513939052820206
were O 0 0.016266370192170143
affected O 0 0.025883158668875694
, O 0 0.01404479518532753
and O 0 0.011000380851328373
in O 0 0.009242469444870949
the O 0 0.013187033124268055
case O 0 0.01687079668045044
of O 0 0.014582323841750622
a O 0 0.02442096546292305
female O 0 0.17811156809329987
transmitting O 1 0.9936925172805786
parent O 1 0.9318532347679138
, O 0 0.030321432277560234
68 O 0 0.07731092721223831
. O 0 0.04086443409323692

7 O 0 0.08317507058382034
% O 0 0.03567551076412201
were O 0 0.023115167394280434
affected O 0 0.049921877682209015
. O 0 0.042783141136169434

Studies O 0 0.0438559427857399
on O 0 0.03381803259253502
meiotic O 1 0.9994749426841736
drive O 0 0.15143164992332458
in O 0 0.04849918931722641
DM B-Disease 1 1.0
have O 0 0.016963571310043335
shown O 0 0.01901254430413246
increased O 0 0.022627605125308037
transmission O 0 0.032934121787548065
of O 0 0.0147091681137681
the O 0 0.01853044703602791
larger O 0 0.022307196632027626
allele O 0 0.04673077538609505
at O 0 0.021653223782777786
the O 0 0.03872336074709892
DM B-Disease 1 1.0
locus O 1 0.814872682094574
in O 0 0.026570333167910576
non O 1 0.9970428347587585
- O 1 1.0
DM O 1 1.0
heterozygotes O 1 0.9984526634216309
for O 0 0.0574578158557415
CTGn O 1 0.9987753033638
. O 0 0.05369747430086136

This O 0 0.028458958491683006
study O 0 0.02687823213636875
provides O 0 0.021808279678225517
further O 0 0.011870669201016426
evidence O 0 0.012504817917943
that O 0 0.011405154131352901
the O 0 0.03457356244325638
DM B-Disease 1 1.0
expansion O 0 0.2486284226179123
tends O 0 0.057552531361579895
to O 0 0.026131045073270798
be O 0 0.022811925038695335
transmitted O 0 0.08066453784704208
preferentially O 0 0.10097848623991013
. O 0 0.041171845048666

Diagnosis O 1 0.9999961853027344
of O 1 0.9861449003219604
hemochromatosis B-Disease 1 1.0
. O 0 0.15968412160873413

If O 0 0.07151664793491364
untreated O 1 0.9999998807907104
, O 1 0.999183714389801
hemochromatosis B-Disease 1 1.0
can O 1 0.8082197308540344
cause O 1 0.9999990463256836
serious O 1 0.9999998807907104
illness O 1 1.0
and O 0 0.04772134870290756
early B-Disease 0 0.03585711494088173
death I-Disease 1 0.9955096244812012
, O 0 0.01546571683138609
but O 0 0.012141254730522633
the O 0 0.023811260238289833
disease O 1 0.9999978542327881
is O 0 0.017725354060530663
still O 0 0.017509296536445618
substantially O 0 0.036215197294950485
under O 0 0.0959300622344017
- O 1 1.0
diagnosed O 1 0.9999998807907104
. O 0 0.06412816047668457

The O 0 0.04791253060102463
cornerstone O 1 0.9985277652740479
of O 0 0.041262440383434296
screening O 1 0.8366544842720032
and O 0 0.023348931223154068
case O 0 0.03522161766886711
detection O 0 0.04591972380876541
is O 0 0.014826305210590363
the O 0 0.017572609707713127
measurement O 0 0.039536040276288986
of O 0 0.03848293423652649
serum O 1 0.9999955892562866
transferrin O 1 0.9999933242797852
saturation O 1 0.9857957363128662
and O 0 0.030087130144238472
the O 0 0.046887870877981186
serum O 1 0.999998927116394
ferritin O 1 0.9999910593032837
level O 0 0.07580240815877914
. O 0 0.04977826401591301

Once O 0 0.07203374058008194
the O 0 0.05239838361740112
diagnosis O 1 0.9999901056289673
is O 0 0.033170972019433975
suspected O 0 0.09387560188770294
, O 0 0.028119908645749092
physicians O 0 0.1251135766506195
must O 0 0.027084438130259514
use O 0 0.03154484182596207
serum O 1 0.9999629259109497
ferritin O 1 0.999992847442627
levels O 0 0.06021350994706154
and O 0 0.04680062457919121
hepatic O 1 1.0
iron O 1 0.9999983310699463
stores O 0 0.07285816222429276
on O 0 0.17592093348503113
liver O 1 1.0
biopsy O 1 0.9999997615814209
specimens O 0 0.045339882373809814
to O 0 0.02702689915895462
assess O 0 0.06511687487363815
patients O 0 0.40963634848594666
for O 0 0.014727188274264336
the O 0 0.021926455199718475
presence O 0 0.040752872824668884
of O 0 0.04836582392454147
iron B-Disease 1 0.9999992847442627
overload I-Disease 1 0.9999985694885254
. O 0 0.061133645474910736

Liver O 1 1.0
biopsy O 1 0.9999998807907104
is O 0 0.03568068519234657
also O 0 0.014797915704548359
used O 0 0.009129968471825123
to O 0 0.010229842737317085
establish O 0 0.02158108353614807
the O 0 0.015066754072904587
presence O 0 0.024046964943408966
or O 0 0.015188127756118774
absence O 0 0.044443581253290176
of O 1 0.7952587008476257
cirrhosis B-Disease 1 1.0
, O 0 0.10509614646434784
which O 0 0.01900993287563324
can O 0 0.01692127250134945
affect O 0 0.04372416064143181
prognosis O 1 0.9999995231628418
and O 0 0.03844441473484039
management O 0 0.08502211421728134
. O 0 0.04562832787632942

A O 0 0.07477410137653351
DNA O 0 0.06647360324859619
- O 1 0.6836417317390442
based O 0 0.01926310732960701
test O 0 0.022200491279363632
for O 0 0.015889225527644157
the O 0 0.0350063294172287
HFE O 1 0.9999984502792358
gene O 0 0.04891759902238846
is O 0 0.021144812926650047
commercially O 0 0.03136582300066948
available O 0 0.011320321820676327
, O 0 0.009382280521094799
but O 0 0.006512816529721022
its O 0 0.009476362727582455
place O 0 0.014081317000091076
in O 0 0.010083754546940327
the O 0 0.023998508229851723
diagnosis O 1 0.9999992847442627
of O 1 0.9976887702941895
hemochromatosis B-Disease 1 1.0
is O 0 0.0792127251625061
still O 0 0.02995474636554718
being O 0 0.030116580426692963
evaluated O 0 0.06264259666204453
. O 0 0.035749126225709915

Currently O 0 0.04326528310775757
, O 0 0.01800323836505413
the O 0 0.017578069120645523
most O 0 0.013649534434080124
useful O 0 0.01838512159883976
role O 0 0.022908370941877365
for O 0 0.011831960640847683
this O 0 0.009220854379236698
test O 0 0.019416697323322296
is O 0 0.009452599100768566
in O 0 0.007907507941126823
the O 0 0.016050541773438454
detection O 0 0.04883363097906113
of O 0 0.03686794266104698
hemochromatosis B-Disease 1 1.0
in O 0 0.019822414964437485
the O 0 0.02116812765598297
family O 0 0.02585592307150364
members O 0 0.017388073727488518
of O 0 0.022047773003578186
patients O 1 0.9838820695877075
with O 0 0.01762174814939499
a O 0 0.02460315264761448
proven O 0 0.039740342646837234
case O 0 0.02483905293047428
of O 0 0.025311965495347977
the O 0 0.07262491434812546
disease O 1 0.9999998807907104
. O 0 0.0625765472650528

It O 0 0.023890450596809387
is O 0 0.018800757825374603
crucial O 0 0.03459729254245758
to O 0 0.039944715797901154
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999948740005493
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999998807907104
because O 1 0.9977053999900818
phlebotomy O 1 1.0
therapy O 1 0.9999980926513672
can O 0 0.03617996349930763
avert O 1 0.9999996423721313
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9998076558113098
can O 0 0.01971009559929371
even O 0 0.01659386418759823
lead O 0 0.028282899409532547
to O 0 0.020114291459321976
normal O 0 0.03613648563623428
life O 0 0.05031229928135872
expectancy O 1 0.8544573187828064
. O 0 0.03223421052098274
. O 0 0.03933143615722656

Prevalence O 1 0.8914592266082764
of O 0 0.039477817714214325
the O 0 0.058569129556417465
I1307K O 1 0.9999949932098389
APC B-Disease 1 0.9999970197677612
gene O 0 0.05761881545186043
variant O 0 0.041122496128082275
in O 0 0.013537712395191193
Israeli O 0 0.031202169135212898
Jews O 0 0.030360979959368706
of O 0 0.014659631997346878
differing O 0 0.0151138324290514
ethnic O 0 0.020773425698280334
origin O 0 0.0162761639803648
and O 0 0.021126730367541313
risk O 1 0.9756383895874023
for O 1 0.999760091304779
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9946020841598511

BACKGROUND O 0 0.1414567083120346
& O 0 0.3759102523326874
AIMS O 0 0.08251401036977768
Israeli O 0 0.04197227582335472
Jews O 0 0.034280020743608475
of O 0 0.01880832388997078
European O 0 0.027505235746502876
birth O 1 0.7589990496635437
, O 0 0.023770377039909363
i O 0 0.028060438111424446
. O 0 0.015781939029693604
e O 0 0.039282914251089096
. O 0 0.011371085420250893
, O 0 0.017504137009382248
Ashkenazim O 1 0.9319907426834106
, O 0 0.01214201096445322
have O 0 0.006642528343945742
the O 0 0.02021286077797413
highest O 1 0.9999991655349731
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 1 0.5262576937675476
any O 0 0.026510972529649734
Israeli O 0 0.046953234821558
ethnic O 0 0.03931049257516861
group O 0 0.04812973365187645
. O 0 0.033764876425266266

The O 0 0.0753873884677887
I1307K O 1 0.9999198913574219
APC B-Disease 1 0.9999957084655762
gene O 0 0.06922738254070282
variant O 0 0.0578252337872982
was O 0 0.029247866943478584
found O 0 0.016412613913416862
in O 0 0.017927616834640503
6 O 0 0.04805991053581238
. O 0 0.036204177886247635

1 O 0 0.05192449316382408
% O 0 0.020357519388198853
of O 0 0.018289338797330856
American O 0 0.03094920702278614
Jews O 0 0.03791270777583122
, O 0 0.016297919675707817
28 O 0 0.02012515440583229
% O 0 0.012011163868010044
of O 0 0.016159294173121452
their O 0 0.03791838884353638
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999951124191284
, O 0 0.03304051235318184
but O 0 0.012210254557430744
not O 0 0.008256352506577969
in O 0 0.012084503658115864
non O 0 0.23774902522563934
- O 1 0.9998979568481445
Jews O 0 0.06687995791435242
. O 0 0.03898723050951958

We O 0 0.03108655847609043
assessed O 0 0.046076517552137375
the O 0 0.03785444051027298
I1307K O 1 0.9988864064216614
prevalence O 1 0.9978677034378052
in O 0 0.022038698196411133
Israeli O 0 0.04012832045555115
Jews O 0 0.03375909850001335
of O 0 0.017750686034560204
differing O 0 0.016590191051363945
ethnic O 0 0.021128762513399124
origin O 0 0.015424017794430256
and O 0 0.020052233710885048
risk O 1 0.9950026869773865
for O 1 0.9997915625572205
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9962254762649536

METHODS O 0 0.06945216655731201
DNA O 0 0.046163443475961685
samples O 0 0.022668248042464256
from O 0 0.013431078754365444
500 O 0 0.029327213764190674
unrelated O 0 0.029361506924033165
Jews O 0 0.0280563123524189
of O 0 0.01807982847094536
European O 0 0.022018995136022568
or O 0 0.0206338781863451
non O 0 0.20281630754470825
- O 1 0.9991751313209534
European O 0 0.01970669813454151
origin O 0 0.011138278059661388
, O 0 0.010615421459078789
with O 0 0.009511500597000122
or O 0 0.010642077773809433
without O 0 0.01070596743375063
a O 0 0.02006937377154827
personal O 0 0.03475409001111984
and O 0 0.0259346105158329
/ O 1 0.9998925924301147
or O 0 0.017573880031704903
family O 0 0.022511009126901627
history O 0 0.02394755370914936
of O 0 0.03956810012459755
neoplasia B-Disease 1 0.9999998807907104
, O 0 0.02329131029546261
were O 0 0.011257546953856945
examined O 0 0.028621604666113853
for O 0 0.013467026874423027
the O 0 0.02400072291493416
I1307K O 1 0.9899444580078125
variant O 0 0.041116952896118164
by O 0 0.014680874533951283
the O 0 0.02552766725420952
allele O 0 0.11245148628950119
- O 1 0.9945448637008667
specific O 0 0.027109812945127487
oligonucleotide O 1 0.9096725583076477
( O 0 0.05447535589337349
ASO O 1 0.9999954700469971
) O 0 0.04420462250709534
method O 0 0.03993091359734535
. O 0 0.035614944994449615

RESULTS O 0 0.0355011448264122
In O 0 0.015633033588528633
persons O 0 0.021961068734526634
at O 0 0.021029217168688774
average O 0 0.026916101574897766
risk O 1 0.8384949564933777
for O 1 0.9970324039459229
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9993253946304321
I1307K O 1 0.9999980926513672
was O 0 0.04134943708777428
found O 0 0.016126152127981186
in O 0 0.0165866669267416
5 O 0 0.037121694535017014
. O 0 0.03188534826040268

0 O 0 0.07944494485855103
% O 0 0.026049260050058365
of O 0 0.021559009328484535
120 O 0 0.03717335686087608
European O 0 0.028146954253315926
and O 0 0.02515481971204281
1 O 0 0.050137732177972794
. O 0 0.03703012689948082

6 O 0 0.05174081400036812
% O 0 0.019871171563863754
of O 0 0.019358813762664795
188 O 0 0.08255714178085327
non O 0 0.27703914046287537
- O 1 0.9982714653015137
European O 0 0.026867922395467758
Jews O 0 0.05071656405925751
( O 0 0.04210376366972923
P O 1 0.999215841293335
= O 0 0.0787501335144043
0 O 0 0.05773957073688507
. O 0 0.02815653756260872
08 O 0 0.12173790484666824
) O 0 0.03373933210968971
. O 0 0.03370122238993645

It O 0 0.028934385627508163
occurred O 0 0.03444370627403259
in O 0 0.021104851737618446
15 O 0 0.039673883467912674
. O 0 0.03880656883120537

4 O 0 0.048974402248859406
% O 0 0.021025124937295914
of O 0 0.019630303606390953
52 O 0 0.05067653954029083
Ashkenazi O 0 0.1382848471403122
Israelis O 0 0.05359998345375061
with O 0 0.03971460461616516
familial O 1 1.0
cancer B-Disease 1 1.0
( O 1 0.9982153177261353
P O 1 0.9999988079071045
= O 0 0.09717603772878647
0 O 0 0.0500916987657547
. O 0 0.02373594045639038
02 O 1 0.999692440032959
) O 0 0.01821638084948063
and O 0 0.012983004562556744
was O 0 0.020532043650746346
not O 0 0.010060058906674385
detected O 0 0.02194155566394329
in O 0 0.010195099748671055
51 O 0 0.04002121090888977
non O 0 0.059189725667238235
- O 1 0.9324116110801697
European O 0 0.02169243060052395
Jews O 0 0.03933703526854515
at O 0 0.03800002112984657
increased O 0 0.31459036469459534
cancer B-Disease 1 1.0
risk O 1 0.9994261264801025
. O 0 0.05769721046090126

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 1 0.6402146220207214
personally O 1 0.9292510747909546
or O 0 0.01912929117679596
in O 0 0.010801564902067184
the O 0 0.015255840495228767
families O 0 0.015867669135332108
of O 0 0.014908604323863983
13 O 0 0.021099137142300606
of O 0 0.01882813684642315
20 O 0 0.03538636863231659
Ashkenazi O 1 0.999028205871582
I1307K O 1 0.9999430179595947
carriers O 0 0.06735095381736755
, O 0 0.01754503697156906
8 O 0 0.022520123049616814
of O 0 0.01707596704363823
whom O 0 0.02706957794725895
also O 0 0.013315058313310146
had O 0 0.01536130253225565
a O 0 0.020039139315485954
personal O 0 0.02814480848610401
or O 0 0.017863254994153976
family O 0 0.027633698657155037
history O 0 0.02838774025440216
of O 0 0.04899100214242935
noncolonic O 1 0.9999994039535522
neoplasia B-Disease 1 0.9999996423721313
. O 0 0.07568961381912231

CONCLUSIONS O 0 0.06753326952457428
The O 0 0.057896509766578674
I1307K O 1 0.9999728202819824
APC O 1 0.999994158744812
variant O 0 0.07402636855840683
may O 0 0.0175735242664814
represent O 0 0.016667978838086128
a O 0 0.028499847277998924
susceptibility O 1 0.9996473789215088
gene O 0 0.04853899031877518
for O 0 0.06098546087741852
colorectal B-Disease 1 1.0
, I-Disease 0 0.04548321291804314
or I-Disease 0 0.01738494634628296
other I-Disease 0 0.012618698179721832
, I-Disease 0 0.022577907890081406
cancers I-Disease 1 0.9998136162757874
in O 0 0.02174319513142109
Ashkenazi O 1 0.9998444318771362
Jews O 0 0.05978018045425415
, O 0 0.017975114285945892
and O 0 0.016153745353221893
partially O 0 0.04166089743375778
explains O 0 0.02571818046271801
the O 0 0.015484978444874287
higher O 0 0.026455333456397057
incidence O 1 0.9999991655349731
of O 1 0.9999982118606567
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.429574191570282
European O 0 0.05016913637518883
Israelis O 0 0.07141195982694626
. O 0 0.03827925771474838

Systematic O 0 0.09881656616926193
analysis O 0 0.02815982513129711
of O 0 0.04079730063676834
coproporphyrinogen O 1 0.9999969005584717
oxidase O 1 0.9999994039535522
gene O 0 0.21477004885673523
defects O 1 0.9979758858680725
in O 0 0.03779686242341995
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999994039535522
and O 0 0.06469952315092087
mutation O 0 0.2008618265390396
update O 0 0.09745901823043823
. O 0 0.04272092878818512

Hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.9999998807907104
( O 1 0.8808046579360962
HC B-Disease 1 1.0
) O 0 0.032240696251392365
is O 0 0.021419407799839973
an O 0 0.07150501012802124
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9998984336853027
autosomal O 1 0.9999998807907104
dominant O 1 0.9999967813491821
inheritance O 1 0.9999195337295532
caused O 1 0.9944802522659302
by O 0 0.03517590090632439
deficient B-Disease 1 0.9995654225349426
activity I-Disease 0 0.02713070437312126
of I-Disease 0 0.03217422217130661
coproporphyrinogen I-Disease 1 0.9999992847442627
III I-Disease 1 1.0
oxidase I-Disease 1 0.9999991655349731
( O 0 0.07595677673816681
CPO O 1 0.9986205101013184
) O 0 0.03987337276339531
. O 0 0.0354781411588192

Clinical O 1 0.9919764399528503
manifestations O 1 0.999560534954071
of O 0 0.12162580341100693
the O 1 0.9981574416160583
disease O 1 1.0
are O 0 0.014737805351614952
characterized O 0 0.28381723165512085
by O 0 0.030733902007341385
acute O 1 1.0
attacks O 1 0.9998594522476196
of O 1 0.999997615814209
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.8009701371192932
precipitated O 1 0.9999992847442627
by O 0 0.03491184115409851
drugs O 1 0.8939805030822754
, O 0 0.028444398194551468
fasting O 1 0.9815183281898499
, O 0 0.04011520370841026
cyclical O 1 0.9999927282333374
hormonal O 1 0.999998927116394
changes O 0 0.0361737422645092
, O 0 0.04330864176154137
or O 1 0.995936393737793
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.9725760817527771

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.0638144239783287
also O 0 0.027246735990047455
be O 0 0.017216689884662628
present O 0 0.031071238219738007
. O 0 0.037064727395772934

The O 0 0.039127759635448456
seven O 0 0.03377256542444229
exons O 0 0.07718068361282349
, O 0 0.02102385275065899
the O 0 0.03543580323457718
exon O 1 0.9894105792045593
/ O 1 0.998645007610321
intron O 1 0.9887626767158508
boundaries O 0 0.025119660422205925
and O 0 0.016002802178263664
part O 0 0.021509580314159393
of O 0 0.019448580220341682
3 O 0 0.03511342406272888
noncoding O 0 0.07564451545476913
sequence O 0 0.01604471541941166
of O 0 0.01731088012456894
the O 0 0.0327712781727314
CPO O 1 0.9992915391921997
gene O 0 0.030924702063202858
were O 0 0.011914482340216637
systematically O 0 0.03395940363407135
analyzed O 0 0.017876695841550827
by O 0 0.011098264716565609
an O 0 0.018050245940685272
exon O 0 0.1594851315021515
- O 1 0.7529886960983276
by O 0 0.028822781518101692
- O 1 0.9994495511054993
exon O 1 0.9177730083465576
denaturing O 1 0.999769389629364
gradient O 1 0.999123752117157
gel O 1 0.9999868869781494
electrophoresis O 1 0.9963610768318176
( O 0 0.06113710626959801
DGGE O 1 0.9999628067016602
) O 0 0.030050434172153473
strategy O 0 0.031168494373559952
followed O 0 0.02276652120053768
by O 0 0.014906728640198708
direct O 0 0.025190383195877075
sequencing O 0 0.02716107666492462
in O 0 0.010352805256843567
seven O 0 0.022105319425463676
unrelated O 0 0.05924609303474426
heterozygous O 1 0.6587199568748474
HC B-Disease 1 1.0
patients O 1 0.9999873638153076
from O 0 0.034160614013671875
France O 0 0.31431928277015686
, O 0 0.028497790917754173
Holland O 1 0.7523146271705627
, O 0 0.022244218736886978
and O 0 0.02219877764582634
Czech O 0 0.09583795815706253
Republic O 0 0.07313161343336105
. O 0 0.04471263289451599

Seven O 0 0.056147947907447815
novel O 0 0.08030900359153748
mutations O 0 0.0458180233836174
and O 0 0.018436815589666367
two O 0 0.016166526824235916
new O 0 0.03470467031002045
polymorphisms O 0 0.0886799618601799
were O 0 0.025172146037220955
detected O 0 0.06286241859197617
. O 0 0.037328001111745834

Among O 0 0.049570996314287186
these O 0 0.01815463788807392
mutations O 0 0.02828538417816162
two O 0 0.01251915656030178
are O 0 0.012460626661777496
missense O 0 0.10910257697105408
( O 0 0.042446501553058624
G197W O 1 0.9997590184211731
, O 0 0.03912976756691933
W427R O 1 0.9999376535415649
) O 0 0.020220236852765083
, O 0 0.011517254635691643
two O 0 0.008120052516460419
are O 0 0.00834424514323473
nonsense O 0 0.07774248719215393
( O 0 0.032860659062862396
Q306X O 1 0.999466598033905
, O 0 0.03563576564192772
Q385X O 1 0.9999475479125977
) O 0 0.019843600690364838
, O 0 0.011352618224918842
two O 0 0.0075173587538301945
are O 0 0.0064578489400446415
small O 0 0.018325412645936012
deletions O 0 0.07305530458688736
( O 0 0.04003497585654259
662de14bp O 1 0.9981464147567749
; O 0 0.03910166770219803
1168del3bp O 1 0.9797810316085815
removing O 0 0.07154089212417603
a O 0 0.03540189191699028
glycine O 0 0.08718778192996979
at O 0 0.022019239142537117
position O 0 0.03295367956161499
390 O 0 0.31674808263778687
) O 0 0.018098535016179085
, O 0 0.011545472778379917
and O 0 0.009747990407049656
one O 0 0.01106294896453619
is O 0 0.011806980706751347
a O 0 0.021703006699681282
splicing O 0 0.0548645481467247
mutation O 0 0.04517536237835884
( O 0 0.030027074739336967
IVS1 O 1 0.9998117089271545
- O 1 0.9999713897705078
15c O 1 0.9999724626541138
- O 1 0.9999997615814209
- O 1 0.9999996423721313
> O 1 0.9998144507408142
g O 0 0.0914798155426979
) O 0 0.01855315826833248
which O 0 0.011979843489825726
creates O 0 0.03125986456871033
a O 0 0.023127999156713486
new O 0 0.040673766285181046
acceptor O 1 0.9704912304878235
splice O 0 0.2758480906486511
site O 0 0.0649552121758461
. O 0 0.038233380764722824

The O 0 0.05460601672530174
pathological O 0 0.32659557461738586
significance O 0 0.03279673308134079
of O 0 0.020208556205034256
the O 0 0.024379169568419456
point O 0 0.03895357996225357
mutations O 0 0.04949473962187767
G197W O 1 0.995581328868866
, O 0 0.031877245754003525
W427R O 1 0.9956724643707275
, O 0 0.0173115786164999
and O 0 0.010215147398412228
the O 0 0.014448394067585468
in O 0 0.018013492226600647
- O 1 0.9999610185623169
frame O 0 0.0836803987622261
deletion O 0 0.11634511500597
390delGly O 1 0.9861525297164917
were O 0 0.013657746836543083
assessed O 0 0.024195030331611633
by O 0 0.011315983720123768
their O 0 0.011782122775912285
respective O 0 0.026059050112962723
expression O 0 0.024187589064240456
in O 0 0.01174889039248228
a O 0 0.023974338546395302
prokaryotic O 0 0.06179051473736763
system O 0 0.02743990533053875
using O 0 0.014345232397317886
site O 0 0.04252862185239792
- O 1 0.9855676889419556
directed O 0 0.05465300381183624
mutagenesis O 0 0.12881700694561005
. O 0 0.045104868710041046

These O 0 0.029991474002599716
mutations O 0 0.044353775680065155
resulted O 0 0.02942899614572525
in O 0 0.015307317487895489
the O 0 0.023166561499238014
absence O 0 0.10093139857053757
or O 0 0.020513441413640976
a O 0 0.02679392695426941
dramatic O 0 0.0430845282971859
decrease O 0 0.04950806871056557
of O 0 0.047301191836595535
CPO O 1 0.9999079704284668
activity O 0 0.0640517920255661
. O 0 0.04371238872408867

The O 0 0.04476155713200569
two O 0 0.02591228112578392
polymorphisms O 0 0.0789656862616539
were O 0 0.017758285626769066
localized O 0 0.05976816639304161
in O 0 0.019626136869192123
noncoding O 0 0.07854125648736954
part O 0 0.021889397874474525
of O 0 0.016329951584339142
the O 0 0.02246430702507496
gene O 0 0.02856210060417652
1 O 0 0.029721183702349663
) O 0 0.017352402210235596
a O 0 0.032173749059438705
C O 1 0.9995213747024536
/ O 1 0.9996277093887329
G O 1 0.8973473906517029
polymorphism O 0 0.06365282833576202
in O 0 0.015663376078009605
the O 0 0.02913030982017517
promotor O 1 0.9999403953552246
region O 0 0.04663736745715141
, O 0 0.02541937865316868
142 O 0 0.08018544316291809
bp O 0 0.06517691910266876
upstream O 0 0.032381244003772736
from O 0 0.010666168294847012
the O 0 0.017993280664086342
transcriptional O 0 0.07272936403751373
initiation O 0 0.08733087033033371
site O 0 0.03422088921070099
( O 0 0.03171183168888092
- O 1 0.999985933303833
142C O 1 0.9999983310699463
/ O 1 0.9999983310699463
G O 1 0.999841570854187
) O 0 0.018108611926436424
, O 0 0.01305733248591423
and O 0 0.014048355631530285
2 O 0 0.025694964453577995
) O 0 0.015018606558442116
a O 0 0.02068530023097992
6 O 0 0.04314495995640755
bp O 0 0.07588379085063934
deletion O 0 0.0738883912563324
polymorphism O 0 0.05105649307370186
in O 0 0.013984808698296547
the O 0 0.021145343780517578
3 O 0 0.03485479950904846
noncoding O 0 0.07506746798753738
part O 0 0.02065254934132099
of O 0 0.019794676452875137
the O 0 0.03732140362262726
CPO O 1 0.9996852874755859
gene O 0 0.048279643058776855
, O 0 0.0285046249628067
574 O 1 0.8978667855262756
bp O 0 0.07483452558517456
downstream O 0 0.03361556679010391
of O 0 0.013262400403618813
the O 0 0.015140223316848278
last O 0 0.018331829458475113
base O 0 0.025368377566337585
of O 0 0.014308798126876354
the O 0 0.019835667684674263
normal O 0 0.04432859644293785
termination O 1 0.9993346333503723
codon O 1 0.8914676308631897
( O 0 0.058950167149305344
+ O 1 0.7787614464759827
574 O 1 0.9976855516433716
delATTCTT O 1 0.999692440032959
) O 0 0.04774938151240349
. O 0 0.03801444172859192

Five O 0 0.06484808772802353
intragenic O 1 0.9993776679039001
dimorphisms O 1 0.9987020492553711
are O 0 0.015500331297516823
now O 0 0.020462138578295708
well O 0 0.015837013721466064
characterized O 0 0.03208959475159645
and O 0 0.014173303730785847
the O 0 0.018383799120783806
high O 0 0.03182219713926315
degree O 0 0.02957167662680149
of O 0 0.030210919678211212
allelic O 1 0.9997687935829163
heterogeneity O 1 0.9997932314872742
in O 0 0.036529529839754105
HC B-Disease 1 1.0
is O 0 0.025799976661801338
demonstrated O 0 0.025108255445957184
with O 0 0.010939189232885838
seven O 0 0.014037356711924076
new O 0 0.016065143048763275
different O 0 0.006958609912544489
mutations O 0 0.01742485910654068
making O 0 0.011150456964969635
a O 0 0.012315202504396439
total O 0 0.013605705462396145
of O 0 0.022033846005797386
nineteen O 1 0.9846907258033752
CPO O 1 0.9999995231628418
gene B-Disease 1 0.9135136008262634
defects I-Disease 1 0.9996354579925537
reported O 0 0.0316876582801342
so O 0 0.01968991942703724
far O 0 0.021366264671087265
. O 0 0.02233273722231388
. O 0 0.032783143222332

Coincidence O 0 0.07322747260332108
of O 0 0.025332875549793243
two O 0 0.018528146669268608
novel O 0 0.06282185018062592
arylsulfatase O 1 0.9827149510383606
A O 0 0.060486696660518646
alleles O 0 0.07052220404148102
and O 0 0.030419105663895607
mutation O 0 0.1181555986404419
459 O 1 0.9999816417694092
+ O 1 0.9999727010726929
1G O 1 0.9999979734420776
> O 0 0.12354989349842072
A O 0 0.02874523401260376
within O 0 0.014097187668085098
a O 0 0.020555350929498672
family O 0 0.03484494239091873
with O 0 0.035665709525346756
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 0.05243758112192154
molecular O 0 0.036436036229133606
basis O 0 0.019945576786994934
of O 0 0.031670115888118744
phenotypic O 0 0.11214380711317062
heterogeneity O 1 0.8452796936035156
. O 0 0.061084795743227005

In O 0 0.028027424588799477
a O 0 0.029583826661109924
family O 0 0.029458461329340935
with O 0 0.015223687514662743
three O 0 0.017342055216431618
siblings O 0 0.058161329478025436
, O 0 0.017254643142223358
one O 0 0.015633150935173035
developed O 0 0.022041060030460358
classical O 0 0.03171176835894585
late O 0 0.0692455992102623
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999004602432251
MLD B-Disease 1 1.0
) O 0 0.040848929435014725
, O 0 0.025510545819997787
fatal O 1 0.9990255832672119
at O 0 0.027424702420830727
age O 0 0.025891443714499474
5 O 0 0.021864699199795723
years O 0 0.014640743844211102
, O 0 0.013568121008574963
with O 0 0.01907539553940296
deficient O 1 0.9999901056289673
arylsulfatase O 1 0.9999954700469971
A O 1 0.8888522386550903
( O 0 0.05686313286423683
ARSA O 1 0.9999994039535522
) O 0 0.028149669989943504
activity O 0 0.023534780368208885
and O 0 0.016524426639080048
increased O 0 0.03743826597929001
galactosylsulfatide O 1 0.9999867677688599
( O 0 0.43468722701072693
GS O 1 1.0
) O 0 0.0643545538187027
excretion O 1 0.9708959460258484
. O 0 0.05569099262356758

The O 0 0.03412312641739845
two O 0 0.015366206876933575
other O 0 0.016085272654891014
siblings O 0 0.05796942859888077
, O 0 0.02118237502872944
apparently O 0 0.027462294325232506
healthy O 0 0.04094138741493225
at O 0 0.02119060605764389
12 O 0 0.025803687050938606
( O 0 0.024370303377509117
1 O 0 0.05156616494059563
/ O 1 0.999574601650238
2 O 0 0.0324554368853569
) O 0 0.01422430481761694
and O 0 0.010840555652976036
15 O 0 0.017081577330827713
years O 0 0.015713749453425407
, O 0 0.015621965751051903
respectively O 0 0.01993602141737938
, O 0 0.012948243878781796
and O 0 0.010944608598947525
their O 0 0.012556059285998344
father O 0 0.052755206823349
, O 0 0.022180721163749695
apparently O 0 0.028514817357063293
healthy O 0 0.038952767848968506
as O 0 0.016187943518161774
well O 0 0.012702946551144123
, O 0 0.015745170414447784
presented O 0 0.041610293090343475
ARSA O 1 0.9999997615814209
and O 0 0.04702230542898178
GS O 1 0.9999997615814209
values O 0 0.027662424370646477
within O 0 0.013251683674752712
the O 0 0.01726710796356201
range O 0 0.027052942663431168
of O 0 0.05727476254105568
MLD B-Disease 1 1.0
patients O 1 0.999995231628418
. O 0 0.06348145753145218

Mutation O 0 0.16377384960651398
screening O 0 0.09424526989459991
and O 0 0.026506813243031502
sequence O 0 0.02246280014514923
analysis O 0 0.014320805668830872
disclosed O 0 0.02888314798474312
the O 0 0.015495549887418747
involvement O 0 0.03456436097621918
of O 0 0.0179098192602396
three O 0 0.01853778213262558
different O 0 0.019154813140630722
ARSA O 1 0.9999949932098389
mutations O 0 0.04337169975042343
being O 0 0.0180961936712265
the O 0 0.019647415727376938
molecular O 0 0.025230154395103455
basis O 0 0.017543476074934006
of O 0 0.03451152518391609
intrafamilial O 1 0.9996594190597534
phenotypic O 0 0.3485475182533264
heterogeneity O 1 0.989237368106842
. O 0 0.06104617938399315

The O 0 0.04901767894625664
late O 0 0.1066707894206047
infantile O 1 1.0
patient O 1 0.9999998807907104
inherited O 1 0.999980092048645
from O 0 0.024599382653832436
his O 0 0.03328092768788338
mother O 1 0.6448498368263245
the O 0 0.021777616813778877
frequent O 0 0.04774007573723793
0 O 0 0.07150787860155106
- O 1 0.999861478805542
type O 0 0.06048034131526947
mutation O 0 0.07516162097454071
459 O 1 0.9997110962867737
+ O 1 0.9999401569366455
1G O 1 0.9999992847442627
> O 1 0.9930909872055054
A O 0 0.04170815274119377
, O 0 0.016817769035696983
and O 0 0.010652792640030384
from O 0 0.011339662596583366
his O 0 0.021934952586889267
father O 0 0.050892993807792664
a O 0 0.02564844861626625
novel O 0 0.03741486370563507
, O 0 0.0196416936814785
single O 0 0.039267364889383316
basepair O 1 0.9874182939529419
microdeletion O 1 0.9520754218101501
of O 0 0.03530803322792053
guanine O 0 0.0961846113204956
at O 0 0.029106397181749344
nucleotide O 0 0.039840906858444214
7 O 0 0.02424844540655613
in O 0 0.017063990235328674
exon O 0 0.17891861498355865
1 O 0 0.05933463200926781
( O 0 0.04932127147912979
7delG O 1 0.9948294758796692
) O 0 0.04131408408284187
. O 0 0.03760196641087532

The O 0 0.04472462832927704
two O 0 0.03316302224993706
clinically O 1 0.982864499092102
unaffected O 1 0.5111209154129028
siblings O 0 0.08114106953144073
carried O 0 0.031006667762994766
the O 0 0.03209618851542473
maternal O 1 0.9991115927696228
mutation O 1 0.9241944551467896
459 O 1 0.9999927282333374
+ O 1 0.9999709129333496
1G O 1 0.999998927116394
> O 1 0.9913232326507568
A O 0 0.0432097427546978
and O 0 0.016191404312849045
, O 0 0.012159089557826519
on O 0 0.012373489327728748
their O 0 0.01592818647623062
paternal O 0 0.4423314332962036
allele O 0 0.07137060165405273
, O 0 0.02128538303077221
a O 0 0.02749529480934143
novel O 0 0.05305301025509834
cytosine O 0 0.09768828749656677
to O 0 0.0326513797044754
thymidine O 0 0.28076550364494324
transition O 0 0.05961693823337555
at O 0 0.03659610450267792
nucleotide O 0 0.07678784430027008
2435 O 1 0.9944561123847961
in O 0 0.026843467727303505
exon O 0 0.2530607283115387
8 O 0 0.03989022597670555
, O 0 0.01823938824236393
resulting O 0 0.021849382668733597
in O 0 0.015350356698036194
substitution O 0 0.04906896501779556
of O 0 0.03726264461874962
alanine O 1 0.9908577799797058
464 O 1 0.9988381266593933
by O 0 0.06060367822647095
valine O 1 0.9999161958694458
( O 0 0.06784934550523758
A464V O 1 0.9974135756492615
) O 0 0.047553882002830505
. O 0 0.03869597986340523

The O 0 0.06024524196982384
fathers O 0 0.12087943404912949
genotype O 0 0.17219412326812744
thus O 0 0.03837403282523155
was O 0 0.06610450893640518
7delG O 1 0.9999790191650391
/ O 1 0.9999707937240601
A464V O 1 0.9994338154792786
. O 0 0.0606207549571991

Mutation O 0 0.20809318125247955
A464V O 1 0.9514890313148499
was O 0 0.035628605633974075
not O 0 0.011223755776882172
found O 0 0.010223220102488995
in O 0 0.01193482056260109
18 O 0 0.03910426050424576
unrelated O 1 0.9857288599014282
MLD B-Disease 1 1.0
patients O 1 0.9999868869781494
and O 0 0.03646066412329674
50 O 0 0.04908665642142296
controls O 0 0.06590082496404648
. O 0 0.03932606801390648

A464V O 1 0.952353298664093
, O 0 0.03217696771025658
although O 0 0.021449778228998184
clearly O 0 0.03634129464626312
modifying O 0 0.1445523202419281
ARSA O 1 0.9999997615814209
and O 0 0.11235129088163376
GS O 1 1.0
levels O 0 0.05177200585603714
, O 0 0.023548288270831108
apparently O 0 0.02718122862279415
bears O 0 0.027064958587288857
little O 0 0.02030814252793789
significance O 0 0.02170346863567829
for O 0 0.01945795863866806
clinical O 1 0.995829164981842
manifestation O 1 0.9999992847442627
of O 1 0.998810887336731
MLD B-Disease 1 1.0
, O 0 0.043940361589193344
mimicking O 1 0.5519905090332031
the O 0 0.04044521227478981
frequent O 1 0.5597657561302185
ARSA O 1 0.9999997615814209
pseudodeficiency O 1 0.9999915361404419
allele O 0 0.31128108501434326
. O 0 0.05271103233098984

Our O 0 0.04824814945459366
results O 0 0.021510347723960876
demonstrate O 0 0.024238379672169685
that O 0 0.008519189432263374
in O 0 0.010281603783369064
certain O 0 0.017064053565263748
genetic O 0 0.03712920844554901
conditions O 0 0.2823590040206909
MLD B-Disease 1 1.0
- O 1 0.9999996423721313
like O 0 0.061654020100831985
ARSA O 1 0.9999998807907104
and O 0 0.05775144696235657
GS O 1 0.9999998807907104
values O 0 0.029349688440561295
need O 0 0.015263019129633904
not O 0 0.007382935844361782
be O 0 0.007876616902649403
paralleled O 0 0.05156497284770012
by O 0 0.02874821424484253
clinical O 1 0.9999973773956299
disease O 1 0.9999998807907104
, O 0 0.028353378176689148
a O 0 0.027325274422764778
finding O 0 0.034782253205776215
with O 0 0.025092480704188347
serious O 1 0.99933260679245
diagnostic O 1 0.9999699592590332
and O 0 0.08194408565759659
prognostic O 1 0.9999996423721313
implications O 1 0.8297824859619141
. O 0 0.053868114948272705

Moreover O 0 0.08606395125389099
, O 0 0.036128874868154526
further O 0 0.04758499562740326
ARSA O 1 0.9999891519546509
alleles O 0 0.13318760693073273
functionally O 0 0.10194572806358337
similar O 0 0.025383561849594116
to O 0 0.029111679643392563
A464V O 1 0.9990276098251343
might O 0 0.022688917815685272
exist O 0 0.012534293346107006
which O 0 0.00793097447603941
, O 0 0.008144723251461983
together O 0 0.009402130730450153
with O 0 0.013386448845267296
0 O 0 0.2147282063961029
- O 1 0.9999992847442627
type O 0 0.4634939730167389
mutations O 0 0.03559694066643715
, O 0 0.019949642941355705
may O 0 0.02564781717956066
cause O 1 0.8725308179855347
pathological O 1 0.9999995231628418
ARSA O 1 1.0
and O 1 0.9805237054824829
GS O 1 1.0
levels O 0 0.03702522814273834
, O 0 0.014398613944649696
but O 0 0.009589051827788353
not O 0 0.01144369039684534
clinical O 1 0.9008954763412476
outbreak O 1 0.999944806098938
of O 0 0.053502827882766724
the O 1 0.9977152347564697
disease O 1 1.0
. O 0 0.040394026786088943
. O 0 0.04261312261223793

Human O 1 0.9898125529289246
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999996423721313
to O 1 0.9579477906227112
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9999011754989624
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999486207962036
1 I-Disease 0 0.09002862870693207
. O 0 0.04632360488176346

Heterozygous O 1 0.8875089883804321
germ O 1 0.9999978542327881
- O 1 0.9999874830245972
line O 0 0.05938625708222389
mutations O 0 0.028370577841997147
in O 0 0.012520890682935715
the O 0 0.022464193403720856
DNA O 0 0.05423372611403465
mismatch O 1 0.9997908473014832
repair O 1 0.9849843978881836
genes O 0 0.027420759201049805
lead O 0 0.03501689434051514
to O 0 0.04245362803339958
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.996353030204773

The O 0 0.3045606315135956
disease O 1 1.0
susceptibility O 1 0.9999953508377075
of O 0 0.08689268678426743
individuals O 0 0.02743188850581646
who O 0 0.03178887069225311
constitutionally O 0 0.4024268686771393
lack O 0 0.028617920354008675
both O 0 0.01666085235774517
wild O 0 0.05065709352493286
- O 1 0.9999990463256836
type O 1 0.6282685399055481
alleles O 0 0.06833072751760483
is O 0 0.02526899054646492
unknown O 0 0.03966444358229637
. O 0 0.03447387367486954

We O 0 0.022819748148322105
have O 0 0.010026326403021812
identified O 0 0.01419552881270647
three O 0 0.008799402043223381
offspring O 0 0.03115706890821457
in O 0 0.012382479384541512
a O 0 0.033748824149370193
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999967813491821
who O 1 0.9865120649337769
developed O 1 0.9724986553192139
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.07125616818666458
a O 0 0.023244142532348633
very O 0 0.014588418416678905
early O 0 0.021699924021959305
age O 0 0.025038864463567734
, O 0 0.015115556307137012
and O 0 0.011513791047036648
at O 0 0.013171062804758549
least O 0 0.008757490664720535
two O 0 0.006039132829755545
of O 0 0.01033871527761221
them O 0 0.009728171862661839
displayed O 0 0.025526344776153564
signs O 0 0.038751859217882156
of O 0 0.0519283190369606
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.999914288520813
1 I-Disease 1 0.8288525938987732
( O 0 0.06584962457418442
NF1 B-Disease 1 0.9999690055847168
) O 0 0.04152287170290947
. O 0 0.03687451034784317

DNA O 0 0.06365905702114105
sequence O 0 0.0287033598870039
analysis O 0 0.017921876162290573
and O 0 0.02125924453139305
allele O 0 0.09586190432310104
- O 1 0.986659049987793
specific O 0 0.022097649052739143
amplification O 0 0.04979788884520531
in O 0 0.011598442681133747
two O 0 0.011800941079854965
siblings O 0 0.04911700263619423
revealed O 0 0.032139502465724945
a O 0 0.031715646386146545
homozygous O 0 0.12683525681495667
MLH1 O 1 0.999997615814209
mutation O 0 0.09776552021503448
( O 0 0.04132752865552902
C676T O 1 0.9999715089797974
- O 1 0.9999998807907104
- O 1 0.9999992847442627
> O 1 0.9995074272155762
Arg226Stop O 1 0.9989228844642639
) O 0 0.04020623490214348
. O 0 0.03534843400120735

Thus O 0 0.03593945503234863
, O 0 0.01774870604276657
a O 0 0.027715353295207024
homozygous O 0 0.10282287001609802
germ O 1 0.9999963045120239
- O 1 0.9999947547912598
line O 0 0.10266001522541046
MLH1 O 1 0.9999977350234985
mutation O 0 0.08361051976680756
and O 0 0.036468930542469025
consequent O 1 0.9999995231628418
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.028050577268004417
in O 0 0.01922592706978321
a O 0 0.04105062037706375
mutator O 1 0.9999992847442627
phenotype O 1 0.9979154467582703
characterized O 0 0.3708283603191376
by O 0 0.0677543357014656
leukemia B-Disease 1 1.0
and O 1 0.999756395816803
/ O 1 1.0
or O 1 0.9997511506080627
lymphoma B-Disease 1 1.0
associated O 1 0.9889849424362183
with O 1 0.9723271727561951
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999294281005859
1 I-Disease 0 0.08203999698162079
. O 0 0.023480629548430443
. O 0 0.02913215197622776

Missense O 1 0.5200628042221069
mutations O 0 0.05598751828074455
in O 0 0.01611161045730114
the O 0 0.018782200291752815
most O 0 0.014435350894927979
ancient O 0 0.025973806157708168
residues O 0 0.0311734601855278
of O 0 0.018549716100096703
the O 0 0.03599152714014053
PAX6 O 1 0.9999998807907104
paired O 0 0.28210291266441345
domain O 0 0.05357765778899193
underlie O 0 0.07202737778425217
a O 0 0.024684224277734756
spectrum O 0 0.04425768926739693
of O 0 0.04818805307149887
human O 1 0.9999985694885254
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9362656474113464

Mutations O 0 0.0555746965110302
of O 0 0.02137829177081585
the O 0 0.02840525470674038
human O 0 0.053526829928159714
PAX6 O 1 0.9999998807907104
gene O 1 0.6353691220283508
underlie O 1 0.9999933242797852
aniridia B-Disease 1 1.0
( O 1 0.9983555674552917
congenital B-Disease 1 1.0
absence I-Disease 1 0.9982865452766418
of I-Disease 0 0.05977773666381836
the I-Disease 0 0.24793602526187897
iris I-Disease 1 0.9999983310699463
) O 0 0.020323891192674637
, O 0 0.012243189848959446
a O 0 0.01854289323091507
rare O 0 0.037946123629808426
dominant O 1 0.9995997548103333
malformation B-Disease 1 1.0
of I-Disease 0 0.47249850630760193
the I-Disease 1 0.9461639523506165
eye I-Disease 1 0.9999964237213135
. O 0 0.04939718171954155

The O 0 0.04903457686305046
spectrum O 0 0.06232775002717972
of O 0 0.04889138415455818
PAX6 O 1 0.9999998807907104
mutations O 0 0.0796746015548706
in O 0 0.03810085356235504
aniridia B-Disease 1 1.0
patients O 1 0.9999927282333374
is O 0 0.02613520808517933
highly O 0 0.03716303035616875
biased O 0 0.046251289546489716
, O 0 0.014043197967112064
with O 0 0.013662179931998253
92 O 0 0.04632159322500229
% O 0 0.015885058790445328
of O 0 0.01312822476029396
all O 0 0.013278422877192497
reported O 0 0.02732735686004162
mutations O 0 0.03314334526658058
leading O 0 0.03545708581805229
to O 0 0.02414989471435547
premature O 1 0.9427064061164856
truncation O 0 0.12508395314216614
of O 0 0.024990584701299667
the O 0 0.03271834924817085
protein O 0 0.04098587855696678
( O 0 0.023002980276942253
nonsense O 0 0.06657275557518005
, O 0 0.02330082468688488
splicing O 0 0.051567237824201584
, O 0 0.021375907585024834
insertions O 0 0.09269286692142487
and O 0 0.025416899472475052
deletions O 0 0.06756868958473206
) O 0 0.019394727423787117
and O 0 0.01472307089716196
just O 0 0.018125027418136597
2 O 0 0.025787215679883957
% O 0 0.016857972368597984
leading O 0 0.027408692985773087
to O 0 0.015749383717775345
substitution O 0 0.03557921200990677
of O 0 0.019087355583906174
one O 0 0.02516762539744377
amino O 0 0.04124976694583893
acid O 0 0.04451260715723038
by O 0 0.021622462198138237
another O 0 0.039115555584430695
( O 0 0.042843617498874664
missense O 0 0.3668087124824524
) O 0 0.03991073742508888
. O 0 0.037765659391880035

The O 0 0.03663782775402069
extraordinary O 0 0.04623454809188843
conservation O 0 0.036225561052560806
of O 0 0.023661332204937935
the O 0 0.03903496637940407
PAX6 O 1 0.9999998807907104
protein O 0 0.04316651076078415
at O 0 0.019772743806242943
the O 0 0.024239132180809975
amino O 0 0.043010562658309937
acid O 0 0.04947208613157272
level O 0 0.029066644608974457
amongst O 0 0.04955574870109558
vertebrates O 0 0.07109155505895615
predicts O 0 0.06920655816793442
that O 0 0.02153748832643032
pathological O 1 0.9973199963569641
missense O 1 0.9991927742958069
mutations O 0 0.04974035173654556
should O 0 0.01586149074137211
in O 0 0.01252004224807024
fact O 0 0.017218949273228645
be O 0 0.011587625369429588
common O 0 0.01760260947048664
even O 0 0.014197863638401031
though O 0 0.010895182378590107
they O 0 0.007108802907168865
are O 0 0.007312550209462643
hardly O 0 0.030561504885554314
ever O 0 0.025280442088842392
seen O 0 0.030478963628411293
in O 0 0.03357416018843651
aniridia B-Disease 1 0.9999995231628418
patients O 1 0.9999388456344604
. O 0 0.06275980919599533

This O 0 0.029824919998645782
indicates O 0 0.03584061563014984
that O 0 0.009995841421186924
there O 0 0.010051505640149117
is O 0 0.0128328250721097
a O 0 0.02265274152159691
heavy O 0 0.1078042984008789
ascertainment O 1 0.9999961853027344
bias O 0 0.06656309962272644
in O 0 0.014715264551341534
the O 0 0.015708640217781067
selection O 0 0.024218201637268066
of O 0 0.02652270533144474
patients O 1 0.9995179176330566
for O 0 0.05199095234274864
PAX6 O 1 1.0
mutation O 0 0.15620018541812897
analysis O 0 0.01771322637796402
and O 0 0.010450391098856926
that O 0 0.007927212864160538
the O 0 0.020349711179733276
missing O 0 0.07237789034843445
PAX6 O 1 0.9999992847442627
missense O 1 0.9967159032821655
mutations O 0 0.07866346091032028
frequently O 0 0.04631974920630455
may O 0 0.04077295586466789
underlie O 1 0.6894080638885498
phenotypes O 0 0.12394464015960693
distinct O 0 0.041682470589876175
from O 0 0.04212449863553047
textbook O 1 0.999492883682251
aniridia B-Disease 1 0.9999951124191284
. O 0 0.06963115930557251

Here O 0 0.030536238104104996
we O 0 0.012545203790068626
present O 0 0.01631508581340313
four O 0 0.019569415599107742
novel O 0 0.07865659147500992
PAX6 O 1 0.9999990463256836
missense O 1 0.9951139092445374
mutations O 0 0.04888099431991577
, O 0 0.015728214755654335
two O 0 0.009492750279605389
in O 0 0.012190664187073708
association O 0 0.030558288097381592
with O 0 0.03034479171037674
atypical O 1 0.9999985694885254
phenotypes O 1 0.9999409914016724
ectopia B-Disease 1 0.9999986886978149
pupillae I-Disease 1 0.9999978542327881
( O 0 0.042952198535203934
displaced B-Disease 0 0.18143153190612793
pupils I-Disease 1 0.9151902198791504
) O 0 0.04408833011984825
and O 1 0.6095590591430664
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 1 0.6712125539779663
searching B-Disease 0 0.402713805437088
gaze I-Disease 1 0.9996353387832642
) O 0 0.02055712789297104
, O 0 0.011076871305704117
and O 0 0.008507874794304371
two O 0 0.007348010316491127
in O 0 0.010360771790146828
association O 0 0.021114181727170944
with O 0 0.014163094572722912
more O 0 0.01816629245877266
recognizable O 1 0.9909716844558716
aniridia B-Disease 1 0.9999980926513672
phenotypes O 1 0.9158698916435242
. O 0 0.05653183162212372

Strikingly O 0 0.1044359877705574
, O 0 0.023429403081536293
all O 0 0.014378489926457405
four O 0 0.020387399941682816
mutations O 0 0.027013210579752922
are O 0 0.007395672611892223
located O 0 0.022876858711242676
within O 0 0.016236938536167145
the O 0 0.03254611790180206
PAX6 O 1 0.9999996423721313
paired O 1 0.7536123394966125
domain O 0 0.04835391417145729
and O 0 0.022332165390253067
affect O 0 0.03466041758656502
amino O 0 0.04243423417210579
acids O 0 0.028137044981122017
which O 0 0.010716704651713371
are O 0 0.006558349821716547
highly O 0 0.02245229296386242
conserved O 0 0.02483564242720604
in O 0 0.011884207837283611
all O 0 0.01584642380475998
known O 0 0.04205774888396263
paired O 0 0.1113898828625679
domain O 0 0.07553142309188843
proteins O 0 0.049316685646772385
. O 0 0.03521806001663208

Our O 0 0.04519248753786087
results O 0 0.018192527815699577
support O 0 0.02233743853867054
the O 0 0.019963910803198814
hypothesis O 0 0.028403274714946747
that O 0 0.006776959169656038
the O 0 0.011270992457866669
under O 0 0.023599078878760338
- O 1 0.9354804754257202
representation O 0 0.027555428445339203
of O 0 0.02493239752948284
missense O 1 0.9792393445968628
mutations O 0 0.04420851916074753
is O 0 0.021441472694277763
caused O 0 0.04013906419277191
by O 0 0.03391565755009651
ascertainment O 1 0.9999998807907104
bias O 1 0.819013774394989
and O 0 0.02062171697616577
suggest O 0 0.014859223738312721
that O 0 0.006496229209005833
a O 0 0.012483460828661919
substantial O 0 0.023296480998396873
burden O 0 0.200157031416893
of O 0 0.06917668133974075
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.9968999624252319
disease I-Disease 1 0.9999998807907104
remains O 0 0.3863780200481415
to O 0 0.02426227554678917
be O 0 0.017644090577960014
uncovered O 0 0.05046463757753372
. O 0 0.021771952509880066
. O 0 0.0313202328979969

The O 0 0.05619874224066734
chromosomal O 0 0.11873795837163925
order O 0 0.03227905184030533
of O 0 0.025031454861164093
genes O 0 0.02616528607904911
controlling O 0 0.04363318905234337
the O 0 0.027231238782405853
major O 1 0.6721439361572266
histocompatibility O 1 1.0
complex O 0 0.10513807088136673
, O 0 0.02750292606651783
properdin O 1 0.9997283816337585
factor O 1 0.9172199964523315
B O 1 0.9999628067016602
, O 0 0.025932712480425835
and O 0 0.028780054301023483
deficiency B-Disease 1 1.0
of I-Disease 0 0.025155281648039818
the I-Disease 0 0.02961253747344017
second I-Disease 0 0.08404505997896194
component I-Disease 0 0.09887318313121796
of I-Disease 0 0.031782377511262894
complement I-Disease 0 0.08384924381971359
. O 0 0.04074639454483986

The O 0 0.038073256611824036
relationship O 0 0.03930150344967842
of O 0 0.02325073815882206
the O 0 0.030774539336562157
genes O 0 0.03436996415257454
coding O 0 0.058280713856220245
for O 0 0.03268156945705414
HLA O 1 0.9999992847442627
to O 0 0.025915583595633507
those O 0 0.016164053231477737
coding O 0 0.04355138912796974
for O 0 0.02122713066637516
properdin O 1 0.9945047497749329
Factor O 1 0.6100521087646484
B O 1 0.9999617338180542
allotypes O 1 0.9997475743293762
and O 0 0.024929556995630264
for O 0 0.030761057510972023
deficiency B-Disease 1 1.0
of I-Disease 0 0.024648098275065422
the I-Disease 0 0.0228867344558239
second I-Disease 0 0.03592216596007347
component I-Disease 0 0.04747705161571503
of I-Disease 0 0.02597292698919773
complement I-Disease 1 0.9313908219337463
( O 0 0.05409443378448486
C2 O 1 0.9999998807907104
) O 0 0.020256176590919495
was O 0 0.017485735937952995
studied O 0 0.013186498545110226
in O 0 0.007720286957919598
families O 0 0.017096485942602158
of O 0 0.026830919086933136
patients O 1 0.9999978542327881
with O 1 0.9999264478683472
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9647720456123352

Patients O 1 0.9903268218040466
were O 0 0.02075444906949997
selected O 0 0.026752278208732605
because O 0 0.01418299600481987
they O 0 0.007709971163421869
were O 0 0.0115921376273036
heterozygous O 0 0.05434896796941757
or O 0 0.02724245935678482
homozygous O 0 0.24418598413467407
for O 1 0.9775585532188416
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.861289918422699

12 O 0 0.04434841871261597
families O 0 0.03029550053179264
with O 0 0.01878375932574272
15 O 0 0.03695475310087204
matings O 1 0.7746086120605469
informative O 0 0.23797757923603058
for O 1 0.9481823444366455
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.044889505952596664
found O 0 0.03383474424481392
. O 0 0.03557144105434418

Of O 0 0.05467407777905464
57 O 0 0.09478185325860977
informative O 0 0.10241713374853134
meioses O 1 0.9595829844474792
, O 0 0.020773138850927353
two O 0 0.012493623420596123
crossovers O 0 0.042175110429525375
were O 0 0.008377528749406338
noted O 0 0.011670471169054508
between O 0 0.01864088885486126
the O 1 0.7161074280738831
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.09106381982564926
and O 0 0.018091022968292236
the O 0 0.058334995061159134
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999963045120239
gene O 0 0.028653915971517563
, O 0 0.011289245449006557
with O 0 0.01161379273980856
a O 0 0.023112494498491287
recombinant O 0 0.07308980822563171
fraction O 0 0.04622546210885048
of O 0 0.03302597254514694
0 O 0 0.07427223771810532
. O 0 0.04092949256300926

035 O 1 0.9877375364303589
. O 0 0.08721468597650528

A O 0 0.09879448264837265
lod O 1 0.996590256690979
score O 0 0.03286401554942131
of O 0 0.020199554041028023
13 O 0 0.023729195818305016
was O 0 0.02098659612238407
calculated O 0 0.01815617084503174
for O 0 0.0163990780711174
linkage O 0 0.1747475564479828
between O 0 0.3303937613964081
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999737739562988
HLA O 1 1.0
- O 1 1.0
B O 1 0.999976634979248
at O 0 0.023263277485966682
a O 0 0.017308365553617477
maximum O 0 0.019167128950357437
likelihood O 0 0.02347348816692829
value O 0 0.009094652719795704
of O 0 0.011480993591248989
the O 0 0.020036572590470314
recombinant O 0 0.06910374015569687
fraction O 0 0.04057030752301216
of O 0 0.03053683415055275
0 O 0 0.07149334251880646
. O 0 0.039107467979192734

04 O 1 0.950842559337616
. O 0 0.07282360643148422

18 O 0 0.05297835171222687
families O 0 0.035738103091716766
with O 0 0.023817256093025208
21 O 0 0.047627028077840805
informative O 0 0.06610586494207382
matings O 0 0.09193437546491623
for O 0 0.019606806337833405
both O 0 0.023803450167179108
properdin O 1 0.999241828918457
Factor O 1 0.6034983396530151
B O 1 0.9996465444564819
allotype O 1 0.9994961023330688
and O 0 0.05544007569551468
HLA O 1 1.0
- O 1 0.9999998807907104
B O 1 0.9995716214179993
were O 0 0.021293943747878075
found O 0 0.022982390597462654
. O 0 0.02855740301311016

Of O 0 0.05436324328184128
72 O 0 0.09452826529741287
informative O 0 0.10366970300674438
meioses O 1 0.9894657135009766
, O 0 0.02258230373263359
three O 0 0.019795052707195282
recombinants O 1 0.859995424747467
were O 0 0.013656591065227985
found O 0 0.01187483873218298
, O 0 0.011434233747422695
giving O 0 0.01735902950167656
a O 0 0.02553628943860531
recombinant O 0 0.07431523501873016
fraction O 0 0.04544821381568909
of O 0 0.03486097604036331
0 O 0 0.07856757193803787
. O 0 0.0398910827934742

042 O 1 0.9495640993118286
. O 0 0.08586128801107407

A O 0 0.09544212371110916
lod O 1 0.960275411605835
score O 0 0.02898559346795082
of O 0 0.019991649314761162
16 O 0 0.032220155000686646
between O 0 0.045237038284540176
HLA O 1 1.0
- O 1 0.9999998807907104
B O 1 0.9998912811279297
and O 0 0.03220111504197121
Factor O 1 0.7728511095046997
B O 1 0.9999171495437622
allotypes O 1 0.999283492565155
was O 0 0.0291596706956625
calculated O 0 0.02058660425245762
at O 0 0.016074908897280693
a O 0 0.015608384273946285
maximum O 0 0.02100503258407116
likelihood O 0 0.027331069111824036
value O 0 0.011458524502813816
of O 0 0.013700711540877819
the O 0 0.02492659166455269
recombinant O 0 0.08121071010828018
fraction O 0 0.0451996885240078
of O 0 0.03252599015831947
0 O 0 0.07116039097309113
. O 0 0.04075038060545921

04 O 1 0.9115797281265259
. O 0 0.0816819965839386

A O 0 0.07429983466863632
crossover O 0 0.10209539532661438
was O 0 0.03523218631744385
shown O 0 0.016483435407280922
to O 0 0.011244062334299088
have O 0 0.00671433936804533
occurred O 0 0.015049425885081291
between O 0 0.012803277000784874
genes O 0 0.013541189953684807
for O 0 0.012955877929925919
Factor O 0 0.0581333264708519
B O 1 0.9998254179954529
and O 0 0.04328778758645058
HLA O 1 1.0
- O 1 1.0
D O 1 0.9998726844787598
, O 0 0.013760882429778576
in O 0 0.009943025186657906
which O 0 0.019774701446294785
HLA O 1 1.0
- O 1 0.9999994039535522
D O 1 0.9999784231185913
segregared O 1 0.998353123664856
with O 0 0.04139062389731407
HLA O 1 1.0
- O 1 0.9999982118606567
A O 0 0.06518299132585526
and O 0 0.037736233323812485
B O 1 0.999453604221344
. O 0 0.04144897311925888

These O 0 0.024910351261496544
studies O 0 0.020383739843964577
suggest O 0 0.015155375935137272
that O 0 0.007068702485412359
the O 0 0.012893633916974068
genes O 0 0.015133528038859367
for O 0 0.01608799770474434
Factor O 1 0.9949553608894348
B O 1 0.9999998807907104
and O 1 0.99974125623703
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.017926232889294624
located O 0 0.03186311945319176
outside O 0 0.019073201343417168
those O 0 0.011015736497938633
for O 0 0.025137441232800484
HLA O 1 1.0
, O 0 0.01639617048203945
that O 0 0.006454960908740759
the O 0 0.00911515299230814
order O 0 0.013690032064914703
of O 0 0.016597675159573555
genese O 1 0.9970716238021851
is O 0 0.03525950014591217
HLA O 1 1.0
- O 1 0.9998118281364441
A O 0 0.03576510772109032
, O 0 0.022288626059889793
- O 1 0.9999172687530518
B O 1 0.9991457462310791
, O 0 0.024042977020144463
- O 1 0.9999914169311523
D O 1 0.9998292922973633
, O 0 0.02125452645123005
Factor O 0 0.11617117375135422
B O 1 0.9999921321868896
allotype O 1 0.9999985694885254
, O 1 0.9968308806419373
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.028331713750958443
that O 0 0.01121541392058134
the O 0 0.018947744742035866
genes O 0 0.0272232573479414
coding O 0 0.05750235170125961
for O 0 0.0529080405831337
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.8807618021965027
Factor O 1 0.9999700784683228
B O 1 0.9999958276748657
allotypes O 1 0.9723653197288513
are O 0 0.007202497683465481
approximately O 0 0.01232488639652729
3 O 0 0.030449453741312027
- O 1 0.999886155128479
- O 1 0.9819878935813904
5 O 0 0.025243667885661125
centimorgans O 0 0.0689384788274765
from O 0 0.01395809929817915
the O 0 0.02680317685008049
HLA O 1 1.0
- O 1 0.999936580657959
A O 0 0.04378914833068848
and O 0 0.03793101757764816
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999998807907104
loci O 0 0.12497343868017197
, O 0 0.01599634625017643
and O 0 0.010653786361217499
that O 0 0.0077824583277106285
the O 0 0.014133092947304249
apparent O 0 0.03749345242977142
lack O 0 0.024356890469789505
of O 0 0.021633446216583252
recombinants O 1 0.993767499923706
between O 0 0.01759604550898075
the O 0 0.02204219624400139
Factor O 1 0.7006781697273254
B O 1 0.9999877214431763
gene O 0 0.06372544169425964
and O 1 0.6658355593681335
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.8467555046081543
suggests O 0 0.029954150319099426
that O 0 0.008981463499367237
these O 0 0.006441343110054731
two O 0 0.010670551098883152
genes O 0 0.021439753472805023
lie O 0 0.03501151129603386
in O 0 0.013712132349610329
close O 0 0.027936289086937904
proximity O 0 0.04290803521871567
to O 0 0.01855960488319397
one O 0 0.020576078444719315
another O 0 0.03529604896903038
. O 0 0.0362517423927784

Distribution O 0 0.05167992785573006
of O 0 0.03909483924508095
emerin O 1 0.9995808005332947
and O 0 0.034619685262441635
lamins O 1 0.9993002414703369
in O 0 0.02122408151626587
the O 0 0.03389599919319153
heart O 1 0.9999816417694092
and O 0 0.021848011761903763
implications O 0 0.03947679325938225
for O 0 0.02658887393772602
Emery B-Disease 1 0.9999982118606567
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.1222897469997406

Emerin O 1 0.975127100944519
is O 0 0.030519265681505203
a O 0 0.033805932849645615
nuclear O 0 0.06929122656583786
membrane O 0 0.4358008801937103
protein O 0 0.029552726075053215
which O 0 0.010879053734242916
is O 0 0.012902956455945969
missing O 0 0.024786891415715218
or O 0 0.01743990369141102
defective O 1 0.6543369293212891
in O 0 0.023212846368551254
Emery B-Disease 1 0.9999942779541016
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999871253967285
EDMD B-Disease 1 1.0
) O 0 0.05452616885304451
. O 0 0.03914779797196388

It O 0 0.020581340417265892
is O 0 0.015022619627416134
one O 0 0.010270264931023121
member O 0 0.017058871686458588
of O 0 0.011719423346221447
a O 0 0.01697600446641445
family O 0 0.0288106556981802
of O 0 0.03592033311724663
lamina O 1 1.0
- O 1 0.9999997615814209
associated O 0 0.03156524524092674
proteins O 0 0.02017766609787941
which O 0 0.01046686340123415
includes O 0 0.024701515212655067
LAP1 O 1 0.9988884329795837
, O 0 0.03269083425402641
LAP2 O 1 0.9998996257781982
and O 0 0.04618929699063301
lamin O 1 0.9999996423721313
B O 1 0.9999996423721313
receptor O 1 0.9999681711196899
( O 0 0.0773472785949707
LBR O 1 0.9999943971633911
) O 0 0.04254782572388649
. O 0 0.03663986548781395

A O 0 0.058301858603954315
panel O 0 0.045062627643346786
of O 0 0.0293357465416193
16 O 0 0.06426531821489334
monoclonal O 1 0.9999637603759766
antibodies O 1 0.9997665286064148
( O 0 0.06665028631687164
mAbs O 1 0.9990977048873901
) O 0 0.030365975573658943
has O 0 0.017210381105542183
been O 0 0.013428810983896255
mapped O 0 0.029537519440054893
to O 0 0.012370669282972813
six O 0 0.012752420268952847
specific O 0 0.010870620608329773
sites O 0 0.013440603390336037
throughout O 0 0.013085555285215378
the O 0 0.023418275639414787
emerin O 1 0.9977160692214966
molecule O 0 0.0586630143225193
using O 0 0.02438124641776085
phage O 1 0.9995591044425964
- O 1 0.9990860223770142
displayed O 0 0.05092616751790047
peptide O 0 0.0778442919254303
libraries O 0 0.03288695216178894
and O 0 0.01612701267004013
has O 0 0.013312427327036858
been O 0 0.011835937388241291
used O 0 0.010679902508854866
to O 0 0.0184317696839571
localize O 1 0.8169682025909424
emerin O 1 0.9954923391342163
in O 0 0.02272830344736576
human O 0 0.03615409508347511
and O 0 0.04316240921616554
rabbit O 1 0.9999862909317017
heart O 1 0.9999977350234985
. O 0 0.060147739946842194

Several O 0 0.04849938675761223
mAbs O 0 0.2129831463098526
against O 0 0.0446341298520565
different O 0 0.020593171939253807
emerin O 1 0.9937291145324707
epitopes O 1 0.8547104001045227
did O 0 0.022828543558716774
not O 0 0.014840276911854744
recognize O 0 0.048495784401893616
intercalated O 1 0.9998005032539368
discs O 0 0.05605797842144966
in O 0 0.018564071506261826
the O 0 0.03491223603487015
heart O 1 0.9999967813491821
, O 0 0.020210402086377144
though O 0 0.012489628978073597
they O 0 0.008449845016002655
recognized O 0 0.033114489167928696
cardiomyocyte O 1 0.9999172687530518
nuclei O 0 0.10284382104873657
strongly O 0 0.02664659358561039
, O 0 0.013347246684134007
both O 0 0.010495953261852264
at O 0 0.016747772693634033
the O 0 0.022758860141038895
rim O 0 0.10901512205600739
and O 0 0.019360912963747978
in O 0 0.023164108395576477
intranuclear O 1 0.9999198913574219
spots O 0 0.08090510964393616
or O 0 0.03163653984665871
channels O 0 0.04105568677186966
. O 0 0.032939039170742035

A O 0 0.13588277995586395
polyclonal O 1 0.9991095662117004
rabbit O 1 0.9941607117652893
antiserum O 1 0.9931315779685974
against O 0 0.06974724680185318
emerin O 1 0.996440589427948
did O 0 0.029089752584695816
recognize O 0 0.03581899031996727
both O 0 0.018882857635617256
nuclear O 0 0.06315307319164276
membrane O 0 0.10780663043260574
and O 0 0.0312582328915596
intercalated O 1 0.9999635219573975
discs O 0 0.06485407054424286
but O 0 0.014765658415853977
, O 0 0.014446196146309376
after O 0 0.02498181350529194
affinity O 0 0.05515419691801071
purification O 0 0.20056605339050293
against O 0 0.031079363077878952
a O 0 0.03316601738333702
pure O 0 0.08479085564613342
- O 1 0.9998148083686829
emerin O 1 0.9827752709388733
band O 0 0.04285707697272301
on O 0 0.014622441492974758
a O 0 0.019296960905194283
western O 0 0.030537905171513557
blot O 1 0.9838926792144775
, O 0 0.020225433632731438
it O 0 0.014126391150057316
stained O 1 0.9951186180114746
only O 0 0.01747776009142399
the O 0 0.028388934209942818
nuclear O 0 0.0710933730006218
membrane O 0 0.0952436774969101
. O 0 0.03940145671367645

These O 0 0.021728474646806717
results O 0 0.01720157451927662
would O 0 0.011142941191792488
not O 0 0.008162354119122028
be O 0 0.007927831262350082
expected O 0 0.015306102111935616
if O 0 0.02008921653032303
immunostaining O 1 0.9972147345542908
at O 0 0.053417839109897614
intercalated O 1 0.9998863935470581
discs O 0 0.05185844004154205
were O 0 0.011539755389094353
due O 0 0.014832756482064724
to O 0 0.011676467023789883
a O 0 0.01532171294093132
product O 0 0.015733055770397186
of O 0 0.014469949528574944
the O 0 0.028078952804207802
emerin O 1 0.9999935626983643
gene O 0 0.04166807234287262
and O 0 0.018812039867043495
, O 0 0.016972431913018227
therefore O 0 0.015674607828259468
, O 0 0.011287296190857887
cast O 0 0.01687448099255562
some O 0 0.007503865752369165
doubt O 0 0.021059611812233925
upon O 0 0.016815025359392166
the O 0 0.018307814374566078
hypothesis O 0 0.0466095395386219
that O 0 0.02512768842279911
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999998807907104
in O 1 0.5994520783424377
EDMD B-Disease 1 1.0
are O 0 0.014916968531906605
caused O 0 0.03097548894584179
by O 0 0.01755698397755623
absence O 0 0.04746253043413162
of O 0 0.04227630794048309
emerin O 1 0.999984622001648
from O 0 0.05660513788461685
intercalated O 1 0.9999120235443115
discs O 0 0.12396463751792908
. O 0 0.05272633209824562

Although O 0 0.048575494438409805
emerin O 1 0.8334835767745972
was O 0 0.03569721058011055
abundant O 0 0.031086888164281845
in O 0 0.012714480981230736
the O 0 0.02157869003713131
membranes O 0 0.06876625120639801
of O 0 0.03428468108177185
cardiomyocyte O 1 0.9999997615814209
nuclei O 1 0.8758763074874878
, O 0 0.01652698405086994
it O 0 0.008743643760681152
was O 0 0.018148155882954597
absent O 0 0.028725245967507362
from O 0 0.009921935386955738
many O 0 0.011340678669512272
non O 1 0.9745745062828064
- O 1 0.9999998807907104
myocyte O 1 0.9999996423721313
cells O 0 0.05020005628466606
in O 0 0.020074479281902313
the O 0 0.04196062684059143
heart O 1 0.9999284744262695
. O 0 0.052877627313137054

This O 0 0.022222381085157394
distribution O 0 0.025881607085466385
of O 0 0.02568204700946808
emerin O 1 0.999342143535614
was O 0 0.027030490338802338
similar O 0 0.01088031567633152
to O 0 0.009782111272215843
that O 0 0.0071793352253735065
of O 0 0.02036174014210701
lamin O 1 0.9998621940612793
A O 0 0.04239760339260101
, O 0 0.016632111743092537
a O 0 0.02109058015048504
candidate O 0 0.03615918010473251
gene O 0 0.02474561519920826
for O 0 0.01359264925122261
an O 0 0.024448039010167122
autosomal O 1 0.9606049656867981
form O 0 0.04297160729765892
of O 0 0.1240682378411293
EDMD B-Disease 1 1.0
. O 0 0.07076394557952881

In O 0 0.0417567640542984
contrast O 0 0.058014556765556335
, O 0 0.051190510392189026
lamin O 1 0.9999972581863403
B1 O 1 0.9999998807907104
was O 0 0.058184850960969925
absent O 0 0.07763758301734924
from O 0 0.03671756014227867
cardiomyocyte O 1 0.9998970031738281
nuclei O 0 0.07876555621623993
, O 0 0.020944489166140556
showing O 0 0.029357872903347015
that O 0 0.026376506313681602
lamin O 1 0.9999991655349731
B1 O 1 1.0
is O 0 0.025614388287067413
not O 0 0.01204890850931406
essential O 0 0.02594255469739437
for O 0 0.01662844605743885
localization O 0 0.061953894793987274
of O 0 0.029831646010279655
emerin O 1 0.909482479095459
to O 0 0.024894719943404198
the O 0 0.03593439608812332
nuclear O 0 0.10751235485076904
lamina O 1 0.9999572038650513
. O 0 0.05571471527218819

Lamin O 1 0.9999978542327881
B1 O 1 0.9999997615814209
is O 0 0.03679046034812927
also O 0 0.017146049067378044
almost O 0 0.020362792536616325
completely O 0 0.04122466221451759
absent O 0 0.09374644607305527
from O 0 0.05208246409893036
skeletal O 1 0.9999996423721313
muscle O 1 0.9999979734420776
nuclei O 1 0.9913791418075562
. O 0 0.059836290776729584

In O 0 0.05682091414928436
EDMD B-Disease 1 0.9999964237213135
, O 0 0.019860658794641495
the O 0 0.01504638884216547
additional O 0 0.015152223408222198
absence O 0 0.03739318996667862
of O 0 0.04300566390156746
lamin O 1 1.0
B1 O 1 1.0
from O 0 0.05947926640510559
heart O 1 0.9999998807907104
and O 1 0.9921614527702332
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.9983512163162231
which O 0 0.0201422031968832
already O 0 0.02430877648293972
lack O 0 0.0423426553606987
emerin O 1 0.9996422529220581
may O 0 0.02100113220512867
offer O 0 0.016998227685689926
an O 0 0.012698312290012836
alternative O 0 0.02366878092288971
explanation O 0 0.02192884497344494
of O 0 0.017618447542190552
why O 0 0.028492743149399757
these O 0 0.016350723803043365
tissues O 0 0.10719187557697296
are O 0 0.012716623954474926
particularly O 0 0.0323081910610199
affected O 0 0.043420933187007904
. O 0 0.028098804876208305
. O 0 0.036288488656282425

Genetic O 0 0.07313282787799835
mapping O 0 0.0441274531185627
of O 0 0.02695344388484955
the O 0 0.04201905429363251
copper B-Disease 1 0.9975506663322449
toxicosis I-Disease 1 0.9999963045120239
locus O 1 0.6903039216995239
in O 0 0.032581936568021774
Bedlington O 1 0.9997366070747375
terriers O 1 0.6899732351303101
to O 0 0.03957943618297577
dog O 1 0.9880965948104858
chromosome O 0 0.06048450246453285
10 O 0 0.01849326677620411
, O 0 0.01208760030567646
in O 0 0.009140446782112122
a O 0 0.018916333094239235
region O 0 0.034660398960113525
syntenic O 1 0.9865127801895142
to O 0 0.024609608575701714
human O 0 0.03608684241771698
chromosome O 0 0.07682166993618011
region O 0 0.06940709054470062
2p13 O 1 0.9998986721038818
- O 1 0.9999829530715942
p16 O 1 0.9767629504203796
. O 0 0.05712299421429634

Abnormal O 1 0.9999995231628418
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999986886978149
accumulation I-Disease 1 0.9996967315673828
is O 0 0.020928220823407173
recognized O 0 0.022259019315242767
as O 0 0.015443586744368076
an O 0 0.029916709288954735
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.8519777059555054
man O 1 0.9998806715011597
, O 0 0.033985428512096405
mouse O 1 0.5198288559913635
, O 0 0.03710953891277313
rat O 1 0.999711811542511
and O 0 0.03639443591237068
dog O 0 0.36744990944862366
. O 0 0.04738529399037361

The O 0 0.04195135086774826
major O 0 0.05383377894759178
cause O 1 0.955706775188446
of O 1 0.9958937168121338
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999995231628418
accumulation I-Disease 1 0.9999508857727051
in O 0 0.01828705705702305
man O 0 0.032818540930747986
is O 0 0.012646293267607689
a O 0 0.022887472063302994
dysfunctional O 1 0.9999399185180664
ATP7B O 1 0.9999996423721313
gene O 0 0.045707233250141144
, O 0 0.02645682543516159
causing O 1 0.9998055100440979
Wilson B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9999271631240845
WD B-Disease 1 1.0
) O 0 0.05399162694811821
. O 0 0.04099345952272415

Mutations O 0 0.06813328713178635
in O 0 0.020760653540492058
the O 0 0.03706949204206467
ATP7B O 1 0.9999966621398926
genes O 0 0.03166999667882919
have O 0 0.008661380968987942
also O 0 0.010616173967719078
been O 0 0.013038444332778454
demonstrated O 0 0.02789362333714962
in O 0 0.024915169924497604
mouse O 0 0.09362677484750748
and O 0 0.04486005753278732
rat O 1 0.9988642930984497
. O 0 0.051640745252370834

The O 0 0.07796721160411835
ATP7B O 1 0.9999982118606567
gene O 0 0.04902780428528786
has O 0 0.017298223450779915
been O 0 0.01237858273088932
excluded O 0 0.02919810637831688
in O 0 0.009418459609150887
the O 0 0.014238993637263775
much O 0 0.019005905836820602
rarer O 1 0.8248880505561829
human O 0 0.19636552035808563
copper B-Disease 1 0.9999985694885254
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9999942779541016
- I-Disease 1 0.9999998807907104
Indian I-Disease 1 0.8777987957000732
childhood I-Disease 1 0.9999998807907104
cirrhosis I-Disease 1 1.0
, O 0 0.3861672580242157
indicating O 0 0.09414195269346237
genetic O 0 0.06672666221857071
heterogeneity O 1 0.9317727088928223
. O 0 0.050482410937547684

By O 0 0.028321778401732445
investigating O 0 0.038743481040000916
the O 0 0.02880825474858284
common O 0 0.06032361462712288
autosomal O 1 0.9999994039535522
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9998307228088379
CT B-Disease 1 1.0
) O 0 0.025552134960889816
in O 0 0.02152152732014656
Bedlington O 1 0.9999336004257202
terriers O 1 0.9389569759368896
, O 0 0.020625468343496323
we O 0 0.009226837195456028
have O 0 0.005567358341068029
identified O 0 0.011588877066969872
a O 0 0.013469365425407887
new O 0 0.02158847451210022
locus O 0 0.07996553182601929
involved O 0 0.025201361626386642
in O 0 0.03752273693680763
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9993802309036255

We O 0 0.026539979502558708
examined O 0 0.04025256633758545
whether O 0 0.020715240389108658
the O 0 0.03635973483324051
WD B-Disease 1 0.9999996423721313
gene O 0 0.07336112856864929
ATP7B O 1 0.9997976422309875
was O 0 0.040437109768390656
also O 0 0.024150097742676735
causative O 1 0.7035841345787048
for O 0 0.027346476912498474
CT B-Disease 1 0.9998053908348083
by O 0 0.01838892139494419
investigating O 0 0.030554326251149178
the O 0 0.025319458916783333
chromosomal O 1 0.995369017124176
co O 1 0.9936376214027405
- O 1 0.9998301267623901
localization O 0 0.0797276645898819
of O 0 0.03687063604593277
ATP7B O 1 0.9999881982803345
and O 0 0.03379160538315773
C04107 O 1 0.9972479939460754
, O 0 0.022740941494703293
using O 0 0.016603730618953705
fluorescence O 0 0.0575789138674736
in O 0 0.025966616347432137
situ O 1 0.9974005222320557
hybridization O 0 0.0927005335688591
( O 0 0.03972458839416504
FISH O 0 0.05305081605911255
) O 0 0.03265303000807762
. O 0 0.035301707684993744

C04107 O 1 0.9223269820213318
is O 0 0.03645589202642441
an O 0 0.03275899589061737
anonymous O 0 0.08024829626083374
microsatellite O 1 0.9163302779197693
marker O 0 0.2087698131799698
closely O 0 0.040605705231428146
linked O 0 0.06191931292414665
to O 0 0.045364607125520706
CT B-Disease 1 0.9999901056289673
. O 0 0.0537707693874836

However O 0 0.04858249053359032
, O 0 0.05112076923251152
BAC O 1 0.999931812286377
clones O 1 0.8193992376327515
containing O 0 0.07580161094665527
ATP7B O 1 0.9995412826538086
and O 0 0.04056066274642944
C04107 O 1 0.6388885378837585
mapped O 0 0.04763694480061531
to O 0 0.018935875967144966
the O 0 0.031185541301965714
canine O 1 0.9999377727508545
chromosome O 0 0.09658373147249222
regions O 0 0.045347560197114944
CFA22q11 O 1 0.999717652797699
and O 0 0.03612956404685974
CFA10q26 O 1 0.9999547004699707
, O 0 0.02530626393854618
respectively O 0 0.023318717256188393
, O 0 0.018203740939497948
demonstrating O 0 0.039352238178253174
that O 0 0.023526642471551895
WD B-Disease 1 0.9999990463256836
cannot O 0 0.03146211430430412
be O 0 0.01800556480884552
homologous O 0 0.07360914349555969
to O 0 0.04668479040265083
CT B-Disease 1 0.9999359846115112
. O 0 0.05486969277262688

The O 0 0.06437069177627563
copper O 1 0.8105502128601074
transport O 0 0.08909834176301956
genes O 0 0.05366888269782066
CTR1 O 1 0.99994957447052
and O 0 0.03511960431933403
CTR2 O 1 0.9999393224716187
were O 0 0.014318255707621574
also O 0 0.013739878311753273
excluded O 0 0.03480631858110428
as O 0 0.01637742668390274
candidate O 0 0.03644533082842827
genes O 0 0.02456292323768139
for O 0 0.02793070487678051
CT B-Disease 1 0.999993085861206
since O 0 0.020183907821774483
they O 0 0.008813169784843922
both O 0 0.012045694515109062
mapped O 0 0.042281508445739746
to O 0 0.032268304377794266
canine O 1 0.9999366998672485
chromosome O 0 0.14650431275367737
region O 0 0.08347396552562714
CFA11q22 O 1 0.9993665814399719
. O 0 0.06093071773648262

2 O 0 0.1131303608417511
- O 1 0.9980487823486328
22 O 0 0.06632637232542038
. O 0 0.04521656036376953

5 O 0 0.09994601458311081
. O 0 0.061988215893507004

A O 0 0.073312908411026
transcribed O 0 0.05909009277820587
sequence O 0 0.01726006157696247
identified O 0 0.014499491080641747
from O 0 0.010840330272912979
the O 0 0.023206239566206932
C04107 O 1 0.999971866607666
- O 1 0.9999953508377075
containing O 0 0.05680963769555092
BAC O 1 0.9999085664749146
was O 0 0.029673660174012184
found O 0 0.0125142065808177
to O 0 0.012038876302540302
be O 0 0.010516654700040817
homologous O 0 0.03640558570623398
to O 0 0.012990144081413746
a O 0 0.02026449143886566
gene O 0 0.020575353875756264
expressed O 0 0.016955289989709854
from O 0 0.014274577610194683
human O 0 0.02867560274899006
chromosome O 1 0.7576632499694824
2p13 O 1 0.9999970197677612
- O 1 0.999998927116394
p16 O 1 0.9897554516792297
, O 0 0.018521975725889206
a O 0 0.01968136616051197
region O 0 0.027569547295570374
devoid O 0 0.05256110429763794
of O 0 0.01976868323981762
any O 0 0.024196472018957138
positional O 0 0.11580818891525269
candidate O 0 0.07433905452489853
genes O 0 0.04399728402495384
. O 0 0.037634532898664474

Molecular O 0 0.06472479552030563
analysis O 0 0.01598108559846878
of O 0 0.01779225282371044
the O 0 0.03177797421813011
APC B-Disease 1 0.999988317489624
gene O 0 0.03438128903508186
in O 0 0.014899460598826408
205 O 0 0.0613415390253067
families O 0 0.029361315071582794
: O 0 0.027118001133203506
extended O 0 0.05413064360618591
genotype O 1 0.9978342652320862
- O 1 0.9999488592147827
phenotype O 1 0.8264255523681641
correlations O 0 0.08520732820034027
in O 0 0.03378484770655632
FAP B-Disease 1 0.9999997615814209
and O 0 0.019944055005908012
evidence O 0 0.014004654251039028
for O 0 0.009782250039279461
the O 0 0.014634279534220695
role O 0 0.030046341940760612
of O 0 0.033573977649211884
APC B-Disease 1 0.9999986886978149
amino O 0 0.06137213110923767
acid O 0 0.05849474295973778
changes O 0 0.030104076489806175
in O 0 0.2056983858346939
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.8885329961776733

BACKGROUND O 0 0.178039088845253
/ O 1 0.977482259273529
AIMS O 0 0.06240984424948692
The O 0 0.022870060056447983
development O 0 0.034355394542217255
of O 1 0.9996507167816162
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.917608916759491
a O 0 0.03785721957683563
variable O 0 0.02742750011384487
range O 0 0.014446569606661797
of O 0 0.01953153870999813
extracolonic O 1 0.9995177984237671
manifestations O 1 0.9990456700325012
in O 0 0.051383182406425476
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999997615814209
FAP B-Disease 1 1.0
) O 0 0.030760837718844414
is O 0 0.012963598594069481
the O 0 0.011811116710305214
result O 0 0.0101276570931077
of O 0 0.011177203617990017
the O 0 0.018017474561929703
dominant O 0 0.053069185465574265
inheritance O 0 0.4354812800884247
of O 1 0.9473481774330139
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999096393585205
APC B-Disease 1 1.0
) O 0 0.05654723942279816
gene O 0 0.05446617305278778
mutations O 0 0.04964393377304077
. O 0 0.032564543187618256

In O 0 0.02881893701851368
this O 0 0.016937129199504852
study O 0 0.022942395880818367
, O 0 0.017978712916374207
direct O 0 0.028339706361293793
mutation O 0 0.03874601796269417
analysis O 0 0.012177188880741596
of O 0 0.015201650559902191
the O 0 0.03259016573429108
APC B-Disease 1 0.9999912977218628
gene O 0 0.03950898349285126
was O 0 0.025352418422698975
performed O 0 0.025241438299417496
to O 0 0.016250668093562126
determine O 0 0.02796880528330803
genotype O 1 0.9980466365814209
- O 1 0.9999791383743286
phenotype O 0 0.17752867937088013
correlations O 0 0.05595122650265694
for O 0 0.02095104195177555
nine O 0 0.04023981839418411
extracolonic O 1 0.9997673630714417
manifestations O 1 0.9886526465415955
and O 0 0.02009810507297516
to O 0 0.015152529813349247
investigate O 0 0.03607179969549179
the O 0 0.023482132703065872
incidence O 1 0.999626874923706
of O 0 0.04471554234623909
APC B-Disease 1 0.9999996423721313
mutations O 0 0.03695888817310333
in O 0 0.020512506365776062
non O 1 0.9998342990875244
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9809070229530334

METHODS O 0 0.053584370762109756
The O 0 0.04813980683684349
APC B-Disease 1 0.9999557733535767
gene O 0 0.04417764022946358
was O 0 0.02949880063533783
analysed O 0 0.03712162747979164
in O 0 0.01486135832965374
190 O 0 0.051637738943099976
unrelated O 0 0.058664437383413315
FAP B-Disease 1 0.9999986886978149
and O 0 0.023468978703022003
15 O 0 0.03627607598900795
non O 1 0.9999158382415771
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
using O 0 0.07999205589294434
denaturing O 1 0.9999978542327881
gradient O 1 0.9997079968452454
gel O 1 0.9998371601104736
electrophoresis O 0 0.12559302151203156
, O 0 0.02421925589442253
the O 0 0.03135944530367851
protein O 0 0.04531353339552879
truncation O 0 0.10969562083482742
test O 0 0.038047533482313156
, O 0 0.020036863163113594
and O 0 0.019778816029429436
direct O 0 0.040133267641067505
sequencing O 0 0.06007900834083557
. O 0 0.03627941012382507

RESULTS O 0 0.07368286699056625
Chain O 0 0.15885832905769348
terminating O 0 0.1819324642419815
signals O 0 0.03205336257815361
were O 0 0.009132047183811665
only O 0 0.010409271344542503
identified O 0 0.017862610518932343
in O 0 0.015219963155686855
patients O 0 0.052786704152822495
belonging O 0 0.03357288986444473
to O 0 0.018764950335025787
the O 0 0.039961058646440506
FAP B-Disease 1 1.0
group O 1 0.6678780317306519
( O 0 0.038606274873018265
105 O 1 0.8644742965698242
patients O 1 0.9997865557670593
) O 0 0.040258996188640594
. O 0 0.0377117358148098

Amino O 0 0.13441817462444305
acid O 0 0.08051566779613495
changes O 0 0.017300307750701904
were O 0 0.010401607491075993
identified O 0 0.01883700303733349
in O 0 0.012426933273673058
four O 0 0.02166033163666725
patients O 0 0.39275240898132324
, O 0 0.015093893744051456
three O 0 0.010907629504799843
of O 0 0.016582133248448372
whom O 0 0.027248883619904518
belonged O 0 0.035042040050029755
to O 0 0.012411119416356087
the O 0 0.016622062772512436
non O 1 0.5455759167671204
- O 1 0.9999985694885254
FAP O 1 1.0
group O 1 0.9665889739990234
of O 1 0.9999595880508423
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 1 0.7096977829933167

Genotype O 1 0.9999136924743652
- O 1 0.9999947547912598
phenotype O 1 0.9163899421691895
correlations O 0 0.07505185902118683
identified O 0 0.02776939980685711
significant O 0 0.014813294634222984
differences O 0 0.015737295150756836
in O 0 0.010165762156248093
the O 0 0.01453645434230566
nature O 0 0.018190765753388405
of O 0 0.016225608065724373
certain O 0 0.021446866914629936
extracolonic O 1 0.9999828338623047
manifestations O 1 0.9999914169311523
in O 0 0.10522498935461044
FAP B-Disease 1 1.0
patients O 1 0.9999895095825195
belonging O 0 0.05003722757101059
to O 0 0.0220097154378891
three O 0 0.02505451627075672
mutation O 0 0.08266857266426086
subgroups O 0 0.1436193287372589
. O 0 0.04827462136745453

CONCLUSIONS O 0 0.09070134162902832
Extended O 0 0.09891032427549362
genotype O 1 0.9997223019599915
- O 1 0.9999922513961792
phenotype O 0 0.3598874509334564
correlations O 0 0.06259844452142715
made O 0 0.01898341253399849
in O 0 0.013429074548184872
this O 0 0.011321133002638817
study O 0 0.017274990677833557
may O 0 0.012854437343776226
have O 0 0.006926052272319794
the O 0 0.01343609020113945
potential O 0 0.01988482102751732
to O 0 0.011561603285372257
determine O 0 0.013090605847537518
the O 0 0.011552941985428333
most O 0 0.011289606802165508
appropriate O 0 0.02665700949728489
surveillance O 0 0.052199836820364
and O 0 0.03152951970696449
prophylactic O 1 1.0
treatment O 1 1.0
regimens O 1 0.9999977350234985
for O 0 0.03049730509519577
those O 0 0.02362808771431446
patients O 1 0.9993670582771301
with O 0 0.027231158688664436
mutations O 0 0.04729846492409706
associated O 0 0.024883732199668884
with O 0 0.02124147303402424
life O 0 0.0672246664762497
threatening O 1 0.998980700969696
conditions O 0 0.1663299798965454
. O 0 0.05126601830124855

This O 0 0.0273238904774189
study O 0 0.02417799085378647
also O 0 0.013896993361413479
provided O 0 0.015053159557282925
evidence O 0 0.0114844786003232
for O 0 0.011736809276044369
the O 0 0.02239692024886608
pathological O 1 0.9873661994934082
nature O 0 0.03215134143829346
of O 0 0.03417741134762764
amino O 0 0.05215753987431526
acid O 0 0.051639385521411896
changes O 0 0.01565699651837349
in O 0 0.01749570108950138
APC O 1 0.9998210072517395
associated O 0 0.01901177130639553
with O 0 0.01192028820514679
both O 0 0.017613183706998825
FAP B-Disease 1 1.0
and O 0 0.029291512444615364
non O 1 0.9999963045120239
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.14221666753292084
. O 0 0.04909279942512512

Inherited B-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999994039535522
cancer B-Disease 1 1.0
risk O 1 0.9999934434890747
of O 1 0.6415141224861145
the O 1 0.9096858501434326
APC O 1 0.9999997615814209
I1307K O 1 0.9998747110366821
polymorphism O 0 0.1356784850358963
. O 0 0.05079426243901253

Germ O 1 0.9999980926513672
- O 1 0.9999383687973022
line O 0 0.06650178134441376
and O 0 0.03353911265730858
somatic O 0 0.3773569166660309
truncating O 1 0.9856945872306824
mutations O 0 0.03939450904726982
of O 0 0.023078853264451027
the O 0 0.038124460726976395
APC B-Disease 1 0.9999980926513672
gene O 0 0.030936019495129585
are O 0 0.006568585056811571
thought O 0 0.013802203349769115
to O 0 0.02068406343460083
initiate O 1 0.9996157884597778
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.9998065829277039
in O 0 0.3607626259326935
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999988079071045
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9185733199119568
respectively O 0 0.05600837990641594
. O 0 0.040817759931087494

Recently O 0 0.055234409868717194
, O 0 0.021866125985980034
an O 0 0.028747767210006714
isoleucine O 1 0.9999903440475464
- O 1 1.0
- O 1 0.9999995231628418
> O 1 0.9977304339408875
lysine O 0 0.13130567967891693
polymorphism O 0 0.07338616997003555
at O 0 0.038072165101766586
codon O 0 0.1249832808971405
1307 O 1 0.9963304400444031
( O 0 0.03752962499856949
I1307K O 1 0.7470508217811584
) O 0 0.015452631749212742
of O 0 0.014943582005798817
the O 0 0.03131731227040291
APC B-Disease 1 0.9999988079071045
gene O 0 0.030609557405114174
has O 0 0.01164553314447403
been O 0 0.009019860997796059
identified O 0 0.013177565298974514
in O 0 0.009714245796203613
6 O 0 0.028020430356264114
% O 0 0.024471428245306015
- O 1 0.957001268863678
7 O 0 0.026973063126206398
% O 0 0.012197326868772507
of O 0 0.014437014237046242
the O 0 0.0257977657020092
Ashkenazi O 1 0.7350782155990601
Jewish O 0 0.06380277127027512
population O 0 0.033786505460739136
. O 0 0.03791240602731705

To O 0 0.03749549016356468
assess O 0 0.0558583065867424
the O 0 0.02622658759355545
risk O 0 0.03390085697174072
of O 0 0.01757456175982952
this O 0 0.015165414661169052
common O 0 0.035852860659360886
APC B-Disease 1 0.9999955892562866
allelic O 1 0.9998914003372192
variant O 1 0.9630877375602722
in O 0 0.22686049342155457
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.03414037451148033
we O 0 0.01321621984243393
have O 0 0.006938513368368149
analyzed O 0 0.015085204504430294
a O 0 0.015791140496730804
large O 0 0.02097734995186329
cohort O 0 0.10525736957788467
of O 0 0.03632514178752899
unselected O 1 0.9288232922554016
Ashkenazi O 1 0.8920656442642212
Jewish O 0 0.06573152542114258
subjects O 0 0.04488182067871094
with O 0 0.04395374283194542
adenomatous B-Disease 1 1.0
polyps I-Disease 1 1.0
and O 0 0.07412713766098022
. O 0 0.04907102882862091
or O 1 0.9999697208404541
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.1045946255326271
for O 0 0.02576715499162674
the O 0 0.0445854477584362
APC O 1 0.999997615814209
I1307K O 1 0.999842643737793
polymorphism O 0 0.13267527520656586
. O 0 0.04557117819786072

The O 0 0.0751652643084526
APC O 1 0.9999294281005859
I1307K O 1 0.9996140599250793
allele O 0 0.09605934470891953
was O 0 0.028894364833831787
identified O 0 0.020085204392671585
in O 0 0.0122536551207304
48 O 0 0.030677814036607742
( O 0 0.018673621118068695
10 O 0 0.015121265314519405
. O 0 0.011038977652788162
1 O 0 0.02754685841500759
% O 0 0.018516693264245987
) O 0 0.0179985873401165
of O 0 0.029511334374547005
476 O 1 0.9992986917495728
patients O 1 0.9996387958526611
. O 0 0.060874372720718384

Compared O 0 0.039610713720321655
with O 0 0.018641073256731033
the O 0 0.02022971585392952
frequency O 0 0.017914272844791412
in O 0 0.00874113105237484
two O 0 0.007176446262747049
separate O 0 0.01158867310732603
population O 0 0.012701665982604027
control O 0 0.021742697805166245
groups O 0 0.013140859082341194
, O 0 0.013366751372814178
the O 0 0.027687909081578255
APC O 1 0.9999995231628418
I1307K O 1 0.9999876022338867
allele O 0 0.09305281192064285
is O 0 0.018874265253543854
associated O 0 0.016112251207232475
with O 0 0.01085724774748087
an O 0 0.013860936276614666
estimated O 0 0.02352932281792164
relative O 0 0.04263061657547951
risk O 0 0.04631203040480614
of O 0 0.03277841582894325
1 O 0 0.06580298393964767
. O 0 0.04405428096652031

5 O 0 0.09733633697032928
- O 1 0.9979104399681091
1 O 0 0.07577885687351227
. O 0 0.04924793913960457

7 O 0 0.07953280210494995
for O 0 0.0815793052315712
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.058977775275707245
both O 0 0.04048323258757591
P O 1 0.999993085861206
= O 0 0.33646708726882935
. O 0 0.036226555705070496
01 O 1 0.9994843006134033
) O 0 0.04011133685708046
. O 0 0.040318235754966736

Furthermore O 0 0.07387808710336685
, O 0 0.027285531163215637
compared O 0 0.023979945108294487
with O 0 0.026888525113463402
noncarriers O 1 0.999514102935791
, O 0 0.04844243824481964
APC O 1 0.9999954700469971
I1307K O 1 0.9998488426208496
carriers O 0 0.054982930421829224
had O 0 0.015935221686959267
increased O 0 0.01700584776699543
numbers O 0 0.013767651282250881
of O 0 0.030722608789801598
adenomas B-Disease 1 1.0
and O 1 0.9973655343055725
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.07169210910797119
patient O 1 0.9999995231628418
( O 0 0.07128947973251343
P O 1 0.9999856948852539
= O 0 0.07727929204702377
. O 0 0.023917710408568382
03 O 1 0.9977290034294128
) O 0 0.018930669873952866
, O 0 0.011292449198663235
as O 0 0.009967492893338203
well O 0 0.009065179154276848
as O 0 0.011708901263773441
a O 0 0.024253882467746735
younger O 0 0.06504517048597336
age O 0 0.04894666373729706
at O 0 0.21155591309070587
diagnosis O 1 0.9999953508377075
. O 0 0.057312678545713425

We O 0 0.03235917538404465
conclude O 0 0.04142409935593605
that O 0 0.011130422353744507
the O 0 0.03128265589475632
APC O 1 0.9999701976776123
I1307K O 1 0.9997491240501404
variant O 0 0.07996638119220734
leads O 0 0.05375869944691658
to O 0 0.030383236706256866
increased O 0 0.08022084087133408
adenoma B-Disease 1 1.0
formation O 1 0.8329694867134094
and O 0 0.02596026100218296
directly O 0 0.024753663688898087
contributes O 0 0.038151368498802185
to O 0 0.01570536196231842
3 O 0 0.024705123156309128
% O 0 0.02091313898563385
- O 0 0.4174991548061371
4 O 0 0.019814351573586464
% O 0 0.010028584860265255
of O 0 0.01042575016617775
all O 0 0.01758851297199726
Ashkenazi O 1 0.9999390840530396
Jewish O 1 0.9999974966049194
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9209581613540649

The O 0 0.04083411768078804
estimated O 0 0.039591606706380844
relative O 0 0.05609423667192459
risk O 0 0.12417628616094589
for O 0 0.029057886451482773
carriers O 0 0.07697486132383347
may O 0 0.02388289012014866
justify O 0 0.04591572657227516
specific O 0 0.021695638075470924
clinical O 1 0.8794283866882324
screening O 0 0.14273953437805176
for O 0 0.01967267133295536
the O 0 0.02697715163230896
360 O 0 0.059469763189554214
, O 0 0.020216496661305428
000 O 0 0.03500844165682793
Americans O 0 0.020582148805260658
expected O 0 0.016836678609251976
to O 0 0.018897639587521553
harbor O 0 0.08965606987476349
this O 0 0.01796664670109749
allele O 0 0.060811761766672134
, O 0 0.01736588031053543
and O 0 0.016345694661140442
genetic O 0 0.023315714672207832
testing O 0 0.01779082976281643
in O 0 0.008106978610157967
the O 0 0.012250491417944431
setting O 0 0.019418463110923767
of O 0 0.015108417719602585
long O 0 0.03391650319099426
- O 1 0.9999359846115112
term O 0 0.04244716092944145
- O 1 0.9944583177566528
outcome O 0 0.02456049621105194
studies O 0 0.014042840339243412
may O 0 0.012384063564240932
impact O 0 0.02017589844763279
significantly O 0 0.029557036235928535
on O 1 0.6516716480255127
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.044763579964637756
this O 0 0.020150279626250267
population O 0 0.02549748495221138
. O 0 0.030321720987558365

Localization O 0 0.13335759937763214
of O 0 0.040012359619140625
human O 0 0.05573983117938042
BRCA1 O 1 0.9997320771217346
and O 0 0.016854669898748398
its O 0 0.01586865447461605
loss O 0 0.02323530800640583
in O 0 0.013919155113399029
high O 0 0.06260513514280319
- O 1 0.9999852180480957
grade O 1 0.6641217470169067
, O 0 0.020518500357866287
non B-Disease 1 0.9927807450294495
- I-Disease 1 1.0
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.1468726247549057

Although O 0 0.025626901537179947
the O 0 0.02069680579006672
link O 0 0.02911929227411747
between O 0 0.01703748106956482
the O 0 0.03580917790532112
BRCA1 O 1 0.9999998807907104
tumour B-Disease 1 1.0
- O 1 1.0
suppressor O 1 0.9999997615814209
gene O 0 0.03757090121507645
and O 0 0.026085278019309044
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.8275830745697021
established O 0 0.030120709910988808
, O 0 0.012204333208501339
the O 0 0.01408815011382103
role O 0 0.02484286017715931
, O 0 0.011450069025158882
if O 0 0.00875287689268589
any O 0 0.006606645882129669
, O 0 0.008145431987941265
of O 0 0.014448083937168121
BRCA1 O 1 0.9968723654747009
in O 0 0.020123586058616638
non B-Disease 1 0.9999847412109375
- I-Disease 1 1.0
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.04680975526571274
unclear O 0 0.04547816514968872
. O 0 0.033475447446107864

BRCA1 O 1 0.9999860525131226
mutations O 0 0.064792700111866
are O 0 0.012474868446588516
rare O 0 0.028631489723920822
in O 0 0.02455027773976326
sporadic B-Disease 1 0.9999326467514038
cancers I-Disease 1 0.9999998807907104
, O 0 0.021957891061902046
but O 0 0.014005772769451141
loss O 0 0.0320904403924942
of O 0 0.03163466975092888
BRCA1 O 1 0.9999891519546509
resulting O 0 0.03485545516014099
from O 0 0.020405465736985207
reduced O 0 0.034146975725889206
expression O 0 0.035491205751895905
or O 0 0.02221103385090828
incorrect O 0 0.05052304267883301
subcellular O 0 0.119783416390419
localization O 0 0.07940684258937836
is O 0 0.020387228578329086
postulated O 0 0.039626725018024445
to O 0 0.010015706531703472
be O 0 0.0059835477732121944
important O 0 0.007227280642837286
in O 0 0.01020058710128069
non B-Disease 1 0.9498961567878723
- I-Disease 1 1.0
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9500557780265808

Epigenetic O 1 0.8563048243522644
loss O 0 0.42998531460762024
, O 0 0.027387334033846855
however O 0 0.017480332404375076
, O 0 0.014255428686738014
has O 0 0.011411983519792557
not O 0 0.009051636792719364
received O 0 0.018260439857840538
general O 0 0.030742749571800232
acceptance O 0 0.06427492946386337
due O 0 0.0243541207164526
to O 0 0.0174005925655365
controversy O 0 0.030903860926628113
regarding O 0 0.019670255482196808
the O 0 0.02190585620701313
subcellular O 0 0.09289450198411942
localization O 0 0.08747740089893341
of O 0 0.04525023698806763
BRCA1 O 1 0.9999973773956299
proteins O 0 0.0321996733546257
, O 0 0.014446902088820934
reports O 0 0.01356110256165266
of O 0 0.013433965854346752
which O 0 0.010693338699638844
have O 0 0.00816969946026802
ranged O 0 0.027171246707439423
from O 0 0.014223421923816204
exclusively O 0 0.02476401813328266
nuclear O 0 0.03182658925652504
, O 0 0.012365619651973248
to O 0 0.014273665845394135
conditionally O 0 0.0869109183549881
nuclear O 0 0.03357458859682083
, O 0 0.011353646405041218
to O 0 0.015032120048999786
the O 0 0.035946473479270935
ER O 1 1.0
/ O 1 0.9999986886978149
golgi O 1 0.9999418258666992
, O 0 0.029816607013344765
to O 0 0.02997921034693718
cytoplasmic O 0 0.1600431501865387
invaginations O 1 0.9313032627105713
into O 0 0.03040914237499237
the O 0 0.03361263871192932
nucleus O 0 0.09745094925165176
. O 0 0.043742671608924866

In O 0 0.02905365079641342
an O 0 0.022608378902077675
attempt O 0 0.04041125252842903
to O 0 0.02025628834962845
resolve O 0 0.04720884934067726
this O 0 0.014202630147337914
issue O 0 0.023620540276169777
, O 0 0.01316431537270546
we O 0 0.008190697990357876
have O 0 0.007784734480082989
comprehensively O 0 0.07859613001346588
characterized O 0 0.0522802397608757
19 O 0 0.05486176535487175
anti O 1 0.9999878406524658
- O 1 1.0
BRCA1 O 1 0.999997615814209
antibodies O 1 0.819060206413269
. O 0 0.050192706286907196

These O 0 0.03780393674969673
reagents O 0 0.1107022762298584
detect O 0 0.05572294816374779
a O 0 0.03058360330760479
220 O 0 0.08483672887086868
- O 1 0.9999955892562866
kD O 1 0.9999904632568359
protein O 0 0.04901929944753647
localized O 0 0.04987550526857376
in O 0 0.014788560569286346
discrete O 0 0.039477456361055374
nuclear O 0 0.048662200570106506
foci O 0 0.26110342144966125
in O 0 0.017284665256738663
all O 0 0.02532128244638443
epithelial O 1 0.9999988079071045
cell O 1 0.6748867630958557
lines O 0 0.0286908857524395
, O 0 0.01329291332513094
including O 0 0.011502822861075401
those O 0 0.013251103460788727
derived O 0 0.02922160178422928
from O 0 0.04433130472898483
breast B-Disease 1 1.0
malignancies I-Disease 1 0.9999996423721313
. O 0 0.08603744208812714

Immunohistochemical O 1 0.9998631477355957
staining O 1 0.9986862540245056
of O 0 0.05584126338362694
human O 1 0.9872305989265442
breast O 1 1.0
specimens O 0 0.05827459320425987
also O 0 0.020890988409519196
revealed O 0 0.04358046129345894
BRCA1 O 1 0.9982648491859436
nuclear O 0 0.0553894117474556
foci O 1 0.9870102405548096
in O 0 0.03486631438136101
benign O 1 1.0
breast O 1 1.0
, O 1 0.9920212626457214
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.38165536522865295
low B-Disease 1 0.9999728202819824
- I-Disease 1 1.0
grade I-Disease 1 0.9999997615814209
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.08504322916269302

Conversely O 1 0.628574013710022
, O 0 0.05664832517504692
BRCA1 O 1 0.9997228980064392
expression O 0 0.04826639965176582
was O 0 0.033212095499038696
reduced O 0 0.03488653153181076
or O 0 0.024469397962093353
undetectable O 1 0.8421182632446289
in O 0 0.010146662592887878
the O 0 0.01033827569335699
majority O 0 0.013808175921440125
of O 0 0.017136160284280777
high O 0 0.1764334887266159
- O 1 0.9999990463256836
grade O 1 0.9996551275253296
, O 0 0.09337561577558517
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.03281499072909355
suggesting O 0 0.026325684040784836
that O 0 0.010077244602143764
absence O 0 0.035853561013936996
of O 0 0.03995014727115631
BRCA1 O 1 0.9999990463256836
may O 0 0.02290792390704155
contribute O 0 0.02304615080356598
to O 0 0.015340933576226234
the O 0 0.023401979357004166
pathogenesis O 1 0.999924898147583
of O 0 0.01824798248708248
a O 0 0.019467728212475777
significant O 0 0.014572043903172016
percentage O 0 0.023571066558361053
of O 0 0.034284282475709915
sporadic B-Disease 1 0.9999908208847046
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.054616037756204605
. O 0 0.049098819494247437

